Citrus Sinensis ID: 015741
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | 2.2.26 [Sep-21-2011] | |||||||
| O64816 | 432 | Casein kinase II subunit | yes | no | 0.845 | 0.784 | 0.858 | 1e-164 | |
| Q08467 | 409 | Casein kinase II subunit | no | no | 0.773 | 0.757 | 0.846 | 1e-147 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.733 | 0.885 | 0.891 | 1e-146 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.755 | 0.751 | 0.847 | 1e-146 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.733 | 0.882 | 0.850 | 1e-140 | |
| O76484 | 353 | Casein kinase II subunit | N/A | no | 0.740 | 0.841 | 0.758 | 1e-126 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.735 | 0.754 | 0.756 | 1e-125 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.735 | 0.754 | 0.756 | 1e-125 | |
| P28020 | 392 | Casein kinase II subunit | N/A | no | 0.735 | 0.752 | 0.753 | 1e-125 | |
| P68400 | 391 | Casein kinase II subunit | yes | no | 0.735 | 0.754 | 0.756 | 1e-125 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 576 bits (1485), Expect = e-164, Method: Compositional matrix adjust.
Identities = 298/347 (85%), Positives = 320/347 (92%), Gaps = 8/347 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347
Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
NAYLNKY IELDP+L +LVGRHSRKPW+KFI ENQHLAVPE V+F+
Sbjct: 348 NAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFV 394
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 521 bits (1341), Expect = e-147, Method: Compositional matrix adjust.
Identities = 265/313 (84%), Positives = 288/313 (92%), Gaps = 3/313 (0%)
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRG 145
PD L + I S ++ A SKARVY+++NV+RP++YWDYESL VQWGEQDDYEVVRKVGRG
Sbjct: 62 PDFLVE-ISDS-NQTRAMSKARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRG 119
Query: 146 KYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205
KYSEVFEG++ EKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKT
Sbjct: 120 KYSEVFEGINVNSKEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKT 179
Query: 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
PSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE
Sbjct: 180 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHEL 239
Query: 266 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFR
Sbjct: 240 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 299
Query: 326 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385
KEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELDP L ALVGRHSRKPWSKFI +
Sbjct: 300 KEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDPQLEALVGRHSRKPWSKFINAD 359
Query: 386 NQHLAVPE-VEFL 397
NQHL PE ++FL
Sbjct: 360 NQHLVSPEAIDFL 372
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-146, Method: Compositional matrix adjust.
Identities = 263/295 (89%), Positives = 280/295 (94%), Gaps = 1/295 (0%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NEKCI
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
KVLGTD LN YLNKY IELDP L ALVGRHSRKPW KF+ +NQHL PE ++FL
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFL 296
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 517 bits (1332), Expect = e-146, Method: Compositional matrix adjust.
Identities = 261/308 (84%), Positives = 283/308 (91%), Gaps = 5/308 (1%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
D+LA+ + S SKARVY+D+NV+RP++YWDYESL VQWGEQDDYEVVRKVGRGK
Sbjct: 60 DSLAK-----ISLSTVMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGK 114
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG++ +NEKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKTP
Sbjct: 115 YSEVFEGINMNNNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTP 174
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE R
Sbjct: 175 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELR 234
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRK
Sbjct: 235 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 294
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
EPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELD L ALVGRHSRKPWSKFI +N
Sbjct: 295 EPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADN 354
Query: 387 QHLAVPEV 394
+HL PE
Sbjct: 355 RHLVSPEA 362
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 251/295 (85%), Positives = 273/295 (92%), Gaps = 1/295 (0%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE+C+
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
KVLGT+EL+ YLNKY ++LDP L ALVGRH KPWSKFI +NQHL PE ++FL
Sbjct: 242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFL 296
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 226/298 (75%), Positives = 260/298 (87%), Gaps = 1/298 (0%)
Query: 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE 160
PS+ARVY+D+N RPREYWDYES V WG Q+DY++VRK+GRGKYSEVFE ++ T+NE
Sbjct: 4 AVPSRARVYADVNSQRPREYWDYESYVVDWGNQEDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 161 KCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
KC++KILKPVKKKKIKREIKIL+NL GG NI+ L +V+D S+TP+LIFEHVNNTDFK
Sbjct: 64 KCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ 123
Query: 221 LYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
LY TLSDYD+RYY+YELLKALDYCHS GIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLSDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHDHRKLRLIDWGLAEFYH 183
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
PG++YNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV
Sbjct: 184 PGQDYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
+IAKVLGT+EL YL+KYHIELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 244 RIAKVLGTEELFEYLDKYHIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling. Spodoptera frugiperda (taxid: 7108) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 224/296 (75%), Positives = 262/296 (88%), Gaps = 1/296 (0%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 224/296 (75%), Positives = 262/296 (88%), Gaps = 1/296 (0%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis GN=csnk2a1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/296 (75%), Positives = 262/296 (88%), Gaps = 1/296 (0%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPR+YWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPRDYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1154), Expect = e-125, Method: Compositional matrix adjust.
Identities = 224/296 (75%), Positives = 262/296 (88%), Gaps = 1/296 (0%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | ||||||
| 224071301 | 448 | predicted protein [Populus trichocarpa] | 0.972 | 0.870 | 0.782 | 1e-169 | |
| 225438980 | 424 | PREDICTED: casein kinase II subunit alph | 0.837 | 0.792 | 0.876 | 1e-166 | |
| 255568569 | 489 | casein kinase II, alpha chain, putative | 0.875 | 0.717 | 0.811 | 1e-166 | |
| 147841853 | 392 | hypothetical protein VITISV_034030 [Viti | 0.800 | 0.818 | 0.922 | 1e-165 | |
| 17977868 | 414 | casein kinase II alpha subunit [Sinapis | 0.927 | 0.898 | 0.757 | 1e-162 | |
| 297825193 | 432 | hypothetical protein ARALYDRAFT_481178 [ | 0.962 | 0.893 | 0.772 | 1e-162 | |
| 15227778 | 432 | casein kinase 2, alpha polypeptide [Arab | 0.845 | 0.784 | 0.858 | 1e-162 | |
| 224081845 | 361 | predicted protein [Populus trichocarpa] | 0.800 | 0.889 | 0.913 | 1e-162 | |
| 449519104 | 441 | PREDICTED: casein kinase II subunit alph | 0.775 | 0.705 | 0.919 | 1e-161 | |
| 449448236 | 423 | PREDICTED: casein kinase II subunit alph | 0.942 | 0.893 | 0.753 | 1e-160 |
| >gi|224071301|ref|XP_002303393.1| predicted protein [Populus trichocarpa] gi|222840825|gb|EEE78372.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-169, Method: Compositional matrix adjust.
Identities = 328/419 (78%), Positives = 348/419 (83%), Gaps = 29/419 (6%)
Query: 1 MAIRPFQF-----TI------HRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSP-LS 48
MAIRPF TI + N N TLFSS I R + + +P L
Sbjct: 1 MAIRPFLLQQKLTTILNRQRQKKKNNINKTLFSSLLFI-------RNNNNNNNNNNPFLF 53
Query: 49 QSSRIFTPFGTLRGLASSAS-LSHARHQHQ--------RLRQLATPPDTLAQKIGKSVRR 99
S + + LR ASS + SH + Q R R L PPDTLAQKIGKS+RR
Sbjct: 54 SSPQSSSISTLLRQFASSTTAFSHQKQGQQEIQHRLPHRFRSLVPPPDTLAQKIGKSIRR 113
Query: 100 SGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN 159
GAPSKARVY+DINV+RP++YWDYESLTVQWGEQDDYEVV+KVGRGKYSEVFEGVHCTDN
Sbjct: 114 PGAPSKARVYADINVIRPKDYWDYESLTVQWGEQDDYEVVKKVGRGKYSEVFEGVHCTDN 173
Query: 160 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219
EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFK
Sbjct: 174 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFK 233
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
VLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY
Sbjct: 234 VLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 293
Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL
Sbjct: 294 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 353
Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
VKIAKVLGTDELNAYLN+Y IELD HLAALVGRHSRKPWSKFI V+NQHLAVPE V+FL
Sbjct: 354 VKIAKVLGTDELNAYLNRYRIELDLHLAALVGRHSRKPWSKFINVDNQHLAVPEAVDFL 412
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438980|ref|XP_002284333.1| PREDICTED: casein kinase II subunit alpha isoform 1 [Vitis vinifera] gi|296087330|emb|CBI33704.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 304/347 (87%), Positives = 321/347 (92%), Gaps = 11/347 (3%)
Query: 61 RGLASSASLSHARHQ---------HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
R +S A LSH + H R L++ P+TLAQ+IGKSVRR GAPSKARVY+D
Sbjct: 42 RLASSPAPLSHPQKSPPPPPPPPSHHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYAD 100
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
INV+RP+EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK
Sbjct: 101 INVIRPKEYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 160
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+R
Sbjct: 161 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIR 220
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 221 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 280
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 281 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 340
Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
NAYLNKY +ELDPHLAALVGRHSRKPW+KF+ +NQHLAVPE ++FL
Sbjct: 341 NAYLNKYRLELDPHLAALVGRHSRKPWTKFVNADNQHLAVPESIDFL 387
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568569|ref|XP_002525258.1| casein kinase II, alpha chain, putative [Ricinus communis] gi|223535416|gb|EEF37086.1| casein kinase II, alpha chain, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-166, Method: Compositional matrix adjust.
Identities = 305/376 (81%), Positives = 325/376 (86%), Gaps = 25/376 (6%)
Query: 47 LSQSSRIFTPFGTLRGLASSASLSHARHQH-----------------------QRLRQ-L 82
L S +F+P + + AS S R QH RL+ +
Sbjct: 78 LPSPSPLFSPQSPITSVLRLASTSSHRKQHLPPPPPPPPPPPPLQPIAEAIRLHRLKNSV 137
Query: 83 ATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKV 142
A +TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWGEQDDYEVVRKV
Sbjct: 138 ALSSETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGEQDDYEVVRKV 197
Query: 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202
GRGKYSEVFEGVHC DNEKC+IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ
Sbjct: 198 GRGKYSEVFEGVHCADNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 257
Query: 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
SKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMID
Sbjct: 258 SKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 317
Query: 263 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322
HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM
Sbjct: 318 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 377
Query: 323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382
IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDPHLAALVGRH+RKPW+KFI
Sbjct: 378 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPHLAALVGRHNRKPWAKFI 437
Query: 383 TVENQHLAVPE-VEFL 397
++NQHLAVPE V FL
Sbjct: 438 NMDNQHLAVPEAVNFL 453
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841853|emb|CAN71837.1| hypothetical protein VITISV_034030 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 298/323 (92%), Positives = 313/323 (96%), Gaps = 2/323 (0%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
H R L++ P+TLAQ+IGKSVRR GAPSKARVY+DINV+RP+EYWDYESLTVQWGEQDD
Sbjct: 34 HHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYADINVIRPKEYWDYESLTVQWGEQDD 92
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL
Sbjct: 93 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 152
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
DIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVK
Sbjct: 153 DIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVK 212
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 315
PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL
Sbjct: 213 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 272
Query: 316 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR 375
GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY +ELDPHLAALVGRHSR
Sbjct: 273 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRLELDPHLAALVGRHSR 332
Query: 376 KPWSKFITVENQHLAVPE-VEFL 397
KPW+KF+ +NQHLAVPE ++FL
Sbjct: 333 KPWTKFVNADNQHLAVPESIDFL 355
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17977868|emb|CAD12663.1| casein kinase II alpha subunit [Sinapis alba] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 303/400 (75%), Positives = 331/400 (82%), Gaps = 28/400 (7%)
Query: 1 MAIRPFQFTIH--RNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFG 58
MA RP +TI R L SF +I S+ + + +S
Sbjct: 1 MAFRPIGYTISSLRKASAANDLRFSFLSIYSSFPAKKNLLLS------------------ 42
Query: 59 TLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPR 118
LRG +S H+ Q+ + +TLAQKIGKS+RR+GAPSKARVY+D+NV++P+
Sbjct: 43 FLRGFSS-------LHRRQQQQSRVNKSETLAQKIGKSIRRAGAPSKARVYADVNVIKPK 95
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE 178
+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKRE
Sbjct: 96 DYWDYESLAVQWGAQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKRE 155
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYIYELL
Sbjct: 156 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIYELL 215
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
KALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE
Sbjct: 216 KALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 275
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
LLVDL DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YLN+Y
Sbjct: 276 LLVDLMDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLNRY 335
Query: 359 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
IELDP+LA+LVGRHSRKPWSKFI ENQHLAVPE V+F+
Sbjct: 336 RIELDPNLASLVGRHSRKPWSKFINSENQHLAVPEAVDFV 375
|
Source: Sinapis alba Species: Sinapis alba Genus: Sinapis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825193|ref|XP_002880479.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] gi|297326318|gb|EFH56738.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-162, Method: Compositional matrix adjust.
Identities = 313/405 (77%), Positives = 345/405 (85%), Gaps = 19/405 (4%)
Query: 1 MAIRPFQ-FTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGT 59
MA+RP FTI ++ +N + + + SSS + + +LFS L
Sbjct: 1 MALRPCTGFTI--SSLRNASAANDNLFSLLSFSSSSSPAKRNLLFSSLRDH--------- 49
Query: 60 LRGLASSASL--SHARHQHQRLR----QLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D+N
Sbjct: 50 LRRFASSASLYRQHLRNQQQQQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYADVN 109
Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
VVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKK
Sbjct: 110 VVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKK 169
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYY
Sbjct: 170 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYY 229
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
I+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 230 IFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 289
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA
Sbjct: 290 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 349
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
YLNKY IELDP+L +LVGRHSRKPW+KFI ENQHLAVPE V+F+
Sbjct: 350 YLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFV 394
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15227778|ref|NP_179889.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] gi|75318502|sp|O64816.1|CSK2P_ARATH RecName: Full=Casein kinase II subunit alpha, chloroplastic; Flags: Precursor gi|3169180|gb|AAC17823.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|17065110|gb|AAL32709.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|20148299|gb|AAM10040.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|330252310|gb|AEC07404.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1485), Expect = e-162, Method: Compositional matrix adjust.
Identities = 298/347 (85%), Positives = 320/347 (92%), Gaps = 8/347 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347
Query: 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
NAYLNKY IELDP+L +LVGRHSRKPW+KFI ENQHLAVPE V+F+
Sbjct: 348 NAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFV 394
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081845|ref|XP_002306501.1| predicted protein [Populus trichocarpa] gi|222855950|gb|EEE93497.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1485), Expect = e-162, Method: Compositional matrix adjust.
Identities = 294/322 (91%), Positives = 305/322 (94%), Gaps = 1/322 (0%)
Query: 77 QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDY 136
R R PDTLAQKIGKS RR GAPSKARVY+D NV+RP++YWDYESLTVQWGEQDDY
Sbjct: 6 HRFRSSVPLPDTLAQKIGKSFRRPGAPSKARVYADANVIRPKDYWDYESLTVQWGEQDDY 65
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
VV+KVGRGKYSEVFEG+HCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD
Sbjct: 66 MVVKKVGRGKYSEVFEGMHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 125
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
IVRDQQSKTPSLIFE+V NTDFKVLYPTLSD+D RYYIYELLKALDYCHSQGIMHRDVKP
Sbjct: 126 IVRDQQSKTPSLIFEYVKNTDFKVLYPTLSDFDTRYYIYELLKALDYCHSQGIMHRDVKP 185
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG
Sbjct: 186 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 245
Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 376
CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD+LNAYLNKY IELDPHLAALVGRHSRK
Sbjct: 246 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDDLNAYLNKYRIELDPHLAALVGRHSRK 305
Query: 377 PWSKFITVENQHLAVPE-VEFL 397
PWSKF V+NQHLAVPE V+FL
Sbjct: 306 PWSKFTNVDNQHLAVPEAVDFL 327
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519104|ref|XP_004166575.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 287/312 (91%), Positives = 305/312 (97%), Gaps = 1/312 (0%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWG+QD+YEVVRKVGRGK
Sbjct: 93 ETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGK 152
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NIVKLLDIVRDQQSKTP
Sbjct: 153 YSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINIVKLLDIVRDQQSKTP 212
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR
Sbjct: 213 SLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 272
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct: 273 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 332
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
EPFFYGHDNYDQLVKIAKVLGTDELN YL+KY IELDPHL+ALVGRHSRKPW+KFI V+N
Sbjct: 333 EPFFYGHDNYDQLVKIAKVLGTDELNTYLSKYRIELDPHLSALVGRHSRKPWTKFINVDN 392
Query: 387 QHLAVPE-VEFL 397
QHLAVPE V+F+
Sbjct: 393 QHLAVPEAVDFV 404
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448236|ref|XP_004141872.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1469), Expect = e-160, Method: Compositional matrix adjust.
Identities = 305/405 (75%), Positives = 332/405 (81%), Gaps = 27/405 (6%)
Query: 1 MAIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTL 60
MAIRP F + N + T ++ S S+ F L
Sbjct: 1 MAIRPLNFKVSSNFH--TLSSILSSPSLFLSAQSPPPSI-----------------FFFL 41
Query: 61 RGLASSAS-------LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
R +ASS + H + +P +TLAQKIGKS+RR GAPSKARVY+D+N
Sbjct: 42 RRIASSTASLSPSHHHHHPPPPPPPRLRSPSPQETLAQKIGKSIRRPGAPSKARVYADVN 101
Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
V+RP++YWDYESLTVQWG+QD+YEVVRKVGRGKYSEVFEGVHCTDNEKC+IKILKPVKKK
Sbjct: 102 VIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGKYSEVFEGVHCTDNEKCVIKILKPVKKK 161
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
KIKREIKILQNLCGG NIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSD+D+RYY
Sbjct: 162 KIKREIKILQNLCGGINIVKLLDIVRDQQSKTPSLIFEHVNNIDFKVLYPTLSDFDIRYY 221
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 222 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 281
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN
Sbjct: 282 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNT 341
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
YL+KY IELDPHL+ALVGRHSRKPW+KFI V+NQHLAVPE V+F+
Sbjct: 342 YLSKYRIELDPHLSALVGRHSRKPWTKFINVDNQHLAVPEAVDFV 386
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 401 | ||||||
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.775 | 0.719 | 0.852 | 1.7e-146 | |
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.733 | 0.882 | 0.833 | 8.5e-136 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.733 | 0.882 | 0.786 | 4.6e-128 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.743 | 0.762 | 0.693 | 4.4e-116 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.743 | 0.762 | 0.693 | 4.4e-116 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.743 | 0.762 | 0.693 | 4.4e-116 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.743 | 0.774 | 0.693 | 4.4e-116 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.743 | 0.762 | 0.693 | 4.4e-116 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.743 | 0.762 | 0.693 | 4.4e-116 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.743 | 0.762 | 0.693 | 4.4e-116 |
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1431 (508.8 bits), Expect = 1.7e-146, P = 1.7e-146
Identities = 266/312 (85%), Positives = 282/312 (90%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR+GAPSKARVY+D+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGK
Sbjct: 83 ETLAQKIGKSIRRAGAPSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGK 142
Query: 147 YSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG+H TDNE LQNLCGGPNIVKLLDIVRDQQSKTP
Sbjct: 143 YSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 202
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQR
Sbjct: 203 SLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQR 262
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct: 263 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 322
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386
EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDP+L +LVGRHSRKPW+KFI EN
Sbjct: 323 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSEN 382
Query: 387 QHLAVPE-VEFL 397
QHLAVPE V+F+
Sbjct: 383 QHLAVPEAVDFV 394
|
|
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 1330 (473.2 bits), Expect = 8.5e-136, P = 8.5e-136
Identities = 246/295 (83%), Positives = 262/295 (88%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NE
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
KVLGT+ LNAYLNKYHIELDP L ALVGRHSRKPWSKFI +NQHL PE V+FL
Sbjct: 242 KVLGTEALNAYLNKYHIELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAVDFL 296
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1257 (447.5 bits), Expect = 4.6e-128, P = 4.6e-128
Identities = 232/295 (78%), Positives = 252/295 (85%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
KVLGT+EL+ YLNKY ++LDP L ALVGRH KPWSKFI +NQHL PE ++FL
Sbjct: 242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFL 296
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/300 (69%), Positives = 244/300 (81%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397
LV+IAKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE ++FL
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6006 | 0.7730 | 0.9144 | yes | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7567 | 0.7356 | 0.7544 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7406 | 0.7281 | 0.8690 | N/A | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7567 | 0.7356 | 0.7544 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.8915 | 0.7331 | 0.8855 | N/A | no |
| O64816 | CSK2P_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8587 | 0.8453 | 0.7847 | yes | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7398 | 0.7356 | 0.8194 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7432 | 0.7356 | 0.8779 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7567 | 0.7356 | 0.7544 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7583 | 0.7406 | 0.8413 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.7118 | 0.7182 | 0.8275 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7567 | 0.7356 | 0.7544 | yes | no |
| Q8SRU0 | CSK2A_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.5269 | 0.6384 | 0.8025 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6993 | 0.7331 | 0.8855 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7288 | 0.7331 | 0.8724 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7533 | 0.7356 | 0.7544 | yes | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7533 | 0.7356 | 0.7525 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7567 | 0.7356 | 0.7544 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 401 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-61 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-60 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-51 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-47 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-46 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-42 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-37 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-37 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-36 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-36 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-35 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-35 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-34 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-34 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-34 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-34 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-33 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-33 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-33 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-32 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-30 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-30 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-29 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-28 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-28 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-28 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-27 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-27 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-26 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-19 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 8e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.003 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 3e-61
Identities = 70/223 (31%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 190
YE++RK+G G + V++ H + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQ 247
IV+L+D D L+ E+ D LS+ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
+D+WSLG + ++ K P F G + DQL I ++LG
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLIRRILGPP 218
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-60
Identities = 76/216 (35%), Positives = 122/216 (56%), Gaps = 13/216 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 191
YE++ K+G G + +V+ + IK++K K KK I REIKIL+ L PNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
V+L D+ D+ L+ E+ D F +L LS+ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N+++D E ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++D+WSLG + ++ K P F G D +L K
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKIG 210
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 4e-51
Identities = 80/223 (35%), Positives = 128/223 (57%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 190
YE + K+G G Y V++ E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
IVKLLD++ ++ L+FE+ + D K LS ++ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIHTERKLY--LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WS+GC+FA MI +P F G DQL KI ++LGT
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGT 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 82/223 (36%), Positives = 129/223 (57%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y+ + K+G G Y V++ E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
I+KLLD+ R + L+FE ++ +K++ L + ++ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHKGDL--YLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++I+ + L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y +D+WS+GC+FA ++ R+ P F G DQL KI + LGT
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT 217
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 9e-46
Identities = 71/228 (31%), Positives = 127/228 (55%), Gaps = 23/228 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 190
YE + ++G G Y +V++ + E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHV--------NNTDFKVLYPTLSDYDVRYYIYELLKALD 242
IV+L +IV + + ++FE++ ++ + K ++ ++ Y+ +LL+ L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQ 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 300
Y HS GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+ A + F +P F G +QL KI ++ G+
Sbjct: 174 LGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGS 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 83/234 (35%), Positives = 127/234 (54%), Gaps = 31/234 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 190
YE+++ +G G Y V V K IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLKAL 241
I+ LLDI+R + F V TD KV+ L+D ++Y++Y++L+ L
Sbjct: 61 IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA + G EY V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PELL+ Y ++D+WS+GC+FA ++ RK P F G D DQL I +VLGT
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGT 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G G + V+ +K IKI+K + REI+IL+ L PNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
D+ L+ E+ K L LS+ ++ + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 313 WSLGCMFAGM 322
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 74/225 (32%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 189
Y+++ ++G G + VF+ E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCH 245
+VKLLD+ L+ E++ + +VL P L + V+ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ YD +DLW++GC+FA ++ P F G ++ +QL + + LGT
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-43
Identities = 88/247 (35%), Positives = 126/247 (51%), Gaps = 24/247 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
YEV+ VG G Y V + + E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHSQ 247
IV L + R + L+FE+V T ++L P D VR YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ E L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 362
Y +D+W++GC+ A ++ EP F G + DQL I K LG L H EL
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP------LPPSHQELFSS 231
Query: 363 DPHLAAL 369
+P A +
Sbjct: 232 NPRFAGV 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 79/226 (34%), Positives = 128/226 (56%), Gaps = 19/226 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE +K+G G Y+ V++ IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDY 243
PNI+ LLD+ + + +L+FE + TD + + L+ D++ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVFGHKSNI--NLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
HS I+HRD+KP+N++I L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+FA ++ R PF G + DQL KI + LGT
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGT 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 81/232 (34%), Positives = 125/232 (53%), Gaps = 33/232 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
Y+ V K+G G Y V++ E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYEL 237
+ L PNIV+LLD+V ++K L+FE ++ D K + ++ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVH-SENKL-YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 296
L+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V + +++
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PE+L+ + Y +D+WS+GC+FA M+ R+ P F G DQL +I + LGT
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGT 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 73/239 (30%), Positives = 134/239 (56%), Gaps = 15/239 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
Y+++ K+G G +SEV + + KC+ K K +++ REI+ L+ L PNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQ 247
++L++++ D+++ +L+FE ++ ++++ P L + V+ Y+Y+LLK+LD+ H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRN 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI HRD+KP N++I L+L D+G + Y +++R+++ PE L+ Y
Sbjct: 120 GIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLNKY-HIELD 363
+D+W++GC+F ++ P F G + DQ+ KI VLGT E+ K H+ +
Sbjct: 178 PKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 20/225 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y+V++++G G + V+ + E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDY 243
PNIVKL ++ R+ + +FE++ ++++ S+ +R IY++L+ L +
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+L+
Sbjct: 115 IHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y +D+W+LGC+ A + + P F G DQL KI VLGT
Sbjct: 174 TSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGT 217
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 77/238 (32%), Positives = 130/238 (54%), Gaps = 31/238 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------REIKIL 182
D YE + K+G G Y +V++ + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 183 QNLCGGPNIVKLLDIVR-DQQSKTPSL--IFEHVNNTDFKVLYPT--------LSDYDVR 231
Q L IV+LLD+ ++++ PSL +FE+++ +D K + L ++
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVA 290
++Y+LLK + +CH G+MHRD+KP N+++D ++ L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L+ Y +D+WS+GC+FA M RK+P F G QL+ I K+LGT
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT 230
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 191
+E++ K+G+G + EV++ H ++ IK++K K+K I EI+IL+ C PNI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ E + D K TL++ + Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFY 331
Y D+WSLG + K P+
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 79/227 (34%), Positives = 129/227 (56%), Gaps = 18/227 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D YE V K+G G Y V++ NE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELLKALD 242
G NIV+L D+V + K L+FE+++ D K + D+ ++ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+FA M+ +K P F G D+L KI ++LGT
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGT 222
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 75/230 (32%), Positives = 127/230 (55%), Gaps = 20/230 (8%)
Query: 136 YEVVRKVGRGKYSEVFEG--VHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 188
YE+++++G+G Y V ++ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 189 PNIVKL--LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDY 243
NI L +DIV L +E + D + + L+D + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPE 298
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ Q Y ++D+WS+GC+ A ++ RK P F G D DQL +I +VLGT
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGT 228
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 79/223 (35%), Positives = 123/223 (55%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
YE + VG G Y V + H + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHS 246
N+V L+++ R + K L+FE V++T L YP D VR Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ + ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ M EP F G + DQL I K LG
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 8e-36
Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGG 188
Y ++RK+G G + EV+ D + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
PNIVKL D +D+ S L+ E+V+ + L LS+ + + + ++L AL+
Sbjct: 58 PNIVKLYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 295
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 296 GPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDEL 351
PE+L+ L S D+WSLG ++ PF Q +KI L T L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 352 NAYLNKYHIELDPHLA 367
+ L+ + EL A
Sbjct: 236 ASPLSPSNPELISKAA 251
|
Length = 384 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 78/227 (34%), Positives = 131/227 (57%), Gaps = 22/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQNL 185
+ YE + K+G G Y VF+ C + E I +K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
PN+V L+++ R + + L+FE+ ++T L P + ++ ++ I++ L+A++
Sbjct: 58 -KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
+CH +HRDVKP N++I + + ++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 302 -DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
D Q Y +D+W++GC+FA ++ +P + G + DQL I K LG
Sbjct: 174 GDTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 80/233 (34%), Positives = 125/233 (53%), Gaps = 32/233 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------KREIKIL 182
YE+++K+G+G Y V++ + E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKA 240
Q L PNIVKLL++++ + K L+FE++ TD + L D RY +Y+LLKA
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------VASRYF 294
L Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ PE+L+ Y +D+WS+GC+ M+ K P F G +QL KI +V+G
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIG 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 73/240 (30%), Positives = 122/240 (50%), Gaps = 43/240 (17%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
YE + ++G G Y V++ + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 183 QNL--CGGPNIVKLLDI---VRDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYY 233
+ L PNIV+LLD+ R + +L+FEHV+ + K P L ++
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----V 289
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 290 ASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L LQ Y +D+WS+GC+FA + FR+ P F G DQL KI V+G
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 39/247 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 187
DYE++ K+G G + EV++ +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIF------EH-----VNNTDFKVLYPTLSDYDVRYY 233
PN+V L+D+ D+ + ++ +H + N K L++ ++ Y
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--------HPG--- 282
+ +LL+ ++Y H I+HRD+K N++ID+ Q L++ D+GLA Y G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
++Y V +R+++ PELL+ + Y ++D+W +GC+FA M R+ P G + DQL
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHL 238
Query: 342 IAKVLGT 348
I K+ GT
Sbjct: 239 IFKLCGT 245
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 79/273 (28%), Positives = 139/273 (50%), Gaps = 24/273 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 188
Y+ + +G G Y V + +K IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 189 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYC 244
NI+ + DI+R + K ++ + + + +++ L++ +RY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 296
HS ++HRD+KP N++++ E +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356
PELL+ L +Y ++D+WS+GC+FA M+ R++ F G + QL I VLG+ LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237
Query: 357 KYHIELDPHLAALVGRHSRKPWSKFITVENQHL 389
+ + + R PWSK +
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA 270
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 75/226 (33%), Positives = 127/226 (56%), Gaps = 21/226 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCG 187
YE + K+G G Y VF+ + +E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDY 243
NIV+L D++ + T L+FE+ + D K + + + V+ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
CHS ++HRD+KP N++I+ + +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y S+D+WS GC+FA + P F G+D DQL +I ++LGT
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 81/237 (34%), Positives = 133/237 (56%), Gaps = 32/237 (13%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------R 177
+G+ + Y+ + K+G G Y+ V++G + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIR 52
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPT-LSDYDVRYY 233
E +L++L NIV L DI+ + KT +L+FE+++ TD K LS ++VR +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+++LL+ L YCH + ++HRD+KP N++I E+ +L+L D+GLA P K Y+ V +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVKIAKVLGT 348
+++ P++L+ +Y SLD+W +GC+F M P F G D DQL KI +VLGT
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 76/230 (33%), Positives = 127/230 (55%), Gaps = 21/230 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 189
Y+ + +G G Y V H K IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 190 NIVKLLDIVR--DQQSKTPSLIFEHVNNTD-FKVLYP-TLSDYDVRYYIYELLKALDYCH 245
NI+ +LDI+R +S I + + TD +K++ LS+ ++Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 298
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++++ + Y ++D+WS+GC+ A M+ + P F G D QL I VLGT
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGT 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 73/224 (32%), Positives = 126/224 (56%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
++ V K+G G Y V++ + E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
NIVKLLD++ + L+FE ++ K + + + ++ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
S ++HRD+KP N++I+ + ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 78/234 (33%), Positives = 127/234 (54%), Gaps = 34/234 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKI 181
DY + K+G G Y V++G + + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIY 235
L+ L PNIV L D++ Q+S+ LIFE ++ D K +L V+ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 294
++L+ + +CHS+ ++HRD+KP N++ID + ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PE+L+ Y +D+WS+G +FA M +K P F+G DQL +I ++LGT
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGT 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 72/243 (29%), Positives = 132/243 (54%), Gaps = 35/243 (14%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
W D Y+ + VG G Y +V T + I K+ +P + K+ RE+++L++
Sbjct: 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYP-------------TLSDYDV 230
+ N++ LLD+ TP+ + + D ++ LSD +
Sbjct: 71 MDH-ENVIGLLDVF------TPA---SSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
++ +Y++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVA 177
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-- 348
+R+++ PE++++ Y+ ++D+WS+GC+ A ++ K F G D+ DQL +I ++GT
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPD 236
Query: 349 DEL 351
+EL
Sbjct: 237 EEL 239
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 72/268 (26%), Positives = 142/268 (52%), Gaps = 32/268 (11%)
Query: 130 WGEQ--DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKIL 182
WG++ D ++++ ++G G Y +V++ E +K ++ +K+ REIKIL
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTP--------SLIFEHVNNTDFKVLYPTLSDYD---VR 231
+ L NIV L +IV D+Q L+FE++++ +L L + ++
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVRV 289
++ +LL+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
+ +++ PELL+ + Y ++D+WS GC+ G +F K+P F + QL I+++ G+
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKP 377
+ P + L ++ KP
Sbjct: 238 CPAVW---------PDVIKLPYFNTMKP 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 73/227 (32%), Positives = 126/227 (55%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 188
++ + K+G G Y+ V++G + T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALD 242
NIV+L D++ + L+FE+++ D K T L V+ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y S+D+WS+GC+ A MI + P F G +N DQL+KI +++GT
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGT 219
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD++ + +G G +S V N++ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF--EHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
P I+KL +D+++ L F E+ N + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------------EYNV 287
Y HS+GI+HRD+KP N+++D + +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 288 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
R F G PELL + + S DLW+LGC+ M+ K PF
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 78/247 (31%), Positives = 134/247 (54%), Gaps = 31/247 (12%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KK 174
Y+ E W D Y +++VG G Y V + K IK L +P + K+
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------- 223
RE+++L+++ N++ LLD+ TP L + + DF ++ P
Sbjct: 61 AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111
Query: 224 --TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
LS+ +++ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QT 168
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
E V +R+++ PE++++ Y ++D+WS+GC+ A M+ K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227
Query: 342 IAKVLGT 348
I KV GT
Sbjct: 228 IMKVTGT 234
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 75/225 (33%), Positives = 124/225 (55%), Gaps = 14/225 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IK--REIKILQNLCGG 188
D+YE + ++ G Y V+ E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDYC 244
PNIV + ++V ++ E+V + D K L T+ +V+ + +LL + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL+
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++Y ++D+WS+GC+FA ++ K+P F G DQL KI K+LGT
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 189
++ +GRG + V+ + E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ RD++ T ++ E+V+ + + L + +R Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++Y + D+WSLGC M K P+ + L KI
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 80/224 (35%), Positives = 119/224 (53%), Gaps = 16/224 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ +EV+ VG G Y V + H E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCH 245
NIV+L + R + L+FE+V ++L P + VR YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
Y ++D+WS+GC+ G + +P F G DQL I KVLG
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-30
Identities = 74/232 (31%), Positives = 127/232 (54%), Gaps = 22/232 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE V ++G G Y +VF+ + + + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 188 --GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELL 238
PN+V+L D+ R + +L+FEHV+ T + KV P + ++ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+L+ Y +DLWS+GC+FA M FR++P F G + DQL KI V+G
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 70/225 (31%), Positives = 127/225 (56%), Gaps = 10/225 (4%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G Y + K+G G Y+ V++G+ + + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYC 244
NIV L DI+ +++ T + H + + + +P L Y+VR ++++LL+ L Y
Sbjct: 61 -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 303
H Q I+HRD+KP N++I + +L+L D+GLA P + Y+ V + +++ P++L+
Sbjct: 120 HGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLG 347
DY +LD+W GC+F M + +P F G + ++QL KI VLG
Sbjct: 179 TDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLG 222
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 76/226 (33%), Positives = 124/226 (54%), Gaps = 17/226 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 194
Y++ +G G + V+E + +EK IK +L+ + K RE+ I++NL NI+ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124
Query: 195 LD------IVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
D +++++ +++ E + T K + L + V+ Y Y+L +AL
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR+++ PEL++
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+Y +DLWSLGC+ A MI P F G + DQLV+I +VLGT
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGT 289
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 75/235 (31%), Positives = 129/235 (54%), Gaps = 27/235 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V +K +K L +P + ++ RE+++L++
Sbjct: 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E+ N D V LSD V++
Sbjct: 71 M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY+LL+ L Y HS GI+HRD+KP NV ++ E +LR++D+GLA E VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++ PE++++ Y+ ++D+WS+GC+ A ++ + + F G+D DQL +I +V+GT
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGT 234
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 76/234 (32%), Positives = 126/234 (53%), Gaps = 34/234 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 190
Y ++ +GRG Y V + NEK IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDFKVLY---PTLSDYDVRYYIYELLKAL 241
++ + DI+ + F V +TD + TLSD +Y++Y+LL+ L
Sbjct: 66 VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHPGKEYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA +F EY V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PELL++ +Y ++D+WS+GC+FA ++ RK P F G D QL I ++LG+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGS 227
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 74/233 (31%), Positives = 127/233 (54%), Gaps = 26/233 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQN 184
W + Y +++VG G Y V + EK IK L +P + K+ RE+ +L++
Sbjct: 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDF-KVLYPTLSDYDVRYYI 234
+ N++ LLD+ T ++ + + TD K++ LS+ V+Y +
Sbjct: 71 M-QHENVIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
Y++L L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E V +R++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ PE++++ Y+ ++D+WS+GC+ A M+ K F G D DQL +I KV G
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTG 232
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 76/235 (32%), Positives = 136/235 (57%), Gaps = 29/235 (12%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ V++G TDN + LK ++ + + RE+ +
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD-------YDVRYYI 234
L++L NIV L DI+ ++S T L+FE+++ K L L D ++V+ ++
Sbjct: 58 LKDL-KHANIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNSINMHNVKLFL 110
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRY 293
++LL+ L+YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++ P++L+ DY +D+W +GC+F M + P F G +QL I ++LGT
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 76/221 (34%), Positives = 120/221 (54%), Gaps = 16/221 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 190
Y ++ VG G + V T I KI+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
I+ L DI S + F + TD L + L ++Y++Y++L+ L Y HS
Sbjct: 71 IISLSDIF---ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE+++ Q YD
Sbjct: 128 GVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+D+WS GC+FA M +P F G D+ +Q I +LGT
Sbjct: 185 VEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGT 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 75/232 (32%), Positives = 134/232 (57%), Gaps = 23/232 (9%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYEL 237
L++L NIV L DIV +S T L+FE+++ D K +S ++V+ ++Y++
Sbjct: 58 LKDL-KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ +Y +D+W +GC+F M + P F G D+L I ++LGT
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 78/270 (28%), Positives = 144/270 (53%), Gaps = 20/270 (7%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G+ D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
NIV L DI+ +++ T L+FE+V+ + + +P L +V+ ++++LL+ L
Sbjct: 61 -KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
Y H + I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L+
Sbjct: 118 YIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
+Y LD+W +GC+F MI F D DQL +I VLGT + + + +
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL- 235
Query: 362 LDPH-----LAALVGRHSRKPWSKFITVEN 386
PH ++ R+ W+K V +
Sbjct: 236 --PHFKPERFTLYSPKNLRQAWNKLSYVNH 263
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 70/237 (29%), Positives = 126/237 (53%), Gaps = 27/237 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V + +K L +P + K+ RE+++L++
Sbjct: 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E N+ D V L+D V++
Sbjct: 73 M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA H E VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 27/231 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL-- 185
YE V ++G G Y V++ D LK V+ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKA---RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 186 CGGPNIVKLLDIV----RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYE 236
PNIV+L+D+ D+++K +L+FEHV+ D KV P L ++ + +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+L+ Y +D+WS+GC+FA M FR++P F G+ DQL KI ++G
Sbjct: 176 PEVLLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 73/232 (31%), Positives = 134/232 (57%), Gaps = 23/232 (9%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYEL 237
L+NL NIV L DI+ ++ T L+FE++++ D K +S ++V+ ++++L
Sbjct: 57 LKNL-KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + I+HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ +Y +D+W +GC+ M + P F G ++L I ++LGT
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLC 186
++E + ++G G Y V+ T E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDY 243
PNIV+L ++V + + L+ E+ +L S+ V+ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+K N+++ + L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ A + +P G +QL I ++LGT
Sbjct: 183 CTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGT 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
YE+++++G+G + +V+ +D + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIF-EHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
NI+K + + K I E+ + D K + + + +L AL
Sbjct: 60 NIIKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI 342
+ + Y+Y D+WSLGC+ + K PF +N +L KI
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 192
Y +R +G G VF V +++ +K + + +K REIKI++ L NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 193 KLLDIVRDQQSKTPSLIFE--HVN---------NTDFKVL--YPTLSDYDVRYYIYELLK 239
K+ +++ S + +N TD + LS+ R ++Y+LL+
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 295
L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK---VLGTDELN 352
P LL+ +Y ++D+W+ GC+FA M+ K P F G +Q+ I + V+ ++ N
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDRN 244
Query: 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQH 388
LN P G R+P + N
Sbjct: 245 ELLNV-----IPSFVRNDGGEPRRPLRDLLPGVNPE 275
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 193
+G G + V+EG++ D + +K + K++++EI +L L PNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L R+ + E V L Y + + +R Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 311 DLWSLGCMFAGMIFRKEPF 329
D+WSLGC M K P+
Sbjct: 184 DIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG 188
D++++ +VG+G Y +VF E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCH 245
+VKLL +D + L E+V DF+ L LS+ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQDDEYLY--LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
YD+++D WSLGCM + PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 32/241 (13%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLC 186
E YE + K+G+G + EVF+ H + +K +L +K+ REIKILQ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68
Query: 187 GGPNIVKLLDIVRDQQSK------TPSLIFE---H-----VNNTDFKVLYPTLSDYDVRY 232
N+V L++I R + + + L+FE H ++N + K TLS+ ++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF---TLSE--IKK 123
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNV 287
+ LL L Y H I+HRD+K N++I + L+L D+GLA + K Y
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
RV + +++ PELL+ +DY +D+W GC+ A M R P G+ QL I+++ G
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCG 241
Query: 348 T 348
+
Sbjct: 242 S 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 70/236 (29%), Positives = 121/236 (51%), Gaps = 25/236 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 189
D E R +G G + V+ D ++ +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 190 NIVKLLDIVRDQQSKTPSL-IFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLK 239
N++ LDI+ + P + FE + +D K++ LS V+ ++Y++L+
Sbjct: 60 NVLSALDIL-----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGP 297
L Y HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
E+L+ + Y ++D+WS+GC+FA ++ R+ F QL I +LGT L A
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + +V + +K+LK KKKI + E IL + P IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGI 249
KL + ++ L+ E+ + F L S+ R+Y E++ AL+Y HS GI
Sbjct: 57 KLHYAFQTEEKL--YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D ++L D+GLA E G N + + PE+L + Y
Sbjct: 115 IYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGK 172
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDN 335
++D WSLG + M+ K P FY D
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP-FYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 64/244 (26%), Positives = 128/244 (52%), Gaps = 33/244 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGV--HCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
YE+ +GRG Y V++ + D ++ IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKA 240
N+V L+++ + K+ L+F++ + ++++ ++ V+ ++++L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRY 293
+ Y HS ++HRD+KP N+++ E+ +++ D GLA ++ P + + V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAK 344
++ PELL+ + Y ++D+W++GC+FA ++ EP F G + DQL +I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 345 VLGT 348
VLGT
Sbjct: 240 VLGT 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKK---KIKREIKILQNLC 186
++++ +K+G+G++S V++ + C + + + ++I + + K +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLK 239
PN++K L + ++ E + D FK + + + Y +L
Sbjct: 60 DHPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 298
AL++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAK 344
+ + Y++ D+WSLGC+ M + PF+ N Y KI K
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
+E+V +G G Y +V++ H + IKI+ ++ +++IK E IL+ PNI
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 192 VKL--LDIVRDQQSKTPSLIF-----------EHVNNTDFKVLYPTLSDYDVRYYIYELL 238
I ++ L + V + L + + Y + E L
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETL 123
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
+ L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 298 E-LLVDLQD---YDYSLDLWSLG 316
E + D Q YD D+WSLG
Sbjct: 183 EVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 189
+Y++ +GRG + V++G++ + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 243
NIVK + + S +I E+ N L + + V Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIETSDSL--YIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
+ + D+WSLGC ++ P++
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 188
+E++R +G+G + +V + K + K K V+K ++ E +ILQ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
P +V L +D+++ L+ + + D + Y S+ V+++I E++ AL+Y
Sbjct: 60 PFLVNLWYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI+HRD+KP N+++D EQ + + D+ +A P + + PE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR- 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
Q Y ++D WSLG + K P + GH
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVK 193
Y+ + K+G G EV++ ++ IK L+ K+ I EI I+++ C PNIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79
Query: 194 LLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ 247
D ++ E+++ TD ++ +++ + Y E+L+ L+Y HSQ
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G A+ + N V + Y+ PE++ +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 307 DYSLDLWSLGCMFAGMI 323
+D+WSLG M M
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 157 TDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSL 208
T I K+ +P + K+ RE+ +++ L NI+ LL++ Q+S + L
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268
+ E ++ +V+ L + Y +Y++L + + HS GI+HRD+KP N+++ + L
Sbjct: 99 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TL 157
Query: 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
+++D+GLA V +RY++ PE+++ + Y ++D+WS+GC+ MI R
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMI-RGTV 215
Query: 329 FFYGHDNYDQLVKIAKVLGT 348
F G D+ DQ KI + LGT
Sbjct: 216 LFPGTDHIDQWNKIIEQLGT 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 69/228 (30%), Positives = 121/228 (53%), Gaps = 18/228 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 190
Y++ +G+G Y V + EK IK + V +I REIK+L+ L P+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60
Query: 191 IVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
IV++ I+ ++ K ++FE + + +V+ L+ ++++Y+LL+AL Y H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++ PEL
Sbjct: 121 TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 302 DL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WS+GC+FA ++ K P F G + QL I +LGT
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGT 226
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 59/230 (25%), Positives = 120/230 (52%), Gaps = 23/230 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEK------CIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + + K+ +P + K+ RE+ +L+ +
Sbjct: 23 YQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V++ L + Y +Y++L +
Sbjct: 78 -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+ Y ++D+WS+GC+ ++ + F G D+ DQ K+ + LGT
Sbjct: 196 GMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 63/227 (27%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C D I K+ +P + K+ RE+ +L
Sbjct: 19 YQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 72
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V+ L + Y +Y++L +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y ++D+WS+GC+ M+ R + F G D DQ K+ + LGT
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 52/193 (26%), Positives = 106/193 (54%), Gaps = 17/193 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 190
++ ++++ K+G G Y V++ +H + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEH-----VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
IVK ++ ++ E+ V++ K+ TL++ ++ +Y+ LK L+Y H
Sbjct: 60 IVKYYGSY--FKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 246 SQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
S +HRD+K N++++ E Q K L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAK--LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE- 173
Query: 304 QDYDYSLDLWSLG 316
Y+ D+WSLG
Sbjct: 174 IGYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 193
+ +G Y VF + + IK++K K I++ E IL P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L Q K L+ E++ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 301
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
Q + ++D WSLGC+ + PF
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKC------IIKILKPVKKKKIKREIKILQNLCGG 188
++++ +K+GRG++SEV+ D + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K LD + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYLDSFIEDNEL---NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 299
+++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + Y++ D+WSLGC+ M + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 61/227 (26%), Positives = 116/227 (51%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + I K+ +P + K+ RE+ +L
Sbjct: 26 YQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 79
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + ++ E ++ +V+ L + Y +Y++L +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y ++D+WS+GC+ MI F G D+ DQ K+ + LGT
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGT 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 66/247 (26%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-----------KREIKIL 182
DD+EV++ +GRG + EV+ D + + +K ++K + +R+I
Sbjct: 1 DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYE 236
+ P IVKL +D++ L+ E++ D L L DV R+YI E
Sbjct: 58 AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNL---LIRKDVFPEETARFYIAE 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLA----------------- 276
L+ ALD H G +HRD+KP N++ID H ++L D+GL
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 277 ---------EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
K+ VR V + + PE+L Y D WSLG + M+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224
Query: 324 FRKEPFF 330
+ PF+
Sbjct: 225 YGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 189
DYEV+ +G+G + V + +D + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIY----ELLKALD 242
NIV+ D + D+ ++T ++ E+ D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 243 YCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 296
CH ++HRD+KP N+ +D ++L D+GLA+ + V + Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVKIAKVLG-----TDE 350
PE L YD D+WSLGC+ + PF +K K + E
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 351 LNAYLNKYHIELDPHL 366
LN + K + +DP
Sbjct: 238 LNEVI-KSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------------REIKILQN 184
+G G Y +V + + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 185 LCGGPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 235
+ NI+ L+D +V D + + D K+ L++ V+ +
Sbjct: 77 I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVV------DRKIR---LTESQVKCILL 126
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---------------EFYH 280
++L L+ H MHRD+ P N+ I+ + ++ D+GLA E
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+E +V + +++ PELL+ + Y +++D+WS+GC+FA ++ K P F G + DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLG 244
Query: 341 KIAKVLGTDELNAY 354
+I ++LGT + +
Sbjct: 245 RIFELLGTPNEDNW 258
|
Length = 335 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 192
++ + +G + V+ + + IK+LK + K ++ K E I+ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQG 248
KL QSK L+ E++N D L T L + + YI E++ ++ H +G
Sbjct: 61 KLYYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DK 172
Query: 309 SLDLWSLGCMFAGMIFRKEPF 329
D WSLGC+ +F PF
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +V++ + D +KIL P+ ++I+ E ILQ+L PN+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + L+ E N L L + + Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 301 VDLQDYDYSL----DLWSLG 316
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 43/217 (19%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVK 193
K+G G + +V+ V+ E K I+I K K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVK-EIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK 63
Query: 194 L--LDIVRDQ--------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+++ R++ T + EH D V +R Y +LL+ L Y
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------- 296
HS GI+HRD+KP N+ +DH ++L D+G A +
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAY 169
Query: 297 --PELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE++ + + + D+WSLGC+ M K P+
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-17
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + EV K + K + KK++K+ E KIL+ IV
Sbjct: 1 LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIV 56
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFK-----VLYPTLSDYDVRYYIYELLKALDYCHS 246
L ++K L+ +N D K V P + +Y +++ L++ H
Sbjct: 57 SL---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + Y
Sbjct: 114 RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D+S+D ++LGC MI + PF
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 59/238 (24%), Positives = 117/238 (49%), Gaps = 34/238 (14%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLG 347
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 59/238 (24%), Positives = 117/238 (49%), Gaps = 34/238 (14%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLG 347
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +VF+ ++ + K +KIL P+ ++I+ E IL+ L PN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + + K L+ E N L + + + Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 301 VDLQD----YDYSLDLWSLG 316
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 52/185 (28%), Positives = 104/185 (56%), Gaps = 12/185 (6%)
Query: 161 KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD- 217
KC+ K I++ +++ I E +IL+ C P IVKL +D++ ++ E+ +
Sbjct: 24 KCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLYRTFKDKKYIY--MLMEYCLGGEL 80
Query: 218 FKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
+ +L +Y R+YI ++ A +Y H++GI++RD+KP N+++D ++L+D+G
Sbjct: 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGF 139
Query: 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
A+ G++ + + PE++++ + YD+S+D WSLG + ++ + PF G D+
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDD 196
Query: 336 YDQLV 340
D +
Sbjct: 197 EDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVK-- 193
+GRG Y V+ G H +KI+ I+RE+ +L L PNI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 194 --LLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
L K P L I E+ + L +++ + I E+L AL Y H
Sbjct: 69 GSYL--------KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G++HRD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + Y
Sbjct: 121 GVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D D+WSLG M P+
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DDYE++ +G G + V+ + +NEK IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
N+VK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG---- 282
+ + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
K V + + PE++ + YD+ D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCGG 188
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 189 PNIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
+ + Y++ D+WSLGC+ M + PF+ N L K
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 187
DD+E ++ +G G + V H + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 244
P +V L +D + L+ E+V + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 296
HS I++RD+KP N+++D +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDS-DGYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE+++ + Y ++D W+LG + M+ PFF
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 189
+G G + V+ G++ + E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ L D + E+V L Y + VR ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 299
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+V Y D+WSLGC+ M+ K PF + QL I K+
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 189
Q+DYE+++++G G Y +V++ E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 190 NIVKLL-DIVRDQQ-------SKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYIYELLKA 240
NIV +R + SL D ++V LS+ + Y E LK
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSL-------QDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 299
L Y H G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 300 LVDLQ--DYDYSLDLWSLG 316
+ YD D+W+LG
Sbjct: 173 AAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++G G V + +H + K I + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLKALDYCH 245
IV + S+ E+++ + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 246 SQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
+ I+HRDVKP N++++ + +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 301 VDLQDYDYSLDLWSLGCMF 319
DY D+WSLG
Sbjct: 172 QGN-DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + L+ E+VN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
+S+D W+LG + M+ + PF DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + ++ +G+G + EV++ + N+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 190 NIVKLLDIVRDQQSKTPSL--IFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCH 245
I K K L I E+ + +L P L + + + + E+L L+Y H
Sbjct: 60 YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+G +HRD+K N+++ E+ ++L D+G++ + + N V + ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173
Query: 305 DYDYSLDLWSLGC 317
YD D+WSLG
Sbjct: 174 GYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNL 185
D++V VGRG + EV + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-------VRYYIYELL 238
P I +L +D L+ E+ D L L+ Y+ ++Y+ EL+
Sbjct: 60 --SPWIPQLQYAFQD--KDNLYLVMEYQPGGD---LLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKG 296
A+ H G +HRD+KP NV+ID ++L D+G A K N + V + +
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 297 PELLVDLQD-----YDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + Y D WSLG + MI+ + PF
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 4e-14
Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 44/260 (16%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCI-IKILKPVK 171
P +Y D ES ++YEV++K+G G++ EVF H E K I + LK +
Sbjct: 2 PGKYDDGES------RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPT 224
K ++ E+ +++ L NIV+ +D ++ ++ ++ E + D ++
Sbjct: 56 KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 225 LSDYDVRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHEQRKL--------- 268
+ ++ + +LL AL YCH+ + ++HRD+KP N+ + R +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 269 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDLWSLGCMFA 320
++ D+GL++ + V + Y+ PELL+ + + YD D+W+LGC+
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 321 GMIFRKEPFFYGHDNYDQLV 340
+ K P F+ +N+ QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 5e-14
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G + +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D Y P LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD----- 229
+++EI+++ L P+I+++L + +L E + L LS Y
Sbjct: 50 LRKEIRLMARL-NHPHIIRMLGAT--CEDSHFNLFVEWMAGGSVSHL---LSKYGAFKEA 103
Query: 230 -VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK 283
+ Y +LL+ L Y H I+HRDVK N++ID ++LR+ D+G A + G+
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-FYGHDNYDQLV-K 341
+ + F PE+L + Y S D+WS+GC+ M K P+ H N+ L+ K
Sbjct: 164 FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 342 IAKVLGTDELNAYLN 356
IA + +L+
Sbjct: 223 IASATTAPSIPEHLS 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
YE+++K+G G + +++ +D+E C+IK + PVK+K+ ++ IL PNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK--------VLYPTLSDYDVRYYIYELLKALDY 243
V Q++ ++ E+ + D VL+ S+ + + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 302
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ Y+ D+WSLGC+ + K PF +N QLV
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DYEVV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D + ++ E++ D L +S+YDV R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 140 RKVGRGKYSEVFEG-VHCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPNIV 192
+K+G G + EV++G + D + +K LK ++K +E ++++ L G PN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDYDVRYYIYELLKA 240
+LL + +++ L+ E++ D TLS D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y S+ +HRD+ N ++ E +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 297 ----PELLVDLQDYDYSL--DLWSLGC 317
PE L+D ++ D+WS G
Sbjct: 172 RWMAPES---LKDGIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D E V+ +G+G V++ H + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
+VK + S++ E+++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y Y+ D+WSLG K PF
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V E+ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + E+VN D L + R+Y E+ AL+Y H +
Sbjct: 58 LVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQ 338
+S+D W+LG + M+ + PF DN DQ
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 52/183 (28%), Positives = 94/183 (51%), Gaps = 12/183 (6%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EV++G+ E IKI+ + + I++EI +L C P I +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+ +I E++ + +L P L + + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD+ D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIW 185
Query: 314 SLG 316
SLG
Sbjct: 186 SLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 139 VRKVGRGKYSEVFEGVH--CTDN--EKCIIKILK----PVKKKKIKREIKILQNLCGGPN 190
++++G G + +V + DN E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR----YYIYELLKALDYCHS 246
IVK + ++ LI E++ + + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 302
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ S D+WS G + F YG + + +++G
Sbjct: 187 SKFSSAS-DVWSFGVTLYEL------FTYGDPSQSPPAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 4e-13
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKL 194
+ K+G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 195 L-DIVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMH 251
++D + +I E++ + +L P L + + + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 311 DLWSLGCMFAGMIFRKEP 328
D+WSLG + A + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DY+VV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D K ++ E++ D L +S+YDV ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 299
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 300 LVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
L Y D WS+G M+ PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 140 RKVGRGKYSEVFEGV--HCTDN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G D + +K LK ++ RE +I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK-VL----YPTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D L LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 188
+G+G Y V+ ++ T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
NIV+ L + + S+ E+V T ++ VR++ ++L+ L Y H
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 301
S+GI+HRD+K N+++D ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 302 DLQDYDYS--LDLWSLGC----MFAG 321
YS +D+WSLGC MFAG
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ ++++IK+EI +L+ NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 194 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 241
K P L+ E L TL + + Y E+L+ L
Sbjct: 68 YYGAF---IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 301 VDLQD----YDYSLDLWSLG 316
++ YD+ DLWSLG
Sbjct: 184 ACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKK----IKREIKILQNLCGGPNIVK 193
R +GRG Y++V +K++K V + ++ E + + P +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
L +T S +F E V+ D L + R+Y E+ AL++ H +
Sbjct: 61 LHSCF-----QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
+S+D W+LG + M+ + PF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+GRG + EV+ G D K + +K + KK+IK +K + L I +L +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERI--MLSLVSTG 54
Query: 202 QS----------KTP---SLIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCH 245
TP S I + +N D + S+ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
YD S D +SLGCM ++ P F H D+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++++ ++K L+ +N D K +Y P + +Y E+L L+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H + ++RD+KP N+++D + +R+ D GLA G+ RV + + PE+L + Q
Sbjct: 119 HRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-Q 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y S D W LGC+ MI + PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKR---------EIKILQNLCGG 188
R +G+G + EV C + K+ K ++KK+IK+ E +IL+ +
Sbjct: 6 RVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDY 243
+V L + + L+ +N D K +Y P + +Y E+ L+
Sbjct: 60 RFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE +V
Sbjct: 118 LHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKN 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y +S D W LGC+ MI K PF
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G VF + ++ IK + K KK+ I EI +++ L PNIV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ H+
Sbjct: 80 NFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K NV++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ + +++IK EI +L+ NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 194 LLDIVRDQQSKTPS-------LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
K+P L+ E V NT L + + Y E+
Sbjct: 78 YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREI 130
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 297 PELLVDLQD----YDYSLDLWSLG 316
PE++ ++ YDY D+WSLG
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 189
YE +R VGRG + V D + IIK + PV ++ + E ++L+ L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLL-SHP 59
Query: 190 NIV---------KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NI+ K L IV + + E++ K L + + ++ ++L A
Sbjct: 60 NIIEYYENFLEDKALMIV--MEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLA 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L + H++ I+HRD+K N+++D + +++ D+G++ K Y V V + + PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPE- 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
L + + Y+ D+W+LGC+ + K F
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYN 286
DV++Y+ EL ALD+ HS GI++RD+KP N+++D E+ ++L D+GL++ H K Y+
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y PE +V+ + + S D WS G + M+ P F G D + + I K
Sbjct: 158 FCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD +T S+ EH+ K Y L++ R Y
Sbjct: 54 EIQLLKNLLH-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y+ PE ++ + Y D+WS+GC M+ K P+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLC 186
D+E++ K+G+G + VF+ V D + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKA 240
I++ + D+ +++ E+ N D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D + Y+ D+W+LG + K PF
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIK-----ILQNLCGGPNIVKL 194
+G+G + +V +D +K+L K + KKK + I +L+NL P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGL 61
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQG 248
Q ++ + ++VN + L+ L + R+Y E+ A+ Y HS
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
I++RD+KP N+++D Q + L D+GL E P + + + + PE+L + YD
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYD 174
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
++D W LG + M++ PF+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 2/100 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
V +Y ++ + + HS I++RD+KP NV++D +Q RL D GLA GK R
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA 155
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 37/234 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNL 185
++D + R +G G++ +V++GV+ + + I +K K P ++K +E I++
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI------------FEHVNNTDFKVLYPTLSDYDVRYY 233
P+IVKL+ ++ + P I + VN + L Y
Sbjct: 65 -DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-------Y 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 294 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
K PE ++ + + + D+W G CM+ ++ +PF G N D + +I
Sbjct: 172 IKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
S+ ++R+Y E++ L++ H++ +++RD+KP N+++D E +R+ D GLA + K
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 152
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ V + + PE+L YD S D +SLGCM ++ PF
Sbjct: 153 H-ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 37/119 (31%), Positives = 65/119 (54%), Gaps = 5/119 (4%)
Query: 212 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
H+ N D + P + +Y +++ L++ H + I++RD+KP NV++D++ +R+
Sbjct: 83 HIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRIS 139
Query: 272 DWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D GLA G+ A + F PELL ++YD+S+D ++LG MI + PF
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G K +K LK ++++ E I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+LL + + ++ E++ D + L+ D+ ++ K ++Y S
Sbjct: 64 VRLLGVCTQGEP--LYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 297
+ +HRD+ N ++ E +++ D+GL+ + Y R +A P
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173
Query: 298 ELLVDLQDYDYSL--DLWSLG 316
E L+D ++ D+WS G
Sbjct: 174 ES---LKDGKFTSKSDVWSFG 191
|
Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ ++E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
Q+D+E+++++G G Y +V++ + E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 191 IVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 245
IV + RD+ + E + +Y LS+ + Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKLW----ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y+ D+W++G + + P F H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 50/183 (27%), Positives = 90/183 (49%), Gaps = 12/183 (6%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+ +I E++ L ++ + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIW 185
Query: 314 SLG 316
SLG
Sbjct: 186 SLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+D++V++ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
IV+L +D K ++ E++ D L +S+YD+ R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
D HS G +HRDVKP N+++D + L+L D+G VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 298 ELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFF 330
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 192
+ ++G G + V+ + NE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 85 EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD+ KT ++ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WSLGC M+ K P+ Y+ + I K+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKK----IKREIKILQNLCGGPNIVKLL 195
+G+G + +V H D + +K+L K + KKK I E +L P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQGI 249
Q + + ++VN + L+ L + R+Y E+ AL Y HS I
Sbjct: 63 --YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D Q + L D+GL E K + + + PE+L Q YD
Sbjct: 118 IYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175
Query: 309 SLDLWSLGCMFAGMIFRKEPFF 330
++D W LG + M++ PF+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 135 DYEVVRKVGRGKYSEVF----EGVHCTDNEKCIIKILKP---VKKKKI----KREIKILQ 183
++E++R +G G Y +VF G H + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKA 240
+ P +V L Q LI ++VN + F LY ++ +VR YI E++ A
Sbjct: 60 AVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPE 298
LD+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 299 LLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
++ +D ++D WSLG + ++ PF
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ NE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 89 EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+G+G + +V H + + +K+L K + KKK ++ I +N+ LL V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--------LLKNV- 53
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLKA 240
K P L+ H + LY L DY R+Y E+ A
Sbjct: 54 ----KHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L Y HS I++RD+KP N+++D Q + L D+GL E + + + PE+
Sbjct: 109 LGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
L Q YD ++D W LG + M++ PF+
Sbjct: 168 L-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
+Y E+ L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ PE +V + Y +S D W+LGC+ MI + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
LD +V D+ ++ E++ TD V + + + E L+AL++ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 304
++HRD+K N+++ + ++L D+G P E + R V + Y+ PE +V +
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
Y +D+WSLG M M+ + P+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+ALD+ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 19/235 (8%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR----- 177
YE + + +E++ ++G G + +V++ + E + K ++ K +
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYM 57
Query: 178 -EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYI 234
EI+IL C P IVKLL + F D +L L++ ++
Sbjct: 58 VEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
++L+AL Y HS I+HRD+K NV++ + ++L D+G+ A+ + + + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 294 FKGPELLV--DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ PE+++ ++D YDY D+WSLG M + EP + + L+KIAK
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-----EIKILQNLCGGP 189
D++V++K+G+G Y V++ +DN+ +K + + +R EI+IL ++ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59
Query: 190 NIVK----LLDIVR----DQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LD + + + L + L P R +I +LL+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE--QEIWRIFI-QLLRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
H Q I+HRD+K N+++ ++ K+ D G+++ + + ++ PE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y Y D+WSLGC+ M PF
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKK---IKREIKILQNLCG 187
DD E ++ VG G + V +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P I++L DQ+ ++ E+V + F L S+ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
++ ++D W+LG + M+ PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGG 188
D+E+ +G G + V H E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDV-RYYIYELLKAL 241
P IV ++ +D+ + E V + F L +P DV ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 298
+Y HS+ I++RD+KP N+++D + +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 299 LL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
L + + + ++D W++G + I PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+G+G + +V++ V D + I +K + KK+I + ++ + G NI +VR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRR--IYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 202 QSKTPSLI---FEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLK 239
++P ++ F ++D LY ++DY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 298
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+L+D + Y +D WSLG + M PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLC 186
++ +E++ ++G G + +V++ + E ++ K + K + EI IL + C
Sbjct: 4 EEFWEIIGELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-C 59
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYC 244
PNIVKLLD + + + F D +L L++ +R + L+AL+Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 301
H I+HRD+K N++ + ++L D+G+ A+ + + + + Y+ PE+++
Sbjct: 120 HENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 302 --DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ YDY D+WSLG M + EP + + L+KIAK
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 189
Q DYE++++VG G Y +V++ + E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS 246
NIV ++ + E+ + +Y LS+ + Y E L+ L Y HS
Sbjct: 67 NIVAYFGSYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ ++
Sbjct: 125 KGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 306 --YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y+ D+W++G + + P F H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 139 VRKVGRGKYSEVF--EGVHCTDNEKCIIKILKPVKKKKIKREIK----------ILQNLC 186
++ +G+G Y +VF V D K I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGK--IFAMKVLKKATIVRNQKDTAHTKAERNILEAV- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYELLKA 240
P IV L I Q LI E+++ + L+ L + +Y+ E+ A
Sbjct: 58 KHPFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLA 112
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L++ H QGI++RD+KP N+++D Q ++L D+GL E H G + + + PE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
L+ + ++D WSLG + M+ PF
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y +R +G+G + E D+ + K L +++ EI IL L PN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60
Query: 191 IVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
I+ + D + + +++ + ++ + V +Y+++++ A+ Y
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSY 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 300
H GI+HRD+K N+ + + ++L D+G+++ G EY++ V + Y+ PE L
Sbjct: 117 IHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE-L 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAY 354
Y++ D+W+LGC+ ++ K F N LV KI + T ++ Y
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVVSVY 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++ + ++K L+ +N D K +Y P + +Y EL L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ I++RD+KP N+++D ++ +R+ D GLA G+ RV + + PE++ + +
Sbjct: 119 QRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-E 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y +S D W LGC+ MI + PF
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRY 293
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ PEL+ L Y +D+WSLG M M+ + P+F
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 49/193 (25%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 190
D +E++ ++G G + +V++ H KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV--LYPTLSDYDVRYYIYELLKALDYCHSQG 248
IV L + + + F D + L L++ +RY ++L+AL++ HS
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV----DL 303
++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 124 VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182
Query: 304 QDYDYSLDLWSLG 316
YDY D+WSLG
Sbjct: 183 NPYDYKADIWSLG 195
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
DD+E+++ +GRG + EV V E+ ++LK + + E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY---DV-RYYIYELLKALD 242
G + L Q L+ ++ D L D D+ R+YI E++ A+
Sbjct: 58 GDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
++D Y D WSLG CM+ M++ + PF+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 35/131 (26%), Positives = 70/131 (53%), Gaps = 7/131 (5%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDV---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
+ E++N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 265 QRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
Query: 324 FRKEPFFYGHD 334
+ P F+GHD
Sbjct: 191 IGQSP-FHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK---CIIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF T ++ +K+L+ V+K K + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
+ P +V L Q LI ++V+ + F LY S+ +VR+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 299
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + ++D WSLG + ++ PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
+D+E+++ +GRG + EV V + +K ++LK + + E +L N
Sbjct: 1 EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 242
G + L Q L+ ++ D L D R+Y+ E++ A+D
Sbjct: 58 GDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
++D Y D WSLG M++ + PF+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 9/107 (8%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVR 288
R+Y+ E++ A+D H G +HRD+KP NV++D + +RL D+G L + NV
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 289 VASRYFKGPELLVDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
V + + PE+L ++D Y D WSLG CM+ M++ + PF+
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 8e-10
Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ I+ + + KK+ I EI +++ PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ HS
Sbjct: 81 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M MI + P+ ++N + + + GT EL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 3/95 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ L Y +D+WSLG M MI + P+F
Sbjct: 186 APEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 294
LKAL + H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ L Y +D+WSLG M M+ + P+F
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYD 229
++ EI++L+NL IV+ +RD + T S+ E++ K Y L++
Sbjct: 49 NALECEIQLLKNL-QHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETV 105
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEY 285
R Y ++L+ ++Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGM 164
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WS+GC M+ K P+ ++ + I K+
Sbjct: 165 KSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI 219
Query: 346 LGTDELNAYLNKYHIELDPHLAALVGR 372
T N L + P + R
Sbjct: 220 -ATQPTNPQLP---SHVSPDARNFLRR 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 204 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 257
+TP +F E VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 258 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 317 CMFAGMIFRKEPF 329
+ M+ PF
Sbjct: 184 VLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 139 VRKVGRGKYSEVF------EGVHCTDN--EKCIIKILKPVKKKK----IKREIKILQNLC 186
+R +G G + +V EG DN E+ +K LKP +K+EI+IL+NL
Sbjct: 9 IRDLGEGHFGKVELCRYDPEG----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
NIVK I + LI E + + K P ++ Y ++ K +D
Sbjct: 65 H-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPE 298
Y S+ +HRD+ NV+++ E + +++ D+GL + KEY + ++ PE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG 316
L+ + Y S D+WS G
Sbjct: 183 CLIQSKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 139 VRKVGRGKYSEVFEGVHCTD------NEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+R +G G + +V ++C D E +K LK K+EI IL+ L
Sbjct: 9 IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
NIVK +Q K LI E+V + P L+ + + ++ + + Y HS
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLV 301
Q +HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLK 183
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ + Y+ D+WS G ++ + +++++ + T
Sbjct: 184 ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 187
DD+E ++ +GRG + EV +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 188 -GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P +VKL +D LI E++ D L T ++ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 244 CHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYH 280
H G +HRD+KP N+++D H ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPN 190
+ E V ++G G V++ +H +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
+VK D+ + ++ E ++ + + L+D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 301
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 302 DLQD--YD-YSLDLWSLG 316
DL YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G+G Y V+ + + IK + P + + + EI + L NIV+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYD--VRYYIYELLKALDYCHSQGIMH 251
D ++ + E V L + L D + + +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 304
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y D+WSLGC M K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 14/175 (8%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD + K S+ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----FYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G ++ G
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WS+ C M+ K P+ Y+ + I K+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 209 IFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
+ E+VN D +D R+Y E+ AL + H G+++RD+K N+++D E
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 266 RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
+L D+G+ E G + + PE+L + +Y S+D W+LG + M+
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMA 191
Query: 325 RKEPFFYGHDNYDQL 339
+ PF DN D L
Sbjct: 192 GQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E+ AL Y HS I++RD+KP N+++D Q + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLV 340
+ + PE++ Q YD ++D W LG + M++ PF+ + YD ++
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 189
+ +R++G G + V+ NE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 190 NIVKLLDI-VRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCH 245
N ++ +R+ T L+ E+ + +D +V L + ++ + L+ L Y H
Sbjct: 76 NTIEYKGCYLREH---TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 246 SQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVD 302
S +HRD+K N+++ + KL D+G A P N V + Y+ PE L +D
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMD 187
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
YD +D+WSLG + RK P F
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 76/361 (21%), Positives = 149/361 (41%), Gaps = 60/361 (16%)
Query: 26 AISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATP 85
+++ + +S + S S+S+ G+ R ++ S R + + A
Sbjct: 23 PVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSH---EGAAT 79
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD-----YEVVR 140
+V + P K +V P + + V GE D ++++
Sbjct: 80 TKQATTTPTTNVEVAPPPKKKKV----TYALPNQSREEGHFYVVLGEDIDVSTQRFKILS 135
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQN--LCGGPNIVKLLD 196
+G G + +V E E C +KI++ V K + K EI+ ++ + L+
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 197 IVRDQQSKT-----------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
I R Q++T P L+ D+ + + S + I++ ALDY H
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLL-------DWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 246 SQ-GIMHRDVKPHNVMIDHEQR---------------KLRLIDWGLAEFYHPGKEYNVR- 288
++ +MH D+KP N++++ ++R+ D G E + R
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CDERHSRT 303
Query: 289 --VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V++R+++ PE+++ L + YS D+WS+GC+ + + + + HDN + L + K L
Sbjct: 304 AIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLEHLHLMEKTL 361
Query: 347 G 347
G
Sbjct: 362 G 362
|
Length = 467 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y VR VG+G Y EV H TD ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--------DVRYYIYELLKALD 242
IV R+ L++ + + LY L + V + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + Y+Y D+W+LGC M K F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYN 286
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ E +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ + PE+L L+ Y +S+D WS G + M+ + P F+G D+ D+L + +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 169 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
P +K+I RE++I ++ C P IVK D+ S + + E+ +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 229 DVRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYH 280
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
+ ++ PE + + Y + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 17/107 (15%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-- 288
R+Y E++ L + H +GI++RD+K NV++D E +++ D+G+ KE +
Sbjct: 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMC------KE-GILGG 150
Query: 289 VASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
V + F G PE+L Q Y ++D W+LG + M+ + PF
Sbjct: 151 VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286
R+Y ELL AL+ H +++RD+KP N+++D+ Q + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTN 151
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PELL+ Y ++D W+LG + M+ PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y V+K+G G + + D ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 191 IVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
IV+ L IV D +++ +N VL+P + + + ++ AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD--LYKKINAQR-GVLFP---EDQILDWFVQICLAL 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-I 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ + Y+ D+W+LGC+ M K F G N LV
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--EFYHPGK 283
+ R+Y E++ L + H +GI++RD+K NV++D + +++ D+G+ GK
Sbjct: 94 DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK 152
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
+ + + PE+L Q Y+ S+D WS G + M+ + P F+G D D+L
Sbjct: 153 A-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 19/41 (46%), Positives = 26/41 (63%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++L ALD HS GI+HRDVKP N++ ++ID G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 91 VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG 149
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
Y ++ + G EVF CT +K I+K + K REI IL+ +
Sbjct: 94 YNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRA 147
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
I+ L+ R + T ++ F + L LL+AL Y H +G
Sbjct: 148 IINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDL 303
I+HRDVK N+ +D + + L D+G A P + Y + PELL L
Sbjct: 206 IIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA-L 261
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF 330
Y D+WS G + M + F
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 174 KIKREIKILQNLCGGPNIVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 224
I E+ I++ PNIV+ L IV D P + EH N+ K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 225 LSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
++ + +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK 283
S+ R+Y E++ ALDY HS I++RD+K N+M+D + +++ D+GL E
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAA 150
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 50/241 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
G +VK+ +D+++ LI E + D L TLS+ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 288
H G +HRD+KP N+++D + ++L D+GL EFY +P +++ +
Sbjct: 118 HQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 289 --------------------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
V + + PE+ + Y+ D WSLG + M+ P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 329 F 329
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE ++ Y +D+WSLG M M+ + P+F
Sbjct: 185 APE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKP---VKKKKIKR---EIKILQNLC 186
++ ++ +G+G VF V + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL- 58
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 241
P + L Q L+ ++ + L LS+ R+Y E+L AL
Sbjct: 59 DHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+Y H GI++RD+KP N+++ HE + L D+ L+
Sbjct: 117 EYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
++GRG + EVF G DN +K L P K K +E +IL+ PNIV+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQGI 249
+ Q + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VC--TQKQPIYIVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E+ L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 307 DYSLDLWSLGCMF 319
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 150
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIK--REIKILQNLCGGPNI 191
Y V+R VG G + H ++K +K ++ P ++ R+ +L PNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF--KV------LYPTLSDYDVRYYIYELLKALDY 243
V + + ++ E+ + D K+ L+P D +++++ ++ + +
Sbjct: 61 VAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFP--EDTILQWFV-QMCLGVQH 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H + ++HRD+K N+ + + K++L D+G A PG V + Y+ PE+ +
Sbjct: 116 IHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y+ D+WSLGC+ + K PF
Sbjct: 175 MP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 55/215 (25%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 135 DYEVVRKVGRGKYSEVF--EGVHCTDNEKC-IIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF V D+ K +K+LK V+K K + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS------DYDVRYYIYELL 238
+ P +V L Q LI +++N + L+ LS + +V+ Y E++
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIV 115
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFK 295
AL++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYM- 173
Query: 296 GPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
P+++ +D ++D WS+G + ++ PF
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KK-----IKREIKILQN 184
+D+ V+ +G+G + EV V D K I +K + K KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P +V L +D Q LI E + D + Y T S+ R+Y+ E + A+
Sbjct: 58 -SDSPWVVSLYYSFQDAQYLY--LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
+ H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT---L 225
+ +RE + L PNIV LLD + P +FE+V + + L
Sbjct: 23 ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGL 275
+ + ++L AL H+QGI+HRD+KP N+M+ + +++D+G+
Sbjct: 77 PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 188
+++ +V+ + RG + +V+ G +++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
P IV L + Q + L+ E++ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE ++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G VF+ H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--------KVLYPTLSDYDVRYYIYELLK 239
P IV S+ EH++ ++ L + ++K
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIK 114
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
L Y + IMHRDVKP N++++ + +++L D+G++ N V +R + PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 172
Query: 299 LLVDLQDYDYSL--DLWSLGCMFAGMIFRKEP 328
LQ YS+ D+WS+G M + P
Sbjct: 173 ---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 46/143 (32%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 281
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQK 162
Query: 282 G-------------------------KEYNVR----------VASRYFKGPELLVDLQDY 306
G + R V + + PE+L+ Y
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGY 221
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D WS+G + M+ + PF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 54/211 (25%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G V + +H K I +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 190 NIVKL---------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 229 DVRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+L+ L Y H IMHRDVKP N++++ + +++L D+G++
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA- 155
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WSLG
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 30/112 (26%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE + ++ + YD D+WSLG + + P+ + QL ++ +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALD 242
P IVK ++ + + + D K+ TLS+ V + +LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K N+ + + L++ D+G++ + + Y+ PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 302 DLQDYDYSLDLWSLGCMFAGM 322
Q YD D+WSLGC+ M
Sbjct: 179 H-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 48/270 (17%)
Query: 156 CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
C DN+ C ++K ++ E IL+ + P+I++L +K LI
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTF--TYNKFTCLILPRYK- 166
Query: 216 TDFKVLYPTLSDY------DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
TD LY L+ D+ +L+A+ Y H I+HRD+K N+ I+H +
Sbjct: 167 TD---LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVC 222
Query: 270 LIDWGLAEFYHPGKEYNVRV-ASRYF--------KGPELLVDLQDYDYSLDLWSLGCMFA 320
L D+G A + V + A++Y+ PELL Y ++D+WS G +
Sbjct: 223 LGDFGAA-------CFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLF 274
Query: 321 GM------IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE----LDPHLAALV 370
M +F K+ D+ Q+ I + GT + N++ I+ LD L
Sbjct: 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT-----HPNEFPIDAQANLDEIYIGLA 329
Query: 371 GRHSRKPWSKFITVENQHLAVPEVEFLVIC 400
+ SRKP S+ + L + ++E+L IC
Sbjct: 330 KKSSRKPGSRPLWTNLYELPI-DLEYL-IC 357
|
Length = 391 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VA 290
+Y E+ L + H +GI++RD+K NVM+D E +++ D+G+ KE+ V V
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVT 157
Query: 291 SRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+R F G PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 158 TRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 46/237 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y V++ + G VF + ++KI +K E +LQN+ P+++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI-------YELLKALDYCHSQG 248
D + ++ H ++ LY L+ I ++L+ L Y H+Q
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 299
I+HRDVK N+ I+ ++ + D G A+F V + F G PE+
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEV 227
Query: 300 LVDLQDYDYSLDLWSLGCMFAGM------IFRKEPFF---YGHDNYDQLVKIAKVLG 347
L Y+ D+WS G + M IF P Y + L+KI L
Sbjct: 228 LAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283
|
Length = 357 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 26/121 (21%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---------FYH 280
R Y E + AL+Y H+ GI+HRD+KP N++I ++L D+GL++ Y
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY- 160
Query: 281 PGKEYNVRVASRYFK-----------GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
E ++ +R F PE+++ Q Y +D W++G + + PF
Sbjct: 161 ---EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216
Query: 330 F 330
F
Sbjct: 217 F 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 3/100 (3%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFC 162
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ F PE+L + Y ++D W LG + M+ + PF
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 52/228 (22%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + ++ K +K LKP + + E +++ L
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKA 240
+V+L +V + + +I E++ DF KVL P L D+ ++ +
Sbjct: 63 LVRLYAVV--TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y + +HRD++ NV++ E ++ D+GLA EY R +++ + P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAK 344
E ++ + D+WS G + ++ + K P + G N D + + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 235 YELLKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 294 FKGPELLVDLQD----YDYSLDLWSLG 316
+ PE + D D YD D+WSLG
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLG 205
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
+D+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
+VK+ +D+ + LI E + D L TL++ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+Y+V Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 287 VRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
V + + Y+ PEL + + Y D+WSLG + ++ PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E G
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 30/111 (27%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQR 266
+S+ + Y + +LKALDY H G +HR VK ++ MI+H QR
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
LR++ H +Y+V+V + PE+L +LQ YD D++S+G
Sbjct: 158 -LRVV--------HDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKKKKIK----REIKILQNLCGGPNIVK 193
K+G G + V G T K I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 194 LLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
L +V ++ E + L TL DY V ++ +
Sbjct: 61 LYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAV-----QIANGMR 111
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPE 298
Y S+ +HRD+ N+++ K+++ D+GL +++ V PE
Sbjct: 112 YLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
L + ++ D+W G ++ + +EP+
Sbjct: 171 SLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 142 VGRGKYSEVFEGV------HCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
+G G + EV+EG + + +K L+ +KK+ +E ++ N PNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF----------KVLYPTLSDYDVRYYIYELLKAL 241
VKLL + + + +I E + D + P L+ ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 293
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 294 FKGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL 339
PE L+D + S D+WS G M+ + ++P + +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 20/45 (44%), Positives = 31/45 (68%), Gaps = 1/45 (2%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 38/170 (22%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
Y+++R +G+G EV+ + + +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 190 NIVKLLDIVRDQQS---------------------KTPSLIFEHVNNTDFKVLYPTLSDY 228
IV + I D + SL E T
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF--- 119
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
+++ ++Y HS+G++HRD+KP N+++ + ++DWG A F
Sbjct: 120 ------HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVKK----KKIKREIKILQNLCGGPNIV 192
R +G+G + V+ G + + C +K L + ++ +E I+++ PN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHS 246
LL I + +P ++ ++ + D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 300
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 301 VDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
LQ ++ D+WS G + ++ R P + D++D V + +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEK-CI---IKILK----PVKKKKIKREIKILQNLCGG 188
E ++ +G G + V++GV + EK I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLI---------FEHV-NNTDFKVLYPTLSDYDVRYYIYELL 238
P++V+LL I S LI ++V N+ D + + + ++
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 294
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 295 KGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPF 329
E ++ + Y + D+WS G ++ M F +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEY 285
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL + H K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY 160
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---------EKCIIKILKPVKKKKIKREIKILQN 184
+D+ +R +G G + V + ++ EK KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--DVR-YYIYELLKAL 241
P V L +D+ L+ E V +F + DV +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDESYLY--LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
++ + + D W+LG ++ PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G V + H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYC 244
P IV S+ EH++ +VL + + + +L+ L Y
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 245 HSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
+ IMHRDVKP N++++ + +++L D+G++ N V +R + PE L
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RL 174
Query: 304 QDYDYSL--DLWSLGCMFAGMIFRKEP 328
Q YS+ D+WS+G + + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 51/226 (22%), Positives = 99/226 (43%), Gaps = 24/226 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+D E + +G G V + H +K + K +K+I RE++I+ C P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSP 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHS- 246
IV ++ + + F + D +K P + + +++ L Y ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLYNV 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVD 302
IMHRD+KP N++++ + +++L D+G++ G+ N V + + PE
Sbjct: 123 HRIMHRDIKPSNILVN-SRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE---R 173
Query: 303 LQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
+Q Y++ D+WSLG + K PF + + + D +L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI------LKPVKKKKIKREIKILQNLCGGPNIVK 193
K+G+G + +V++GV + + L P K+K +E +IL+ PNIVK
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 194 LLDIVRDQQSKTPSLI-FEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCH 245
L+ + +Q P I E V + R + +LL+ ++Y
Sbjct: 57 LIGVCVQKQ---PIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE 110
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLV 301
S+ +HRD+ N ++ E L++ D+G++ G Y V + + PE L
Sbjct: 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL- 167
Query: 302 DLQDYDYSLDLWSLG 316
+ Y D+WS G
Sbjct: 168 NYGRYTSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 10/129 (7%)
Query: 157 TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
T +E ++KI K +RE+ ILQ L V + + + L+ E +
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLID 272
+S+ + +L + L H + H D+ P N+++D + + L +ID
Sbjct: 78 ET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIID 132
Query: 273 WGLAEFYHP 281
W A + P
Sbjct: 133 WEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKI-LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200
+G+G Y V+ G+ + ++ L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 201 ----QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
T S+ E V + + L + Y ++L + Y H+ ++HRD
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127
Query: 254 VKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQDY 306
+K +NVM+ ++LID+G LA G N+ + Y+ PE++ + Y
Sbjct: 128 IKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGY 185
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D+WS+GC M K P
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 15/89 (16%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--------YHPGKEYNV 287
+LL A+DY H +GI+HRD+K NV+++ + + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLG 316
PE+L Y S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 40/214 (18%), Positives = 85/214 (39%), Gaps = 40/214 (18%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV--HCTDNE---KCIIKILKPV----KKKKIKREIKILQ 183
++ ++R++G+G + V+EG+ E + IK + ++ + E +++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 184 NL-CGGPNIVKLLDIVRDQQSKTPSLIF--------------EHVNNTDFKVLYPTLSDY 228
C ++V+LL +V Q P+L+ + +
Sbjct: 65 EFNC--HHVVRLLGVVSTGQ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
E+ + Y ++ +HRD+ N M+ E +++ D+G+ ++Y G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
+ + V R+ PE L D + D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 43/194 (22%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192
+++G G + V +GV+ + K +K LK KK+ RE ++ L P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 248 GIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVD 302
+HRD+ NV++ + Q K+ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKIS--DFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CIN 171
Query: 303 LQDYDYSLDLWSLG 316
+ D+WS G
Sbjct: 172 YGKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVR 288
Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA ++Y K N R
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYK--KTTNGR 200
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
+ ++ PE L D + Y + D+WS G +
Sbjct: 201 LPVKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 195
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 4/110 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ +V+ I +L++AL+ H I+H D+K NV+ D + ++ L D+GL +
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y+ + YF PE + +YD S D W++G + ++ K PF D
Sbjct: 166 YDGTLD--YFS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 18/83 (21%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 197 IVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
++ D + +++ E++ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 256 PHNVMIDHEQRKLRLIDWGLAEF 278
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 13/48 (27%), Positives = 22/48 (45%)
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 152 LLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 47/216 (21%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 132 EQDDYEVVRKVGRGKYSEVFE----GVHCTDNE-KCIIKILKPVKKKK----IKREIKIL 182
+D + + +G G + +V + G+ + +K+LK +K + E++++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFE---HVNNTDF----------------KVLYP 223
+ + NI+ LL + Q ++ E H N DF +
Sbjct: 70 KMIGKHKNIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+ D+ + Y++ + +++ S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHID 186
Query: 284 EYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLG 316
Y R + PE L D + Y + D+WS G
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281
L+ D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNID 188
Query: 282 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPNIVKLLD- 196
+G G V++ H +K++ +K+I E++IL C P I+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67
Query: 197 -IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
V ++ S+ E ++ V Y + ++ + ++K L Y S I+HRDVK
Sbjct: 68 FFVENR----ISICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 256 PHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
P N++++ + +++L D+G++ K Y V + + PE + Q Y D+W
Sbjct: 123 PSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVW 177
Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
SLG F + + P+ N L+ +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPL 206
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLC----GGPNIVK 193
+ +G G++ V EG D+ K +K +K + + E + + +C PN+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 194 LLDI----VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRY-------YIYELLKA 240
L+ + V + +P +I + + D +LY L D ++ ++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK--GP 297
++Y S+ +HRD+ N M++ E + + D+GL++ + G Y R+A K
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQL 339
E L D + Y D+WS G + R + + G +N YD L
Sbjct: 184 ESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
L + +R ++ P F+ + ++ + D+ Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFK-----DLVSCAYQVARGMEYLESRRCIHRD 159
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 309
+ NV++ E +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 310 LDLWSLGCM 318
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 40/199 (20%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
E+ D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 190 NIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
N+V+LL + + + T + +++ + + + + + Y ++ A++
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAME 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPEL 299
Y + +HRD+ N ++ E +++ D+GL+ G Y +++ + PE
Sbjct: 119 YLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 176
Query: 300 LVDLQDYDYSLDLWSLGCM 318
L + D+W+ G +
Sbjct: 177 LA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQ 183
+++ + +G G + +V E K +K+LKP +++ + E+KI+
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 238
+L NIV LL +I E+ D + L+ D+ + Y++
Sbjct: 94 HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 295
K + + S+ +HRD+ NV++ H + +++ D+GLA Y V+ +R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE + + Y + D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 47/226 (20%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++++K+G G++ EV+ G N K +K LKP + + E +I++ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62
Query: 191 IVKLLDIVRDQ--------QSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKAL 241
+V+L +V ++ SK L F + + + + L P L D ++ +
Sbjct: 63 LVQLYAVVSEEPIYIVTEYMSKGSLLDF--LKDGEGRALKLPNLVDMAA-----QVAAGM 115
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 298
Y +HRD++ N+++ + ++ D+GLA EY R +++ + PE
Sbjct: 116 AYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + D+WS G + ++ + + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 164 IKILKPVKKKKI---KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
+K L+ + + +REI+IL++L NIVK + + L+ E++
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLP------ 90
Query: 221 LYPTLSDYDVRY-----------YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
Y +L DY ++ Y ++ K ++Y S+ +HRD+ N++++ E R ++
Sbjct: 91 -YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VK 148
Query: 270 LIDWGLAEFYHPGKE-YNVRVASR---YFKGPELLVDLQDYDYSLDLWSLG 316
+ D+GL + KE Y VR ++ PE L + + + D+WS G
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFG 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------DVRYYIYELLKALD 242
PN+V L + + S +F + + + L+ +S + V+ + E++ ALD
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 243 YCHSQGIMHRDVKPHNVMIDH 263
H +GI+ RD+ P+N+++D
Sbjct: 100 ALHREGIVCRDLNPNNILLDD 120
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNI 191
++ + RK+G G + EV+EG+ + + IKILK +K++ ++E++ L+ L ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64
Query: 192 VKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
+ L I+ + K L F + + + +VL P S D+ + E +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAF--LRSPEGQVL-PVASLIDMACQVAE---GMA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y Q +HRD+ N+++ E ++ D+GLA
Sbjct: 119 YLEEQNSIHRDLAARNILVG-EDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 44/213 (20%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--REIKILQNLCGGPNIVKLLDIVR 199
+G+G++ +V G + +K +K LK E ++ L PN+V+LL +V
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVL 70
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ 247
++ E++ +L DY + ++ + ++Y +
Sbjct: 71 QGNPLY--IVTEYMAKG-------SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELLVDL 303
+HRD+ NV++ E ++ D+GLA KE + S PE L
Sbjct: 122 NFVHRDLAARNVLVS-EDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEAL-RE 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
+ + D+WS G I E + +G Y
Sbjct: 174 KKFSTKSDVWSFG------ILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 44/207 (21%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + + K IK LK + + E +++ L P
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLK 239
+V+L +V ++ P I E++ N DF K+ L D ++ +
Sbjct: 63 LVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA-----QIAE 113
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 296
+ + + +HRD++ N+++ ++ D+GLA EY R +++ +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMI 323
PE ++ + D+WS G + ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 37/186 (19%)
Query: 161 KCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
KC I K VK +++ EI L L NI+K+ +I+R + + +
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMITQK 244
Query: 216 TDFKVLYPTLSDYDV-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++ +
Sbjct: 245 YDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303
Query: 265 QRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDLWSLGC 317
K+ L D+G A + R A Y PE+L Y D+WS G
Sbjct: 304 G-KIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGL 356
Query: 318 MFAGMI 323
+ M+
Sbjct: 357 ILLDML 362
|
Length = 501 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
++ +++RK+G G++ EV+EG+ + +K LKP + K E +I++ L P
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKA 240
+++L + ++ K SL+ E++ + L P L D ++
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y +Q +HRD+ NV++ E ++ D+GLA Y R +++ + P
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E + D+WS G
Sbjct: 174 E-AALYNRFSIKSDVWSFG 191
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLD 196
RK+G G++ EV+ G K +K LKP + + +E +I++ L +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYA 68
Query: 197 IVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKALDYCH 245
+ +++ P I E+++ DF K+ P L D ++ + + Y
Sbjct: 69 VCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLE 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
S+ +HRD+ N+++ E ++ D+GLA EY R +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 235 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVAS 291
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 292 RYFKGPELLV--DLQDYDYSLDLWSLG 316
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLD 196
KV +G+ + E + T IK LK P +++ ++E +++ +L PNIV LL
Sbjct: 20 KVYKGELTGPNERLSAT---SVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG 75
Query: 197 IVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDY----------------DVRYYIYEL 237
+ + + ++FE++ + D F V SD D + ++
Sbjct: 76 VC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++Y S +HRD+ N ++ E +++ D+GL+ + Y RV S+
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY--RVQSK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.08 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.71 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.58 | |
| PLN02236 | 344 | choline kinase | 97.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.06 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.9 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.5 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.42 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.42 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.21 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.15 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.89 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.82 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.3 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 95.29 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-60 Score=407.13 Aligned_cols=296 Identities=83% Similarity=1.392 Sum_probs=288.5
Q ss_pred CCCCcccccCCCcCCCCCcccccccccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHH
Q 015741 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181 (401)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~i 181 (401)
.++.++++.+++..+|++.|+++...+.|+.+++|++++++|+|.+++||.|....++++++||++++.+.+.+.+|+.|
T Consensus 6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI 85 (338)
T KOG0668|consen 6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI 85 (338)
T ss_pred cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence 56777889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE
Q 015741 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (401)
Q Consensus 182 l~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 261 (401)
|+.|++||||++++++..|+......+++||+++.++..+.+.++..+++.++.|++.||.|+|++||+|||+||.|++|
T Consensus 86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI 165 (338)
T ss_pred HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence 99998899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 262 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
|.+...++|+|+|+|.++.++..++.++.+.+|..||.+.+.+.|+...|+|||||++..|+..+.|||.|.++.+|+++
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 99888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccccCCCCc-cccc
Q 015741 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEFL 397 (401)
Q Consensus 342 i~~~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~~~~~~-~dl~ 397 (401)
|.+.+|..++..++.+.-+.+||+.-..+.+-.+++|..++.++|++++.|| +||+
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDll 302 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLL 302 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHH
Confidence 9999999999999999999999999999999999999999999999999999 9987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=401.73 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=208.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++.. ...+.+|++||++| +|||||+++++|+++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC-
Confidence 477999999999999999999999999999999996432 13367999999999 999999999999874
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccce
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAE 277 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~ 277 (401)
.+.||||||+.||+|.+.. +.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ .-.+||+|||+|+
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 4568999999999997765 458888899999999999999999999999999999999754 2379999999999
Q ss_pred ecCCCCcccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---C-----
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---G----- 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---~----- 347 (401)
......-..+.|||+.|.|||++.+. ..+..++|+|||||+||-+++|.+||.....+.....+|.+.- +
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 98877778899999999999999752 2344588999999999999999999965544443444444431 1
Q ss_pred --ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 --TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 --~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+++..++|.+ ||.+||+.|++++++|+|||++-.+
T Consensus 408 ~Iseea~dlI~~-mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 408 RISEEALDLINW-MLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhHHHHHHHHH-hhEeCcccCcCHHHHhcChhhhccc
Confidence 3455666777 8999999999999999999999544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=383.06 Aligned_cols=247 Identities=29% Similarity=0.500 Sum_probs=218.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||+||.++.+++++.||+|++++. ..+....|..||.++ +||+||+++..|.+ ...+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEeccc--CCeE
Confidence 57899999999999999999999999999999999753 246688999999998 99999999999955 6789
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-CCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~-~~~ 282 (401)
|+|+||+.||.|...++ .++|..++.++.+|+.||.|||++|||||||||+|||+|.+| +++|+|||+++.. ..+
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCC
Confidence 99999999999998886 699999999999999999999999999999999999999777 8999999999854 444
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (401)
....+.+||+.|||||++.+ ..|+..+|+||||+++|||++|..|| .+.+..+...+|.+.. -+++..+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 55667899999999999998 79999999999999999999999998 5566666666776654 256778888
Q ss_pred HhcCCCCChhhHH----HhhhhcCCCccccccccc
Q 015741 356 NKYHIELDPHLAA----LVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 356 ~~~~l~~dP~~R~----~~~~~l~~~~~~~~~~~~ 386 (401)
.+ +++.||..|. .+.++.+|||++.++.+.
T Consensus 258 ~~-LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 258 KK-LLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HH-HhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 88 6999999995 789999999999988754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=386.94 Aligned_cols=248 Identities=21% Similarity=0.372 Sum_probs=217.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEe----cccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~----~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++.+.++.||+|..|+||+++|+.+++.+|+|++ ++...+++.+|+++++.. +||+||++|+.|..... .++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 4667789999999999999999999999999998 345568899999999998 99999999999987543 58999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||||++|+|+.+++ +++|.....++.++++||.|||+ ++||||||||+|||++..+ .|||||||.++.+... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hc
Confidence 99999999998886 49999999999999999999995 9999999999999999777 8999999999887544 55
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHh--------CChhHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG----HDNYDQLVKIAKVL--------GTDELNA 353 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~----~~~~~~l~~i~~~~--------~~~~~~~ 353 (401)
.+.+||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||-.. .+..+.+..|.... -++++..
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 77899999999999998 79999999999999999999999999653 24555666665531 2567899
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
|+.. ||+.||..|++++|+++|||.+.....+.
T Consensus 314 FV~~-CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 314 FVSC-CLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred HHHH-HhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 9998 89999999999999999999998665544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=400.27 Aligned_cols=241 Identities=23% Similarity=0.448 Sum_probs=213.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.+|+..+.||+|||+.||++++..+|+.||+|++.+ ..++++.+|++|.+.| +|||||+++++|+| ..++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FED--s~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFED--SNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeec--CCceE
Confidence 579999999999999999999999999999999853 4567899999999999 99999999999987 67899
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
||+|+|..++|..+++ .++|.+++.+++||+.||.|||+++|+|||||..|+|++.+. .|||+|||+|..+..+ .
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCccc
Confidence 9999999999877764 699999999999999999999999999999999999999766 8999999999988755 5
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
...+.||||.|.|||++.. ..++..+||||+||++|-|+.|++|| ...+-.+.+.+|...- -+.+..++|.+
T Consensus 174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPF-etk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPF-ETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCc-ccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 6678899999999999986 78999999999999999999999999 3444444555544331 25677888888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
||+.||..||+++++|.|+|++.
T Consensus 252 -lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 252 -LLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -HhcCCcccCCCHHHHhcCHhhhC
Confidence 79999999999999999999944
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-53 Score=374.92 Aligned_cols=244 Identities=32% Similarity=0.606 Sum_probs=217.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+.|+.+.++|+|+||.||+|+++.+|+.||||.+.... ++-..+|+++|++| +|+|+|.++++|.. ...+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence 46888999999999999999999999999999986432 35578999999999 99999999999964 678899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CCCc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~~~ 284 (401)
|+|||+..-|..+- ..+++..++.+++|++.|+.|+|++++|||||||+|||++.++ .+||||||+|+.+. ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence 99999998766553 4589999999999999999999999999999999999999777 89999999999887 7778
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~---------------- 348 (401)
++..+.|++|+|||.+.+...|+..+||||+||++.||++|. |++++.++.+|+..|.+.+|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 899999999999999999889999999999999999999997 666999999999999998771
Q ss_pred ---------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 349 ---------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 349 ---------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+-+.+++.+ |+++||..|.+.+|++.|++|+.+.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~-cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKK-CLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHH-HhcCCccccccHHHHhcChHHHHHH
Confidence 123445556 8999999999999999999997654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=385.96 Aligned_cols=249 Identities=29% Similarity=0.494 Sum_probs=220.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..+|..++.||.|+|++|++|+++.+++.||||++.+ .+.+-+.+|-.+|.+|.+||.|++||-.|.| ...+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence 4689999999999999999999999999999999853 3345678899999999999999999999976 6789
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|+|+||+++|+|..++. .+.+..++.++.||+.||+|||++|||||||||+|||+|.|+ ++||+|||.|+.+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhh
Confidence 99999999999987774 589999999999999999999999999999999999999887 89999999998875321
Q ss_pred c--------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--
Q 015741 284 E--------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-- 347 (401)
Q Consensus 284 ~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-- 347 (401)
. ....+||..|.+||++.+ +..++.+|||+||||||+|+.|.+|| .+.+++-.+++|.+..-
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhcccC
Confidence 1 144799999999999987 78999999999999999999999998 77888888898888732
Q ss_pred ----ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 348 ----TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 348 ----~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.+...+++.+ +|..||..|++++++.+||||+-+..+|-
T Consensus 307 p~~fp~~a~dLv~K-LLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 307 PEGFPEDARDLIKK-LLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred CCCCCHHHHHHHHH-HHccCccccccHHHHhhCcccccCChhhh
Confidence 4567777788 69999999999999999999999988773
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=372.59 Aligned_cols=245 Identities=29% Similarity=0.491 Sum_probs=208.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|.+.+.||.|+||.||+|+++.++..||||.+... ..+.+..|+.+|+.+ +|||||.+++++.+ ..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCeEE
Confidence 57899999999999999999999999999999998654 345678999999999 89999999999976 46899
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--C---CeEEEEecccceec
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q---RKLRLIDWGLAEFY 279 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~---~~vkl~DFg~a~~~ 279 (401)
+|||||.||+|..++. .++|..++.++.||+.||++||+++||||||||+||||+.. . ..+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999988864 58999999999999999999999999999999999999753 2 36899999999999
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChh
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDE 350 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~ 350 (401)
.++....+.+|++.|||||++.. +.|+.|+|+||+|+|||+|++|+.|| ...+..+.+..+.+.- .+++
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhccccccCchhhhccCc
Confidence 98888888999999999999976 78999999999999999999999998 4444444444444331 1344
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..+++.. .+..+|..|....+.+.|++...-+
T Consensus 244 ~~~Ll~~-ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 244 LRELLIS-LLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhhH-HHhcCccccCchHHhhhhhhcccCc
Confidence 4555555 4777888888888888887776543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=381.01 Aligned_cols=246 Identities=33% Similarity=0.622 Sum_probs=217.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..+.|+.+++||+|.||.||+|++..+|+.||+|.+.-. ......+||.||++| +||||+++.++..+.....+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence 357899999999999999999999999999999988533 235578999999999 99999999999998767889
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||+|||+......... .+++.+++.+++||+.||+|+|++||+|||||.+|||||.++ .+||+|||+|+++....
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCC
Confidence 99999999765443332 599999999999999999999999999999999999999777 89999999999876554
Q ss_pred --cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhHH---------
Q 015741 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN--------- 352 (401)
Q Consensus 284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~--------- 352 (401)
.++.++.|.+|+|||.+.|...|+.++|+||.||||.||++|+ |++.+.++.+|+..|.+..|+|...
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 4788899999999999999899999999999999999999998 4459999999999999998855322
Q ss_pred --------------------------HHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 353 --------------------------AYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 353 --------------------------~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.+ ||.+||.+|.++.++|+++||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~-lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEK-LLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHH-HhccCccccccHHHHhcCccccc
Confidence 23445 79999999999999999999944
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=350.42 Aligned_cols=243 Identities=35% Similarity=0.677 Sum_probs=213.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|..+++||+|.||.||+|++..+|+.||||.++..+. ....+|++.|+.+ +|+||+.++++|.. ...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~--~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPH--KSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccC--CCceEE
Confidence 468888999999999999999999999999999875433 4578999999999 89999999999954 677889
Q ss_pred EEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
|+|||+. +|+..++ .++..+++.++.++++||+|||++.|+||||||.|+|++.++ .+||+|||+|+.+.+. .
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCc
Confidence 9999985 5555553 488999999999999999999999999999999999999877 8999999999988644 3
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChh-------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE------------- 350 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~------------- 350 (401)
..+..+.|++|+|||.+.|.+.|+..+|+||.|||+.||+-|. ||++|.++.+|+..|.+.+|.|.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 4455689999999999999999999999999999999999775 88899999999999999988543
Q ss_pred ---------------------HHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 351 ---------------------LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 351 ---------------------~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..+++.+ |+.+||..|.++.|+|.|+|++-.+
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~-m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSK-MLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHh-hhccCchhcccHHHHhcchhhhcCC
Confidence 3334555 8999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=353.14 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=214.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||.|+||.|.+++++.+|..||+|++++.. .+...+|..+|+.+ .||+++++++.+.| ..++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCeE
Confidence 478999999999999999999999999999999997543 35577899999999 89999999999966 6789
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
||||||++||.|..+++ ++++..++.+++||+.||+|||+++|++|||||+|||+|.+| .+||+|||+|+.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-
Confidence 99999999999877764 699999999999999999999999999999999999999877 8999999999987533
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
+.+.|||+.|+|||++.. ++|+.++|+|||||++|||+.|..||+ ..+......+|.+.. -++++++++.+
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~-~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFY-DDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCc-CCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 667899999999999987 899999999999999999999999995 445577777777652 26788999998
Q ss_pred cCCCCChhhHH-----HhhhhcCCCcccccccc
Q 015741 358 YHIELDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 358 ~~l~~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
+++.|-.+|. -.+++..|||++-...+
T Consensus 275 -LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 275 -LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred -HHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 5999999993 36789999999876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=382.46 Aligned_cols=249 Identities=29% Similarity=0.542 Sum_probs=217.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
-++|.++++||.|.||.||+|+.+.+++.||||.+++.-. -.-.||+..|++|..|||||++.+++.|.+. .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 3789999999999999999999999999999999875321 2246899999999449999999999988643 8999
Q ss_pred EEeecCCCchh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 209 IFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 209 v~e~~~~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|||||+..... +..+.+++..++.|+.||++||+|+|.+|+.|||+||+|||+.... .+||+|||+|+.+.....+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCCCc
Confidence 99999876433 2234599999999999999999999999999999999999998544 8999999999999888999
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChh---------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE--------------- 350 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~--------------- 350 (401)
+..+.|++|+|||++.....|+.++|+||+|||++|+.+-+ |.|+|.++.|++.+|.+++|.|.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 99999999999999988889999999999999999999987 55699999999999999998543
Q ss_pred ---------------------HHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 351 ---------------------LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 351 ---------------------~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
..+++.+ |+..||.+||++.|+|+|||++.-...
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~-ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIER-LLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHH-HhcCCCccCccHHHHhcCccccccccc
Confidence 2233444 899999999999999999999885544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=359.49 Aligned_cols=247 Identities=31% Similarity=0.577 Sum_probs=217.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC---CcEEEEe
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFE 211 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~---~~~lv~e 211 (401)
.|.-.+.+|.|+||.||+|....+++.||||..-+..+ --.+|+++|+.+ +|||||++.-+|....+. +..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 58889999999999999999999999999998754332 335799999988 999999999988754444 6778999
Q ss_pred ecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 212 HVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 212 ~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+........ ++++..+++.+..||++||.|||+.||+||||||.|+|+|.+.+.+||||||.|+.+..+...
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 99976554443 468889999999999999999999999999999999999999889999999999999888888
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC-----------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------------- 348 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~----------------- 348 (401)
.....|++|+|||.+.+...|+.+.||||.||++.||+-|+ |.|.|.+..+|+..|.+.+|.
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~-plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~ 261 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ-PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK 261 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC-cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence 88889999999999999999999999999999999999997 555899999999999999873
Q ss_pred ------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 349 ------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 349 ------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++..+++.+ +++++|.+|.++.+++.||++.-....
T Consensus 262 ~p~ik~~~~~~~~~~~~~~d~~dll~~-~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 262 FPQIKAHPWHKVFFKRLPPDALDLLSK-LLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccceeecccCCCHHHHHHHHH-HhccChhhcCCHHHHhcchhhHHhhCc
Confidence 355566777 799999999999999999999775443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=369.15 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=211.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|+++..||+|+||+||+|+.+.+|..+|+|++++. ..+.++.|-.+|... ++|.||++|..|.+ ..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CCe
Confidence 468999999999999999999999999999999999753 345688899999995 99999999999965 689
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-
Q 015741 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~- 281 (401)
+||||||++||++..++. .+++..++.++.+++.|++.||+.|+|||||||+|+|||..| ++||+|||++.-+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence 999999999999887764 599999999999999999999999999999999999999877 899999999843210
Q ss_pred ---------------------CC-c-----c--------------------cccccCCCccccccccCCCCCCcccchHH
Q 015741 282 ---------------------GK-E-----Y--------------------NVRVASRYFKGPELLVDLQDYDYSLDLWS 314 (401)
Q Consensus 282 ---------------------~~-~-----~--------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 314 (401)
.. . . ...+|||.|+|||++.+ .+|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 00 0 0 11379999999999998 77999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---C-------ChhHHHHHHhcCCCCChhhHHH---hhhhcCCCcccc
Q 015741 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---G-------TDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKF 381 (401)
Q Consensus 315 lG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---~-------~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~ 381 (401)
||||+||||.|.+|| .+.+..+...+|.... . +++..++|.++| . ||+.|.- ++|+..|||++.
T Consensus 374 LG~ImyEmLvGyPPF-~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll-~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPF-CSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL-C-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh-c-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999998 5666677666665542 2 568889999954 3 9999985 899999999999
Q ss_pred cccccc
Q 015741 382 ITVENQ 387 (401)
Q Consensus 382 ~~~~~~ 387 (401)
+..++-
T Consensus 451 v~W~~l 456 (550)
T KOG0605|consen 451 VDWDHL 456 (550)
T ss_pred CCcchh
Confidence 887663
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=371.01 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=211.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..+.|.+.+.||+|+||+|++|.+..+++.||+|+++.. ..+.+.+|+.+++.+..||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 357899999999999999999999999999999987653 2346778999999994499999999999764
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-
Q 015741 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY- 279 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~- 279 (401)
..+|+||||+.+|+|.+.+ .++.|.+++.+++|++.|++|||++||+||||||+|||++.+...+||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 4489999999999987665 468999999999999999999999999999999999999977248999999999988
Q ss_pred CCCCcccccccCCCccccccccCCCCC-CcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hC-ChhH
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDY-DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LG-TDEL 351 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~-~~~~ 351 (401)
..+....+.+||+.|+|||++.+...| +.++||||+||+||.|++|..||.. .+.......|.+. .- +++.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 466777889999999999999885525 5899999999999999999999944 3444444444433 12 6677
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
..++.+ |+..||..|+++.++++|||++.
T Consensus 252 ~~Li~~-mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEK-MLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHH-HcCCCcccCCCHHHHhhChhhcc
Confidence 888888 89999999999999999999997
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=364.59 Aligned_cols=246 Identities=29% Similarity=0.549 Sum_probs=209.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------hHHHHHHHHHHHHhcCCCCeeEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL 195 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~il~~l~~hpniv~~~ 195 (401)
.++|++++.||+|.||.|-+|++..+++.||||++.+.. .++..+|+.||++| +|||||+++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 478999999999999999999999999999999985321 25688999999999 999999999
Q ss_pred eEEEcCCCCCcEEEEeecCCCchhhhcC--C-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEe
Q 015741 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYP--T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (401)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~-~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~D 272 (401)
++..|+....+|||+|||..|.+...-. . +.+.+++.|+++++.||+|||.+|||||||||+|+|++.++ +|||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeec
Confidence 9999999999999999999998765542 3 88999999999999999999999999999999999999776 999999
Q ss_pred cccceecCCC------CcccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 015741 273 WGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 273 Fg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~ 343 (401)
||.+.....+ ......+||+.|+|||...+. ...+.+.||||+||+||.|+.|+.||+ +....+...+|.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHHh
Confidence 9999866322 223457999999999998762 235678999999999999999999994 445555555655
Q ss_pred HH-hC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 344 KV-LG-------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 344 ~~-~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.. +. .+.++++|.+ ||+.||+.|.++.++-.|||..+-
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~-lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKR-LLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHH-HhhcChhheeehhhheecceeccC
Confidence 43 11 3466777777 899999999999999999998763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=351.40 Aligned_cols=247 Identities=30% Similarity=0.508 Sum_probs=215.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH-----HHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..++|+.++.|++|+||.||+|+++.+++.||+|.++....+ .-.+||.+|.++ +|||||.+-++....+-..+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEecccccee
Confidence 347899999999999999999999999999999999754432 358999999998 89999999999987777789
Q ss_pred EEEEeecCCCc--h-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 207 SLIFEHVNNTD--F-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 207 ~lv~e~~~~~~--l-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
|+|||||+... | ...-+++...+++.++.|++.||+|||.+.|+||||||+|+|+++.| .+||+|||+|+.+...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCc
Confidence 99999998752 2 22234789999999999999999999999999999999999999777 8999999999987544
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChh------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE------------ 350 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~------------ 350 (401)
..++..+.|.+|+|||.+.+...|+.+.|+||+|||+.||++++ |.++|....+|+.+|.+.+|.|.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 55778899999999999999999999999999999999999997 55599999999999999987431
Q ss_pred --------------------------HHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 351 --------------------------LNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 351 --------------------------~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
-.+++.. ++.+||..|.+++++|.|.|+.-.
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~-llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNK-LLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHH-HhccCccccccHHHhhcccccccC
Confidence 1233444 799999999999999999999873
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=350.83 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=219.9
Q ss_pred ccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEc-
Q 015741 127 TVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRD- 200 (401)
Q Consensus 127 ~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~- 200 (401)
...+.....|..++.||+|+||.|+.+.++.+|+.||||.+. ....++..+|+++|+.+ +|+||+.+++++..
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPP 93 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccc
Confidence 344445677777899999999999999999999999999875 23457789999999999 79999999999875
Q ss_pred --CCCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 201 --QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 201 --~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
.....+|+|+|+|+ .+|...++ .+++..++.+++||+.||.|+|+.||+||||||.|+|++.+. .+||||||+
T Consensus 94 ~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGL 171 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGL 171 (359)
T ss_pred cccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccc
Confidence 23456899999994 56665553 389999999999999999999999999999999999999777 789999999
Q ss_pred ceecCC---CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCCh---
Q 015741 276 AEFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD--- 349 (401)
Q Consensus 276 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~--- 349 (401)
|+.... ....+..+.|.+|+|||++.....|+.+.||||+|||+.||++|+.-| .|.+..+|+..|.+.+|+|
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHH
Confidence 998864 444577899999999999998899999999999999999999998555 9999999999999988743
Q ss_pred ----------------------------------hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccccc
Q 015741 350 ----------------------------------ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQH 388 (401)
Q Consensus 350 ----------------------------------~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~ 388 (401)
...+++.+ ||..||.+|++++++|+||++..+...+..
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlek-mL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEK-MLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHH-HhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 33344556 899999999999999999999887655543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=370.86 Aligned_cols=246 Identities=24% Similarity=0.431 Sum_probs=216.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+-|++++.||.|+-|.|.+|++..||+.+|||++.+. ....+++|+-||+-| .|||++++|+++++ ..++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeecc--CceEE
Confidence 4478899999999999999999999999999998643 246799999999998 99999999999976 57889
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+|.||+.+|.|.+++ +++++.+++.+++||+.|+.|+|..+|+||||||+|+|+|.++ .+||+|||+|..-.++.-
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCcc
Confidence 999999999987765 4699999999999999999999999999999999999999877 599999999998878888
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHHh------CChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~~------~~~~~~~~l~~ 357 (401)
..+.||++.|.|||++.|..+.+.++||||.|||||.|++|+.||. +++...+. ++.++. -+++..++|.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 8899999999999999997777899999999999999999999994 55555554 444332 25677888888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
|+.+||+.|.++++++.|||..-.....
T Consensus 246 -ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 246 -MLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred -HhccCccccccHHHHhhCchhhcCCCCC
Confidence 8999999999999999999997765544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=367.44 Aligned_cols=244 Identities=23% Similarity=0.426 Sum_probs=215.3
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.....|....+||+|+.|.||.|+...+++.||||.+.. ..++-+.+|+.+|+.+ +|+|||.+++.|.. ...++
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv--~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLV--GDELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcc--cceeE
Confidence 445779999999999999999999999999999999853 3456689999999999 99999999998765 36789
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
+|||||+||+|.+... .++|.++..+++++++||+|||.+||+|||||.+|||++.++ .+||+|||++..+.... .
T Consensus 347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCc
Confidence 9999999999988875 489999999999999999999999999999999999999877 79999999998886554 4
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYL 355 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l 355 (401)
..+.+||++|||||++.. ..|++++||||||++++||+-|.+||++ .++...+..|...- -++.+++||
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 567899999999999886 7999999999999999999999999975 55556666655432 267899999
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+ ||+.|++.|+++.++|+|||++.
T Consensus 504 ~~-cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 504 DR-CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HH-HhhcchhcCCCHHHHhcChhhhh
Confidence 99 89999999999999999999954
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=347.42 Aligned_cols=232 Identities=27% Similarity=0.538 Sum_probs=194.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..+|+|+++||+|+||+||++.+..+|..+|.|.++ ...+..+..|+.+|++| +|||||++++.-...+..-++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence 357899999999999999999999999999999875 23456789999999999 999999999944344456688
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHh--CC--ceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~--~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
+|||||..|+|...++ .++|..++.++.|++.||..+|+ .+ |+||||||.||+++.+| .|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhH
Confidence 9999999999987763 58999999999999999999999 45 99999999999999776 8999999999
Q ss_pred eecCCCCcc-cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHHhC-------
Q 015741 277 EFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLG------- 347 (401)
Q Consensus 277 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~~~------- 347 (401)
+.+...... ...+|||+||+||.+.+ .+|++++||||+||++|||+.-..||+ +. +...+. +|.++--
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~-g~-n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY-GD-NLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc-cc-cHHHHHHHHHcCCCCCCcHHH
Confidence 988755443 45799999999999987 799999999999999999999999994 43 555555 4444322
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHh
Q 015741 348 -TDELNAYLNKYHIELDPHLAALV 370 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~ 370 (401)
+.++..++ ..|+..||+.||+.
T Consensus 253 YS~~l~~li-~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELI-NMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHH-HHHccCCcccCCCc
Confidence 22444444 45899999999973
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=366.73 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=217.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|.+++.||+|+||+|+++..+.+++.||||++++. ..+....|-+|+....+||.++.++..|. ...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cCCe
Confidence 358899999999999999999999999999999999753 34678889999998878999999999995 4689
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
+|+||||+.||++..++ ..+++..++.|++.++.||.|||++||||||||.+|||+|.+| .+||+|||+++..- .+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCC
Confidence 99999999999965544 3699999999999999999999999999999999999999888 89999999998654 55
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
....+.+||+.|||||++.+ ..|+.++|+|||||+||||+.|..|| .++++.+....|...- -+.+....+.
T Consensus 523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 66788999999999999998 89999999999999999999999999 6777777777665431 1446667777
Q ss_pred hcCCCCChhhHHH-----hhhhcCCCccccccccc
Q 015741 357 KYHIELDPHLAAL-----VGRHSRKPWSKFITVEN 386 (401)
Q Consensus 357 ~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~~~ 386 (401)
+ ++..+|++|.- ++++..|||++-+....
T Consensus 601 ~-ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 601 R-LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred H-HhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 7 69999999985 58999999999887543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=353.09 Aligned_cols=246 Identities=25% Similarity=0.424 Sum_probs=201.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.+|...+.||+|+||.||++.+..+|+..|||.+...+ .+.+.+|+.+|.+| +|||||++++.........+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 34667899999999999999998889999999987554 45689999999999 699999999974433224678999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC----C
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----G 282 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~----~ 282 (401)
||+.+|+|..++. .+++..++.+.+||++||+|||++|||||||||+|||++..++.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999988764 5899999999999999999999999999999999999997434899999999987653 1
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (401)
.......||+.|||||++.......+++|||||||++.||+||+.||.......+.+..+...-. +++..+|
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF 255 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 22345789999999999985233446999999999999999999998542222233333322211 3478899
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+ |+..||+.|+++.++|+|||.+.
T Consensus 256 l~~-C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 256 LRK-CFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHH-HhhcCcccCcCHHHHhhChhhhc
Confidence 999 79999999999999999999966
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=336.29 Aligned_cols=243 Identities=27% Similarity=0.483 Sum_probs=211.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.+.|++.+.||+|.|+.||++.+..+|+.+|+|++.. ...+.+.+|+.|.+.| +|||||++.+.+.. ..+.|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcc--cceeE
Confidence 4789999999999999999999999999999998753 3457899999999999 99999999998854 57889
Q ss_pred EEEeecCCCchhhh-cC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVL-YP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~-~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~ 282 (401)
+|+|+|.|++|..- .+ -.+|..+-.+++||+++|.|+|.+||||||+||+|+|+.. .+..+||+|||+|..+..+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999998533 23 3688889999999999999999999999999999999953 3347999999999998866
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------ChhHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (401)
.....++|||.|||||++.. ..|+..+|||+.||+||-|+.|..||+ +.+..+..++|.+.-. +++.+
T Consensus 167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 66778899999999999987 789999999999999999999999994 5555666666665421 56778
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.+ ||..||.+|.++.++|+|||.+-
T Consensus 245 ~Lvrr-ML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRR-MLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHH-HhccChhhhccHHHHhCCchhcc
Confidence 88888 99999999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.82 Aligned_cols=248 Identities=29% Similarity=0.505 Sum_probs=203.8
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeE
Confidence 55789999999999999999999998899999999986432 34578899999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
++||||+.++.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCC
Confidence 9999999765444333 3478899999999999999999999999999999999999766 8999999998754322
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......+++.|+|||++.+...++.++|||||||++|+|++|..||....+..+.+..+...++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22344578899999999876567889999999999999999999999654444445444433222
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+.+.+++.+ |++.||..|+++.++++|||++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASK-LLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHH-HhccCchhccCHHHHhcCcccccCC
Confidence 1345577777 8999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=359.97 Aligned_cols=239 Identities=29% Similarity=0.505 Sum_probs=205.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH-----HHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+. .+.+|++|++.| +|||||.++++|+. ...+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt--~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFET--SAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcc--cceEEE
Confidence 4688889999999999999999999999999999765543 489999999999 99999999999965 678899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
|+||+.| +|..++ ..++|+.++.++++++.||.|||+.+|+|||+||.|||++..+ .+|+||||+|+.+..+..
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCcee
Confidence 9999998 777666 4699999999999999999999999999999999999999666 899999999998765543
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH-HHHHh------CChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVL------GTDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~-i~~~~------~~~~~~~~l~~ 357 (401)
.+...||+.|||||.+.+ +.|+..+|+||||||+|||++|++||+.. ..-++.+ |.+.. .+..+..|+..
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 345689999999999986 89999999999999999999999999532 2223332 22211 14577788888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.||..|.+..+++.|||-|-
T Consensus 234 -LL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 234 -LLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred -HhhcChhhcccHHHHhcChHHhh
Confidence 69999999999999999998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=351.58 Aligned_cols=246 Identities=28% Similarity=0.563 Sum_probs=215.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.|++.+.||+|.||.||+|+++.+|+.+|+|++++.. .+.+.+|+.+|+++..|||||.++++|++. ..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence 467999999999999999999999999999999996543 257999999999995599999999999874 578
Q ss_pred EEEEeecCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC---CeEEEEecccceecCC
Q 015741 207 SLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---~~vkl~DFg~a~~~~~ 281 (401)
++|||++.||.|.+.+.. +++.++..++.|++.++.|||+.||+||||||+|+|+.... ..+|++|||++.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999998776643 99999999999999999999999999999999999996442 3799999999999887
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------ChhH
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDEL 351 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~~~ 351 (401)
+......+||++|+|||++.. ..|+..+||||+||++|.|++|..||+ +.+.......+.+.-- +...
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW-GETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 667788999999999999876 689999999999999999999999994 4555555555555411 4577
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++++.+ |+..||..|.++.++|+|||.+-..
T Consensus 270 kd~i~~-ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 270 KDFIRK-LLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHH-hcccCcccCCCHHHHhcCccccCCc
Confidence 888888 7999999999999999999987753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=361.97 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=205.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC------CCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------QSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~------~~~~ 205 (401)
...+|++.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.+ +||||+++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence 356899999999999999999999899999999988543 23456799999999 999999999876432 1235
Q ss_pred cEEEEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 206 PSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+++||||++++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 6799999997543322 1358899999999999999999999999999999999999876657999999999877
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
..........+++.|+|||++.+...++.++|||||||++|||++|..|| .+....+++.++.+.++
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 65555555678999999999877567999999999999999999999888 55666666666655432
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ ||+.||..|+++.+++.|||++-+..
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~-~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQ-FLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHH-HCCCChhHCcCHHHHhCChhHHhhhc
Confidence 2356677777 89999999999999999999976543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=342.18 Aligned_cols=241 Identities=27% Similarity=0.532 Sum_probs=199.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..++|++.+.||.|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~ 79 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCLT 79 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEE
Confidence 457899999999999999999999999999999998632 234678999999999 99999999999865 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
+||||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCC
Confidence 99999986 555443 2368889999999999999999999999999999999999766 8999999999765322
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 22334567889999999876567899999999999999999999998 44455555544443322
Q ss_pred ---------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+++..+++.+ |++.||..|++++++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~-mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSS-LLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHH-hcCcCcccCCCHHHHhcCCCC
Confidence 2345567777 899999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=358.09 Aligned_cols=249 Identities=21% Similarity=0.395 Sum_probs=197.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhc-----CCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~-----~hpniv~~~~~~~~~~~~ 204 (401)
..++|++++.||+|+||+||+|.+..+++.||||+++.. .......|+++++.+. +|.+++++++++... ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence 357899999999999999999999999999999999642 2345677888888772 234689999988754 45
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCC---------------
Q 015741 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR--------------- 266 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~--------------- 266 (401)
.+++|||++.+..+..+. ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 678999988554443332 358999999999999999999998 59999999999999986542
Q ss_pred eEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh
Q 015741 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 267 ~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
.+||+|||.+... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+.+..+.+.+
T Consensus 286 ~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccC--ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence 4999999988643 223345689999999999987 68999999999999999999999998 4555555555444432
Q ss_pred C------------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 347 G------------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 347 ~------------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
+ .+.+.++|.+ ||+.||+.|++++|+|+|||
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG-LLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH-hCCcChhhCCCHHHHhcCcc
Confidence 2 1234466777 89999999999999999999
Q ss_pred cccccccc
Q 015741 379 SKFITVEN 386 (401)
Q Consensus 379 ~~~~~~~~ 386 (401)
+..+..+.
T Consensus 441 ~~~~~~~~ 448 (467)
T PTZ00284 441 VLKYYPEC 448 (467)
T ss_pred ccccCCcc
Confidence 98865544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=337.67 Aligned_cols=244 Identities=22% Similarity=0.363 Sum_probs=201.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +|+||+++++++.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 3788999999999999999999999999999986422 23577899999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC
Confidence 99999999986553 2478889999999999999999999999999999999998666 89999999998765544
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--HHHHH-HHHH------hCChhHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVK-IAKV------LGTDELNAY 354 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--~~l~~-i~~~------~~~~~~~~~ 354 (401)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... +.+.. +... .-++.+.++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 4455678999999999986 689999999999999999999999995433221 11111 1111 124567777
Q ss_pred HHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
+.+ |+..||..|++ ++++++|||++.+..
T Consensus 236 i~~-~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 236 CRM-LLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHH-HhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 777 89999999997 899999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=354.50 Aligned_cols=239 Identities=31% Similarity=0.573 Sum_probs=206.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHhcCC-----CCeeEEeeEEEcCCCCCcE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h-----pniv~~~~~~~~~~~~~~~ 207 (401)
+|+|++.||+|+||.|.+|.+..+++.||||+++.... .+-..|+.+|..|.+| -|+|+++++|.. ..+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence 78999999999999999999999999999999986543 5678899999999534 399999999965 67889
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC-CCCeEEEEecccceecCC
Q 015741 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~vkl~DFg~a~~~~~ 281 (401)
||+|.+.. +|.++++ .++...++.++.||+.||.+||+.||||+||||+||||.+ +...|||+|||.+....
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~- 342 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES- 342 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC-
Confidence 99998874 4444443 4889999999999999999999999999999999999953 33479999999998754
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCCh------------
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD------------ 349 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~------------ 349 (401)
....+.+.+++|+|||++.| ..|+.+.||||||||++||++| .|+|+|.++.+|+..|.+.+|.|
T Consensus 343 -q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 343 -QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred -Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 33337889999999999998 7899999999999999999999 58889999999999999987621
Q ss_pred ---------------------------------------------------------hHHHHHHhcCCCCChhhHHHhhh
Q 015741 350 ---------------------------------------------------------ELNAYLNKYHIELDPHLAALVGR 372 (401)
Q Consensus 350 ---------------------------------------------------------~~~~~l~~~~l~~dP~~R~~~~~ 372 (401)
.+.+|+.+ |++.||..|++..+
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~-~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR-CLEWDPAERITPAQ 498 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH-HhccCchhcCCHHH
Confidence 23455666 89999999999999
Q ss_pred hcCCCcccc
Q 015741 373 HSRKPWSKF 381 (401)
Q Consensus 373 ~l~~~~~~~ 381 (401)
+|+|||+.-
T Consensus 499 al~Hpfl~~ 507 (586)
T KOG0667|consen 499 ALNHPFLTG 507 (586)
T ss_pred HhcCccccc
Confidence 999999983
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=342.83 Aligned_cols=243 Identities=21% Similarity=0.370 Sum_probs=203.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 4789999999999999999999989999999998642 234578899999999 99999999998865 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence 999999999987765 3588999999999999999999999999999999999998766 8999999999866432
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.... .++.+.+++.+
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~- 231 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF-DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK- 231 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH-
Confidence 234578999999999876 678999999999999999999999984 344444444443321 14567787877
Q ss_pred CCCCChhhHHH-----hhhhcCCCcccccccc
Q 015741 359 HIELDPHLAAL-----VGRHSRKPWSKFITVE 385 (401)
Q Consensus 359 ~l~~dP~~R~~-----~~~~l~~~~~~~~~~~ 385 (401)
|++.||..|++ ++++++|||++.+...
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 89999999994 9999999999875543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=348.78 Aligned_cols=244 Identities=27% Similarity=0.496 Sum_probs=203.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 47899999999999999999999999999999998632 245678999999999 99999999999864322
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
..+++||||+.++.+......+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc
Confidence 35789999999876666556788999999999999999999999999999999999999776 89999999997654444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.++
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 4455678999999999877 678999999999999999999999984 3444443333322211
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+.+++.+ |+..||+.|+++.++++|||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSK-MLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHH-HhccCcccCCCHHHHhcCchhhh
Confidence 2345677777 89999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=326.05 Aligned_cols=255 Identities=22% Similarity=0.411 Sum_probs=215.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------c----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------K----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-------~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
+.|.-.+.||.|..+.|.++.++.++..+|+|++... . .+.-.+|+.||+++.+||+|+++.++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 5677788999999999999999999999999998521 1 23456899999999999999999999965
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...+++|+|.|+.|.|.+++. .++|.+.+.+++|+++|++|||.++||||||||+|||++++. .+||+|||++..+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQL 173 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeecc
Confidence 578899999999999988875 489999999999999999999999999999999999999666 8999999999999
Q ss_pred CCCCcccccccCCCcccccccc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---C----
Q 015741 280 HPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---G---- 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---~---- 347 (401)
.++......|||+.|+|||.+. +..+|+..+|+|++|||+|.|+.|..||+.- ...-.+..|.+.. +
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccCCcch
Confidence 9999999999999999999984 3457899999999999999999999999642 1222222333331 1
Q ss_pred ---ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccccCCCCc
Q 015741 348 ---TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE 393 (401)
Q Consensus 348 ---~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~~~~~~ 393 (401)
+...++++.+ +|+.||..|.+++++|.|||+.-+...+.....|-
T Consensus 253 adis~~~KdLIsr-lLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~ 300 (411)
T KOG0599|consen 253 ADISATVKDLISR-LLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPV 300 (411)
T ss_pred hhccccHHHHHHH-HHeeCchhcccHHHHhcChHHHHHHHhcccccCCC
Confidence 3467788888 69999999999999999999977666655555553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=319.15 Aligned_cols=242 Identities=24% Similarity=0.413 Sum_probs=213.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++.+.||+|.||.||+|+.+.++-.||+|++.+. ...++.+|++|...| +||||+++|++|.| ...
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd--~~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHD--SKR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheec--cce
Confidence 357899999999999999999999999999999998542 346789999999999 99999999999987 678
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+|+++||...|++...++ ++.+..+..+++|++.||.|+|.++|+||||||+|+|++.++ .+||+|||.+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC
Confidence 999999999998865543 588999999999999999999999999999999999999877 89999999998664
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------ChhHHHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAY 354 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------~~~~~~~ 354 (401)
.....+.+||..|.+||...+ ..++..+|+|++|++.||++.|..||.. ....+...+|.+.-- +....++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHccccCCcccChhHHHH
Confidence 555677899999999999887 7899999999999999999999999954 346666677766522 5577888
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|.+ |+..+|..|..+.+++.|||...
T Consensus 253 I~~-ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISR-LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHH-HhccCccccccHHHHhhhHHHHh
Confidence 888 79999999999999999999865
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.36 Aligned_cols=239 Identities=34% Similarity=0.597 Sum_probs=199.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998642 235678999999999 99999999999865 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
||||+.++.+..+. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence 99999998876554 3588999999999999999999999999999999999998766 89999999998764332
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFP-GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2234578899999999876 678999999999999999999998884 4444444443333211
Q ss_pred ----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |++.||++|++++++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~-~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKN-LLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHH-HccCCcccCCCHHHHhcCCCC
Confidence 2346677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.90 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=204.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence 36899999999999999999999999999999998642 235688999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++|||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC-
Confidence 9999999999987665 3578899999999999999999999999999999999999766 8999999999876432
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.... .++.+.+++.+
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFF-DDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCC-CCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 234578999999999876 678999999999999999999999994 334444444443221 23567788888
Q ss_pred cCCCCChhhHHH-----hhhhcCCCcccccc
Q 015741 358 YHIELDPHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~-----~~~~l~~~~~~~~~ 383 (401)
|++.||..|++ +++++.|||++-..
T Consensus 249 -~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 249 -LLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred -HhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 89999999986 79999999997643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=331.65 Aligned_cols=246 Identities=32% Similarity=0.576 Sum_probs=209.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCC-eeEEeeEEEcCC----C
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN-IVKLLDIVRDQQ----S 203 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpn-iv~~~~~~~~~~----~ 203 (401)
..|+.+++||+|+||+||+|+.+.+|+.||+|.+.-.. .....+|+.+|+.| +|+| ||.+++++.... .
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence 45777889999999999999999999999999986432 34568999999999 8999 999999987643 2
Q ss_pred CCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
..+++|+||++-. |..++. .++...++.+++||+.||+|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 90 ~~l~lvfe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchH
Confidence 3788999999754 433332 366678999999999999999999999999999999999866 8999999999
Q ss_pred eecC-CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCCh------
Q 015741 277 EFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD------ 349 (401)
Q Consensus 277 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~------ 349 (401)
+... +...++..++|..|+|||++.+...|+..+||||+|||++||++++ |.|.+..+.+++..|.+.+|.|
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 8765 4556788899999999999999778999999999999999999976 5569999999999999998743
Q ss_pred ------------------------------hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 350 ------------------------------ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 350 ------------------------------~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+..+++.+ |++.+|..|.+++.++.|||+.-...
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~-~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSK-LLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHH-HhccCcccCcCHHHHhcChhhccccc
Confidence 33344556 79999999999999999999988643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.02 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+.|++...||.|..++||+|+...+++.||||++.-. ..+.+.+|+..|..+ +||||++++..|.. +..+++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cceeEE
Confidence 47899999999999999999999999999999998632 246789999999988 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
||.||.+|++.++++ .+.|..+..+++++++||.|||.+|.||||||+.||||+.+| .|||+|||.+..+....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSG 180 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccC
Confidence 999999999887764 588999999999999999999999999999999999999887 89999999976654332
Q ss_pred -c----ccccccCCCcccccc-ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 284 -E----YNVRVASRYFKGPEL-LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 284 -~----~~~~~~t~~y~aPE~-~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
. +.+.+|+++|||||+ .....+|+.|+||||||++..||.+|..||. .-.+++.+..-.+.-.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-KYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhcCCCCCcccccCCh
Confidence 1 145689999999999 5666789999999999999999999999994 2233333322111100
Q ss_pred ------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
...++.++.. ||+.||.+||++.++|.|+|++..-.
T Consensus 260 d~~k~~~ksf~e~i~~-CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIAL-CLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHhhhhcHHHHHHHHH-HhhcCcccCCCHHHHhccHHHhhccc
Confidence 1134455555 89999999999999999999987544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=334.21 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=211.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+.|++++.||.|.-|+||+|+...++..+|+|++.+. +..+.+.|-+||+.+ +||.++.+|..|+. ..+.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cceeE
Confidence 5688999999999999999999999999999999643 335678899999999 99999999999965 67899
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-
Q 015741 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~- 281 (401)
++||||.||+|..+++ .+++..++.++.+++.||+|||..|||+|||||+||||..+| +|.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCC
Confidence 9999999999987764 489999999999999999999999999999999999999777 899999998732210
Q ss_pred --------------------------------C-C-----------------------cccccccCCCccccccccCCCC
Q 015741 282 --------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDLQD 305 (401)
Q Consensus 282 --------------------------------~-~-----------------------~~~~~~~t~~y~aPE~~~~~~~ 305 (401)
. . .....+||-.|.|||++.| ..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence 0 0 0122478889999999998 78
Q ss_pred CCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-C-------ChhHHHHHHhcCCCCChhhHHH----hhhh
Q 015741 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-G-------TDELNAYLNKYHIELDPHLAAL----VGRH 373 (401)
Q Consensus 306 ~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-~-------~~~~~~~l~~~~l~~dP~~R~~----~~~~ 373 (401)
.+.++|+|+|||++|||++|..|| .|.++.+.+..|.... . +...+++|.+ +|..||.+|.- +.++
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~-LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRK-LLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHH-HhccChhhhhccccchHHh
Confidence 999999999999999999999999 6777777777665431 1 2467888888 69999999998 9999
Q ss_pred cCCCccccccccccc
Q 015741 374 SRKPWSKFITVENQH 388 (401)
Q Consensus 374 l~~~~~~~~~~~~~~ 388 (401)
-+|||++-+.++--+
T Consensus 390 K~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 390 KRHPFFEGVNWALIR 404 (459)
T ss_pred hcCccccCCChhhee
Confidence 999999998876433
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.94 Aligned_cols=243 Identities=22% Similarity=0.467 Sum_probs=212.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..+|++.+.||+|.||.|-+|.....|+.||||.+++.. .-.+.+|++||..| +||||+.+|++|+. ...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFEN--kdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFEN--KDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcC--CceE
Confidence 568999999999999999999998999999999986532 24588999999999 99999999999965 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||..+|.|.+++ +.+++.+++.+++||..|+.|+|.++++|||||.+|||+|.++ .+||+|||++..+..+.
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcccc
Confidence 9999999999998886 4699999999999999999999999999999999999999777 79999999999998888
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----ChhHHHHHHhcC
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----TDELNAYLNKYH 359 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----~~~~~~~l~~~~ 359 (401)
...++||++.|.+||++.+...-++.+|-|||||+||.|++|..|| .+.+....+.+|...-. .|.-..-|.+.|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISRGAYREPETPSDASGLIRWM 286 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhcccccCCCCCchHHHHHHHH
Confidence 8899999999999999988666689999999999999999999999 56665555556655422 233344455669
Q ss_pred CCCChhhHHHhhhhcCCCccc
Q 015741 360 IELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~ 380 (401)
|..||+.|++++++-.|=|..
T Consensus 287 LmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HhcCcccchhHHHHhhhheee
Confidence 999999999999999997764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=347.82 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=200.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.++.++ +||||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 4789999999999999999999999999999998642 224578899999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence 999999999987765 3589999999999999999999999999999999999999766 89999999987543211
Q ss_pred -----------------------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCC
Q 015741 284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 284 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~P 328 (401)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0123478999999999876 6799999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCCCCChhh---HHHhhhhcCCCccccccccc
Q 015741 329 FFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHL---AALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 329 f~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~---R~~~~~~l~~~~~~~~~~~~ 386 (401)
|. +.+..+....+.... .+++..+++.+++ . +|.. |++++++++|||++.+..+.
T Consensus 236 f~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 236 FC-SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC-C-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CC-CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc-C-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 94 444455555554311 2457788888743 2 4554 47899999999998765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=345.71 Aligned_cols=322 Identities=20% Similarity=0.336 Sum_probs=237.4
Q ss_pred CCCccCCCccCCCCCCCCccccccccCCCCccccCcccc------chhhhhcccCCCC-----CC------hhhhhhccc
Q 015741 34 SRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHA------RHQHQRLRQLATP-----PD------TLAQKIGKS 96 (401)
Q Consensus 34 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-----~~------~~~~~~~~~ 96 (401)
||..++..+..+....++++.+.+.+..+..+.+..... ...|+++++...- .+ .+.+.+.-.
T Consensus 89 sR~~ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~ 168 (468)
T KOG0197|consen 89 SREEAERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERELFSSLQQLVNYY 168 (468)
T ss_pred cHHHHHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHHhhhhHHHHHhhh
Confidence 566677777788888999999998777776665543322 5567777765432 11 011111000
Q ss_pred cccCCCCCCcccccCCCc----CCC------CCcccccccccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEE
Q 015741 97 VRRSGAPSKARVYSDINV----VRP------REYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI 166 (401)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~ 166 (401)
.. .+........+... ..| ++.|.+. .+.+.+++.||+|.||+||+|.+ .....||+|.
T Consensus 169 ~~--~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~--------r~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ 237 (468)
T KOG0197|consen 169 SK--NADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIP--------REELKLIRELGSGQFGEVWLGKW-NGSTKVAVKT 237 (468)
T ss_pred hc--cCcchhhcccCchhccCCCCCCCCccccCCeeec--------HHHHHHHHHhcCCccceEEEEEE-cCCCcccceE
Confidence 00 00000000000000 001 2333322 34556789999999999999998 4556899999
Q ss_pred ecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHH
Q 015741 167 LKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLK 239 (401)
Q Consensus 167 ~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~ 239 (401)
++. ...+.|.+|+++|++| +|+|||++++++..+ ..+|||||||..|+|.++++ .+...+...++.||++
T Consensus 238 ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIae 314 (468)
T KOG0197|consen 238 IKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAE 314 (468)
T ss_pred EeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHH
Confidence 976 4457899999999999 999999999999763 47899999999999988875 3778889999999999
Q ss_pred HHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCC---CccccccccCCCCCCcccchHHHH
Q 015741 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDLWSLG 316 (401)
Q Consensus 240 ~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~---~y~aPE~~~~~~~~~~~~DiwSlG 316 (401)
|++||+++++|||||.+.|||++.+. .+||+|||+|+.. .++.++...|.. -|+|||++.. ..++.+|||||||
T Consensus 315 GM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFG 391 (468)
T KOG0197|consen 315 GMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLI-GDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFG 391 (468)
T ss_pred HHHHHHhCCccchhhhhhheeeccCc-eEEEccccccccc-CCCceeecCCCCCCceecCHHHHhh-CCcccccceeehh
Confidence 99999999999999999999999766 9999999999944 344555555544 4999999876 7899999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhh
Q 015741 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRH 373 (401)
Q Consensus 317 ~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~ 373 (401)
|+||||+|-...++.+.++.+.+..+.+... ++++.+.+.. |+..+|+.||+.+.+
T Consensus 392 VlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~-CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 392 VLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS-CWHEDPEDRPTFETL 454 (468)
T ss_pred hhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH-HhhCCcccCCCHHHH
Confidence 9999999855555588888898888888754 4466665555 899999999998755
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=345.96 Aligned_cols=245 Identities=25% Similarity=0.469 Sum_probs=204.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---- 202 (401)
..++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 357899999999999999999999999999999998642 235678899999998 9999999999876432
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
...+|+||||+.++........+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCC
Confidence 235799999998876665556788999999999999999999999999999999999999766 8999999999876544
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 44455678999999999877 67899999999999999999999998 44455555444433222
Q ss_pred ---------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ---------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ---------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
...+.+++.+ |++.||..|++++++|+|||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~-mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK-MLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHH-hcCcCcccCCCHHHHhcCccccc
Confidence 1245677777 89999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=342.66 Aligned_cols=237 Identities=23% Similarity=0.352 Sum_probs=196.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+|+.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 224577899999999 99999999999876 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence 999987665 3588999999999999999999999999999999999999766 899999999875422 23334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~d 363 (401)
|++.|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+... .-++.+.+++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILMEEIRFPRTLSPEAKSLLAG-LLKKD 233 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 9999999999876 67899999999999999999999999532 222222222211 124577888888 89999
Q ss_pred hhhHH-----HhhhhcCCCcccccc
Q 015741 364 PHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 364 P~~R~-----~~~~~l~~~~~~~~~ 383 (401)
|+.|+ ++.++++|||++.+.
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999 899999999997754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.10 Aligned_cols=242 Identities=29% Similarity=0.456 Sum_probs=204.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 4699999999999999999999989999999998643 234578899999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence 9999999999988763 578999999999999999999999999999999999999766 899999999976543 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------------CChh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------------GTDE 350 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------------~~~~ 350 (401)
.....|++.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.... -+++
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 345678999999999887 589999999999999999999999984 444444443333211 1456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.+++.+ |+..+|..|++++++++|||++....
T Consensus 233 ~~~li~~-~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 233 AWDLITK-LINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHH-HhhChhhhcCCHHHHHhCcccCCCCH
Confidence 7778887 78899999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.51 Aligned_cols=241 Identities=30% Similarity=0.582 Sum_probs=195.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEEeeEEEc---CC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRD---QQ 202 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~--~hpniv~~~~~~~~---~~ 202 (401)
++|++++.||+|+||.||+|++.. +++.||+|+++.. ....+.+|+.+++.+. +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 468999999999999999999854 5788999998632 2245677888887763 69999999998853 23
Q ss_pred CCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 203 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
...++++|||+.+ +|..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence 4568999999985 554443 2378899999999999999999999999999999999999766 89999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
............++..|+|||.+.+ ..++.++|||||||++|||++|+.|| .+..+.+.+..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 7655444455678999999999876 67899999999999999999999887 55556666666654332
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |++.||+.||++.++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHH-HhccCchhcCCHHHHhcCCCC
Confidence 1234566667 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.51 Aligned_cols=245 Identities=26% Similarity=0.487 Sum_probs=202.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----C
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~ 203 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccccc
Confidence 57899999999999999999999889999999998642 235677899999999 9999999999886432 2
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
...+++|||++++.+......+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 173 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc
Confidence 35789999999876665556788999999999999999999999999999999999999766 89999999998765444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.++
T Consensus 174 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP-GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred ccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 4455678999999999876 678999999999999999999999984 4443333333222211
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
...+.+++.+ |+..||+.|+++.++++|||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK-MLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHH-HhcCCchhcCCHHHHhcCcchhcc
Confidence 1234667777 899999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=346.18 Aligned_cols=243 Identities=25% Similarity=0.409 Sum_probs=201.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 4799999999999999999999999999999999642 224577899999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..+.....
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence 999999999998765 3589999999999999999999999999999999999999776 899999999875432110
Q ss_pred ---------------------------------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcC
Q 015741 285 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325 (401)
Q Consensus 285 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg 325 (401)
....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 012368999999999876 6789999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCCCCChhhHHH---hhhhcCCCccccccc
Q 015741 326 KEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITV 384 (401)
Q Consensus 326 ~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~ 384 (401)
..||. +.+..+....+.+.. .++...+++.+ |+. +|..|++ +.+++.|||++....
T Consensus 236 ~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~-ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 236 YPPFC-SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCC-CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH-Hcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99994 334444444443211 14567788887 565 9999998 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=341.86 Aligned_cols=242 Identities=20% Similarity=0.358 Sum_probs=202.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--CCE
Confidence 478999999999999999999876554 78999998532 235678899999999 99999999999976 467
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCCC
Confidence 899999999999877753 588999999999999999999999999999999999998766 8999999999876432
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+.......+.+.. -++...+++.
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 260 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260 (340)
T ss_pred --cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 334678999999999876 678999999999999999999999995 334444444443322 1456778888
Q ss_pred hcCCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 357 KYHIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 357 ~~~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
+ |++.||+.|+ +++++++|||++.+.
T Consensus 261 ~-~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 261 K-LLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred H-HcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 8 8999999995 899999999998754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.97 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=196.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
..+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+++++++ +||||+++++++.. ....+++||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEEec
Confidence 468999999999999999999999999999999763 45678999999999 99999999999976 4577899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC--Ccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNV 287 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~--~~~~~ 287 (401)
+.+ +|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccccccccc
Confidence 975 444333 3588999999999999999999999999999999999999766 8999999999754221 22334
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHhC--------------
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVLG-------------- 347 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~------~~~~l~~i~~~~~-------------- 347 (401)
..||+.|+|||++.+ ..++.++|||||||++|||++|..||+.... ...++..+.+..+
T Consensus 243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 579999999999876 6799999999999999999999998864321 1222222222111
Q ss_pred ---------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..++.+++.+ ||..||+.|++++++|+|||++.+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~-mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICK-MLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHH-HhcCChhhCCCHHHHhcChhhccCC
Confidence 1245566777 8999999999999999999998753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=339.12 Aligned_cols=247 Identities=29% Similarity=0.549 Sum_probs=198.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---CCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---~~~ 206 (401)
+|++.+.||+|+||.||+|++..+++.||+|+++.. ...++.+|+++++++ +||||+++++++..... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 589999999999999999999999999999998632 234688999999999 99999999998864322 357
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+ +|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence 999999975 555544 2588999999999999999999999999999999999999766 89999999997543221
Q ss_pred c----ccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------
Q 015741 284 E----YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------- 347 (401)
Q Consensus 284 ~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------- 347 (401)
. .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||. +.+...++..+.+..+
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345789999999997642 468899999999999999999998883 4333333332222211
Q ss_pred --------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 --------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 --------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
.+.+.+++.+ |+..||+.||+++++++|||++.+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER-LLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHH-HcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 2344567777 8999999999999999999998866543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=338.22 Aligned_cols=246 Identities=23% Similarity=0.430 Sum_probs=219.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+-|.+.+.||+|.|+.|-+|++.-+|++||||++.+.+. ..+.+|++.|+.. .|||||++|++... ...+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcc--cceEEE
Confidence 458889999999999999999999999999999976543 5688999999988 99999999999854 457899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|+|..++|+|.+++ ..+.|..++.|+.||+.|+.|+|+..+|||||||+||++-...+-|||.|||++..+.++..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999998776 35899999999999999999999999999999999999876666899999999999999999
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------ChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (401)
.++.+|+..|.|||++.+..+-.+++||||||||||.|++|+.|| ...++.+.+..|.++.. +.+.+++|..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDCKYtvPshvS~eCrdLI~s- 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDCKYTVPSHVSKECRDLIQS- 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhcccccCchhhhHHHHHHHHH-
Confidence 999999999999999999655568899999999999999999998 66778888888887643 4567777777
Q ss_pred CCCCChhhHHHhhhhcCCCccccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
||.-||++|++++++..++|.+-...
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999987654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.15 Aligned_cols=241 Identities=24% Similarity=0.417 Sum_probs=197.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+++++.+ +||||+++++++.+ ..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 4789999999999999999999999999999998532 235678899999998 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence 999999999997765 3588999999999999999999999999999999999999766 899999999863311000
Q ss_pred ------------------------------------------------ccccccCCCccccccccCCCCCCcccchHHHH
Q 015741 285 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316 (401)
Q Consensus 285 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 316 (401)
....+||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 012468999999999876 6799999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHH---h-------CChhHHHHHHhcCCCCChhhH---HHhhhhcCCCccccc
Q 015741 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKV---L-------GTDELNAYLNKYHIELDPHLA---ALVGRHSRKPWSKFI 382 (401)
Q Consensus 317 ~ll~elltg~~Pf~~~~~~~~~l~~i~~~---~-------~~~~~~~~l~~~~l~~dP~~R---~~~~~~l~~~~~~~~ 382 (401)
|++|||++|..||. +.+..+.+..+... + -++++.+++.+ |+. +|..| +++.+++.|||++-.
T Consensus 236 vil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~-lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 236 AIMFECLIGWPPFC-SENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhhcCCCCCC-CCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHH-Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999984 34444444444321 1 13567788888 576 77776 499999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.97 Aligned_cols=242 Identities=22% Similarity=0.390 Sum_probs=209.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
...|+..+.||+|+||.||+|.+..+++.||+|++.-. ..+.+++|+.+|..+ +++||.++|+.+.. +..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccHHH
Confidence 35678889999999999999999999999999998632 346789999999998 89999999998876 567889
Q ss_pred EEeecCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 209 IFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
+||||.||++...++. +.+.++..++++++.||.|||.++.+|||||+.|||+..++ .+||+|||.+..+.....
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhc
Confidence 9999999998888752 48888999999999999999999999999999999999775 899999999987754432
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-------hCChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~~ 357 (401)
..+.+||++|||||++.+ ..|+.++||||||++.+||.+|.+|+ ....++..+..|.+. .-++.+++|+..
T Consensus 168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~-s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPH-SKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCC-cccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 367899999999999985 79999999999999999999999998 444444444444443 225678999888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
||+.||+.||++.++|.|+|.|+
T Consensus 246 -CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 246 -CLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -HhhcCcccCcCHHHHhhhHHHHh
Confidence 89999999999999999999998
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=344.58 Aligned_cols=242 Identities=22% Similarity=0.374 Sum_probs=199.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++++.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++++ +||||+++++.+.+ ...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEEE
Confidence 588999999999999999999999999999998643 234678899999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC---
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--- 282 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~--- 282 (401)
||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence 99999999987765 3478999999999999999999999999999999999999766 8999999997532100
Q ss_pred ---------------------------------------------CcccccccCCCccccccccCCCCCCcccchHHHHH
Q 015741 283 ---------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (401)
Q Consensus 283 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 317 (401)
......+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence 00112468999999999876 67999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHH----------hCChhHHHHHHhcCCCCChhhHHH---hhhhcCCCccccccc
Q 015741 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKV----------LGTDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITV 384 (401)
Q Consensus 318 ll~elltg~~Pf~~~~~~~~~l~~i~~~----------~~~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~ 384 (401)
++|||++|+.||. +.+..+....+... ..+++..+++.++ + .+|..|++ ++++++|||++.+..
T Consensus 237 il~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 237 ILYEMLVGQPPFL-AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL-C-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHHhCCCCCC-CCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH-c-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999999999994 44444444444321 1256778888884 4 49999997 999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=335.29 Aligned_cols=237 Identities=22% Similarity=0.359 Sum_probs=196.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||++.+..+|+.||+|+++.. ....+.+|+++++.+ +||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 224567899999999 99999999999976 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence 999987654 3588999999999999999999999999999999999999766 899999999875422 22234457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~d 363 (401)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+... .-++.+.+++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILMEEIRFPRTLSPEAKSLLAG-LLKKD 233 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999876 67899999999999999999999999533 333333333211 124677788888 89999
Q ss_pred hhhHH-----HhhhhcCCCcccccc
Q 015741 364 PHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 364 P~~R~-----~~~~~l~~~~~~~~~ 383 (401)
|..|+ ++.++++|+|+....
T Consensus 234 P~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99998 899999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=333.98 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=200.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|.+++..+.+|++|+++++++.+ ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 588999999999999999999999999999998642 235577899999998555678999998865 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CCCc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~~~ 284 (401)
||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence 99999999997665 3578999999999999999999999999999999999999766 89999999987532 2233
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.. -++.+.+++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~- 234 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 345678999999999886 678999999999999999999999984 444444444444322 14466677777
Q ss_pred CCCCChhhHHHh-----hhhcCCCcccccc
Q 015741 359 HIELDPHLAALV-----GRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~~~-----~~~l~~~~~~~~~ 383 (401)
|+..||..|++. +++++|||++.+.
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 899999999976 8999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=334.81 Aligned_cols=236 Identities=20% Similarity=0.333 Sum_probs=192.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeE-EEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++..+.+.||+|+||+||+|.+ .|+. ||+|++.... .+.|.+|+.+|.++ +|||||+++|++.++.. ...
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ceE
Confidence 3445556799999999999997 3555 9999997543 45899999999999 99999999999976532 678
Q ss_pred EEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+||||+.+|+|..++ ..++...+..++.||+.||+|||+++ ||||||||+|||++.+...+||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999998776 35889999999999999999999999 999999999999997655899999999987654
Q ss_pred C-CcccccccCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhH
Q 015741 282 G-KEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDEL 351 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~ 351 (401)
. ...+...||..|||||++.+ ...|+.++||||||+++|||+||+.||.. ....+....+..... .+.+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~-~~~~~~~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED-LAPVQVASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 3 33444789999999999985 26899999999999999999999999943 333444444432211 3455
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
..++.+ |+..||..||+..+++.
T Consensus 276 ~~l~~~-CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 276 SSLMER-CWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHH-hCCCCCCcCCCHHHHHH
Confidence 566666 89999999999877753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=327.79 Aligned_cols=240 Identities=30% Similarity=0.578 Sum_probs=196.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEeeEEEcC---CCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---QSK 204 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~hpniv~~~~~~~~~---~~~ 204 (401)
+|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++.+. +||||+++++++.+. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999986421 235677888887763 699999999988643 234
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
.++++|||+.+ ++..++ ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence 57899999986 454443 2378999999999999999999999999999999999999766 8999999999876
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
..........++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+.+.++....+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54444455678889999999876 67899999999999999999998877 45555555555544322
Q ss_pred ---------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++.+ |++.||+.|+++.+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLE-MLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHH-HhccCcccCCCHHHHhcCCCC
Confidence 2234566777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=343.27 Aligned_cols=243 Identities=21% Similarity=0.353 Sum_probs=197.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++++.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEEE
Confidence 588999999999999999999999999999998642 234578999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence 99999999997765 3588999999999999999999999999999999999999766 89999999975331000
Q ss_pred ----------------------------------------------cccccccCCCccccccccCCCCCCcccchHHHHH
Q 015741 284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (401)
Q Consensus 284 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 317 (401)
.....+||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 0123468999999999876 67899999999999
Q ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHhc-CCCCChhhHHHhhhhcCCCcccccc
Q 015741 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKY-HIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 318 ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~-~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++|||++|..||... +..+....+.... -+++..+++.++ |+..+|..|+++.+++.|||++.+.
T Consensus 237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 237 ILFEMLVGQPPFLAP-TPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHhCCCCCcCC-CHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999999999543 3333333333211 246778888873 3344555699999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.50 Aligned_cols=245 Identities=29% Similarity=0.481 Sum_probs=205.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.++..+ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 4799999999999999999999989999999998642 235678899999999 89999999999876 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 999999999987765 3588999999999999999999999999999999999999776 89999999997664333
Q ss_pred -----------------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 015741 284 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334 (401)
Q Consensus 284 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~ 334 (401)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYS-DT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCC-CC
Confidence 2234578999999999887 6899999999999999999999999954 33
Q ss_pred CHHHHHHHHHH---hC-------ChhHHHHHHhcCCCCChhhHHH-hhhhcCCCccccccccc
Q 015741 335 NYDQLVKIAKV---LG-------TDELNAYLNKYHIELDPHLAAL-VGRHSRKPWSKFITVEN 386 (401)
Q Consensus 335 ~~~~l~~i~~~---~~-------~~~~~~~l~~~~l~~dP~~R~~-~~~~l~~~~~~~~~~~~ 386 (401)
..+....+... .. ++++.+++.+ |+. ||..|++ +++++.|||++-+..+.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~-ll~-dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHH-Hcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 44444444431 11 4667788888 566 9999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.66 Aligned_cols=247 Identities=27% Similarity=0.529 Sum_probs=200.8
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+..++|.+.+.||+|+||.||+|++..+++.||+|.++... ...+.+|+.+++++ +||||+++++++.+ ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 79 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKSL 79 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCeE
Confidence 34578999999999999999999999899999999986332 24577899999999 99999999999876 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCc
Confidence 9999999874433332 2378889999999999999999999999999999999999766 89999999997653322
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+.+..+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP-GSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 22345678899999998765678999999999999999999999984 4444444443333221
Q ss_pred ---------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+++..+++.+ |++.||.+|+++.++++|||++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTK-FLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHH-hccCChhhCCCHHHHhcChhhhhcc
Confidence 2345667777 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.01 Aligned_cols=242 Identities=22% Similarity=0.355 Sum_probs=198.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.+|++++.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++.+ +||||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence 3699999999999999999999999999999998642 235678999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC--
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-- 282 (401)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccc
Confidence 9999999999987753 478889999999999999999999999999999999999776 8999999997432100
Q ss_pred ------------------------------------------CcccccccCCCccccccccCCCCCCcccchHHHHHHHH
Q 015741 283 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320 (401)
Q Consensus 283 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ 320 (401)
......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence 00012468999999999876 67899999999999999
Q ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCCCCChhhHH---HhhhhcCCCcccccc
Q 015741 321 GMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAA---LVGRHSRKPWSKFIT 383 (401)
Q Consensus 321 elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~R~---~~~~~l~~~~~~~~~ 383 (401)
||++|+.||.. .+..+....+.... -++...+++.+ |+ .+|..|+ ++.+++.|||++-+.
T Consensus 236 ell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~-l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 236 EMLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ehhhCCCCCCC-CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHH-Hh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999999943 33344333332211 14567788888 34 5999999 999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=334.55 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=198.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.++.+++.||+|++++. ..+.+..|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998642 234567888888887689999999999976 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence 999997655 3588999999999999999999999999999999999999776 899999999875432 22334457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (401)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -++++.+++.+ |++.|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~L~~d 234 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILNDEVVYPTWLSQDAVDILKA-FMTKN 234 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HcccC
Confidence 8999999999876 678999999999999999999999984 444444444443321 24567788887 89999
Q ss_pred hhhHHHh------hhhcCCCccccccc
Q 015741 364 PHLAALV------GRHSRKPWSKFITV 384 (401)
Q Consensus 364 P~~R~~~------~~~l~~~~~~~~~~ 384 (401)
|..|+++ ++++.|||++.+..
T Consensus 235 P~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999998 99999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=335.21 Aligned_cols=236 Identities=23% Similarity=0.358 Sum_probs=195.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||++.+..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999998642 234678899999999 99999999999875 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~~~ 289 (401)
.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .......
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence 999987665 3588999999999999999999999999999999999999766 8999999998754322 2234457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~d 363 (401)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+... .-++++.+++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSG-LLIKD 233 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCccCCCCCCHHHHHHHHH-HcCCC
Confidence 8999999999876 6789999999999999999999999943 3333333322211 114577888888 89999
Q ss_pred hhhHH-----HhhhhcCCCccccc
Q 015741 364 PHLAA-----LVGRHSRKPWSKFI 382 (401)
Q Consensus 364 P~~R~-----~~~~~l~~~~~~~~ 382 (401)
|..|+ ++.++++|||+...
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99997 89999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=332.82 Aligned_cols=235 Identities=21% Similarity=0.352 Sum_probs=195.0
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 69999999999999999999999998642 234577899999999 99999999999865 4678999999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-CcccccccC
Q 015741 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (401)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~~~~t 291 (401)
++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .......|+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence 9997665 3588999999999999999999999999999999999999766 8999999999754322 223445789
Q ss_pred CCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCChh
Q 015741 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELDPH 365 (401)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~dP~ 365 (401)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+.... -++.+.+++.+ |+..||.
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~ 233 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIG-LLSRDPT 233 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-HcCCCHH
Confidence 99999999886 6789999999999999999999999953 33333333333211 14577888888 8999999
Q ss_pred hHH---HhhhhcCCCcccccc
Q 015741 366 LAA---LVGRHSRKPWSKFIT 383 (401)
Q Consensus 366 ~R~---~~~~~l~~~~~~~~~ 383 (401)
.|+ ++.+++.|||++...
T Consensus 234 ~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 234 RRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HcCCCCCHHHHHcCCCcCCCC
Confidence 997 579999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=334.72 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=198.6
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
+|++++.||+|+||.||++++. .+++.||+|+++.. ..+.+.+|+.+++.+.+||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999999864 46899999998642 124577899999999779999999999865 46
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++||||+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence 788999999999987665 3589999999999999999999999999999999999999776 899999999976533
Q ss_pred CC--cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHH-HHHHH------hCChh
Q 015741 282 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV-KIAKV------LGTDE 350 (401)
Q Consensus 282 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~-~i~~~------~~~~~ 350 (401)
.. ......|+..|+|||++.+...++.++|||||||++|||++|+.||.... .....+. .+.+. .-.+.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 22345789999999998764568899999999999999999999995322 2222222 22211 11346
Q ss_pred HHHHHHhcCCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 351 LNAYLNKYHIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
+.+++.+ |+..||+.|+ +++++++|||++...
T Consensus 238 ~~~li~~-~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 238 AQDLLHK-LLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHHH-HcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 6777887 8999999999 889999999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=341.27 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=203.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCEE
Confidence 57899999999999999999999999999999998632 224477899999998 99999999999876 5678
Q ss_pred EEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
++||||+.+|+|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCc
Confidence 99999999999987764 478888999999999999999999999999999999999766 89999999998764332
Q ss_pred -cccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CCh
Q 015741 284 -EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTD 349 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~ 349 (401)
......|++.|+|||++.+. ..++.++|||||||++|||++|+.||. +.+....+..+.... -+.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC-CCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 22345789999999998652 247899999999999999999999994 344444444443321 145
Q ss_pred hHHHHHHhcCCCCChhh--HHHhhhhcCCCccccc
Q 015741 350 ELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFI 382 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~ 382 (401)
.+.+++.+ |++.+|.. |++++++++|||++..
T Consensus 277 ~~~~li~~-~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 277 QAKDLICA-FLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHH-HccChhhccCCCCHHHHhcCcccCCC
Confidence 67777877 78888987 9999999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=332.56 Aligned_cols=242 Identities=21% Similarity=0.356 Sum_probs=199.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCCCCCcE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~~~~~~ 207 (401)
|++++.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|++++..+. +||||+++++++.+ ...++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 67899999999999999999999999999998642 2345677777665331 79999999999975 46789
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCc
Q 015741 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~ 284 (401)
+||||+.+++|...+. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence 9999999999976653 589999999999999999999999999999999999999776 899999999875422 222
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -++.+.+++.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~- 234 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVNDEVRYPRFLSREAISIMRR- 234 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 344678999999999876 678999999999999999999999984 444444444443321 24567788888
Q ss_pred CCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 359 HIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
|+..||..|+ ++.++++|||++.+.
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 8999999999 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=340.62 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~~ 118 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DKYL 118 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEE
Confidence 47899999999999999999999999999999998632 234577899999998 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 207 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc
Confidence 99999999999987764 478889999999999999999999999999999999999766 899999999987643322
Q ss_pred --ccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CCh
Q 015741 285 --YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTD 349 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~ 349 (401)
.....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||. +.+....+..+.+.. -+.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2356799999999998652 237889999999999999999999994 444444455554321 134
Q ss_pred hHHHHHHhcCCCCChhh--HHHhhhhcCCCccccc
Q 015741 350 ELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFI 382 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~ 382 (401)
...+++.+ |+..++.. |+++.++++|||++..
T Consensus 277 ~~~~li~~-~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICA-FLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHH-HccCchhccCCCCHHHHhcCcccCCC
Confidence 56677776 67644443 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=333.68 Aligned_cols=239 Identities=23% Similarity=0.324 Sum_probs=198.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|++..+++.||+|+++.. ....+..|.+++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 4699999999999999999999999998642 224567888898877789999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence 999997654 3588899999999999999999999999999999999999776 899999999875432 22334457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -++++.+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~-~L~~d 234 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILHDDVLYPVWLSKEAVSILKA-FMTKN 234 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HhccC
Confidence 8999999999876 678999999999999999999999994 444444444443321 24577788887 89999
Q ss_pred hhhHH-------HhhhhcCCCccccccc
Q 015741 364 PHLAA-------LVGRHSRKPWSKFITV 384 (401)
Q Consensus 364 P~~R~-------~~~~~l~~~~~~~~~~ 384 (401)
|+.|+ +++++++|||++.+..
T Consensus 235 p~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 99999 8999999999977543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.60 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=201.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+|++.+.||+|+||.||+|.+..+++.||+|+++... ...+..|..++..+.+|++|+++++++.+ ...+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 4889999999999999999999999999999986421 23466788888887678999999999866 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~ 284 (401)
||||+.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence 99999999997665 3588999999999999999999999999999999999999776 899999999975432 223
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.... .++++.+++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 234 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHNVAYPKSMSKEAVAICKG- 234 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH-
Confidence 345678999999999886 679999999999999999999999994 444444444444321 24567777777
Q ss_pred CCCCChhhHHHh-----hhhcCCCcccccc
Q 015741 359 HIELDPHLAALV-----GRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~~~-----~~~l~~~~~~~~~ 383 (401)
|++.||..|++. .++++|||++.+.
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 899999999974 8999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=339.63 Aligned_cols=243 Identities=28% Similarity=0.531 Sum_probs=199.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---CCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---~~~ 206 (401)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ..+++.+|+.+++.+ +||||+++++++.+... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 477889999999999999999889999999998542 235688999999999 99999999999875431 267
Q ss_pred EEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
|+||||+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence 8999999864333332 3588999999999999999999999999999999999999766 89999999998654332
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
......++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2234467889999999887566899999999999999999999998 45555566555544332
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |++.||..|+++.++++|||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR-MLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHH-hCCCChhhCcCHHHHhcCHhhCC
Confidence 2345566777 89999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.09 Aligned_cols=238 Identities=25% Similarity=0.515 Sum_probs=188.7
Q ss_pred EeeecccCCeeEEEEEEc--CCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 139 VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
.++||+|+||.||+|+++ .+++.||+|.++... ...+.+|+.+++++ +||||+++++++.+.....++++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 368999999999999975 367899999986533 35678999999999 99999999999977666778999999886
Q ss_pred Cchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC---CCCeEEEEecccceecC
Q 015741 216 TDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 216 ~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~vkl~DFg~a~~~~ 280 (401)
. +..++ ..+++..++.++.||+.||+|||++||+||||||+|||++. ..+.+||+|||+++...
T Consensus 85 ~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 D-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred C-HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 4 33222 14788899999999999999999999999999999999942 23479999999998764
Q ss_pred CCC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--------CHHHHHHHHHHhC-
Q 015741 281 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKIAKVLG- 347 (401)
Q Consensus 281 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--------~~~~l~~i~~~~~- 347 (401)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||..... ..+++..+...++
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 321 233457889999999988756789999999999999999999999853222 1233333333222
Q ss_pred -------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ ||+.||.+|++++++++|||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK-LLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHH-HhccCcccCCCHHHHhcCCCC
Confidence 1234456667 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.91 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=200.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++.+.+ ...+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence 4889999999999999999998899999999986422 23467899999999 99999999999865 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+++|...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC
Confidence 99999999987554 2478999999999999999999999999999999999998665 89999999998765444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH----h------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----L------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----~------~~~~~~~ 353 (401)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+... . -++.+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ-RKEKVKREEVERRVKEDQEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC-CchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence 4445678899999999876 6789999999999999999999999953 3322222222111 1 1345677
Q ss_pred HHHhcCCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 354 YLNKYHIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
++.+ |+..||..|+ +++++++|||+....
T Consensus 235 li~~-~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 235 ICRQ-LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHH-HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 7777 8999999999 899999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=336.96 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 4689999999999999999999999999999998743 234578899999988 99999999999876 46789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 999999999998775 3588999999999999999999999999999999999999766 89999999998765433
Q ss_pred cc--cccccCCCccccccccC-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------
Q 015741 284 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------- 346 (401)
Q Consensus 284 ~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------- 346 (401)
.. ....|++.|+|||++.. ...++.++|||||||++|+|++|+.||.. ....+.+..+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCCCC
Confidence 22 23468999999999863 35678899999999999999999999943 34444444443321
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
-++++.+++.+ |+. +|..|+++.+++.|||++.+...
T Consensus 236 ~~~~~~~li~~-ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 236 VSSDFLDLIQS-LLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCHHHHHHHHH-Hcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 13466777777 677 99999999999999999875443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=338.60 Aligned_cols=243 Identities=25% Similarity=0.408 Sum_probs=200.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +||||+++++.+.+ ...++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999998632 235678899999998 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++..+....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999998765 3588999999999999999999999999999999999999766 89999999986542110
Q ss_pred -----------------------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCC
Q 015741 284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 284 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~P 328 (401)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0123478999999999876 6799999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCCCCChhhHH---HhhhhcCCCccccccc
Q 015741 329 FFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAA---LVGRHSRKPWSKFITV 384 (401)
Q Consensus 329 f~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~R~---~~~~~l~~~~~~~~~~ 384 (401)
|. +.+..+....+.... -++...+++.+ ++ .||..|+ ++++++.|||++-+..
T Consensus 236 f~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~-l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 236 FC-SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR-FC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CC-CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHH-hc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 94 444444444443211 24577788888 44 4999998 4899999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=339.10 Aligned_cols=245 Identities=26% Similarity=0.463 Sum_probs=213.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
-++|..++.+|+|+||.+++++++.++..|++|.+.-. .+....+|+.+++++ .|||||.+.+.|.+. +.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 36799999999999999999999999999999998522 234678999999998 999999999999863 45689
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|+|+|++||++...+. .++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++ .|||+|||+|+.+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence 9999999999987763 489999999999999999999999999999999999999888 6899999999999877
Q ss_pred C-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
. .....+||++|++||++.+ ..|+.++|||||||++|||++-+.+| .+.+......+|.+... +.++..+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 6 5567899999999999988 79999999999999999999999888 45555555667777653 3355555
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+.. |+..+|+.||++.++|.+|...+..
T Consensus 238 v~~-~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 238 VKS-MLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHH-HhhcCCccCCCHHHHhhChhhhhHH
Confidence 555 8999999999999999998887654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=332.41 Aligned_cols=244 Identities=20% Similarity=0.383 Sum_probs=198.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|+.++.||+|+||.||+|++..+++.||||++.... ...+.+|+++++.+ +|+||+++++++.+ ...+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence 367888999999999999999998899999999985432 35688999999999 99999999999865 567899
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cccc
Q 015741 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~ 287 (401)
||||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.... ....
T Consensus 150 v~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 150 LLEFMDGGSLEGTH-IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred EEecCCCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccc
Confidence 99999999986542 456778889999999999999999999999999999999766 89999999998764332 2345
Q ss_pred cccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHHHH-HHHHH-------hCChhHHHH
Q 015741 288 RVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLV-KIAKV-------LGTDELNAY 354 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~l~-~i~~~-------~~~~~~~~~ 354 (401)
..|+..|+|||++.. ....+.++|||||||++|||++|+.||..... +...+. .+... ...+++.++
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 307 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHH
Confidence 678999999998743 13345789999999999999999999963221 222221 11111 113567888
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |+..||+.|+++.++++|||+..-
T Consensus 308 i~~-~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 308 ISC-CLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHH-HccCChhhCcCHHHHhcCcccccC
Confidence 888 899999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.10 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=202.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||.||++++..++..+|+|++... ..+.+.+|+++++++ +||||+++++++.+ ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEEE
Confidence 47899999999999999999999999999999998643 235689999999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+++|..++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-c
Confidence 999999999987763 478899999999999999999986 699999999999999776 8999999999765432 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH----------------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI---------------------- 342 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i---------------------- 342 (401)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.... . ..+..+
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPD-A-KELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCC-H-HHHHHHhcccccccccCCccccCccccc
Confidence 334578999999999876 678999999999999999999999984321 1 111110
Q ss_pred ---------------------HHH------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 343 ---------------------AKV------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 343 ---------------------~~~------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+. ..++++.+++.+ |++.||+.|++++++++|||++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK-CLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH-HccCCcccCCCHHHHhcChHHhhccc
Confidence 000 113567788888 89999999999999999999987443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=335.60 Aligned_cols=247 Identities=30% Similarity=0.539 Sum_probs=201.1
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--- 202 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~--- 202 (401)
...++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence 3457899999999999999999999999999999998642 234577899999999 9999999999876432
Q ss_pred -CCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 -SKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
....++++|++ +++|..+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~ 168 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQA 168 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceec
Confidence 23468899987 566665553 589999999999999999999999999999999999999766 8999999999875
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
.. ......+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 43 2344578999999999877567899999999999999999999998 44444444444333221
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+.+.+++.+ |++.||..|+++.+++.|||+..+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEK-MLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCcchhccCC
Confidence 1234566767 89999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.55 Aligned_cols=239 Identities=24% Similarity=0.387 Sum_probs=196.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999998642 234567788888776689999999999976 46889999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence 999987665 3588999999999999999999999999999999999999766 899999999875322 22334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.... .+.++.+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~d 234 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESIRVDTPHYPRWITKESKDILEK-LFERD 234 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999886 678999999999999999999999994 333333333332211 24567788888 89999
Q ss_pred hhhHHHh-hhhcCCCccccccc
Q 015741 364 PHLAALV-GRHSRKPWSKFITV 384 (401)
Q Consensus 364 P~~R~~~-~~~l~~~~~~~~~~ 384 (401)
|..|+++ ++++.|||++.+..
T Consensus 235 P~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 235 PTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HHHcCCChHHHHcCCCcCCCCH
Confidence 9999997 68999999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.24 Aligned_cols=239 Identities=24% Similarity=0.406 Sum_probs=195.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|..+++.+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999999742 224577899999998789999999999976 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-CCCCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~-~~~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.. ..........
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence 999987654 3689999999999999999999999999999999999999766 8999999998753 2233344567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-------CCHHHHHH-HHHH------hCChhHHHHH
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLVK-IAKV------LGTDELNAYL 355 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-------~~~~~l~~-i~~~------~~~~~~~~~l 355 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+.+.. +... .-++.+.+++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8999999999886 678999999999999999999999994211 11111211 1111 1134667778
Q ss_pred HhcCCCCChhhHHH------hhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAAL------VGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~------~~~~l~~~~~~~~~ 383 (401)
.+ |+..||..|++ +.+++.|||++...
T Consensus 237 ~~-~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 237 KG-FLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HH-HhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 77 89999999987 78999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=333.37 Aligned_cols=237 Identities=23% Similarity=0.362 Sum_probs=195.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||++.+..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 224567899999998 99999999999876 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~ 288 (401)
.+++|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence 999987665 358899999999999999999997 7999999999999999766 899999999875432 2233445
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIEL 362 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~ 362 (401)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+... .-.+++.+++.+ |++.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~-~L~~ 233 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLSG-LLKK 233 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-Hhhc
Confidence 78999999999876 6789999999999999999999999943 3333333332211 124677888887 8999
Q ss_pred ChhhHH-----HhhhhcCCCcccccc
Q 015741 363 DPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
||+.|+ ++.++++|||++...
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 999997 899999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.12 Aligned_cols=238 Identities=24% Similarity=0.399 Sum_probs=194.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|..++..+.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998642 223456677777766689999999999865 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence 999997665 3588999999999999999999999999999999999999776 8999999999765322 2334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (401)
|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... -+.++.+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~-~l~~~ 234 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILNDRPHFPRWISKEAKDCLSK-LFERD 234 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999876 678999999999999999999999984 444444444433221 13567777877 89999
Q ss_pred hhhHHHh-hhhcCCCcccccc
Q 015741 364 PHLAALV-GRHSRKPWSKFIT 383 (401)
Q Consensus 364 P~~R~~~-~~~l~~~~~~~~~ 383 (401)
|..|+++ .+++.|||++.+.
T Consensus 235 P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 235 PTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHcCCChHHHHcCcccCCCC
Confidence 9999986 5888999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=320.38 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=193.1
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||+|+||+||+|.+..+++.||+|.+.... .+.+..|+++++.+ +|+||+++++++.. ....++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 699999999999999999999999986421 24567899999999 99999999999865 4568999999999
Q ss_pred Cchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-ccc
Q 015741 216 TDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNV 287 (401)
Q Consensus 216 ~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~~ 287 (401)
++|...+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++..+..... ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence 9997543 2478999999999999999999999999999999999998666 899999999977644322 234
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHH---HHHHHHH------hCChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ---LVKIAKV------LGTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~---l~~i~~~------~~~~~~~~~l~~~ 358 (401)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...+... .-++.+.+++.+
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 234 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA- 234 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHH-
Confidence 578899999999987 67899999999999999999999999543322111 1111111 014567777877
Q ss_pred CCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 359 HIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 359 ~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
|+..||+.|+ +++++++|||++....
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred HhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 7999999999 8899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.46 Aligned_cols=237 Identities=24% Similarity=0.391 Sum_probs=195.4
Q ss_pred eeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+.||+|+||.||++++. .+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+|+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEEE
Confidence 67999999999999864 46889999998642 124567899999999 99999999999976 4578999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccc
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~ 285 (401)
|||+.+++|...+. .+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 99999999977653 478888999999999999999999999999999999999766 8999999998754322 223
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcC
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYH 359 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~ 359 (401)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.+.. .++.+.+++.+ |
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 234 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLTPEARDLLKK-L 234 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-H
Confidence 44578999999999876 678899999999999999999999984 344444444443321 14567788888 8
Q ss_pred CCCChhhHH-----HhhhhcCCCcccccc
Q 015741 360 IELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 360 l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
++.||+.|+ ++++++.|||++...
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.48 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=198.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||++++..+++.||+|++.+. ..+.+.+|+.+++.+ +|+||+++++++.+ ..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 4799999999999999999999999999999998642 234578899999998 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 999999999997765 2588999999999999999999999999999999999998766 89999999997664333
Q ss_pred cc--cccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------
Q 015741 284 EY--NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (401)
Q Consensus 284 ~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------- 346 (401)
.. ....|++.|+|||++.. ...++.++|||||||++|+|++|+.||. +....+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCcccCCCccCC
Confidence 22 23568999999999863 2457889999999999999999999994 333344444443211
Q ss_pred CChhHHHHHHhcCCCCChhh--HHHhhhhcCCCcccccc
Q 015741 347 GTDELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFIT 383 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~~ 383 (401)
.++.+.+++.+ |+..+++. |++++++++|||++...
T Consensus 236 ~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 236 VSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CCHHHHHHHHH-HccCcccccCCCCHHHHhcCCCCCCCC
Confidence 14567777777 56554443 77999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=328.43 Aligned_cols=239 Identities=24% Similarity=0.407 Sum_probs=194.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998743 224577888888887789999999999876 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CCCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence 999987654 3689999999999999999999999999999999999999776 89999999987542 223334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-------CCHHHHHH-HHHH------hCChhHHHHH
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLVK-IAKV------LGTDELNAYL 355 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-------~~~~~l~~-i~~~------~~~~~~~~~l 355 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+.+.. +... ..+..+.+++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 8999999999886 678999999999999999999999994211 11122222 1111 1134666777
Q ss_pred HhcCCCCChhhHHH------hhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAAL------VGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~------~~~~l~~~~~~~~~ 383 (401)
.+ |+..||..|++ +.++++|||++.+.
T Consensus 237 ~~-~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 237 KS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HH-HhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 77 89999999998 57999999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=326.93 Aligned_cols=238 Identities=22% Similarity=0.357 Sum_probs=196.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|..+++.+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998642 234567888999888789999999999876 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence 999987665 3589999999999999999999999999999999999999766 899999999875322 22234457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.... -++.+.+++.+ |+..|
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~d 234 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSILEDEVRYPRWLSKEAKSILKS-FLTKN 234 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-HccCC
Confidence 8999999999876 678999999999999999999999994 333333333332211 24567777877 89999
Q ss_pred hhhHHHh-----hhhcCCCcccccc
Q 015741 364 PHLAALV-----GRHSRKPWSKFIT 383 (401)
Q Consensus 364 P~~R~~~-----~~~l~~~~~~~~~ 383 (401)
|..|+++ .+++.|||++...
T Consensus 235 P~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999 9999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.20 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=198.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++.+.||+|+||.||+|.++.+++.||+|++... ....+.+|+.+++.+ +||||+++++.+.+ ..+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence 357899999999999999999999999999999998532 224477899999998 99999999999975 567
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCC
Confidence 899999999999987764 478888999999999999999999999999999999999766 89999999998764332
Q ss_pred c--ccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CC
Q 015741 284 E--YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GT 348 (401)
Q Consensus 284 ~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~ 348 (401)
. .....||+.|+|||++.+. ..++.++|||||||++|||++|..||. +.+.......+.... .+
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2356799999999998652 237889999999999999999999994 334344444443321 13
Q ss_pred hhHHHHHHhcCCCCChhh---HHHhhhhcCCCccccc
Q 015741 349 DELNAYLNKYHIELDPHL---AALVGRHSRKPWSKFI 382 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~---R~~~~~~l~~~~~~~~ 382 (401)
+.+.+++.+ |+. +|.. |++++++++|+|++-.
T Consensus 276 ~~~~~li~~-~L~-~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICA-FLT-DREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHH-HcC-ChhhhcCCCCHHHHhcCcccCCC
Confidence 456677777 676 5554 6789999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=325.47 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=195.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998643 234466788888775599999999999976 45789999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence 9999987763 578899999999999999999999999999999999999766 899999999875422 22334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELD 363 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~d 363 (401)
|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+... .-+.++.+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~~ 234 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH-GHDEEELFQSIRMDNPCYPRWLTREAKDILVK-LFVRE 234 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH-HhccC
Confidence 8999999999876 678999999999999999999999984 33333333333221 123466788888 79999
Q ss_pred hhhHHHhh-hhcCCCccccccc
Q 015741 364 PHLAALVG-RHSRKPWSKFITV 384 (401)
Q Consensus 364 P~~R~~~~-~~l~~~~~~~~~~ 384 (401)
|..|+++. ++++|||++.+..
T Consensus 235 P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 235 PERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HhhcCCChHHHHcCcccCCCCH
Confidence 99999996 9999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.93 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=196.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc--CCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+++++++ +||||+++++++.. ...++++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 467999999999999999999764 34678999988643 3457899999999 99999999999875 46788999
Q ss_pred eecCCCchhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---c
Q 015741 211 EHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y 285 (401)
Q Consensus 211 e~~~~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~---~ 285 (401)
|++.+..+..+ ...+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..+..... .
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccc
Confidence 99976444333 23589999999999999999999999999999999999999766 899999999976643322 2
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHHhC----------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~~~---------------- 347 (401)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||+.... ...++..+.+.++
T Consensus 245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 34578999999999876 6789999999999999999999999965332 2333333333221
Q ss_pred ------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
..++.+++.+ |+..||+.|+++.+++.|||++....
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAK-MLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHH-HhccChhhCCCHHHHhhCchhhccch
Confidence 1234556666 89999999999999999999987544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.01 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=196.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.++.++.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999999743 224577899999998789999999999876 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CCCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence 999997654 4689999999999999999999999999999999999999776 89999999997532 233344567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-----CCHHHHHHHHHHh-------CChhHHHHHHh
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKIAKVL-------GTDELNAYLNK 357 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-----~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (401)
|++.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...+.+....... .++.+.+++.+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876 688999999999999999999999995321 1222222222111 13456777777
Q ss_pred cCCCCChhhHHH------hhhhcCCCcccccc
Q 015741 358 YHIELDPHLAAL------VGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~------~~~~l~~~~~~~~~ 383 (401)
|+..||..|++ +++++.|||++.+.
T Consensus 237 -~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 237 -FLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -HhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 79999999997 46999999998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=332.04 Aligned_cols=240 Identities=21% Similarity=0.318 Sum_probs=192.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
..+|++++.||+|+||.||+|++..+++.||+|+... .....|+.+++++ +||||+++++++.+ ....++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEEEEc
Confidence 4679999999999999999999998999999998643 3346799999999 99999999999976 4567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.............
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccc
Confidence 9764443332 3588999999999999999999999999999999999999766 79999999997654333444567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC---------HHHHHHHHHHhC-------------
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---------YDQLVKIAKVLG------------- 347 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~---------~~~l~~i~~~~~------------- 347 (401)
|+..|+|||++.+ ..++.++|||||||++|||+++..|++..... ...+..+...++
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 8999999999877 67899999999999999999977776543221 112222222111
Q ss_pred ---------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
..+..+++.+ |++.||.+||++.++++|||++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK-MLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHH-HHcCCcccCcCHHHHhcCchhcc
Confidence 1223345666 89999999999999999999975
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=317.45 Aligned_cols=244 Identities=22% Similarity=0.361 Sum_probs=201.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|++++++++.+.+ ...+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 3778899999999999999999999999999986421 23467899999999 99999999999865 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc
Confidence 99999999997665 2488889999999999999999999999999999999999766 79999999998765444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHHH-------hCChhHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKV-------LGTDELNAY 354 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~--~~~l~~i~~~-------~~~~~~~~~ 354 (401)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+....+.+. ...+++.++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 4445678999999999876 67899999999999999999999999643321 1222222111 124567777
Q ss_pred HHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
+.+ |++.||+.|++ ++++++|||++....
T Consensus 236 i~~-~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 236 CKM-LLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHH-HhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 877 89999999999 899999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.04 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=199.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+|+..+.||+|+||.||+|.+..+++.||+|+++.. ..+.+..|..++..+.+|++|+++++++.+ ...+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 477889999999999999999999999999998642 224567888898888667889999998866 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
||||+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence 99999999997765 3589999999999999999999999999999999999999776 8999999998754322 22
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.... -++++.+++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~- 234 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH-
Confidence 334568999999999876 678999999999999999999999984 334444444443321 14566777777
Q ss_pred CCCCChhhHHH-----hhhhcCCCcccccc
Q 015741 359 HIELDPHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~~-----~~~~l~~~~~~~~~ 383 (401)
|+..||..|++ .+++++|||++.+.
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 79999999997 47899999998765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=311.05 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=204.7
Q ss_pred CCCeEE-EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCCcEEE
Q 015741 133 QDDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i-~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~~~lv 209 (401)
+++|.+ -++||-|-.|.|..|.++.+++++|+|++... ....+|+++.-....|||||.++++|+.. +..++.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 567777 46899999999999999999999999999643 44568888776667899999999998753 34578899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~ 282 (401)
||.|+||.|...++ .++|.++..|++||..|+.|||+.+|.||||||+|+|... .+..+||+|||+|+.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 99999999977663 4899999999999999999999999999999999999964 2347999999999987766
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC---CHHHHHHHHHHhC----------Ch
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---NYDQLVKIAKVLG----------TD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~---~~~~l~~i~~~~~----------~~ 349 (401)
....+.+-|++|.|||++.. ..|+..+|+||+||++|-|++|.+|||..+. ....-.+|....- ++
T Consensus 218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 67778899999999999765 7899999999999999999999999986543 1222223322211 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
..++++.+ +|+.+|..|.+|++++.|||..-...
T Consensus 297 ~aKdlIR~-LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 297 AAKDLIRK-LLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHH-HhcCCchhheeHHHhhcCchhccccc
Confidence 55666666 79999999999999999999876543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.33 Aligned_cols=244 Identities=27% Similarity=0.559 Sum_probs=198.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..++|++.+.||.|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeEE
Confidence 457899999999999999999999889999999998632 234678899999999 99999999999976 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+.+ +|...+ ..+++..++.++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC
Confidence 99999985 554433 2478889999999999999999999999999999999999766 89999999987543222
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+++..+...++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP-GSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 22334668889999998765668899999999999999999999984 3344444433332211
Q ss_pred ---------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+.+++.+ |++.||.+|++++++++|||++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSK-LLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHH-HhcCCcccCcCHHHHhcCcccccc
Confidence 2345667777 899999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.68 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=193.5
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||+|+||.||++.++.+|+.||+|.+... ....+..|+++++++ +||||+++++++.+ ....++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 69999999999999999999999998532 123456799999999 99999999999865 4678999999999
Q ss_pred CchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccccc
Q 015741 216 TDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (401)
Q Consensus 216 ~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 290 (401)
++|..... .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.............+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence 99976542 377888889999999999999999999999999999999766 899999999987755544455678
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--HHH-HHHHHH-------hCChhHHHHHHhcCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQL-VKIAKV-------LGTDELNAYLNKYHI 360 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--~~l-~~i~~~-------~~~~~~~~~l~~~~l 360 (401)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..+ ..+... .-++++.+++.+ |+
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L 234 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL-FL 234 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH-Hh
Confidence 899999999877 569999999999999999999999985432221 111 111110 114567787888 89
Q ss_pred CCChhhHHHh----hhhcCCCccccccc
Q 015741 361 ELDPHLAALV----GRHSRKPWSKFITV 384 (401)
Q Consensus 361 ~~dP~~R~~~----~~~l~~~~~~~~~~ 384 (401)
+.||+.|+++ ++++.|+|++.+..
T Consensus 235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 235 AKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 9999999998 77889999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=327.66 Aligned_cols=240 Identities=19% Similarity=0.320 Sum_probs=188.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.++..+.+||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3578999999999999999999752 345789999986432 356889999999987899999999988653
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------------------------------------------------
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP----------------------------------------------------------- 223 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 223 (401)
...++++|||+++|+|..++.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 346789999999999876542
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc---cccccCCCc
Q 015741 224 ------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYF 294 (401)
Q Consensus 224 ------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y 294 (401)
.+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........ ....++..|
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccc
Confidence 256677888999999999999999999999999999999766 8999999999765332221 223455679
Q ss_pred cccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH-------hCChhHHHHHHhcCCCCChhh
Q 015741 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLNKYHIELDPHL 366 (401)
Q Consensus 295 ~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~~~~l~~dP~~ 366 (401)
+|||++.+ ..++.++|||||||++|||++ |..||............+... ..++.+.+++.+ |+..||..
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dp~~ 320 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA-CWQGDPKE 320 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HccCChhh
Confidence 99999876 678999999999999999997 888884333332222222211 113467777888 89999999
Q ss_pred HHHhhhhcC
Q 015741 367 AALVGRHSR 375 (401)
Q Consensus 367 R~~~~~~l~ 375 (401)
||++.++++
T Consensus 321 RPs~~el~~ 329 (338)
T cd05102 321 RPTFSALVE 329 (338)
T ss_pred CcCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.87 Aligned_cols=240 Identities=30% Similarity=0.556 Sum_probs=199.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|+||.||+|++..+|+.+|+|.++.. ....+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 488999999999999999999999999999998632 124578899999999 99999999999976 4578999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cc
Q 015741 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~ 285 (401)
+||+.++.+..+. ..+++..++.++.||++||.|||++||+||||||+||+++.++ .++|+|||+++...... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCc
Confidence 9999865443332 3589999999999999999999999999999999999999766 89999999997654332 23
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------ 347 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------------ 347 (401)
....++..|+|||.+.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+..+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567788999999877556789999999999999999999998877766666555544322
Q ss_pred -----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |+..||..|+++.+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQN-LLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHH-HhcCChhhcCCHHHHhcCCCC
Confidence 2445667777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=326.77 Aligned_cols=237 Identities=23% Similarity=0.380 Sum_probs=191.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHH-HHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~i-l~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||+||+|++..+++.||+|++.... ...+..|..+ ++.+ +||||+++++++.+ ....++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 46999999999999999999999999986421 2334555554 4566 99999999999875 4678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~ 288 (401)
+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence 9999997665 3588999999999999999999999999999999999999776 899999999875422 2233445
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (401)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.... -++.+.+++.+ |++.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLKPNISVSARHLLEG-LLQK 233 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-Hhhc
Confidence 78999999999876 679999999999999999999999995 333333333333221 14567777777 8999
Q ss_pred ChhhHHHh----hhhcCCCcccccc
Q 015741 363 DPHLAALV----GRHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~~~----~~~l~~~~~~~~~ 383 (401)
||..|+++ .++++|||++...
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99999987 5999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.20 Aligned_cols=244 Identities=23% Similarity=0.378 Sum_probs=197.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||++++..+++.+|+|++.+. ....+.+|+.++..+ +|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence 4799999999999999999999999999999998532 123477889999888 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 999999999998776 3478889999999999999999999999999999999999666 89999999997654332
Q ss_pred c--ccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------
Q 015741 284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (401)
Q Consensus 284 ~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------- 346 (401)
. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||. ..+..+.+..+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCCccccCCCcccc
Confidence 2 233578999999999862 3468899999999999999999999994 444444444443321
Q ss_pred CChhHHHHHHhcCCCCChhh--HHHhhhhcCCCcccccc
Q 015741 347 GTDELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFIT 383 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~~ 383 (401)
-++.+.+++.+ |+..++.. |+++.++++|||++.+.
T Consensus 236 ~s~~~~~li~~-ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 236 VSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CCHHHHHHHHH-HccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 14567777877 56554443 57899999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.19 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=205.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||.|+||.||+|.+..++..+|+|++... ....+..|+.+++.| +|||||+++++|.+.....+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEE
Confidence 47899999999999999999999999999999998632 235688999999999 999999999998776667789
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC-------CceeecCCCCCeeEeCC---------
Q 015741 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE--------- 264 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-------~ivHrDlkp~NIll~~~--------- 264 (401)
+||||+.+++|..++ ..+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999997665 2589999999999999999999984 49999999999999642
Q ss_pred -------CCeEEEEecccceecCCCCcccccccCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH
Q 015741 265 -------QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (401)
Q Consensus 265 -------~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~ 336 (401)
...+||+|||++..+..........||+.|+|||++.+ ...++.++||||||||||+|++|..||.. .+..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~-~~~~ 249 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK-ANNF 249 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc-CCcH
Confidence 12489999999987654444455679999999999864 24588999999999999999999999954 3444
Q ss_pred HHHHHHHHH-h------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 337 DQLVKIAKV-L------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 337 ~~l~~i~~~-~------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..+...... . .++++.++|.+ ||..+|..||++.++|.|+|++.+.
T Consensus 250 ~qli~~lk~~p~lpi~~~S~eL~dLI~~-~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 250 SQLISELKRGPDLPIKGKSKELNILIKN-LLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHhcCCCCCcCCCCHHHHHHHHH-HhcCChhHCcCHHHHhccHHHhhcC
Confidence 444433222 1 14567788877 8999999999999999999998653
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.39 Aligned_cols=239 Identities=25% Similarity=0.528 Sum_probs=186.5
Q ss_pred EeeecccCCeeEEEEEEcC--CCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 139 VRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
..+||+|+||.||+|.+.. ++..||+|.++... ...+.+|+++++++ +||||+++++++.......++++|||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3689999999999999754 56889999987543 34678999999999 99999999999876666788999999987
Q ss_pred Cchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC---CCCeEEEEecccceecCC
Q 015741 216 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 216 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~vkl~DFg~a~~~~~ 281 (401)
..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +.+.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 5433221 13788889999999999999999999999999999999942 334799999999987643
Q ss_pred CC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC--------HHHHHHHHHHhC--
Q 015741 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIAKVLG-- 347 (401)
Q Consensus 282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~--------~~~l~~i~~~~~-- 347 (401)
.. ......++..|+|||++.+...++.++|||||||++|||++|+.||.....+ ..++..+...++
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 22 2234577889999999876566899999999999999999999998533221 112222221111
Q ss_pred ------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++.+ |++.||.+|+++.++++|||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK-LLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH-HhccCcccccCHHHHhcCCCC
Confidence 1234455666 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=311.12 Aligned_cols=238 Identities=31% Similarity=0.563 Sum_probs=198.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH-----HHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
|++++.||+|+||.||++.+..+++.||+|++...... ...+|+.+++++ +||||+++++++.+ ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 78999999999999999999999999999999765432 234599999999 99999999999976 56788999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-CCCCccc
Q 015741 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYN 286 (401)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~-~~~~~~~ 286 (401)
||+.+++|..++ ..+++..+..++.||++||++||++||+|+||||+||+++.++ .++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 999999887654 4689999999999999999999999999999999999999655 8999999999864 2334445
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------------ChhHHH
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------TDELNA 353 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------------~~~~~~ 353 (401)
...++..|+|||++.....++.++||||||+++|+|++|..||... ...+....+.+... .+.+.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 6678889999999873478999999999999999999999999543 22222222222211 156777
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+ |+..||+.||++.++++|||+
T Consensus 236 li~~-~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKK-MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHH-HSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHH-HccCChhHCcCHHHHhcCCCC
Confidence 7777 899999999999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.72 Aligned_cols=239 Identities=22% Similarity=0.313 Sum_probs=193.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|+++ +|+|||++++++.. ....+++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEEc
Confidence 457999999999999999999999999999999643 34567899999999 99999999999865 4567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---cc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~---~~ 286 (401)
+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccccccc
Confidence 9754433332 2488999999999999999999999999999999999999766 799999999987643222 12
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHhC-------------
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVLG------------- 347 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~------~~~~l~~i~~~~~------------- 347 (401)
...||..|+|||++.+ ..++.++|||||||++|||++|..|++.... ...++.++.+..+
T Consensus 321 ~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred ccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 3468999999999977 6789999999999999999999887764332 1223333322211
Q ss_pred ----------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 348 ----------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 348 ----------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
.+++.+++.+ ||+.||.+||++.++|+|||++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCR-ALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHH-HcccChhhCcCHHHHhhCcccC
Confidence 1245566777 8999999999999999999996
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.88 Aligned_cols=238 Identities=30% Similarity=0.565 Sum_probs=193.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|++|.||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 488999999999999999999889999999998632 235688999999999 89999999999976 4678999
Q ss_pred EeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 210 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||+.+ ++..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 999985 554443 3478899999999999999999999999999999999999766 89999999997654322
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------------
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------------- 346 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------------- 346 (401)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +....+.+..+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 22334567889999998765567899999999999999999998884 333333332222111
Q ss_pred -------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 -------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 -------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
-++++.+++.+ |+..||..||++.+++.|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEK-MLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHH-HhcCChhhCCCHHHHhcCCCC
Confidence 13455677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=326.14 Aligned_cols=237 Identities=22% Similarity=0.387 Sum_probs=191.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHH-HHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~i-l~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||+||+|++..+|+.||+|++... ....+..|..+ ++.+ +||||+++++++.+ ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 4699999999999999999999999998642 22345556554 5556 99999999999876 4678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~ 288 (401)
+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence 9999987655 3588999999999999999999999999999999999999776 899999999875422 2233456
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (401)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||. ..+..+....+.... .+..+.+++.+ |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-ll~~ 233 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHKPLVLRPGASLTAWSILEE-LLEK 233 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC-CCCHHHHHHHHHcCCccCCCCCCHHHHHHHHH-Hhcc
Confidence 78999999999876 678999999999999999999999995 334444434333221 23466677777 8999
Q ss_pred ChhhHHHh----hhhcCCCcccccc
Q 015741 363 DPHLAALV----GRHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~~~----~~~l~~~~~~~~~ 383 (401)
||..|+++ .+++.|||++...
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 99999976 5899999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=327.38 Aligned_cols=237 Identities=27% Similarity=0.411 Sum_probs=195.9
Q ss_pred eeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
+.||+|+||.||++++. .+|+.||+|+++.. ....+.+|+++++++ +||||+++++++.+ ...+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 67999999999998763 57899999998642 234567899999999 99999999999976 467899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccccc
Q 015741 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (401)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~ 287 (401)
|+.+++|...+. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence 999999876653 488999999999999999999999999999999999999766 8999999999765433 22344
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCC
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIE 361 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~ 361 (401)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.. -++.+.+++.+ |++
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~-~l~ 234 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKAKLGMPQFLSPEAQSLLRA-LFK 234 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-Hhh
Confidence 578999999999876 678899999999999999999999984 444444444443321 14566777777 899
Q ss_pred CChhhHHH-----hhhhcCCCcccccc
Q 015741 362 LDPHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 362 ~dP~~R~~-----~~~~l~~~~~~~~~ 383 (401)
.||..|++ +.+++.|||++.+.
T Consensus 235 ~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 235 RNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred cCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 99999999 78899999997653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=338.54 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=201.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC-CeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ...+.+|+.+++.+ +|||||++++++.+ ...+++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEEE
Confidence 4599999999999999999998777 7889999764332 24577899999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|||+.+++|...+. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence 99999999976431 478889999999999999999999999999999999999766 8999999999876433
Q ss_pred Cc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHH
Q 015741 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELN 352 (401)
Q Consensus 283 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~ 352 (401)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -++.+.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 22 234568999999999876 679999999999999999999999984 334444444443321 135677
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+++.+ |+..||+.||++.+++.|+|.+.+
T Consensus 301 ~li~~-~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 301 ALLDP-LLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHH-HhccChhhCcCHHHHHhCHHHHHH
Confidence 88888 899999999999999999998764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.66 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=202.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
.++|.+.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.++..+ +|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcc
Confidence 57999999999999999999999999999999998642 235678899999998 99999999987753221
Q ss_pred --CCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 204 --KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
..+++||||+.+|+|...+. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence 13689999999999976652 478899999999999999999999999999999999999766 89999999
Q ss_pred cceecCCC---CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 275 LAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 275 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
+++.+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~-~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhcCCCCCCC
Confidence 99865432 12234578999999999886 679999999999999999999999984 333334434333221
Q ss_pred --CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 347 --GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
-++++.+++.+ |+..||..||++.++++|||.+.+.
T Consensus 267 ~~~~~~l~~li~~-~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 267 PSISPEMQEIVTA-LLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCHHHHHHHHH-HcccChhhCcCHHHHHhCHHHHHhh
Confidence 13567777777 8999999999999999999987643
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=328.10 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=191.7
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
||+|+||+||+|++..+++.||+|++.... ......|..++..+. +||||+++++++.+ ...+++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 699999999999999999999999985321 123455677776654 79999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~~ 289 (401)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence 999987655 3589999999999999999999999999999999999999766 899999999875432 22334567
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-------hCChhHHHHHHhcCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLNKYHIEL 362 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~~~~l~~ 362 (401)
|+..|+|||++.+...++.++|||||||++|+|++|+.||.. .+..+....+... .-++.+.+++.+ |+..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~-~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG-LLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH-HcCC
Confidence 899999999987655689999999999999999999999953 3333333333211 124567778887 8999
Q ss_pred ChhhHH----HhhhhcCCCcccccc
Q 015741 363 DPHLAA----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~----~~~~~l~~~~~~~~~ 383 (401)
||..|+ ++.++++|||++...
T Consensus 236 ~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CHHHCCCCCCCHHHHhcCccccCCC
Confidence 999998 799999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.42 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=198.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||++++..+++.||+|++... ....+.+|..++..+ +|+||+++++++.+ ..+.|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 5799999999999999999999999999999998642 123477888998888 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+.+|+|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 999999999998765 3578899999999999999999999999999999999999766 89999999998765433
Q ss_pred cc--cccccCCCccccccccCC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------
Q 015741 284 EY--NVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (401)
Q Consensus 284 ~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------- 346 (401)
.. ....|+..|+|||++.+. +.++.++|||||||++|+|++|+.||. ..+..+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc-CCCHHHHHHHHHcCCCcccCCCcccc
Confidence 22 235689999999998642 357889999999999999999999994 333444444433211
Q ss_pred CChhHHHHHHhcCCCCChhh--HHHhhhhcCCCcccccccc
Q 015741 347 GTDELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~~~~ 385 (401)
-++.+.+++.+ |+..++.. |.++++++.|+|++.+..+
T Consensus 236 ~~~~~~~li~~-ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 236 VSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred CCHHHHHHHHH-HccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 14567778877 56655543 4589999999999875443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.81 Aligned_cols=243 Identities=22% Similarity=0.359 Sum_probs=200.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.++||+|+||.||+|.+..++..+|+|+++.. ....+.+|+++++.+ +||||+++++++.+ ...+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEEE
Confidence 47899999999999999999999999999999988643 235688999999999 89999999999976 457899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+++|..++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++..+... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-c
Confidence 999999999987753 478888999999999999999985 799999999999998766 7999999998765322 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH-----------------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK----------------------- 341 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~----------------------- 341 (401)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCcc
Confidence 234568889999999876 6789999999999999999999999853221 11110
Q ss_pred ------------------HHHH------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 342 ------------------IAKV------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 342 ------------------i~~~------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+... ..++++.+++.+ |++.||..|+++.+++.|+|++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH-hccCCcccCcCHHHHhhCHHHhcCcc
Confidence 0110 012456778888 89999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=299.53 Aligned_cols=250 Identities=18% Similarity=0.328 Sum_probs=211.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++.+.+..||.|+.|.||+++.+.+|...|||.+... ..+++...+.++..-.+.|.||+.+|+|.. +..+.+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHH
Confidence 45667788999999999999999999999999998643 346678888887776568999999999975 345567
Q ss_pred EEeecCCC---chhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~---~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
.||.|..- .|.....+++|.-+-.+...++.||.||.+ +||+|||+||+|||+|..+ .+||||||++..+-....
T Consensus 169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeecccc
Confidence 78876532 344444678999899999999999999986 5999999999999999666 899999999988887888
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNA 353 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~ 353 (401)
.+...|.+.|||||.+.- ...|+.++||||||+.++||.||..||.....+.+.+.++.+... ++++.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 888899999999999853 357899999999999999999999999888899999998887532 567788
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
|+.. ||..|+..||.-.++|+|||.++....+
T Consensus 328 fv~~-CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 328 FVKD-CLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred HHHH-HhhcCcccCcchHHHhcCcceeecchhh
Confidence 8888 8999999999999999999998865443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=313.61 Aligned_cols=244 Identities=29% Similarity=0.525 Sum_probs=197.7
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
++.++|.+++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.+ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 78 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeE
Confidence 45688999999999999999999998899999999986432 23578899999999 99999999999875 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
++||||+.+..+.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||+++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCC
Confidence 8999999755544433 2467888999999999999999999999999999999999766 8999999998754322
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......++..|+|||.+.+...++.++|||||||++|+|++|..||....+..+.+..+....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22233456888999999876456888999999999999999999999655444444444332211
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |+..||..|+++++++.|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQ-MLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHH-HhCcCcccCcCHHHHhcCCCC
Confidence 2355667777 899999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.97 Aligned_cols=244 Identities=27% Similarity=0.492 Sum_probs=199.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----C
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~ 203 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence 57899999999999999999999999999999998532 234677899999999 9999999999886432 2
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
...++||||+.+.........+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCC
Confidence 35799999998744444444588999999999999999999999999999999999999776 89999999998765443
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..+..+.+..+.+.++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP-GTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 3344567889999999876 688999999999999999999999984 4444444443332222
Q ss_pred ---------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ---------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ---------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+.+++.+ |++.||..|+++.++|.|||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK-MLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHH-HcCCChhhCcCHHHHhcChhHhh
Confidence 1134567777 89999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.93 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=200.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|+..+.||+|+||+||+|.+..+++.+|+|++.... ...+.+|+++++.+ +|+||+++++.+.+ ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 3778899999999999999999999999999986432 23467899999999 99999999998865 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC
Confidence 99999999987554 2488999999999999999999999999999999999998766 89999999997765444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||... .+......+.... ..+.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 4445678999999999876 67899999999999999999999999533 3322222222111 1345677
Q ss_pred HHHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 354 YLNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
++.+ |+..||+.|++ +.+++.|+|+..+..
T Consensus 235 li~~-~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 235 ICKM-LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHH-HccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 7777 89999999999 889999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=322.88 Aligned_cols=237 Identities=22% Similarity=0.372 Sum_probs=191.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||.||+|++..+++.||+|++.... ...+..|.. +++.+ +||||+++++++.+ ...+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 46999999999999999999999999986421 123444544 45566 99999999999976 4578999999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCccccc
Q 015741 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (401)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~~~~ 288 (401)
+.+++|...+. .+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence 99999977653 478889999999999999999999999999999999999766 899999999875422 2333456
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (401)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... -.+.+.+++.+ |++.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKPLQLKPNITNSARHLLEG-LLQK 233 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHH-Hccc
Confidence 78999999999886 678999999999999999999999995 344444444443321 14567778888 8999
Q ss_pred ChhhHHHhh----hhcCCCcccccc
Q 015741 363 DPHLAALVG----RHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~~~~----~~l~~~~~~~~~ 383 (401)
||..|+++. ++++|+|++.+.
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCCCC
Confidence 999999876 899999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=317.19 Aligned_cols=246 Identities=28% Similarity=0.483 Sum_probs=202.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++... ...+.+|+.+++++ +|+||+++++++.+.....++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 578999999999999999999999999999999986322 23467899999999 999999999999766556789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
+||||+.+ +|..++ ..+++.++..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCcc
Confidence 99999986 443332 3578999999999999999999999999999999999999766 8999999999876533
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 22233455778999999876567899999999999999999999888 44555555555544321
Q ss_pred ---------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++...+++.+ |+..||+.|++++++++|||++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNF-LLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHH-HhcCChhhCcCHHHHhcChhhccCC
Confidence 3455667777 8999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.37 Aligned_cols=240 Identities=30% Similarity=0.581 Sum_probs=200.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +|||++++++++.+ ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 4799999999999999999999889999999988532 224578999999999 89999999999976 467889
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
+|||++++.+..+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence 999999998877653 588999999999999999999999999999999999999776 89999999998765433 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....++..|+|||.+.+...++.++||||||+++|+|++|+.||. +..+.+.+..+.+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 3344677889999998765568899999999999999999998884 4444444444332211
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |+..||+.||++.+++.|||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKG-CLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHH-HhcCCccccCCHHHHhcCCCC
Confidence 2345677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=321.17 Aligned_cols=237 Identities=22% Similarity=0.358 Sum_probs=189.7
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||.||+|++..+++.||+|++.... ...+.+|.. +++.+ +||||+++++++.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 46999999999999999999999999986421 233555554 46666 99999999999876 4678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CCCccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVR 288 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~~~~~~~ 288 (401)
+++++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence 9999987654 3588999999999999999999999999999999999999776 89999999987532 22233445
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhcCCCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (401)
.|++.|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+.... ....+.+++.+ |++.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPLQLPGGKTVAACDLLVG-LLHK 233 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HccC
Confidence 78999999999876 6789999999999999999999999953 33333333332211 13456777777 8999
Q ss_pred ChhhHHHh----hhhcCCCcccccc
Q 015741 363 DPHLAALV----GRHSRKPWSKFIT 383 (401)
Q Consensus 363 dP~~R~~~----~~~l~~~~~~~~~ 383 (401)
||..|++. .++++|+|+....
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 99999875 4999999987644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.76 Aligned_cols=242 Identities=19% Similarity=0.321 Sum_probs=199.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++++ +||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEE--CCEEEEE
Confidence 3678899999999999999999999999999998532 235688999999999 99999999999976 4567899
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
|||++++++... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++ .++|+|||++..+... ......
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence 999999998654 4678889999999999999999999999999999999999776 8999999999766432 234457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH------HHHHHHHHH--------hCChhHHHHH
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY------DQLVKIAKV--------LGTDELNAYL 355 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~------~~l~~i~~~--------~~~~~~~~~l 355 (401)
++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... +....+... ..++++.+++
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 8889999999876 678999999999999999999999995422211 111111111 1234677888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ |+..||..||++++++.|||+....
T Consensus 234 ~~-~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQ-CMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HH-HhhCChhhCCCHHHHhcCccccccc
Confidence 88 8999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.96 Aligned_cols=244 Identities=25% Similarity=0.454 Sum_probs=191.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
...|+++++||+||.+.||++.. .+.+.||+|.+. ......+.+|+..|.+|++|.+||++++|-.. +.++|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lY 436 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLY 436 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEE
Confidence 46799999999999999999986 556677766543 23345689999999999999999999998754 67999
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||||.+. +|..+++ ..+...++.+..||++|+.++|++||||.||||+|+|+. .| .+||+|||+|..+.++.
T Consensus 437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCccc
Confidence 99998764 5555543 255568999999999999999999999999999999998 44 79999999999887654
Q ss_pred cc---cccccCCCccccccccCCC----------CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-----
Q 015741 284 EY---NVRVASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----- 345 (401)
Q Consensus 284 ~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----- 345 (401)
.. ...+||..||+||.+.... ..+.++||||||||||+|++|+.||....+-...+..|..-
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 42 4569999999999985411 25789999999999999999999994332222222222211
Q ss_pred ---hCCh-hHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 346 ---LGTD-ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 346 ---~~~~-~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
...+ ++.+ +.+.||..||.+|+++.++|+|||...++
T Consensus 594 fp~~~~~~~li~-~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 594 FPDIPENDELID-VMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred ccCCCCchHHHH-HHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 0011 2333 44558999999999999999999998844
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.45 Aligned_cols=243 Identities=31% Similarity=0.573 Sum_probs=196.9
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+..++|++.+.||+|++|.||+|.+..+++.||+|.+.... ...+.+|+++++++ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~ 78 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL 78 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence 34578999999999999999999998899999999986422 24567899999999 99999999999875 4678
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++||||+.+ +|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCC
Confidence 999999986 665543 2478889999999999999999999999999999999999766 8999999998754321
Q ss_pred -CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------------
Q 015741 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------- 347 (401)
Q Consensus 283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------------- 347 (401)
.......++..|+|||.+.+...++.++||||||+++|+|++|+.||.......+++..+.+.++
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 12223346778999999876556889999999999999999999998544434444443332211
Q ss_pred ----------------------C--hhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ----------------------T--DELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ----------------------~--~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
. .+..+++.+ |+..+|..||++.++++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALK-FLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHH-HhccCcccccCHHHHhcCCCC
Confidence 1 445577777 899999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=306.25 Aligned_cols=239 Identities=21% Similarity=0.364 Sum_probs=197.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+.|++.+.||+|++|.||+|.+..+++++|+|.+... ....+.+|+++++++ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRD--DET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEcc--CCe
Confidence 4688999999999999999999889999999987532 124678899999999 99999999999976 458
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++++||+.+++|...+. .+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||+++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccc
Confidence 899999999999876653 578888999999999999999999999999999999999666 8999999999765432
Q ss_pred Ccc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 283 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+....+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhccCCCCCCCccCCHH
Confidence 211 23457788999999987 56899999999999999999999998433 3333333332221 1456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+++.+ |+..+|..||++.++++|+|+
T Consensus 236 ~~~li~~-~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRR-TFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHH-HhhcCcccCCCHHHHhhCCCC
Confidence 7777777 899999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.57 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=211.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++++.||+|+||+|.+++++.+++.||+|++++ ....-|..|-.+|..- +.+-|+.++..|.| ..+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~~~ 149 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--ERY 149 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--ccc
Confidence 35889999999999999999999999999999999864 2234578888888875 88999999999965 789
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+|+|||||+||+|..++. ++++..++.|+.+|+.||+-||+.|+|||||||+|||||..| ++||+|||.+-.+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCC
Confidence 999999999999887764 588999999999999999999999999999999999999877 8999999999877644
Q ss_pred Cc--ccccccCCCccccccccC---C-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---hC------
Q 015741 283 KE--YNVRVASRYFKGPELLVD---L-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LG------ 347 (401)
Q Consensus 283 ~~--~~~~~~t~~y~aPE~~~~---~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---~~------ 347 (401)
.. ....+|||.|.+||++.. + +.|+..+|+||+||++|||++|..|||. +.-.+...+|... +.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccc
Confidence 43 456799999999999842 2 5799999999999999999999999964 3334444444443 33
Q ss_pred -ChhHHHHHHhcCCCCChhhHHH---hhhhcCCCccccccccccc
Q 015741 348 -TDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITVENQH 388 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~~~~~ 388 (401)
+++.+++|.+ +-.+|+.|.- ++++..||||+-+.+++-+
T Consensus 308 VSeeakdLI~~--ll~~~e~RLgrngiedik~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 308 VSEEAKDLIEA--LLCDREVRLGRNGIEDIKNHPFFEGIDWDNIR 350 (1317)
T ss_pred cCHHHHHHHHH--HhcChhhhcccccHHHHHhCccccCCChhhhh
Confidence 4577888888 4678999998 9999999999999886643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=309.29 Aligned_cols=244 Identities=30% Similarity=0.553 Sum_probs=196.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---CC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---~~ 205 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999987632 225678899999999667999999998865322 23
Q ss_pred cEEEEeecCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 206 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
.|++|||+.+ ++..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++..+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7899999997 454432 2368899999999999999999999999999999999999745589999999997
Q ss_pred ecCCC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------
Q 015741 278 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------- 346 (401)
Q Consensus 278 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------- 346 (401)
.+... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||. +.++.+.+..+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP-GDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHHhCCCChhhCcc
Confidence 65322 222334567889999998765668899999999999999999998884 444444443333221
Q ss_pred ------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 347 ------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 347 ------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
.++.+.+++.+ |+..||..|+++++++.|||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQK-MLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHH-HccCChhhcCCHHHHhcCCCcC
Confidence 13456677777 8999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=309.55 Aligned_cols=238 Identities=31% Similarity=0.574 Sum_probs=199.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||.|+||.||+|.+..+|+.||+|++.... ...+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5889999999999999999998899999999986432 35788999999999 89999999999976 5678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
|||+ +++|...+ ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCC
Confidence 9999 88887664 3488999999999999999999999999999999999999766 89999999998765432
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+..+.+.+..+...++
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF-PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc-CCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578889999999876556789999999999999999996554 66665555555443322
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++.+ |+..||..|++++++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKG-LLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHH-HhccChhhCCCHHHHhhCcCc
Confidence 2345566777 899999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=307.87 Aligned_cols=240 Identities=30% Similarity=0.559 Sum_probs=195.9
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
|++++.||+|+||.||+|.+..+++.||+|+++... .....+|+.++.++.+|+|++++++++.+.....+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999998999999999986421 2234578889999867999999999998764578899999
Q ss_pred ecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccc
Q 015741 212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (401)
Q Consensus 212 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~ 288 (401)
|+.+..+..+. ..+++.+++.++.|++.||+|||++|++||||||+||+++. +.+||+|||++............
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence 99865444443 24789999999999999999999999999999999999997 48999999999877544444455
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------------
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------------- 347 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------------- 347 (401)
.++..|+|||.+...+.++.++|||||||++|||++|..|| .+.+..+.+..+.+..+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 67889999998765466789999999999999999999888 44444444443333221
Q ss_pred --------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+..+.+++.+ |+..+|+.||+++++++|||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKK-LLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHH-HhccCcccccCHHHHhhCCCC
Confidence 2456677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=308.49 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=202.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||++.+..+++.+|+|++... ..+.+.+|+++++++ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 4699999999999999999999889999999998642 235688999999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence 999999999987765 3589999999999999999999999999999999999999766 8999999999876433
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||... +..+....+.... ..+.+.+++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 231 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKVRFPSFFSPDAKDLIRN- 231 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCccCCccCCHHHHHHHHH-
Confidence 334568889999999876 57888999999999999999999998533 3333333332211 14577788888
Q ss_pred CCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 359 HIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
|+..||..|+ ++.++++|||++...
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 8999999999 999999999998765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.25 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=211.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..+|++++.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +|+||+++++++.. ....++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEEe
Confidence 47899999999999999999999889999999998642 335678899999998 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
|||+++++|..+.. .+++.++..++.|++.||.|||+.|++||||||+|||++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcC
Confidence 99999999987763 478889999999999999999999999999999999998666 899999999976643322 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------hCChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---------LGTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---------~~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... +....+..+... .-.+.+.+++.+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 4567888999999876 67889999999999999999999999543 222222222111 012346677777
Q ss_pred cCCCCChhhHHHhhhhcCCCcccccccccccCCCCc---ccccccCC
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE---VEFLVICS 401 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~~~~~~---~dl~~~c~ 401 (401)
|+..||..|+++.+++.|||++.....-. +..+. .|+++.|+
T Consensus 252 -~l~~~p~~Rps~~~il~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 296 (297)
T cd06656 252 -CLEMDVDRRGSAKELLQHPFLKLAKPLSS-LTPLIIAAKEAIKNSS 296 (297)
T ss_pred -HccCChhhCcCHHHHhcCchhcccccccc-cCHHHHHHHHHHhhcc
Confidence 89999999999999999999987544333 33333 47778875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.39 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=199.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~ 216 (401)
+.||+|+|+.|--|+...++..||||++.+. .+.++.+|++++.+.++|+||++++++|++ +...|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccCc
Confidence 6799999999999999999999999999754 467899999999999999999999999987 56789999999999
Q ss_pred chhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEEecccceecCCC--------C
Q 015741 217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPG--------K 283 (401)
Q Consensus 217 ~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~DFg~a~~~~~~--------~ 283 (401)
.|...+. .++|.++..++++|+.||.|||.+||.||||||+|||..+.+. -||||||.++..+... .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9876653 5999999999999999999999999999999999999965442 5899999987544221 2
Q ss_pred cccccccCCCcccccccc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--------------CHHHHHHHHHH
Q 015741 284 EYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------------NYDQLVKIAKV 345 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--------------~~~~l~~i~~~ 345 (401)
...+.+|+..|||||+.. ....|+.++|.||||||||-|+.|..||...-. ....+..|.+.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 234567888999999963 224689999999999999999999999942111 11223344443
Q ss_pred hC----------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 346 LG----------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 346 ~~----------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.. +.+.++++.+ ++..|+..|.++.++++|||.++...++.
T Consensus 322 kYeFPdkdWahIS~eakdlisn-Llvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISN-LLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHH-HHhccHHhhhhhhhccCCccccccchhcc
Confidence 22 2345555666 58899999999999999999999877654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.52 Aligned_cols=246 Identities=26% Similarity=0.454 Sum_probs=200.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~~~ 206 (401)
..++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.+++++.+|||++++++++.... ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 468899999999999999999999999999999998653 34667889999999878999999999987543 2468
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
++||||+.+++|..++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~ 178 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 178 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence 9999999999987654 3578899999999999999999999999999999999998766 7999999998765
Q ss_pred CCCC-cccccccCCCccccccccCCC----CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 280 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 280 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
.... ......++..|+|||.+.... .++.++|||||||++|+|++|+.||.. .+..+.+..+.+...
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHhcCCCCCCCccc
Confidence 4322 223346788899999975422 367899999999999999999999853 333333333322211
Q ss_pred --ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 348 --TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 348 --~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
...+.+++.+ |+..+|+.||++.++++|||++
T Consensus 258 ~~~~~l~~li~~-~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQ-CLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHH-HhhcChhhCcCHHHHhcCcccC
Confidence 2346677877 8999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=308.58 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=201.6
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
...+.|++++.||.|+||.||+|.+..+++.+++|++.... .+.+.+|+.+++.+ +||||+++++.+.. ....+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CCeEE
Confidence 34578999999999999999999998899999999987544 34678899999998 89999999999875 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
+||||+.++++..++ ..+++..+..++.|++.+|.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccc
Confidence 999999999987654 3478999999999999999999999999999999999998665 8999999998754322
Q ss_pred CcccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------Ch
Q 015741 283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~ 349 (401)
.......++..|+|||.+.+ ...++.++|||||||++|+|++|..||.. .+..+....+.+... +.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc-ccHHHHHHHHhcCCCccCCCCcccCH
Confidence 22234567889999999852 24578899999999999999999999843 233333333322211 23
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+++.+ |+..||+.||+++++++|||+..+..
T Consensus 244 ~~~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 244 EFRDFLKT-ALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred HHHHHHHH-HhcCCcccCcCHHHHhcCcccccccc
Confidence 56777777 89999999999999999999976554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.98 Aligned_cols=245 Identities=22% Similarity=0.406 Sum_probs=199.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----CCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~~~ 205 (401)
+.+.|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+|+||+++++++.+.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 357789999999999999999999999999999998643 34578899999999877999999999987532 245
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++++|||+.+++|..++. .+++..+..++.|++.||+|||+++|+|+||||+||+++.++ .++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~ 162 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence 789999999999877643 478888999999999999999999999999999999999766 89999999997654
Q ss_pred CC-CcccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------C
Q 015741 281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------G 347 (401)
Q Consensus 281 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~ 347 (401)
.. .......|+..|+|||++.+ ...++.++|||||||++|+|++|+.||.... .......+.... .
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCCCCc
Confidence 32 22334568889999999853 2357889999999999999999999985332 222222222111 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+..+.+++.+ |+..||..||++.+++.|||+
T Consensus 242 ~~~~~~li~~-~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 242 SKKFQSFIES-CLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CHHHHHHHHH-HcCCChhhCCCHHHHhhCCCC
Confidence 3467778888 799999999999999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.44 Aligned_cols=241 Identities=31% Similarity=0.543 Sum_probs=198.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||.|+||.||+|.+..+++.+++|.++... ...+.+|+.+++++ +||||+++++++.+......++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEE
Confidence 57899999999999999999998899999999986432 23467899999999 8999999999987765578999
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
+|||+.+ +|..++ ..+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCcc
Confidence 9999986 655443 2488999999999999999999999999999999999999766 8999999999876543 2
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||. .....+.+.++....+
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 33445677889999998765567889999999999999999998884 4444444443332221
Q ss_pred ----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |+..||+.|+++.+++.|+|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNR-LLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHH-HhccCccccCCHHHHhcCCCC
Confidence 3445677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.39 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=206.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
-++|..++.||+|.||+|.+++.+.+++.||+|++++. ....-..|-++|+.. +||.+..+...|.. ...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhcc--CceE
Confidence 36789999999999999999999999999999999753 223456788999997 99999988887744 5788
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-CCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~-~~~ 282 (401)
++||||..||.|...+. .+++..++.+..+|+.||.|||+++||.||||.+|+|+|+++ ++||+|||+++.- ..+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccccc
Confidence 99999999999977664 489999999999999999999999999999999999999888 8999999999743 345
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH-HHhC-----ChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA-KVLG-----TDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~-~~~~-----~~~~~~~l~ 356 (401)
....+.|||+.|+|||++.. ..|+.++|+|.+||++|||++|+.||++.+ ....+..|. ..+. +++.+.++.
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccc-hhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 56778999999999999987 799999999999999999999999996543 222222221 1222 567788888
Q ss_pred hcCCCCChhhHH-----HhhhhcCCCcccccccc
Q 015741 357 KYHIELDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 357 ~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
. +|..||.+|. .+.++.+|+|+.-+..+
T Consensus 401 G-LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 401 G-LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred H-HhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 7 6899999997 58899999998876654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=306.41 Aligned_cols=245 Identities=21% Similarity=0.374 Sum_probs=197.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... ...+..|+.++.+..+||||+++++++.+ ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 47899999999999999999999999999999986432 24566677765555599999999999975 4568999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
|||+++ +|..++ ..+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++..+..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 999985 443222 2478999999999999999999997 999999999999999766 899999999987643
Q ss_pred CCcccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 282 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.......+.+..+.... -+++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 3333445678889999987542 3468899999999999999999999965555555555543321 1356
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+.+++.+ |+..+|..||++++++.|||++...
T Consensus 237 l~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 237 FQDFVNK-CLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHH-HccCChhhCcCHHHHhcCchhhhcc
Confidence 7778888 8999999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=315.31 Aligned_cols=247 Identities=30% Similarity=0.572 Sum_probs=198.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.. ....+.+|+.+++++ +||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 47899999999999999999999999999999998642 234578899999999 8999999999876532 235
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++++||+.+ ++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccc
Confidence 7899999986 444333 3589999999999999999999999999999999999999766 89999999997654322
Q ss_pred c----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
. .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+....+..+...++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP-GKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 1234678899999987665678999999999999999999999884 3333332222222111
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |++.||+.|+++.++++|||++..-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK-MLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHH-HcCCChhhCcCHHHHhcCccccccCC
Confidence 3345667777 89999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=310.91 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=199.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||+|+||.||++.+..++..+|+|.++.. ...++.+|+++++++ +||||+++++++.+ ...++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 4689999999999999999999999999999998643 235588999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|||+++++|..++. .+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .++|+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence 99999999987763 57889999999999999999998 5999999999999999766 7999999998765322 22
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH---------------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--------------------- 344 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~--------------------- 344 (401)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... . .....+..
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD-A-KELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc-h-hhHHHhhcCccccccccCCcccccCCCCC
Confidence 34578889999999876 678899999999999999999999984322 1 11111100
Q ss_pred ------------H------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 345 ------------V------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 345 ------------~------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
. ..++++.+++.+ |+..||..||++.++++|||+.....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK-CLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHH-HccCChhhCcCHHHHhcChhhhhcccc
Confidence 0 013456788888 899999999999999999999875443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.19 Aligned_cols=240 Identities=24% Similarity=0.444 Sum_probs=199.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||.|+||.||+|.+..+++.+++|++... ..+.+.+|+++++++ +||||+++++++.+ ...++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 47899999999999999999999888999999998643 346789999999999 99999999999866 4678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
|||+.+++|..++ ..+++.++..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.+....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence 9999999988765 3588999999999999999999999999999999999999766 79999999987654322 2
Q ss_pred ccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-----------hCChhH
Q 015741 285 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-----------LGTDEL 351 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-----------~~~~~~ 351 (401)
.....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||... +..+....+.+. ..+.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345678889999998652 26888999999999999999999998543 333333332222 012456
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
.+++.+ |+..+|..||++.+++.|+|
T Consensus 237 ~~li~~-~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKK-CLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHH-HcCCChhhCCCHHHHhcCCC
Confidence 677777 89999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=331.08 Aligned_cols=246 Identities=24% Similarity=0.435 Sum_probs=208.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+-|+|+..||.|+||.||+|..+.++-..|.|++..... +.+.-|++||..+ +||+||++++.|.. ...++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEEEE
Confidence 345678899999999999999998888889999875543 5677899999997 99999999997643 56788999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-CCcc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~~~~ 285 (401)
|||.||....++ ..+.+.++..+++|++.||.|||+++|||||||..|||++.+| .++|+|||.+..... ....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhhh
Confidence 999999876554 5699999999999999999999999999999999999999888 899999999754322 2233
Q ss_pred cccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHH
Q 015741 286 NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELN 352 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~ 352 (401)
..+.||+||||||++.. ..+|++++||||||++|.||..+.+|- ...+.+..+.+|.+.-. +..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 56799999999999743 367999999999999999999998775 66777888878776522 34678
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
+||.+ ||..||..||++.+++.|||+...++.
T Consensus 267 DfLk~-cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 267 DFLKR-CLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHH-HHhcCCccCCCHHHHhhCcccccCCcc
Confidence 88888 799999999999999999999976664
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.84 Aligned_cols=245 Identities=24% Similarity=0.426 Sum_probs=199.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEc---CCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~---~~~~~~ 206 (401)
..++|++.+.||+|+||.||+|.+..+++.+|+|+++... ...+.+|+.+++.+.+||||+++++++.. .....+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4688999999999999999999999999999999986532 35688899999998679999999998753 234578
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+++|||+++++|..++ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++..+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence 9999999999987653 2477888999999999999999999999999999999999776 7999999999876
Q ss_pred CCCC-cccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------
Q 015741 280 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (401)
Q Consensus 280 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------- 346 (401)
.... ......|+..|+|||++.. ...++.++|||||||++|+|++|+.||... ...+.+..+.+..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPPTLHQPE 253 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC-chhHHHhhccccCCCcccCCC
Confidence 4332 2234568889999999753 245788999999999999999999998543 3333333322211
Q ss_pred -CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 -GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 -~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
....+.+++.+ |+..||+.||++.++++|+|+
T Consensus 254 ~~~~~~~~li~~-~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRK-CLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHH-HccCCcccCCCHHHHhhcccC
Confidence 12357777888 899999999999999999995
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=307.20 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=199.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----CCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~~~~ 205 (401)
+.+.|++.+.||.|+||.||+|.+..+++.+|+|++... ....+..|+.+++++.+|+||+++++++... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 357789999999999999999999999999999998643 3356888999999987899999999988532 2457
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++++|||+.+++|..++. .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~ 172 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhh
Confidence 899999999999877653 377888899999999999999999999999999999999766 79999999987553
Q ss_pred CC-CcccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------C
Q 015741 281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------G 347 (401)
Q Consensus 281 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~ 347 (401)
.. .......++..|+|||.+.. ...++.++|||||||++|+|++|..||... .+.+....+.+.. .
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPPPKLKSKKW 251 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc-CHHhhhhhHhhCCCCCCccccc
Confidence 22 22334568889999999752 246788999999999999999999998533 2333333222221 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++++.+++.+ |+..||..||++.++++|||+
T Consensus 252 ~~~~~~li~~-cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEG-CLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHH-HhCCChhhCcCHHHHhcCCCC
Confidence 3467788887 899999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=303.26 Aligned_cols=245 Identities=22% Similarity=0.409 Sum_probs=201.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----CCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~~~ 205 (401)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... .+.+.+|+.+++++.+|+||+++++++.+.. ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4689999999999999999999998889999999987543 4678899999999877999999999987643 446
Q ss_pred cEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
++++|||+.+++|.++. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence 79999999999887654 2578889999999999999999999999999999999999766 899999999876
Q ss_pred cCCCC-cccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------
Q 015741 279 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------- 346 (401)
Q Consensus 279 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------- 346 (401)
..... ......++..|+|||++.. ...++.++|||||||++|+|++|+.||.. ......+..+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc-cchHHHHHHhhccCCCCCCch
Confidence 54322 2234567888999998753 23577899999999999999999999953 33334444433321
Q ss_pred --CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 --GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
....+.+++.+ |+..||+.||++.+++.|||.
T Consensus 242 ~~~~~~~~~li~~-~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISE-CLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHH-HhhcChhhCcCHHHHhcCCCC
Confidence 12356777888 899999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.92 Aligned_cols=240 Identities=21% Similarity=0.423 Sum_probs=196.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++.+.+ ....+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence 467889999999999999999998999999999987543 24578899999999 99999999999876 4678999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cc
Q 015741 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~ 285 (401)
|||+.+++|..++ ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCccccc
Confidence 9999999998765 3589999999999999999999999999999999999999766 79999999987654322 22
Q ss_pred cccccCCCcccccccc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-h----------CChhHH
Q 015741 286 NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-L----------GTDELN 352 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-~----------~~~~~~ 352 (401)
....|+..|+|||.+. ....++.++|+|||||++|+|++|..||+.... ...+..+... . -++.+.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-hhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 3457888999999974 224688899999999999999999999864432 2222221111 1 123566
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
+++.+ |+..+|+.||++++++.|||
T Consensus 243 ~li~~-~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKM-ALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHH-HccCCchhCcCHHHHhcCCC
Confidence 77777 89999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.09 Aligned_cols=233 Identities=16% Similarity=0.347 Sum_probs=190.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..++..+...||+|.||+||+|++ --.||||+++.. ..+.|++|+.++++- +|.||+-+.|++..+. +
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~---~ 462 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP---L 462 (678)
T ss_pred CHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc---e
Confidence 346677899999999999999987 346899999643 347799999999998 9999999999997642 3
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee---c
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---Y 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~---~ 279 (401)
.||+.+|+|.+|..++. ++.....+.|++||++|+.|||.++|||||||..||++..++ +|||+|||++.. +
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeeeeee
Confidence 89999999999977763 477778899999999999999999999999999999999665 999999999843 2
Q ss_pred CCCCcccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHHh----------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL---------- 346 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~~---------- 346 (401)
..+.......|...|||||++.. ...|++.+||||||+++|||++|..||. ..+.+++. .+-+.+
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccchhhhc
Confidence 23344455677788999999853 3478999999999999999999999995 44555443 222221
Q ss_pred -CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 -GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 -~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+...+++++.. |+..+++.||...++|.
T Consensus 620 ~~pk~mk~Ll~~-C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSD-CWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHH-HHhcCcccCccHHHHHH
Confidence 12377787777 89999999999888776
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=315.33 Aligned_cols=241 Identities=19% Similarity=0.230 Sum_probs=189.6
Q ss_pred EEeeeccc--CCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 138 VVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 138 i~~~Lg~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++++||+| +|++||++.+..+|+.||+|.++... .+.+.+|+.+++.+ +||||+++++++.+ ....++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEE--CCEEEEEE
Confidence 45789999 78999999999999999999986432 24577899999998 99999999999976 45678999
Q ss_pred eecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
||+.++++.+++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .++++||+.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999987765 2478899999999999999999999999999999999999776 899999987543321110
Q ss_pred -------ccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-----------
Q 015741 285 -------YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----------- 345 (401)
Q Consensus 285 -------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----------- 345 (401)
.....++..|+|||++.+. ..++.++|||||||++|+|++|+.||............+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 1123456679999998653 468899999999999999999999995322211111111000
Q ss_pred ----------------------------------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 346 ----------------------------------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 346 ----------------------------------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..++.+.+++.+ |++.||+.||+++++++|||++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ-CLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH-HHhhCchhcCCHHHHhcChhhhhcc
Confidence 002356677777 8999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=322.15 Aligned_cols=247 Identities=23% Similarity=0.463 Sum_probs=212.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
...|.+.++||+|.|+.|.+|++..++..||||++++. ....+.+|+++|+.| +|||||+++.+.+. ...+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--cceeE
Confidence 46799999999999999999999999999999998753 335589999999999 99999999999975 57889
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+|.+.+++. ++.+.+++.++.|++.|++|||+++|||||||++||||+.+. .+||+|||++..+..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeeccccc
Confidence 9999999999987763 578899999999999999999999999999999999999766 699999999999988888
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~ 358 (401)
..+.+|++.|.|||++.+.+..++.+|+||+|++||-|+.|..||. +.+-.+.-.+.... .-+-+.+++|.+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk- 288 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK- 288 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-CcccccccchheeeeecccceeechhHHHHHH-
Confidence 8889999999999999987777899999999999999999999994 22221111111111 124567777888
Q ss_pred CCCCChhhHHHhhhhcCCCcccccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.++|..|.+++++..|+|......+
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhh
Confidence 799999999999999999999875544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=305.78 Aligned_cols=238 Identities=31% Similarity=0.622 Sum_probs=193.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++++.||.|++|.||+|++..+++.||||.++.. ....+.+|+++++++ +||||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 488999999999999999999889999999988632 235688999999999 99999999999865 5678999
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
|||+.+ ++..++ ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 999974 555443 3478899999999999999999999999999999999999776 89999999987654322
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......++..|+|||.+.+...++.++|||||||++|+|+||+.||. +.+..+.+.++.+..+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22334567889999998765557889999999999999999999984 3333333333322211
Q ss_pred -------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |++.||..||++.+++.|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQ-MLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHH-hcCCCcccCCCHHHHhcCCCC
Confidence 2445567777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=309.38 Aligned_cols=242 Identities=21% Similarity=0.359 Sum_probs=204.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+-|.++.+||+|+||.||+|.++.+|+.+|||.+.. .+...+..|+.||+++ +.|++|++|+.+-. ...+++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehhh
Confidence 447789999999999999999999999999998864 4567899999999997 99999999997643 4568999999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccccc
Q 015741 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (401)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~ 287 (401)
|..|+..+++ +.+.+.++..+++..+.||+|||...-||||||..|||++.++ ..||+|||.|..+... ...++
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCc
Confidence 9999987765 4699999999999999999999999999999999999999887 8999999999776432 23456
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------hCChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---------LGTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---------~~~~~~~~~l~~~ 358 (401)
..||++|||||++.. -.|+.++||||||++..||..|++||. +-.++..+..|... .-+.++.+|+.+
T Consensus 189 VIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYs-DIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~- 265 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYS-DIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS- 265 (502)
T ss_pred cccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcc-cccccceeEeccCCCCCCCCChHhhhhHHHHHHHH-
Confidence 799999999999987 679999999999999999999999983 33333322222111 113467888888
Q ss_pred CCCCChhhHHHhhhhcCCCccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
||...|+.|.++.++++|+|.+.-
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 799999999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=306.85 Aligned_cols=240 Identities=30% Similarity=0.567 Sum_probs=197.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 4689999999999999999999888999999987532 235678999999999 99999999999965 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
+|||+.++.+..+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence 999999998876653 478999999999999999999999999999999999998766 89999999998764332 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....++..|+|||++.+...++.++||||||+++|+|++|+.||. .....+.+..+....+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC-CCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 3345678889999998765567889999999999999999987773 4444444433332111
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++.+ |+..+|..||++.++++|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ-CLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHH-HhcCCcccchhHHHHhcCCCC
Confidence 2345566667 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=310.29 Aligned_cols=242 Identities=26% Similarity=0.494 Sum_probs=193.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcC--CCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ...+.+|+.+++.+ +||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999987 78999999987522 35678899999999 99999999999987655789
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC----CCCeEEEEeccc
Q 015741 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGL 275 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~----~~~~vkl~DFg~ 275 (401)
++||||+++..+.... ..+++..++.++.|++.||+|||+++|+||||||+||+++. ++ .+||+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence 9999999875443221 14788899999999999999999999999999999999986 55 899999999
Q ss_pred ceecCCCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--------HHHHHHH
Q 015741 276 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--------DQLVKIA 343 (401)
Q Consensus 276 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--------~~l~~i~ 343 (401)
+........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||....... ..+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 986543221 2234677889999998765678899999999999999999999985332211 1111111
Q ss_pred HH-------------------------------------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 344 KV-------------------------------------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 344 ~~-------------------------------------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.. .....+.+++.+ |+..||+.||++.+++.|||+
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK-LLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH-HhcCCcccCcCHHHHhcCCCC
Confidence 11 112345566777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.11 Aligned_cols=243 Identities=31% Similarity=0.581 Sum_probs=196.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|++|.||+|.+..+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 5799999999999999999999889999999988532 235688999999999 99999999999975 467899
Q ss_pred EEeecCCCchhhhc-C----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 209 IFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 209 v~e~~~~~~l~~~~-~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
||||+++ ++.... . .+++..++.++.||+.||+|||++|++||||+|+||+++.++..+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9999976 443333 2 24677888999999999999999999999999999999866668999999999765332
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......++..|+|||.+.+...++.++|||||||++|+|++|..||.. .+..+.+.++....+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG-DSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 2223446678899999987655688999999999999999999999843 344444443332211
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+.+++.+ |+..+|+.|+++.++++|||++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSK-MLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHH-HccCChhhCcCHHHHhcCchHhHH
Confidence 3445667777 899999999999999999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=318.66 Aligned_cols=240 Identities=23% Similarity=0.418 Sum_probs=209.2
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
.+.||+|.||+||-|+++.+|+.||||++.+ .....+.+|+.||+++ +||.||.+--.|+. ...+++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhh
Confidence 4789999999999999999999999999864 3457799999999999 99999999999966 46789999999
Q ss_pred CCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCCCcccc
Q 015741 214 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 214 ~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
.|.-|+.++ .++++...+.++.||+.||.|||-+||+|+||||+|||+.. +..++||||||+|+++....-...
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 998887776 46999999999999999999999999999999999999964 335899999999999977666677
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHhcCC
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHI 360 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l 360 (401)
.+||+.|+|||++.+ +.|+...|+||.|||+|--+.|..||-.+.+-.+|++.-.-.+. ++...++|.+ +|
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~-LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN-LL 803 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH-HH
Confidence 899999999999987 89999999999999999999999999766666666665433332 4566778888 58
Q ss_pred CCChhhHHHhhhhcCCCcccccc
Q 015741 361 ELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 361 ~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+..=.+|-++++.+.|||.+-..
T Consensus 804 qVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999998654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.92 Aligned_cols=243 Identities=29% Similarity=0.481 Sum_probs=192.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----- 202 (401)
-++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+++++++ +||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 367999999999999999999999999999999885321 23467899999999 9999999999886532
Q ss_pred -CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 -SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
....++||||+.+.....+.. .+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCccc
Confidence 235689999998643333322 478999999999999999999999999999999999999766 899999999976
Q ss_pred cCCCCc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------
Q 015741 279 YHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (401)
Q Consensus 279 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------ 347 (401)
...... .....++..|+|||.+.+...++.++||||||+++|+|++|..||. +.+....+..+.+..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ-GNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhh
Confidence 543221 1234567789999998765567889999999999999999998874 4443333333333211
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |+..||..|++++++++|||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~-~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDK-LLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHH-HhcCChhhccCHHHHhcCCCC
Confidence 2344567777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.11 Aligned_cols=240 Identities=23% Similarity=0.416 Sum_probs=195.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.+|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 4789999999999999999999999999999987521 124678899999999 9999999999987655567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++++|||+++++|..++ ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence 88999999999998765 3578888999999999999999999999999999999999766 8999999998755321
Q ss_pred ----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------Chh
Q 015741 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (401)
Q Consensus 283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (401)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+.......+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCc-cchHHHHHHHhcCCCCCCCchhhCHH
Confidence 12233467888999999876 6789999999999999999999999843 233333332221111 234
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+++.+ |+ .+|..||+++++++|||.
T Consensus 238 ~~~~i~~-~l-~~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 238 CRDFLKR-IF-VEAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHH-Hh-cChhhCCCHHHHhcCccc
Confidence 5677777 45 489999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=304.28 Aligned_cols=241 Identities=23% Similarity=0.393 Sum_probs=196.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEe--CCEEEE
Confidence 357899999999999999999999899999999998643 234578899999998 99999999999876 457889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
||||+++++|..++ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence 99999999998765 3578899999999999999999999999999999999998766 79999999998664322 2
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-----------hCChhH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-----------LGTDEL 351 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-----------~~~~~~ 351 (401)
.....++..|+|||.+.. ...++.++|||||||++|+|++|+.||+... ..+....+.+. .-+..+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc-hhhhheeeecCCCCCCCCccccccCHHH
Confidence 234567889999998742 2457889999999999999999999985432 22221111111 013467
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
.+++.+ |+..||+.||+++++++|+|
T Consensus 242 ~~li~~-~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKI-SLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHH-HhhCChhhCcCHHHHhcCCC
Confidence 788877 89999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=298.16 Aligned_cols=239 Identities=22% Similarity=0.385 Sum_probs=200.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++.+ +|||++++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 588999999999999999999999999999998542 245688999999999 99999999998865 4678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|.+++. .+++..+..++.|++.+|+|||++|++|+||||+||+++.++..++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999877653 3788899999999999999999999999999999999987666789999999987754444
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (401)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. +.+.......+.... .++++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE-AANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc-cCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 444678889999999876 578899999999999999999999984 333333333333221 13567788887
Q ss_pred cCCCCChhhHHHhhhhcCCCcc
Q 015741 358 YHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
|+..||..||++.+++.|||+
T Consensus 236 -~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 -MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -HccCChhhCCCHHHHhhCCCC
Confidence 899999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.98 Aligned_cols=244 Identities=24% Similarity=0.435 Sum_probs=203.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..+|++.+.||.|++|.||+|.+..+++.|++|.+... ..+.+.+|+.+++.+ +||||+++++++.+ ...+++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence 46799999999999999999999999999999988532 346688899999999 99999999999875 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
+||+.+++|..++. .+++.++..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCC
Confidence 99999999987764 478999999999999999999999999999999999998766 899999999876543322 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+..+.+..+.... -.+.+.+++.+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3467888999999876 6788999999999999999999999844 33444443333211 13457777877
Q ss_pred cCCCCChhhHHHhhhhcCCCcccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|+..||..|+++.+++.|||++...
T Consensus 252 -~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 252 -CLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -HhhcChhhCCCHHHHhhChHhhhcc
Confidence 8999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=303.93 Aligned_cols=240 Identities=33% Similarity=0.567 Sum_probs=199.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +|+||+++++++.+ ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4699999999999999999999889999999988642 246789999999999 89999999999976 467899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
+|||++++.+..+.. .+++.++..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccc
Confidence 999999988765543 488999999999999999999999999999999999999766 89999999998765443
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------------- 346 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------------- 346 (401)
......++..|+|||++.+...++.++||||||+++|+|++|..||. +....+.+..+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 33445678889999999874478999999999999999999998874 333333333322211
Q ss_pred ---------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 ---------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ---------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
-++++.+++.+ |+..+|..||++.+++.|||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKA-CLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHH-HhccCchhcccHHHHhcCCCC
Confidence 13456777777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.09 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=188.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|++... +..||+|+++... ...+.+|+++++.+.+|+||+++++++.+ .
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--G 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--C
Confidence 57899999999999999999986443 3579999986432 34678999999998789999999999865 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (401)
...++||||+.+|+|..++.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 57899999999999876541
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc---c
Q 015741 224 -------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---V 287 (401)
Q Consensus 224 -------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~---~ 287 (401)
++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence 256778899999999999999999999999999999999665 89999999997654332211 1
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH-h-------CChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-L-------GTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~-~-------~~~~~~~~l~~~ 358 (401)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||....... .+..+.+. . .++++.+++.+
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~- 350 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYSIMKM- 350 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHHHHHH-
Confidence 234457999999876 679999999999999999997 999985433322 22222221 1 14677787877
Q ss_pred CCCCChhhHHHhhhhcC
Q 015741 359 HIELDPHLAALVGRHSR 375 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~ 375 (401)
|+..||..||++.++.+
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 89999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=309.43 Aligned_cols=244 Identities=22% Similarity=0.372 Sum_probs=201.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|++|.||+|.+..+++.||+|.+... ..+.+..|+++++.+ +||||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 4689999999999999999999888999999998643 234588899999999 89999999999865 56789
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++|||+.+++|..++. .+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence 9999999999987753 478889999999999999999999999999999999999766 8999999998654321
Q ss_pred Cc------------------------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 015741 283 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (401)
Q Consensus 283 ~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~ 332 (401)
.. .....|+..|+|||++.+ ..++.++||||||+++|+|++|..||. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence 11 112357888999999876 578899999999999999999999984 4
Q ss_pred CCCHHHHHHHHHH-h-------CChhHHHHHHhcCCCCChhhHHH----hhhhcCCCccccccc
Q 015741 333 HDNYDQLVKIAKV-L-------GTDELNAYLNKYHIELDPHLAAL----VGRHSRKPWSKFITV 384 (401)
Q Consensus 333 ~~~~~~l~~i~~~-~-------~~~~~~~~l~~~~l~~dP~~R~~----~~~~l~~~~~~~~~~ 384 (401)
.+..+.+..+... . -++.+.+++.+ |+..||+.|++ +++++.|||++-...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRK-LLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred CchHHHHHHHhcCCccCCCccccCHHHHHHHHH-HccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 4444444443321 1 14567777777 89999999999 999999999976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=311.23 Aligned_cols=252 Identities=26% Similarity=0.513 Sum_probs=201.3
Q ss_pred cccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 128 ~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..+...++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++....
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPAR 89 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecc
Confidence 34456789999999999999999999998899999999986422 35677899999999 9999999999886432
Q ss_pred ----CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 203 ----SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 203 ----~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
....+++++++ +++|..++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~ 167 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA 167 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccc
Confidence 23467888876 56776554 3588999999999999999999999999999999999999776 8999999998
Q ss_pred eecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------- 346 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------- 346 (401)
.... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. ..+....+..+.+..
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 168 RHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 7643 223345678889999998765578899999999999999999999984 333333333322211
Q ss_pred ---------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 347 ---------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 347 ---------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
..+.+.+++.+ |++.||..|+++.++++|||++.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH-HcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 13455677777 8999999999999999999998654433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.71 Aligned_cols=243 Identities=22% Similarity=0.404 Sum_probs=201.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..+|++.+.||+|+||.||+|++..+++.|++|.+... ..+.+.+|+.+++.+ +|+||+++++.+.+ ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEEEEe
Confidence 46899999999999999999999889999999988643 235688999999998 99999999999876 4578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
|||+.+++|..++. .+++.++..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++........ ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccC
Confidence 99999999987764 478889999999999999999999999999999999998766 899999999876543322 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +..+.+..+.... -.+.+.+++.+
T Consensus 175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCC-CHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 4578889999999876 67889999999999999999999999543 3333332222111 12456777777
Q ss_pred cCCCCChhhHHHhhhhcCCCccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+..||+.||++.+++.|+|++..
T Consensus 253 -~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 -CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -HCcCCcccCcCHHHHhhChhhhcc
Confidence 899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=300.68 Aligned_cols=246 Identities=27% Similarity=0.508 Sum_probs=202.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccch-----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~~-----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
...|+++..||+|.||.||+|..++++. .+|||.++..+. ...-+|+.+++.| +|||++.+..+|... +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-C
Confidence 3579999999999999999997665543 789999976532 4567999999999 999999999998754 6
Q ss_pred CCcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC---CCeEEEEec
Q 015741 204 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDW 273 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~vkl~DF 273 (401)
..+++++||.+...+..+. +.++...++.++.||+.|++|||++-|+||||||+|||+..+ .+.|||+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 7889999999987654332 358899999999999999999999999999999999999765 248999999
Q ss_pred ccceecCCCC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--------CCHHHHHH
Q 015741 274 GLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--------DNYDQLVK 341 (401)
Q Consensus 274 g~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--------~~~~~l~~ 341 (401)
|+++.+...- .....+.|.+|+|||.+.|...|+++.||||+|||+.||+|-++-|.... -..+++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9998875332 23456778899999999999999999999999999999999876663211 14578888
Q ss_pred HHHHhCChh-------------------------------------------HHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 342 IAKVLGTDE-------------------------------------------LNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 342 i~~~~~~~~-------------------------------------------~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
|.+.+|.|. ..+++.+ ||++||.+|.+++++++|++
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k-lL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK-LLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH-HhccCchhhccHHHHhcccc
Confidence 888887432 2233556 79999999999999999999
Q ss_pred ccc
Q 015741 379 SKF 381 (401)
Q Consensus 379 ~~~ 381 (401)
|..
T Consensus 340 F~~ 342 (438)
T KOG0666|consen 340 FTE 342 (438)
T ss_pred ccc
Confidence 865
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.56 Aligned_cols=241 Identities=22% Similarity=0.383 Sum_probs=194.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.+|++.+.||+|+||.||+|.+..++..|++|++... ....+.+|+.+++.+ +||||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 3688899999999999999999899999999987532 124578899999999 8999999999987655567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++++||+.+++|...+ ..+++..++.++.|++.||+|||+++|+||||||+||+++.++ .++|+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence 88999999999987665 3478888999999999999999999999999999999998666 7999999998765321
Q ss_pred ----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +..+....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHHHHHHHhcCCCCCCCchhcCHH
Confidence 11223457788999999876 67889999999999999999999998433 3333333322111 1334
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
+..++ + |+..+|+.||+++++++|||++
T Consensus 238 ~~~li-~-~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFL-G-CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHH-H-HhcCChhhCcCHHHHhcCcccc
Confidence 55566 4 4557999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.70 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=207.6
Q ss_pred ccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 129 ~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
+....+.|..-+.||+|+||+||-+.-+.+|+.||.|.+.+.. .....+|-.+|.++ +.+.||.+-..|+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeT-- 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFET-- 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecC--
Confidence 4445688999999999999999999999999999999885322 23367899999998 88999999888865
Q ss_pred CCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
...+++||..|+||+|..++- .+++..++.++++|+.||++||+.+||+|||||+|||+|+.| +|+|+|.|+|.
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAv 335 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAV 335 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEE
Confidence 456789999999999987652 589999999999999999999999999999999999999766 89999999999
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHH-------hCC
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV-------LGT 348 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~-------~~~ 348 (401)
.+..+.....++||.+|||||++.+ +.|+...|+|||||+||||+.|+.||..-. ...+.+.+.... .-+
T Consensus 336 ei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS 414 (591)
T KOG0986|consen 336 EIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFS 414 (591)
T ss_pred ecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccC
Confidence 9988888888899999999999988 569999999999999999999999994321 122222221111 114
Q ss_pred hhHHHHHHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
++.++++.. +|..||.+|.- ++++.+||+++-++.
T Consensus 415 ~eakslc~~-LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 415 EEAKSLCEG-LLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHHH-HHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 566666665 69999999974 679999999998764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=306.37 Aligned_cols=244 Identities=23% Similarity=0.406 Sum_probs=201.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||.|+||.||+|.+..+++.+|+|+++... .+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence 467999999999999999999998889999999986543 34678899999999 89999999999875 4578999
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
|||+++++|..++. .+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence 99999999977753 488999999999999999999999999999999999999766 89999999986553222 2
Q ss_pred ccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhH
Q 015741 285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDEL 351 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~ 351 (401)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||. +.+..+.+..+.... -+..+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 234568889999999752 2457789999999999999999999984 334444444443321 12467
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+++.+ |++.+|..||++.++++|+|+...
T Consensus 239 ~~li~~-~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKS-CLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHH-HhccChhhCcCHHHHhcChhhccc
Confidence 777887 899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=297.62 Aligned_cols=239 Identities=26% Similarity=0.420 Sum_probs=196.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||.|++|.||++.+..+++.||+|.+... ..+.+.+|+++++++ +|+|++++++.+... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 489999999999999999999889999999998532 235678899999999 999999999987532 3467899
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
|||+.+++|...+ ..+++.+++.++.|++.||++||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence 9999999987664 2478999999999999999999999999999999999999766 89999999998764322
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||. ..+.......+.... .++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 2234467888999999876 678899999999999999999999984 333333333332221 1356777788
Q ss_pred hcCCCCChhhHHHhhhhcCCCcc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ |+..||..||++.++++|||+
T Consensus 236 ~-~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 T-MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred H-HhccCcccCCCHHHHhcCCCC
Confidence 8 899999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.04 Aligned_cols=243 Identities=23% Similarity=0.407 Sum_probs=200.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+-|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+++++.+ +||||+++++++.+ ....+++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEE
Confidence 34678899999999999999998899999999986533 35678899999999 99999999999876 45789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~ 285 (401)
||+.++++...+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccccc
Confidence 999999987654 3588999999999999999999999999999999999998766 8999999998755322 122
Q ss_pred cccccCCCcccccccc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHH
Q 015741 286 NVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELN 352 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~ 352 (401)
....++..|+|||++. ....++.++|||||||++|+|++|+.||. ..+..+....+.+.. -+.++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc-ccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 3456788999999974 22457889999999999999999999984 344444444443321 134678
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+++.+ |+..||..||++.++++|||++.-
T Consensus 240 ~li~~-~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 240 DFLKK-CLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHH-HccCChhhCcCHHHHhcCCCEecc
Confidence 88888 899999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.08 Aligned_cols=250 Identities=30% Similarity=0.561 Sum_probs=199.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---C
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---~ 204 (401)
.++|.+.+.||+|+||.||+|++..+++.||+|.++.. ....+.+|+.+++.+ +|+||+++++++..... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 46899999999999999999999999999999988642 234677899999999 99999999998764322 4
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++++||+.+ +|...+ ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++.....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence 57999999974 554443 3588999999999999999999999999999999999999766 899999999986643
Q ss_pred C-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------------
Q 015741 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------------- 346 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------------- 346 (401)
. .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+.......+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP-GKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 3 222344678889999998754568899999999999999999999883 333222222221111
Q ss_pred -----------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 347 -----------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 347 -----------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.++.+.+++.+ |++.||+.|+++.++++|||++.+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEK-MLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHH-HhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 13345567777 89999999999999999999987654443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.02 Aligned_cols=243 Identities=32% Similarity=0.578 Sum_probs=200.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+|++.+.||+|+||.||+|.+..+++.||+|.++... ...+..|+++++++ +|+||+++++++.+ ...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 4788999999999999999998899999999986432 23467899999999 89999999999976 5678
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++||||+ +++|..++. .+++..++.++.||++||.|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCC
Confidence 9999999 888877653 478999999999999999999999999999999999999766 8999999999876543
Q ss_pred C-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------------
Q 015741 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------- 347 (401)
Q Consensus 283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------------- 347 (401)
. ......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.++.+.+.++....+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL-PGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc-cCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 2 2333456778999999866567889999999999999999995444 66666665555543321
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+..+.+++.+ |+..||..|+++.++++|+|++.-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQR-LLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHH-HhcCCcccCcCHHHHhhCccccCCCC
Confidence 2345566777 89999999999999999999988443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.35 Aligned_cols=242 Identities=21% Similarity=0.378 Sum_probs=203.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ...+.+|+++++.+ +|+||+++++++.+ ...++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEE--CCeEEEE
Confidence 46888999999999999999999899999999986432 35678999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cccc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~ 286 (401)
+||+.+++|..++. .+++..++.++.|++.||.|||+++++||||+|+||+++.++ .++|+|||++..+... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence 99999999987765 579999999999999999999999999999999999999766 8999999999877543 2234
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~~~ 358 (401)
...++..|+|||.+.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+.. -.+++.+++.+
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~- 233 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL- 233 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCccc-CchHHHHHHhhhcCCCCCcccccCHHHHHHHHH-
Confidence 4567888999999887 5689999999999999999999999843 33333333333321 13457778877
Q ss_pred CCCCChhhHHHhhhhcCCCccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+..||+.||++++++.|||++..
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCC
Confidence 799999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.81 Aligned_cols=238 Identities=24% Similarity=0.411 Sum_probs=198.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|++|.||+|.+..+++.|++|.+.. .....+.+|+++++.+ +||||+++++++.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 47889999999999999999999999999998753 2346688999999999 99999999999865 4678999
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..+.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999987765 3478888999999999999999999999999999999999766 899999999987654332
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.. .+..+....+.+.. -.+++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQLID 234 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 233467888999999876 6788999999999999999999999843 33333333333221 1346777888
Q ss_pred hcCCCCChhhHHHhhhhcCCCcc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ |++.+|+.||++.++++|||.
T Consensus 235 ~-~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 235 Q-CLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred H-HccCCcccCcCHHHHhhCCCC
Confidence 8 899999999999999999994
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=331.99 Aligned_cols=241 Identities=20% Similarity=0.295 Sum_probs=187.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeE-EEcC---C-CC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDI-VRDQ---Q-SK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~-~~~~---~-~~ 204 (401)
..+++|.+.|.+|||+.||+|.+...+..||+|.+-.. ..+.+.+|+++|+.|.+|+|||.+++. .... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46788999999999999999999877799999987433 346689999999999889999999993 2211 1 23
Q ss_pred CcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 205 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
.++|+||||.+|.|.+++. +++|.++..|+.|+++|+.+||... |||||||-+||||+.++ .+||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccc
Confidence 4678999999888766653 5999999999999999999999997 99999999999999777 89999999985
Q ss_pred ecCCCC--c--------ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Q 015741 278 FYHPGK--E--------YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345 (401)
Q Consensus 278 ~~~~~~--~--------~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~ 345 (401)
-..... . .-....|+.|+|||++.- +...+.|+|||||||+||.||+...||..... ...+..--..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-laIlng~Y~~ 273 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-LAILNGNYSF 273 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-eeEEeccccC
Confidence 322111 1 122467899999999732 35788999999999999999999999954311 1111100000
Q ss_pred h----CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 346 L----GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 346 ~----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
. .+..+.++|.. ||+.||.+||.|-|++.+
T Consensus 274 P~~p~ys~~l~~LI~~-mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 274 PPFPNYSDRLKDLIRT-MLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCCccHHHHHHHHHHH-HhccCcccCCCHHHHHHH
Confidence 0 12245566666 899999999999999865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.81 Aligned_cols=250 Identities=30% Similarity=0.581 Sum_probs=201.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~ 205 (401)
.++|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999998642 235678899999999 899999999987643 2356
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++||||+.+ +|...+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence 8999999975 666554 3588999999999999999999999999999999999999766 8999999999765332
Q ss_pred Cc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
.. .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+...++..+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~-~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP-GKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC-CCChHHHHHHHHHHhCCChhHhhhhh
Confidence 21 1234678889999998765568999999999999999999999983 3333333332222111
Q ss_pred ---------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
++++.+++.+ |++.+|..||++.+++.|||++.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ-MLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHH-HccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 3456677777 89999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.05 Aligned_cols=245 Identities=21% Similarity=0.357 Sum_probs=200.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|+..+.||.|++|.||+|.+..+++.+|+|.+... ...++.+|+++++++ +||||+++++++.+.....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999999889999999998643 235688999999999 89999999999876656678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|||+++++|.+++ ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence 9999999987653 2378888999999999999999999999999999999999766 8999999998755322
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC----CCHHHHHHHHHHh----C-------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----DNYDQLVKIAKVL----G------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~----~~~~~l~~i~~~~----~------- 347 (401)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ...+....+.... .
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 123456778999999876 678999999999999999999999996542 2222222222110 0
Q ss_pred --ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 --TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 --~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+.+.+++.+ |+..+|..||++.+++.|||++...
T Consensus 237 ~~~~~~~~li~~-~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQ-CLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHH-HcCCCcccCCCHHHHHhCccccccc
Confidence 1346677777 8999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=299.30 Aligned_cols=238 Identities=24% Similarity=0.457 Sum_probs=195.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+.... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 3667789999999999999998889999999875321 14578899999999 99999999999876
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+.+++|||+.+++|..++. .+++..+..++.|++.||+|||+.|++||||+|+||+++.++ .++|+|||.++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccc
Confidence 467889999999999877763 478888999999999999999999999999999999998666 8999999998766
Q ss_pred CCCCc-------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------
Q 015741 280 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (401)
Q Consensus 280 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------ 346 (401)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +....+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGENASPEIPS 234 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHhccCCCcCCc
Confidence 42211 112357788999999876 67888999999999999999999999533 3333333333321
Q ss_pred -CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 -GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 -~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
....+.+++.+ |++.||..||++.++++|||+
T Consensus 235 ~~~~~~~~li~~-~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEK-TFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHH-HccCCchhCcCHHHHhhCCCC
Confidence 13566777877 899999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.73 Aligned_cols=239 Identities=20% Similarity=0.320 Sum_probs=188.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.. ..+.+.+|+.+++.+.+||||+++++++.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 46899999999999999999974 345678999998743 235688999999998789999999999966 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (401)
...++||||+.+|+|..++.
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 56789999999999865542
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 224 ------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 224 ------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccc
Confidence 256677888999999999999999999999999999999655 8999999999866433221
Q ss_pred c---ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHH
Q 015741 286 N---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAY 354 (401)
Q Consensus 286 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~ 354 (401)
. ...++..|+|||++.+ ..++.++|||||||++|||++ |..||............+.... ...++.++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI 349 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence 1 1233456999999876 679999999999999999998 7778743322222222222211 23467777
Q ss_pred HHhcCCCCChhhHHHhhhhcCC
Q 015741 355 LNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+ |+..||+.||++.++++.
T Consensus 350 i~~-cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 350 MKS-CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHH-HccCChhHCcCHHHHHHH
Confidence 777 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=298.47 Aligned_cols=240 Identities=23% Similarity=0.425 Sum_probs=200.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+..+++.+++|.++... .+.+.+|+++++++ +||||+++++++.+ ....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence 468999999999999999999998889999999987543 56799999999999 99999999999976 467899999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
|+.+++|..++ ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccc
Confidence 99999998775 3478999999999999999999999999999999999999766 89999999998764433 223
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------hCChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---------LGTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---------~~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... ...+....+... .-...+.+++.+
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-chhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 4457888999999876 67899999999999999999999998532 222222221111 112466777887
Q ss_pred cCCCCChhhHHHhhhhcCCCcc
Q 015741 358 YHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
|++.||..||++.+++.|||+
T Consensus 236 -~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 -CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -HHhcChhhCcCHHHHhcCCCC
Confidence 799999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.19 Aligned_cols=240 Identities=20% Similarity=0.378 Sum_probs=198.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||.|+||+||+|....++..+++|++... ..+.+.+|+++++.+ +|+||+++++.+.+ ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 4799999999999999999998889999999998632 346788999999998 99999999998866 4678899
Q ss_pred EeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
||++.+++|...+. .+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCc
Confidence 99999999877752 378889999999999999999999999999999999999765 79999999987664432
Q ss_pred cc-----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------------
Q 015741 284 EY-----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------------ 346 (401)
Q Consensus 284 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------------ 346 (401)
.. ....++..|+|||.+.....++.++|+|||||++|+|++|+.||... ...+.+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhcCCCCCcCCcccccc
Confidence 22 33467888999999876447899999999999999999999998433 3333333322211
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
-.+.+.+++.+ |+..||..||++.+++.|||+
T Consensus 236 ~~~~~~~li~~-~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISL-CLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHH-HcCCChhhCcCHHHHhhCCCC
Confidence 12455677777 899999999999999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=298.58 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=189.8
Q ss_pred CCeEEEeee--cccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 134 DDYEVVRKV--GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 134 ~~y~i~~~L--g~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
++|++.+.+ |+|+||.||++.++.+++.+|+|++........ |+.+...+.+||||+++++.+.+. ...++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence 456666665 999999999999999999999999875433222 343444344799999999999764 47899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccc
Q 015741 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (401)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~ 288 (401)
|+++++|..++. .+++.+++.++.|++.||.|||+.|++||||||+||+++.++..++|+|||++...... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 999999987653 58999999999999999999999999999999999999976658999999999866432 234
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH---HHHHHHHHH------hCChhHHHHHHhcC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKV------LGTDELNAYLNKYH 359 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~---~~l~~i~~~------~~~~~~~~~l~~~~ 359 (401)
.++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... +.+...... ..++.+.+++.+ |
T Consensus 167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 244 (267)
T PHA03390 167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS-M 244 (267)
T ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH-H
Confidence 67888999999876 678999999999999999999999996332221 112111110 124677888887 8
Q ss_pred CCCChhhHHH-hhhhcCCCccc
Q 015741 360 IELDPHLAAL-VGRHSRKPWSK 380 (401)
Q Consensus 360 l~~dP~~R~~-~~~~l~~~~~~ 380 (401)
++.+|..|++ ++++++|||++
T Consensus 245 l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 245 LKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hccChhhCCchHHHHhcCCccc
Confidence 9999999995 79999999986
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.60 Aligned_cols=240 Identities=27% Similarity=0.460 Sum_probs=199.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||.|+||.||++.+..+++.+|+|+++.. ..+++..|+++++.+ +||||+++++++........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 488999999999999999999999999999998532 235688899999999 99999999998876666778999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----hCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH-----~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
|||+.+++|..++ ..+++..++.++.||+.||+||| +.+++|+||||+||+++.++ .+||+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccc
Confidence 9999999987665 35788899999999999999999 89999999999999999766 89999999998
Q ss_pred ecCCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 278 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccC-cCHHHHHHHHhcCCCCCCccccCH
Confidence 7754433 334578889999999876 5688999999999999999999999843 333332233322211 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+++.+ |+..+|..||++.++++|||.
T Consensus 237 ~~~~l~~~-~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKS-MLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHH-HccCCcccCCCHHHHhhCCCC
Confidence 66777887 899999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.41 Aligned_cols=247 Identities=27% Similarity=0.489 Sum_probs=197.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~------ 203 (401)
..+|.+.+.||.|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence 47899999999999999999999999999999998643 235688999999999 99999999987754322
Q ss_pred ------CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 204 ------KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 204 ------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
...+++|||+.+ +|...+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++..++|+|||.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 246899999985 665554 35889999999999999999999999999999999999986666899999999
Q ss_pred ceecCCCC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 276 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 276 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
+....... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||... .+.+....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA-HELEQMQLILESVPVVRE 240 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 97653221 1123457788999998765567889999999999999999999999433 3333322221110
Q ss_pred -------------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 347 -------------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 347 -------------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
-..++.+++.+ |+..||..|+++.+++.|||++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ-ILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH-HhCCCchhccCHHHHhCCCcccccc
Confidence 12345567777 8999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=299.13 Aligned_cols=241 Identities=23% Similarity=0.413 Sum_probs=196.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+|+..+.||+|++|.||+|.+..+++.+|+|++.... .+.+.+|+.+++++ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence 3778899999999999999999999999999986422 35688999999999 99999999999965 467
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
.++||||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++..++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 88999999999998765 357889999999999999999999999999999999999876657999999998766432
Q ss_pred Cc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHHhC--------
Q 015741 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLG-------- 347 (401)
Q Consensus 283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~~~-------- 347 (401)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 11 123457788999999876 6788999999999999999999999853321 1222222211111
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
.+++.+++.+ |+..+|..|+++.+++.|||++
T Consensus 237 ~~~~~~~i~~-~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLR-CLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHH-HcCCCcccCcCHHHHhcCcccC
Confidence 3466677777 8999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.56 Aligned_cols=243 Identities=30% Similarity=0.540 Sum_probs=195.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----- 202 (401)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+|+++++.+ +||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 578999999999999999999999999999999885321 24578899999999 9999999999876533
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...++++|||+.+..+..+. ..+++..++.++.|+++||.|||++||+|+||||+||+++.++ .++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence 23578999999875544433 2589999999999999999999999999999999999999766 899999999976
Q ss_pred cCCCCc------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh
Q 015741 279 YHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 279 ~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
...... .+...++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHh
Confidence 532211 122356778999999876556889999999999999999999887 4444444444433321
Q ss_pred C------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 G------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ~------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ .+.+.+++.+ |+..||..|+++.+++.|||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK-LLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH-HcccCcccCcCHHHHhcCCCC
Confidence 1 1345577777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.22 Aligned_cols=242 Identities=22% Similarity=0.358 Sum_probs=200.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||.|++|.||+|.+..+++.+++|.+... ....+.+|+++++++ +||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeec--CCEEEEE
Confidence 4678889999999999999999889999999998643 235688999999999 79999999999876 4678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||+.+++|..++ ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence 9999999988776 357888999999999999999999 9999999999999999766 899999999876533222
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC----CCHHHHHHHHHHh--------CChhHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----DNYDQLVKIAKVL--------GTDELN 352 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~----~~~~~l~~i~~~~--------~~~~~~ 352 (401)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ...+.+..+.... -++++.
T Consensus 157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 2 2667888999999876 688999999999999999999999996543 2222222222211 234677
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+++.+ |+..||..||++.+++.|||++.+
T Consensus 235 ~li~~-~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 235 DFVNL-CLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHH-HcCCCchhCcCHHHHhhCchhhcc
Confidence 77877 899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.82 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=184.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-eEEEEE------------------Eecc--cchHHHHHHHHHHHHhcCCCCe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI 191 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~-~~vavK------------------~~~~--~~~~~~~~E~~il~~l~~hpni 191 (401)
.++|++++.||+|+||+||+|..+... ..+++| .++. .....+.+|+.+|+++ +||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 468999999999999999998764322 222222 1111 1124578999999999 99999
Q ss_pred eEEeeEEEcCCCCCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 192 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
+++++++.+. ...|+++|++.+..+..+.. .....+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999764 56789999987655544322 23456778899999999999999999999999999999976
Q ss_pred CCeEEEEecccceecCCCCc--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHH
Q 015741 265 QRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV 340 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~ 340 (401)
+ .+||+|||+++.+..... .....|+..|+|||++.+ ..++.++|||||||++|||++|..+++... ....++.
T Consensus 304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 6 899999999987754322 223578999999999887 679999999999999999999987654322 2333333
Q ss_pred HHHHHhC--------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 341 KIAKVLG--------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 341 ~i~~~~~--------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+.++ ..++.+++.+ ||..||+.|+++.++|.|||+...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k-mL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK-MLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH-HhccCcccCcCHHHHhhChhhhcC
Confidence 3332211 1233344556 899999999999999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.97 Aligned_cols=235 Identities=18% Similarity=0.329 Sum_probs=185.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv 192 (401)
.++|.+.++||+|+||.||+|.+.. ++..||+|++.... ...+.+|++++.++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 4689999999999999999997532 34579999987532 34688999999999 999999
Q ss_pred EEeeEEEcCCCCCcEEEEeecCCCchhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015741 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------TLSDYDVRYYIYELLKALDYCHSQGIM 250 (401)
Q Consensus 193 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~L~~LH~~~iv 250 (401)
++++++.+ ....+++|||+.+++|..++. .+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999976 456799999999999876642 245667889999999999999999999
Q ss_pred eecCCCCCeeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc--C
Q 015741 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--R 325 (401)
Q Consensus 251 HrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt--g 325 (401)
||||||+|||++.++ .+||+|||+++........ ....++..|+|||++.+ +.++.++|||||||++|+|++ +
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999766 8999999999866433221 22344677999999876 679999999999999999986 4
Q ss_pred CCCCCCCCCCHHHHHHHHHHh--------------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 326 KEPFFYGHDNYDQLVKIAKVL--------------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 326 ~~Pf~~~~~~~~~l~~i~~~~--------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..||. +.+..+.+..+.... .++.+.+++.+ |+..||+.||++.++.
T Consensus 239 ~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 239 EQPYG-ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ-CWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCC-cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHH-HccCCchhCcCHHHHH
Confidence 56663 333333333322211 12456777777 8999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=298.53 Aligned_cols=239 Identities=25% Similarity=0.421 Sum_probs=200.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+|++.+.||.|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence 488999999999999999999889999999998632 246788999999999 99999999999865 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|+||+.+++|...+. .+++..+..++.|+++||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence 999999999987763 588999999999999999999999999999999999999766 8999999999876554444
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC-HHHHHHHHHH-------hCChhHHHHHHh
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKV-------LGTDELNAYLNK 357 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~-~~~l~~i~~~-------~~~~~~~~~l~~ 357 (401)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .+.+...... .-++++.+++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 45667888999999876 56899999999999999999999998544321 2222222221 014577788888
Q ss_pred cCCCCChhhHHHh--hhhcCCCcc
Q 015741 358 YHIELDPHLAALV--GRHSRKPWS 379 (401)
Q Consensus 358 ~~l~~dP~~R~~~--~~~l~~~~~ 379 (401)
|+..||..|++. +++++|||+
T Consensus 236 -~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 -LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -HccCChhHcCCccHHHHhcCCCC
Confidence 899999999999 999999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=298.79 Aligned_cols=238 Identities=30% Similarity=0.612 Sum_probs=194.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+|++.+.||.|++|.||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence 488999999999999999999889999999998643 245678899999999 99999999999976 45778999
Q ss_pred eecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
||+.+ ++..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence 99996 554432 2478999999999999999999999999999999999999666 8999999999755332 2
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------------- 346 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------------- 346 (401)
......++..|++||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+.+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 22334567889999998765567899999999999999999999984 444444444333221
Q ss_pred ------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 ------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.++.+.+++.+ |++.||..|+++.++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHR-LLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHH-HhcCCcccCCCHHHHhcCCCC
Confidence 13345566777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=297.62 Aligned_cols=237 Identities=22% Similarity=0.363 Sum_probs=194.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+|++.+.||.|+||+||+|.. .+++.+|+|.++... ...+.+|+++++.+ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence 477889999999999999986 578899999875321 24588899999999 89999999999976 467
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++ .++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence 899999999999987753 478889999999999999999999999999999999999666 8999999998754211
Q ss_pred -------CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------
Q 015741 283 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------- 346 (401)
Q Consensus 283 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------- 346 (401)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... +.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGLMPRLPDS 233 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccC-ChHHHHHHhhhccCCCCCCCCC
Confidence 11223467888999999876 67889999999999999999999999533 3333322222221
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
..+.+.+++.+ |+..+|..||++.+++.|||+
T Consensus 234 ~~~~~~~~i~~-~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 234 FSAAAIDFVTS-CLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCHHHHHHHHH-HhcCCcccCCCHHHHhcCCCC
Confidence 13467778888 899999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.21 Aligned_cols=244 Identities=21% Similarity=0.388 Sum_probs=198.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++++.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +||||+++++.+.. ...++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 4688999999999999999999889999999988642 135688999999998 99999999998875 4678999
Q ss_pred EeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|||+++++|..++. .+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999876653 57889999999999999999997 5999999999999999765 8999999998765322
Q ss_pred CcccccccCCCccccccccCC-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 283 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.... .......+.... -
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCCCCCCccc
Confidence 22334677889999998542 235789999999999999999999995432 222222222111 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+++.+++.+ |+..+|..||++++++.|||+.....
T Consensus 235 ~~~~~~li~~-~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAK-CLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHH-HcccCcccCCCHHHHhcChhhhhccC
Confidence 3566778888 89999999999999999999977544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.90 Aligned_cols=239 Identities=31% Similarity=0.571 Sum_probs=196.1
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
|++.+.||.|+||.||+|.+..+++.+|+|.+... ....+.+|+++++.+ +|+|++++++++.+......++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 67889999999999999999888999999998754 234678899999999 899999999999765346889999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--c
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--~ 284 (401)
||+.+ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCccc
Confidence 99986 555443 2588999999999999999999999999999999999999766 89999999998765433 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....++..|+|||.+.+...++.++||||||+++|+|++|+.||.. .+..+.+..+.+..+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG-STELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 33446678899999887655688999999999999999999999843 333343333332211
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |+..+|..||++.+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDK-LLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHH-HcCCChhhCcCHHHHhhCcCC
Confidence 3455667777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=320.53 Aligned_cols=201 Identities=25% Similarity=0.440 Sum_probs=177.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----CCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~~~ 205 (401)
.-|...+.||+|+||.||+|+++.+|+.||||.+++ ...++.-+|+++|++| +|+|||+++++-++.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence 445667889999999999999999999999999875 4467889999999999 7999999999876655 556
Q ss_pred cEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--C-CeEEEEecccc
Q 015741 206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q-RKLRLIDWGLA 276 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~-~~vkl~DFg~a 276 (401)
..++||||.+|+|...++ .+++.+.+.++.++..||.|||++||+||||||.||++-.. + ...||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 789999999999998875 48999999999999999999999999999999999998422 2 25799999999
Q ss_pred eecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~ 335 (401)
+.++.+......+||+.|++||++...+.|+..+|.|||||++|+..||..||-+...+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99998888899999999999999985478999999999999999999999999654443
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.73 Aligned_cols=246 Identities=20% Similarity=0.339 Sum_probs=199.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+|+++++.+ +||||+++++.+.. ..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 46899999999999999999999999999999986432 34577899999998 99999999999865 45789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 999999999998776 3478889999999999999999999999999999999998666 89999999986421100
Q ss_pred ---------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--
Q 015741 284 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-- 346 (401)
Q Consensus 284 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-- 346 (401)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+.+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccC
Confidence 0112356778999999876 678999999999999999999999985 333334344333221
Q ss_pred -------CChhHHHHHHhcCCCCChhhHHH---hhhhcCCCccccccccc
Q 015741 347 -------GTDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITVEN 386 (401)
Q Consensus 347 -------~~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~~~ 386 (401)
.++++.+++.+ |+..||..|++ +.++++|||+.....+.
T Consensus 235 ~~~~~~~~~~~~~~li~~-~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 235 WPEGDEALPADAQDLISR-LLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCccccCCHHHHHHHHH-HhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 13457778888 89999999997 79999999986655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.37 Aligned_cols=242 Identities=23% Similarity=0.389 Sum_probs=203.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..|.-++.||.|+||.||-|++..+.+.||||.+.-. +-.++..|+..|+++ +|||+|.+.++|.. ....+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLr--e~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLR--EHTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeec--cchHH
Confidence 3477789999999999999999999999999998632 235689999999999 99999999999865 45678
Q ss_pred EEEeecCCCc--h-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTD--F-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~--l-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+|||||-|.. + ....+++.+.++..|..+.+.||.|||+++.||||||..|||++..+ .|||+|||.|....+.
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCch--
Confidence 9999998763 3 44456799999999999999999999999999999999999999666 8999999999876544
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH----hC----ChhHHHH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----LG----TDELNAY 354 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----~~----~~~~~~~ 354 (401)
..++|||+|||||++.. .+.|+-++||||||++..||.-.++|+|+. +.+..+..|.+. +. +..+..|
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 45799999999999853 467999999999999999999999998643 344444555543 22 3466777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.. ||+..|..||+.++++.|+|..|...
T Consensus 258 vd~-CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 258 VDS-CLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHH-HHhhCcccCCcHHHHhhcchhccCCC
Confidence 777 89999999999999999999988543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=301.38 Aligned_cols=228 Identities=18% Similarity=0.204 Sum_probs=186.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEc--CCCCCcEEEEe
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFE 211 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~--~~~~~~~lv~e 211 (401)
..||+|++|.||+|.+ +|+.||||+++... .+.+.+|+.+|+++ +||||+++++++.+ ....+++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999987 78999999986432 25677999999999 99999999999876 44567899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccc
Q 015741 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
|+.+|+|..++. .+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++...... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~~--~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSPP--FK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcccc--cc
Confidence 999999988763 478888899999999999999984 999999999999999766 89999999997654222 23
Q ss_pred cccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~~~ 358 (401)
..++..|+|||++.+. ..++.++|||||||++|||++|+.||. +.+..+....+.+.. .++.+.+++.+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~- 257 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA- 257 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH-
Confidence 5678899999998652 578999999999999999999999994 333334333332221 13467777777
Q ss_pred CCCCChhhHHHhhhhcC
Q 015741 359 HIELDPHLAALVGRHSR 375 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~ 375 (401)
|++.||..||++.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 89999999999999873
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=307.52 Aligned_cols=247 Identities=30% Similarity=0.558 Sum_probs=199.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence 47899999999999999999999889999999998632 124578999999999 99999999999864321
Q ss_pred CCcEEEEeecCCCchhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
...++++||+.. ++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||+++....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~- 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA- 169 (342)
T ss_pred ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC-
Confidence 345899999975 5554443 689999999999999999999999999999999999999776 899999999876432
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------------- 346 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------------- 346 (401)
......++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+....+..+....
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 22334667889999998764568899999999999999999999984 333333333332211
Q ss_pred ---------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 347 ---------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 347 ---------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
..+.+.+++.+ |++.||..|+++.+++.|||++.+...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK-MLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHH-HcCCChhhCcCHHHHhcCcchhhccccc
Confidence 12345677777 8999999999999999999998876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.07 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=190.1
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l--~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.||+|+||.||++.+..+++.+|+|.+.+.. .....+|..+++.+ .+||||+.+++++.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999998899999999885421 12334454444433 278999999999875 4567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
+.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++...... ......
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc-CccCcC
Confidence 9999997665 3589999999999999999999999999999999999998666 8999999998755432 223356
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHHh-------CChhHHHHHHhcCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVL-------GTDELNAYLNKYHIE 361 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~l~~i~~~~-------~~~~~~~~l~~~~l~ 361 (401)
++..|+|||.+.+...++.++|||||||++|+|++|..||..... ....+....... -++++.+++.+ |+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG-LLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH-Hhc
Confidence 889999999986545688999999999999999999999954322 222222221111 24577888888 899
Q ss_pred CChhhHH-----HhhhhcCCCccccccccc
Q 015741 362 LDPHLAA-----LVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 362 ~dP~~R~-----~~~~~l~~~~~~~~~~~~ 386 (401)
.||..|+ ++.++++|||++.+....
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 9999999 699999999999876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=272.00 Aligned_cols=244 Identities=30% Similarity=0.558 Sum_probs=208.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|.-.++||+|.||+||+|+...+++.||+|.++-. -.....+|+-+++.| +|.|||+++++... +..+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEEe
Confidence 466678999999999999999999999999988632 235688999999999 99999999999865 5677899
Q ss_pred EeecCCCch---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccc
Q 015741 210 FEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (401)
Q Consensus 210 ~e~~~~~~l---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~ 285 (401)
+|||....- ......+..+.++.++.|++.||.++|++++.||||||.|+||+.++ .+||+|||+++.+.-. .-+
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEee
Confidence 999985432 22234578888999999999999999999999999999999999777 8999999999876433 345
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhH--------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL-------------- 351 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~-------------- 351 (401)
...+.|.+|++|.++.+.+-|+...|+||.|||+.|+.....|.+++.+-.+|+.+|.+.+|.+..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 566788999999999998899999999999999999999889999999999999999999885322
Q ss_pred ---------------------HHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 352 ---------------------NAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 352 ---------------------~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++++.+ ++..+|..|.+++.+++||++.-++
T Consensus 239 yp~ypattswsqivp~lns~grdllqk-ll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQK-LLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHH-HhccCcccccCHHHHhcCccccccC
Confidence 233555 6899999999999999999987643
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=295.36 Aligned_cols=243 Identities=23% Similarity=0.422 Sum_probs=203.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||.|++|.||+|.+..+++.|++|++.... ...+.+|+..+.++ +|+||+++++++.. ....+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence 46889999999999999999998899999999987543 46789999999999 89999999999865 4678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|||+.+++|..++. .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence 99999999987763 58999999999999999999999 9999999999999999766 8999999999876544332
Q ss_pred -cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHHh--------CChhHHHH
Q 015741 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKVL--------GTDELNAY 354 (401)
Q Consensus 286 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~~--------~~~~~~~~ 354 (401)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ...+....+.... -++.+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 24567888999999876 678899999999999999999999985443 2222222322211 23467788
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |+..+|..||++.++++|||++.+
T Consensus 236 i~~-~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISA-CLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHH-HccCChhhCCCHHHHHhCHHHHhc
Confidence 888 899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.43 Aligned_cols=245 Identities=19% Similarity=0.376 Sum_probs=201.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+.|.....||+|+||.||++.+..++..||||.+... ..+.+.+|+.+++.+ +|+||+++++.+.+ ....+++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 3455567799999999999999889999999998643 235688999999998 99999999999876 46789999
Q ss_pred eecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cccc
Q 015741 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (401)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~ 287 (401)
||+.+++|..++ ..+++.++..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence 999999998775 3578899999999999999999999999999999999999766 89999999987553222 2234
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~ 358 (401)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||.. .+..+.+..+.... .++.+.+++.+
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 254 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL- 254 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHHHHH-
Confidence 568889999999876 6788999999999999999999999853 34444444333221 13456777777
Q ss_pred CCCCChhhHHHhhhhcCCCcccccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
|+..||..||+++++++|||++.....
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 899999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=307.58 Aligned_cols=248 Identities=31% Similarity=0.597 Sum_probs=201.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+.+|+.+++++.+||||+++++++...+....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4789999999999999999999988899999998743 22345778999999987899999999998765566789
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
+||||+.+ +|...+. .+.+..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence 99999985 6665543 478888889999999999999999999999999999999776 89999999997654322
Q ss_pred ----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 284 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
......++..|+|||.+.+...++.++||||||+++|+|++|+.|| .+....+...++....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2233467889999999876567889999999999999999999998 44444444333322211
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+..+.+++.+ |++.||..|+++.++++|||++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK-LLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHH-hccCCcccccCHHHHhhChhhhhhcc
Confidence 3345667777 89999999999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.33 Aligned_cols=248 Identities=29% Similarity=0.536 Sum_probs=199.8
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC--
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-- 203 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~-- 203 (401)
...++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence 3468899999999999999999999899999999998532 124578999999999 99999999999865322
Q ss_pred --CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...++||||+ +++|..+. ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccccc
Confidence 2458999998 56776655 3689999999999999999999999999999999999999766 7999999999765
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------------- 346 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------------- 346 (401)
... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||. +.+.......+.+..
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 322 2334668889999998764568899999999999999999999984 333333333222211
Q ss_pred ------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 347 ------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 347 ------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
..+.+.+++.+ |+..||..|+++.+++.|||++.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK-MLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHH-HcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 12345667777 899999999999999999999886443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.04 Aligned_cols=236 Identities=23% Similarity=0.416 Sum_probs=196.7
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||.|++|.||+|++..+++.+|+|++... ..+.+.+|+.+++.+ +||||+++++.+.+ ....+++|||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 69999999999999888999999998642 235688999999999 99999999999876 4678999999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCC
Q 015741 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292 (401)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~ 292 (401)
++|...+. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence 99987753 478899999999999999999999999999999999999776 89999999998765443334457788
Q ss_pred CccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHHh--------CChhHHHHHHhcCCCCC
Q 015741 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVL--------GTDELNAYLNKYHIELD 363 (401)
Q Consensus 293 ~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~l~~i~~~~--------~~~~~~~~l~~~~l~~d 363 (401)
.|++||.+.+ ..++.++|+||||+++|+|++|..||..... ..+....+.... ..+.+.+++.+ |+..+
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~ 234 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ-LLRRN 234 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH-HccCC
Confidence 9999999876 6788999999999999999999999965443 233333333111 13567788888 79999
Q ss_pred hhhHHH-----hhhhcCCCcccccc
Q 015741 364 PHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 364 P~~R~~-----~~~~l~~~~~~~~~ 383 (401)
|..|++ +.++++|||++-+.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCC
Confidence 999999 99999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=303.03 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=197.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|+..+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+.++.++.+|+||+++++++.+ ....+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence 4566778999999999999999999999999998643 235678899999998569999999998865 4567899
Q ss_pred EeecCCC--chhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 210 FEHVNNT--DFKVL-----YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 210 ~e~~~~~--~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
|||+... ++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++|+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence 9998753 22211 13588999999999999999999975 999999999999999766 899999999976644
Q ss_pred CCcccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------CC
Q 015741 282 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-----------GT 348 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-----------~~ 348 (401)
........++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.......+.+.++.... -+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4333445678889999998764 3688999999999999999999999854432223332221110 12
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
+.+.+++.+ |+..||+.||++++++.|||++.....+
T Consensus 241 ~~l~~li~~-~l~~~p~~Rpt~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 241 PSFVNFINL-CLIKDESKRPKYKELLEHPFIKDYEERN 277 (288)
T ss_pred HHHHHHHHH-HccCChhhCcCHHHHhcChhhhchhhcc
Confidence 356778887 8999999999999999999998865433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.61 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=194.9
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||+|+||+||+|.+..+++.||+|++... ....+.+|+++++.+ +||||+++++++.. ....++||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 68999999999999889999999998532 133467899999999 89999999999875 4578999999999
Q ss_pred Cchhhhc---C--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccccc
Q 015741 216 TDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (401)
Q Consensus 216 ~~l~~~~---~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 290 (401)
++|...+ . .+++.++..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence 9997664 2 488899999999999999999999999999999999999766 899999999876654433444567
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHH-------hCChhHHHHHHhcCCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV-------LGTDELNAYLNKYHIE 361 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~-------~~~~~~~~~l~~~~l~ 361 (401)
+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..+.+...... .-++.+.+++.+ |++
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA-LLQ 234 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH-Hcc
Confidence 788999999876 5688999999999999999999999954332 22222211110 114677888888 799
Q ss_pred CChhhHH-----HhhhhcCCCcccccccc
Q 015741 362 LDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 362 ~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
.||..|+ ++.+++.|||++.++..
T Consensus 235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 235 KDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred CChhHccCCCcccHHHHHhChhhhcCChh
Confidence 9999999 88889999999887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=316.75 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=201.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
..++|++...+|.|+|+.|-.+.+..+++..++|++... .....+|+.++....+||||+++.+++.+ ....|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence 367899999999999999999999999999999999765 34556788888888899999999999976 678899999
Q ss_pred ecCCCchhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 212 HVNNTDFKVLYPTL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 212 ~~~~~~l~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
.+.++.+...+... ...++..|++||+.|+.|||++|||||||||+|||++.+.+.++|+|||.++..... ....+
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~ 474 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA 474 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence 99999886665433 335777899999999999999999999999999999523338999999999877544 44456
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH----hCChhHHHHHHhcCCCCChh
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----LGTDELNAYLNKYHIELDPH 365 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----~~~~~~~~~l~~~~l~~dP~ 365 (401)
-|..|.|||++.. ..|+.++||||||++||+|++|+.||.......+...++... .-++..++++.+ ||+.||.
T Consensus 475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~-LL~~dP~ 552 (612)
T KOG0603|consen 475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQ-LLQVDPA 552 (612)
T ss_pred hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHH-hccCChh
Confidence 6788999999885 899999999999999999999999996555443444443322 225677888888 8999999
Q ss_pred hHHHhhhhcCCCcc
Q 015741 366 LAALVGRHSRKPWS 379 (401)
Q Consensus 366 ~R~~~~~~l~~~~~ 379 (401)
+|+++++++.|||+
T Consensus 553 ~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLGADEIGAHPWF 566 (612)
T ss_pred hCcChhhhccCcch
Confidence 99999999999999
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.89 Aligned_cols=238 Identities=21% Similarity=0.406 Sum_probs=197.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|+||.||++.+..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 588999999999999999999999999999988532 235688999999999 99999999999865 4678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 99999999876652 367888999999999999999999999999999999998766 899999999976643322
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||... +..+....+.... ...++.+++.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 223457888999999876 67888999999999999999999998543 3333333332221 1346777788
Q ss_pred hcCCCCChhhHHHhhhhcCCCcc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ |++.+|..||++.++++|||+
T Consensus 235 ~-~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 235 Q-LFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred H-HhhCChhhCcCHHHHhhCcCC
Confidence 8 799999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.70 Aligned_cols=239 Identities=25% Similarity=0.449 Sum_probs=198.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+|+..+.||+|++|.||+|....+++.|++|.+... ..+.+.+|+.+++.+ +|+||+++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 366778999999999999999888999999987542 235688999999999 99999999999865 4678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++++||+.+++|..++. .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc
Confidence 89999999999987753 378888999999999999999999999999999999999766 89999999998765444
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYL 355 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l 355 (401)
......++..|++||.+.....++.++|+|||||++|+|++|+.||.... ..+....+.+.. -.+.+.+++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 34456788889999998763338899999999999999999999985433 344444433311 135677778
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+ |+..+|..||++.+++.|||.
T Consensus 236 ~~-~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LK-CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HH-HhhcCcccCcCHHHHhcCCCC
Confidence 87 899999999999999999995
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=309.03 Aligned_cols=239 Identities=18% Similarity=0.293 Sum_probs=189.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++... .+.+.+|+.+++++.+|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 5789999999999999999997543 35789999986422 245778999999987899999999988653 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (401)
..++++|||+.+++|..++.
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 67889999999999876541
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---ccccccCCCccc
Q 015741 224 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296 (401)
Q Consensus 224 ----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~a 296 (401)
.+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..+..... .....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 467788899999999999999999999999999999999766 899999999987643322 122344567999
Q ss_pred cccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH-HHHh-------CChhHHHHHHhcCCCCChhhH
Q 015741 297 PELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI-AKVL-------GTDELNAYLNKYHIELDPHLA 367 (401)
Q Consensus 297 PE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i-~~~~-------~~~~~~~~l~~~~l~~dP~~R 367 (401)
||++.+ ..++.++|||||||++|||++ |..||.. ....+.+... .... ..+.+.+++.+ |++.+|+.|
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-cl~~~p~~R 320 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD-CWHNNPEDR 320 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCC-CCccHHHHHHHhccCCCCCCccCCHHHHHHHHH-HccCChhhC
Confidence 999877 689999999999999999997 8888843 2222333222 2211 14567777877 899999999
Q ss_pred HHhhhhcCC
Q 015741 368 ALVGRHSRK 376 (401)
Q Consensus 368 ~~~~~~l~~ 376 (401)
|++++++++
T Consensus 321 Ps~~ell~~ 329 (337)
T cd05054 321 PTFSELVEI 329 (337)
T ss_pred cCHHHHHHH
Confidence 999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.15 Aligned_cols=238 Identities=20% Similarity=0.356 Sum_probs=207.3
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec-------ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-------~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
...||+|+|-+||+|.|..+|..||--.++ +...++|..|+.+|+.| +||||+++|+++.+....++.+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence 478999999999999999999888743322 23347899999999999 9999999999999888888999999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
.+..|+|..+++ ++....++.|++||++||.|||++. |||||||-+||+|+.+.+.|||+|+|+|........ .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-k 202 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-K 202 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-c
Confidence 999999988874 5788899999999999999999984 999999999999998888999999999987754443 3
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~~~ 358 (401)
..+|||.|||||++. ..|+..+||||||+++.||+|+.+||....+..+...++..+. ..|++++||.+
T Consensus 203 svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek- 279 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK- 279 (632)
T ss_pred eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH-
Confidence 479999999999987 4899999999999999999999999977777777666665543 36799999999
Q ss_pred CCCCChhhHHHhhhhcCCCccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+.. ...|+++.++|.|||+..-
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 5666 9999999999999999873
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.65 Aligned_cols=242 Identities=22% Similarity=0.370 Sum_probs=193.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+.+.....||+|+||.||+|.+..++..|++|.+.... .+.+.+|+.+++.+ +|+||+++++++.+ ....++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEEE
Confidence 44445578999999999999998899999999886543 35688999999999 99999999999865 46789999
Q ss_pred eecCCCchhhhcC----CC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 211 EHVNNTDFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||+.+++|...+. .+ ++..+..++.||+.||.|||++||+||||||+||+++.+...++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999987653 24 67788889999999999999999999999999999986555899999999876543222
Q ss_pred -ccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH--HH------hCChhHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA--KV------LGTDELNAY 354 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~--~~------~~~~~~~~~ 354 (401)
.....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||.............. .. ...+++.++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2334578889999998552 3478899999999999999999999854433222222111 11 113467778
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+ |+..+|..||++.+++.|||+
T Consensus 245 i~~-~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILR-CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHH-HcCCCchhCCCHHHHHhCCCC
Confidence 877 899999999999999999995
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=307.54 Aligned_cols=249 Identities=28% Similarity=0.551 Sum_probs=201.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~--- 203 (401)
..++|++.+.||+|++|.||+|++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence 357899999999999999999999889999999998632 234577899999999 99999999987754321
Q ss_pred -CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 204 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 204 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
...++|+||+. ++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence 34789999985 5776655 3589999999999999999999999999999999999999766 89999999997653
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------------
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------------- 346 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------------- 346 (401)
.. .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 22 3345678889999998664568899999999999999999999984 444444444433221
Q ss_pred -----------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 347 -----------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 347 -----------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.++.+.+++.+ |+..||..||++.+++.|||++.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~-~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK-MLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH-hCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 14456677777 89999999999999999999987655443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.61 Aligned_cols=243 Identities=26% Similarity=0.484 Sum_probs=196.2
Q ss_pred CCCeEE-EeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----------------HHHHHHHHHHHHhcCCCCeeEE
Q 015741 133 QDDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVKL 194 (401)
Q Consensus 133 ~~~y~i-~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~il~~l~~hpniv~~ 194 (401)
.++|.. .+.||.|+||.||+|.+..+++.||+|+++.... ..+.+|+++++.+ +|+||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 85 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGL 85 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeee
Confidence 356664 5779999999999999988999999999864321 1477899999999 99999999
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
++++.. ....+++|||+.+ +|...+ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+
T Consensus 86 ~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~ 161 (335)
T PTZ00024 86 VDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA 161 (335)
T ss_pred eEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence 999865 4678999999985 565544 2588999999999999999999999999999999999999766 89999
Q ss_pred ecccceecCCC---------------CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH
Q 015741 272 DWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (401)
Q Consensus 272 DFg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~ 336 (401)
|||.+...... .......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 99999765411 11123346778999999876556789999999999999999999888 455555
Q ss_pred HHHHHHHHHhC----------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 337 DQLVKIAKVLG----------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 337 ~~l~~i~~~~~----------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+..+....+ +..+.+++.+ |+..+|+.|+++++++.|||++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS-LLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH-HcCCCchhccCHHHHhcCcccCCC
Confidence 55555444322 2345667777 899999999999999999999864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.99 Aligned_cols=238 Identities=18% Similarity=0.279 Sum_probs=188.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeE--EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..++.. +++|.++.. ....+.+|+.++.++.+||||+++++++.+ ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence 36899999999999999999998777654 577776532 234678899999998789999999999865 4678
Q ss_pred EEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 207 SLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
+++|||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~ 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-c
Confidence 99999999999877652 367888999999999999999999999999999999999766 8
Q ss_pred EEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh
Q 015741 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhcCC
Confidence 99999999864321111122233556999999866 678899999999999999998 898884 333333333332221
Q ss_pred -------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 -------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 -------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++++.+++.+ |+..+|+.||++++++..
T Consensus 241 ~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 13566777777 899999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=296.22 Aligned_cols=236 Identities=14% Similarity=0.257 Sum_probs=188.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++... ...+.+|+.+++++ +||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CCC
Confidence 467999999999999999999865 346789999987532 24688999999998 99999999999865 467
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+++++|..++. .+++..++.++.|++.||+|||++|++||||||+|||++.++ .++++|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence 899999999999987652 478999999999999999999999999999999999998766 899999998765432
Q ss_pred CCccc--ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 282 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
..... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+.+..+.+... ...+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 22111 1234567999999876 689999999999999999775 988884 3344444444433221 3456
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+++.+ |+..+|..||+++++++
T Consensus 238 ~~li~~-c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLD-CWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHH-HcCCCchhCCCHHHHHH
Confidence 677777 79999999999988854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=291.31 Aligned_cols=238 Identities=23% Similarity=0.412 Sum_probs=198.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++++.||.|+||.||.+++..+++.+++|.+... ....+.+|+++++++ +|+||+++++++.+ ...++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 488999999999999999999999999999987532 235688999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
|||+.+++|...+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 99999999987663 378889999999999999999999999999999999999766 89999999998764333
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+.... .+.++.+++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFD-ATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 2334568889999999876 568889999999999999999999984 344444444433221 1346778888
Q ss_pred hcCCCCChhhHHHhhhhcCCCcc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ |+..+|..|+++.+++.|+|.
T Consensus 235 ~-~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 235 S-LLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred H-HcccCcccCCCHHHHhhCcCC
Confidence 8 799999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=299.29 Aligned_cols=243 Identities=28% Similarity=0.569 Sum_probs=197.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----- 202 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+++++++ +||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence 47899999999999999999999889999999998632 224577899999999 9999999999887543
Q ss_pred ---CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 203 ---SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 203 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
...+++++||+++..+..+. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++ .+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCccccc
Confidence 23789999999985444333 2578999999999999999999999999999999999999766 8999999999
Q ss_pred eecCCCC--cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 277 EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 277 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
....... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. ..+..+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhc
Confidence 8664332 12233456789999988764567889999999999999999998884 3444454444433321
Q ss_pred -----------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |+..||..||++.+++.|||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH-MLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHH-HccCChhhCCCHHHHhcCCCC
Confidence 3455666777 899999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.87 Aligned_cols=236 Identities=26% Similarity=0.509 Sum_probs=194.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|++..+++.||+|.++.. ....+.+|+++++.+ +||||+++++++.+ ....+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIE--DNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEE--CCeEE
Confidence 5799999999999999999999999999999987531 224578899999999 99999999999876 35778
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++|||+++++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence 9999999999876542 378888999999999999999999999999999999998766 79999999998764
Q ss_pred CCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------Chh
Q 015741 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDE 350 (401)
Q Consensus 281 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~ 350 (401)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+....+...+.......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 3322 223467788999999876 67889999999999999999999999765544433333322211 235
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..+|..||++.++++
T Consensus 237 ~~~li~~-cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 237 LRELVSM-CIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHH-HCCCCcccCcCHHHHHH
Confidence 6777777 89999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=300.56 Aligned_cols=247 Identities=30% Similarity=0.533 Sum_probs=198.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
...++|++++.||.|+||.||+|.+..+++.||+|.+.. ...+.+.+|+++++.+ +||||+++++++... ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence 457889999999999999999999999999999998753 2245688999999999 999999999998653 346
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
.+++|||+. ++|...+. .+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||.+.....
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--
Confidence 789999985 46766553 578888889999999999999999999999999999998665 899999999875432
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------------- 346 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------------- 346 (401)
......++..|+|||.+.+...++.++|||||||++|+|++|+.||. ..+.......+.+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-GKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 22334667889999998665678999999999999999999998883 322222111111111
Q ss_pred --------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 347 --------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 347 --------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
..+.+.+++.+ |++.+|+.|+++++++.|+|++.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEK-MLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCCccccccCC
Confidence 12456677777 899999999999999999999775544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.18 Aligned_cols=237 Identities=33% Similarity=0.625 Sum_probs=192.0
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
|++.+.||.|++|.||+|.+..+|..||+|++... ....+.+|+++++.+ +|||++++++++.+ ....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 56789999999999999999889999999998632 235688899999999 89999999999875 46789999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
||++ ++|..++. .+++..+..++.|++.||+|||+++++||||+|+||+++.++ .++|+|||++...... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 9996 46655542 478999999999999999999999999999999999999765 8999999999765322 22
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....++..|+|||++.+...++.++||||||+++|+|++|+.||.. .++.+.+..+.+..+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG-DSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 23345678899999887645678899999999999999999999843 333333333322111
Q ss_pred ------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 ------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++.+.+++.+ |++.||..||++++++.|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSK-MLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHH-HhcCChhhCcCHHHHhcCCCC
Confidence 2345667777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.43 Aligned_cols=236 Identities=18% Similarity=0.349 Sum_probs=190.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
++|++.+.||+|+||.||+|.+...+ ..||+|.++... ...+.+|+.++.++ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--CC
Confidence 57889999999999999999876555 789999986432 35688999999999 99999999999865 45
Q ss_pred CcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC
Q 015741 205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 265 (401)
..+++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 678999999999987665 2367788899999999999999999999999999999999766
Q ss_pred CeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 015741 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~ 341 (401)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+ +....+....
T Consensus 162 -~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~-~~~~~~~~~~ 238 (283)
T cd05048 162 -TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEM 238 (283)
T ss_pred -cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence 899999999976543321 223455678999999876 678999999999999999998 998985 3333343333
Q ss_pred HHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 342 IAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 342 i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+.. -++.+.+++.+ |+..||..||++.+++++
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~-c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIE-CWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 33221 13466777777 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=298.88 Aligned_cols=245 Identities=22% Similarity=0.384 Sum_probs=200.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..|+..+.||.|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence 45778899999999999999998899999999986432 35688899999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
|||+.+++|..++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence 99999999887664 478889999999999999999999999999999999999766 899999999976643322 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcC
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYH 359 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~ 359 (401)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.. .........+.... ...++.+++.+ |
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 236 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA-C 236 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCC-cChHhHhhhhhcCCCCCCchhhhHHHHHHHHH-H
Confidence 3467788999999876 6789999999999999999999999843 23332222221111 12456677777 8
Q ss_pred CCCChhhHHHhhhhcCCCcccccccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.+|+.||++.+++.|+|+......
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcchh
Confidence 99999999999999999999775553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.43 Aligned_cols=251 Identities=32% Similarity=0.595 Sum_probs=204.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~~~ 206 (401)
+|++.+.||.|++|.||+|.+..+++.+|+|.+... ..+.+.+|+.+++.+ +|+||+++++++.+.. ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 588999999999999999999888999999988643 235788999999999 8999999999987642 2467
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|++|||+.+ +|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccc
Confidence 999999985 5554442 578999999999999999999999999999999999999775 89999999998765443
Q ss_pred ----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 284 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2344567889999999987447899999999999999999999998 34444444443333222
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccccCC
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 390 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~~~ 390 (401)
.+.+.+++.+ |+..+|..||++.+++.|||++.+........
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEK-MLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHH-HccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 2345566777 89999999999999999999998776655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=293.36 Aligned_cols=239 Identities=22% Similarity=0.413 Sum_probs=193.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
+|.+.+.||.|+||.||+|.+..+++.+|+|.++... .+.+.+|+.+++.+ +|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 4778899999999999999998899999999875311 13578899999999 99999999999865
Q ss_pred CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...+++||||+.+++|...+. .+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~ 157 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKK 157 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccc
Confidence 467889999999999987653 478888999999999999999999999999999999999666 899999999976
Q ss_pred cCCCC---cccccccCCCccccccccCCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------
Q 015741 279 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (401)
Q Consensus 279 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------- 346 (401)
..... ......++..|+|||.+.... .++.++|+||||+++|+|++|..||. ..+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-DEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc-CcchHHHHHHhhccccCCcCCcc
Confidence 53221 122345778899999987532 47899999999999999999999984 333333232221110
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
-...+.+++.+ |+..||..||+++++++|||+
T Consensus 237 ~~~~~~~~~~~li~~-~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNA-CFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHH-HhcCChhhCCCHHHHhhCCCC
Confidence 13467777877 899999999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.49 Aligned_cols=202 Identities=22% Similarity=0.350 Sum_probs=172.9
Q ss_pred ccccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 125 ~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.+.....++++|...+.||+|+||.||+|.. .+++.||||.+.... ..+|.+|+.++.++ +|||+|+++|||.+.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEG 143 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecC
Confidence 3444445689999999999999999999997 555999999987644 46799999999999 799999999999874
Q ss_pred CCCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCCeeEeCCCCeEEEEec
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDW 273 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~vkl~DF 273 (401)
.. ..+||+|||.+|+|.+.+. .++|.....|+.+++.||+|||+. .||||||||+|||+|.+. ..||+||
T Consensus 144 ~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDF 221 (361)
T KOG1187|consen 144 GE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDF 221 (361)
T ss_pred Cc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCc
Confidence 32 5789999999999987762 568999999999999999999985 399999999999999666 8999999
Q ss_pred ccceecCC-CCccccc-ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 274 GLAEFYHP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 274 g~a~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
|+|+.... ....... .||..|+|||++.. +..+.++|||||||+|.||++|+.|...
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCC
Confidence 99976654 3333333 89999999999876 6899999999999999999999988754
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.97 Aligned_cols=237 Identities=18% Similarity=0.289 Sum_probs=187.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ..+.+.+|+.++.++.+||||+++++++.+ ...++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 579999999999999999999876664 4688887642 235688899999998779999999999865 45689
Q ss_pred EEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeE
Q 015741 208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~v 268 (401)
++|||+++++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence 9999999999876652 367788999999999999999999999999999999998766 89
Q ss_pred EEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-
Q 015741 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL- 346 (401)
Q Consensus 269 kl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~- 346 (401)
||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~-~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHhcCCC
Confidence 9999999864322111111223456999999876 678999999999999999997 988984 333334444443322
Q ss_pred ------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 ------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
-++.+.+++.+ |+..+|..||++.++++.
T Consensus 237 ~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 MEKPRNCDDEVYELMRQ-CWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 13467777777 899999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.36 Aligned_cols=244 Identities=24% Similarity=0.438 Sum_probs=199.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCCCCCcEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~~~~~~l 208 (401)
.|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+. .|||++++++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 477889999999999999999899999999998532 2356889999999984 39999999999865 467899
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-c
Q 015741 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (401)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~ 285 (401)
+|||+.+++|..++. .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence 999999999877653 578889999999999999999999999999999999999766 899999999987654332 2
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------hCChhHHHHHHh
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------LGTDELNAYLNK 357 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------~~~~~~~~~l~~ 357 (401)
....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.. .........+... ....++.+++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC-CChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 3346888899999987655678999999999999999999999843 2222222211111 023467777877
Q ss_pred cCCCCChhhHHHhhhhcCCCcccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|++.||..|+++.+++.|+|++...
T Consensus 238 -~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 -CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -HcCCCcccCcCHHHHhhChHhhccc
Confidence 8999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.02 Aligned_cols=239 Identities=22% Similarity=0.454 Sum_probs=197.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|+||.||+|.+..++..+|+|.+... ..+.+.+|+++++.+ +|+||+++++.+.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 488999999999999999999999999999998542 345788999999999 99999999999865 4678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||+++.++..++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999877653 3688889999999999999999999999999999999987765689999999876643322
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+.... .+.++.+++.
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 223467888999999876 5788999999999999999999999843 33333333322211 1346777787
Q ss_pred hcCCCCChhhHHHhhhhcCCCcc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+ |+..+|+.||++.+++.|||+
T Consensus 236 ~-~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 Q-LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred H-HhccChhhCcCHHHHhhCCCC
Confidence 7 899999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=291.03 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=195.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.+|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+|+++++++ +|+||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999999999999998742 1224688999999999 9999999999987765667
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++++||+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence 88999999999987665 3478889999999999999999999999999999999998766 7999999999765321
Q ss_pred ----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 283 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.. ....+.+..+.... -.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAE-YEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc-cCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 11223467888999999876 6788999999999999999999999843 33333333332211 1346
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+++.+ |++ +|..||++.++++|||.
T Consensus 238 ~~~~i~~-~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQ-IFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHH-Hhc-CcccCccHHHHhcCCCC
Confidence 7788888 566 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=316.92 Aligned_cols=239 Identities=21% Similarity=0.366 Sum_probs=201.7
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~ 216 (401)
-.||+|.||+||-|++..+....|||-+.... ..-+..|+.+.++| +|.|||+++|.+.+ +.++-+.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 36899999999999999999999999986433 34588999999999 99999999999854 56888999999999
Q ss_pred chhhhcC----CC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cccccc
Q 015741 217 DFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV 289 (401)
Q Consensus 217 ~l~~~~~----~~--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~~~ 289 (401)
+|..+++ ++ .|..+..+.+||++||.|||++.|||||||-+|||++.-.+.+||+|||-++.+..-. -..+..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9988874 45 6778889999999999999999999999999999998766699999999998775333 345678
Q ss_pred cCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHHHHHHhcCC
Q 015741 290 ASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAYLNKYHI 360 (401)
Q Consensus 290 ~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~~~l~~~~l 360 (401)
||..|||||++.. ..+|++++|||||||++.||.||++||..-..+...+.++--... +.+.+.||.+ |.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr-cF 816 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR-CF 816 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH-Hc
Confidence 9999999999954 457999999999999999999999999766665544443311111 3466788988 79
Q ss_pred CCChhhHHHhhhhcCCCccccc
Q 015741 361 ELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 361 ~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
..||-.||++.++|..||.+.-
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 9999999999999999999874
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=301.62 Aligned_cols=244 Identities=23% Similarity=0.394 Sum_probs=199.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+.|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+++++++ +||||+++++.+.+ ....++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence 34677789999999999999998889999999986322 34688999999999 99999999999875 4578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
|||+++++|...+. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..+..... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhh
Confidence 99999999977764 478889999999999999999999999999999999999766 899999999976643321 22
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcC
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYH 359 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~ 359 (401)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. ..........+.+.. ...++.+++.+ |
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 236 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNS-DLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA-C 236 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCc-ccchhhHHhhhhcCCCCCCCcccCHHHHHHHHH-H
Confidence 3457888999999876 678899999999999999999999984 223333332222211 13457778887 8
Q ss_pred CCCChhhHHHhhhhcCCCccccccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+..+|..||++.+++.|||++....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred ccCCcccCcCHHHHHHhHHHHHHhh
Confidence 9999999999999999999987554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=290.91 Aligned_cols=240 Identities=25% Similarity=0.442 Sum_probs=197.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|+||.||+|.+..+++.|++|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 588999999999999999999889999999998643 335788999999999 99999999998765 4678899
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc-
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~- 285 (401)
+||+.+++|.++.. .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++ .+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcc
Confidence 99999999987763 378888999999999999999999999999999999999765 8999999998766433221
Q ss_pred ----cccccCCCccccccccCCC--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------C--Chh
Q 015741 286 ----NVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------G--TDE 350 (401)
Q Consensus 286 ----~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~--~~~ 350 (401)
....++..|+|||.+.+.. .++.++||||||+++|+|++|+.||............+.... . .+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence 1245677899999987632 378899999999999999999999954433333332222211 0 346
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+++.+ |++.+|..|+++.+++.|||.
T Consensus 237 ~~~li~~-~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDR-CLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHH-HccCCcccCCCHHHHhcCCCC
Confidence 6778887 899999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.92 Aligned_cols=238 Identities=35% Similarity=0.660 Sum_probs=195.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.+++++ +|+||+++++++.+ ....++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence 567789999999999999998899999999986432 35688899999999 89999999999865 46788999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
||+.+..+..+. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||.+....... ...
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccccc
Confidence 999874333332 2578899999999999999999999999999999999999766 89999999998775443 233
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------------------
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------- 347 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------------- 347 (401)
...++..|+|||.+.+...++.++|+||||+++|+|++|+.|| ...+..+.+..+...++
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 4567788999999877447899999999999999999999887 44555555444433221
Q ss_pred -----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++++.+++.+ |+..||..||++.+++.|||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQ-MLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHH-HhccCcccCcCHHHHhhCCCC
Confidence 3456677777 899999999999999999995
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=287.33 Aligned_cols=241 Identities=27% Similarity=0.463 Sum_probs=202.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|.+.+.||+|++|.||+|.+..+++.+++|++.... .+.+.+|+.+++++ +||||+++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 4788899999999999999998899999999987544 56789999999999 89999999999876433678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
+||+.+++|.+++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence 99999999887653 578999999999999999999999999999999999999765 899999999987755442
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------hCChhHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------LGTDELNAYL 355 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------~~~~~~~~~l 355 (401)
.....++..|++||.+.+ ..++.++||||||+++|+|++|..||....+....+..+... .....+.+++
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 345677888999999876 568899999999999999999999996544333333333210 0145677888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+ |+..||..||++.+++.|||+
T Consensus 238 ~~-~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RK-CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HH-hCcCChhhCCCHHHHhhCCCC
Confidence 88 899999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.67 Aligned_cols=244 Identities=25% Similarity=0.485 Sum_probs=202.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCC-C----CeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-P----NIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h-p----niv~~~~~~~~~~~~~ 205 (401)
.++|+++.++|+|.||.|-++.+..++..||||+++... ++...-|+++|+++..+ | .+|++.++|.- ..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cCc
Confidence 689999999999999999999999999999999998654 35677899999999433 2 47888888844 578
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-----------------
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----------------- 264 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~----------------- 264 (401)
+++|+|.++......+. .+++...++.+.+|+++++++||+.+++|-||||+|||+.+.
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 89999998754443332 248999999999999999999999999999999999999432
Q ss_pred --CCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 015741 265 --QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 265 --~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i 342 (401)
...|+|+|||.|..-.. .....+.|..|+|||++.+ -+++.++||||+||||+||++|...| +++++.+++..+
T Consensus 246 ~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLaMM 321 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLAMM 321 (415)
T ss_pred CCCcceEEEecCCcceecc--CcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHHHH
Confidence 12589999999987543 3366789999999999998 58999999999999999999999888 677788888777
Q ss_pred HHHhCCh----------------------------------------------------hHHHHHHhcCCCCChhhHHHh
Q 015741 343 AKVLGTD----------------------------------------------------ELNAYLNKYHIELDPHLAALV 370 (401)
Q Consensus 343 ~~~~~~~----------------------------------------------------~~~~~l~~~~l~~dP~~R~~~ 370 (401)
.+.+|.. ++-+++.+ ||..||..|+++
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~-mL~fDP~~RiTl 400 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR-MLEFDPARRITL 400 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH-HHccCccccccH
Confidence 6666521 23344555 899999999999
Q ss_pred hhhcCCCcccccc
Q 015741 371 GRHSRKPWSKFIT 383 (401)
Q Consensus 371 ~~~l~~~~~~~~~ 383 (401)
.++|.|||+++..
T Consensus 401 ~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 401 REALSHPFFARLT 413 (415)
T ss_pred HHHhcCHHhhcCC
Confidence 9999999999854
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.91 Aligned_cols=238 Identities=24% Similarity=0.329 Sum_probs=187.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|.+.+.||+|+||.||+|.+... +..||||+++... .+.+.+|+++++++..||||+++++++.+ .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--S 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--C
Confidence 57899999999999999999986433 3579999996432 35688999999999559999999999965 5
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (401)
..+++||||+.+|+|..++.
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 67899999999999865431
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 224 ---------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 224 ---------------------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
.+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 25666778899999999999999999999999999999976
Q ss_pred CCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHH
Q 015741 265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 340 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~ 340 (401)
+ .+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.....+.....
T Consensus 274 ~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 274 K-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred C-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 6 8999999999866433221 22345677999999876 678999999999999999997 8888854333322222
Q ss_pred HHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 341 KIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 341 ~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.... ....+.+++.+ |+..||+.||++.++.+
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVK-CWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHH-HCccCHhHCcCHHHHHH
Confidence 222221 13456777777 89999999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.12 Aligned_cols=235 Identities=18% Similarity=0.315 Sum_probs=187.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..+|++.+.||+|+||.||+|.+..+++ .||+|+++... ..++.+|+.+++.+ +||||+++++++.. .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~---~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---S 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC---C
Confidence 4679999999999999999998766655 48999986432 35688899999999 99999999999865 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++||+.+|+|.+.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence 4679999999999877653 367888899999999999999999999999999999998766 89999999998765
Q ss_pred CCCccc---ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-C-------C
Q 015741 281 PGKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-G-------T 348 (401)
Q Consensus 281 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-~-------~ 348 (401)
...... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +. ....+..+.... . .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GI-PASEISSILEKGERLPQPPICT 237 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CC-CHHHHHHHHhCCCCCCCCCCCC
Confidence 433221 1223457999999876 678999999999999999997 888873 33 233333332221 1 2
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++.+++.+ |+..||..||++.+++.+
T Consensus 238 ~~~~~li~~-cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 238 IDVYMIMVK-CWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 356666777 899999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=285.20 Aligned_cols=237 Identities=32% Similarity=0.546 Sum_probs=198.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
+|++.+.||+|++|.||++.+..+++.+++|++... ....+.+|+.+++.+ +|+|++++++++... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence 478899999999999999999888999999998654 346789999999999 799999999998763 66789999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccc
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
|+++++|..++ ..+++..+..++.|++.||.+||++|++||||+|+||+++.++ .++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccccccccccc
Confidence 99999998775 2578999999999999999999999999999999999999765 899999999987654433345
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~ 358 (401)
..++..|++||.+.+ ..++.++|+||||+++|+|++|+.||... +..+.+..+..... ...+.+++.+
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~- 233 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSEL-PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK- 233 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCC-chHHHHHHHHhcCCCCcCcccccCHHHHHHHHH-
Confidence 678888999999876 56889999999999999999999998543 23333332222111 3566788887
Q ss_pred CCCCChhhHHHhhhhcCCCc
Q 015741 359 HIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~ 378 (401)
|+..||+.||++.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 89999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=289.86 Aligned_cols=235 Identities=17% Similarity=0.304 Sum_probs=190.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||++.. .++..+|+|.++.. ..+.+.+|+++++++ +||||+++++++.+ ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence 35789999999999999999987 45668999987643 346789999999999 99999999999865 45689999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
||+++++|...+. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceec
Confidence 9999999887653 378888999999999999999999999999999999998666 89999999987653322211
Q ss_pred --ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 287 --~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
...++..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| ...+..+.+..+.+.. ....+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 2234457999999876 678999999999999999999 88887 4444445555544321 1345677777
Q ss_pred hcCCCCChhhHHHhhhhcC
Q 015741 357 KYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~ 375 (401)
+ |+..+|..||++.++++
T Consensus 236 ~-c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 S-CWHEKPEGRPTFAELLR 253 (256)
T ss_pred H-HccCCcccCcCHHHHHH
Confidence 7 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.61 Aligned_cols=242 Identities=23% Similarity=0.418 Sum_probs=200.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||+|+||.||++.+..+++.|++|.+... ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcEEEE
Confidence 47899999999999999999998888999999998532 235688899999999 89999999999876 4577899
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-cc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~ 286 (401)
+||+++++|..++. .+++.++..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccc
Confidence 99999999987764 478889999999999999999999999999999999999766 899999999876543322 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +..+.+..+.... -.+.+.+++.+
T Consensus 174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 3467788999999876 67889999999999999999999999433 3333322221110 12356777877
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|+..+|+.|+++++++.|+|++.
T Consensus 252 -~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 252 -CLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred -HccCChhhCcCHHHHhcCHHHhc
Confidence 89999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.57 Aligned_cols=247 Identities=19% Similarity=0.323 Sum_probs=198.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||.||+|.+..+++.||||.++.. ....+..|+.++.++.+||||+++++++.+ ....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEE
Confidence 47899999999999999999999888999999998643 224566788777777579999999999976 467899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+ .+..+. ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .+||+|||++..+....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCC
Confidence 9999865 443332 357888899999999999999997 5999999999999998666 89999999997665444
Q ss_pred cccccccCCCccccccccCC---CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhH
Q 015741 284 EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDEL 351 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~ 351 (401)
......++..|+|||.+.+. +.++.++||||||+++|+|++|+.||.....+.+.+..+.... -.+.+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 34445677889999998652 2478899999999999999999999965444444444433221 13356
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+++.+ |+..||..||+++++++|+|+++...
T Consensus 250 ~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 250 CSFVDL-CLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHH-HccCChhhCCCHHHHhcChhhhccch
Confidence 777777 89999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=289.09 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=189.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccch------HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||.|+||.||+|.+..+++.||+|+++.... ..+..|..++....+|+|++++++++.+ ...++++|||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 568999999999999988999999999864321 2344555555554589999999999975 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccccc
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 290 (401)
.+++|..++ ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++..... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence 999998776 3588999999999999999999999999999999999999766 899999999875432 223457
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHI 360 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l 360 (401)
+..|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+.... -++.+.+++.+ |+
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l 232 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR-LL 232 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH-Hc
Confidence 788999999877 458899999999999999999999984 333333333332211 14567788888 89
Q ss_pred CCChhhHH---HhhhhcCCCcccccc
Q 015741 361 ELDPHLAA---LVGRHSRKPWSKFIT 383 (401)
Q Consensus 361 ~~dP~~R~---~~~~~l~~~~~~~~~ 383 (401)
..||..|+ ++.+++.|||++.+.
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCC
Confidence 99999999 557999999997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.57 Aligned_cols=240 Identities=19% Similarity=0.355 Sum_probs=198.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.|+....||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.. ....+++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEEe
Confidence 344556899999999999999889999999998532 345688999999999 99999999999876 467899999
Q ss_pred ecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccccc
Q 015741 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (401)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~~ 288 (401)
|+++++|..+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..+.... .....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccce
Confidence 999999987753 578999999999999999999999999999999999999766 89999999987554322 22345
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhcC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYH 359 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~ 359 (401)
.++..|+|||.+.+ ..++.++|||||||++|+|++|+.||+. .+..+.+..+.... ..+.+.+++.+ |
T Consensus 178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~-~ 254 (297)
T cd06659 178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER-M 254 (297)
T ss_pred ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH-H
Confidence 68889999999876 5789999999999999999999999953 33444444332211 13466778888 8
Q ss_pred CCCChhhHHHhhhhcCCCcccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+|..||++.+++.|||+.-
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred hcCCcccCcCHHHHhhChhhcc
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=290.63 Aligned_cols=235 Identities=20% Similarity=0.376 Sum_probs=192.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+|++.+.||.|+||.||++.+..+++.+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++.+.+ ...++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 588999999999999999999999999999998532 235678899999999 99999999999976 46789999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
||++++++...+. .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||.+........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence 9999998876542 378888999999999999999999999999999999998766 899999999976643322
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (401)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+.... -+..+.+++.+
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 234567888999999876 5789999999999999999999999853 33223333322211 13456777777
Q ss_pred cCCCCChhhHHHhhhhcCC
Q 015741 358 YHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~ 376 (401)
|+..||..||++.+++..
T Consensus 235 -~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 -MFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhCCcccCCCHHHHhhc
Confidence 799999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=294.31 Aligned_cols=235 Identities=19% Similarity=0.334 Sum_probs=190.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|.+.+.||+|+||.||++.+. .++..+|+|.+.... .+.+.+|+++++++ +||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 478999999999999999999852 345678999986433 35688999999999 89999999999865 46
Q ss_pred CcEEEEeecCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeE
Q 015741 205 TPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~v 268 (401)
..+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~ 159 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV 159 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cE
Confidence 7899999999999876652 378899999999999999999999999999999999999766 89
Q ss_pred EEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Q 015741 269 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 344 (401)
Q Consensus 269 kl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~ 344 (401)
+|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+.+..+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~-~~~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc
Confidence 9999999976543221 122334667999999876 678999999999999999998 787774 3344444444433
Q ss_pred Hh-------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 345 VL-------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 345 ~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.. .++.+.+++.+ |++.||..||++.+++
T Consensus 238 ~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLG-CWQREPHMRLNIKEIH 273 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHH-HccCChhhCCCHHHHH
Confidence 22 14577788888 8999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=289.79 Aligned_cols=234 Identities=18% Similarity=0.327 Sum_probs=190.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|+++++||+|+||.||+|.+ .++..||+|.+... ..+.+.+|+.+++.+ +|+||+++++.+.+ ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEEE
Confidence 57899999999999999999986 46678999988643 346789999999999 99999999999865 46679999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT 159 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee
Confidence 9999999877652 467788889999999999999999999999999999999766 8999999999876432211
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ......+....+..... +.++.+++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 12234567999999876 678899999999999999998 88887 44444444444443322 34667777
Q ss_pred HhcCCCCChhhHHHhhhhc
Q 015741 356 NKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l 374 (401)
.+ |+..+|+.||+++++.
T Consensus 238 ~~-~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 238 KT-CWKEKAEERPTFDYLQ 255 (261)
T ss_pred HH-HccCCcccCcCHHHHH
Confidence 77 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=311.87 Aligned_cols=225 Identities=19% Similarity=0.284 Sum_probs=188.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
..-++-||.|+.|.||+|+. .++.||||.++.. -+.+|+.|++| +||||+++.++|.. ..+++||||||..
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----kETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----KETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh----hhhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeecccc
Confidence 34567899999999999986 5889999987532 24678899999 99999999999965 6788999999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCC
Q 015741 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292 (401)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~ 292 (401)
|-|..+++ .+.......|..+|+.|+.|||.+.|||||||.-||||..+. .|||+|||-++.+........++||.
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhH
Confidence 99988874 578888899999999999999999999999999999999777 89999999998876666666789999
Q ss_pred CccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------ChhHHHHHHhcCCC
Q 015741 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-----------TDELNAYLNKYHIE 361 (401)
Q Consensus 293 ~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-----------~~~~~~~l~~~~l~ 361 (401)
.|||||++.+ ..++.|+|||||||+||||+||..||..- + ....|. ..| .|+=-.+|.+.|++
T Consensus 276 aWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdV-d---ssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 276 AWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDV-D---SSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcccc-c---hheeEE-eccCCcccccCcccCchHHHHHHHHHHh
Confidence 9999999987 89999999999999999999999998422 1 111111 111 23333456666999
Q ss_pred CChhhHHHhhhhcCC
Q 015741 362 LDPHLAALVGRHSRK 376 (401)
Q Consensus 362 ~dP~~R~~~~~~l~~ 376 (401)
-.|..||+..+++.|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 999999999999987
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=293.44 Aligned_cols=238 Identities=29% Similarity=0.554 Sum_probs=194.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
|++.+.||+|++|+||+|+...+++.|++|.+... ......+|+..++++.+|+|++++++++.+ ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 67889999999999999999888999999998643 223456799999999449999999999876 567899999
Q ss_pred ecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
|+ ++++...+ ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++..........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcC
Confidence 99 56665443 2478899999999999999999999999999999999999766 89999999998776554455
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------------------
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------- 347 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------------- 347 (401)
...++..|+|||++.+...++.++|+||||+++++|++|+.|| ......+.+..+...++
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 5678889999999866566889999999999999999999887 44444444433322211
Q ss_pred -----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |++.||..||++++++.|||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKD-MLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHH-hcccCcccCCCHHHHhhCCCC
Confidence 2456677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.88 Aligned_cols=239 Identities=30% Similarity=0.583 Sum_probs=193.6
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCCC---CC
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQS---KT 205 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~~---~~ 205 (401)
|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++. +|||++++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999986321 235667888887773 59999999999876432 24
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++++|||+.+ ++..++ ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence 8899999986 454433 2478999999999999999999999999999999999999775 89999999998765
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------------
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------- 347 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------- 347 (401)
.........++..|+|||.+.+ ..++.++|+|||||++|+|++|..|| .+....+.+.++.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4444444567888999999876 67889999999999999999998777 45555555555544321
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+.+.+++.+ |+..||..||++++++.|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKK-MLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHH-HhccCCccCCCHHHHhcCcCC
Confidence 1344566666 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.67 Aligned_cols=234 Identities=23% Similarity=0.328 Sum_probs=185.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.++||+|+||.||+|.+..+++.||+|+++.. ..+++.+|+++++++ +||||+++++++.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 5799999999999999999999999999999998642 235688999999999 99999999999876 45789
Q ss_pred EEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEec
Q 015741 208 LIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DF 273 (401)
++|||+++++|..++. ..+...+..++.||+.||+|||++||+||||||+|||++.++ .++|+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence 9999999999976642 234456788999999999999999999999999999999766 7999999
Q ss_pred ccceecCCCC-------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 015741 274 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334 (401)
Q Consensus 274 g~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~ 334 (401)
|+++...... .....+||+.|+|||.+.+ ..++.++|||||||++|||++|..||... +
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~-~ 235 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRK-K 235 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCc-c
Confidence 9998652110 0112468999999999876 67899999999999999999999999542 2
Q ss_pred CHHHHHH--HHH---H----hCChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 335 NYDQLVK--IAK---V----LGTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 335 ~~~~l~~--i~~---~----~~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..+.... +.. . .-++.+.+++.+ |+..||+.|++..+.+
T Consensus 236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~r-cL~~DP~kR~ss~eeL 283 (932)
T PRK13184 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMK-ALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhhhhhccChhhccccccCCHHHHHHHHH-HccCChhhCcCHHHHH
Confidence 2111111 000 0 113456677777 8999999997654444
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=292.47 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=200.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+-|++.+.||.|+||.||+|.+..+++.+|+|++.... ...+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEE
Confidence 34778899999999999999998899999999976322 35688899999998 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
|||+.+++|..++. .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++..+.... ...
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhc
Confidence 99999999987764 478899999999999999999999999999999999999766 89999999987664332 123
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcC
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYH 359 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~ 359 (401)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. ..........+.... -..++.+++.+ |
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~ 236 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHS-ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA-C 236 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-ccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH-H
Confidence 3467788999999876 678889999999999999999999984 333333333322211 13467788888 8
Q ss_pred CCCChhhHHHhhhhcCCCccccccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+..+|..||++.++++|||+.....
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999999987533
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=293.99 Aligned_cols=236 Identities=17% Similarity=0.339 Sum_probs=187.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEc----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
++|++.+.||+|+||.||+|... .++..+++|.++... ...+.+|+.+++++ +||||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CCc
Confidence 57899999999999999999853 356789999986422 25688999999999 99999999999865 456
Q ss_pred cEEEEeecCCCchhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP--------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 265 (401)
.+++|||+.+++|..++. .+++.++..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 789999999999877651 367788889999999999999999999999999999999766
Q ss_pred CeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 015741 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~ 341 (401)
.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+....
T Consensus 162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~~~~ 238 (283)
T cd05090 162 -HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIEM 238 (283)
T ss_pred -cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence 799999999976543321 222344567999999876 678999999999999999998 888874 3333333333
Q ss_pred HHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 342 IAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 342 i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.... ..+.+.+++.+ |+..||..||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTE-CWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHH-HcccCcccCcCHHHHHHH
Confidence 32211 13466677777 899999999999988643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.84 Aligned_cols=245 Identities=30% Similarity=0.538 Sum_probs=194.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCC--CeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~ 205 (401)
+|++.+.||+|+||.||++.+..+ +..||+|.+... ..+.+.+|+.+++++.+||||+++++..... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999877 889999998632 2356788999999996799999999875432 2345
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
.++++||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..+...
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence 7888898875 555443 3588999999999999999999999999999999999999766 8999999999865432
Q ss_pred Cc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
.. .....|+..|+|||.+.+...++.++|||||||++|+|++|..||. ..+....+..+...++
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK-GKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC-CCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 2234678899999988765678999999999999999999998874 3333333332222111
Q ss_pred ---------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
...+.+++.+ |++.||..|+++.+++.|||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK-LLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHH-HccCCcccCCCHHHHhcChhhhhhc
Confidence 2456677777 7999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.49 Aligned_cols=236 Identities=20% Similarity=0.341 Sum_probs=190.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|.+.+.||+|+||.||+|.+.. +++.||+|+++... .+.+.+|+++++.+ +|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEec--C
Confidence 4678899999999999999998743 35789999986432 35789999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~ 266 (401)
...+++|||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~- 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL- 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence 67899999999999977652 267788899999999999999999999999999999999776
Q ss_pred eEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 015741 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 267 ~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i 342 (401)
.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||+. .+..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence 899999999976533221 122344667999999876 679999999999999999998 9999853 3334433333
Q ss_pred HHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 343 AKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 343 ~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
..... +..+.+++.+ |+..||..||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLG-CWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 32211 3467777887 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.92 Aligned_cols=236 Identities=26% Similarity=0.510 Sum_probs=193.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|.+..+++.||+|.++. ...+.+.+|+++++++ +|+|++++++++.+ ....+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIE--NNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeec--CCeEE
Confidence 579999999999999999999988999999998753 1246788999999999 99999999999976 45778
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++|||+.+++|..++. .+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence 9999999999876652 368889999999999999999999999999999999999766 79999999987664
Q ss_pred CCC-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHH--------hCChh
Q 015741 281 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKV--------LGTDE 350 (401)
Q Consensus 281 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~--------~~~~~ 350 (401)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.....+...+. .+... ....+
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 332 2233467888999999876 6789999999999999999999999965544433222 21111 11236
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..+|..||++.++++
T Consensus 237 ~~~~i~~-cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 237 LRDLVSR-CINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHH-HcCCCcccCCCHHHHHH
Confidence 6777777 89999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=290.33 Aligned_cols=236 Identities=18% Similarity=0.322 Sum_probs=191.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..+|++.+.||+|+||.||+|.+..+++.+|+|+++... ...+.+|+++++.+ +||||+++++++.. ...++++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEEE
Confidence 356899999999999999999998899999999987543 35688999999999 99999999999865 45778999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceee
Confidence 9999999987653 378888899999999999999999999999999999998666 8999999999766433211
Q ss_pred c--ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 286 N--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 286 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
. ....+..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+..... ++.+.+++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1 1223456999999876 678899999999999999998 88887 34443333333333221 34677778
Q ss_pred HhcCCCCChhhHHHhhhhcC
Q 015741 356 NKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+ |+..||..||++.++++
T Consensus 239 ~~-cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RA-CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HH-HccCCcccCCCHHHHHH
Confidence 87 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.25 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=194.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
...|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.+ +||||+++++++.+ ....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~--~~~~ 90 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLR--EHTA 90 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEe--CCeE
Confidence 45688999999999999999999889999999988532 124688999999999 99999999999976 4567
Q ss_pred EEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+..+... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++......
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence 899999986543332 23588999999999999999999999999999999999999766 8999999999765433
Q ss_pred cccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~ 353 (401)
....++..|+|||++.+ ...++.++||||||+++|+|++|..||... +.......+.... -+..+.+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 23467788999998742 256888999999999999999999998533 2222222222110 1345677
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+ |+..||+.||++.+++.|||+..-
T Consensus 246 li~~-~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 246 FVDS-CLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHH-HhcCChhhCcCHHHHhcChhhccc
Confidence 7877 899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.40 Aligned_cols=237 Identities=18% Similarity=0.323 Sum_probs=186.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+.. ++..||+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35789999999999999999998642 3578999988542 234578999999998 99999999999865
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEE
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vk 269 (401)
....++||||+.+++|..++.. ++...+..++.|++.||+|||+.|++||||||+||+++.++ .++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~ 159 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVK 159 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEE
Confidence 4678999999999999876532 34567888999999999999999999999999999999766 899
Q ss_pred EEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Q 015741 270 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (401)
Q Consensus 270 l~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~ 345 (401)
|+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+.+..+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC
Confidence 9999998765332221 12244667999999876 678999999999999999999 56776 444443333333222
Q ss_pred h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 346 L-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 346 ~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
. ..+.+.+++.+ |++.||+.||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIIS 273 (277)
T ss_pred CcCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 1 13456777777 89999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.41 Aligned_cols=238 Identities=22% Similarity=0.377 Sum_probs=188.1
Q ss_pred CCe-EEEeeecccCCeeEEEEE----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 134 DDY-EVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 134 ~~y-~i~~~Lg~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
++| ++.+.||+|+||.||++. ...++..||+|+++.. ....+.+|+++++++ +||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 445 899999999999998865 3356789999998743 245678999999999 999999999998765566
Q ss_pred CcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
.++++|||+.+++|..++. .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence 7899999999999987754 589999999999999999999999999999999999998766 8999999999876433
Q ss_pred Ccc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH----------HHHH----
Q 015741 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV----------KIAK---- 344 (401)
Q Consensus 283 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~----------~i~~---- 344 (401)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........+. ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 221 12244567999999876 6789999999999999999999999854322211111 0100
Q ss_pred Hh-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 345 VL-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 345 ~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.. ....+.+++.+ |++.||..||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKN-CWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHH-HhccChhhCCCHHHHHH
Confidence 00 12466677777 89999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=290.40 Aligned_cols=235 Identities=19% Similarity=0.351 Sum_probs=187.0
Q ss_pred eEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
|++.+.||+|+||.||+|....+ +..||+|.++... ...+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 46789999999999999987654 4789999986432 24688999999998 99999999998765322
Q ss_pred CCcEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
...+++|||+.+++|...+ ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence 3478999999999987664 2478888999999999999999999999999999999998765 89999999
Q ss_pred cceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh----
Q 015741 275 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL---- 346 (401)
Q Consensus 275 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~---- 346 (401)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..+.+.+..+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCC
Confidence 99876433221 12234567999999865 678999999999999999999 77776 4545544444433321
Q ss_pred ---CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 ---GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ---~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-.+.+.+++.+ |+..||..||++.+++.
T Consensus 237 ~~~~~~~~~~li~~-~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 237 PEDCLDELYDLMYS-CWRADPKDRPTFTKLRE 267 (273)
T ss_pred CcCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 13567788888 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.50 Aligned_cols=240 Identities=22% Similarity=0.352 Sum_probs=189.2
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHh--cCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l--~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.||+|+||.||+|.+..+++.||+|++.... ...+..|..+++.+ .+||+|+++++++.+ ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999998899999999985421 11233444333332 278999999999976 4578899999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
+.+++|...+. .+++..++.++.|++.||+|||+.+|+||||||+||+++.++ .++|+|||++...... ......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcC
Confidence 99999976653 488999999999999999999999999999999999999766 8999999998765322 223457
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHH-------hCChhHHHHHHhcCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKV-------LGTDELNAYLNKYHIE 361 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~l~~i~~~-------~~~~~~~~~l~~~~l~ 361 (401)
|+..|+|||.+.+...++.++||||+||++|+|++|+.||..... ........... ..++++.+++.+ |+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~-~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG-LLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH-Hhh
Confidence 889999999987645688999999999999999999999954422 12222211111 124677788888 799
Q ss_pred CChhhHH-----HhhhhcCCCcccccccc
Q 015741 362 LDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 362 ~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
.+|..|+ ++.++++|||++.+...
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 9999999 99999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=291.75 Aligned_cols=238 Identities=18% Similarity=0.311 Sum_probs=189.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ...+.+|+.+++.+ +|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--C
Confidence 5789999999999999999999876 67899999886432 34588899999999 99999999998865 3
Q ss_pred CCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI 271 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~ 271 (401)
...+++|||+.+++|..++. .+++..+..++.||+.||+|||+++++||||||+||+++.++ ..+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 56789999999999987652 377888999999999999999999999999999999998543 368999
Q ss_pred ecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-
Q 015741 272 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL- 346 (401)
Q Consensus 272 DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~- 346 (401)
|||+++.+...... .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTGGGR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHcCCc
Confidence 99999866322211 11222456999999876 679999999999999999997 888874 333333333322211
Q ss_pred ------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 ------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+..+.+++.+ |++.+|+.||++.++++|
T Consensus 240 ~~~~~~~~~~~~~~i~~-cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDPPKGCPGPVYRIMTD-CWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHHH
Confidence 13466777777 899999999999999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.14 Aligned_cols=248 Identities=20% Similarity=0.371 Sum_probs=198.1
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.|++.+.||.|+||.||+|.+. .+|+.||+|+++.. ..+.+.+|+++++++.+|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4789999999999999999874 47899999998642 235678899999999779999999999865 45
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|...+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence 788999999999987765 3478889999999999999999999999999999999999766 899999999976643
Q ss_pred CC--cccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHH-HHHHh------CCh
Q 015741 282 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVK-IAKVL------GTD 349 (401)
Q Consensus 282 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~-i~~~~------~~~ 349 (401)
.. ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||..... ....+.. +.... -.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 32 12234678889999998642 3567899999999999999999999843221 1112211 11111 134
Q ss_pred hHHHHHHhcCCCCChhhHH-----HhhhhcCCCccccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAA-----LVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~~~ 386 (401)
.+.+++.+ |+..||..|+ ++++++.|||++....++
T Consensus 238 ~~~~ll~~-~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 238 LAKDIIQR-LLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred HHHHHHHH-HhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 56677777 8999999997 899999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=295.33 Aligned_cols=242 Identities=20% Similarity=0.340 Sum_probs=197.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||+||++.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++.+. ...++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEE
Confidence 46789999999999999999999889999999987533 246788999999999 999999999999764 67899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+++++|..++. .+++..+..++.|++.||.|||+ ++++||||||+||+++.++ .++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-c
Confidence 999999999977653 47888999999999999999997 6999999999999999666 8999999998654322 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC----------HHHHHHHHHHh--------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN----------YDQLVKIAKVL-------- 346 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~----------~~~l~~i~~~~-------- 346 (401)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+.+..+....
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 234578889999999876 57889999999999999999999999543321 11111211110
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
-...+.+++.+ |++.||..||++++++.|+|+..
T Consensus 238 ~~~~~~~li~~-~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 238 FPEDLRDFVDA-CLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred cCHHHHHHHHH-HhcCCcccCcCHHHHhcCccccc
Confidence 12356677777 89999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.45 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=206.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
-++.-..+||.|.||.||.|.+..+|+..|+|-++-. ..+.+.+|..++..+ +|||+|++|++-.+ ....+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH--Rekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH--REKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec--HHHHHH
Confidence 3566678999999999999999999999999987532 225578999999999 99999999998765 345679
Q ss_pred EEeecCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
.||||.+|+|..+.+. .+|...+.+..|++.|+.|||++|||||||||+||+++.++ .+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence 9999999999888753 55666778889999999999999999999999999999777 89999999998876442
Q ss_pred ---cccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 284 ---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 284 ---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
......||+.|||||++.+. ++..-++|||||||++.||+||+.||..-+++...+..+.-+.. ++.-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 23456899999999999763 34567899999999999999999999777777776666544432 3456
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+||.+ |++.||+.|-++.|+++|.|-+.-..
T Consensus 1471 ~dFle~-Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1471 RDFLEH-CLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHH-HHhcCchhhhHHHHHHHhhccccccc
Confidence 788998 89999999999999999999887443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=288.00 Aligned_cols=236 Identities=16% Similarity=0.287 Sum_probs=189.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+. ++..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK--QRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEcc--CCCcEEEE
Confidence 367999999999999999999874 4556999988643 246789999999999 89999999999865 45679999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
||+.+++|..++. .+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.++.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceee
Confidence 9999999877652 478889999999999999999999999999999999999666 89999999987664332211
Q ss_pred --ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 287 --~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
...++..|++||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+.+.. .++.+.+++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1234456999999876 578899999999999999998 888883 333333333443322 1346777777
Q ss_pred hcCCCCChhhHHHhhhhcCC
Q 015741 357 KYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~ 376 (401)
+ |+..||..||++.+++.+
T Consensus 236 ~-cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 S-CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred H-HcCCCcccCCCHHHHHHh
Confidence 7 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.09 Aligned_cols=242 Identities=20% Similarity=0.386 Sum_probs=198.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..|...+.||+|++|.||++.+..+++.+++|.++.. ..+.+.+|+.+++.+ +||||+++++++.. ....++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEE
Confidence 3455668999999999999999889999999988532 235678999999998 99999999999875 45778999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cccc
Q 015741 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (401)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~ 287 (401)
||+.+++|...+. ++++.++..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCccccc
Confidence 9999999987653 578889999999999999999999999999999999999766 89999999886553322 1233
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhc
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKY 358 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~ 358 (401)
..++..|+|||.+.+ ..++.++|||||||++|+|++|+.||+. .+..+.+..+.... -++.+.+++.+
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 251 (285)
T cd06648 175 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR- 251 (285)
T ss_pred ccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH-
Confidence 467889999999876 5789999999999999999999999854 33333333333221 12467788888
Q ss_pred CCCCChhhHHHhhhhcCCCccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+..+|..||++.++++|+|++..
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HcccChhhCcCHHHHccCcccccC
Confidence 899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.31 Aligned_cols=234 Identities=17% Similarity=0.306 Sum_probs=187.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.++||+|+||.||+|.+..+ ..||+|+++.. ..+.+.+|+++++++ +||||+++++.+.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEEE
Confidence 46799999999999999999988544 56999998742 346789999999999 89999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||.+..+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence 9999999987764 367888999999999999999999999999999999999766 7999999999876433321
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (401)
....++..|+|||...+ ..++.++|||||||++|+|++ |..|| .+....+....+.... -...+.+++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 12334567999999875 678999999999999999999 66666 4444444444433221 134567777
Q ss_pred HhcCCCCChhhHHHhhhhcC
Q 015741 356 NKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+ |++.||..||++.++++
T Consensus 237 ~~-~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQ-CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HH-HccCCcccCCCHHHHHH
Confidence 77 79999999999888753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=301.81 Aligned_cols=240 Identities=19% Similarity=0.312 Sum_probs=188.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ...+.+|+.++.++.+||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 478999999999999999999843 457899999996432 245788999999997789999999988654 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (401)
..++++|||+.+++|..++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999876542
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc---ccccc
Q 015741 224 ----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVA 290 (401)
Q Consensus 224 ----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~ 290 (401)
.++...+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......... ....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence 245667788999999999999999999999999999999666 8999999999765332221 11234
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcCCCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~ 362 (401)
+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.......+....+.+.. ..+.+.+++.+ |+..
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-cl~~ 321 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHG 321 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH-HccC
Confidence 556999999876 678999999999999999997 8888844333322222222211 23467777777 7999
Q ss_pred ChhhHHHhhhhcCC
Q 015741 363 DPHLAALVGRHSRK 376 (401)
Q Consensus 363 dP~~R~~~~~~l~~ 376 (401)
||+.||++.++++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=286.30 Aligned_cols=233 Identities=20% Similarity=0.362 Sum_probs=190.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|++|.||+|.+ .+++.||+|.++.. ..+.+.+|+.+++++ +||||+++++++.. ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeeee
Confidence 46799999999999999999987 45678999998753 346788999999999 89999999999865 45678999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcc-
Confidence 9999999987753 478889999999999999999999999999999999999766 799999999987653221
Q ss_pred ccccc---CCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHH
Q 015741 286 NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAY 354 (401)
Q Consensus 286 ~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~ 354 (401)
....+ +..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| .+....+.+..+.+.. ..+.+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11222 346999999876 678999999999999999999 88887 4444444444443332 13566777
Q ss_pred HHhcCCCCChhhHHHhhhhc
Q 015741 355 LNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+ |+..+|..||++++++
T Consensus 237 i~~-~l~~~P~~Rp~~~~l~ 255 (261)
T cd05068 237 MLD-CWKEDPDDRPTFETLQ 255 (261)
T ss_pred HHH-HhhcCcccCCCHHHHH
Confidence 777 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=290.16 Aligned_cols=234 Identities=19% Similarity=0.354 Sum_probs=183.9
Q ss_pred EEEeeecccCCeeEEEEEEcCCCe--EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----CCCC
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT 205 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~~~~ 205 (401)
.+.+.||+|+||.||+|.+..++. .+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 467899999999999999876664 6899987642 235688899999999 999999999976432 1235
Q ss_pred cEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 206 PSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
.+++|||+.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 78999999999987654 1367888999999999999999999999999999999998666 8999999999
Q ss_pred eecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-----
Q 015741 277 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG----- 347 (401)
Q Consensus 277 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~----- 347 (401)
+.+...... ....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+....+....+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcCCCCCCCC
Confidence 876433221 22345667999999876 678999999999999999999 67777 44444443333332211
Q ss_pred --ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 --TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 --~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
...+.+++.+ |+..||+.||+++++++
T Consensus 238 ~~~~~~~~li~~-~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 238 DCLDGLYSLMSS-CWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 2456677777 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=286.91 Aligned_cols=229 Identities=22% Similarity=0.380 Sum_probs=182.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +||||+++++++.+ ....++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 4689999999999999889999999987532 235689999999999 99999999999865 4578899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc---cc
Q 015741 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---VR 288 (401)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~---~~ 288 (401)
++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence 99987752 378889999999999999999999999999999999999766 79999999987543221111 11
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHI 360 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l 360 (401)
..+..|+|||.+.+ +.++.++|||||||++|+|++ |..||. .....+....+.... .+..+.+++.+ |+
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l 233 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA-NLSNQQTREAIEQGVRLPCPELCPDAVYRLMER-CW 233 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHH-Hc
Confidence 22345999999876 678999999999999999998 777773 333333222222211 13566777777 89
Q ss_pred CCChhhHHHhhhhcC
Q 015741 361 ELDPHLAALVGRHSR 375 (401)
Q Consensus 361 ~~dP~~R~~~~~~l~ 375 (401)
..+|+.||++.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=290.46 Aligned_cols=235 Identities=26% Similarity=0.486 Sum_probs=191.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++.+.||+|+||.||+|.+..+++.++||.+... ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence 5688899999999999999999889999999987532 235678899999999 99999999999876 45788
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
++|||+.+++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence 9999999999876642 378889999999999999999999999999999999999766 89999999987664
Q ss_pred CCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChh
Q 015741 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDE 350 (401)
Q Consensus 281 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~ 350 (401)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....+...+....... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 3322 223467889999999876 6788999999999999999999999965443333332222111 1246
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+++.+ |+..||..||++.+++
T Consensus 237 ~~~li~~-~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 237 LRQLVNM-CINPDPEKRPDITYVY 259 (267)
T ss_pred HHHHHHH-hcCCCcccCCCHHHHH
Confidence 7777777 8999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.59 Aligned_cols=236 Identities=17% Similarity=0.311 Sum_probs=189.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ...+.+|+.+++.+ +||||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--C
Confidence 57899999999999999999987643 3789999986432 24678899999998 99999999999876 4
Q ss_pred CCcEEEEeecCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl 270 (401)
...+++|||+.+++|..++. .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl 160 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKI 160 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEE
Confidence 67899999999999987653 246678889999999999999999999999999999999776 8999
Q ss_pred EecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh
Q 015741 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 271 ~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
+|||+++.+..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC-ccCCHHHHHHHHhcCC
Confidence 99999876543321 123345678999999876 678999999999999999998 88777 4444333333333211
Q ss_pred -------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 -------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 -------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-...+.+++.+ |++.+|..||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~li~~-~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HLDLPENCPDKLLELMRM-CWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCHHHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 13466777777 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=283.52 Aligned_cols=238 Identities=24% Similarity=0.482 Sum_probs=197.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||.|+||.||++.+..+++.+++|++... ....+.+|+++++.+ +|||++++++.+.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~--~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEE--KGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEec--CCEEEEE
Confidence 488999999999999999999888999999998642 345688999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+||+++++|...+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 9999999987665 3478899999999999999999999999999999999999665 8999999999776443
Q ss_pred C-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-------hCChhHHHH
Q 015741 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-------LGTDELNAY 354 (401)
Q Consensus 283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-------~~~~~~~~~ 354 (401)
. ......+++.|+|||...+ ..++.++|+||+|+++|+|++|..||... +..+........ .-...+.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQYPPIPSQYSSELRNL 234 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 3 2233567888999999876 56889999999999999999999998433 222222222221 113466777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.+ |+..+|..||++.++++|||+
T Consensus 235 i~~-~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 235 VSS-LLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHH-HcCCChhhCcCHHHHhcCCCC
Confidence 777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.45 Aligned_cols=238 Identities=18% Similarity=0.336 Sum_probs=189.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||++.+... ...+|+|.+.... ...+.+|+.+++++.+|+||+++++++.. .
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--E 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--C
Confidence 47899999999999999999987643 3789999986432 24578899999998789999999999865 4
Q ss_pred CCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
..++++|||+.+++|..++ ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 5789999999999987665 246788899999999999999999999999999999999976
Q ss_pred CCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHH
Q 015741 265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 340 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~ 340 (401)
+ .+||+|||+++.+...... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+...
T Consensus 169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~ 245 (293)
T cd05053 169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEELFK 245 (293)
T ss_pred C-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHHHHH
Confidence 6 8999999999876433221 11233456999999876 678999999999999999997 888873 333333333
Q ss_pred HHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 341 KIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 341 ~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+..... ...+.+++.+ |+..||..||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRD-CWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHH-HcccCcccCcCHHHHHHH
Confidence 3322211 3467777888 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=288.55 Aligned_cols=233 Identities=18% Similarity=0.332 Sum_probs=186.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+++ +||+|+++... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---C
Confidence 4789999999999999999999776665 48999986432 35678899999998 99999999999864 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++||+++|+|...+. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence 4679999999999877653 478899999999999999999999999999999999998666 79999999998765
Q ss_pred CCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC--------C
Q 015741 281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG--------T 348 (401)
Q Consensus 281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~--------~ 348 (401)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .... +.+........ +
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPA-REIPDLLEKGERLPQPPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHCCCcCCCCccCC
Confidence 33221 11233567999999876 678999999999999999998 787773 3332 22222222211 3
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.++.+++.+ |+..||+.||++.+++
T Consensus 238 ~~~~~li~~-~l~~dp~~Rp~~~~l~ 262 (279)
T cd05109 238 IDVYMIMVK-CWMIDSECRPRFRELV 262 (279)
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHH
Confidence 456677777 8999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=286.09 Aligned_cols=233 Identities=18% Similarity=0.338 Sum_probs=190.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|+++++||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++++ +|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEEE
Confidence 57899999999999999999986 56788999998743 346789999999999 89999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|...+. .+++.++..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc
Confidence 9999999877652 478888999999999999999999999999999999999766 8999999999876532211
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
....++..|+|||++.. ..++.++||||||+++|+|++ |+.|| .+.+..+....+.+... +..+.+++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPY-PGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCC-CCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 12234567999999876 678899999999999999999 88888 44444444444433321 24677888
Q ss_pred HhcCCCCChhhHHHhhhhc
Q 015741 356 NKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l 374 (401)
.+ |+..+|+.||++++++
T Consensus 237 ~~-~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 237 RL-CWKEKPEERPTFEYLR 254 (260)
T ss_pred HH-HccCChhhCCCHHHHH
Confidence 88 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.87 Aligned_cols=248 Identities=26% Similarity=0.477 Sum_probs=207.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCC-------CCeeEEeeEEE--cC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-------PNIVKLLDIVR--DQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h-------pniv~~~~~~~--~~ 201 (401)
..+|.+.++||-|.|++||+|.+..+.+.||+|+.+.. -.+....||++|++++.+ .+||++++.|. .+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 48999999999999999999999999999999999743 346678999999998543 37999999987 45
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCC----------
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR---------- 266 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~---------- 266 (401)
++.+++||+|++....|..+. +.++...++.|++||+.||.|||.+ ||||-||||+|||+.....
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~ 236 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG 236 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence 677899999999887776543 4699999999999999999999975 9999999999999932200
Q ss_pred --------------------------------------------------------------------------------
Q 015741 267 -------------------------------------------------------------------------------- 266 (401)
Q Consensus 267 -------------------------------------------------------------------------------- 266 (401)
T Consensus 237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v 316 (590)
T KOG1290|consen 237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV 316 (590)
T ss_pred cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence
Q ss_pred ---------------------------------------------------------------------------eEEEE
Q 015741 267 ---------------------------------------------------------------------------KLRLI 271 (401)
Q Consensus 267 ---------------------------------------------------------------------------~vkl~ 271 (401)
+|||+
T Consensus 317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa 396 (590)
T KOG1290|consen 317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA 396 (590)
T ss_pred hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence 07899
Q ss_pred ecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC-----CCCHHHHHHHHHHh
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG-----HDNYDQLVKIAKVL 346 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~-----~~~~~~l~~i~~~~ 346 (401)
|||.|.+. ...++.-..|+.|+|||++.+ ..|++.+||||++|++|||+||...|.+. ..+.+.+..|.+.+
T Consensus 397 DlGNACW~--~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL 473 (590)
T KOG1290|consen 397 DLGNACWV--HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL 473 (590)
T ss_pred eccchhhh--hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence 99998876 355667788999999999998 78999999999999999999999998542 24667788887776
Q ss_pred CC------------------------------------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 347 GT------------------------------------------------DELNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 347 ~~------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
|. .++.+||.- ||+.+|++|+++.++|+|||
T Consensus 474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P-mLef~PeKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP-MLEFDPEKRPTAAQCLKHPW 552 (590)
T ss_pred hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH-HHhcCccccccHHHHhcCcc
Confidence 51 245566777 89999999999999999999
Q ss_pred cccccc
Q 015741 379 SKFITV 384 (401)
Q Consensus 379 ~~~~~~ 384 (401)
..-+..
T Consensus 553 Ln~~~~ 558 (590)
T KOG1290|consen 553 LNPVAG 558 (590)
T ss_pred ccCCCC
Confidence 985443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=289.03 Aligned_cols=243 Identities=16% Similarity=0.313 Sum_probs=190.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.++. .+..||+|.++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35789999999999999999997642 35589999876432 23577899999999 89999999999865
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEE
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vk 269 (401)
....+++|||+.+++|..++.. .....+..++.|++.||.|||+++|+||||||+||+++.++ .++
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~ 159 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVK 159 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEE
Confidence 3567999999999999877632 24567788999999999999999999999999999999766 899
Q ss_pred EEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Q 015741 270 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (401)
Q Consensus 270 l~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~ 345 (401)
|+|||+++....... .....++..|+|||.+.+ +.++.++|||||||++|||++ |..|| .+....+....+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC
Confidence 999999876533221 112234567999999876 678999999999999999998 67777 344433333333221
Q ss_pred h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC------CCcccc
Q 015741 346 L-------GTDELNAYLNKYHIELDPHLAALVGRHSR------KPWSKF 381 (401)
Q Consensus 346 ~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~------~~~~~~ 381 (401)
. ..+.+.+++.+ |++.||..||++.++++ |||+.-
T Consensus 238 ~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCCCHHHHHHHHH-HcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 13567777887 89999999999999986 777654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=292.85 Aligned_cols=237 Identities=21% Similarity=0.341 Sum_probs=189.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|.+.+.||+|+||.||+|.+. .++..+|+|+++... .+.+.+|+.+++++.+||||+++++++.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 478999999999999999999752 345689999986432 24688999999999779999999999865 4
Q ss_pred CCcEEEEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 204 KTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...+++|||+.+++|..++.. +++.++..++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||+++.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~ 190 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARD 190 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCccccc
Confidence 578999999999999876532 78899999999999999999999999999999999998665 899999999976
Q ss_pred cCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH-Hh-------
Q 015741 279 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK-VL------- 346 (401)
Q Consensus 279 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~-~~------- 346 (401)
+...... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..... .+.+..... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHcCCcCCCCCC
Confidence 5433221 12234567999999876 678999999999999999998 8888854333 222222222 11
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.++.+.+++.+ |+..+|+.||++.+++.
T Consensus 269 ~~~~~~~li~~-cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKT-CWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHH-HcCCCchhCcCHHHHHH
Confidence 24567778888 89999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=294.52 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=204.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..+|..+..||+|+||.|.+|..+.+.+.||||++++. +.+--..|-++|....+-|.+++++..|.. -..+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 35789999999999999999999999999999999752 122234566677766567899999998854 5678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
|+||||+.||+|.+.++ ++.|..+..++.+|+-||-+||++|||.||||.+|||++.++ ++||+|||+++.-- .+
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFDG 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccCC
Confidence 99999999999987765 588899999999999999999999999999999999999888 89999999997432 34
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------ChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~ 356 (401)
....+.+||+.|+|||++.- ++|+..+|+||+||+||||+.|+.|| .+.++.+.+..|.+... +.+..+...
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehnvsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHNVSYPKSLSKEAVAICK 582 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence 55677899999999999875 89999999999999999999999998 67777777777766532 223333334
Q ss_pred hcCCCCChhhHHHh-----hhhcCCCccccccccc
Q 015741 357 KYHIELDPHLAALV-----GRHSRKPWSKFITVEN 386 (401)
Q Consensus 357 ~~~l~~dP~~R~~~-----~~~l~~~~~~~~~~~~ 386 (401)
. .+...|.+|.-. .++.+|||+.++..+.
T Consensus 583 g-~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 583 G-LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred H-HhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 4 567778887643 5788999999987654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.38 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=202.7
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
...+.|++.+.||+|++|.||+|.+..+++.+++|+++... .+.+.+|+++++.+ +|+|++++++.+.. ....++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEE--CCEEEE
Confidence 34577999999999999999999998889999999997544 56788999999999 99999999999876 467899
Q ss_pred EEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
++||+.+++|.+++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchh
Confidence 999999999987753 578889999999999999999999999999999999999766 89999999986553322
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAY 354 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~ 354 (401)
......++..|++||.+.+ ..++.++|+|||||++|+|++|..||.. .+.......+.... -...+.++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 1223456788999999876 6789999999999999999999999843 33333333322211 12456777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |+..+|..||++.++++|+|++..
T Consensus 250 i~~-~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 250 LNK-CLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHH-HhccChhhCcCHHHHhhChHhhcc
Confidence 777 899999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=276.32 Aligned_cols=244 Identities=19% Similarity=0.276 Sum_probs=189.8
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC---CC
Q 015741 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---QS 203 (401)
Q Consensus 130 ~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~---~~ 203 (401)
+...++|.+.+.||+|||+.||++....+++.||+|.+... ..+...+|++..+++ +|||+++++++.... ..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence 34578999999999999999999999999999999988643 346688999999999 999999999865421 24
Q ss_pred CCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
...|++++|+..|+|.+.+. .++|.++..|+.++++||++||+.. ++||||||.|||+..++ .++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEecc
Confidence 56899999999998876652 4899999999999999999999998 99999999999999756 89999999
Q ss_pred cceecCCC---C-------cccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHH-----
Q 015741 275 LAEFYHPG---K-------EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD----- 337 (401)
Q Consensus 275 ~a~~~~~~---~-------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~----- 337 (401)
.+....-. . .......|..|+|||.+.- ....+.++|||||||+||.|++|..||...-..-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 98654211 0 0112245677999999742 24567899999999999999999999942111000
Q ss_pred ----HHHHHHHHhCChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 338 ----QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 338 ----~l~~i~~~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
++..-.+..-++.+.+++.. |++.||..||++.+++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~-mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKS-MLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHH-HhcCCcccCCCHHHHHHH
Confidence 00000001124566666666 899999999999998754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=286.00 Aligned_cols=233 Identities=18% Similarity=0.345 Sum_probs=189.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+. ++..+|+|.++.. ..+.+.+|+.+++++ +|+|++++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence 468999999999999999999874 6677999998743 346789999999999 99999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc
Confidence 9999999987652 378889999999999999999999999999999999999665 8999999999876433211
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (401)
....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+.... .+..+.+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11234456999999875 678899999999999999999 77777 4445555555544321 134677778
Q ss_pred HhcCCCCChhhHHHhhhhc
Q 015741 356 NKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l 374 (401)
.+ |+..||..||++.++.
T Consensus 237 ~~-~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 237 LQ-CWKKDPEERPTFEYLQ 254 (260)
T ss_pred HH-HcccCcccCcCHHHHH
Confidence 88 7999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=285.81 Aligned_cols=249 Identities=29% Similarity=0.468 Sum_probs=206.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~------ 201 (401)
...|+-..+||+|.||+||+|+.+.+|++||+|+.- ..-.....+|+++|+.| +|+|++.+++++...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence 356788899999999999999999999999988642 22235678999999999 999999999877532
Q ss_pred CCCCcEEEEeecCCCch---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 202 QSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l---~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
....+|+|+.+|+.... .....+++..++..++.+++.||.|+|...|+|||+||+|+||+.++ .+||+|||+++.
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccc
Confidence 22358999999987543 33335689999999999999999999999999999999999999877 899999999976
Q ss_pred cCCC-----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC-----
Q 015741 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----- 348 (401)
Q Consensus 279 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~----- 348 (401)
+... ..++.++.|.+|++||.+.+...|+++.|||..|||+.||+|+. |...+.++..++..|....|+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccCCccc
Confidence 6422 33566788999999999999999999999999999999999997 555888888888888777551
Q ss_pred ------------------------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 349 ------------------------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 349 ------------------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++..+++.+ ++.+||.+|+.++++++|.|+..-++.
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~-ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK-LLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH-HhccCcccCcchHhhhchhhhhcCCcc
Confidence 133445556 799999999999999999999875543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=296.79 Aligned_cols=237 Identities=19% Similarity=0.229 Sum_probs=184.7
Q ss_pred CCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhh
Q 015741 146 KYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220 (401)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 220 (401)
++|.||.++...+++.||+|+++.. ..+.+.+|+++++.+ +|+||+++++++.+ ....+++|||+.++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIV--DSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence 4455666666678999999998643 235789999999999 89999999999876 456789999999999877
Q ss_pred hcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--------ccc
Q 015741 221 LYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------YNV 287 (401)
Q Consensus 221 ~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~--------~~~ 287 (401)
++. .+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccc
Confidence 653 478889999999999999999999999999999999999766 899999999865532211 123
Q ss_pred cccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------------------
Q 015741 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------------------- 345 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------------------- 345 (401)
..++..|+|||++.+. ..++.++|+|||||++|+|++|..||.........+..+...
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 3466779999998652 358899999999999999999999996443222222221100
Q ss_pred ------------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 346 ------------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 346 ------------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.-++++.+++.+ |+..||+.||+++++++|||++.....+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~ 306 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVEL-CLQRDPESRPSASQLLNHSFFKQCKRRNT 306 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHH-HhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence 001345566777 89999999999999999999998764443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=298.75 Aligned_cols=239 Identities=16% Similarity=0.231 Sum_probs=186.1
Q ss_pred eeeccc--CCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
..||+| +||+||++.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.. ....+++|||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 456666 99999999999999999999986432 35678899998888 99999999999976 4578999999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---
Q 015741 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 284 (401)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~--- 284 (401)
+.++++..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 99999877653 378888999999999999999999999999999999999766 899999986533221110
Q ss_pred -----ccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH--------------
Q 015741 285 -----YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-------------- 344 (401)
Q Consensus 285 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~-------------- 344 (401)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML-RTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHhcCCCCCCccccccch
Confidence 0112344569999998652 357899999999999999999999984332 2222211110
Q ss_pred ---------------------------------------HhCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 345 ---------------------------------------VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 345 ---------------------------------------~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
....+.+.+++.+ |+..||+.||+++++++|+|++.+-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL-CLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH-HccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0012356677777 89999999999999999999977543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=286.19 Aligned_cols=234 Identities=17% Similarity=0.296 Sum_probs=188.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.+|++.+.||+|+||.||+|.+. ++..+|+|++... ....+.+|+++++.+ +||||+++++++.+ ....+++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEEe
Confidence 46888999999999999999874 5678999998643 345788999999999 99999999999865 457899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc-
Q 015741 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN- 286 (401)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~- 286 (401)
|+++++|.+++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceeccccccccc
Confidence 999999887652 478889999999999999999999999999999999999766 89999999997654322111
Q ss_pred -ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHh
Q 015741 287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNK 357 (401)
Q Consensus 287 -~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..++.+....+.... .++.+.+++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1122346999999876 678999999999999999999 787873 444444444443322 14567777777
Q ss_pred cCCCCChhhHHHhhhhcC
Q 015741 358 YHIELDPHLAALVGRHSR 375 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~ 375 (401)
|+..+|+.||++.++++
T Consensus 237 -cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 237 -CWHEKPEDRPAFKKLLS 253 (256)
T ss_pred -HhcCChhhCcCHHHHHH
Confidence 89999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=292.90 Aligned_cols=236 Identities=19% Similarity=0.311 Sum_probs=187.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.+|++.+.||+|+||.||+|.+..+ ++.||+|+++... .+.+.+|+.++..+ +||||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE--Q 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--C
Confidence 4578889999999999999987543 5789999987432 24578899999998 999999999998663 5
Q ss_pred CcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC
Q 015741 205 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 265 (401)
..++++||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 6789999999998876641 367778889999999999999999999999999999998665
Q ss_pred CeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 015741 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~ 341 (401)
.+||+|||+++....... .....+++.|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+.+..
T Consensus 162 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~~ 238 (283)
T cd05091 162 -NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIEM 238 (283)
T ss_pred -ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence 799999999876543222 122345678999999876 578999999999999999998 66666 44444444444
Q ss_pred HHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 342 IAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 342 i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+... ...+.+++.+ |++.+|..||++.+++..
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPCPDDCPAWVYTLMLE-CWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHH-HhCCCcccCCCHHHHHHH
Confidence 433221 2356677777 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.57 Aligned_cols=235 Identities=20% Similarity=0.313 Sum_probs=188.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..+|.+.+.||+|+||.||+|.+. .++..+++|.++... .+.+.+|+++++++ +|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence 356899999999999999999853 245678999986543 35688999999999 99999999999865 45
Q ss_pred CcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC
Q 015741 205 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 265 (401)
..++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 7899999999999987752 267888999999999999999999999999999999999766
Q ss_pred CeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 015741 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~ 341 (401)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||+. ....+.+..
T Consensus 161 -~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~ 237 (291)
T cd05094 161 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIEC 237 (291)
T ss_pred -cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 899999999976543221 123345678999999876 678999999999999999998 8888843 333333333
Q ss_pred HHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 342 IAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 342 i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+.... .+..+.+++.+ |+..||..||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLG-CWQREPQQRLNIKEIY 276 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHH-HcccChhhCcCHHHHH
Confidence 32221 13467777777 8999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=286.04 Aligned_cols=236 Identities=17% Similarity=0.298 Sum_probs=189.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+ ...||+|+++... ...+.+|+.+++++ +||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence 36799999999999999999988644 4589999986432 34678899999999 99999999999865 456
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccc
Confidence 889999999999987753 478899999999999999999999999999999999999766 899999999987642
Q ss_pred C-Ccccc--cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Chh
Q 015741 282 G-KEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (401)
Q Consensus 282 ~-~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (401)
. ..... ..++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. ....+....+.+... ++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRLPPPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2 11111 233457999999876 678999999999999999998 9888843 333333334433211 346
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |++.+|..||++.++++
T Consensus 237 l~~li~~-cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 237 LYQLMLD-CWQKDRNERPTFSQIVS 260 (266)
T ss_pred HHHHHHH-HcCCCcccCcCHHHHHH
Confidence 6777777 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.11 Aligned_cols=235 Identities=18% Similarity=0.348 Sum_probs=192.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..+|++.+.||.|+||.||+|.+.. ++.+++|++.... ...+.+|+.+++.+ +||||+++++++.+ ....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence 4678999999999999999999866 8899999987543 46788999999999 99999999999876 4578899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCccc
Confidence 99999999987764 378888999999999999999999999999999999999766 899999999976543221
Q ss_pred c-cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 285 Y-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 285 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
. ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| ...+..+.+..+..... ++.+.+++
T Consensus 160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1 12234557999999876 678899999999999999998 78887 44444444444443321 34667777
Q ss_pred HhcCCCCChhhHHHhhhhcC
Q 015741 356 NKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+ |++.||..||++.++++
T Consensus 238 ~~-~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LE-CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HH-HcCCCchhCcCHHHHHH
Confidence 77 89999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=289.29 Aligned_cols=239 Identities=20% Similarity=0.362 Sum_probs=188.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~----~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..+|++++.||+|+||.||+|.. ..+++.||+|.++... .+.+.+|+++++++ +||||+++++++.......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 35789999999999999999974 4578899999986543 34688999999999 9999999999886655567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+++||||+.+++|..++. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccC
Confidence 899999999999987753 378889999999999999999999999999999999998766 899999999987643
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--------------HHHHHHH
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--------------DQLVKIA 343 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--------------~~l~~i~ 343 (401)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++|..|+....... ..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3321 11123345999999876 678999999999999999999877653221110 0111111
Q ss_pred HHh--------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 344 KVL--------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 344 ~~~--------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.. ..+++.+++.+ |+..+|+.||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKE-CWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 111 12467777888 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.24 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=214.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.+++++..||-|+||.|=++........+|+|++++. ..+.+..|-+||... +.|.||++|..|.+ ..++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyvY 496 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYVY 496 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhhh
Confidence 5678889999999999999987666666899988642 345678899999998 79999999999976 68999
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
++||-|-||.+-..++ .+.+..++.++.-+++|++|||++|||+|||||+|++++.++ .+||.|||+|+.+..+..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCCc
Confidence 9999999999877663 588999999999999999999999999999999999999877 799999999999998988
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~~~l~ 356 (401)
+.+.+||+.|.|||++.+ +..+.++|.||||+++|||++|.+|| .+.+++.....|.+.+. .....+++.
T Consensus 576 TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 999999999999999998 78999999999999999999999998 78888888888877654 234456677
Q ss_pred hcCCCCChhhHHH-----hhhhcCCCccccccccc
Q 015741 357 KYHIELDPHLAAL-----VGRHSRKPWSKFITVEN 386 (401)
Q Consensus 357 ~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~~~ 386 (401)
++ ...+|..|.- +.++-.|.|+.-+..+.
T Consensus 654 ~L-Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 654 KL-CRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred HH-HhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 75 4668888875 89999999999888765
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.10 Aligned_cols=230 Identities=18% Similarity=0.280 Sum_probs=180.2
Q ss_pred eeecccCCeeEEEEEEcCCCe--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.+..++. .+++|.++.. ....+.+|+++++++.+||||+++++++.. ...++++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 358999999999999877765 4688887642 235688899999999889999999999976 45689999999
Q ss_pred CCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 214 NNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 214 ~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
.+++|..++. .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 157 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFG 157 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCC
Confidence 9999877652 267888999999999999999999999999999999999766 89999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL------- 346 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~------- 346 (401)
++..............+..|+|||++.. ..++.++|||||||++|||++ |..||. +.+..+....+....
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHHhCCCCCCCCCc
Confidence 9863321111112223456999999865 678999999999999999997 888883 333333333332221
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
...++.+++.+ |+..||..||++.+++.
T Consensus 236 ~~~~~~~li~~-~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 236 CDDEVYDLMRQ-CWREKPYERPSFAQILV 263 (270)
T ss_pred CCHHHHHHHHH-HcccChhhCCCHHHHHH
Confidence 13466677777 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.75 Aligned_cols=240 Identities=31% Similarity=0.523 Sum_probs=197.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++.+||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 4789999999999999999999889999999998642 235678899999999449999999999865 46788
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
++|||+.+++|...+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence 9999999999977663 578999999999999999999999999999999999999766 79999999987654322
Q ss_pred --------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 015741 284 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 284 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~ 343 (401)
......++..|+|||.+.+ ..++.++|+||||++++++++|+.||... .....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKIL 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHH
Confidence 1123356778999999876 56888999999999999999999998433 3333333333
Q ss_pred HHhC------ChhHHHHHHhcCCCCChhhHHHh----hhhcCCCcc
Q 015741 344 KVLG------TDELNAYLNKYHIELDPHLAALV----GRHSRKPWS 379 (401)
Q Consensus 344 ~~~~------~~~~~~~l~~~~l~~dP~~R~~~----~~~l~~~~~ 379 (401)
.... .+.+.+++.+ |+..+|..||++ ++++.|||+
T Consensus 236 ~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEK-LLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hcCCCCCCccCHHHHHHHHH-HhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2211 3466777888 899999999999 999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=287.88 Aligned_cols=237 Identities=34% Similarity=0.621 Sum_probs=194.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
|++.+.||+|++|.||+|+...+++.+|+|++.... .+.+..|+.+++.+ +|+|++++++++.+ ....+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence 567789999999999999998899999999987532 35678899999999 89999999999875 46789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~ 285 (401)
||+++ +|..++ ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcccc
Confidence 99985 676555 2578999999999999999999999999999999999999765 89999999997664332 23
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------ 347 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------------ 347 (401)
....++..|+|||.+.+...++.++|||||||++|+|++|..|| .+....+.+..+.+..+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 33456678999999876457899999999999999999998887 44444444444333221
Q ss_pred -----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 -----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++.+ |+..||..||++.+++.|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSK-MLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHH-hhccCcccCCCHHHHhhCcCC
Confidence 2356677777 899999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=302.66 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=196.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+.-|..++.||-|+||+|.+++..++...||+|.+++.+ ...++.|-.||... +++-||+||..|.| ..++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQD--kdnL 704 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNL 704 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEecc--CCce
Confidence 345889999999999999999998999999999986432 35578899999997 99999999999966 6789
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec----
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY---- 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~---- 279 (401)
|+||+|++||++..++ .-+.|..++.+++++..|+++.|..|+|||||||+|||||.+| +|||.|||++.-+
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceecc
Confidence 9999999999976654 3478888999999999999999999999999999999999888 8999999998421
Q ss_pred -----CCCCcc----------------------------------cccccCCCccccccccCCCCCCcccchHHHHHHHH
Q 015741 280 -----HPGKEY----------------------------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320 (401)
Q Consensus 280 -----~~~~~~----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ 320 (401)
..+... -..+||+.|+|||++.. ..|+..+|+||.|||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILY 862 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHH
Confidence 111000 11379999999999987 78999999999999999
Q ss_pred HHHcCCCCCCCCCCCHHHHHHHHH---H-------hCChhHHHHHHhcCCCCChhhHH---HhhhhcCCCccccccccc
Q 015741 321 GMIFRKEPFFYGHDNYDQLVKIAK---V-------LGTDELNAYLNKYHIELDPHLAA---LVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 321 elltg~~Pf~~~~~~~~~l~~i~~---~-------~~~~~~~~~l~~~~l~~dP~~R~---~~~~~l~~~~~~~~~~~~ 386 (401)
||+.|+.||.... ..+.-.++.. . .-+.+..++|.++| .+++.|. -.+++-.||||+-|...+
T Consensus 863 em~~g~~pf~~~t-p~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc--~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT-PGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC--CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HHhhCCCCccCCC-CCcceeeeeehhhccccccccccCHHHHHHHHHHh--cChhhhhcccchhhhhcCccccccchHh
Confidence 9999999995433 2222222111 1 12567778888865 4455554 357799999999887655
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=292.86 Aligned_cols=237 Identities=19% Similarity=0.320 Sum_probs=187.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|.+.+.||+|+||.||+|.+. .....+|+|+++... ...+.+|+++++.+.+||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 478999999999999999999763 234578999987432 24578899999998679999999999865
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
...++++|||+.+++|..++. .+++.++..++.|++.||.|||++|++||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 457899999999999877652 267778889999999999999999999999999999998
Q ss_pred CCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus 169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~ 245 (314)
T cd05099 169 EDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL 245 (314)
T ss_pred CCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence 766 8999999999765432211 11223457999999876 678999999999999999999 78787 34333333
Q ss_pred HHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
...+..... ..++.+++.+ |+..||+.||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRE-CWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 333333211 2467778877 89999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=291.23 Aligned_cols=241 Identities=20% Similarity=0.369 Sum_probs=198.1
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
....+||+|+||.||++....+++.||+|.+... ....+.+|+.+++.+ +|+||+++++.+.+ ....+++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEecC
Confidence 3347799999999999999899999999987532 335688899999999 89999999999976 46789999999
Q ss_pred CCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccccccc
Q 015741 214 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVA 290 (401)
Q Consensus 214 ~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~~~~ 290 (401)
.+++|..+. ..+++..++.++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++....... ......+
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceeccccccccccccc
Confidence 999998775 3578889999999999999999999999999999999999766 79999999987654322 2233567
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhcCCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYHIE 361 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~l~ 361 (401)
+..|+|||.+.+ ..++.++|+||||+++|+|++|..||. +....+.+..+.... ..+.+.+++.+ |+.
T Consensus 179 ~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~ 255 (292)
T cd06657 179 TPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR-LLV 255 (292)
T ss_pred CccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH-HHh
Confidence 888999999865 678899999999999999999999985 333333333332222 14567777877 899
Q ss_pred CChhhHHHhhhhcCCCccccccc
Q 015741 362 LDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 362 ~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.||..|+++.+++.|||+...-.
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.30 Aligned_cols=241 Identities=22% Similarity=0.391 Sum_probs=199.3
Q ss_pred cccccCCCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEee
Q 015741 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 196 (401)
Q Consensus 126 ~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~ 196 (401)
..+......+.+..+.||+|+||+||+|+.. .....||||.++... ..+|++|++++..| +|||||+++|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEE
Confidence 3334445677888999999999999999753 335689999998543 46799999999999 9999999999
Q ss_pred EEEcCCCCCcEEEEeecCCCchhhhcC-------------C----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCe
Q 015741 197 IVRDQQSKTPSLIFEHVNNTDFKVLYP-------------T----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (401)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 259 (401)
++.+ +..+++|+|||..|||.+++. . ++..+...|+.||+.|++||-++.+|||||...|+
T Consensus 557 VC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 9976 567899999999999988862 2 67788999999999999999999999999999999
Q ss_pred eEeCCCCeEEEEecccceecCCCCccccc---ccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCC
Q 015741 260 MIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDN 335 (401)
Q Consensus 260 ll~~~~~~vkl~DFg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~ 335 (401)
||..+. .|||+|||+++.+...+.+... .-...||+||.+.. +.|+.+|||||+||+|||+++ |+.|| .+..+
T Consensus 635 LVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn 711 (774)
T KOG1026|consen 635 LVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSN 711 (774)
T ss_pred eeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccch
Confidence 999555 9999999999876544433322 22346999999986 799999999999999999986 77787 57777
Q ss_pred HHHHHHHHHHh--C-----ChhHHHHHHhcCCCCChhhHHHhhhh
Q 015741 336 YDQLVKIAKVL--G-----TDELNAYLNKYHIELDPHLAALVGRH 373 (401)
Q Consensus 336 ~~~l~~i~~~~--~-----~~~~~~~l~~~~l~~dP~~R~~~~~~ 373 (401)
.+.+..|.+.. . +..+..++.. |++..|+.||++.++
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~-CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCPTEVYSLMLE-CWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHHHHcCCcccCCCCCCHHHHHHHHH-HhhcCcccCCCHHHH
Confidence 77777765542 2 3467777777 899999999999887
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=303.79 Aligned_cols=235 Identities=23% Similarity=0.377 Sum_probs=188.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe---E-EEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---K-CIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~-vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
++-.+.++||+|+||+||+|..+..+. . ||+|..+. .....+.+|+++|+++ +|||||++||+..+ .
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~--~ 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVL--E 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--C
Confidence 455567999999999999998865422 3 89998873 2346789999999999 99999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 KTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+++|||+|.||+|..+++. ++..+...++.+.+.||+|||++++|||||-..|+|++.++ .+||+|||+++..
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAG 312 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCC
Confidence 688999999999999988853 78899999999999999999999999999999999999666 6899999998754
Q ss_pred CCCCccc-ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH-Hh------CChh
Q 015741 280 HPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK-VL------GTDE 350 (401)
Q Consensus 280 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~-~~------~~~~ 350 (401)
..-.... ..--...|+|||.+.. ..|+.++|||||||++||+++ |..|| .+....+...+|.. .. ..|.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~~~r~~~~~~~p~ 390 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKNGYRMPIPSKTPK 390 (474)
T ss_pred cceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence 3111111 1123456999999987 599999999999999999998 67776 67777777667633 21 1333
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
....+...|...||+.|+++.++.
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHH
Confidence 344444458999999999988774
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=283.31 Aligned_cols=233 Identities=18% Similarity=0.318 Sum_probs=186.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+... ..+.+.+|+++++++ +|+|++++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence 36799999999999999999987544 56899987643 346788999999999 99999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCccc
Confidence 9999999877653 267888999999999999999999999999999999999766 8999999999876433211
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
....++..|+|||...+ ..++.++||||||+++|+|++ |..|| .+..+.+....+..... ...+.+++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 12234567999998876 678999999999999999999 78887 44444444444433321 24566777
Q ss_pred HhcCCCCChhhHHHhhhhc
Q 015741 356 NKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l 374 (401)
.+ |+..||..||++++++
T Consensus 237 ~~-~l~~~p~~Rp~~~~i~ 254 (260)
T cd05069 237 KL-CWKKDPDERPTFEYIQ 254 (260)
T ss_pred HH-HccCCcccCcCHHHHH
Confidence 77 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=285.08 Aligned_cols=234 Identities=28% Similarity=0.457 Sum_probs=192.5
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||.|+||.||++.+..+++.+++|++... ..+.+.+|+++++++ +||||+++++.+.. ....+++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence 68999999999999888999999998643 235688899999999 89999999998865 5678999999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC---------
Q 015741 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (401)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--------- 283 (401)
++|..++ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence 9987765 3578999999999999999999999999999999999999776 89999999987543321
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-h-------CChhHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-L-------GTDELNAYL 355 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-~-------~~~~~~~~l 355 (401)
......++..|++||...+ ..++.++||||||+++|+|++|..||.. ....+....+... . ..+.+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 1233457778999999876 5688999999999999999999999843 3333333333221 0 145677888
Q ss_pred HhcCCCCChhhHHHh---hhhcCCCccccc
Q 015741 356 NKYHIELDPHLAALV---GRHSRKPWSKFI 382 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~---~~~l~~~~~~~~ 382 (401)
.+ |++.+|..||++ .++++|||++-+
T Consensus 235 ~~-~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SK-LLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HH-HhcCCHhhcCCCccHHHHhcCccccCC
Confidence 88 799999999999 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=282.88 Aligned_cols=226 Identities=17% Similarity=0.309 Sum_probs=181.2
Q ss_pred eecccCCeeEEEEEE--cCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 141 KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+||+|+||.||+|.+ ..++..+|+|+++... .+.+.+|+.+++.+ +||||+++++++.+ ...+++|||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999964 4567899999986432 35688999999999 99999999998753 4568999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc----c
Q 015741 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 286 (401)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~----~ 286 (401)
.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..+...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecC
Confidence 999987765 3578999999999999999999999999999999999999765 8999999999766433221 1
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
...++..|+|||.+.. ..++.++|||||||++|||++ |..||. .....+....+.+.. .++++.+++.+
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~- 233 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIESGERMECPQRCPPEMYDLMKL- 233 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-
Confidence 2233467999999865 678899999999999999998 888884 333444444443321 14577777777
Q ss_pred CCCCChhhHHHhhhhc
Q 015741 359 HIELDPHLAALVGRHS 374 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l 374 (401)
|++.||+.||++.++.
T Consensus 234 ~~~~~p~~Rp~~~~i~ 249 (257)
T cd05116 234 CWTYGVDERPGFAVVE 249 (257)
T ss_pred HhccCchhCcCHHHHH
Confidence 8999999999988874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=287.86 Aligned_cols=229 Identities=16% Similarity=0.255 Sum_probs=181.2
Q ss_pred eeecccCCeeEEEEEEcCCCe-------EEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 140 RKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+.||+|+||.||+|.+...+. ++++|.+.... .+.+.+|+.+++.+ +||||+++++++.. ....++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEe--CCCcEEE
Confidence 368999999999998865443 48888875432 25678899999998 99999999999976 3567899
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC-------eEEEEeccccee
Q 015741 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-------KLRLIDWGLAEF 278 (401)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-------~vkl~DFg~a~~ 278 (401)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+||+++.++. .++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999987763 3788888999999999999999999999999999999986653 279999999865
Q ss_pred cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----CChhHHH
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-----GTDELNA 353 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-----~~~~~~~ 353 (401)
.... ....++..|+|||++.+...++.++|||||||++|+|++|..+++...+............ ...++.+
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHH
Confidence 4322 2346778899999998655689999999999999999999655545444443332222111 1245777
Q ss_pred HHHhcCCCCChhhHHHhhhhcC
Q 015741 354 YLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+ |++.||+.||+++++++
T Consensus 235 li~~-~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 235 LINQ-CMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHH-HhccChhhCCCHHHHHH
Confidence 8888 89999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.46 Aligned_cols=235 Identities=17% Similarity=0.316 Sum_probs=185.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC--------------CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD--------------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKL 194 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~--------------~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~ 194 (401)
.++|++.+.||+|+||.||+|++..+ ...||+|.++... ...+.+|+++++++ +|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 46899999999999999999987543 2358999986532 34688999999999 99999999
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCe
Q 015741 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (401)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 259 (401)
++++.. ....++||||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999865 467889999999999876652 256778889999999999999999999999999999
Q ss_pred eEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCC
Q 015741 260 MIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHD 334 (401)
Q Consensus 260 ll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt--g~~Pf~~~~~ 334 (401)
+++.++ .+||+|||++......... ....++..|+|||.+.+ +.++.++|||||||++|+|++ |..||. ...
T Consensus 161 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~ 237 (295)
T cd05097 161 LVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS 237 (295)
T ss_pred EEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence 999665 7999999999765433221 12234567999999876 678999999999999999988 566763 333
Q ss_pred CHHHHHHHHHHh--------------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 335 NYDQLVKIAKVL--------------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 335 ~~~~l~~i~~~~--------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..+.+..+.+.. .++.+.+++.+ |+..||+.||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR-CWSRDIKDRPTFNKIH 290 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHH-HcCCCchhCcCHHHHH
Confidence 333333322211 13567788888 8999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=287.30 Aligned_cols=234 Identities=16% Similarity=0.302 Sum_probs=184.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+++ ++++|.+.... ...+..|+.++.++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 4678999999999999999999877766 47777775322 24567788888888 99999999998743 4
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++||+.+++|..++. .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence 5679999999999987762 478889999999999999999999999999999999998665 89999999998764
Q ss_pred CCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH-h-------CC
Q 015741 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-L-------GT 348 (401)
Q Consensus 281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~-~-------~~ 348 (401)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +..... +..+... . ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRPHE-VPDLLEKGERLAQPQICT 237 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHH-HHHHHHCCCcCCCCCCCC
Confidence 3322 223345667999999876 678999999999999999998 888883 333222 2222221 1 12
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.++..++.+ |+..||..||++.+++.
T Consensus 238 ~~~~~li~~-c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 238 IDVYMVMVK-CWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 355566666 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=288.81 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=188.5
Q ss_pred CCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.-|++++.||+|+||.||+|.. ..++..||+|.++... ...+.+|+++++.+ +||||+++++++.+.....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999974 3568899999986432 35688999999999 9999999999988765567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++|||+++++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++..+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcccccccc
Confidence 899999999999987752 478889999999999999999999999999999999998766 799999999986643
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-------------CHHHHHHHHH
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-------------NYDQLVKIAK 344 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-------------~~~~l~~i~~ 344 (401)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|+++..|+..... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3221 23455667999999876 6788999999999999999998776532111 1111111111
Q ss_pred H-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 345 V-L-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 345 ~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
. . .++.+.+++.+ |++.||..||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRK-CWEFQPSKRTTFQNLIE 278 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHH-HccCCcccCcCHHHHHH
Confidence 0 0 13467777777 89999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.71 Aligned_cols=238 Identities=27% Similarity=0.515 Sum_probs=198.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||+|++|.||++.+..+++.|++|.+.... .+.+.+|++++.++ +|||++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence 4889999999999999999998899999999986443 35688999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-c
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~ 285 (401)
|||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccc
Confidence 99999999987663 589999999999999999999999999999999999999765 899999999987654332 2
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
....++..|+|||...+ ..++.++|||+||+++|+|++|..||.... .......+.... ..+.+.+++.+
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~- 233 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHPPLPEGISPELKDFLMQ- 233 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhccCCCCCCCCCCHHHHHHHHH-
Confidence 34467888999999876 458899999999999999999999985433 333333322111 13567788888
Q ss_pred CCCCChhhHHHhhhhcCCCcc
Q 015741 359 HIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~ 379 (401)
|+..+|+.||++.+++.|||+
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 799999999999999999996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.44 Aligned_cols=242 Identities=23% Similarity=0.375 Sum_probs=194.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+-|...+.||+|+||.||+|++..+++.|++|++.... ...+.+|+++++.+ +|||++++++++.+ ....+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 97 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLK--EHTAW 97 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEE
Confidence 34667788999999999999998899999999986321 24578899999999 89999999999976 46778
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
++|||+.+..+..+. ..+++.++..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.... .
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS---P 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC---C
Confidence 999999765443332 3578889999999999999999999999999999999998766 89999999986432 2
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHHHH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (401)
.....++..|+|||.+.. ...++.++|||||||++|+|++|..||+.. +....+..+..... ...+.++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 234568889999999742 256888999999999999999999998543 33343333332211 2356777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.+ |++.+|..||++.+++.|||+.....
T Consensus 253 i~~-~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 253 VDY-CLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHH-HccCChhhCcCHHHHhcCcccCCCch
Confidence 777 89999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=288.51 Aligned_cols=235 Identities=17% Similarity=0.308 Sum_probs=188.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC----------------eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----------------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIV 192 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv 192 (401)
.++|++++.||+|+||.||+|.+...+ ..||+|.+... ..+.+.+|+++++++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 468999999999999999999876533 56899998643 245688999999999 999999
Q ss_pred EEeeEEEcCCCCCcEEEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCC
Q 015741 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (401)
Q Consensus 193 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 258 (401)
++++++.+ ....+++|||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999865 467899999999999877652 46788899999999999999999999999999999
Q ss_pred eeEeCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc--CCCCCCCCC
Q 015741 259 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH 333 (401)
Q Consensus 259 Ill~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt--g~~Pf~~~~ 333 (401)
|+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~~ 237 (296)
T cd05051 161 CLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-HL 237 (296)
T ss_pred eeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-Cc
Confidence 9999765 899999999976543322 122345667999999876 578999999999999999998 667773 33
Q ss_pred CCHHHHHHHHHHh--------------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 334 DNYDQLVKIAKVL--------------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 334 ~~~~~l~~i~~~~--------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
...+.+....... .++++.+++.+ |+..||..||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE-CWRRDEEDRPTFREIH 291 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHH-HhccChhcCCCHHHHH
Confidence 3444444333220 12467777777 8999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=287.36 Aligned_cols=235 Identities=17% Similarity=0.320 Sum_probs=188.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.+|.+.++||+|+||.||++... .++..+++|.++... ...+.+|+++++.+ +|+||+++++++.+ ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--GRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--CCc
Confidence 57888999999999999999642 346789999886533 35688999999999 99999999999876 456
Q ss_pred cEEEEeecCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 206 PSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+|||++.++ .
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~ 160 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-V 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-C
Confidence 789999999999876652 367888999999999999999999999999999999999665 8
Q ss_pred EEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 015741 268 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~ 343 (401)
+||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+.+..+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY-QLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCc-cCCHHHHHHHHH
Confidence 999999999765432221 12234567999999876 678999999999999999998 888874 333444444443
Q ss_pred HHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 344 KVL-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 344 ~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.. .++.+.+++.+ |+..||..||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~-cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQG-CWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 321 13567777777 89999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=282.78 Aligned_cols=226 Identities=17% Similarity=0.300 Sum_probs=180.0
Q ss_pred eecccCCeeEEEEEEc--CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecC
Q 015741 141 KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
.||+|+||.||+|.+. .++..||+|+++... .+.+.+|+.+++++ +||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999764 445679999986543 35588999999999 99999999998743 46789999999
Q ss_pred CCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc----c
Q 015741 215 NTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 286 (401)
Q Consensus 215 ~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~----~ 286 (401)
+++|..++. .+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence 999987653 478999999999999999999999999999999999998666 8999999999765433221 1
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +....+....+.+.. ..+++.+++.+
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 233 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK-KMKGPEVMSFIEQGKRLDCPAECPPEMYALMKD- 233 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-
Confidence 1122457999999876 678999999999999999996 888884 333333333333221 14677788888
Q ss_pred CCCCChhhHHHhhhhc
Q 015741 359 HIELDPHLAALVGRHS 374 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l 374 (401)
|+..||+.||++.++.
T Consensus 234 c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 234 CWIYKWEDRPNFAKVE 249 (257)
T ss_pred HcCCChhhCcCHHHHH
Confidence 7999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=282.29 Aligned_cols=233 Identities=16% Similarity=0.305 Sum_probs=186.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||++.. .+..+|+|.++... .+.+.+|+.+++++ +|+|++++++++... ....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence 35789999999999999999976 47889999987543 45688999999999 999999999976543 456799999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
|+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--C
Confidence 999999987653 267888999999999999999999999999999999999766 89999999987653222 2
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||. .....+....+.+.. ..+.+.+++.+
T Consensus 158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 234 (256)
T cd05082 158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ- 234 (256)
T ss_pred CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-
Confidence 2334567999999876 678899999999999999997 888884 222222223332221 13567777887
Q ss_pred CCCCChhhHHHhhhhcC
Q 015741 359 HIELDPHLAALVGRHSR 375 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~ 375 (401)
|+..+|..||++.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 89999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=281.93 Aligned_cols=235 Identities=18% Similarity=0.345 Sum_probs=192.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+.. ...+.+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 3578999999999999999999974 567899999874 3457799999999999 89999999999865 4568999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..+.....
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhh
Confidence 99999999987763 478889999999999999999999999999999999999776 899999999987643211
Q ss_pred c--cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 Y--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
. .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.|| .+.+....+..+..... .+.+.++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 11223457999999876 678999999999999999998 88887 45555555555544322 3467777
Q ss_pred HHhcCCCCChhhHHHhhhhc
Q 015741 355 LNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+ |+..+|..||+++++.
T Consensus 237 i~~-~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 237 MLQ-CWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHH-HcccCcccCCCHHHHH
Confidence 777 7999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=291.78 Aligned_cols=237 Identities=21% Similarity=0.336 Sum_probs=186.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|.+.+.||+|+||.||+|.+.. +...+|+|+++... ...+.+|+.+++.+.+||||+++++++.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3789999999999999999998643 23579999987532 24578899999998789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
....++||||+.+++|..++. .++..++..++.|++.||+|||++|++||||||+||+++
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 457889999999999876653 267788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||.+......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+ .+.+.
T Consensus 175 ~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~-~~~~~ 250 (307)
T cd05098 175 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PG-VPVEE 250 (307)
T ss_pred CCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-Cc-CCHHH
Confidence 776 8999999998765422211 11223457999999876 678999999999999999998 77776 33 33343
Q ss_pred HHHHHH-HhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAK-VLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~-~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+..... ... ...+.+++.+ |+..+|..||++.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHH-HcccChhhCcCHHHHHHH
Confidence 333222 211 3466777777 899999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=288.44 Aligned_cols=233 Identities=17% Similarity=0.327 Sum_probs=183.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence 47788999999999999998743 23578999886432 34688999999999 99999999999865 456
Q ss_pred cEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 258 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 789999999999977642 35678889999999999999999999999999999
Q ss_pred eeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCC
Q 015741 259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD 334 (401)
Q Consensus 259 Ill~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~ 334 (401)
||++.++ .+||+|||+++........ ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+..
T Consensus 158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~ 234 (290)
T cd05045 158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA 234 (290)
T ss_pred EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence 9998666 8999999999765433221 22234567999999876 678999999999999999998 88887 3433
Q ss_pred CHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 335 NYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 335 ~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..+....+.+.. ...++.+++.+ |+..+|..||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLT-CWKQEPDKRPTFADIS 280 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHH-HccCCcccCCCHHHHH
Confidence 333333222211 13467777777 8999999999999885
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=289.85 Aligned_cols=238 Identities=18% Similarity=0.304 Sum_probs=187.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|.+.+.||+|+||.||+|.+. .++..||+|.++.. ....+.+|+.+++.+.+||||+++++++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 578999999999999999999752 23457999998642 235688999999998789999999999876
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
....+++|||+.+++|..++. .++...+..++.||+.||.|||++||+||||||+||+++
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 457789999999999877652 256677888999999999999999999999999999998
Q ss_pred CCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||.++........ ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+....+.
T Consensus 172 ~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~ 248 (304)
T cd05101 172 ENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEEL 248 (304)
T ss_pred CCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHH
Confidence 666 8999999999876432221 22234567999999876 678999999999999999998 67776 33333333
Q ss_pred HHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
...+.... ....+.+++.+ |+..+|..||++.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRD-CWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHH-HcccChhhCCCHHHHHHH
Confidence 33332221 13467777777 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=283.51 Aligned_cols=236 Identities=18% Similarity=0.311 Sum_probs=188.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence 357899999999999999999876444 47999988643 235688999999999 99999999999865 457
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++|||+++++|..++. .+++.++..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCccccccc
Confidence 899999999999987753 468888999999999999999999999999999999998766 899999999987643
Q ss_pred CCcc--c--ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 282 GKEY--N--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 282 ~~~~--~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
.... . ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||. +....+....+.+... ++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-EMSNQDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcc-cCCHHHHHHHHhCCCcCCCCCCCCH
Confidence 3221 1 1122456999999876 678999999999999999886 999984 3334444444443322 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |++.+|..||++.++++
T Consensus 237 ~~~~li~~-~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLD-CWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHH-HcccCchhCCCHHHHHH
Confidence 66777777 89999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=298.74 Aligned_cols=239 Identities=21% Similarity=0.317 Sum_probs=188.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|.+.+.||+|+||.||+|++. .+++.||+|+++... ...+.+|+.+|.++..||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3577899999999999999999863 345789999997432 24688999999999449999999999865
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------------------------------------------------
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP----------------------------------------------------------- 223 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 223 (401)
...+++||||+.+|+|.+++.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 457899999999999876542
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE
Q 015741 224 ------------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (401)
Q Consensus 224 ------------------------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 261 (401)
.+++..+..++.||+.||+|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 13455677889999999999999999999999999999
Q ss_pred eCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHH
Q 015741 262 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (401)
Q Consensus 262 ~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~ 337 (401)
+.++ .+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+
T Consensus 273 ~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~-~~~~~~ 349 (401)
T cd05107 273 CEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYP-ELPMNE 349 (401)
T ss_pred eCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCC-CCCchH
Confidence 9655 899999999986532221 122356678999999876 678999999999999999998 888874 333333
Q ss_pred HHHHH-HHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 338 QLVKI-AKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 338 ~l~~i-~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+... .... -+..+.+++.+ |+..+|..||++.++++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~-cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQK-CWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 33332 2211 13567788888 799999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=282.73 Aligned_cols=228 Identities=18% Similarity=0.270 Sum_probs=176.5
Q ss_pred eeecccCCeeEEEEEEcC------------CCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 140 RKVGRGKYSEVFEGVHCT------------DNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
+.||+|+||.||+|.... ....+++|++..... ..+.+|+.++..+ +||||+++++++.+ ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~--~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVR--DV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CC
Confidence 368999999999998532 233688998865433 3678889999998 99999999999875 35
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC------eEEEEecc
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWG 274 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~------~vkl~DFg 274 (401)
..+++|||+++++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++. .++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 6689999999998876652 4788899999999999999999999999999999999975542 38999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH-h-----C
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKV-L-----G 347 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell-tg~~Pf~~~~~~~~~l~~i~~~-~-----~ 347 (401)
++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..|| ......+. ...... . .
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~-~~~~~~~~~~~~~~ 232 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL-KDKTLAEK-ERFYEGQCMLVTPS 232 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCcchhHH-HHHHhcCccCCCCC
Confidence 98654322 23457788999999875567899999999999999998 477666 33322221 111111 1 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+++.+++.+ |++.||..||++.+++++
T Consensus 233 ~~~~~~li~~-cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTH-CMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHH-HcCCChhhCcCHHHHHHh
Confidence 2456677777 899999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.73 Aligned_cols=232 Identities=19% Similarity=0.335 Sum_probs=189.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||.|+||.||+|.. .++.||+|.++... .+++.+|+.+++.+ +|+||+++++++.+ ....+++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence 46789999999999999999986 47899999987543 46788999999999 89999999999875 56788999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence 9999999987753 478899999999999999999999999999999999999766 89999999998663222
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHh
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (401)
.....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. ....+....+.+... ++.+.+++.+
T Consensus 157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 22334557999999876 578889999999999999997 8888843 332222222222211 3567788888
Q ss_pred cCCCCChhhHHHhhhhcC
Q 015741 358 YHIELDPHLAALVGRHSR 375 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~ 375 (401)
|+..+|+.||++.+++.
T Consensus 235 -~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 -CWELDPAKRPTFKQLRE 251 (256)
T ss_pred -HhccChhhCcCHHHHHH
Confidence 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.74 Aligned_cols=235 Identities=18% Similarity=0.329 Sum_probs=187.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..|++.+.||+|+||.||+|.+..+++ .||+|+++.. ....+..|+.+++.+ +||||+++++++.+ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCce
Confidence 468999999999999999999876654 6999998643 235788999999999 99999999999865 5677
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++|||+.+++|..++. .+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccC
Confidence 89999999999987653 378889999999999999999999999999999999998665 8999999998765432
Q ss_pred Ccc---ccccc---CCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 015741 283 KEY---NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (401)
Q Consensus 283 ~~~---~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~ 348 (401)
... ....+ +..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .+..+....+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~ 237 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYRLPPPMDCP 237 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcCCCcccCC
Confidence 211 11111 346999999876 678999999999999999886 9989843 333444444432211 2
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~~~~li~~-~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 238 TALHQLMLD-CWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 356667777 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=288.10 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=193.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..|+..+.||+|+||.||+|++..++..+|+|.+... ....+.+|+++++++ +|||++++++++.+ ....+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLR--EHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCeEE
Confidence 4578889999999999999999889999999998632 124688899999999 89999999999876 45678
Q ss_pred EEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+..+... ...+++.++..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||++......
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASPA-- 178 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCCc--
Confidence 99999986433322 23578899999999999999999999999999999999998766 8999999998754322
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHHHH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (401)
....++..|+|||.+.. .+.++.++|||||||++|+|++|+.||... +....+..+.+... .+.+.++
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 33467888999999742 246888999999999999999999998543 33333333333211 2356777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |++.+|..||++.++++|+|....
T Consensus 257 i~~-~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 257 VDS-CLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHH-HccCCcccCcCHHHHHhChhhhcc
Confidence 777 899999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.77 Aligned_cols=237 Identities=20% Similarity=0.364 Sum_probs=190.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..++|++.+.||+|+||.||+|.+.. ++..|++|+++... .+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence 35789999999999999999999865 36889999886432 35578999999999 999999999987654 4
Q ss_pred CCcEEEEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEe
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~D 272 (401)
...++++||+.+++|..++. .+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d 160 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITD 160 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECC
Confidence 56789999999999877652 367888999999999999999999999999999999998665 899999
Q ss_pred cccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-
Q 015741 273 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG- 347 (401)
Q Consensus 273 Fg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~- 347 (401)
||+++.+...... ....++..|+|||++.+ ..++.++|||||||++|++++ |+.||. ..+..+....+.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV-EIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC-cCCHHHHHHHHHcCCCC
Confidence 9999866433221 12234567999999876 678999999999999999998 998884 3333333333332211
Q ss_pred ------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 ------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 ------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
++.+.+++.+ |+..||+.||++.+++
T Consensus 239 ~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 239 AQPINCPDELFAVMAC-CWALDPEERPSFSQLV 270 (280)
T ss_pred CCCCcCCHHHHHHHHH-HcCCChhhCCCHHHHH
Confidence 3467777777 8999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=287.73 Aligned_cols=235 Identities=18% Similarity=0.326 Sum_probs=183.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv 192 (401)
.++|++.+.||+|+||.||++.+.. ++..+|+|+++... ...+.+|+++++.+ +|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 4679999999999999999985432 34578999987432 35688999999999 999999
Q ss_pred EEeeEEEcCCCCCcEEEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCC
Q 015741 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (401)
Q Consensus 193 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 258 (401)
++++++.+ ....+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999866 456799999999999977653 24566789999999999999999999999999999
Q ss_pred eeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc--CCCCCCCCC
Q 015741 259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH 333 (401)
Q Consensus 259 Ill~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt--g~~Pf~~~~ 333 (401)
||++.++ .++|+|||++..+...... ....++..|++||...+ +.++.++|||||||++|||++ |..||.. .
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~-~ 237 (296)
T cd05095 161 CLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ-L 237 (296)
T ss_pred EEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc-c
Confidence 9998665 8999999999765433211 12233567999998776 678999999999999999998 6778743 3
Q ss_pred CCHHHHHHHHHH--------------hCChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 334 DNYDQLVKIAKV--------------LGTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 334 ~~~~~l~~i~~~--------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
...+.+....+. ...+.+.+++.+ |++.||..||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS-CWRRNAKERPSFQEIH 291 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHH
Confidence 333322222111 012456677777 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.68 Aligned_cols=236 Identities=22% Similarity=0.434 Sum_probs=195.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|++.+.||.|+||.||++.+..+++.+++|.+... ....+.+|+++++.+ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD--GNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc--CCEEEEE
Confidence 488999999999999999999889999999998642 234677899999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|||+.+++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 9999999987765 2478888999999999999999999999999999999999765 8999999999776544
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (401)
......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||. ..+..+....+.... ...++.+++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence 3334567889999999876 678889999999999999999999984 333333222222211 124567777
Q ss_pred HhcCCCCChhhHHHhhhhcCCCc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
.+ |+..+|..||++.++++||.
T Consensus 234 ~~-~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 234 RS-MLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred HH-HcCCCcccCCCHHHHhcCCC
Confidence 77 89999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=284.32 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=195.1
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
+|++.+.||+|++|.||++.+. .+++.||+|+++.. ..+.+.+|++++.++.+||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4789999999999999999864 45788999998632 224578899999999779999999998865 46
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|...+ ..+++..++.++.|++.+|.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence 788999999999987665 3478889999999999999999999999999999999999766 899999999876543
Q ss_pred CCc--ccccccCCCccccccccCCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCC--HHHHH-HHHHHh------CCh
Q 015741 282 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLV-KIAKVL------GTD 349 (401)
Q Consensus 282 ~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~--~~~l~-~i~~~~------~~~ 349 (401)
... .....++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...... ...+. .+.... -.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 12245788899999986522 3678999999999999999999998432211 11111 111111 135
Q ss_pred hHHHHHHhcCCCCChhhHHH---hhhhcCCCcccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITVE 385 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~~ 385 (401)
.+.+++.+ |+..||+.|++ +.++++|||++.+..+
T Consensus 238 ~l~~li~~-~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 238 EARDFIQK-LLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred HHHHHHHH-HhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 67888888 89999999998 5678999999887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=286.34 Aligned_cols=236 Identities=19% Similarity=0.300 Sum_probs=187.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... ...+.+|+.+++++ +||||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 35789999999999999999998743 57899999986432 35688899999999 99999999999865
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 257 (401)
....+++|||+.+++|..++. .+++..+..++.|++.||+|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 456799999999999877653 2567788999999999999999999999999999
Q ss_pred CeeEeCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 015741 258 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 333 (401)
Q Consensus 258 NIll~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~ 333 (401)
||+++.++ .++|+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||+. .
T Consensus 160 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~-~ 236 (288)
T cd05050 160 NCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYG-M 236 (288)
T ss_pred heEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Confidence 99998766 899999999876533221 112233456999999876 678999999999999999997 7778843 3
Q ss_pred CCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 334 DNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 334 ~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
...+....+.+.. -...+.+++.+ |++.||..||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRL-CWSKLPSDRPSFASIN 283 (288)
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HcccCcccCCCHHHHH
Confidence 3333333332221 13467777877 8999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.27 Aligned_cols=141 Identities=28% Similarity=0.509 Sum_probs=126.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|.++++||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.+ +||||+++++++.. ..++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence 368999999999999999999998899999999986432 25688899999998 99999999998865 4678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
|+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 99999999999987763 578889999999999999999999999999999999999766 89999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=281.73 Aligned_cols=235 Identities=22% Similarity=0.396 Sum_probs=188.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|.+.+.||+|+||.||+|.+... ...|++|..... ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---CC
Confidence 46789999999999999999987544 357899987643 235688999999999 89999999999864 34
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence 679999999999987763 378889999999999999999999999999999999999766 899999999987644
Q ss_pred CCccc--ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 282 GKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 282 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
..... ...++..|+|||.+.. ..++.++||||||+++|+|++ |..||. +....+.+..+.+... ++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 32221 1223457999999865 678999999999999999986 998984 4444444444433211 3567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~li~~-~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 238 YSLMTK-CWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHH-HcCCChhhCcCHHHHHH
Confidence 777777 89999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.71 Aligned_cols=236 Identities=18% Similarity=0.324 Sum_probs=188.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|+..+.||+|+||.||+|.+..++. .+++|.++.. ..+.+.+|+++++++ +||||+++++++.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CCC
Confidence 4578899999999999999999875554 7899998643 235688999999999 99999999999965 457
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceeccc
Confidence 889999999999977752 478889999999999999999999999999999999999766 899999999976643
Q ss_pred CCcc--cc--cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 282 GKEY--NV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 282 ~~~~--~~--~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
.... .. ...+..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .+..+....+.+... ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCCCCCCCCCH
Confidence 2211 11 112346999999876 678999999999999999997 9999843 333444444433222 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..+|..||++.++++
T Consensus 238 ~~~~li~~-c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQ-CWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 56677777 78999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.47 Aligned_cols=233 Identities=16% Similarity=0.303 Sum_probs=187.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||++.+ ..+..+++|.+.... .+.+.+|+++++.+ +|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEEE
Confidence 47899999999999999999986 456679999886533 35788999999999 89999999999865 4678999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence 9999999987763 357778889999999999999999999999999999998766 8999999999766433221
Q ss_pred --cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 286 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
....++..|+|||++.. ..++.++|+|||||++|+|++ |..|| .+.+..+....+..... ...+.+++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 12234556999999876 678999999999999999998 88887 44444444444433321 34677778
Q ss_pred HhcCCCCChhhHHHhhhhc
Q 015741 356 NKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l 374 (401)
.+ |+..+|..||++.+++
T Consensus 237 ~~-~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 237 MR-CWKNRPEERPTFEYIQ 254 (260)
T ss_pred HH-HcccCcccCcCHHHHH
Confidence 77 8999999999988765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=279.11 Aligned_cols=230 Identities=23% Similarity=0.403 Sum_probs=188.9
Q ss_pred eeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||.||+|.+... +..+++|+++... .+.+.+|+++++.+ +|+||+++++++.+ ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999998765 8999999987533 46788999999999 79999999999876 5678999999
Q ss_pred cCCCchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 213 VNNTDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 213 ~~~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+.+++|..++ ..+++.+++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccc
Confidence 9999987665 3468999999999999999999999999999999999999766 89999999998765
Q ss_pred CCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 281 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 281 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..|| ......+....+.+.. .++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPY-PGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 432 1233456778999999876 578999999999999999999 57777 3444444444443221 135
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+++.+ |+..+|..||++.+++.+
T Consensus 235 ~~~~li~~-~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLS-CWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHH-HccCCcccCcCHHHHHHh
Confidence 67777777 899999999999998754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.32 Aligned_cols=238 Identities=18% Similarity=0.296 Sum_probs=187.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-------CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
..+|++.+.||+|+||.||+|.+... +..||+|+++.. ..+.+.+|+++++++.+||||+++++++.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 35799999999999999999986432 246899988642 235688999999998789999999999865
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
...++++|||+.+++|..++. .++...+..++.|++.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 457899999999999877652 256677888999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.
T Consensus 169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~ 245 (334)
T cd05100 169 EDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEEL 245 (334)
T ss_pred CCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHH
Confidence 766 8999999999866432211 11223456999999876 678999999999999999998 77777 34333333
Q ss_pred HHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
...+..... ...+.+++.+ |+..+|..||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRE-CWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHH-HcccChhhCcCHHHHHHH
Confidence 333322211 3366677777 899999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=279.17 Aligned_cols=227 Identities=18% Similarity=0.316 Sum_probs=180.9
Q ss_pred eeecccCCeeEEEEEEcCCC---eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
++||+|+||.||+|.+...+ ..+|+|.+.... .+.+.+|+++++.+ +||||+++++++.. ...+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876554 789999987433 35688999999999 99999999998753 356899999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc---
Q 015741 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN--- 286 (401)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~--- 286 (401)
+.+++|..++. .+++..+..++.|++.||+|||+++++||||||+|||++.++ .+||+|||+++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence 99999987763 488999999999999999999999999999999999999766 89999999998764433221
Q ss_pred -ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHh
Q 015741 287 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNK 357 (401)
Q Consensus 287 -~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+.... .++.+.+++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112346999999876 678999999999999999998 888874 333333333332221 13466777887
Q ss_pred cCCCCChhhHHHhhhhc
Q 015741 358 YHIELDPHLAALVGRHS 374 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l 374 (401)
|+..||..||++.+++
T Consensus 234 -cl~~~p~~Rp~~~~l~ 249 (257)
T cd05060 234 -CWKYRPEDRPTFSELE 249 (257)
T ss_pred -HhcCChhhCcCHHHHH
Confidence 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.54 Aligned_cols=234 Identities=19% Similarity=0.311 Sum_probs=187.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+++ .+|+|.++... ...+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---C
Confidence 4678999999999999999999876654 68999886432 35688999999999 99999999999865 5
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+++|||+.+++|...+. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||.++...
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence 6789999999999887653 478999999999999999999999999999999999998666 89999999998765
Q ss_pred CCCcccc---cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 281 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 281 ~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
....... ..++..|+|||.+.. ..++.++|+||||+++||+++ |..||. +....+....+.+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 3332211 122456999999865 678899999999999999998 998883 333333333332221 124
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
++.+++.+ |+..||..||++.+++
T Consensus 239 ~~~~~~~~-~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 239 DVYMVLVK-CWMIDAESRPTFKELI 262 (279)
T ss_pred HHHHHHHH-HcCCChhhCCCHHHHH
Confidence 56677777 8999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=281.55 Aligned_cols=237 Identities=24% Similarity=0.447 Sum_probs=190.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
+|.+.+.||+|+||.||++.+...+..+++|+++.. ....+..|+.+++.+ +||||+++++++.+ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLE--RDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhc--CCce
Confidence 588999999999999999998877777777776532 223567789999999 99999999999865 4567
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+++|||+.+++|...+ ..+++..++.++.|++.||.|||++|++|+||||+||+++. + .++|+|||.+...
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeec
Confidence 8999999999987654 34788999999999999999999999999999999999974 4 6999999999776
Q ss_pred CCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhH
Q 015741 280 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDEL 351 (401)
Q Consensus 280 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~ 351 (401)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. ..........+.... ...++
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRIVEGPTPSLPETYSRQL 233 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHcCCCCCCcchhcHHH
Confidence 43322 234457788999999865 678889999999999999999999984 333333333332211 13466
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.+++.+ |+..||+.||++.++++|||+
T Consensus 234 ~~li~~-~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQS-MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHH-HhcCChhhCcCHHHHhhCCCC
Confidence 677777 799999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=282.76 Aligned_cols=232 Identities=24% Similarity=0.432 Sum_probs=180.1
Q ss_pred EEEeeecccCCeeEEEEEEc----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 137 EVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++.+.||.|.||.||+|... ..+..|+||+++.. ..+.+.+|++.++++ +||||+++++++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence 46789999999999999987 44678999999643 246789999999999 99999999999984 455889
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+|+|.+++ ..+++..+..++.||+.||.|||+++++|+||+++||+++.++ .+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999997664 2578899999999999999999999999999999999999766 99999999998763222
Q ss_pred cc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHH
Q 015741 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (401)
Q Consensus 284 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (401)
.. ........|+|||.+.+ ..++.++||||||+++|||++ |+.|| ...+..+....+.+... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccc-cccccccccccccccccceeccchhHHHH
Confidence 21 22345567999999876 568999999999999999999 66777 44455554455433321 33566
Q ss_pred HHHHhcCCCCChhhHHHhhhhcC
Q 015741 353 AYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+++.+ |+..||+.||++.++++
T Consensus 236 ~li~~-C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQ-CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHH-HT-SSGGGS--HHHHHH
T ss_pred HHHHH-HcCCChhhCcCHHHHHh
Confidence 66666 89999999999999863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=277.78 Aligned_cols=232 Identities=22% Similarity=0.377 Sum_probs=189.1
Q ss_pred EEEeeecccCCeeEEEEEEcCCC----eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++.+.||.|+||.||+|.+...+ ..+|+|+++... .+.+..|+.+++.+ +|+||+++++++.+. ...++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence 46789999999999999997766 899999997543 45788999999999 999999999999763 67889
Q ss_pred EEeecCCCchhhhcC---C--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLYP---T--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~--~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|||+.+++|..++. . +++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceeccccc
Confidence 999999999877653 2 88999999999999999999999999999999999999766 89999999998765442
Q ss_pred cccc--cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHH
Q 015741 284 EYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNA 353 (401)
Q Consensus 284 ~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~ 353 (401)
.... ..++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| ...+..+....+.+.. .+..+.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 2221 235678999999865 678999999999999999998 66666 4444444444433321 1456677
Q ss_pred HHHhcCCCCChhhHHHhhhhcC
Q 015741 354 YLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+ |+..||+.||++.++++
T Consensus 236 ~i~~-~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQ-CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHH-HCcCChhhCcCHHHHHh
Confidence 7777 89999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=282.03 Aligned_cols=228 Identities=14% Similarity=0.207 Sum_probs=177.0
Q ss_pred eecccCCeeEEEEEEcCC------------------------CeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeE
Q 015741 141 KVGRGKYSEVFEGVHCTD------------------------NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVK 193 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~------------------------~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~ 193 (401)
.||+|+||.||+|....+ ...|++|++.... ...+.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 599999999999975321 2468899886533 24577889999998 9999999
Q ss_pred EeeEEEcCCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC----
Q 015741 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---- 265 (401)
Q Consensus 194 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---- 265 (401)
+++++.+ ....++||||+++++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999976 456789999999999877652 478889999999999999999999999999999999997532
Q ss_pred --CeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHH-cCCCCCCCCCCCHHHHHHH
Q 015741 266 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 266 --~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell-tg~~Pf~~~~~~~~~l~~i 342 (401)
..+|++|||.+...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.. ....+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~ 234 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEKERFY 234 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc-cChHHHHHHH
Confidence 24899999988644222 22456778999999876567899999999999999995 68888743 3332222222
Q ss_pred HHHhC-----ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 343 AKVLG-----TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 343 ~~~~~-----~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+... .+.+.+++.+ |+..+|+.||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQ-CLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHH-HcccChhhCcCHHHHHHh
Confidence 22111 2457777887 899999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=276.42 Aligned_cols=235 Identities=17% Similarity=0.338 Sum_probs=188.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..+|++.+.||+|+||.||+|.+. ++..+|+|+++.. ....+.+|+++++++ +|||++++++++.+ ....+++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEE
Confidence 357899999999999999999874 4678999988643 346789999999999 99999999999865 45778999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc-
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~- 285 (401)
||+.+++|..++. .+++..++.++.|++.||+|||+++++|+||||+||+++.++ .++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCcccc
Confidence 9999999877652 378888999999999999999999999999999999998655 8999999998765332211
Q ss_pred -cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH-------hCChhHHHHHH
Q 015741 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLN 356 (401)
Q Consensus 286 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~ 356 (401)
....++..|+|||.+.+ +.++.++||||||+++|+|++ |..||. .....+.+..+.+. ..+..+.+++.
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 12234457999999876 678899999999999999998 888873 33333334333322 12456677777
Q ss_pred hcCCCCChhhHHHhhhhcC
Q 015741 357 KYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~ 375 (401)
+ |+..+|+.||++.++++
T Consensus 236 ~-~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 236 H-CWKERPEDRPSFSLLLH 253 (256)
T ss_pred H-HcccChhhCCCHHHHHH
Confidence 7 79999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=281.72 Aligned_cols=237 Identities=18% Similarity=0.349 Sum_probs=188.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|+.+. +.+.+++|.+.... .+.+.+|+++++++ +|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence 4678999999999999999999653 34679999886533 25689999999999 99999999999865 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
...++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEc
Confidence 57799999999999987652 478899999999999999999999999999999999999776 89999
Q ss_pred ecccceecCCCC--cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh--
Q 015741 272 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-- 346 (401)
Q Consensus 272 DFg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-- 346 (401)
|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ...+.+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQAGKLE 237 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHcCCcC
Confidence 999986543221 1223355667999999876 568889999999999999998 777873 333333333332111
Q ss_pred ------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 ------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
..+.+.+++.+ |+..+|..||++.+++..
T Consensus 238 ~~~~~~~~~~l~~~i~~-~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 LPVPEGCPSRLYKLMTR-CWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHHHH
Confidence 13466777777 899999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=278.31 Aligned_cols=231 Identities=20% Similarity=0.347 Sum_probs=180.1
Q ss_pred eeecccCCeeEEEEEEcC---CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|+||.||+|.+.. .+..+|+|.+... ..+.+.+|+.+++.+ +||||+++++++... ....+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 3467999988532 235678899999998 999999999977543 3457899999
Q ss_pred cCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc----
Q 015741 213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---- 284 (401)
Q Consensus 213 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~---- 284 (401)
+.+++|..++. ...+..+..++.|++.||+|||+.+++||||||+|||++.++ .+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence 99999987763 356677888999999999999999999999999999999766 899999999975532211
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.|++...+..+....+.... .++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 112234567999999876 6789999999999999999997666555555444433332211 1345677777
Q ss_pred hcCCCCChhhHHHhhhhcC
Q 015741 357 KYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~ 375 (401)
+ |+..+|+.||++.+++.
T Consensus 237 ~-cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 237 S-CWHPKPEMRPTFSELVS 254 (262)
T ss_pred H-HcCCChhhCCCHHHHHH
Confidence 7 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=281.15 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=204.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++.+-+..||.|+||+|++..++.+|+..|||.++.. ..+++..|.+...+-.+.||||++||..-. +...++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeee
Confidence 4455668899999999999999999999999998642 346788898887777789999999997644 3445789
Q ss_pred EeecCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 210 FEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 210 ~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
||.|.- ++..++ ..++|.-+-.+..-.+.||+||-. ..|||||+||+|||++..| .|||||||++..+.
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 998874 333332 358888888888889999999986 4899999999999999777 89999999998887
Q ss_pred CCCcccccccCCCccccccccCCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------------C
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------------G 347 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------------~ 347 (401)
..-..+.-.|...|||||.+.... .|+.++||||||++|||+.||..||....+-.+|+..+...- -
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 666677788999999999996544 499999999999999999999999966666666666654431 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQH 388 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~ 388 (401)
+.++..|+.- |+..|...||.-.+++.+|+.+....+...
T Consensus 300 s~~~~~fint-Cl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 300 SFSMVRFINT-CLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred CHHHHHHHHH-HhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 3466777776 899999999999999999999987765543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=286.82 Aligned_cols=239 Identities=23% Similarity=0.380 Sum_probs=192.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.|+..+.||.|+||.||+|++..+++.+|+|.+... ...++.+|+++++.+ +|+|++++++++.+ ....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 90 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA 90 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCee
Confidence 45688889999999999999999889999999987532 124577899999999 99999999999876 4577
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++||||+.+ ++...+ ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++......
T Consensus 91 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 91 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc
Confidence 899999985 443332 3478899999999999999999999999999999999998766 8999999998765432
Q ss_pred CcccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHH
Q 015741 283 KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELN 352 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~ 352 (401)
....++..|+|||.+.+ ...++.++|||||||++|+|++|..||... +..+.+..+.+.. -+..+.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc-cHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 23467888999999752 245788999999999999999999998543 2333333333221 123566
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.+ |+..+|..||++++++.|+|+..
T Consensus 245 ~li~~-cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 245 NFVDS-CLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHH-HhhCCcccCCCHHHHhhCccccc
Confidence 77777 89999999999999999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.71 Aligned_cols=239 Identities=21% Similarity=0.362 Sum_probs=190.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.+.|++.+.||+|+||.||+|... .+++.+|+|+++... .+.+.+|+++++.+ +|+||+++++++.+....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence 356888899999999999999864 347899999987543 35789999999999 999999999998776667
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+++|||+++++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccccccc
Confidence 8899999999999987763 378889999999999999999999999999999999999776 89999999998765
Q ss_pred CCCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH-------------HHHHHHH
Q 015741 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY-------------DQLVKIA 343 (401)
Q Consensus 281 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~-------------~~l~~i~ 343 (401)
..... ....++..|++||.+.+ ..++.++||||||+++|+|++|..|+....... ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 33221 12234456999999876 578899999999999999999999985432221 1111111
Q ss_pred HHh--------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 344 KVL--------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 344 ~~~--------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.. ....+.+++.+ |+..+|..||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKL-CWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHH-HhccChhhCCCHHHHHH
Confidence 111 12356676777 89999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.88 Aligned_cols=247 Identities=18% Similarity=0.240 Sum_probs=172.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC----CeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEE----cCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----DQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~----~~~~ 203 (401)
..++|++.+.||+|+||.||+|++..+ +..||+|.++.........+.. +... .+.+++.++..+. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhh-chhhHHHHHHhhhcccccccC
Confidence 468999999999999999999999888 8999999886533222211111 1221 2223332222111 1234
Q ss_pred CCcEEEEeecCCCchhhhcCCC-----------------------CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCee
Q 015741 204 KTPSLIFEHVNNTDFKVLYPTL-----------------------SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~-----------------------~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 260 (401)
...++||||+.+++|..++... .+..+..++.||+.||+|||++||+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 5788999999999987665311 12345678999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccceecCCCC--cccccccCCCccccccccCCC---------------------CCCcccchHHHHH
Q 015741 261 IDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDLWSLGC 317 (401)
Q Consensus 261 l~~~~~~vkl~DFg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwSlG~ 317 (401)
++.+...+||+|||+++.+.... ......+++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 98655589999999998654332 224567889999999763211 2345679999999
Q ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------------Chh--------------HHHHHHhcCCCCChhhHHH
Q 015741 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------TDE--------------LNAYLNKYHIELDPHLAAL 369 (401)
Q Consensus 318 ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------~~~--------------~~~~l~~~~l~~dP~~R~~ 369 (401)
+||||+++..|+ .++..++..+.+..+ .++ ..+++.+ ||+.||++|++
T Consensus 368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~-mL~~dP~kR~t 443 (566)
T PLN03225 368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS-MMRFKGRQRIS 443 (566)
T ss_pred HHHHHHhCcCCC---chHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH-HccCCcccCCC
Confidence 999999876554 222222222211111 111 1256766 89999999999
Q ss_pred hhhhcCCCccccccc
Q 015741 370 VGRHSRKPWSKFITV 384 (401)
Q Consensus 370 ~~~~l~~~~~~~~~~ 384 (401)
+.++|+|||+.....
T Consensus 444 a~e~L~Hpff~~~~~ 458 (566)
T PLN03225 444 AKAALAHPYFDREGL 458 (566)
T ss_pred HHHHhCCcCcCCCCc
Confidence 999999999987443
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=274.89 Aligned_cols=228 Identities=21% Similarity=0.373 Sum_probs=181.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
+.||+|+||.||+|.. .++..+|+|+++... ...+.+|+++++.+ +||||+++++++.+ ....+++|||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999986 578899999986432 24588999999999 99999999999875 4568899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc--cccc
Q 015741 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRV 289 (401)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~--~~~~ 289 (401)
++|..++. .+.+..+..++.|++.+|.|||++|++||||||+||+++.++ .+||+|||++......... ....
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence 99887653 367888999999999999999999999999999999998666 8999999999765332211 1123
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHhcCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHIE 361 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~ 361 (401)
++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.........+.+... ...+.+++.+ |+.
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 232 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR-CWD 232 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-Hcc
Confidence 3456999999876 678899999999999999998 888884 3333333333332211 3567777777 799
Q ss_pred CChhhHHHhhhhcC
Q 015741 362 LDPHLAALVGRHSR 375 (401)
Q Consensus 362 ~dP~~R~~~~~~l~ 375 (401)
.+|+.||++.+++.
T Consensus 233 ~~p~~Rp~~~~l~~ 246 (250)
T cd05085 233 YKPENRPKFSELQK 246 (250)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999998853
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=284.00 Aligned_cols=236 Identities=16% Similarity=0.288 Sum_probs=186.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..++|++.+.||+|+||.||+|.+..+++ .+|+|.+.... ...+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS--- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC---
Confidence 35788999999999999999999877775 57888876432 23578899999999 99999999998864
Q ss_pred CCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...++++||+.+|+|...+. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL 159 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccc
Confidence 24578999999999877653 478888999999999999999999999999999999998666 7999999999866
Q ss_pred CCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC--------
Q 015741 280 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------- 347 (401)
Q Consensus 280 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------- 347 (401)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.. . ....+..+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~-~-~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDG-I-PTREIPDLLEKGERLPQPPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCC-C-CHHHHHHHHHCCCCCCCCCCC
Confidence 43322 122334567999999876 678999999999999999997 8888832 2 2333333332211
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
..++.+++.+ |+..+|+.||++.+++..
T Consensus 237 ~~~~~~li~~-c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVK-CWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 2356677777 799999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=276.16 Aligned_cols=230 Identities=16% Similarity=0.316 Sum_probs=184.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
++|++.+.||+|+||.||++.. +++.+|+|+++.. ....+.+|+.+++++ +|||++++++++.. ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEEC
Confidence 5799999999999999999864 7888999998643 346788999999999 99999999999864 346899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccc
Q 015741 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
+.+++|..++. .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CCC
Confidence 99999977653 367888899999999999999999999999999999998766 8999999999764322 122
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHhcC
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYH 359 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~ 359 (401)
...+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||. ..+..+....+.+... ++.+.+++.+ |
T Consensus 157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 233 (254)
T cd05083 157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS-C 233 (254)
T ss_pred CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH-H
Confidence 234567999999876 678999999999999999997 888873 3333333333332221 2456677777 8
Q ss_pred CCCChhhHHHhhhhcC
Q 015741 360 IELDPHLAALVGRHSR 375 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~ 375 (401)
+..+|..||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=275.41 Aligned_cols=231 Identities=26% Similarity=0.428 Sum_probs=191.5
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
||.|+||.||++.+..+++.+++|++... ....+..|+.+++.+ +||||+++++.+.+ ...++++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 69999999999999888999999998643 234688999999999 89999999999865 5678999999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-CcccccccC
Q 015741 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (401)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~~~~t 291 (401)
++|...+. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence 99877653 478999999999999999999999999999999999999766 8999999999776443 233445678
Q ss_pred CCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHhcCCCCChh
Q 015741 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELDPH 365 (401)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~dP~ 365 (401)
..|++||...+ ...+.++|+||||+++|+|++|..||.. .+..+....+... ..+..+.+++.+ |+..||+
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~-~l~~~p~ 233 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLRFPEFLSPEARDLISG-LLQKDPT 233 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HhcCCHh
Confidence 88999999876 5678899999999999999999999943 3333323333221 114567788888 8999999
Q ss_pred hHHHh---hhhcCCCcc
Q 015741 366 LAALV---GRHSRKPWS 379 (401)
Q Consensus 366 ~R~~~---~~~l~~~~~ 379 (401)
.|+++ ++++.|||+
T Consensus 234 ~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hCCCcccHHHHHhCCCC
Confidence 99999 999999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.19 Aligned_cols=240 Identities=24% Similarity=0.404 Sum_probs=189.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEc--------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD-------- 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~-------- 200 (401)
..+|+.++.||+||||.||+++.+-+|+.||||.+.-. ...++.+|+..|.+| +|||||++|..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence 35788899999999999999999999999999987532 335689999999999 99999999852211
Q ss_pred -----------------------------------------------C---------------------C----------
Q 015741 201 -----------------------------------------------Q---------------------Q---------- 202 (401)
Q Consensus 201 -----------------------------------------------~---------------------~---------- 202 (401)
. +
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred -----------------------C--------CCcEEEEeecCCCchhhhcCC--C--CHHHHHHHHHHHHHHHHHHHhC
Q 015741 203 -----------------------S--------KTPSLIFEHVNNTDFKVLYPT--L--SDYDVRYYIYELLKALDYCHSQ 247 (401)
Q Consensus 203 -----------------------~--------~~~~lv~e~~~~~~l~~~~~~--~--~~~~~~~i~~qi~~~L~~LH~~ 247 (401)
. .++||-||||+..++.+++.. + ....++.+++||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 346889999999998887742 3 3667899999999999999999
Q ss_pred CceeecCCCCCeeEeCCCCeEEEEecccceecC-------------------CCCcccccccCCCccccccccCCC--CC
Q 015741 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY 306 (401)
Q Consensus 248 ~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~ 306 (401)
|||||||||.||+++.++ .|||+|||+|.... .....+..+||..|+|||++.+.. .|
T Consensus 717 giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999666 89999999997521 112346678999999999998755 69
Q ss_pred CcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----C---------hhHHHHHHhcCCCCChhhHHHhhhh
Q 015741 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----T---------DELNAYLNKYHIELDPHLAALVGRH 373 (401)
Q Consensus 307 ~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----~---------~~~~~~l~~~~l~~dP~~R~~~~~~ 373 (401)
+.|+|+||||+|++||+. ||. +.++....+...-. . +.... +.+.|++.||.+||++.++
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~---TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~s-lI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFG---TSMERASILTNLRKGSIPEPADFFDPEHPEEAS-LIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCC---chHHHHHHHHhcccCCCCCCcccccccchHHHH-HHHHHhcCCCccCCCHHHH
Confidence 999999999999999985 663 34444443332211 1 11223 3344899999999999999
Q ss_pred cCCCcccc
Q 015741 374 SRKPWSKF 381 (401)
Q Consensus 374 l~~~~~~~ 381 (401)
|.+.|+..
T Consensus 869 L~s~llpp 876 (1351)
T KOG1035|consen 869 LNSELLPP 876 (1351)
T ss_pred hhccCCCc
Confidence 99999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=283.05 Aligned_cols=239 Identities=17% Similarity=0.219 Sum_probs=172.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccch----H----------HHHHHHHHHHHhcCCCCeeEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK----K----------KIKREIKILQNLCGGPNIVKLL 195 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~~----~----------~~~~E~~il~~l~~hpniv~~~ 195 (401)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+...... + ....+...+..+ .|+++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEE
Confidence 46899999999999999999998777 66778886432211 0 111222334445 799999999
Q ss_pred eEEEcCCC--CCcEEEEeecCCCc--hhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 196 DIVRDQQS--KTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 196 ~~~~~~~~--~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
+....... .+.++++|++.... +.......++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEE
Confidence 87654322 24467777765432 222223467888899999999999999999999999999999998666 79999
Q ss_pred ecccceecCCCC--------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH---
Q 015741 272 DWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV--- 340 (401)
Q Consensus 272 DFg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~--- 340 (401)
|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+...
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999997663221 1123468999999999876 6799999999999999999999999954433332221
Q ss_pred -----HHHHH-----hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 341 -----KIAKV-----LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 341 -----~i~~~-----~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+. ...+.+.+++.. |+.++|+.||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIEC-VTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHH-HHhCCCCCCCCHHHHHH
Confidence 11111 113345566666 78999999999888753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=272.48 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=201.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|.+++.||+|+|++|.+++++.+.+.||+|++++. ..+-.+.|-.+..+..+||.+|-+...|.. +..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 47899999999999999999999999999999998753 234467788888888899999999999954 6789
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee-cCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~-~~~~ 282 (401)
++|.||++||+|...+ ++++++.++.+..+|+.||.|||++|||.||||.+|+|+|.++ .+||.|+|+++. +.++
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC
Confidence 9999999999986544 4699999999999999999999999999999999999999888 899999999975 3566
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC------CCCHHHHHH-HHHH-hC---C--h
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG------HDNYDQLVK-IAKV-LG---T--D 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~------~~~~~~l~~-i~~~-~~---~--~ 349 (401)
....+.+||+.|.|||++.+ ..|++.+|+|+|||+++||+.|+.||..- .+..+.+.+ |.+. .. + -
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 77788999999999999988 79999999999999999999999999521 112222222 2221 11 1 1
Q ss_pred hHHHHHHhcCCCCChhhHHH------hhhhcCCCcccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAAL------VGRHSRKPWSKFITVE 385 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~------~~~~l~~~~~~~~~~~ 385 (401)
.....+.. .|..||..|.- ..++-.|+|+..+..+
T Consensus 485 kas~vlkg-flnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 485 KASHVLKG-FLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred hhHHHHHH-hhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 11222333 57789999864 5688899999877643
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=275.52 Aligned_cols=228 Identities=19% Similarity=0.289 Sum_probs=182.6
Q ss_pred eeecccCCeeEEEEEEcC-CC--eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 140 RKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~-~~--~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
+.||+|++|.||+|.+.. ++ ..+|+|.+.... .+.+.+|+.+++++ +||||+++++++.+ ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 33 368999987543 35688999999999 99999999999865 677899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---
Q 015741 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 284 (401)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~--- 284 (401)
+.+++|...+. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 99999877652 367888999999999999999999999999999999999776 899999999987643221
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh--------CChhHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (401)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+.+..+.... .+..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 112345677999999876 678999999999999999998 999983 333334333333211 13466677
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..+|..||++.++++
T Consensus 234 i~~-~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQ-CWAHNPADRPTFAALRE 253 (257)
T ss_pred HHH-HCCCCcccCCCHHHHHH
Confidence 777 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=275.84 Aligned_cols=227 Identities=18% Similarity=0.233 Sum_probs=179.6
Q ss_pred eeecccCCeeEEEEEEcCCC----------eEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 140 RKVGRGKYSEVFEGVHCTDN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+.||+|+||.||+|.+..++ ..+++|++.... ...+.+|+.+++.+ +||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 46899999999999997666 458888876443 46788999999999 99999999998865 3468
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC------eEEEEecccce
Q 015741 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWGLAE 277 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~------~vkl~DFg~a~ 277 (401)
+||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999987753 4788889999999999999999999999999999999986542 59999999998
Q ss_pred ecCCCCcccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHH-----hCChh
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKV-----LGTDE 350 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg-~~Pf~~~~~~~~~l~~i~~~-----~~~~~ 350 (401)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++| ..||.. .+..+........ .....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST-LSSSEKERFYQDQHRLPMPDCAE 232 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc-CCchhHHHHHhcCCCCCCCCchH
Confidence 6543 2234566779999998763 3788999999999999999995 666633 3222222221111 11246
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..+|..||++.++++
T Consensus 233 ~~~li~~-~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 233 LANLINQ-CWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHH-HhccChhhCCCHHHHHH
Confidence 7777877 89999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=275.53 Aligned_cols=225 Identities=17% Similarity=0.250 Sum_probs=178.3
Q ss_pred cCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhc--
Q 015741 145 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-- 222 (401)
Q Consensus 145 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 222 (401)
|.+|.||++++..+++.||+|.+.... ...+|...+... .||||+++++++.+ ....+++|||+.+++|...+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 334555555555 79999999999875 46789999999999987665
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCcccccccc
Q 015741 223 -PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (401)
Q Consensus 223 -~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 301 (401)
..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++++|||.+...... .....++..|+|||.+.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 3588999999999999999999999999999999999999776 7999999987655322 22345567799999986
Q ss_pred CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH-HHHhCChhHHHHHHhcCCCCChhhHHHh-----hhhcC
Q 015741 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDELNAYLNKYHIELDPHLAALV-----GRHSR 375 (401)
Q Consensus 302 ~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i-~~~~~~~~~~~~l~~~~l~~dP~~R~~~-----~~~l~ 375 (401)
+ ..++.++|+||+|+++|+|++|..||............+ .....++.+.+++.+ |++.||..|+++ ++++.
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ-LLQFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHH-HccCCHHHhcCCCccchHHHHc
Confidence 5 678899999999999999999998874322111100000 001124567788888 899999999985 99999
Q ss_pred CCcc
Q 015741 376 KPWS 379 (401)
Q Consensus 376 ~~~~ 379 (401)
|||+
T Consensus 234 h~~~ 237 (237)
T cd05576 234 HPFF 237 (237)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=273.41 Aligned_cols=228 Identities=21% Similarity=0.361 Sum_probs=181.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
++||+|+||.||+|.+.. ++.|++|+++.. ....+.+|+++++++ +|+||+++++++.+ ....+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 469999999999999866 999999987643 235788999999999 99999999999865 4678899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc---ccc
Q 015741 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288 (401)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~ 288 (401)
++|..++. .+++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||.+......... ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence 99877652 367888899999999999999999999999999999999766 8999999999765422111 112
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHhcCC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHI 360 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l 360 (401)
..+..|+|||.+.+ +.++.++|||||||++|+|++ |..|| ...........+..... ...+.+++.+ |+
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l 232 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY-PGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQ-CW 232 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC-ccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHH-Hh
Confidence 22456999999876 678999999999999999999 67776 33333333333322211 2466777777 79
Q ss_pred CCChhhHHHhhhhcC
Q 015741 361 ELDPHLAALVGRHSR 375 (401)
Q Consensus 361 ~~dP~~R~~~~~~l~ 375 (401)
..+|..||++.++++
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.39 Aligned_cols=247 Identities=22% Similarity=0.420 Sum_probs=208.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEc---CCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~---~~~~~~ 206 (401)
..+.|++.+.||.|.+|.||+++.+.+++.+|+|++... ..+.++.|.++|+.+.+|||++.+|++|.- .....+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 467899999999999999999999999999999998754 346788999999999999999999998753 234578
Q ss_pred EEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+||||||.+|+.-++.+ ++.|..+.+|++.++.||.+||...++|||||-.|||++.++ .|||+|||.+..+..
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeeec
Confidence 99999999999877764 578889999999999999999999999999999999999777 899999999987754
Q ss_pred C-CcccccccCCCccccccccCC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------C
Q 015741 282 G-KEYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------G 347 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~ 347 (401)
. ....+.+||++|||||++... ..|+..+|+||||++..||.-|.+|+. +-.+...+..|.+.. -
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~-DmHPmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc-CcchhhhhccCCCCCCccccchhhH
Confidence 3 345678999999999999653 347789999999999999999999984 333444444433321 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.++.+||.. ||..|-+.||++.++++|||.+.
T Consensus 255 s~~FndFIs~-cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 255 SKKFNDFIST-CLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHH-HHhhccccCcchhhhccCCcccc
Confidence 4577889998 79999999999999999999984
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=276.35 Aligned_cols=229 Identities=17% Similarity=0.214 Sum_probs=173.3
Q ss_pred eeecccCCeeEEEEEEc--CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|... .++..+|+|.++... ...+.+|+.+++++ +||||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999864 345679999886432 24688899999999 99999999999865 45678999999
Q ss_pred CCCchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 214 NNTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 214 ~~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
.+++|..++. ..++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCccee
Confidence 9999977653 234566778999999999999999999999999999999765 899999999865432221
Q ss_pred --ccccccCCCccccccccCC------CCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh---------
Q 015741 285 --YNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL--------- 346 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~--------- 346 (401)
.....++..|+|||++.+. ..++.++||||||+++|||++ |..||.. ..+.+.........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHhhcccCCCCCCcc
Confidence 1223566789999998542 135789999999999999996 9989843 33333332221110
Q ss_pred ---CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 ---GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ---~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
..+.+.+++.. |+ .+|..||++++++.
T Consensus 236 ~~~~~~~~~~l~~~-c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVMQF-CW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHH-Hh-cCcccCCCHHHHHH
Confidence 12344556655 55 68999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.17 Aligned_cols=238 Identities=21% Similarity=0.387 Sum_probs=195.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
....-+..+.||+|+||.||.|...... ..||+|.+++. ....|.+|..+|+++ +|||||+++|++-+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD-- 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence 3567788999999999999999875433 34899998753 456799999999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEe
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~D 272 (401)
....++++|||.+|+|..+++ .+...+...++.||++|+.||+++++|||||...|+|++... .|||+|
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaD 845 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIAD 845 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEcc
Confidence 567789999999999988874 277889999999999999999999999999999999999665 899999
Q ss_pred cccceecCCCCccccc---ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--hC
Q 015741 273 WGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--LG 347 (401)
Q Consensus 273 Fg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--~~ 347 (401)
||+|+.+.....+... .-...|||||.+.. +.++.++|||||||+|||++|...+.|.+.++.+.+....+. +.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 9999955433222211 11235999999987 799999999999999999999666656888888877754443 11
Q ss_pred -----ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 -----TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 -----~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+.+.+.. |++.+|+.||+...+++
T Consensus 925 ~P~~CP~~ly~lM~~-CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQ-CWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHH-HccCChhhCccHHHHHh
Confidence 3466666666 89999999999988887
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=275.62 Aligned_cols=240 Identities=27% Similarity=0.510 Sum_probs=200.9
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC---CcEEEE
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIF 210 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~---~~~lv~ 210 (401)
.+.||.|+||.||.+.+..+|+.||+|.+.. ...+++.+|+++|.-+ +|.|++..+++...+.-. .+|+++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3779999999999999999999999998753 2457889999999998 999999999987544322 357788
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--cc
Q 015741 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY 285 (401)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--~~ 285 (401)
|.|... |..++ +.++...++.+++||+.||.|||+.||.||||||.|+|++.+. .+||||||+++..+.+. ..
T Consensus 137 ELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 137 ELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhhhhh
Confidence 888754 33333 3588889999999999999999999999999999999999766 89999999999776543 34
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhHHHH-----------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY----------- 354 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~~~----------- 354 (401)
+..+.|.+|+|||++.|...|+.+.||||.|||+.||+..+..| ....+.+++..|.+.+|.|.+++.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 56688999999999999889999999999999999999777766 778899999999999886543332
Q ss_pred ----------------------------HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 ----------------------------LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 ----------------------------l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+...|+..||.+|.++.+.+.|++.++.
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 2233789999999999999999998763
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=277.26 Aligned_cols=235 Identities=19% Similarity=0.410 Sum_probs=189.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ...++.+|+.++.+..+||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999877 6789999987521 123467788888764499999999999865
Q ss_pred CCCCCcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEe
Q 015741 201 QQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLID 272 (401)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~D 272 (401)
....+++|||+.+++|...+ ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence 56789999999999887654 247888999999999999999996 7899999999999999766 899999
Q ss_pred cccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------
Q 015741 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (401)
Q Consensus 273 Fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------ 346 (401)
||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|+.||... ........+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCCcCCc
Confidence 999987654444445678888999999876 67899999999999999999999998432 2222233332221
Q ss_pred --CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 --GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
..+.+.+++.+ |+..||..||++.++..
T Consensus 236 ~~~~~~l~~li~~-cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 236 GMYSEDVTDVITS-CLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccCCHHHHHHHHH-HCCCCCccCCCHHHHHH
Confidence 13567778887 89999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=278.01 Aligned_cols=230 Identities=22% Similarity=0.360 Sum_probs=180.7
Q ss_pred eeecccCCeeEEEEEEcCCC------eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 140 RKVGRGKYSEVFEGVHCTDN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+.||+|+||.||+|.+.... +.+|+|.+... ....+.+|+.+++.+ +||||+++++++.+ ....+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999875433 78999987542 345788999999999 99999999999865 4568999
Q ss_pred EeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC----CeEEEEeccc
Q 015741 210 FEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGL 275 (401)
Q Consensus 210 ~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~vkl~DFg~ 275 (401)
|||+++++|..++. .+++.++..++.|++.||.|||+++++|+||||+||+++.++ ..++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999876652 266788899999999999999999999999999999998644 2699999999
Q ss_pred ceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 276 AEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 276 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
+......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..++.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTAGGRLQKP 235 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc-ccCHHHHHHHHhcCCccCCc
Confidence 8765332211 12244567999999876 678999999999999999998 888883 333334333322211
Q ss_pred --CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 --GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.++.+.+++.+ |+..+|..||+++++++
T Consensus 236 ~~~~~~~~~li~~-~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 236 ENCPDKIYQLMTN-CWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccchHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 13467777777 89999999999998753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.77 Aligned_cols=245 Identities=28% Similarity=0.506 Sum_probs=205.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---- 202 (401)
...+|.-++.+|.|.- .|..+.+.-.++.||+|.+.. ...++..+|..++..+ +|+||++++.+|....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 3467888899999998 788888888899999998642 2336678999999999 9999999999987532
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
....|+|||+|....-...+-.+....+..++.|++.|+.|||+.||+||||||+||++..+. .+||.|||+|+.-...
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTD 171 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCcc
Confidence 235689999998765444445677888999999999999999999999999999999999777 8999999999876655
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCCh-------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD------------- 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~------------- 349 (401)
-..+..+.+++|.|||++.+. .|...+||||+||++.||++|+.-| +|.+..+++.++.+.+|.+
T Consensus 172 ~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 456778999999999999985 4999999999999999999999877 7889999998888877632
Q ss_pred -----------------------------------hHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 350 -----------------------------------ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 350 -----------------------------------~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
..++++.+ ||.+||+.|.+++++|+||+++.+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~-MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSK-MLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHH-hhccChhhcccHHHHhcCCeeeee
Confidence 23333445 999999999999999999999854
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.28 Aligned_cols=229 Identities=18% Similarity=0.281 Sum_probs=170.9
Q ss_pred eeecccCCeeEEEEEEcC--CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|.... ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+.+ ....++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996533 34578888775332 24578899999998 99999999999865 45689999999
Q ss_pred CCCchhhhcCC--------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 214 NNTDFKVLYPT--------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 214 ~~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
.+++|..++.. .++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhe
Confidence 99999877532 34667788999999999999999999999999999999766 899999999865432221
Q ss_pred --ccccccCCCccccccccC------CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC--------
Q 015741 285 --YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------- 347 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------- 347 (401)
.....++..|+|||++.. ...++.++|||||||++|||++ |..|| ....+.+.+..+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCccCCCCcc
Confidence 122344567999998742 2356889999999999999999 56666 44444444443322211
Q ss_pred ----ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 ----TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 ----~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+....++.. |+ .||+.||+++++++
T Consensus 236 ~~~~~~~~~~~~~~-~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 236 DLKYSDRWYEVMQF-CW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccCCHHHHHHHHH-Hh-cCcccccCHHHHHH
Confidence 1233344444 44 59999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=274.83 Aligned_cols=235 Identities=18% Similarity=0.337 Sum_probs=182.2
Q ss_pred eEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 136 YEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
|++.+.||+|+||.||+|.+. .+++.+|+|+++.. ..+.+.+|+++++.+ +||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 567789999999999999864 35789999998642 235688999999999 99999999998864322
Q ss_pred CCcEEEEeecCCCchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
...++++||+.++++..++. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence 23478899999999865431 367888999999999999999999999999999999998665 89999999
Q ss_pred cceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh----
Q 015741 275 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL---- 346 (401)
Q Consensus 275 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~---- 346 (401)
+++....... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHcCCcCCC
Confidence 9986543321 122334567999999876 678899999999999999999 77776 4444333333332221
Q ss_pred ---CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 ---GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ---~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
....+.+++.+ |+..+|..||++.+++.
T Consensus 237 ~~~~~~~~~~l~~~-~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 237 PPDCLEDVYELMCQ-CWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 12466677777 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=283.25 Aligned_cols=245 Identities=24% Similarity=0.425 Sum_probs=202.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.++|-++.+||+|||++||+|.+....+.||+|+-...+ .+..-+|.+|.+.| +||.||++|++|.-.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec-
Confidence 467889999999999999999999899999999863211 13456899999999 999999999999854
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhC--CceeecCCCCCeeEeCCC--CeEEEEeccc
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQ--RKLRLIDWGL 275 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~--~~vkl~DFg~ 275 (401)
...++-|+|||+|.+|..+++ .+++.+++.|+.||+.||.||.+. -|||-||||.|||+.... +.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 456689999999999988775 489999999999999999999987 599999999999996432 4799999999
Q ss_pred ceecCCCCc--------ccccccCCCccccccccC---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH--H
Q 015741 276 AEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK--I 342 (401)
Q Consensus 276 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~--i 342 (401)
++++..+.. .....||.+|++||.+.- ....+.++||||+|||+|+.++|+.||.......+.+.. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 998864322 234578999999999853 245788999999999999999999999776665555553 2
Q ss_pred HHH---------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 343 AKV---------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 343 ~~~---------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
.+. ..+++..+||.+ ||.+--+.|..+.++-.+|++-
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRR-CLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRR-CLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHH-HHHhhhhhhhhHHHHccCcccc
Confidence 222 125678899998 7999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.99 Aligned_cols=242 Identities=27% Similarity=0.489 Sum_probs=203.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcC-----CCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-----GPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~-----hpniv~~~~~~~~~~~~ 204 (401)
-..+|.+....|+|-|++|..|.+..-|+.||||++.... .+.=+.|++||++|.. --|+++++..|.. ..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--kn 507 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--KN 507 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--cc
Confidence 4688999999999999999999999889999999997543 2556789999999942 2489999988854 57
Q ss_pred CcEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 205 TPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
+++||+|-+.- .|.++++ .+....++.|+.|++.||..|-..||+|.||||+|||++.....+||||||.|..
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 88999997753 4444443 3777889999999999999999999999999999999998777899999999987
Q ss_pred cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC----------
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------- 348 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~---------- 348 (401)
.. ....+....+.+|.|||++.| -.|+...|+||.||+||||.||+..| +|.++.+++....+..|.
T Consensus 587 ~~-eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 587 AS-ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cc-cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 64 445667778889999999998 68999999999999999999999888 788877777665555330
Q ss_pred --------------------------------------------------------hhHHHHHHhcCCCCChhhHHHhhh
Q 015741 349 --------------------------------------------------------DELNAYLNKYHIELDPHLAALVGR 372 (401)
Q Consensus 349 --------------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~~~ 372 (401)
..+.++|.+ |+.+||++|.++.|
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk-ml~LdP~KRit~nq 742 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK-MLILDPEKRITVNQ 742 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH-HhccChhhcCCHHH
Confidence 135566777 89999999999999
Q ss_pred hcCCCccc
Q 015741 373 HSRKPWSK 380 (401)
Q Consensus 373 ~l~~~~~~ 380 (401)
+|.|||+.
T Consensus 743 AL~HpFi~ 750 (752)
T KOG0670|consen 743 ALKHPFIT 750 (752)
T ss_pred HhcCCccc
Confidence 99999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=254.13 Aligned_cols=208 Identities=20% Similarity=0.398 Sum_probs=177.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++...+..||+|++|.|-+.++..+|+..|+|.+.. ...+++.+|+.+..+....|.+|++|+.+.+ ...+++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEE
Confidence 3556667899999999999999999999999998853 3346788899988887789999999997754 566789
Q ss_pred EEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
.||.|.. +|..+. ..++|.-+-.|+..+..||+|||++ .+||||+||+|||++.++ +||+||||++..+.
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV 200 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence 9999875 343332 3588988999999999999999987 899999999999999888 89999999999887
Q ss_pred CCCcccccccCCCccccccccC---CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~ 344 (401)
..-..+...|...|||||.+.. ...|+.++||||||+++.||.+++.||....++.+++.++.+
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 6666666789999999999843 247999999999999999999999999999999999888754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=270.37 Aligned_cols=228 Identities=17% Similarity=0.259 Sum_probs=170.7
Q ss_pred eeecccCCeeEEEEEEcCC--CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+.||+|+||.||+|....+ ...+++|.++.. ..+.+.+|+.+++.+ +||||+++++.+.+ ....+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecC
Confidence 3599999999999975433 235667776532 235788999999998 99999999999875 45779999999
Q ss_pred CCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC---
Q 015741 214 NNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283 (401)
Q Consensus 214 ~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--- 283 (401)
.+++|..++. ..++..++.++.||+.||+|||+++++||||||+|||++.++ .++|+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhh
Confidence 9999987653 245566788999999999999999999999999999998766 89999999986432211
Q ss_pred cccccccCCCccccccccCC------CCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHhC---------
Q 015741 284 EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLG--------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~ll~elltg-~~Pf~~~~~~~~~l~~i~~~~~--------- 347 (401)
......++..|+|||++... ..++.++|||||||++|||+++ ..|| ....+.+.+..+.+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhhcccccCCCccC
Confidence 11234677889999997431 2457899999999999999975 4455 44455555444332211
Q ss_pred ---ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 ---TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 ---~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.+.+.+++.. |+ .+|..||++++++
T Consensus 236 ~~~~~~~~~l~~~-c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 236 LPYSERWYEVLQF-CW-LSPEKRATAEEVH 263 (268)
T ss_pred CCCcHHHHHHHHH-Hh-hCcccCCCHHHHH
Confidence 2334455555 55 6799999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.00 Aligned_cols=232 Identities=19% Similarity=0.385 Sum_probs=193.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.+....++||-|.||.||.|.++.-.-.||||.++. +..++|..|..+|+.+ +|||+|+++++|.. +...|||+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEEe
Confidence 456678999999999999999998899999999975 4568899999999999 99999999999965 577899999
Q ss_pred ecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
||..|.|.++++. ++.--..+++.||..|++||..+++|||||...|+|+..+. .||++|||+++++. ++.++
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt-gDTYT 421 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT-GDTYT 421 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhc-CCcee
Confidence 9999999888754 44445677889999999999999999999999999999655 89999999999885 55666
Q ss_pred ccccCCC---ccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHH
Q 015741 287 VRVASRY---FKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (401)
Q Consensus 287 ~~~~t~~---y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (401)
...|..+ |.|||-+.- ..++.++|||+|||+|||+.| |..|| ++.+-.+....+.+.+. .+.+.+++
T Consensus 422 AHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred cccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence 6666554 999999874 789999999999999999987 45555 67665555555444432 34666766
Q ss_pred HhcCCCCChhhHHHhhhh
Q 015741 356 NKYHIELDPHLAALVGRH 373 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~ 373 (401)
.. |++.+|..||+..++
T Consensus 500 ra-CW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 500 RA-CWNWSPSDRPSFAEI 516 (1157)
T ss_pred HH-HhcCCcccCccHHHH
Confidence 66 899999999997776
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.71 Aligned_cols=233 Identities=21% Similarity=0.386 Sum_probs=189.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC----CeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~----~~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+..++.+.||.|.||.||+|....- .--||||+-+. .+.+.|..|..+|+++ +|||||+++|++.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---cc
Confidence 3445567899999999999986422 34688898764 4567899999999999 99999999999976 46
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++|||.+..|.|..+++ .++......++.||+.||.|||+.++|||||...|||+.... .|||+|||+++++..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLED 543 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccc
Confidence 789999999999988875 477778888999999999999999999999999999998766 899999999999977
Q ss_pred CCcccccccC--CCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 282 GKEYNVRVAS--RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 282 ~~~~~~~~~t--~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
...+....|. .-|||||.+.- ..++.++|||.|||++||++. |..|| .+..+.+.+..+.+.-. .|.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf-qgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF-QGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred cchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc-ccccccceEEEecCCCCCCCCCCCChHH
Confidence 6655544443 34999999764 789999999999999999875 78888 56666666666655422 3455
Q ss_pred HHHHHhcCCCCChhhHHHhhhhc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..+..+ |+.++|.+||...++.
T Consensus 622 Yslmsk-cWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSK-CWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHH-HhccCcccCCcHHHHH
Confidence 555555 8999999999876653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=270.87 Aligned_cols=246 Identities=30% Similarity=0.566 Sum_probs=209.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+.|.++++||.|.|++||++.+.. .++.||+|.+.. ....++.+|++.|..+.++.||+++.+.+.. +....+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence 3568899999999999999999876 788999998864 5568899999999999999999999999965 567789
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC--------
Q 015741 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------- 280 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-------- 280 (401)
|+||++.....++...++-.+++.+++.++.||.++|.+|||||||||.|+|.+....+-.|+|||+|...+
T Consensus 113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999877788999999986210
Q ss_pred ---------C--C--------------Cc------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHH
Q 015741 281 ---------P--G--------------KE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323 (401)
Q Consensus 281 ---------~--~--------------~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell 323 (401)
+ + .. ...+.||++|+|||++...+..++++||||.|||+..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 0 00 012468999999999998888999999999999999999
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHhCC-------------------------------------------------------
Q 015741 324 FRKEPFFYGHDNYDQLVKIAKVLGT------------------------------------------------------- 348 (401)
Q Consensus 324 tg~~Pf~~~~~~~~~l~~i~~~~~~------------------------------------------------------- 348 (401)
++..||+...++.+.+.++.-.+|.
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 9999999887777666655444331
Q ss_pred --hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 349 --DELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 349 --~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
....+++.+ |+++||.+|.+++++|.|||+.-
T Consensus 353 ~~~~~~dlLdk-~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 353 FPALLLDLLDK-CLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccHHHHHHHHH-HccCChhhcccHHHHhcCcCCcc
Confidence 023445667 79999999999999999999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=289.16 Aligned_cols=236 Identities=18% Similarity=0.328 Sum_probs=199.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.....|.+.||.|.||+|++|+.+..+ ..||||.+|. ..+.+|..|+.||-++ +||||+++.|+... ...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SKP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cce
Confidence 355778999999999999999987655 5799999984 3456799999999999 99999999999965 678
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
++||+|||++|.|+.+++ ++...+...+++.|+.|+.||-++|+|||||...|||++.+- .+|++|||+++.+++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvled 783 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED 783 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeeccc
Confidence 899999999999998875 477888999999999999999999999999999999999665 899999999998865
Q ss_pred CC--cccccccC--CCccccccccCCCCCCcccchHHHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHhCCh-------
Q 015741 282 GK--EYNVRVAS--RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGTD------- 349 (401)
Q Consensus 282 ~~--~~~~~~~t--~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell-tg~~Pf~~~~~~~~~l~~i~~~~~~~------- 349 (401)
+. .+++..|. ..|.|||.+.- ..++.++||||+|+++||.+ +|..||+ +-.+.+.+..|.+.+.-|
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred CCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCCCCCCCcH
Confidence 54 23333332 35999999986 78999999999999999965 6899984 567888999999887633
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.. |++.|...||...|+..
T Consensus 862 aL~qLMld-CWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 862 ALYQLMLD-CWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHH-HHHHHhhcCCCHHHHHH
Confidence 56666666 79999999998777653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=280.40 Aligned_cols=247 Identities=18% Similarity=0.249 Sum_probs=172.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc----------------CCCeEEEEEEecccch---H--------------HHHHH
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC----------------TDNEKCIIKILKPVKK---K--------------KIKRE 178 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~~---~--------------~~~~E 178 (401)
..++|++.++||+|+||.||+|.+. ..++.||||.++.... + ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999752 2456799999864221 1 22346
Q ss_pred HHHHHHhcCCCC-----eeEEeeEEEcC------CCCCcEEEEeecCCCchhhhcCC-----------------------
Q 015741 179 IKILQNLCGGPN-----IVKLLDIVRDQ------QSKTPSLIFEHVNNTDFKVLYPT----------------------- 224 (401)
Q Consensus 179 ~~il~~l~~hpn-----iv~~~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~----------------------- 224 (401)
+.++.++ +|.+ ++++++++... .....++||||+.+++|.+++..
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777 4443 46777776532 12457899999999998765421
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccc--cccCCCccccc
Q 015741 225 ----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPE 298 (401)
Q Consensus 225 ----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~--~~~t~~y~aPE 298 (401)
+++..++.++.|++.+|.|||+++|+||||||+|||++.++ .+||+|||++........... ..+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23456778999999999999999999999999999999776 899999999976543332222 23478899999
Q ss_pred cccCCCC-------------------CC--cccchHHHHHHHHHHHcCCC-CCCCCC---CCHHHHHHHHH----H----
Q 015741 299 LLVDLQD-------------------YD--YSLDLWSLGCMFAGMIFRKE-PFFYGH---DNYDQLVKIAK----V---- 345 (401)
Q Consensus 299 ~~~~~~~-------------------~~--~~~DiwSlG~ll~elltg~~-Pf~~~~---~~~~~l~~i~~----~---- 345 (401)
.+..... |+ .+.||||+||++|+|++|.. ||.... ..........+ .
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9754211 11 24799999999999999986 553211 01110000000 0
Q ss_pred -------hCChhHHHHHHhcCCCCCh---hhHHHhhhhcCCCcccc
Q 015741 346 -------LGTDELNAYLNKYHIELDP---HLAALVGRHSRKPWSKF 381 (401)
Q Consensus 346 -------~~~~~~~~~l~~~~l~~dP---~~R~~~~~~l~~~~~~~ 381 (401)
..++...+++.+ |+..+| ..|+++.++|.|||+..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~-LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACK-LITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHH-HhccCCCCcccCCCHHHHhCCCCcCC
Confidence 124566788888 455544 68999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.54 Aligned_cols=196 Identities=27% Similarity=0.504 Sum_probs=171.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhc--CCCCeeEEeeEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--GGPNIVKLLDIV 198 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~--~hpniv~~~~~~ 198 (401)
...+|..++.+|.|+||.|++|.++.+...|+||.+.+.+ ...+-.|++||..|. .|+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999999999999999986432 123567999999992 289999999999
Q ss_pred EcCCCCCcEEEEeec-CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 199 RDQQSKTPSLIFEHV-NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 199 ~~~~~~~~~lv~e~~-~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
++ ..++|++||-- ++.+|.+++ +++.|.++..|++|++.|+++||+.||||||||-+|+.++.+| .+||+|||
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfg 715 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFG 715 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeecc
Confidence 87 56789999965 455676665 4699999999999999999999999999999999999999777 89999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
.+.... ...+...+||..|.|||++.|....+..-|||+||++||.+++...|||+
T Consensus 716 saa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998664 55677899999999999999877778899999999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=307.75 Aligned_cols=231 Identities=20% Similarity=0.278 Sum_probs=180.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
.|...+.||+|+||.||+|.+..++..||+|.++.... ....|+++++++ +|||||++++++.+. ...++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence 45667889999999999999988999999999864332 234678899999 999999999999763 56789999999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccC
Q 015741 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291 (401)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t 291 (401)
+++|.+++..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ ..++. ||........ ....++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~---~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD---TKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC---CCcccc
Confidence 9999999988999999999999999999999 66999999999999998665 55554 6655433211 233678
Q ss_pred CCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------------hC---C------
Q 015741 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------------LG---T------ 348 (401)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------------~~---~------ 348 (401)
..|+|||++.+ ..++.++|||||||++|||++|+.||.........+....+. .. .
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 89999999876 679999999999999999999999985432211111111110 00 0
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++.+++.+ |++.||+.||++.++++.
T Consensus 921 ~~~~~l~~~-Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 921 VEVMNLALH-CTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHh-hCcCCchhCcCHHHHHHH
Confidence 022334445 899999999999999755
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=275.21 Aligned_cols=236 Identities=20% Similarity=0.329 Sum_probs=187.9
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.+...++++||+|.||+|.+|.- ..+.+||+|++++.. ++.|.+|+++|.+| +|||||.++++|.. +..+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~--DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ--DDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec--CCch
Confidence 4557788999999999999999986 457999999998643 46799999999999 99999999999975 4677
Q ss_pred EEEEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 207 SLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
++++|||++|+|..++.. +.......|+.||+.|++||.+.++|||||.+.|+|++.+. ++||+|||+++-+..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCccccccccc
Confidence 899999999999888742 23344567999999999999999999999999999999777 899999999987655
Q ss_pred CCcccc---cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHHhC---------
Q 015741 282 GKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHDNYDQLVKIAKVLG--------- 347 (401)
Q Consensus 282 ~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt--g~~Pf~~~~~~~~~l~~i~~~~~--------- 347 (401)
+..+.. .+-...|||||.+.. +.++.++|+|+||+++||+++ ...||.. ..+.+........+.
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~-lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQ-LTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhh-hhHHHHHHhhhhhcCCCCcceecc
Confidence 544332 244567999999987 789999999999999999764 6778833 222222222222211
Q ss_pred -----ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 -----TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 -----~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
...+.+++.+ |+..+.+.||+.+++-
T Consensus 768 ~P~~cp~~lyelml~-Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 768 RPPACPQGLYELMLR-CWRRESEQRPSFEQLH 798 (807)
T ss_pred CCCcCcHHHHHHHHH-HhchhhhcCCCHHHHH
Confidence 2356677777 7899999999988873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=253.93 Aligned_cols=228 Identities=31% Similarity=0.537 Sum_probs=189.8
Q ss_pred CCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhh
Q 015741 146 KYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221 (401)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 221 (401)
+||.||+|.+..+++.+++|++.... .+.+.+|++.++++ +|+|++++++.+.. ....++++||+.+++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999986543 57899999999999 99999999999875 3677899999999998877
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccc
Q 015741 222 YPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298 (401)
Q Consensus 222 ~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE 298 (401)
+.. +++..+..++.+++.+|.+||+.+++|+||+|+||+++.++ .++|+|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHH
Confidence 642 78889999999999999999999999999999999999765 89999999998776554455667888899999
Q ss_pred cccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhcCCCCChhhHHH
Q 015741 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYHIELDPHLAAL 369 (401)
Q Consensus 299 ~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~l~~dP~~R~~ 369 (401)
.+.+ ..++.++|||+||+++|+|++|..||....+.......+.+.. ...++.+++.+ |+..+|..||+
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~Rp~ 234 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRK-LLVKDPEKRLT 234 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHH-HccCCchhccC
Confidence 9875 6788899999999999999999999854333322222222221 22456677777 79999999999
Q ss_pred hhhhcCCCcc
Q 015741 370 VGRHSRKPWS 379 (401)
Q Consensus 370 ~~~~l~~~~~ 379 (401)
+.++++|||+
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999995
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.26 Aligned_cols=241 Identities=17% Similarity=0.291 Sum_probs=196.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++..+.++||+|.||.|++|.+..-+ ..||||.++.. ....|.+|+.+|.+| +|||++++||++.+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---ch
Confidence 355667799999999999999886432 46899999754 346899999999999 99999999999976 45
Q ss_pred cEEEEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+.||||.+..|+|.+.+.. +.......|+.||+.|+.||.++++|||||...|+|+.... .|||+|||+.+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALG 263 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccC
Confidence 7899999999999877643 55667788999999999999999999999999999998655 89999999999887
Q ss_pred CCCccccccc----CCCccccccccCCCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHhC-------C
Q 015741 281 PGKEYNVRVA----SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLG-------T 348 (401)
Q Consensus 281 ~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg-~~Pf~~~~~~~~~l~~i~~~~~-------~ 348 (401)
.++......+ ...|.|||.+.. ..++.++|||++||+||||+++ ..|| .+....+.++.|.+.-. +
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhccccccCCCCCCCh
Confidence 6655433222 235999999876 7899999999999999999985 5566 78888888887764321 3
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.++.+.+.+ |+..+|+.|++...+.+.-+...
T Consensus 342 edIY~imk~-cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 342 EDIYQIMKN-CWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHHHH-hccCCccccccHHHHHHhHHHHh
Confidence 466666666 89999999999888865444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=281.34 Aligned_cols=234 Identities=24% Similarity=0.351 Sum_probs=185.3
Q ss_pred eEEEeeecccCCee-EEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecC
Q 015741 136 YEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 136 y~i~~~Lg~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+-....+...+|+..|+.--.|||||++|+.- .+..+.|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence 44456789999986 699987 78999999987777778899999999988899999998865 44678999999987
Q ss_pred CCchhhhcCC-------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC---CC-CeEEEEecccceecCCCC
Q 015741 215 NTDFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQ-RKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 215 ~~~l~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~-~~vkl~DFg~a~~~~~~~ 283 (401)
. +|.+++.. ....+.+.++.|++.||++||+.+||||||||.||||+. ++ .+++|+|||+++.+..+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 5 44444432 122456788999999999999999999999999999976 22 479999999999887654
Q ss_pred c----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHh------C-Ch--
Q 015741 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVL------G-TD-- 349 (401)
Q Consensus 284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg-~~Pf~~~~~~~~~l~~i~~~~------~-~~-- 349 (401)
. .....||.+|+|||++.+ ..-+.++|||||||++|+.++| ..||. +..+.-..|.... . .+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG---d~~~R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG---DSLERQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC---chHHhhhhhhcCccceeeeccCchH
Confidence 3 244578999999999987 4556799999999999999987 78883 2333333333221 1 22
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...++|.+ |+..+|..||++.++|.||+|
T Consensus 742 eA~dLI~~-ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 742 EAKDLISR-MLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HHHHHHHH-hcCCCcccCCCHHHHhCCCcc
Confidence 55677777 899999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=259.40 Aligned_cols=237 Identities=19% Similarity=0.282 Sum_probs=184.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEeeEEEcCC--CCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~hpniv~~~~~~~~~~--~~~~~lv~ 210 (401)
+..++.+.||+|.||.||+|.. +++.||||++....+..+.+|-+|.... ..|+||+++++.-.... ...+.||+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4566778999999999999986 6799999999999999999999888763 48999999998754322 34678999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
||.+.|+|.+++. .+++.+...++..+++||+|||+. .|+|||||..|||+..|. ++.|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEe
Confidence 9999999998885 489999999999999999999963 599999999999999777 8999999999888
Q ss_pred CCCCcc---cccccCCCccccccccCCCCCC-----cccchHHHHHHHHHHHcCCCCCCC---------------CCCCH
Q 015741 280 HPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDLWSLGCMFAGMIFRKEPFFY---------------GHDNY 336 (401)
Q Consensus 280 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwSlG~ll~elltg~~Pf~~---------------~~~~~ 336 (401)
.++... -..+||..|||||++.+.-.+. .+.||||+|.+||||++...-++. .+...
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 765432 3468999999999997643333 468999999999999986433321 12233
Q ss_pred HHHHHH-HHHhCCh-------------hHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 337 DQLVKI-AKVLGTD-------------ELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 337 ~~l~~i-~~~~~~~-------------~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+.++.. ......| .+.+-+.. |+..||+.|.++.-+-
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~Ee-CWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEE-CWDHDAEARLTAGCVE 497 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHH-HcCCchhhhhhhHHHH
Confidence 333322 1222222 33333555 7999999999976653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=253.93 Aligned_cols=238 Identities=18% Similarity=0.285 Sum_probs=181.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHH-hcCCCCeeEEeeEEEcCC--CCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQN-LCGGPNIVKLLDIVRDQQ--SKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~-l~~hpniv~~~~~~~~~~--~~~~~lv 209 (401)
..+..+.+.||+|.||+||+|.+ .|+.||||++...+...+.+|.+|.+. +.+|+||+.+++.-.... .-.++||
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 46788999999999999999987 589999999998888999999999886 349999999998643222 2357899
Q ss_pred EeecCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
++|-+.|+|.+++.+ ++......++..++.||++||.. .|.|||||..|||+.+++ .+.|+|+|+|...
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h 366 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 366 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeEEe
Confidence 999999999998864 78888999999999999999963 499999999999999777 8999999999766
Q ss_pred CCC-----CcccccccCCCccccccccCCCC---C--CcccchHHHHHHHHHHHcC----------CCCCCCCC---CCH
Q 015741 280 HPG-----KEYNVRVASRYFKGPELLVDLQD---Y--DYSLDLWSLGCMFAGMIFR----------KEPFFYGH---DNY 336 (401)
Q Consensus 280 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~---~--~~~~DiwSlG~ll~elltg----------~~Pf~~~~---~~~ 336 (401)
... ...+.++||..|||||++.+.-. + -..+||||||.++||+.-. +.||+.-. ...
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 543 23467899999999999864211 1 1368999999999998743 46776433 344
Q ss_pred HHHHHHH--HHhCC---------hhHHHH--HHhcCCCCChhhHHHhhhh
Q 015741 337 DQLVKIA--KVLGT---------DELNAY--LNKYHIELDPHLAALVGRH 373 (401)
Q Consensus 337 ~~l~~i~--~~~~~---------~~~~~~--l~~~~l~~dP~~R~~~~~~ 373 (401)
+.+.++. +.+.+ +.+... +.+-|+-.+|..|.++-++
T Consensus 447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 4443321 11111 111111 2233688888888877665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=270.88 Aligned_cols=244 Identities=23% Similarity=0.419 Sum_probs=202.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+++|+++..+|.|.||.||+++++.+++..|+|+++- ....-+++|+-+++.. +|||||.+++.+.. ...+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCcEE
Confidence 46889999999999999999999999999999999874 3345678899999987 99999999998754 456789
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
+||||.+|+|.+... .+++.++.++.++.++||+|||++|=+|||||-.|||+++.+ .+|++|||.+..+... ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhhh
Confidence 999999999988763 689999999999999999999999999999999999999776 8999999998665432 22
Q ss_pred ccccccCCCcccccccc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------ChhH
Q 015741 285 YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-----------TDEL 351 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-----------~~~~ 351 (401)
.....||++|||||+.. ..+.|...+|||++|+...|+---+.|.+ ...++..+..+.+..- ++.+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf-dlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF-DLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc-ccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 35578999999999962 23579999999999999999988887764 3344444444444321 3456
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+|+.. .+..+|++||+++.+|.||+..-
T Consensus 248 h~fvK~-altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 248 HNFVKG-ALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHH-HhcCCCccCCChhhheeceeecc
Confidence 666665 79999999999999999998754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=266.66 Aligned_cols=236 Identities=21% Similarity=0.351 Sum_probs=186.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
++..+.+.||+|.||.||+|.... ....||||.++.. ..+.+..|+++|+.+..|+||+.+++.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 444677799999999999997431 1567999998742 346799999999999899999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC--C-----------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP--T-----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~--~-----------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 263 (401)
...+++|+||+..|+|..+++ + ++..+...++.||+.|++||+++++|||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 677899999999999877652 3 778889999999999999999999999999999999996
Q ss_pred CCCeEEEEecccceecCCCCccccc--cc--CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHH
Q 015741 264 EQRKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQ 338 (401)
Q Consensus 264 ~~~~vkl~DFg~a~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~ 338 (401)
+. .+||+|||+|+.......+... .+ ...|||||.+.. ..|+.++||||+||+|||+++..-+.+.+-. ..+.
T Consensus 454 ~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 454 NK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 65 8999999999976554444322 21 234999999987 7899999999999999999985544445544 4444
Q ss_pred HHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+..+.++.. .+++.+++.. |+..+|+.||+..++.
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~-CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKS-CWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHH-HhCCCcccCCCHHHHH
Confidence 443443322 4455655555 8999999999987774
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=228.57 Aligned_cols=192 Identities=33% Similarity=0.624 Sum_probs=165.9
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
|.+.+.||.|++|.||++.+..+++.+++|.+... ..+.+.+|++.++++ +|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999888999999999754 456789999999999 99999999999865 357789999
Q ss_pred ecCCCchhhhcC---C-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--cc
Q 015741 212 HVNNTDFKVLYP---T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY 285 (401)
Q Consensus 212 ~~~~~~l~~~~~---~-~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--~~ 285 (401)
++.+++|..++. . +++..+..++.+++.+|.+||+++++|+||+|.||+++.++ .++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccc
Confidence 999999887763 2 78888999999999999999999999999999999999765 89999999998775443 33
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
....++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4456778899999973336788899999999999999999999943
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=233.21 Aligned_cols=196 Identities=20% Similarity=0.376 Sum_probs=160.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.+.|.|.+.||+|.||.+-+|+++.+++.+++|.+.. ...++|.+|...--.|..|.||+.-|++--.. ..++++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEee
Confidence 4789999999999999999999999999999999864 34577899987666677899999998864322 45778999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE-eCCCCeEEEEecccceecCCCCcccc
Q 015741 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll-~~~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
||++.|+|..... .+.|...+.++.|++.|++|+|++++||||||.+|||| +.+..+|||||||..+... .....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTVKY 179 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--ceehh
Confidence 9999999987764 47888899999999999999999999999999999998 5566799999999987542 21122
Q ss_pred cccCCCccccccccCC----CCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 288 RVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
.-.+-.|.+||..... -...+..|||.||+++|.++||..||..
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 2233458899886431 1246789999999999999999999963
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=221.17 Aligned_cols=205 Identities=30% Similarity=0.538 Sum_probs=175.8
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCc
Q 015741 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 142 Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~ 217 (401)
||+|++|.||++....+++.+++|++..... ..+.+|++.++.+ .|++++++++++.. ....++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 6899999999999977799999999986654 6899999999999 88999999999975 367889999999999
Q ss_pred hhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC-CCCeEEEEecccceecCCCC-cccccccC
Q 015741 218 FKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGK-EYNVRVAS 291 (401)
Q Consensus 218 l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~vkl~DFg~a~~~~~~~-~~~~~~~t 291 (401)
|..++. .++...+..++.+++.+|.+||++|++|+||+|.||+++. ++ .++|+|||.+....... ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCC
Confidence 887764 4788899999999999999999999999999999999997 44 89999999998764332 13335567
Q ss_pred CCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHHhcCCCCChhhHHHhh
Q 015741 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 371 (401)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dP~~R~~~~ 371 (401)
..|++||.......++.+.|+|+||+++++| +.+.+++.+ |+..||..|+++.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------~~~~~~l~~-~l~~~p~~R~~~~ 209 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------PELKDLIRK-MLQKDPEKRPSAK 209 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------HHHHHHHHH-HhhCCcccCcCHH
Confidence 7899999987633788899999999999999 445667777 7889999999999
Q ss_pred hhcCCC
Q 015741 372 RHSRKP 377 (401)
Q Consensus 372 ~~l~~~ 377 (401)
++++++
T Consensus 210 ~l~~~~ 215 (215)
T cd00180 210 EILEHL 215 (215)
T ss_pred HHhhCC
Confidence 998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=256.71 Aligned_cols=230 Identities=17% Similarity=0.314 Sum_probs=181.6
Q ss_pred eEEEeeecccCCeeEEEEEEcCCC----eEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~----~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
....++||+|+||+||+|.+...| .+||+|++.. .....+.+|+.+|.++ +|||++++++++... .+.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TLQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hHH
Confidence 445689999999999999886555 4688898753 3357799999999999 999999999999653 378
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
||++|++.|.|.++.+ ++...+...|..||++||.|||++++|||||-..|||+..-+ .+||.|||+++.+.++.
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCccc
Confidence 9999999999977753 578888999999999999999999999999999999998655 89999999999887654
Q ss_pred cc-ccccc--CCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH---HhCCh-----hH
Q 015741 284 EY-NVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK---VLGTD-----EL 351 (401)
Q Consensus 284 ~~-~~~~~--t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~---~~~~~-----~~ 351 (401)
.. ....| ..-|||-|.+.. ..|+.++|||||||++||++| |..|++. . ..+.+....+ .+..| ++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~g-i-~~~eI~dlle~geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDG-I-PAEEIPDLLEKGERLSQPPICTIDV 929 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCC-C-CHHHhhHHHhccccCCCCCCccHHH
Confidence 33 32222 234889998876 789999999999999999987 7778742 2 2233332222 22222 55
Q ss_pred HHHHHhcCCCCChhhHHHhhhhc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
...+.+ |+..|+..||..+++.
T Consensus 930 y~~mvk-Cwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 930 YMVMVK-CWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHH-HhccCcccCccHHHHH
Confidence 555677 7999999999887764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=261.24 Aligned_cols=188 Identities=9% Similarity=0.129 Sum_probs=134.3
Q ss_pred CCeeEEeeEEEc-----CCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCe
Q 015741 189 PNIVKLLDIVRD-----QQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (401)
Q Consensus 189 pniv~~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 259 (401)
+||++++++|.. .....++.++|++. ++|..++. .+++.+++.+++||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 466666666521 11245677888874 47776663 388999999999999999999999999999999999
Q ss_pred eEeCC------------------CCeEEEEecccceecCCCC-----------------cccccccCCCccccccccCCC
Q 015741 260 MIDHE------------------QRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ 304 (401)
Q Consensus 260 ll~~~------------------~~~vkl~DFg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~ 304 (401)
||+.. ...+|++|||+++...... ......||++|||||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 99532 2256777777775421100 0112357889999999887 6
Q ss_pred CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCCC
Q 015741 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRKP 377 (401)
Q Consensus 305 ~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~ 377 (401)
.|+.++|||||||+||||++|..|+.... ..+..+.... ..+....++.+ |+..+|..||++.++++||
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQILLNWPKEASFCLW-LLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChhhhhcCHHHHHHHHH-hCCCChhhCcChHHHhhch
Confidence 78999999999999999999987763211 1111111111 12344455555 8999999999999999999
Q ss_pred ccccc
Q 015741 378 WSKFI 382 (401)
Q Consensus 378 ~~~~~ 382 (401)
|+...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=219.09 Aligned_cols=158 Identities=18% Similarity=0.262 Sum_probs=125.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeE-EeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~-~~~~~~~~~ 202 (401)
.++|.+.+.||+|+||+||+|.+.. +++.+|||++... ....+.+|+++|+++ +|+|++. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc-----
Confidence 4679999999999999999998875 6788899986422 235689999999999 8999885 4432
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCCeeEeCCCCeEEEEecccceecCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
...++||||+.|++|.... ... ...++.|++++|.|||++||+|||| ||+|||++.++ .+||+|||+|+.+..
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRR 164 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceeccc
Confidence 2468999999999987432 111 2467899999999999999999999 99999998665 799999999987654
Q ss_pred CCc---------ccccccCCCccccccccC
Q 015741 282 GKE---------YNVRVASRYFKGPELLVD 302 (401)
Q Consensus 282 ~~~---------~~~~~~t~~y~aPE~~~~ 302 (401)
... .+...++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 321 134467778999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=214.91 Aligned_cols=238 Identities=16% Similarity=0.298 Sum_probs=186.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.+++++....+-+|.||.||.|.+... .+.|.+|.++.. ....+..|.-.+..+ .|||+..+.++..+.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~- 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED- 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-
Confidence 467788999999999999999976533 244566766532 345678888888888 899999999988764
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
....++++.+++-|+|..++. .++..+...++.|++.|++|||++||||.||...|.+|++. .+|||+
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVklt 438 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLT 438 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEec
Confidence 567789999999999987763 26677788899999999999999999999999999999954 599999
Q ss_pred ecccceecCCCCcccc---cccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC
Q 015741 272 DWGLAEFYHPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG 347 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~ 347 (401)
|=.+++.+-+.+.... .....-||+||.+.+ ..|+.++|+|||||+||||+| |+.|+ ..-++.+...-+.+...
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKDGYR 516 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhccce
Confidence 9999987765543211 122345999999987 789999999999999999998 66776 66677776666655532
Q ss_pred ------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 ------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 ------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.|+.-=-+..+|+..+|+.||+.+|+.
T Consensus 517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 232222245668999999999988864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=198.06 Aligned_cols=143 Identities=19% Similarity=0.267 Sum_probs=115.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCC
Q 015741 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303 (401)
Q Consensus 224 ~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 303 (401)
.+++.+++.++.|++.||.|||+++ ||+|||++.++ .+|+ ||++....... ..|++.|+|||++.+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~- 78 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQG- 78 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcC-
Confidence 4899999999999999999999998 99999998766 7888 99998764322 267899999999987
Q ss_pred CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC---------------hhHHHHHHhcCCCCChhhHH
Q 015741 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------DELNAYLNKYHIELDPHLAA 368 (401)
Q Consensus 304 ~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~---------------~~~~~~l~~~~l~~dP~~R~ 368 (401)
..++.++|||||||++|||++|+.||.........+..+...... ..+.+++.+ |+..||..||
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-cl~~~p~~Rp 157 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV-CASRLPQRRE 157 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH-HHhccccccc
Confidence 678999999999999999999999995443323333333222111 146777777 8999999999
Q ss_pred HhhhhcCCCcccc
Q 015741 369 LVGRHSRKPWSKF 381 (401)
Q Consensus 369 ~~~~~l~~~~~~~ 381 (401)
++.++++|+|...
T Consensus 158 ~~~~ll~~~~~~~ 170 (176)
T smart00750 158 AANHYLAHCRALF 170 (176)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=189.05 Aligned_cols=196 Identities=22% Similarity=0.364 Sum_probs=160.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..++|.++++||.|+||.+|+|....+|+.||||+-.. ....++..|..+...|++...|+.+..+..+ ..+-++||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence 35789999999999999999999999999999999754 3446788999999999777888888888765 45668999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCCCc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+.+.. +|+++. +.++...+..++-|++.-++|+|.+++|||||||+|+|..- ...++.|+|||+|+.+.+...
T Consensus 91 dLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 98754 454443 46888889999999999999999999999999999999853 334789999999987643221
Q ss_pred --------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 285 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
-....||..|.+-....+ ...+.+.|+-|+|.+|.++.-|..||..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 233578888888777665 5677889999999999999999999943
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=203.55 Aligned_cols=195 Identities=24% Similarity=0.310 Sum_probs=156.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEecccc---hHHHHHHHHHHHHhcC---CCCeeEEeeEEEcCCCCCcE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPVK---KKKIKREIKILQNLCG---GPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~E~~il~~l~~---hpniv~~~~~~~~~~~~~~~ 207 (401)
+|.+.++||+|+||.||+|.+..++ ..+|+|+..... ...+..|+.++..+.. ..++..+++... ....+-+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999987664 688999875432 2278999999999852 368999998874 2245667
Q ss_pred EEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC----CeEEEEecccce-
Q 015741 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAE- 277 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~vkl~DFg~a~- 277 (401)
+||+.+. .+|.++. +.++...+..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 98 iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 8887665 4555444 4689999999999999999999999999999999999998653 479999999998
Q ss_pred -ecC-CCC-------c-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 015741 278 -FYH-PGK-------E-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (401)
Q Consensus 278 -~~~-~~~-------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~ 332 (401)
.+. ... . .....||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||...
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 321 111 1 123458999999999887 78899999999999999999999998443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=198.37 Aligned_cols=240 Identities=30% Similarity=0.496 Sum_probs=189.6
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCC-CeeEEeeEEEcCCCCCcEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hp-niv~~~~~~~~~~~~~~~l 208 (401)
|.+.+.||.|+||.||++.+. ..+++|.+... ....+.+|+.++..+ .|+ +++++++.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence 778899999999999999985 78899988632 245689999999999 665 89999999954 344789
Q ss_pred EEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++++.++++..... .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+..++++|||.+......
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999999885553 58888999999999999999999999999999999999966546999999999865433
Q ss_pred C-------cccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHHhCC---
Q 015741 283 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGT--- 348 (401)
Q Consensus 283 ~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~~~~--- 348 (401)
. ......++..|++||.+.+. ..++...|+|++|++++++++|..||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 24567899999999998763 4788899999999999999999999744332 13333333222221
Q ss_pred -------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 349 -------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 349 -------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
....+++.+ ++..+|..|........+++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKK-LLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccCccccchhhHHHHHHHHH-HHhcCchhcCCHHHHhhchHhhCc
Confidence 245666666 577799999988888777655543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=190.29 Aligned_cols=210 Identities=21% Similarity=0.346 Sum_probs=170.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
.|.+.++||+|+||.+++|...-+++.||||.-. +....++..|.+..+.|...+.|...|.+..+ +.+-.||||.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhhhhhhh
Confidence 5899999999999999999999999999999753 33456789999999999888999999887643 56667899987
Q ss_pred CCC--chhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC----CCCeEEEEecccceecCCCCc--
Q 015741 214 NNT--DFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 214 ~~~--~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~----~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
... +|.++. ++++...+..++.|++.-++|+|++.+|.|||||+|+||.. +...|.|+|||+|+.+.+...
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 543 333333 46999999999999999999999999999999999999953 233799999999987754322
Q ss_pred ------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHhC
Q 015741 285 ------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLVKIAKVLG 347 (401)
Q Consensus 285 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~--~~~~~~~l~~i~~~~~ 347 (401)
.....||..||+-....+ ...+.+.|+-|||-++++++-|..||.. ..++.+..++|-+...
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred cCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 244578999999998887 7889999999999999999999999953 2345555566654433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=227.99 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=178.9
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEec----ccch-----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~----~~~~-----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.-.+.+|.|++|.|+.+......+.++.|... +... ..+..|+-+-..| .|||++..+..+.+.... +
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~--~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGI--L 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccc--h
Confidence 34678999999988888877666666666543 1111 1145566666667 899998888776553322 2
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
-.|||+++ +|..++. .+...++..+++|++.|+.|+|+.||.|||||++|+++...+ .+||+|||.+..+..+..
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 34999999 8766653 488899999999999999999999999999999999999776 899999999876643322
Q ss_pred -----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH------HHhCC-----
Q 015741 285 -----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA------KVLGT----- 348 (401)
Q Consensus 285 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~------~~~~~----- 348 (401)
....+|+..|+|||++.+...-....||||.|++++.|++|+.||.......++...+. ...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 34568899999999998844444568999999999999999999965443333211100 00111
Q ss_pred ---hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 349 ---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ---~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
...+..+.+ ||+.||.+|.+++++++.+|++.+..
T Consensus 556 ~lp~~~~~~~~~-~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 556 LLPRETRIIIYR-MLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hchhhHHHHHHH-HccCChhheecHHHHhhChHhhhcce
Confidence 122233444 89999999999999999999998654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=189.30 Aligned_cols=169 Identities=15% Similarity=0.192 Sum_probs=131.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---h---HH------HHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---K---KK------IKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~---~~------~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
.++|++++.||.|+||.||++.. ++..+|+|++.+.. . .. +.+|++.+.++ .|++|..+.+++.+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 58899999999999999999654 57789999996432 1 11 57899999999 99999999998764
Q ss_pred CC------CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 201 QQ------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 201 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
.. ....+++|||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||+||+||+++.++ ++|+|||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg 179 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLS 179 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECC
Confidence 32 23578999999999997763 2333 3456999999999999999999999999998665 9999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHH
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell 323 (401)
............. .+.. ..|+.++|+|+||+++..+.
T Consensus 180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence 8875532222111 2232 45678999999999876653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=181.59 Aligned_cols=182 Identities=17% Similarity=0.132 Sum_probs=138.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-------HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+...|++|+||+||.+.. .+.+++.+.+..... ..+.+|+++|++|.+++++++++++. ..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 567899999999997764 788888777753221 25789999999997778999999862 358999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCCeeEeCCCCeEEEEecccceecCCCCcc----
Q 015741 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---- 285 (401)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---- 285 (401)
||+.|.+|..... .. ...++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~---~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 78 SYLAGAAMYQRPP---RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eeecCccHHhhhh---hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHH
Confidence 9999998865432 11 2457789999999999999999999 79999998666 7999999999865443311
Q ss_pred ----------cccccCCCccccccccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCC
Q 015741 286 ----------NVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYG 332 (401)
Q Consensus 286 ----------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwSlG~ll~elltg~~Pf~~~ 332 (401)
.....++.|+.|+...-....+ ...++++.|+-+|.++|++.|.+.+
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0112456677777643322333 5678999999999999999997543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=179.23 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=104.4
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch------------H-----------------HHHHHHHHHHHhcCCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------K-----------------KIKREIKILQNLCGGP 189 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~-----------------~~~~E~~il~~l~~hp 189 (401)
...||+|+||.||+|.+. +|+.||||++++... . ...+|++++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 367999999999999985 899999999864311 1 123499999999 666
Q ss_pred CeeEEeeEEEcCCCCCcEEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCCeeEeCCC
Q 015741 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 190 niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NIll~~~~ 265 (401)
++.....+.. ...++||||++++++... ...+++.++..++.|++.+|.++ |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILL----KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEe----cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 6643333221 123799999999766432 23578889999999999999999 799999999999999998 34
Q ss_pred CeEEEEecccceec
Q 015741 266 RKLRLIDWGLAEFY 279 (401)
Q Consensus 266 ~~vkl~DFg~a~~~ 279 (401)
.++|+|||+|...
T Consensus 155 -~v~LiDFG~a~~~ 167 (190)
T cd05147 155 -KLYIIDVSQSVEH 167 (190)
T ss_pred -cEEEEEccccccC
Confidence 7999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-24 Score=205.52 Aligned_cols=229 Identities=25% Similarity=0.348 Sum_probs=183.1
Q ss_pred ecccCCeeEEEEEE---cCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec
Q 015741 142 VGRGKYSEVFEGVH---CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (401)
Q Consensus 142 Lg~G~fg~V~~~~~---~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~ 213 (401)
+|+|+||.|++++. ...+.-||+|++++.. +.....|..++...++||.+|++...+.. ...+++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 79999999997653 2457788999876321 22455678888888779999999998865 45678999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccccc
Q 015741 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (401)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 290 (401)
.+|++..... .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+| .+++.|||+++..-..+. .+|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---ccc
Confidence 9999876654 367778889999999999999999999999999999999887 899999999987643332 289
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-HhCC-----hhHHHHHHhcCCCCCh
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLGT-----DELNAYLNKYHIELDP 364 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~-~~~~-----~~~~~~l~~~~l~~dP 364 (401)
|..|||||++. ....++|+||||++++||++|..||.. +.+..|.+ .++. ....+++.. +...+|
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~-l~~r~p 226 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQ-LFKRNP 226 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHH-HHhhCH
Confidence 99999999986 467789999999999999999999954 66666666 3332 344555555 677889
Q ss_pred hhHHH-----hhhhcCCCcccccccc
Q 015741 365 HLAAL-----VGRHSRKPWSKFITVE 385 (401)
Q Consensus 365 ~~R~~-----~~~~l~~~~~~~~~~~ 385 (401)
..|.- ++++.+|+++.-+...
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHhccCcchhHHHhccchheeeeHh
Confidence 98874 5789999988877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=173.93 Aligned_cols=134 Identities=17% Similarity=0.211 Sum_probs=106.7
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP 189 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~~hp 189 (401)
.+.||+|++|.||+|.+. +|+.||||++++.. ...+..|.+.+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 468999999999999986 89999999987431 11235788999998 788
Q ss_pred CeeEEeeEEEcCCCCCcEEEEeecCCCchhhh-c--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCC
Q 015741 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 190 niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~ 265 (401)
++.....+... ..++||||++++++... + ..+++.++..++.|++.+|.++|+ +||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 87544443322 23799999998854222 2 246778899999999999999999 9999999999999998 55
Q ss_pred CeEEEEecccceecC
Q 015741 266 RKLRLIDWGLAEFYH 280 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~ 280 (401)
.++|+|||++....
T Consensus 155 -~~~liDFG~a~~~~ 168 (190)
T cd05145 155 -KPYIIDVSQAVELD 168 (190)
T ss_pred -CEEEEEcccceecC
Confidence 79999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=208.22 Aligned_cols=191 Identities=21% Similarity=0.412 Sum_probs=157.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcC---CCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCG---GPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~---hpniv~~~~~~~~~~~~~~~lv 209 (401)
.+.|.|.+.||+|+||+||+|.+.+ |+.||+|+-++....+|.--.+++.+| + -+.|..+...+.-.+ .-++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~--~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL-KPQMLPSIMHISSAHVFQN--ASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh-chhhhcchHHHHHHHccCC--cceee
Confidence 4789999999999999999999855 999999999988877776667777777 3 123444444333232 34699
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC------CCCeEEEEeccccee--
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAEF-- 278 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~------~~~~vkl~DFg~a~~-- 278 (401)
+||.+.|+|.+++. .+++.-+..++.|++..++.||..+|||+||||+|+||.. +...++|+|||.+.-
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999988875 4788889999999999999999999999999999999942 334699999999843
Q ss_pred -cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCC
Q 015741 279 -YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 279 -~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~P 328 (401)
+.++..+...++|..+-++|+..| ..+++..|.|.|+-+++-|+.|++-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence 344556778899999999999887 8999999999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=203.19 Aligned_cols=215 Identities=22% Similarity=0.372 Sum_probs=147.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.++|+.++.|..|+||.||.++|+.+.+.+|+|+-+. +.+.+- |+... .+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~lilRn--ilt~a-~npfvv-------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NLILRN--ILTFA-GNPFVV-------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc---chhhhc--ccccc-CCccee--------------------
Confidence 4789999999999999999999999999999965432 111111 22222 444444
Q ss_pred cCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC---------
Q 015741 213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (401)
Q Consensus 213 ~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--------- 283 (401)
.+..++......++.. ++.+++|||+.||+|||+||+|.+|+.-+ ++|+.|||+++..-...
T Consensus 136 gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcch
Confidence 1112222222334332 27899999999999999999999999666 89999999986432110
Q ss_pred -----c--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------
Q 015741 284 -----E--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------- 347 (401)
Q Consensus 284 -----~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------- 347 (401)
. -...+||+.|.|||++.. +.|+..+|+|++|+|+||.+-|..||+ +++..+.+..+.....
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i~wpE~dea~ 284 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIEWPEEDEAL 284 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhccccccCcCC
Confidence 0 123489999999999986 789999999999999999999999995 4455555544433221
Q ss_pred ChhHHHHHHhcCCCCChhhHHH---hhhhcCCCcccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAAL---VGRHSRKPWSKFITVE 385 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~---~~~~l~~~~~~~~~~~ 385 (401)
.++..+++.+ +|+.+|..|.. .-++.+|++++-+...
T Consensus 285 p~Ea~dli~~-LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 285 PPEAQDLIEQ-LLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CHHHHHHHHH-HHHhChHhhcccchhhhhhhccceeecccc
Confidence 2344444555 46666666653 4556666666665543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=180.27 Aligned_cols=193 Identities=21% Similarity=0.321 Sum_probs=122.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcC---------CCCeeEEeeEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCG---------GPNIVKLLDIV 198 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~---------hpniv~~~~~~ 198 (401)
..+...+.||.|+++.||.+++..+|+.+|+|++.- ...+.+++|.-....+.+ |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 346678999999999999999999999999999742 123455665544433211 22333333332
Q ss_pred EcC---------CC---C---CcEEEEeecCCCchhhhcC------CC---CHHHH-HHHHHHHHHHHHHHHhCCceeec
Q 015741 199 RDQ---------QS---K---TPSLIFEHVNNTDFKVLYP------TL---SDYDV-RYYIYELLKALDYCHSQGIMHRD 253 (401)
Q Consensus 199 ~~~---------~~---~---~~~lv~e~~~~~~l~~~~~------~~---~~~~~-~~i~~qi~~~L~~LH~~~ivHrD 253 (401)
..+ .. . +.+++|+-+. ++|..+.. .. ....+ ..+..|+++.+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 211 11 1 2356666664 45544432 11 11223 33448999999999999999999
Q ss_pred CCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCC-------CCCCcccchHHHHHHHHHHHcCC
Q 015741 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRK 326 (401)
Q Consensus 254 lkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~ll~elltg~ 326 (401)
|||+|++++.+| .++|+||+...... ........+..|.+||..... -.++.+.|.|+||+++|.|.+|.
T Consensus 171 i~~~nfll~~~G-~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLLDQDG-GVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE-TTS--EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEEcCCC-CEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999877 89999999876543 222224455778999986431 24788999999999999999999
Q ss_pred CCCC
Q 015741 327 EPFF 330 (401)
Q Consensus 327 ~Pf~ 330 (401)
.||.
T Consensus 248 lPf~ 251 (288)
T PF14531_consen 248 LPFG 251 (288)
T ss_dssp -STC
T ss_pred CCCC
Confidence 9995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=168.99 Aligned_cols=135 Identities=21% Similarity=0.296 Sum_probs=104.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhc----CCCCeeEEeeEEEcCCC-CCcE-EE
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQS-KTPS-LI 209 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~----~hpniv~~~~~~~~~~~-~~~~-lv 209 (401)
.+.||+|+||.||. +..++.+ +||++... ..+.+.+|+.+++.+. .||||+++++++.+..+ ..++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 36799999999995 6667666 69988653 4567999999999983 47999999999987532 3334 78
Q ss_pred Eee--cCCCchhhhcCC--CCHHHHHHHHHHHHHHH-HHHHhCCceeecCCCCCeeEeCC---CCeEEEEe-ccccee
Q 015741 210 FEH--VNNTDFKVLYPT--LSDYDVRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLID-WGLAEF 278 (401)
Q Consensus 210 ~e~--~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L-~~LH~~~ivHrDlkp~NIll~~~---~~~vkl~D-Fg~a~~ 278 (401)
+|| +.+++|.+++.. +++. ..++.|++.++ +|||+++|+||||||+|||++.. +..++|+| ||....
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence 999 447899888753 3333 45678888888 99999999999999999999742 23799999 554433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-22 Score=202.00 Aligned_cols=236 Identities=20% Similarity=0.337 Sum_probs=167.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHH-HHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il-~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+|...+.||++.|=+|.+|++ ..|. |+||++-+.. .+.++++++-+ ..+.++||++.+..+... .+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence 677889999999999999987 4454 8999985433 23344333322 234589999999887543 4566788
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec--CCCC--
Q 015741 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--HPGK-- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~--~~~~-- 283 (401)
-+|........+- +-+...+.+.|+.|++.||.-+|..||+|||||.+||||+.-+ -+.|+||..-+.. ..++
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcc
Confidence 8888765443332 2366778899999999999999999999999999999999777 5899999865432 2221
Q ss_pred ccccc----ccCCCccccccccCCC----------CCCcccchHHHHHHHHHHHcCCCCCCCC-------CCCHHHHHHH
Q 015741 284 EYNVR----VASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMIFRKEPFFYG-------HDNYDQLVKI 342 (401)
Q Consensus 284 ~~~~~----~~t~~y~aPE~~~~~~----------~~~~~~DiwSlG~ll~elltg~~Pf~~~-------~~~~~~l~~i 342 (401)
.++.. ..-.+|.|||.+.... ..+++.||||+||+++||++-+.|.|.- ..+.+.....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 12222 2334799999985411 1568899999999999998865553310 0112222233
Q ss_pred HHHhCChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 343 ~~~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+......++.++.. |++.||.+|.++++.|++
T Consensus 259 Le~Ied~~~Rnlil~-Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILS-MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHH-HHccCchhccCHHHHHHh
Confidence 344555677888877 899999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=177.28 Aligned_cols=146 Identities=23% Similarity=0.328 Sum_probs=107.4
Q ss_pred cCCCCeeEEeeEEEcC-------------------------CCCCcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHH
Q 015741 186 CGGPNIVKLLDIVRDQ-------------------------QSKTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLK 239 (401)
Q Consensus 186 ~~hpniv~~~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~ 239 (401)
.+|||||++.+.|.+. ....+|+||.-+....-.++. +..+....+.++.|+++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 4799999999877552 134567888766643332222 34677778889999999
Q ss_pred HHHHHHhCCceeecCCCCCeeEeC--C-CCeEEEEecccceecCC-------CCcccccccCCCccccccccCCCCC---
Q 015741 240 ALDYCHSQGIMHRDVKPHNVMIDH--E-QRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQDY--- 306 (401)
Q Consensus 240 ~L~~LH~~~ivHrDlkp~NIll~~--~-~~~vkl~DFg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~--- 306 (401)
|+.|||++||.|||+|.+|||+.- | -..+.|+|||++-.-+. ........|....||||+.......
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 999999999999999999999832 2 23689999998742211 1223445677789999997542211
Q ss_pred --CcccchHHHHHHHHHHHcCCCCCCC
Q 015741 307 --DYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 307 --~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
-.++|.|+.|.+.||++....|||.
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccc
Confidence 1378999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=165.44 Aligned_cols=136 Identities=15% Similarity=0.203 Sum_probs=107.7
Q ss_pred CeEEEeeecccCCeeEEEEE-EcCCCeEEEEEEecccc---------------------------hHHHHHHHHHHHHhc
Q 015741 135 DYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVK---------------------------KKKIKREIKILQNLC 186 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~il~~l~ 186 (401)
-|.+.+.||+|+||.||+|. +..+|+.||+|+++... ...+.+|+.+++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 47788999999999999998 66789999999986421 02356899999999
Q ss_pred CC--CCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCCee
Q 015741 187 GG--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVM 260 (401)
Q Consensus 187 ~h--pniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIl 260 (401)
.+ ..++++++. ...++||||+++.++.... ......++..++.|++.+|.+||++| |+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 43 334444442 1247999999998875443 23455567889999999999999999 999999999999
Q ss_pred EeCCCCeEEEEecccceec
Q 015741 261 IDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 261 l~~~~~~vkl~DFg~a~~~ 279 (401)
++ ++ .++|+|||.+...
T Consensus 182 i~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred EE-CC-CEEEEEChhhhcc
Confidence 98 44 7999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.2e-19 Score=157.33 Aligned_cols=131 Identities=24% Similarity=0.365 Sum_probs=108.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
+.||+|++|.||+|.+ +|..+++|+..... ..++.+|+.++..+ .|++++....++.+ ....++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~--~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVD--PENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEe--CCCCEE
Confidence 5799999999999986 67789999865321 23577899999998 78887766666544 345689
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
+|||++|++|......... ....++.+++.+|.++|+.|++|||++|.|||++ ++ .++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 9999999999887755444 7788999999999999999999999999999998 44 799999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=154.22 Aligned_cols=134 Identities=19% Similarity=0.335 Sum_probs=105.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------------------hHHHHHHHHHHHHhcCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP 189 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~il~~l~~hp 189 (401)
.|.+.+.||+|+||.||++.. .+|+.||||++.... ......|+.++..+ .++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence 377789999999999999987 479999999865321 12356788889888 665
Q ss_pred --CeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 190 --NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 190 --niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
.++..++. ...+++|||+.++++...... .....++.+++.++.++|+.||+||||||+||+++.++ .
T Consensus 94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~ 163 (198)
T cd05144 94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-K 163 (198)
T ss_pred CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-c
Confidence 34444432 345899999999988765431 34567889999999999999999999999999998655 8
Q ss_pred EEEEecccceecC
Q 015741 268 LRLIDWGLAEFYH 280 (401)
Q Consensus 268 vkl~DFg~a~~~~ 280 (401)
++|+|||.+....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-18 Score=149.75 Aligned_cols=128 Identities=20% Similarity=0.365 Sum_probs=99.2
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.||+|+||.||+|.. ++..+++|+..... ..++.+|++++..+ .|+++.....++.+ ....+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~--~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVD--PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEE--CCCCEEE
Confidence 389999999999984 67889999864311 24577899999999 66654433333332 2345799
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||++|++|......... .++.+++.+|.+||+.|++|||++|.||+++ ++ .++++|||++...
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence 999999998876533211 7889999999999999999999999999998 44 7999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.1e-18 Score=171.54 Aligned_cols=135 Identities=18% Similarity=0.317 Sum_probs=106.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEe--ccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~--~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
...|...+.||+|+||.||+|.+... .+++|+. +.. ..+++.+|+++++.+ +|++++....+..+
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVD- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEe-
Confidence 34456789999999999999987433 3344432 111 124578999999999 88998887766654
Q ss_pred CCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
....++||||+++++|...+. ....++.|++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++..
T Consensus 408 -~~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~ 477 (535)
T PRK09605 408 -PEEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYS 477 (535)
T ss_pred -CCCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCcccccC
Confidence 345679999999999987653 4577899999999999999999999999999995 44 7999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-19 Score=169.96 Aligned_cols=170 Identities=17% Similarity=0.237 Sum_probs=128.3
Q ss_pred CCcEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 204 KTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
.++|+.|++|...+|.+++. ..+......++.|+..|++| +|.+|+|+||.||++..+. .+||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhhee
Confidence 36899999999999999984 24566788899999999999 9999999999999998666 89999999987
Q ss_pred ecCCCC-------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHH-HHH--HHh
Q 015741 278 FYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV-KIA--KVL 346 (401)
Q Consensus 278 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~-~i~--~~~ 346 (401)
...... ..+..+||..||+||.+.+ +.|+.++||||||+||+|++. -..+|.......+.-. .+. -..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence 665444 4566789999999999998 799999999999999999997 3334321111111100 011 112
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
..|....|+.+ |+...|..||++-..-.|+|.
T Consensus 484 d~p~e~~ll~~-lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 484 DYPEEYTLLQQ-LLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCcHHHHHHHH-hcCCCcccCchHHHHhhhhhc
Confidence 23444567777 788999999977666666654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=142.37 Aligned_cols=133 Identities=20% Similarity=0.321 Sum_probs=96.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HH----------------------HHHHHHHHHHhcCC-CC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN 190 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~----------------------~~~E~~il~~l~~h-pn 190 (401)
.+.||+|+||.||+|.+. +++.||||++++... .. ...|...+.++..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999985 899999999864221 11 13566666666222 23
Q ss_pred eeEEeeEEEcCCCCCcEEEEeecCCCchhh-hcCCCCH-HHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCe
Q 015741 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LYPTLSD-YDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 191 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~-~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~ 267 (401)
+.+.++. ...+++|||+.++.+.. .+..... .+++.++.+++.++.++|. .||+||||||+||+++ ++ .
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 4454443 23479999999954321 1111122 6678899999999999999 9999999999999999 55 7
Q ss_pred EEEEecccceecC
Q 015741 268 LRLIDWGLAEFYH 280 (401)
Q Consensus 268 vkl~DFg~a~~~~ 280 (401)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-18 Score=150.44 Aligned_cols=228 Identities=18% Similarity=0.225 Sum_probs=165.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+..++-+|.....|+.|+|++ .|..+++|+++. .....|..|.-.|+.+ .||||+.+++.+.. ..++.+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacns--ppnlv~ 264 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNS--PPNLVI 264 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccC--CCCceE
Confidence 3455677889999999999997 455667777753 2346788999888888 99999999999965 467889
Q ss_pred EEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEE--EEecccceec
Q 015741 209 IFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLR--LIDWGLAEFY 279 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vk--l~DFg~a~~~ 279 (401)
+..||+.|+|...+.. ....++..++.+++.|++|||+.. |.---|....+++|.+- +.+ .+|--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfq- 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQ- 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeee-
Confidence 9999999999877642 456788999999999999999963 44446788889998654 333 444333321
Q ss_pred CCCCcccccccCCCccccccccCCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH-HHhC------Chh
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA-KVLG------TDE 350 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~-~~~~------~~~ 350 (401)
...+.-.+.||+||.+..... .-.++|+|||++++|||.|...|| .+-.+++--.+|. +.+. ...
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf-adlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc-ccCCchhhhhhhhhccccccCCCCccH
Confidence 112344578999999875322 224789999999999999999999 5555665544442 2221 112
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
-..-+.++|+..||.+||..+++.
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 233355668999999999877663
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=144.05 Aligned_cols=132 Identities=17% Similarity=0.313 Sum_probs=99.5
Q ss_pred eeec-ccCCeeEEEEEEcCCCeEEEEEEecc----------------cchHHHHHHHHHHHHhcCCCCe--eEEeeEEEc
Q 015741 140 RKVG-RGKYSEVFEGVHCTDNEKCIIKILKP----------------VKKKKIKREIKILQNLCGGPNI--VKLLDIVRD 200 (401)
Q Consensus 140 ~~Lg-~G~fg~V~~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~il~~l~~hpni--v~~~~~~~~ 200 (401)
..|| .|+.|+||.+.. .+..++||.+.. ....++.+|++++.+| .|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4576 788888888875 477889987742 1224578899999999 77664 677776443
Q ss_pred CCCC--CcEEEEeecCC-CchhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 201 QQSK--TPSLIFEHVNN-TDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 201 ~~~~--~~~lv~e~~~~-~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
.... ..++|||++++ .+|..++.. +++. .+.|++.+|.+||++||+||||||+|||++.++ .++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 2221 23599999997 578766543 3332 367899999999999999999999999998766 799999999
Q ss_pred ceec
Q 015741 276 AEFY 279 (401)
Q Consensus 276 a~~~ 279 (401)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=131.45 Aligned_cols=133 Identities=22% Similarity=0.302 Sum_probs=109.6
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCC-CCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h-pniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
+++.||.|.++.||++... +..+++|...... ...+.+|+.+++.+.++ .++++++.+... ....+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCC
Confidence 4578999999999999873 4789999986543 35789999999999444 689999887754 3567899999999
Q ss_pred CchhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 216 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+... +......++.+++.+|.+||.. +++|+|++|+||+++..+ .++++|||.+...
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGYG 139 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccCC
Confidence 877644 5566677889999999999985 799999999999999644 8999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-18 Score=173.99 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=186.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC-CeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~-~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
..|.+.+.||+|+|+.|-......+ ...+|+|.+.... ...+..|..+-+.+.+|+|++++++...+ ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 4577788899999999988876333 3456666654321 24455688888888559999999998866 45667
Q ss_pred EEEeecCCCchhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 208 LIFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-~----~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+.++|..++++.... . ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+..++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999887666 2 3567788999999999999999 999999999999999986553689999999977654
Q ss_pred -CC---ccccccc-CCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHH----h-----
Q 015741 282 -GK---EYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKV----L----- 346 (401)
Q Consensus 282 -~~---~~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~----~----- 346 (401)
.. .....+| ++.|+|||...+.....+..|+||.|+++.-+++|..|+........... .+... .
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 22 2345577 99999999998755677889999999999999999999854332221111 11111 0
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
......+.+.+ ++..+|..|.+++++-.++|.-.
T Consensus 258 ~~~~~~~~l~k-~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHK-ILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccc-cccCCchhccccccccccccccc
Confidence 12345556666 67789999999999999999977
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-16 Score=150.59 Aligned_cols=187 Identities=20% Similarity=0.302 Sum_probs=139.1
Q ss_pred HHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCc-eeecCCCC
Q 015741 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGI-MHRDVKPH 257 (401)
Q Consensus 183 ~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i-vHrDlkp~ 257 (401)
+.+ .|.|+.++++.+.++ ...++|.+||..|+|.+.+. .+...-...++++|+.||+|||...| .|+.++..
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 455 899999999999875 67789999999999988874 35666677888999999999998765 99999999
Q ss_pred CeeEeCCCCeEEEEecccceecCCC---CcccccccCCCccccccccCCC--C----CCcccchHHHHHHHHHHHcCCCC
Q 015741 258 NVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ--D----YDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 258 NIll~~~~~~vkl~DFg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~----~~~~~DiwSlG~ll~elltg~~P 328 (401)
|.+++. ...+||.|||+....... ...........|.|||.+.+.. . .+.+.||||+|++++|+++.+.|
T Consensus 79 nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999994 559999999998765321 1111122334599999987621 1 46679999999999999999999
Q ss_pred CCCCCCCH---HHHHHHHHHhC-------------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 329 FFYGHDNY---DQLVKIAKVLG-------------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 329 f~~~~~~~---~~l~~i~~~~~-------------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
|....... +.+..+.+... .+.+...+.+ |+..+|+.||+++++.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~-cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVAR-CWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHH-hcccChhhCccHHHHH
Confidence 97644333 23334333111 1123334445 8999999999998874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-14 Score=140.14 Aligned_cols=138 Identities=18% Similarity=0.288 Sum_probs=94.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHH-------------------------------------------
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------------------------------------- 176 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------------- 176 (401)
+.||.|++|.||+|+. .+|+.||||+.++...+.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999997 57899999998765433332
Q ss_pred HHHHHHHHhc---CCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCC--CCHHHHHHHHHHHHH-HHHHHHhCCce
Q 015741 177 REIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK-ALDYCHSQGIM 250 (401)
Q Consensus 177 ~E~~il~~l~---~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~-~L~~LH~~~iv 250 (401)
+|...+.++. .+.+-+.+-.++.+. ....+++|||++|+++.+.... ... +...++.+++. .+..+|..|++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence 3444333331 122233333344322 2345899999999988765321 111 23345555555 47889999999
Q ss_pred eecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 251 HrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
|+|+||.||+++.++ .++++|||++..+.+
T Consensus 280 H~D~hPgNilv~~~g-~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDG-KIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCC-cEEEEeCCCeeECCH
Confidence 999999999998666 899999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.3e-14 Score=119.64 Aligned_cols=127 Identities=21% Similarity=0.263 Sum_probs=97.2
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~ 216 (401)
++.|+.|.++.||++.. .++.|++|+..... ...+..|+.+++.+.+...+++++.... ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence 46789999999999986 47889999976543 3457889999999844434556665542 2247999999998
Q ss_pred chhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 217 ~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-----vHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
++... ......++.+++.+|..||..++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 77 ~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred ccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 87643 11123466899999999999885 9999999999998 44 799999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=142.27 Aligned_cols=243 Identities=21% Similarity=0.242 Sum_probs=181.0
Q ss_pred CCeEEEeeecc--cCCeeEEEEEE--cCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 134 DDYEVVRKVGR--GKYSEVFEGVH--CTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 134 ~~y~i~~~Lg~--G~fg~V~~~~~--~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+ +....+-.+|+.-..++..|+|.++.+..+.. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 45667788999 99999999987 7888999999743 12334456788877888789999998888765 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHH----HHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~----~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
..++-+|.+......... ..+++..++..+.+... ||.++|+.+++|-|+||+||++..+...++++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 778899998844333222 23788889999999999 99999999999999999999998774589999999998
Q ss_pred ecCCCCcc-cc----c-ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-CCHHHHHH--H-HHHh-
Q 015741 278 FYHPGKEY-NV----R-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVK--I-AKVL- 346 (401)
Q Consensus 278 ~~~~~~~~-~~----~-~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-~~~~~l~~--i-~~~~- 346 (401)
.+..+.-. .. . .+..-|++||...+ -++...||++||.++.+..++..++..+. +...++.. + .+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 87655421 11 1 56667999999875 78899999999999999988877664331 11111111 1 1111
Q ss_pred -CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 347 -GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 347 -~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++..+.. ....|++.+|..|++...++.++..+-
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccc
Confidence 1222233 444589999999999999999988874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-12 Score=114.49 Aligned_cols=133 Identities=17% Similarity=0.260 Sum_probs=98.5
Q ss_pred eeecccCCeeEEEEEEcC------CCeEEEEEEecccc-------------------------hHHH----HHHHHHHHH
Q 015741 140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK-------------------------KKKI----KREIKILQN 184 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~------~~~~vavK~~~~~~-------------------------~~~~----~~E~~il~~ 184 (401)
..||.|--+.||.|.... .+..+|||+.+... .+.+ ++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 35799999974210 1122 389999999
Q ss_pred hcCC-CCeeEEeeEEEcCCCCCcEEEEeecCCCchhh-hcC--CCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCCe
Q 015741 185 LCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LYP--TLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNV 259 (401)
Q Consensus 185 l~~h-pniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NI 259 (401)
+... -++++.+++. ..++||||+++..+.. .++ .+++.++..+..+++.+|..| |+.|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8443 5777777652 3469999998753311 111 244556677889999999998 899999999999999
Q ss_pred eEeCCCCeEEEEecccceecC
Q 015741 260 MIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 260 ll~~~~~~vkl~DFg~a~~~~ 280 (401)
|+.. + .+.|+|||.+....
T Consensus 157 L~~~-~-~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWHD-G-KVWFIDVSQSVEPT 175 (197)
T ss_pred EEEC-C-cEEEEECCCceeCC
Confidence 9974 4 69999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.4e-13 Score=134.95 Aligned_cols=139 Identities=14% Similarity=0.330 Sum_probs=93.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHH---------------------------------------
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK--------------------------------------- 174 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------------------- 174 (401)
.+|+. +.||+|++|+||+|+.+.+|+.||||+.++...+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 78999999999999997779999999997542211
Q ss_pred ----HHHHHHHHHHhc---CCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhc--C--C-----CCHHHHHHHHHHHH
Q 015741 175 ----IKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--T-----LSDYDVRYYIYELL 238 (401)
Q Consensus 175 ----~~~E~~il~~l~---~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~-----~~~~~~~~i~~qi~ 238 (401)
+.+|+..+.++. .+.+.+.+-.++.+- ....++||||+.|+.+.+.. . . +.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 233443333332 133334444444432 33457999999999886531 1 1 2222233344444
Q ss_pred HHHHHHHhCCceeecCCCCCeeEeCCC---CeEEEEecccceecCC
Q 015741 239 KALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP 281 (401)
Q Consensus 239 ~~L~~LH~~~ivHrDlkp~NIll~~~~---~~vkl~DFg~a~~~~~ 281 (401)
...|++|+|+||.||+++.++ +.++++|||++..+.+
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 458999999999999998654 3799999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-12 Score=128.78 Aligned_cols=165 Identities=22% Similarity=0.353 Sum_probs=124.2
Q ss_pred EEEEcCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHH
Q 015741 152 EGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228 (401)
Q Consensus 152 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~ 228 (401)
.|..+.++.+|.|++.+.... ....+-++.|+.+ +||||+++++.++. ...+|+|+|-+.-. ...++.+...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTErV~Pl--~~~lk~l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTERVRPL--ETVLKELGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEeeccccH--HHHHHHhHHH
Confidence 456667888999988876554 5567778889998 99999999999876 45889999988643 3344456688
Q ss_pred HHHHHHHHHHHHHHHHH-hCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-ccccccCCCccccccccCCCCC
Q 015741 229 DVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306 (401)
Q Consensus 229 ~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 306 (401)
.+...+.||+.||.||| +.+++|++|.-+.|+++..| ..||++|.++........ .....--..|..|+.+.. .
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s-- 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S-- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--
Confidence 88889999999999998 56899999999999999777 899999998754432211 011111123556665533 1
Q ss_pred CcccchHHHHHHHHHHHcC
Q 015741 307 DYSLDLWSLGCMFAGMIFR 325 (401)
Q Consensus 307 ~~~~DiwSlG~ll~elltg 325 (401)
.-..|.|-|||++++++.|
T Consensus 181 ~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhhHHHHHHHHhCc
Confidence 1356999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-13 Score=135.38 Aligned_cols=245 Identities=18% Similarity=0.063 Sum_probs=170.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-CCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..+|..+..||.|.|+.|+.+... .++..|++|-+.+.. ...-..|+.+...+.-|.+++.++..+.. ....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence 467899999999999999988754 678899999775322 12235677777777788899998877654 3455
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|+-.||+.++++.... ..+.+...+.+..|++.++.++|++.++|+|+||+||++..++...++.|||.+..+. -
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--F 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--e
Confidence 6899999998865443 3477888899999999999999999999999999999998764578999999986421 1
Q ss_pred cccccccCCCcc-ccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH-HHHHhCChhHHHHHHhcCCC
Q 015741 284 EYNVRVASRYFK-GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVLGTDELNAYLNKYHIE 361 (401)
Q Consensus 284 ~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~-i~~~~~~~~~~~~l~~~~l~ 361 (401)
..........++ ..|++.....+..+.|+++||.-+.+.+++..--..+......... .....+.....+-+.+.|..
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~ 499 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKVMIN 499 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhhhcC
Confidence 111222233334 3555555467888999999999999999886332221111111100 11111111222234555788
Q ss_pred CChhhHHHhhhhcCCCcccc
Q 015741 362 LDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 362 ~dP~~R~~~~~~l~~~~~~~ 381 (401)
.|+..|+++.++..|.-+.+
T Consensus 500 ~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 500 PDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred Cccccchhhhhhcccchhhh
Confidence 89999999888887776655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.4e-13 Score=139.86 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=180.9
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
...+.+.+.+-+-+|.++.++.+.-..++...+.|+... ...+....+-.++-.- .+|.++.....+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rs 877 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRS 877 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCC
Confidence 346789999999999999999988777776666665432 1223333333333222 456666555443 3356
Q ss_pred CcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-
Q 015741 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH- 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~- 280 (401)
..+++++|+++++|...+. ...++.++.++..+.+++++||...+.|+|++|.|+|+..++ ..++.|||......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGL 956 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCcccccccccc
Confidence 7789999999998876653 356667888889999999999999999999999999998776 78999998432110
Q ss_pred --------------------C---------C--CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCC
Q 015741 281 --------------------P---------G--KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 281 --------------------~---------~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf 329 (401)
. + .......+|+.|.+||...+ ......+|+|++|++++|.++|..||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 00122467889999999988 67788899999999999999999988
Q ss_pred CCCCCCHHHHHHHHHH---------hCChhHHHHHHhcCCCCChhhHHHhh---hhcCCCcccccccccc
Q 015741 330 FYGHDNYDQLVKIAKV---------LGTDELNAYLNKYHIELDPHLAALVG---RHSRKPWSKFITVENQ 387 (401)
Q Consensus 330 ~~~~~~~~~l~~i~~~---------~~~~~~~~~l~~~~l~~dP~~R~~~~---~~l~~~~~~~~~~~~~ 387 (401)
......+.+..|... .+.+...+.+.+ .+..+|..|..+. ++-.|++++-.+.++-
T Consensus 1036 -na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~-ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1036 -NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINR-LLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred -CCcchhhhhhccccCCCCCCCCccccChhhhhhhhh-hhccCchhccCcccccccccCCccCCCCcccc
Confidence 444444444444443 224555666666 5788999999887 8889999988877664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-11 Score=102.06 Aligned_cols=127 Identities=18% Similarity=0.309 Sum_probs=93.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-----------chHHHHHHHHHHHHhcCC-CCeeEEeeEEEcCCCCCcE
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~~h-pniv~~~~~~~~~~~~~~~ 207 (401)
..+++|+-+.+|.+.. -|..+++|.--+. ...+-.+|+.++.++..- =+++.++++. + ....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCE
Confidence 3578899999999865 3445777764221 235577899999987322 2445555543 3 3446
Q ss_pred EEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 208 LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
++|||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..+ .+.++|||++..
T Consensus 76 I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 999999999998766443 24566777778888999999999999999999854 489999999974
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.4e-12 Score=115.44 Aligned_cols=196 Identities=19% Similarity=0.197 Sum_probs=137.3
Q ss_pred HHHhcCCCCeeEEeeEEEcCC---CCCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 015741 182 LQNLCGGPNIVKLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ--GI 249 (401)
Q Consensus 182 l~~l~~hpniv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~--~i 249 (401)
|..+ .|.|||+++.|+.+.. .....+++|||..|++..+++ .+.....++|+-||+.||.|||+. -|
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3344 6889999999987643 245788999999999987764 367778889999999999999997 59
Q ss_pred eeecCCCCCeeEeCCCCeEEEEecccceecCCC------CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHH
Q 015741 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323 (401)
Q Consensus 250 vHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ell 323 (401)
+|+++..+.|++..++ -+|+.--.-. ...+. .......+-++|.+||.=.. ...+.++|||+||....+|.
T Consensus 200 ihgnlTc~tifiq~ng-LIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNG-LIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccCCcchhheeecCCc-eEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHH
Confidence 9999999999999665 5565421110 01110 11122345577889987332 34567899999999999999
Q ss_pred cCCCCCCCCCCCHHHHHHHHHH---hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 324 FRKEPFFYGHDNYDQLVKIAKV---LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 324 tg~~Pf~~~~~~~~~l~~i~~~---~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+..--..+....+.-..+... +..+--..++.+ |++-.|..|+++..++.||..=..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~k-cl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITK-CLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeeccCccccCcCcc-cccCCCCCCcchhhhhcCceeeec
Confidence 8876543443333333333332 333344556667 899999999999999999976443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.4e-11 Score=99.00 Aligned_cols=136 Identities=20% Similarity=0.291 Sum_probs=97.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+..+-+|+-+.|+++.+ .|+.++||.--+ -.+.+.++|+++|.++ .--.|.--.=++.|. ..-
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~--~~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDT--YGG 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEec--CCC
Confidence 457889999999999986 788888886321 1246678999999987 322332222234343 333
Q ss_pred EEEEeecCCC-chhhhc----CC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeE--EEEeccccee
Q 015741 207 SLIFEHVNNT-DFKVLY----PT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEF 278 (401)
Q Consensus 207 ~lv~e~~~~~-~l~~~~----~~-~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~v--kl~DFg~a~~ 278 (401)
.++|||++|. ++..++ .. ........++.+|-+.+.-||..+|||+||..+||++.+++..+ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5999999884 344333 22 22333367888999999999999999999999999998776655 8999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=104.23 Aligned_cols=138 Identities=24% Similarity=0.411 Sum_probs=104.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCC-CCeeEEeeEEEcCC-CCCcEEEEeec
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQ-SKTPSLIFEHV 213 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h-pniv~~~~~~~~~~-~~~~~lv~e~~ 213 (401)
+.|+.|..+.||++.. .+|+.+++|+.... ....+..|.++++.+..+ ..+++++.+..... ....+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999987 34689999997643 246789999999999432 34677777654321 12568999999
Q ss_pred CCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 015741 214 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS--------------------------------------------- 246 (401)
Q Consensus 214 ~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------------- 246 (401)
+|.++.... ..+++.+...++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 999887654 346667777778888888888873
Q ss_pred -----------CCceeecCCCCCeeEeCC-CCeEEEEeccccee
Q 015741 247 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEF 278 (401)
Q Consensus 247 -----------~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~ 278 (401)
..++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999863 33689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-10 Score=100.03 Aligned_cols=123 Identities=24% Similarity=0.381 Sum_probs=82.9
Q ss_pred eEEEEEEcCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCC-CCeeEEeeEE
Q 015741 149 EVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNIVKLLDIV 198 (401)
Q Consensus 149 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~~h-pniv~~~~~~ 198 (401)
.||.|.. .+|..+|||+.+... ....++|.+.|.++... -++++.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 678899999974210 13367899999999433 2677877653
Q ss_pred EcCCCCCcEEEEeecC--CCchhhhcCC-CCHHHHHHHHHHHHHHHHH-HHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 199 RDQQSKTPSLIFEHVN--NTDFKVLYPT-LSDYDVRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 199 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~-LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
.-++||||++ |..+..+... +...+...++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 2369999999 6555444322 2245567788888885555 579999999999999999855 69999999
Q ss_pred cceecC
Q 015741 275 LAEFYH 280 (401)
Q Consensus 275 ~a~~~~ 280 (401)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.2e-09 Score=97.12 Aligned_cols=128 Identities=17% Similarity=0.158 Sum_probs=90.8
Q ss_pred eEEEEEEcCCCeEEEEEEecccch--------------HHHHHHHHHHHHhcCC-CCeeEEeeEEEcCC---CCCcEEEE
Q 015741 149 EVFEGVHCTDNEKCIIKILKPVKK--------------KKIKREIKILQNLCGG-PNIVKLLDIVRDQQ---SKTPSLIF 210 (401)
Q Consensus 149 ~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~E~~il~~l~~h-pniv~~~~~~~~~~---~~~~~lv~ 210 (401)
.|+++.. +|+.|.||....... ..+.+|...+.+|... -.+++.+.+.+... ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3556543 677889996643221 1377899988887321 23334444443221 23467999
Q ss_pred eecCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC------CCCeEEEEeccccee
Q 015741 211 EHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAEF 278 (401)
Q Consensus 211 e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~------~~~~vkl~DFg~a~~ 278 (401)
|++++. +|.++.. ...+.....++.+++..+.-||..||+|+|+++.|||++. +...+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999986 7776643 3445667789999999999999999999999999999975 235899999998853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.4e-09 Score=100.12 Aligned_cols=163 Identities=17% Similarity=0.262 Sum_probs=124.9
Q ss_pred CCeeEEEEEEcCCCeEEEEEEec---ccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCCcEEEEeecCCC-chh
Q 015741 146 KYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNT-DFK 219 (401)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~---~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~~~lv~e~~~~~-~l~ 219 (401)
.-.+.|++....+|..|++|.+. .........-++.++++ .|+|+|++.++|... ....+++|++|+++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34578999999999999999983 23333445567889999 899999999988621 245678999999875 444
Q ss_pred hhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 220 VLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 220 ~~~------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
++. ...+|..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+. +++|...|+...+..
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 332 1367889999999999999999999999999999999998655 788888887776654
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCC
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKE 327 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~ 327 (401)
+.. +| +.+. .+-|.=.||.+++.|.||..
T Consensus 446 d~~-----------~~--le~~----Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT-----------EP--LESQ----QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-----------cc--hhHH----hhhhHHHHHHHHHHHhhccc
Confidence 431 11 2211 25699999999999999953
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=94.37 Aligned_cols=134 Identities=21% Similarity=0.350 Sum_probs=101.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-------c------------------chHHHHHHHHHHHHhcCC-C
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V------------------KKKKIKREIKILQNLCGG-P 189 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-------~------------------~~~~~~~E~~il~~l~~h-p 189 (401)
+.+..+||-|.-|.||.|.+ ..|.++|||.-+. . .+...++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44678999999999999997 5789999997431 0 112367899999999333 2
Q ss_pred CeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEE
Q 015741 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (401)
Q Consensus 190 niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vk 269 (401)
.+++.+++ +...+|||+++|..|.... +..+....++..|++-+.-+-..||||+|+.+=||+++.++ .+.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~ 242 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIV 242 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEE
Confidence 56666664 4557999999997765443 23555666777777777777799999999999999999876 689
Q ss_pred EEecccceec
Q 015741 270 LIDWGLAEFY 279 (401)
Q Consensus 270 l~DFg~a~~~ 279 (401)
++||-.+...
T Consensus 243 vIDwPQ~v~~ 252 (304)
T COG0478 243 VIDWPQAVPI 252 (304)
T ss_pred EEeCcccccC
Confidence 9999877543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.6e-10 Score=110.79 Aligned_cols=144 Identities=16% Similarity=0.260 Sum_probs=103.9
Q ss_pred HHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccc----------cccCCCccccccccCCC
Q 015741 236 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----------RVASRYFKGPELLVDLQ 304 (401)
Q Consensus 236 qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~----------~~~t~~y~aPE~~~~~~ 304 (401)
+++.||.|+|.. ++||++|.|++|.++..+ .+||+.|+.+........+.. ......|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 444999999986 899999999999999666 899999999866544222111 123446999999987 6
Q ss_pred CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH--HH---HHHhC-----ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV--KI---AKVLG-----TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 305 ~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~--~i---~~~~~-----~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
..+.++|++||||++|-+..|+.+............ .. ....+ .+++.+-+.+ ++..++..|+++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k-~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK-LLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH-HhcCCcccCcchhhhh
Confidence 788999999999999998866666543332111111 10 01111 3567777878 6899999999999999
Q ss_pred CCCccccc
Q 015741 375 RKPWSKFI 382 (401)
Q Consensus 375 ~~~~~~~~ 382 (401)
..+++.-.
T Consensus 264 ~~~ff~D~ 271 (700)
T KOG2137|consen 264 SIPFFSDP 271 (700)
T ss_pred cccccCCc
Confidence 99888653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.8e-08 Score=92.48 Aligned_cols=189 Identities=16% Similarity=0.216 Sum_probs=123.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEee----EEEcCC-CCCcEEEEee
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD----IVRDQQ-SKTPSLIFEH 212 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~----~~~~~~-~~~~~lv~e~ 212 (401)
..+.||+|+-+.+|-.-. -.-.+.|+...-....-.+.+..|...-.||-+-.-+. .....+ ...+-++|..
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 347799999999996432 22335677654333222233334444445554332111 111111 2235667776
Q ss_pred cCCCc-hhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 213 VNNTD-FKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 213 ~~~~~-l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+.+.. ...++ ....+.-+....+.++.+.+.||..|.+-+|+.++|+|+++++ .|.|.|=..-.....+
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng 170 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANG 170 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCC
Confidence 66542 11221 2255666788899999999999999999999999999999766 8899986544443445
Q ss_pred CcccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcC-CCCCC
Q 015741 283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFR-KEPFF 330 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg-~~Pf~ 330 (401)
..+...+|...|++||.-.- ...-+...|.|.||+++++++.| +.||.
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 55666788999999998531 12346788999999999999988 78873
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1e-07 Score=83.70 Aligned_cols=134 Identities=17% Similarity=0.182 Sum_probs=96.2
Q ss_pred cccCCeeEEEEEEcCCCeEEEEEEec---------ccchHHHHHHHHHHHHhcCC-CCeeEEe--eEEEcCCCCCcEEEE
Q 015741 143 GRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-PNIVKLL--DIVRDQQSKTPSLIF 210 (401)
Q Consensus 143 g~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~il~~l~~h-pniv~~~--~~~~~~~~~~~~lv~ 210 (401)
|+||-+.|+.... .|+.+-+|.-. +.....|.+|+..|++|... -.+++.. +.-..+.....+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888998765 34467788643 44567899999999998422 1244443 222223334567999
Q ss_pred eecCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC-CeEEEEeccccee
Q 015741 211 EHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEF 278 (401)
Q Consensus 211 e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~vkl~DFg~a~~ 278 (401)
|-+.+. +|..++. +.++.....++.+++..+.-||+.|+.|+|+-+.||+++.++ ..++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 977754 6665542 345666778999999999999999999999999999997554 2499999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.9e-08 Score=86.43 Aligned_cols=108 Identities=25% Similarity=0.369 Sum_probs=82.1
Q ss_pred hHHHHHHHHHHHHhcC-CCCeeEEeeEEEcCCC--CCcEEEEeecCCC-chhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 015741 172 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS--KTPSLIFEHVNNT-DFKVLYPT---LSDYDVRYYIYELLKALDYC 244 (401)
Q Consensus 172 ~~~~~~E~~il~~l~~-hpniv~~~~~~~~~~~--~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~i~~qi~~~L~~L 244 (401)
..+..+|...+..|.. .=.+++.+++...... ...++|+|++++. +|..+... .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567889888888732 2234555665544222 3457999999985 67777654 56667788999999999999
Q ss_pred HhCCceeecCCCCCeeEeCCC--CeEEEEecccceec
Q 015741 245 HSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY 279 (401)
Q Consensus 245 H~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~~ 279 (401)
|+.||+|+|+++.|||++.++ ..+.++||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999998654 36899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-07 Score=81.58 Aligned_cols=136 Identities=16% Similarity=0.257 Sum_probs=90.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch------------HHHHHHHHHHHHhc--CCCCeeEEeeEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------KKIKREIKILQNLC--GGPNIVKLLDIV 198 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~il~~l~--~hpniv~~~~~~ 198 (401)
..+|.+.+.+-......|.+-. -+|+.+++|..++... ....+++..+.++. +-.....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4778999999888887777765 4789999999865332 11233444444441 222333322222
Q ss_pred EcC---CCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 199 RDQ---QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 199 ~~~---~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
+-. .....+++|||++|..+.+.. .+.+ .+...+.+++.-||+.|+.|+|..|.|++++.+ .++++||+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~ 180 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG 180 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence 211 122346899999998876543 2332 244567788999999999999999999999854 489999986
Q ss_pred ce
Q 015741 276 AE 277 (401)
Q Consensus 276 a~ 277 (401)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 64
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=93.36 Aligned_cols=136 Identities=16% Similarity=0.346 Sum_probs=87.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHH-------------------------------------------H
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------------------------------------K 176 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------------~ 176 (401)
+.|+.++-|+||+|+. .+|+.||||+.++.-.+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999998 5699999999876433322 2
Q ss_pred HHHHHHHHhc----CCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhc--C--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 015741 177 REIKILQNLC----GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--TLSDYDVRYYIYELLKALDYCHSQG 248 (401)
Q Consensus 177 ~E~~il~~l~----~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~~~~~~~~~i~~qi~~~L~~LH~~~ 248 (401)
+|..-+.++. +.++ +++=.++.+- ...-+++|||++|..+.+.. + .++...+...+.++ -+.-+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 3443333331 1222 2233333322 23447999999998776552 1 23322222222211 123333489
Q ss_pred ceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 249 ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+.|.|.+|.||+++.++ ++.+.|||+...+.+
T Consensus 286 ffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence 99999999999999876 899999999877654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.1e-07 Score=80.11 Aligned_cols=133 Identities=15% Similarity=0.241 Sum_probs=95.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------------------h-----HHHHHHHHHHHHhc-CCCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------------------K-----KKIKREIKILQNLC-GGPN 190 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------------~-----~~~~~E~~il~~l~-~hpn 190 (401)
...|.+|.-+.||+|.. .++..+|+|+++... . .....|..-|+++. .+=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34778888899999985 678999999985321 0 11356777777762 2345
Q ss_pred eeEEeeEEEcCCCCCcEEEEeecCCCchh-hhcC--CCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCC
Q 015741 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR 266 (401)
Q Consensus 191 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~ 266 (401)
+++-+.+.. -.|||||++....- -.++ .+...++..+..++++.+.-|-. .++||+||..=|||+. ++
T Consensus 132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~- 203 (268)
T COG1718 132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG- 203 (268)
T ss_pred CCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence 566666542 26999999876211 0111 12333678888899999998876 8999999999999998 45
Q ss_pred eEEEEecccceecC
Q 015741 267 KLRLIDWGLAEFYH 280 (401)
Q Consensus 267 ~vkl~DFg~a~~~~ 280 (401)
.+.|+|||.|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 79999999997654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.2e-07 Score=79.73 Aligned_cols=138 Identities=20% Similarity=0.403 Sum_probs=83.9
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEEeeEEEcC-CCCCcEEEEeecCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQ-QSKTPSLIFEHVNN 215 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-pniv~~~~~~~~~-~~~~~~lv~e~~~~ 215 (401)
++.|+.|..+.||++.... ..+++|+.... ....+.+|..+++.+..+ ..+++++...... .....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4779999999999998633 59999998765 557788999999988544 2366777644322 23346899999999
Q ss_pred Cchhhh----------------c-------CC---CCHHH------HHH---H------------HHHHHH-HHHHHHh-
Q 015741 216 TDFKVL----------------Y-------PT---LSDYD------VRY---Y------------IYELLK-ALDYCHS- 246 (401)
Q Consensus 216 ~~l~~~----------------~-------~~---~~~~~------~~~---i------------~~qi~~-~L~~LH~- 246 (401)
..+... + .. ..... ... . ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 877660 0 00 00000 000 0 111222 2333332
Q ss_pred ------CCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 247 ------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 247 ------~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
..++|+|+.|.||+++.+++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999994444668999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.2e-07 Score=76.29 Aligned_cols=130 Identities=19% Similarity=0.296 Sum_probs=93.3
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecC
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
-.+.+.|++|.+|.||+|.+ .|..+|+|+-+. ..+..++.|+++|+.+..----.++|.+..+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence 34568899999999999986 566889998764 4567799999999999554455677776533 35699999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC-CCCeeEeCCCCeEEEEeccccee
Q 015741 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK-PHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk-p~NIll~~~~~~vkl~DFg~a~~ 278 (401)
|-.|...-.... +.-+..+++.---|-..||-|+.|. |..+++..++ .+.|+||..|..
T Consensus 96 G~~L~~~~~~~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGGD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhccc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 987765543222 3334455666555677899999994 5544444354 689999999874
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=78.61 Aligned_cols=72 Identities=24% Similarity=0.375 Sum_probs=52.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCC-CeeEEeeEEEcCCCCCcEEEEeecCCCc
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hp-niv~~~~~~~~~~~~~~~lv~e~~~~~~ 217 (401)
..||.|..+.||+. .+..+++|+..+. ....+.+|.++++.+.... .+++.+++..+ .....++||++.|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCcc
Confidence 56899999999984 2456789987653 3466899999999984332 25777777654 334568999999963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-06 Score=78.17 Aligned_cols=76 Identities=20% Similarity=0.215 Sum_probs=55.3
Q ss_pred eecccCC-eeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchh
Q 015741 141 KVGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (401)
Q Consensus 141 ~Lg~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (401)
.|-.|.. +.||+... .+..+++|+........+.+|+++++.+..+--+++++++.... ...++|||+++|..+.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHh
Confidence 3445555 78999864 34788899886554556789999999986665667888877543 4567999999998765
Q ss_pred h
Q 015741 220 V 220 (401)
Q Consensus 220 ~ 220 (401)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.5e-06 Score=71.53 Aligned_cols=125 Identities=24% Similarity=0.324 Sum_probs=91.0
Q ss_pred CCeEEEeeecccCC-eeEEEEEEcCCCeEEEEEEecc------------------------cchHHHHHHHHHHHHhc--
Q 015741 134 DDYEVVRKVGRGKY-SEVFEGVHCTDNEKCIIKILKP------------------------VKKKKIKREIKILQNLC-- 186 (401)
Q Consensus 134 ~~y~i~~~Lg~G~f-g~V~~~~~~~~~~~vavK~~~~------------------------~~~~~~~~E~~il~~l~-- 186 (401)
.+++.++.||.|.- |.||++.. +|+.||+|+++. .....|..|.+..-+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999986 788999999421 00124778888887773
Q ss_pred CCCCe--eEEeeEEEcCC----------------CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015741 187 GGPNI--VKLLDIVRDQQ----------------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG 248 (401)
Q Consensus 187 ~hpni--v~~~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 248 (401)
++.++ |+++||+.-.. .....||.||+.... .+ ...-+.+|++-|..+|..|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~----~~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PL----QIRDIPQMLRDLKILHKLG 184 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------cc----chhHHHHHHHHHHHHHHCC
Confidence 33455 99999874220 112356777776543 12 2234567888889999999
Q ss_pred ceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 249 ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
|+-+|+++.|.. ++ +|+|||.+
T Consensus 185 I~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 185 IVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred eeeccCcccccc---CC---EEEecccC
Confidence 999999999986 34 89999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.6e-06 Score=87.72 Aligned_cols=79 Identities=18% Similarity=0.264 Sum_probs=57.2
Q ss_pred EeeecccCCeeEEEEEEcCCC--eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCe--eEEeeEEEcCC-CCCcEEE
Q 015741 139 VRKVGRGKYSEVFEGVHCTDN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNI--VKLLDIVRDQQ-SKTPSLI 209 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~il~~l~~hpni--v~~~~~~~~~~-~~~~~lv 209 (401)
++.++.|.++.+|+.....++ ..+++|+..+. ....+.+|.++|+.+..|.++ ++++.++.+.. ....|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998764332 46788875432 335789999999999546554 78888776532 2356899
Q ss_pred EeecCCCc
Q 015741 210 FEHVNNTD 217 (401)
Q Consensus 210 ~e~~~~~~ 217 (401)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3e-06 Score=84.57 Aligned_cols=134 Identities=19% Similarity=0.268 Sum_probs=85.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchH----------------------------------H------HHHHH
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----------------------------------K------IKREI 179 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~------~~~E~ 179 (401)
+.||.-+.|.||+|+.+ +|+.||||+-++.-.+ . |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67999999999999985 5999999997643211 1 23333
Q ss_pred HHHHHhc---CCCC------eeEEeeEEEcCCCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 015741 180 KILQNLC---GGPN------IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246 (401)
Q Consensus 180 ~il~~l~---~hpn------iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~ 246 (401)
+-..+.. .|-+ |+++|-.+ ...-+|+||||+|.-+.+.- ..++..++...+.++. ++-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHh
Confidence 3322221 2333 33333322 23457999999998654442 2355554433333322 122334
Q ss_pred CCceeecCCCCCeeEeC---CCCeEEEEecccceecC
Q 015741 247 QGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 247 ~~ivHrDlkp~NIll~~---~~~~vkl~DFg~a~~~~ 280 (401)
.|++|+|-+|.||++.+ .+..+.+.|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999984 34589999999987664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.5e-08 Score=94.77 Aligned_cols=180 Identities=16% Similarity=0.182 Sum_probs=131.1
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCC-eeEEeeEEEcCCCCCcEEEEeecC
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpn-iv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.++ +||| .+..++- ++.+.+..+.++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d--~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLED--YDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCccccccc--CCcccccchhhhhhc
Confidence 455678899999999998865444443 6655433 4455678889998 9999 4443333 344667889999998
Q ss_pred CC-chhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccc
Q 015741 215 NT-DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (401)
Q Consensus 215 ~~-~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 289 (401)
++ +-..... .+.+.+...+.+.-+++|++||+.-=+|+| ||+... + ..+..||+....+..........
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCCcccCcccccccCC
Confidence 87 2111111 233444556677788899999998778998 888874 3 68999999998776655566778
Q ss_pred cCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCC
Q 015741 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 290 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~P 328 (401)
+++.++|||+..+ ..+....|.|++|+--.+|.-|-.|
T Consensus 392 ~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 392 GTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCC
Confidence 9999999999876 6788899999999877777666554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.1e-05 Score=74.03 Aligned_cols=79 Identities=10% Similarity=0.159 Sum_probs=58.9
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCC-CCCcEEEEeec
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIFEHV 213 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~-~~~~~lv~e~~ 213 (401)
-.+.||.|..+.||.... ++..+++|..+.. ....+..|...|+.|..+ -.++++++++.+.. ....++|||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 457899999999999864 2335778886552 456899999999999554 46889998875432 34478999999
Q ss_pred CCCch
Q 015741 214 NNTDF 218 (401)
Q Consensus 214 ~~~~l 218 (401)
++..+
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=71.79 Aligned_cols=75 Identities=11% Similarity=0.161 Sum_probs=47.7
Q ss_pred eeecccCCe-eEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCC-CCcEEEEeecC
Q 015741 140 RKVGRGKYS-EVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQS-KTPSLIFEHVN 214 (401)
Q Consensus 140 ~~Lg~G~fg-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~-~~~~lv~e~~~ 214 (401)
+.|+.|+.. .||+. +..+++|+.... ....+.+|.++++.+..+ --+.++++....... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457767666 58875 235778886653 345789999999998433 134555544322211 24578999999
Q ss_pred CCchh
Q 015741 215 NTDFK 219 (401)
Q Consensus 215 ~~~l~ 219 (401)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.2e-05 Score=66.71 Aligned_cols=129 Identities=21% Similarity=0.389 Sum_probs=90.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------------hHHHHHHHHHHHHhc-----CCCCeeEEe
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKLL 195 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~il~~l~-----~hpniv~~~ 195 (401)
..||+|+.-.||.- ..+....||+..+.. .++..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999999963 456667899987766 567788888877773 267999999
Q ss_pred eEEEcCCCCCcEEEEeecCCC------chhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--C
Q 015741 196 DIVRDQQSKTPSLIFEHVNNT------DFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q 265 (401)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~ 265 (401)
|+.+. ...+-+|+|.+.+. +|.++.. .+++ .+...+-+-..||-+.+|+.+||+|.||++... +
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99875 34556888876543 3444443 2333 233334445568889999999999999999643 2
Q ss_pred C-eEEEEe-cccce
Q 015741 266 R-KLRLID-WGLAE 277 (401)
Q Consensus 266 ~-~vkl~D-Fg~a~ 277 (401)
. .+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 2 577777 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.9e-05 Score=67.56 Aligned_cols=74 Identities=14% Similarity=0.260 Sum_probs=50.9
Q ss_pred EeeecccCCeeEEEEEEcC-CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 139 VRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
++.|..|-...+|++.... .++.|++|+...... -...+|+.+++.+..+.-.++++..... .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN------GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC------cEEEEeeCC
Confidence 4667888889999987532 357899998764322 2235799999988555556666654421 379999998
Q ss_pred Cch
Q 015741 216 TDF 218 (401)
Q Consensus 216 ~~l 218 (401)
..+
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.4e-05 Score=83.02 Aligned_cols=201 Identities=17% Similarity=0.188 Sum_probs=130.2
Q ss_pred HHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC--cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015741 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKT--PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGI 249 (401)
Q Consensus 175 ~~~E~~il~~l~~hpniv~~~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i 249 (401)
..-|+..+.++ .|+|++.++.|........ ..+..|++...++.... ..++...++.+..++++||.|+|+...
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34566667777 8999999999875433222 22345677666665554 357888899999999999999999966
Q ss_pred eeecCCCC---CeeEeCCCCeEEEE--ecccceecCCCCcccccccCCCccccccccCCCCCCc--ccchHHHHHHHHHH
Q 015741 250 MHRDVKPH---NVMIDHEQRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDLWSLGCMFAGM 322 (401)
Q Consensus 250 vHrDlkp~---NIll~~~~~~vkl~--DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~~DiwSlG~ll~el 322 (401)
.|.-+... +-..+.++ .+.+. ||+..+.+..............+.++|.... ..+.. ..|+|.+|.++..+
T Consensus 308 ~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence 66555444 33333333 45555 8888776654433333344445668887654 33333 46999999999999
Q ss_pred HcCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 323 ltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..|..+-.... ...............+.+.+ |+.-++++|..+.+++.|++.+.-.
T Consensus 386 ~~~~~i~~~~~----~~~~~l~~~~~~~~~d~~~~-~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 386 SQGEDISEKSA----VPVSLLDVLSTSELLDALPK-CLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhcCccccccc----chhhhhccccchhhhhhhhh-hcchhhhhccchhhhhhchhccccc
Confidence 98875532211 11122211112134455555 6788899999999999999987743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.7e-05 Score=66.55 Aligned_cols=96 Identities=22% Similarity=0.165 Sum_probs=77.7
Q ss_pred HHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchh-------hhcCCCCHHHHHHHHHHHHHHHHHHHh--
Q 015741 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKALDYCHS-- 246 (401)
Q Consensus 176 ~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~-- 246 (401)
..|.-+++.+.+.+++++++|++.. +++.||...+.+. .+ -..++.....++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3578888888666799999999832 5789999977553 22 246788899999999999999987
Q ss_pred -CCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 247 -QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 247 -~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+.-.|++++|+-++.++ .+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 3588899999999999666 8999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.3e-05 Score=68.13 Aligned_cols=129 Identities=22% Similarity=0.232 Sum_probs=77.4
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCc
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~ 217 (401)
.+..|-.+.+|+.. .+++.+++|+...... -...+|..+++.+..+.-.++++.... -++||||++|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCcc
Confidence 35567788999886 4577888998643221 135789999999854433455555431 258999999876
Q ss_pred hhhh-------c-----------C------CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeecCC
Q 015741 218 FKVL-------Y-----------P------TLSD-YDVRYYIYEL---------LKALDYCHS--------QGIMHRDVK 255 (401)
Q Consensus 218 l~~~-------~-----------~------~~~~-~~~~~i~~qi---------~~~L~~LH~--------~~ivHrDlk 255 (401)
+... . . .+.. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 0 0 0111 1111221111 111222211 248999999
Q ss_pred CCCeeEeCCCCeEEEEecccceec
Q 015741 256 PHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 256 p~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|.||+++.++ +.|+||..+..-
T Consensus 155 ~~Nil~~~~~--~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG--LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC--CEEEeccccCcC
Confidence 9999998654 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00023 Score=66.88 Aligned_cols=137 Identities=13% Similarity=0.213 Sum_probs=84.8
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEEeeEEE----cCCCCCcEEEEeec
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVR----DQQSKTPSLIFEHV 213 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hp-niv~~~~~~~----~~~~~~~~lv~e~~ 213 (401)
++.|..|....+|+... ++..+++|+........+..|+.+++.|..+- .+++++.... .......+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 56788888889999864 44578999987655677888999999884331 3455544210 01123567999999
Q ss_pred CCCchhhh----c--------------CCCC---------HH-HH--H--------HHHHHHHHHHHHHHh-------CC
Q 015741 214 NNTDFKVL----Y--------------PTLS---------DY-DV--R--------YYIYELLKALDYCHS-------QG 248 (401)
Q Consensus 214 ~~~~l~~~----~--------------~~~~---------~~-~~--~--------~i~~qi~~~L~~LH~-------~~ 248 (401)
+|..+... . ..+. .. .. . .....+..++.++.+ .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 98764320 0 0000 00 00 0 011112333444443 47
Q ss_pred ceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 249 ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 99999999999998654 568999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00026 Score=66.84 Aligned_cols=73 Identities=16% Similarity=0.198 Sum_probs=49.9
Q ss_pred eeecccCCeeEEEEEEcC------CCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~------~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
+.|..|-...||+..... .++.+++|+.... ......+|.++++.+..+.-.++++.++.+ .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchhh
Confidence 556677777899887532 2578999997653 224568899999988554445566666532 25789
Q ss_pred ecCCCch
Q 015741 212 HVNNTDF 218 (401)
Q Consensus 212 ~~~~~~l 218 (401)
|++|..+
T Consensus 78 ~i~G~~l 84 (302)
T cd05156 78 FIPSRTL 84 (302)
T ss_pred eeCCCcC
Confidence 9888654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00036 Score=66.45 Aligned_cols=136 Identities=13% Similarity=0.211 Sum_probs=78.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEeeE-----EEcCCCCCcEEEEee
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI-----VRDQQSKTPSLIFEH 212 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-pniv~~~~~-----~~~~~~~~~~lv~e~ 212 (401)
.+.|+.|....+|.... . +..+++|++.....+.+..|..+++.|..+ -.+++.+.. +.. .....++++||
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~-~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE-LAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee-eCCEEEEEEEe
Confidence 35677788889999864 3 347899988643456667778888777322 123444421 111 12346899999
Q ss_pred cCCCchhh-----h------c-------CCC--------C--H-HHH------------HHHHHH-HHHHHHHHH-----
Q 015741 213 VNNTDFKV-----L------Y-------PTL--------S--D-YDV------------RYYIYE-LLKALDYCH----- 245 (401)
Q Consensus 213 ~~~~~l~~-----~------~-------~~~--------~--~-~~~------------~~i~~q-i~~~L~~LH----- 245 (401)
++|..+.. . + ..+ . . .+. ...+.+ +...++.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99874311 0 0 001 0 0 000 001111 111222332
Q ss_pred --hCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 246 --SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 246 --~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
..++||+|+.|.||+++.+. ..-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 23899999999999998443 457999998853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00044 Score=67.42 Aligned_cols=74 Identities=16% Similarity=0.248 Sum_probs=54.5
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec----------ccchHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCCCCc
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------PVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~----------~~~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~~~~ 206 (401)
.+.||.|.+..||++....+++.++||.-. +...++...|.+.|+.+..+ .++++++.+- ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 477999999999999985444689999843 12446778888888887433 4678888873 2345
Q ss_pred EEEEeecCCC
Q 015741 207 SLIFEHVNNT 216 (401)
Q Consensus 207 ~lv~e~~~~~ 216 (401)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 7999998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=4.3e-05 Score=70.90 Aligned_cols=134 Identities=18% Similarity=0.288 Sum_probs=97.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-------cc--ch----------------HHHHHHHHHHHHhcCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PV--KK----------------KKIKREIKILQNLCGGP 189 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-------~~--~~----------------~~~~~E~~il~~l~~hp 189 (401)
-+.+.+.||-|.-+.||.+-+ ..|++.++|+-+ .. ++ -...+|...|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467889999999999999987 678899999742 10 00 12457888888885543
Q ss_pred -CeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeE
Q 015741 190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (401)
Q Consensus 190 -niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~v 268 (401)
-+++.+++ ...++|||++.+..|.....-.. +..+...++.-+.-|..+|+||+|..-=||+++.++ .+
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i 241 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRHVED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KI 241 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeeecCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC-CE
Confidence 34455543 34579999999988765543222 334445566667788899999999999999999666 79
Q ss_pred EEEecccceec
Q 015741 269 RLIDWGLAEFY 279 (401)
Q Consensus 269 kl~DFg~a~~~ 279 (401)
+++||-.+...
T Consensus 242 ~vIDFPQmvS~ 252 (465)
T KOG2268|consen 242 VVIDFPQMVST 252 (465)
T ss_pred EEeechHhhcc
Confidence 99999876544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00053 Score=64.96 Aligned_cols=138 Identities=17% Similarity=0.251 Sum_probs=82.9
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCeeEEeeEEE----cCCCCCcEEEE
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVR----DQQSKTPSLIF 210 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-pniv~~~~~~~----~~~~~~~~lv~ 210 (401)
..++.++.|....+|+... ++..+++|+.... ..+.+..|.+++..|.++ -.+++++.... .......++++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3456778888889998864 3446889987653 346677888888888432 12445444211 01134568999
Q ss_pred eecCCCchhh--------h-------c---CCCC-------HHHHH----------------HHHHHHHHHHHHHHh---
Q 015741 211 EHVNNTDFKV--------L-------Y---PTLS-------DYDVR----------------YYIYELLKALDYCHS--- 246 (401)
Q Consensus 211 e~~~~~~l~~--------~-------~---~~~~-------~~~~~----------------~i~~qi~~~L~~LH~--- 246 (401)
||++|..+.. . . ..++ ....+ .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854310 0 0 0010 00000 001122334555542
Q ss_pred ----CCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 247 ----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 247 ----~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
.+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 5899999999999998665 56899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00066 Score=64.21 Aligned_cols=134 Identities=19% Similarity=0.272 Sum_probs=94.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------------------------ch-----HHHHHHHHHHHHhcCC
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------------------------KK-----KKIKREIKILQNLCGG 188 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------------------------~~-----~~~~~E~~il~~l~~h 188 (401)
+-..|..|.-+.||.|.. .+|..+|||+++.. +. -....|++-|+++ +.
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence 456788999999999986 67888999997521 00 1246788888888 44
Q ss_pred CCeeEEeeEEEcCCCCCcEEEEeecCCCchhh-hc--CCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCCeeEeCC
Q 015741 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY--PTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 189 pniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~--~~~~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NIll~~~ 264 (401)
-.|+----+.. ...+|||+|+....... .+ ..++...+..+-.|++.-+.-| |..++||.||.-=|+|+- +
T Consensus 226 aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 226 AGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred cCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 44432222221 23479999998544321 11 1467777888888888888877 456999999999999997 4
Q ss_pred CCeEEEEecccceec
Q 015741 265 QRKLRLIDWGLAEFY 279 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~ 279 (401)
+ .+.|+|.+.+...
T Consensus 301 G-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVEH 314 (520)
T ss_pred C-EEEEEEccccccC
Confidence 5 7999999988654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0038 Score=60.07 Aligned_cols=134 Identities=19% Similarity=0.251 Sum_probs=80.7
Q ss_pred EeeecccCCeeEEEEEEcC----CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 139 VRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~----~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
++.|-.|-...+|++.... .++.|++|+...... -.-.+|..+++.+..+.--+++++.+.. + .|.||
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g----~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G----RVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--c----eEEEe
Confidence 3455558888999986432 246899998754321 1126799999998665555677776632 2 57899
Q ss_pred cCCCchhhh--c----------------C-C------CC-HHHHHHHHHHH-----------------HHHHHHH----H
Q 015741 213 VNNTDFKVL--Y----------------P-T------LS-DYDVRYYIYEL-----------------LKALDYC----H 245 (401)
Q Consensus 213 ~~~~~l~~~--~----------------~-~------~~-~~~~~~i~~qi-----------------~~~L~~L----H 245 (401)
+++.++... . . . .. ...+..+..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 877664311 0 0 0 00 11222222111 1111122 1
Q ss_pred ----hCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 246 ----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 246 ----~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...++|+|+++.|||++.++..+.++||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 225899999999999986545799999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0046 Score=58.33 Aligned_cols=143 Identities=17% Similarity=0.282 Sum_probs=82.9
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHhcCC-CCeeEEeeEEEcCCCCCcEEEE
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~h-pniv~~~~~~~~~~~~~~~lv~ 210 (401)
.+++.+-.|.-..+|.... +++++++. .. ........+|..+++.+..- --+...++++.+..-...+.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3445554454455666554 38888888 22 12335678899999987332 2334455666543324678999
Q ss_pred eecCCCchhhhcCCC-----------------------------------CHHHHHHHHHH--------------HHHHH
Q 015741 211 EHVNNTDFKVLYPTL-----------------------------------SDYDVRYYIYE--------------LLKAL 241 (401)
Q Consensus 211 e~~~~~~l~~~~~~~-----------------------------------~~~~~~~i~~q--------------i~~~L 241 (401)
+|++|.......... ...++..+..+ +..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999984322111100 00011111111 11223
Q ss_pred HHHHhC--------CceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 242 DYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 242 ~~LH~~--------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
.+|+.+ .++|+|+.+.||+++.++ .+-+.||+.+..-.+..
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGDPLE 233 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCCcHH
Confidence 444432 489999999999999777 58999999998654443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0033 Score=58.55 Aligned_cols=32 Identities=34% Similarity=0.641 Sum_probs=26.1
Q ss_pred CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 248 ~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
.++|+|++|.|||++.++...-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 48999999999999864534579999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0034 Score=60.08 Aligned_cols=138 Identities=16% Similarity=0.241 Sum_probs=79.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++ +.|..|=...+|+...... +..|++|+...... -.-.+|..+++.+..+.--+++++++. .+ +|
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G----~i 88 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--NG----MI 88 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--Cc----Ee
Confidence 3444 4555577788998865332 34889998754322 123578889998855544466776652 12 58
Q ss_pred EeecCCCchhhh-------c-----------C-C------CC-HHHHHHHHHHH----------------------HHHH
Q 015741 210 FEHVNNTDFKVL-------Y-----------P-T------LS-DYDVRYYIYEL----------------------LKAL 241 (401)
Q Consensus 210 ~e~~~~~~l~~~-------~-----------~-~------~~-~~~~~~i~~qi----------------------~~~L 241 (401)
.+|+++..+... . . . .. ...+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 888877654210 0 0 0 10 11122222111 1111
Q ss_pred HHH---H-hC----CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 242 DYC---H-SQ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 242 ~~L---H-~~----~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+ . .. -++|.|+.+.|||++.++..++++||..|..-
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 111 1 11 27999999999999755447999999988643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0039 Score=59.32 Aligned_cols=134 Identities=25% Similarity=0.346 Sum_probs=82.0
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCC-----eeEEeeEEEcCCC--CCcEEEEee
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQS--KTPSLIFEH 212 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpn-----iv~~~~~~~~~~~--~~~~lv~e~ 212 (401)
.|.+ .-..||+... .+| .+++|+..+. ....+..|+..++.|..+.- +...-|-....-. .+.+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 4567898875 333 4499999885 67888999999999854421 1222121111112 367788999
Q ss_pred cCCCchhh-hc------------------CCC----------CHHH--------------HHHHHHHHHHHHHHHHhC--
Q 015741 213 VNNTDFKV-LY------------------PTL----------SDYD--------------VRYYIYELLKALDYCHSQ-- 247 (401)
Q Consensus 213 ~~~~~l~~-~~------------------~~~----------~~~~--------------~~~i~~qi~~~L~~LH~~-- 247 (401)
++|..+.. .. +.+ .... -.....++...++.+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987762 11 001 0111 001233445555555542
Q ss_pred ------C--ceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 248 ------G--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 248 ------~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
+ +||+|+.|.||+++.+...+.++||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 99999999999999665337899999885
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.06 E-value=7.3e-05 Score=81.34 Aligned_cols=152 Identities=11% Similarity=-0.044 Sum_probs=107.8
Q ss_pred HHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC
Q 015741 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ 247 (401)
Q Consensus 175 ~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~ 247 (401)
...|...++.. .|+++...+.-..+......+..++|+.+|.+...+- .+.+.-+.....+.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34455555555 7888887776655544556678999999998876652 122222333333436777777764
Q ss_pred -----CceeecCCCCCeeEeCCCCeEEEEecccceecCCC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHH
Q 015741 248 -----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG 321 (401)
Q Consensus 248 -----~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~e 321 (401)
-.+|++||+-|.+|..+. .+|++++|+.+...+. ......+++++|+.|+.... -.++.++|+|..|+.+|.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence 278999999999998655 7999999999944333 23345677888999998654 567778999999999999
Q ss_pred HHcCCCCC
Q 015741 322 MIFRKEPF 329 (401)
Q Consensus 322 lltg~~Pf 329 (401)
..-|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887666
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0076 Score=57.73 Aligned_cols=72 Identities=17% Similarity=0.283 Sum_probs=48.7
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEec----------ccchHHHHHHHHHHHHhcCC-C-CeeEEeeEEEcCCCCCcEE
Q 015741 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----------PVKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 141 ~Lg~G~fg~V~~~~~~~~~~~vavK~~~----------~~~~~~~~~E~~il~~l~~h-p-niv~~~~~~~~~~~~~~~l 208 (401)
.||.|....||++.+..+++.++||.-. +...++...|...|+..... | .++++|.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 5799999999999975444689999743 12235666788888776332 3 566676653 234468
Q ss_pred EEeecCCC
Q 015741 209 IFEHVNNT 216 (401)
Q Consensus 209 v~e~~~~~ 216 (401)
+||++...
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0032 Score=56.04 Aligned_cols=54 Identities=15% Similarity=0.121 Sum_probs=34.8
Q ss_pred CeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCch
Q 015741 159 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (401)
Q Consensus 159 ~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l 218 (401)
++.|+||+.... ..-.-..|..+++.+..+-.-+++++.+.+ .+|.||+++..+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~------g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN------GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT------EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC------CcEEEEeccccc
Confidence 467888988654 334456788888888666666778887633 267799977664
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.024 Score=53.61 Aligned_cols=66 Identities=14% Similarity=0.137 Sum_probs=39.6
Q ss_pred eEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEeeE-----EEcCCCCCcEEEEeecCCCch
Q 015741 149 EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI-----VRDQQSKTPSLIFEHVNNTDF 218 (401)
Q Consensus 149 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-pniv~~~~~-----~~~~~~~~~~lv~e~~~~~~l 218 (401)
.||++.. ++..+++|++.. ....+..|..++..|..+ -.+++++.. +.. .+...++++||++|..+
T Consensus 11 ~v~~v~t--~~g~~~LK~~~~-~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~-~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVET--DSGNKCLKKINY-PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVK-YNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEe--CCCCeEEEEcCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE-ECCEEEEEehhccCcCC
Confidence 4888763 334688998753 345566778877777332 134444432 111 13457899999998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.021 Score=55.50 Aligned_cols=73 Identities=19% Similarity=0.230 Sum_probs=51.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec---------ccchHHHHHHHHHHHHhcCC-C-CeeEEeeEEEcCCCCCcE
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~il~~l~~h-p-niv~~~~~~~~~~~~~~~ 207 (401)
.+.||.|.-.-||++.+..+++.++||.-. +...++..-|.++|+.+... | .++++|.+-. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 578999999999999874345678998742 22346677788888876332 3 5777777542 3345
Q ss_pred EEEeecCC
Q 015741 208 LIFEHVNN 215 (401)
Q Consensus 208 lv~e~~~~ 215 (401)
+|||++..
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998865
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.036 Score=54.10 Aligned_cols=75 Identities=16% Similarity=0.174 Sum_probs=47.6
Q ss_pred EeeecccCCeeEEEEEEcCC-CeE-----EEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 139 VRKVGRGKYSEVFEGVHCTD-NEK-----CIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~-~~~-----vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++.|..|-...+|++..... +.. |.+++...... -.-.+|+++++.|..+..-+++++.+.. .++.
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~ 128 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQ 128 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEEE
Confidence 35566688889999875332 122 44444321111 1235789999999667677888887732 4899
Q ss_pred eecCCCchh
Q 015741 211 EHVNNTDFK 219 (401)
Q Consensus 211 e~~~~~~l~ 219 (401)
||++|..+.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0099 Score=57.21 Aligned_cols=124 Identities=20% Similarity=0.208 Sum_probs=73.5
Q ss_pred eeecccCCeeEEEEEE---------------cCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEE-----
Q 015741 140 RKVGRGKYSEVFEGVH---------------CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----- 199 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~----- 199 (401)
..||.|+-+.||+|.. +.+.+.+|+|+..+.-.+.+...+.||.-..+-+|+|.-..+..
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v 274 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV 274 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence 4689999999998852 23346789999987766666666555554322222222111100
Q ss_pred ---------------------------------------cCCCCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHH
Q 015741 200 ---------------------------------------DQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELL 238 (401)
Q Consensus 200 ---------------------------------------~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~ 238 (401)
.+......++-+|..|..+..+.+ ..++.-.+.++.-..
T Consensus 275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~ 354 (565)
T KOG1236|consen 275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV 354 (565)
T ss_pred HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence 011122345556777777766654 344444445544444
Q ss_pred HHHH-HHHhCCceeecCCCCCeeEeC
Q 015741 239 KALD-YCHSQGIMHRDVKPHNVMIDH 263 (401)
Q Consensus 239 ~~L~-~LH~~~ivHrDlkp~NIll~~ 263 (401)
.||- -|--.+++|.|+.|.||++..
T Consensus 355 ~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 355 NALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred HHHHHHHHhhcceecccCCCcEEEEe
Confidence 4433 334568999999999999953
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.019 Score=54.40 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=26.2
Q ss_pred CceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 248 ~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
+++|+|+.+.|||++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998665 689999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.05 Score=59.86 Aligned_cols=137 Identities=20% Similarity=0.307 Sum_probs=78.7
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-CC--eeEEee--------EEEc-CCCCCc
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PN--IVKLLD--------IVRD-QQSKTP 206 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-pn--iv~~~~--------~~~~-~~~~~~ 206 (401)
+.|+ |..-.+|+... .+++.+++|+.++. ....+..|..+|..|..+ +. +.+++. ...+ ....+.
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 34577888764 56778999999854 334556677777776432 22 333332 1112 112256
Q ss_pred EEEEeecCCCchhhhc---------------------CC---------CC-----------------HHHHHHHHHHHHH
Q 015741 207 SLIFEHVNNTDFKVLY---------------------PT---------LS-----------------DYDVRYYIYELLK 239 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---------------------~~---------~~-----------------~~~~~~i~~qi~~ 239 (401)
+.+++|++|..+.... +. +. ..+.+.++.++++
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 7789999997664310 00 00 0111223333333
Q ss_pred HHHH-----HH--hCCceeecCCCCCeeEeCCC--CeEEEEeccccee
Q 015741 240 ALDY-----CH--SQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEF 278 (401)
Q Consensus 240 ~L~~-----LH--~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~ 278 (401)
...- +. .+++||+|+.+.|||++.++ ...-|+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3221 21 24799999999999998653 2345999998853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.029 Score=52.43 Aligned_cols=76 Identities=16% Similarity=0.202 Sum_probs=50.7
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCCCCCcEEEEeecC
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~~~~~~lv~e~~~ 214 (401)
+-.+.++.|....+|+.. .+++.+.||+-.......+..|..-|+.|. .--.+++++++.... ...+++|||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEeec
Confidence 346788999999999876 688899999988666778999999999983 234678888887653 33489999998
Q ss_pred CC
Q 015741 215 NT 216 (401)
Q Consensus 215 ~~ 216 (401)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.053 Score=52.95 Aligned_cols=72 Identities=17% Similarity=0.211 Sum_probs=50.9
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCCCC
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~~~ 205 (401)
..+.||.|....||+..+ .+..++||.-.+ ....+-..|...|+.+... .++++++.+..+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 357899999999999876 345688997531 1344556667777766322 478889888753 3
Q ss_pred cEEEEeecCC
Q 015741 206 PSLIFEHVNN 215 (401)
Q Consensus 206 ~~lv~e~~~~ 215 (401)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 4689999977
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.079 Score=50.59 Aligned_cols=70 Identities=14% Similarity=0.203 Sum_probs=43.0
Q ss_pred CCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEEe---e-EEEcCCCCCcEEEEeecCCCc
Q 015741 146 KYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLL---D-IVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hp-niv~~~---~-~~~~~~~~~~~lv~e~~~~~~ 217 (401)
.-..||+... .++..+++|+.++. ....+..|++.+..|..+. .++... + .+.. .+...+.++++++|..
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~-~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE-HQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE-ECCEEEEEEeeeCCCC
Confidence 3357898864 56778999998653 4567888999988884331 122211 1 1111 1245677888888764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.032 Score=55.34 Aligned_cols=154 Identities=20% Similarity=0.281 Sum_probs=87.4
Q ss_pred hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015741 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 251 (401)
Q Consensus 172 ~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 251 (401)
..++.-..+.++.+ .|+|...++++..... ....+|||++.-. +++....-. .. ..+++ .+|+.|
T Consensus 26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~-~r~IVV~e~~~~S-led~~~~~~-l~-------~~s~~----~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKH-ERVIVVMEHYTMS-LEDILKTGN-LK-------DESLL----AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhh-cCccceeeEeeecCcc-ceEEEEehhhccc-hHHHHHhcc-cc-------hhhhc----ccccce
Confidence 34566677888998 8999999999876543 3478899998643 332221100 00 00111 122222
Q ss_pred ecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 015741 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (401)
Q Consensus 252 rDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~ 331 (401)
- | .++.+| ... | .| |- ...+++|||++|.++.++.-|..-+ .
T Consensus 91 ~-----~--------~~~~td----~~~-----------t-~~--~~------~~~pKsdVwsl~~i~~el~L~~~l~-~ 132 (725)
T KOG1093|consen 91 L-----N--------IIYITD----HFL-----------T-KY--PS------PIGPKSDVWSLGFIILELYLGISLE-A 132 (725)
T ss_pred e-----h--------hhhccc----ccc-----------c-cC--CC------CCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence 1 1 234444 000 0 01 11 1114999999999999999887665 4
Q ss_pred CCCCHHHHHHHHHHhCCh------------------hHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 332 GHDNYDQLVKIAKVLGTD------------------ELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 332 ~~~~~~~l~~i~~~~~~~------------------~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
...+.+++..+.+....+ ...+++.+ |+-..|..|+.-.++..++-+
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~-c~~~~~~ir~l~~~~~k~~i~ 197 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKK-CLWLEPIIRPLPMELSKRCSF 197 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhcc-CCccccccccchhHHhcCccH
Confidence 445556666555554322 22333444 677888888866666666544
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.15 Score=56.12 Aligned_cols=76 Identities=9% Similarity=0.176 Sum_probs=45.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC---CCeeEEee--------EEEcCCCCCcE
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLD--------IVRDQQSKTPS 207 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h---pniv~~~~--------~~~~~~~~~~~ 207 (401)
..|+.+. -.+|+... ++..+++|+..+. ....+..|..++..|... -.+.+.+- ........+.+
T Consensus 37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v 113 (972)
T PRK06149 37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV 113 (972)
T ss_pred EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence 4555333 36787764 2357889998743 445677888888887433 22333332 11112234567
Q ss_pred EEEeecCCCch
Q 015741 208 LIFEHVNNTDF 218 (401)
Q Consensus 208 lv~e~~~~~~l 218 (401)
.+++|++|..+
T Consensus 114 rL~~~l~G~~~ 124 (972)
T PRK06149 114 RLLDYLPGQPL 124 (972)
T ss_pred EEEEecCCccc
Confidence 88999998654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.28 Score=48.80 Aligned_cols=75 Identities=13% Similarity=0.142 Sum_probs=48.6
Q ss_pred EEeeecccCCeeEEEEEEcCC--------CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 138 VVRKVGRGKYSEVFEGVHCTD--------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~--------~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
-++.|..|-.-.+|++..... ++.|++++.-.... -.-..|..+++.+..+.--.++++.+.. .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g------g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFSG------G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeCC------C
Confidence 457777788888999875321 46889998754321 1235688888888555444566766521 3
Q ss_pred EEEeecCCCch
Q 015741 208 LIFEHVNNTDF 218 (401)
Q Consensus 208 lv~e~~~~~~l 218 (401)
.+.||++|..+
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 67899987643
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.0089 Score=48.05 Aligned_cols=45 Identities=20% Similarity=0.426 Sum_probs=40.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHh
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL 185 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l 185 (401)
+.||.|+.|+||+|+. .+|+.||||+.++.-.+.+...+.+++.+
T Consensus 17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 6799999999999997 45999999999998888898998888876
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 401 | ||||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-144 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-144 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-144 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-144 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-144 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-143 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-143 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-143 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-142 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-142 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-124 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-124 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-124 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-124 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-124 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-124 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-124 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-124 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-124 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-124 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-124 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-124 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-124 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-124 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-123 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-119 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-119 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-26 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-26 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-26 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-25 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-24 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-24 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-24 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-24 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-24 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-24 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-24 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-24 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-24 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-24 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-24 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-24 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-24 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-24 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-24 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-24 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-24 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-24 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-24 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-24 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-24 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-24 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-24 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-23 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-23 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-20 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-20 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-04 |
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 504 bits (1301), Expect = 0.0
Identities = 222/291 (76%), Positives = 258/291 (88%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 64
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE 393
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE
Sbjct: 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-55
Identities = 83/275 (30%), Positives = 134/275 (48%), Gaps = 15/275 (5%)
Query: 85 PPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGR 144
P T + K V++ A +V D + + ++ Y + +G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 145 GKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
G + V++ C E IK +L+ K+ RE++I++ L NIV+L
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGE 121
Query: 204 KTPS----LIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
K L+ ++V T ++V TL V+ Y+Y+L ++L Y HS GI HRD
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+ DY S+D+W
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 241
Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
S GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 242 SAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGT 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 74/229 (32%), Positives = 121/229 (52%), Gaps = 14/229 (6%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+ Y + +G G + VF+ +E I K+L+ K+ RE++I++ + P
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHP 92
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELLK 239
N+V L K L+ E+V T ++ Y T+ ++ Y+Y+LL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
+L Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +Y ++D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGT 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGP 189
E D ++V R G+G + V G + IK I P + + + ++ L L P
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHP 79
Query: 190 NIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELL 238
NIV+L + ++ E+V +T + Y ++ ++++L+
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 239 KALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+++ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY++
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNA 353
PEL+ Q Y ++D+WS+GC+FA M+ + P F G ++ QL +I +VLG + L
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRK 258
Query: 354 YLNKYHIELDPHLAALVGRHSRKPWSK 380
+ + PWS
Sbjct: 259 LNPSHTDVDLYNS-------KGIPWSN 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 71/232 (30%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ YE + K+G G Y VF+ + + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYEL 237
+L+ L PN+V LL++ R ++ L+FE+ ++T L Y + ++ V+ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 296
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PELLV Y +D+W++GC+FA ++ P + G + DQL I K LG
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-51
Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 14/224 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGG 188
+ YE + VG G Y V + + IK K +K REIK+L+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH- 83
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALDYCH 245
N+V LL++ + ++ L+FE V++T L +P L V+ Y+++++ + +CH
Sbjct: 84 ENLVNLLEVCKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELLV
Sbjct: 142 SHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ M F EP F G + DQL I LG
Sbjct: 201 KYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN 243
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 55/290 (18%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y + + +G G + V E ++ +K + + K RE+ I++ L NI+KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 196 DIVRDQQSKTPS------------------------------------LIFEHVNNTDFK 219
D + P +I E+V +T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 220 VLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
VL ++ + YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
G A+ P + + SR+++ PEL++ +Y S+DLWS+GC+F +I K P F G
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245
Query: 334 DNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380
+ DQLV+I +++GT +++ Y P L K W K
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRK 288
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 73/233 (31%), Positives = 123/233 (52%), Gaps = 31/233 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G G Y VF+ + +E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
+L+ L NIV+L D++ + T L+FE + D K L V+ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LLK L +CHS+ ++HRD+KP N++I+ L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L + Y S+D+WS GC+FA + P F G+D DQL +I ++LGT
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-49
Identities = 68/236 (28%), Positives = 121/236 (51%), Gaps = 34/236 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
D Y + K+G G Y EV++ + NE V K+I+ RE+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIREVS 85
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYEL 237
+L+ L NI++L ++ LIFE+ D K P +S ++ ++Y+L
Sbjct: 86 LLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYH-PGKEYNVRVASR 292
+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ PE+L+ + Y S+D+WS+ C++A M+ K P F G DQL KI +VLG
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGL 256
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-49
Identities = 70/233 (30%), Positives = 123/233 (52%), Gaps = 33/233 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ Y + K+G G Y V++ + + KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
IL+ L NIVKL D++ ++ L+FEH++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LL + YCH + ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ + Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 71/232 (30%), Positives = 125/232 (53%), Gaps = 31/232 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
+ Y + K+G G Y+ V++G + V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYEL 237
L++L NIV L DI+ ++S T L+FE+++ D K ++ ++V+ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH Q ++HRD+KP N++I+ L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ DY +D+W +GC+F M + P F G +QL I ++LGT
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGT 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 78/236 (33%), Positives = 127/236 (53%), Gaps = 33/236 (13%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 177
G + Y+ + KVG G Y V++ + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYY 233
EI +L+ L PNIV L+D++ ++ T L+FE + D K + L D ++ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQIKIY 124
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ P++L+ + Y S+D+WS+GC+FA MI K P F G + DQL KI +LGT
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGT 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-48
Identities = 69/242 (28%), Positives = 116/242 (47%), Gaps = 40/242 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----------------R 177
YE V ++G G Y V++ V K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60
Query: 178 EIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSD 227
E+ +L+ L PN+V+L+D+ ++ L+FEHV+ D + P L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
++ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTP 178
Query: 288 RVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V + +++ PE+L LQ Y +D+WS+GC+FA M FR++P F G+ DQL KI ++
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235
Query: 347 GT 348
G
Sbjct: 236 GL 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 72/239 (30%), Positives = 123/239 (51%), Gaps = 36/239 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE V ++G G Y +VF+ + + V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 181 ILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSDYDV 230
+L++L PN+V+L D+ ++ + L+FEHV+ D P + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETI 122
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
+ +++LL+ LD+ HS ++HRD+KP N+++ + ++L D+GLA Y V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVV 181
Query: 291 SRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L LQ Y +DLWS+GC+FA M FR++P F G + DQL KI V+G
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGL 237
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 69/237 (29%), Positives = 124/237 (52%), Gaps = 36/237 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
++ + K+G G Y+ V++G++ T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---------YPTLSDYDVRY 232
++ L NIV+L D++ + T L+FE ++ D K L V+Y
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVAS 291
+ ++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ P++L+ + Y S+D+WS GC+ A MI +P F G ++ +QL I ++GT
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGT 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 74/228 (32%), Positives = 126/228 (55%), Gaps = 19/228 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL 185
YE + +G G+++ V++ N+ IK +K + + K REIK+LQ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKAL 241
PNI+ LLD + + + L+F+ + TD +V+ L+ ++ Y+ L+ L
Sbjct: 70 SH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 300
+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+W++GC+ A ++ R PF G + DQL +I + LGT
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGT 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 72/248 (29%), Positives = 129/248 (52%), Gaps = 18/248 (7%)
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPV 170
++++R + ++ + W Y VG G Y V + EK IK + +P
Sbjct: 2 LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 171 KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVL 221
+ K+ RE+ +L+++ N++ LLD+ S L+ + TD K++
Sbjct: 62 QSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM 119
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
S+ ++Y +Y++LK L Y HS G++HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADA 178
Query: 282 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
Y V +R+++ PE+++ Y+ ++D+WS+GC+ A M+ K F G D DQL
Sbjct: 179 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLT 234
Query: 341 KIAKVLGT 348
+I KV G
Sbjct: 235 QILKVTGV 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-46
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 22/233 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 192
Y ++ +G G VF V +++ IK + P K REIKI++ L NIV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLK 239
K+ +I+ S+ + ++ L + R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 295
L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P LL+ +Y ++D+W+ GC+FA M+ K F G +Q+ I + +
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPV 243
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-46
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 40/243 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G+G + EVF+ H +K V KK+ REIK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPS------LIFEHVNNTDFKVL----YPTLSDYDV 230
ILQ L N+V L++I R + S L+F+ D L + ++
Sbjct: 69 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEI 126
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-----PGKEY 285
+ + LL L Y H I+HRD+K NV+I + L+L D+GLA + Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
RV + +++ PELL+ +DY +DLW GC+ A M + + P G+ QL I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244
Query: 346 LGT 348
G+
Sbjct: 245 CGS 247
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 32/289 (11%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
E + + Q Y V R + G Y V GV ++ IK + V
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62
Query: 173 -----------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF 218
K++ REI++L + PNI+ L DI + L+ E + TD
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDL 120
Query: 219 -KVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
+V++ +S ++Y++Y +L L H G++HRD+ P N+++ + + + D+
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFN 179
Query: 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
LA V R+++ PEL++ + + +D+WS GC+ A M RK F G
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGST 238
Query: 335 NYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380
Y+QL KI +V+GT +++ + + + +L + + W+
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARD---YLRNSLSNVPARAWTA 284
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 70/241 (29%), Positives = 121/241 (50%), Gaps = 24/241 (9%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQ 183
+ + D+++ +G G Y V H E IK ++P K + REIKIL+
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELL 238
+ NI+ + +I R + + +I E + TD +V+ LSD ++Y+IY+ L
Sbjct: 65 HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------- 288
+A+ H ++HRD+KP N++I+ L++ D+GLA N
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 289 -VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
VA+R+++ PE+++ Y ++D+WS GC+ A + R+ P F G D QL+ I ++G
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIG 240
Query: 348 T 348
T
Sbjct: 241 T 241
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 72/238 (30%), Positives = 127/238 (53%), Gaps = 19/238 (7%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKR 177
E W + Y ++ VG G Y V V K IK + +P + K+ R
Sbjct: 14 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSDYDVR 231
E+++L+++ N++ LLD+ ++ L+ + TD K++ L + ++
Sbjct: 74 ELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQ 131
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVA 290
+ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA Y V
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VV 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGT 244
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 68/244 (27%), Positives = 122/244 (50%), Gaps = 32/244 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
YE+V+K+G+G Y V++ + E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYCHS 246
NIV LL+++R + L+F+++ TD V+ L +Y +Y+L+K + Y HS
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------------------ 288
G++HRD+KP N++++ + +++ D+GL+ + +
Sbjct: 128 GGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 289 ----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
VA+R+++ PE+L+ Y +D+WSLGC+ ++ K P F G +QL +I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIG 245
Query: 345 VLGT 348
V+
Sbjct: 246 VIDF 249
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 66/242 (27%), Positives = 126/242 (52%), Gaps = 19/242 (7%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKK 173
++ E W + Y+ + VG G Y V + +K L + K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSD 227
+ RE+++L+++ N++ LLD+ +S L+ + D ++ L+D
Sbjct: 74 RTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTD 131
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286
V++ IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY- 189
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246
Query: 347 GT 348
GT
Sbjct: 247 GT 248
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 61/242 (25%), Positives = 116/242 (47%), Gaps = 13/242 (5%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
R ++ E + Y+ ++ +G G V IK + +P +
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 173 --KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLS 226
K+ RE+ +++ + NI+ LL++ Q+S ++ E ++ +V+ L
Sbjct: 67 HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMT 184
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V +RY++ PE+++ Y ++D+WS+GC+ MI F G D+ DQ K+ + L
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242
Query: 347 GT 348
GT
Sbjct: 243 GT 244
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 67/232 (28%), Positives = 121/232 (52%), Gaps = 17/232 (7%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNL 185
+ Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKA 240
NI+ + DI+R + ++ + + TD K+L LS+ + Y++Y++L+
Sbjct: 83 -RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
L Y HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PE++++ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 19/244 (7%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK--- 172
+++ E + Y+ ++ +G G V + IK + +P +
Sbjct: 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSD 227
K+ RE+ +++ + NI+ LL++ Q++ L+ E ++ +V+ L
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP 222
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y V +RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277
Query: 345 VLGT 348
LGT
Sbjct: 278 QLGT 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 64/268 (23%), Positives = 121/268 (45%), Gaps = 49/268 (18%)
Query: 121 WDYESLTVQWGE--QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK- 176
+D++ E +D +E KVGRG Y V++ + + K+I+
Sbjct: 5 YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEG 58
Query: 177 --------REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL------- 221
REI +L+ L PN++ L + + L+F++ D +
Sbjct: 59 TGISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRAS 116
Query: 222 -----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK---LRLIDW 273
L V+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 274 GLA-EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
G A F P K + V + +++ PELL+ + Y ++D+W++GC+FA ++ EP
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPI 235
Query: 330 FYGHD---------NYDQLVKIAKVLGT 348
F+ ++DQL +I V+G
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 26/231 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 303
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 304 ----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WSLGC+ M + K PF + +L I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 31/292 (10%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H P + ++ + + +D + E ++V+
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGR-- 56
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG- 187
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 57 -IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCH 245
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 115 SDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 173 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 303 ----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WSLGC+ M + K PF + +L I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 37/253 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 303 ---------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
D+WSLGC+ M + K PF + +L I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235
Query: 354 YLNKYHIELDPHL 366
+ IE
Sbjct: 236 --PNHEIEFPDIP 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 21/251 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M + Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
+ Y ++DLWS+G F PF + K++ A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 354 YLNKYHIELDP 364
E P
Sbjct: 248 ISGVQKAENGP 258
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y+ V+K+G G Y EV + + IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL D D+++ L+ E D + ++ D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ YD D+WS+G + ++ PF
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFG 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 47/199 (23%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
D + RK+G G + +V + + +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYELLKAL 241
PNI+K+ ++ D + ++ E + LS+ V + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 300 LVDLQDYDYSLDLWSLGCM 318
+D + D+WS G +
Sbjct: 198 F--KRDVTFKCDIWSAGVV 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 47/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
D++ + +G G + +VF+ H D + +IK +K +K +RE+K L L NIV
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------------------PTLSDYDVRY 232
+ + K L+ L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++ K +DY HS+ +++RD+KP N+ + + ++++ D+GL + +
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+ PE + QDY +DL++LG + A ++ + F + L
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 72/328 (21%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSE 149
AQ+ + + + S+ + W D YE+ +G G Y
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 150 VFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204
V E + IK IL+ + K+I REI IL L ++VK+LDIV + +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVE 127
Query: 205 TPS---LIFEHVNNTDF-KVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258
++ E + +DF K+ L++ ++ +Y LL + Y HS GI+HRD+KP N
Sbjct: 128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----------------------------VA 290
+++ + +++ D+GLA + N + V
Sbjct: 187 CLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPFFYGHD------ 334
+R+++ PEL++ ++Y ++D+WS+GC+FA ++ + P F G
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305
Query: 335 --------------NYDQLVKIAKVLGT 348
N DQL I +LGT
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGT 333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF---FYGHDNYDQLVKIAK 344
+ Y ++DLWS+G F PF N + + KI
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D Y+ R +G+G + EV ++C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
PNI+KL + D+ L+ E D + S+ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 244 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 302 DLQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 201 -HGTYDEKCDVWSTGVI 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 37/242 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
D+E + +G+G + +V + + D+ IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y---PTLSDY-----------DVRYYIY 235
+V+ ++++ + +T F + Y TL D +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+ H + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 296 G---------------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
E+L Y+ +D++SLG +F MI+ PF G + + L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 341 KI 342
K+
Sbjct: 240 KL 241
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKAL 241
PNI+KL +I+ D S ++ E + L+ S++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCM 318
L YD D+WS G +
Sbjct: 195 L--RGTYDEKCDVWSAGVI 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 57/272 (20%), Positives = 95/272 (34%), Gaps = 21/272 (7%)
Query: 71 HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQW 130
H H H L T + RV + Y+ +
Sbjct: 2 HHHHHHSSGVDLGTE--------NLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPES 53
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 185
Q ++ + ++G G Y EVF+ D +K P + + E+ + +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALD 242
P V+L ++ L E + + +L + V Y+ + L AL
Sbjct: 114 GQHPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y + D++SLG + E G
Sbjct: 231 --SYGTAADVFSLGLTILEVACNMELPHGGEG 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 53/245 (21%), Positives = 101/245 (41%), Gaps = 28/245 (11%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRKV-GRGKY 147
A P + ++ L ++ DDY+V +V G G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 148 SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
+V + + EK +K+L+ K +RE+++ P+IV+++D+ + +
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 208 --LIFEHVN------------NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
++ E ++ + F ++ + + + +A+ Y HS I HRD
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 254 VKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 311
VKP N++ ++ L+L D+G A+ + Y+ PE+L + YD S D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCD 245
Query: 312 LWSLG 316
+WSLG
Sbjct: 246 MWSLG 250
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
DDY++ ++V G G +V E H +KC +K+L K ++E+ GGP+I
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 192 VKLLDIVRDQQSKTPS--LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKALDYC 244
V +LD+ + +I E + + + ++ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS I HRDVKP N++ +++ L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 303 LQDYDYSLDLWSLG 316
+ YD S D+WSLG
Sbjct: 203 PEKYDKSCDMWSLG 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 190
+ Y + +GRG++ V V + + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 191 IVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
I+ L + + +I FE +N + F+ L++ ++ Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 242 DYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 301 VDLQDYDYSLDLWSLG 316
+ D+WSLG
Sbjct: 176 -QHDVVSTATDMWSLG 190
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
Y + +GRG + EV V + K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NI++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 247 QGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 305 DYDYSLDLWSLGCM 318
Y D WS G M
Sbjct: 183 LYGPECDEWSAGVM 196
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 27/251 (10%)
Query: 84 TPPDTLAQKIGKSVRRSGAPSKAR----VYSDINVVRPREYWDYESLTVQWGE-QDDYEV 138
P D ++ G V G + + D V + + + + ++ D Y++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
++G G + V + K+ +++EI+ + L P +V L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLH 220
Query: 196 DIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
D D +I FE V + K +S+ + Y+ ++ K L + H
Sbjct: 221 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE 273
Query: 247 QGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M +L+LID+GL P + V + F PE+ + +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKP 332
Query: 306 YDYSLDLWSLG 316
Y D+WS+G
Sbjct: 333 VGYYTDMWSVG 343
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------------PVKKKKIKR 177
+ Y VRK+G G Y EV + + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FK--VLYPTLSDYDVRYYI 234
EI +L++L PNI+KL D+ D++ L+ E + F+ + + D +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++L + Y H I+HRD+KP N++++ + ++++D+GL+ F+ + R+ +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCM 318
Y+ PE+L + Y+ D+WS G +
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVI 236
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-36
Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ N++ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 189
D Y+++ ++G G + V V I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 190 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
++ L D D+ LI F+ + D+K +S+ +V Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 241 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 300 LVDLQDYDYSLDLWSLG 316
+ D + + D+W++G
Sbjct: 222 V-DREPVGFYTDMWAIG 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 64/276 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
D+Y + +GRG Y V+ + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALD 242
I++L D++ ++ E + +D K+ L++ ++ +Y LL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 288
+ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 144 FIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 289 ---------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPF 329
V +R+++ PEL++ ++Y S+D+WS GC+FA ++ + P
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 330 FYG-----------------HDNYDQLVKIAKVLGT 348
F G N DQL I ++GT
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGT 298
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 46/227 (20%), Positives = 93/227 (40%), Gaps = 18/227 (7%)
Query: 132 EQDDYEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
+ + +G G V+ G+ DN +K + P RE+++L+ PN
Sbjct: 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPN 79
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+++ +D+Q + + E T + + + + + L + HS
Sbjct: 80 VIRYFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 248 GIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 299
I+HRD+KPHN++I + K + D+GL + G+ R + + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 300 LVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
L + ++ Y++D++S GC+F +I F + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
P A + + R E+ S D+Y+V ++G+G +S V VH T +
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFS----DNYDVKEELGKGAFSVVRRCVHKTTGLE 56
Query: 162 CIIKI-----LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
KI L +K++RE +I + L PNIV+L D ++++ L+F+ V
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH--YLVFDLVTGG 113
Query: 217 ---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLI 271
+ V S+ D + I ++L+++ YCHS GI+HR++KP N+++ + ++L
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
D+GLA + + ++ + + PE+L Y +D+W+ G +
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVI 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 41/197 (20%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLC 186
+ Y + K GRGK++ V + + + ++ K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F----KVLYPTLSDYDVRYYIYELLKAL 241
P ++ L ++ + LI E+ + F L +S+ DV I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+H D+KP N+++ + ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 300 LVDLQDYDYSLDLWSLG 316
L + + D+W++G
Sbjct: 205 L-NYDPITTATDMWNIG 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------------PVKKKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + D+ TLS+ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 298 ELL-----VDLQDYDYSLDLWSLGCM 318
E++ + Y +D+WS G +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL +I+ D S ++ E D + S++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 303 LQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 196 RGTYDEKCDVWSAGVI 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 19/227 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
+E+ ++G G + V +H E K + L P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLK 239
N+V ++ Q P+ L E+ D K L L + +R + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 240 ALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
AL Y H I+HRD+KP N+++ ++ ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
ELL + + Y ++D WS G + I P F + Q +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVR 237
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 24/251 (9%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H + + L + SV S AP A + D + + + ++L+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWI----DGSNRDALS------ 52
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIV 192
D +EV ++GRG S V+ + +K + K V KK ++ EI +L L PNI+
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNII 111
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
KL +I SL+ E V T D V S+ D + ++L+A+ Y H
Sbjct: 112 KLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 248 GIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CA 226
Query: 306 YDYSLDLWSLG 316
Y +D+WS+G
Sbjct: 227 YGPEVDMWSVG 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
Y+V +G G + V+ G+ +DN IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 185 LC-GGPNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYIYE 236
+ G +++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+L+A+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 297 PELLVDLQDYD-YSLDLWSLG 316
PE + Y S +WSLG
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLG 236
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 50/247 (20%), Positives = 100/247 (40%), Gaps = 49/247 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D+E ++ +GRG + VFE + D+ IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDY------------- 228
IV+ + ++ + + ++ LY L D+
Sbjct: 64 GIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHP 281
+ ++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTV 177
Query: 282 GKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
G PE + Y + +D++SLG + +++ PF +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMER 233
Query: 336 YDQLVKI 342
L +
Sbjct: 234 VRTLTDV 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
+D YE+ +G+G +S V ++ ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYEL 237
L P+IV+LL+ ++FE ++ S+ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 238 LKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE++ + Y +D+W G +
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVI 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ PNI+ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 18/196 (9%)
Query: 133 QDDYEV---VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
Y++ + +G G +S + VH N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL ++ DQ L+ E +N + F K + S+ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 244 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 300
H G++HRD+KP N++ E ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 301 VDLQDYDYSLDLWSLG 316
+ YD S DLWSLG
Sbjct: 182 -NQNGYDESCDLWSLG 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
D+Y+V ++G+G +S V VH T + KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNIV+L D ++++ L+F+ V + V S+ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS GI+HR++KP N+++ + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 303 LQDYDYSLDLWSLG 316
Y +D+W+ G
Sbjct: 181 KDPYSKPVDIWACG 194
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 41/244 (16%), Positives = 88/244 (36%), Gaps = 37/244 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
++ + +G G V +K + EIK+L PN++
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 193 KLLDIVRDQQSKTPSLIFEH---------VNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+ + + E + +Y+ + ++ + +
Sbjct: 73 RYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 244 CHSQGIMHRDVKPHNVMID------------HEQRKLRLIDWGLAEFYHPGKEY-----N 286
HS I+HRD+KP N+++ E ++ + D+GL + G+ N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 287 VRVASRYFKGPELLVDLQD------YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ ++ PELL + + S+D++S+GC+F ++ + + F D Y +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRES 248
Query: 341 KIAK 344
I +
Sbjct: 249 NIIR 252
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D YE+ ++G G+++ V + ++ K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PNI+ L DI ++ LI E V + DF +L++ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 179 APEIV-NYEPLGLEADMWSIG 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 22/275 (8%)
Query: 61 RGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREY 120
R L + + +R + D + + ++ + ++
Sbjct: 21 RARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPE 80
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------- 173
+ Y+ +GRG S V VH + +KI++ ++
Sbjct: 81 DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140
Query: 174 ----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLS 226
+RE IL+ + G P+I+ L+D L+F+ + D+ LS
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALS 198
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + R + LL+A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLR 257
Query: 287 VRVASRYFKGPELL-----VDLQDYDYSLDLWSLG 316
+ + PE+L Y +DLW+ G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 48/201 (23%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
D Y+ ++G G+++ V + + + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELV--AGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS I H D+KP N+M+ + + ++++ID+GLA G E+ + F
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 185 APEIV-NYEPLGLEADMWSIG 204
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D L + V + +L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAK 344
PE + Y+ D+WSLGC+ + PF + +L KI +
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIRE 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 48/251 (19%), Positives = 101/251 (40%), Gaps = 29/251 (11%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK 173
RE ++ V + Y ++K+G G +S V D +K + + ++
Sbjct: 13 GRENLYFQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS--LIFEHVNNTD-------FKVLYPT 224
+ +RE + + PNI++L+ ++ L+ K
Sbjct: 72 EAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
L++ + + + + + L+ H++G HRD+KP N+++ ++ + L+D G E
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVE 189
Query: 285 YNVRVASR----------YFKGPELLVDLQDY---DYSLDLWSLGCMFAGMIFRKEPFFY 331
+ + + ++ PE L +Q + D D+WSLGC+ M+F + P+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 332 GHDNYDQLVKI 342
D +
Sbjct: 249 VFQKGDSVALA 259
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 52/268 (19%), Positives = 101/268 (37%), Gaps = 58/268 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
Q Y + +G+G Y V + IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 185 LCGGPNIVKLLDIVRDQQS----------------------------------------- 203
L PNI +L ++ D+Q
Sbjct: 85 LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263
+ + + L + + + ++ AL Y H+QGI HRD+KP N +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 264 -EQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ ++ P F G ++ D + ++
Sbjct: 264 VLLHLLLMGAVP-FPGVNDADTISQVLN 290
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
+Y + +G+G + VF G TD + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 185 LCGG---PNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYI 234
+ G P +++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+++ A+ +CHS+G++HRD+K N++ID + +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 295 KGPELLVDLQDYD-YSLDLWSLG 316
PE + Y +WSLG
Sbjct: 205 SPPEWISR-HQYHALPATVWSLG 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKI 181
+D+Y + + +G G EV +K IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 297 PELLVDLQD--YDYSLDLWSLGCM 318
PE+LV + Y+ ++D WSLG +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 50/243 (20%), Positives = 108/243 (44%), Gaps = 25/243 (10%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRK--VGRGK 146
R SK +++ P +D+ +T + G Y V + +G G+
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 147 YSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
+ +V + K IIK K+++K EI ++ L N+++L D +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160
Query: 204 KTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
L+ F+ + + + L++ D ++ ++ + + + H I+H D+
Sbjct: 161 IV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 255 KPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
KP N++ ++ + +++++ID+GLA Y P ++ V + F PE++ + + D+W
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMW 272
Query: 314 SLG 316
S+G
Sbjct: 273 SVG 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKI 181
+D+Y + + +G G EV +K I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 297 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE+LV + Y+ ++D WSLG +G PF +I
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 38/229 (16%), Positives = 78/229 (34%), Gaps = 31/229 (13%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 187
++ + K+G G++ VF+ V D IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNN-------TDFKVLYPTLSDYDVRYYIYELLK 239
++V+ + LI E+ N ++ + + +++ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-------------- 285
L Y HS ++H D+KP N+ I + G + + K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
V F E+L + + D+++L + G
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 43/208 (20%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 188
+D Y++ V G G ++ V ++ +++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALD 242
N+++L++ ++ L+FE + + + ++ + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNV--------RVASR 292
+ H++GI HRD+KP N++ +H + +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 293 YFKGPELL----VDLQDYDYSLDLWSLG 316
+ PE++ + YD DLWSLG
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKRE 178
D+ TV+ GE V R + G ++ V+E + +K L + K + I +E
Sbjct: 17 DFVGQTVELGELR-LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 179 IKILQNLCGGPNIVKLLD--IVRDQQSKTPSLIF----EHVNNTDFKVLYPT-----LSD 227
+ ++ L G PNIV+ + ++S T F E + L LS
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 228 YDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
V Y+ +A+ + H Q I+HRD+K N+++ Q ++L D+G A +Y
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDY 194
Query: 286 NVRVASR-------------YFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ R ++ PE ++DL D+W+LGC+ + FR+ PF
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 193
D YEV +G G YS +H N + +KI+ K+ EI+IL PNI+
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 194 LLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L D+ D + ++ E + D + S+ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 251 HRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 307 DYSLDLWSLG 316
D + D+WSLG
Sbjct: 198 DAACDIWSLG 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----------PVKKKKIKREIKILQ 183
Y + +G G + V+ V N++ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIF----EHVNNT---DFKVLYPTLSDYDVRYYIYE 236
+ NI+K+LDI + +H + F +P L + Y +
Sbjct: 85 RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ A+ Y + I+HRD+K N++I E ++LID+G A + GK + + +
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 297 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
PE+L+ Y L++WSLG ++F + PF ++ V+
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF----CELEETVE 238
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + + +G G +SEVF + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYC 244
NIV L DI L+ + V + D + ++ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 303 LQDYDYSLDLWSLGCM 318
+ Y ++D WS+G +
Sbjct: 182 -KPYSKAVDCWSIGVI 196
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 38/239 (15%), Positives = 84/239 (35%), Gaps = 31/239 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVKKKKIKREIKILQNLCGG 188
V +G G +++V+E N +K ++K+ KP + ++++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 189 --PNIVKLLDIVRDQQSKTPSLIFEHVN--------NTDFKVLYPTLSDYDVRYYIYELL 238
+K Q L+ E + N + V + +L
Sbjct: 125 MQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDH----------EQRKLRLIDWGLA---EFYHPGKEY 285
++ H I+H D+KP N ++ + L LID G + + + G +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + F+ E+L + + ++Y +D + + M+F + + +
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 48/200 (24%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74
Query: 193 KLLDIVRDQQSKTPS--LIFEHV------------NNTDFKVLYPTLSDYDVRYYIYELL 238
+++D+ + + ++ E + + F ++ + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 127
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+A+ Y HS I HRDVKP N++ ++ L+L D+G A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 167
Query: 297 PELLVDLQDYDYSLDLWSLG 316
E + YD S D+WSLG
Sbjct: 168 KETT--GEKYDKSCDMWSLG 185
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 50/194 (25%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
++Y++ ++G+G +S V V ++ I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
PNIV+L D + ++ LIF+ V + V S+ D + I ++L+A+ +CH
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 246 SQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
G++HR++KP N+++ + ++L D+GLA + + + + PE+L
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-R 186
Query: 303 LQDYDYSLDLWSLG 316
Y +DLW+ G
Sbjct: 187 KDPYGKPVDLWACG 200
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 57/232 (24%), Positives = 116/232 (50%), Gaps = 34/232 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YEV++ +G+G + +V + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 189 PNIVKLLD---------IVRDQQSKTPSL---IFEHVNNTDFKVLYPTLSDYDVRYYIYE 236
N++ +L+ + L ++E + F+ L VR + +
Sbjct: 159 MNVIHMLENFTFRNHICMT------FELLSMNLYELIKKNKFQGFSLPL----VRKFAHS 208
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+L+ LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYR 266
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+++ Y +D+WSLGC+ A + P G D DQL + ++LG
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLG 316
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 132 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 158 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCG 187
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + +++ E + D FK + + V Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAK 344
+ + Y++ D+WSLGC+ M + PF+ N L KI +
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 47/234 (20%), Positives = 106/234 (45%), Gaps = 17/234 (7%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIK 176
D + + + + Y ++K+G G + + D + +IK + ++++ +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----YPTLSDYDVR 231
RE+ +L N+ PNIV+ + + S ++ ++ D FK + + +
Sbjct: 72 REVAVLANMKH-PNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVA 290
+ ++ AL + H + I+HRD+K N+ + + ++L D+G+A + E +
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIG 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ Y+ PE+ + + Y+ D+W+LGC+ + K F + ++KI
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKNLVLKIIS 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 125 SLTVQWGEQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKR 177
SL GE+ +D++V +G+G ++ V+ + IK++ K ++++
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP---TLSDYDVRYY 233
E+KI L P+I++L + D S L+ E +N + + L S+ + R++
Sbjct: 61 EVKIHCQLKH-PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------- 284
+++++ + Y HS GI+HRD+ N+++ +++ D+GLA E
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
Y ++ PE+ + D+WSLGCMF ++ + PF
Sbjct: 177 NY---IS------PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
+D+E+ R +G+GK+ V+ +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALD 242
PNI++L D + LI E+ ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 294
YCHS+ ++HRD+KP N+++ +L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
PE++ + +D +DLWSLG + + K P F + + +I++V
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 52/194 (26%), Positives = 102/194 (52%), Gaps = 20/194 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
+Y +++ +G+G +++V H + IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 190 NIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL +++ +T LI E+ + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
CH + I+HRD+K N+++D +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 304 QDYD-YSLDLWSLG 316
+ YD +D+WSLG
Sbjct: 188 KKYDGPEVDVWSLG 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 60/231 (25%), Positives = 117/231 (50%), Gaps = 30/231 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 189 PNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 239
IV L +V + S +L ++ + NT+F+ +S R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFR----GVSLNLTRKFAQQMCT 168
Query: 240 ALDYCHSQ--GIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
AL + + I+H D+KP N+++ + +R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+L+ + YD ++D+WSLGC+ M EP F G + DQ+ KI +VLG
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 17/196 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGG 188
Y + +G G Y +V E + + +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYC 244
N+++L+D++ +++ + ++ E+ V Y +L+ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 301
HSQGI+H+D+KP N+++ L++ G+AE HP + S F+ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 302 DLQDYD-YSLDLWSLG 316
L + + +D+WS G
Sbjct: 185 GLDTFSGFKVDIWSAG 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 62/277 (22%), Positives = 102/277 (36%), Gaps = 29/277 (10%)
Query: 80 RQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
LA+ T + K R ++P +Y +Y Q
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP----- 64
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+VGRG + EV +C +K ++ + E+ L P IV L VR
Sbjct: 65 -RVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRIVPLYGAVR 120
Query: 200 DQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
+ ++ E + L + YY+ + L+ L+Y H++ I+H DVK
Sbjct: 121 EGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSL 310
NV++ + + L D+G A P + Y G PE +V + D +
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKV 237
Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQ---LVKIAK 344
D+WS CM M+ P+ Y + +KIA
Sbjct: 238 DIWSSCCMMLHMLNGCHPWT----QYFRGPLCLKIAS 270
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 37/255 (14%), Positives = 70/255 (27%), Gaps = 44/255 (17%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 184
+ ++V + G S VF E +K+ + +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 185 L-----------------------CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L P +L D L+ + D ++L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL 177
Query: 222 YPTLSDYD----------VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
+ TL + +L++ S+G++H P N+ I + R L L
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLG 236
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
D + G + E L + ++L+ W LG + PF
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 331 YGHDNYDQLVKIAKV 345
K +
Sbjct: 295 LVTPGIKGSWKRPSL 309
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
DD+++ R +G+GK+ V+ + +K+L K + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALD 242
PNI+++ + D K L+ E + +K L + + ++ EL AL
Sbjct: 72 RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 293
YCH + ++HRD+KP N+++ + + +L++ D+G + + P +Y +
Sbjct: 129 YCHERKVIHRDIKPENLLMGY-KGELKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
PE++ + +D +DLW G + + P F + + +I V
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTETHRRIVNV 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 58/254 (22%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 186
Y +VRK+G G +S V+ +N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 187 ---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY--------- 228
G +I+KLLD F H F+VL L
Sbjct: 81 DSMGANHILKLLD------------HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 229 ---DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR-----KLRLIDWGLAEFY 279
V+ +LL LDY H + GI+H D+KP NV+++ ++++ D G A +Y
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----- 334
+ Y + +R ++ PE+L+ + D+WS C+ +I F +
Sbjct: 189 D--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYT 244
Query: 335 -NYDQLVKIAKVLG 347
+ D + +I ++LG
Sbjct: 245 KDDDHIAQIIELLG 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 46/247 (18%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V + D I + + FE + +F+ VR+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQ----PYPLPHVRHMAYQLC 133
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK------------------LRLIDWGLAEFYH 280
AL + H + H D+KP N++ + + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ VA+R+++ PE++++L + D+WS+GC+ +R F H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249
Query: 341 KIAKVLG 347
+ K+LG
Sbjct: 250 MMEKILG 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 52/251 (20%), Positives = 108/251 (43%), Gaps = 54/251 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V++L+ IV + S ++ + F +R Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFL----PFRLDHIRKMAYQIC 128
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR------------------KLRLIDWGLAEFYH 280
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNY 336
+ V++R+++ PE+++ L + D+WS+GC + G F HD+
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240
Query: 337 DQLVKIAKVLG 347
+ L + ++LG
Sbjct: 241 EHLAMMERILG 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KIKREI+ L+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TP+ F E+V+ D+ + + + + R ++L A+
Sbjct: 71 -PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 184 G-RLYAGPEVDIWSCG 198
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 56/251 (22%), Positives = 112/251 (44%), Gaps = 50/251 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 189
+ V+RK+G G + V H + + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 190 NIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NIVK ++ + PSL +E + ++ + ++ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK------------------------LRLIDWGLA 276
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
F ++ + +R ++ PE++++L +D S D+WS GC+ A + + F H++
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265
Query: 337 DQLVKIAKVLG 347
+ L + ++
Sbjct: 266 EHLAMMESIIQ 276
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 56/229 (24%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK------------------- 173
Y + ++G+G Y V + DN +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 174 -------KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT- 224
++ +EI IL+ PN+VKL++++ D ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ R+Y +L+K ++Y H Q I+HRD+KP N+++ E +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 285 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDLWSLGC-MFAGMIFRKEPF 329
+ V + F PE L + + + +LD+W++G ++ +F + PF
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPF 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
Y + +G G + +V H +K +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYC 244
+I+KL D++ TP+ I E+ D+ V +++ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H I+HRD+KP N+++D + +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 305 DYD-YSLDLWSLG 316
Y +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 47/193 (24%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNI 191
D Y+ V+ +G G + E +K + + ++REI ++L PNI
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 192 VKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
V+ +++ TP+ + E+ + + S+ + R++ +LL + YCH
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 246 SQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S I HRD+K N ++D +L++ D+G ++ + V + + PE+L+ Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192
Query: 305 DYD-YSLDLWSLG 316
+YD D+WS G
Sbjct: 193 EYDGKIADVWSCG 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-27
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KI+REI+ L+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TPS IF E+V+ D+ L + + R ++L +
Sbjct: 76 -PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 130 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 189 G-RLYAGPEVDIWSSG 203
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 17/215 (7%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 195
++GRG + V++G+ + L+ K K K E ++L+ L PNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 196 DIVRDQQSKTPSLIF--EHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-- 248
D ++ E + + + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
S+D+++ G M + P + N Q+ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRV 242
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 42/319 (13%), Positives = 91/319 (28%), Gaps = 67/319 (21%)
Query: 71 HARHQHQRLRQ---LATPPDTLAQKIGKSVRRSGAPSKA-RVYSDINVVRPREYWDYES- 125
H H H R+ P D + +++ + ++ + + + S + + W+
Sbjct: 2 HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 126 ---LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIK 176
+ +G+ E E + + ++ K++K
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------ 230
E+ L+ L G N + +R P + + + D V
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 231 ------------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
++++ L H G++H ++P +++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSL 310
+D + L + V SR F+ PEL +S
Sbjct: 239 LDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 311 DLWSLGCMFAGMIFRKEPF 329
D W+LG + + P
Sbjct: 295 DAWALGLVIYWIWCADLPI 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 50/246 (20%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------------------PVKKK 173
+DY ++R + +GK++++ DN+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----------Y 222
K E++I+ ++ + I+ + +I+E++ N K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ ++ I +L + Y H++ I HRDVKP N+++D + +++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
K+ + F PE + Y+ +D+WSLG M + P F + +L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-FSLKISLVELF 262
Query: 341 -KIAKV 345
I
Sbjct: 263 NNIRTK 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 190
+E+V VG G Y +V++G H + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 191 IVKLLDIVRDQQSKTPS----LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
I + L+ E + NT TL + + Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 297 PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ ++ YD+ DLWSLG M P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 50/288 (17%), Positives = 103/288 (35%), Gaps = 84/288 (29%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGG 188
D+E ++ +GRG + VFE + D+ IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 189 PNIVKLLD----------------------------------------IVRDQQSKTPSL 208
P IV+ + I R T +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 209 IFEHVNNTDFKVLY--------PTLSDY-------------DVRYYIYELLKALDYCHSQ 247
+ + ++ LY L D+ + ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 296
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 297 --PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+DDYE+ +G G + V EK IK + ++ +EI+ + C
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72
Query: 189 PNIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS 226
PNIV +LDI++ +K L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVLD 119
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + + E+L+ L+Y H G +HRDVK N+++ E +++ D+G++ F G +
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDIT 178
Query: 287 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCM 318
+ F G PE++ ++ YD+ D+WS G
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 28/200 (14%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 198
+G+G Y V+ G ++ + IK + + + EI + ++L NIV+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 199 RDQQSKTPSLIFEHVNN----TDFKVLYPTLSDYD--VRYYIYELLKALDYCHSQGIMHR 252
+ + E V + + L D + + +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 305
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 306 YDYSLDLWSLGC----MFAG 321
Y + D+WSLGC M G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 59/282 (20%), Positives = 113/282 (40%), Gaps = 42/282 (14%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSV---RRSGAPSKARVYSDINVVRPREYWDYES 125
+S+ H H + T + Q + R+G+ V P +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEK------ 54
Query: 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREI 179
+ +R++G G + V+ ++E IK + K+ I +E+
Sbjct: 55 ---------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 180 KILQNLCGGPNIVKLLD-IVRDQQSKTPSL--IFEHVN---NTDFKVLYPTLSDYDVRYY 233
+ LQ PN ++ +R+ + E+ + +V L + ++
Sbjct: 106 RFLQK-LRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 159
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
+ L+ L Y HS ++HRDVK N+++ E ++L D+G A P + V + Y
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF---VGTPY 215
Query: 294 FKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
+ PE+++ + + YD +D+WSLG + RK P F +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 45/195 (23%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 191
++ ++V+ K+G G Y V++ +H + IK + ++I +EI I+Q C P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 192 VKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 244
VK ++ L + E+ +D ++ TL++ ++ + LK L+Y
Sbjct: 87 VKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
H +HRD+K N++++ + +L D+G+ + + N + + ++ PE++ +
Sbjct: 142 HFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199
Query: 304 QDYDYSLDLWSLGCM 318
Y+ D+WSLG
Sbjct: 200 IGYNCVADIWSLGIT 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
++ + + K+G+G + EVF+G+ + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
P + K ++D + +I E++ D + L + + + E+LK LDY
Sbjct: 80 PYVTKYYGSYLKDTKL---WIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+ +HRD+K NV++ E +++L D+G+ + + N V + ++ PE++
Sbjct: 136 HSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF 330
YD D+WSLG + + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 36/322 (11%), Positives = 83/322 (25%), Gaps = 69/322 (21%)
Query: 71 HARHQH---------QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
H H H Q R + + + + + + + S + + W
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 122 ----DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----- 172
+ + +G+ E E + + ++
Sbjct: 62 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV- 230
K++K E+ L+ L G N + +R P + + + D V
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 231 -----------------------------------RYYIYELLKALDYCHSQGIMHRDVK 255
++++ L H G++H ++
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YD 307
P ++++D + L + G + + +L Q
Sbjct: 239 PVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
++ D W+LG + P
Sbjct: 296 FAFDTWTLGLAIYWIWCADLPN 317
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + K + + + R+Y E++ AL+Y
Sbjct: 89 HPFFVKLYFTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE 298
H +GI+HRD+KP N++++ + +++ D+G A+ + R S F G PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQYVSPE 202
Query: 299 LLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
LL + + S DLW+LGC + AG+ P F + Y KI K
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQKIIK 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-21
Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 189
+ +E+V ++G G + +V++ + K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 190 NIVKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALD 242
IVKLL D + L + E L L++ ++ ++L+AL+
Sbjct: 77 YIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS+ I+HRD+K NV++ + +RL D+G+ A+ ++ + + + Y+ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 302 DLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
YDY D+WSLG M + P +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 17/203 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 190
YEV + G ++ + + ++K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS 246
IV++ + V + + E+V K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G+++ D+KP N+M+ EQ K LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
+ D++++G A +
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTR 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
NIV LD +V D+ L + E++ TD V + + + E L+AL+
Sbjct: 78 NIVNYLDSYLVGDE------LWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALE 130
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS ++HRD+K N+++ ++L D+G A+ + + V + Y+ PE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VV 188
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
+ Y +D+WSLG M MI + P+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 46/212 (21%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + K+G G V + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
N+V++ +V ++ L + E + TD V L++ + +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
Y H+QG++HRD+K ++++ +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y +D+WSLG M M+ + P+F
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 39/227 (17%)
Query: 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQN 184
E YE++ +G+G V + E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 185 LCGGPNIVKLLD-IVRDQQ-----------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRY 232
L PNIV + D + S LI H + +++ + Y
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDG--------MNELAIAY 132
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVA 290
+ +LKALDY H G +HR VK +++I K+ L H ++ V
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 291 SRYFKG------PELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+Y PE+L +LQ YD D++S+G + PF
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 32/312 (10%)
Query: 46 PLSQSSRIFTPFGTLRGLASSASLS--HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAP 103
L S IF + LA S S H L + PPD L Q + + ++
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPD-LFQPYIEEICQNLRG 159
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
+ + + + W L + +D+ V R +GRG + EV+ +
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTM-NDFSVHRIIGRGGFGEVYGCRKADTGKMYA 218
Query: 164 IKILKPVKKKKIKR---------EIKILQ--NLCGGPNIVKLLDIVRDQQSKTPS---LI 209
+K L KK+IK E +L + P IV + TP I
Sbjct: 219 MKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-----SYAFHTPDKLSFI 270
Query: 210 FEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
+ +N D L S+ D+R+Y E++ L++ H++ +++RD+KP N+++D
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
+R+ D GLA K+ + V + + PE+L YD S D +SLGCM ++
Sbjct: 331 -VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 327 EPFFYGHDNYDQ 338
P F H D+
Sbjct: 389 SP-FRQHKTKDK 399
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 43/241 (17%), Positives = 90/241 (37%), Gaps = 51/241 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D E + ++G G +V++ +K + + K+I ++ ++ P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + + + I E +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERI--------------- 125
Query: 229 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ ++KAL Y + G++HRDVKP N+++D + +++L D+G++ K +
Sbjct: 126 -LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDR 183
Query: 288 RVASRYFKGPE----LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
+ PE DYD D+WSLG + + P+ +++ L K+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 344 K 344
+
Sbjct: 244 Q 244
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 41/273 (15%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y + +QW + + R +G+G + EV + K L+ KK+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKR 221
Query: 175 IKR---------EIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD----- 217
IK+ E +IL+ +V L +T L+ +N D
Sbjct: 222 IKKRKGEAMALNEKQILE-KVNSRFVVSLA-----YAYETKDALCLVLTLMNGGDLKFHI 275
Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
+ + + +Y E+ L+ H + I++RD+KP N+++D +R+ D GLA
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAV 334
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
G+ RV + + PE++ + + Y +S D W+LGC+ MI + P F
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKI 392
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 370
+ ++ +++ +Y P +L
Sbjct: 393 KREEVERLVKEVPE-----EYSERFSPQARSLC 420
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 58/218 (26%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D + + ++GRG Y V + VH + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 229 DVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS------GQLVD 178
Query: 288 RVASRYFKG------PELL---VDLQDYDYSLDLWSLG 316
+A G PE + Q YD D+WSLG
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 49/245 (20%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y +QW D + R +GRG + EVF + K L KK+
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKR 222
Query: 175 IKR---------EIKILQNLCGGPNIVKL-------------LDIVR--DQQSKTPSLIF 210
+K+ E KIL IV L + I+ D I
Sbjct: 223 LKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTDLCLVMTIMNGGD--------IR 273
Query: 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
H+ N D P + +Y +++ L++ H + I++RD+KP NV++D + +R+
Sbjct: 274 YHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRI 330
Query: 271 IDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D GLA E + + F PELL+ ++YD+S+D ++LG MI + P
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP- 388
Query: 330 FYGHD 334
F
Sbjct: 389 FRARG 393
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 60/214 (28%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
IV L ++ K I E +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQI-------------- 132
Query: 228 YDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283
+ ++K L Y + IMHRDVKP N++++ + +++L D+G++ G+
Sbjct: 133 --LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLID 184
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WS+G
Sbjct: 185 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMG 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
DD+E+++ +GRG +SEV + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I +L + + + L+ E+ D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 295
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 296 G------PELL------VDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQL 339
G PE+L Y D W+LG + M + + PF+ D+ +
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET 278
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 194
+ V +K+G G + E+ G + NE IK+ + ++ E + + L G I ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F + T S V +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RDVKP N +I + Q+ + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 61/323 (18%), Positives = 114/323 (35%), Gaps = 100/323 (30%)
Query: 109 YSDINVVRPREYWDYESLTVQWGE--QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI 166
D P +Y V+ G+ Y V+RK+G G +S V+ + +K+
Sbjct: 10 SDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV 69
Query: 167 LKPVKK--KKIKREIKILQNLC-------GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
+K + + EI++L+++ +V+LLD F+
Sbjct: 70 VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD------------FKISGVNG 117
Query: 218 ------FKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
F+VL L + V+ I ++L+ LDY H++ I+H D+KP N
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 259 VMI------------------------------------------------DHEQRKLRL 270
+++ + E+ K+++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
D G A K + + +R ++ E+L+ Y+ D+WS CM + + F
Sbjct: 238 ADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLF 293
Query: 331 YGHDNY------DQLVKIAKVLG 347
H D + I ++LG
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLG 316
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F S V +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 248 GIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 279
+HRDVKP N ++ ++ + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
Y++V K+G G S V+ N K IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV ++D+ + L+ E++ + LS + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
I+HRD+KP N++ID + L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D+E+++ +GRG + EV ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I L + + + L+ ++ D +L L + R+Y+ E+
Sbjct: 131 GDSKWITTL------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFK 295
+ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC------LKLMEDGTVQSSVAV 237
Query: 296 G------PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
G PE+L ++ Y D WSLG M++ + PF+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK +++ E + + L G I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
++ PSL E + + S V ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 48/230 (20%), Positives = 96/230 (41%), Gaps = 36/230 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D +E++R +G+G + +V + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKA 240
P +V L S + ++ + + D L + V+ +I EL+ A
Sbjct: 74 HPFLVNL------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
LDY +Q I+HRD+KP N+++D E + + D+ +A G
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKPY 180
Query: 297 --PELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVK 341
PE+ Y +++D WSLG ++ + P+ + ++V
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D ++ ++ +G G + V H +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P +VKL + K S ++ E+V + F L S+ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
PE+++ + Y+ ++D W+LG + M PFF D Q+
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 44/218 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIV 192
+ EV VGRG + V + + IK ++ +K E++ L + PNIV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNH-PNIV 64
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK---ALD------Y 243
KL L+ E+ LY L + Y L Y
Sbjct: 65 KLYGACL----NPVCLVMEYAEGGS---LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 244 CHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
HS + ++HRD+KP N+++ L++ D+G A +
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGS 166
Query: 297 -----PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+ +Y D++S G + +I R++PF
Sbjct: 167 AAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 187
+DYEVV+ +GRG + EV H + + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELL 238
P +V+L + + ++ E++ D L +S+YD R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 296
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 297 ------PELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE+L Y D WS+G M+ PF+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPN 190
D +G+G + + + H E ++K L ++ +E+K+++ L PN
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PN 68
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD------Y 243
++K + ++ + K + I E++ L + D +Y + + A D Y
Sbjct: 69 VLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---------YHPGKEYNVRVASRYF 294
HS I+HRD+ HN ++ E + + + D+GLA + R
Sbjct: 124 LHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
G PE++ + YD +D++S G + +I R
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 69 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 176
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+A PE+L +DY +S+D W+LG + M+ + PF
Sbjct: 177 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 211
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 44/211 (20%), Positives = 83/211 (39%), Gaps = 45/211 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++GRG Y V + H + K I + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 190 NIVKL--------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 229
V LD Q I E +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI---------------- 110
Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++KAL++ HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDID 169
Query: 289 VASRYFKGPE---LLVDLQDYDYSLDLWSLG 316
+ + PE ++ + Y D+WSLG
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKI---LQNLC 186
Y + R VGRG +V+E +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P++V + D + + +N D + L+ + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLV 301
H+ G HRDVKP N+++ + L+D+G+A K + V + Y+ PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y D+++L C+ + P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 21/169 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 193
+ + +K+G G + ++ EK ++K + + E+K Q + I K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKV-----LYPTLSDY----------DVRYYIY 235
++ + P ++ L L V
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
+L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 46/231 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ ++ +G+G + +V H + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELL 238
P +V L S +T + +++N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
+A PE+L Q YD ++D W LG + M++ PF+ N ++
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM 247
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 52/229 (22%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQ 183
++ E +++G+G + V +G D IK L K ++ +RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD 242
NL PNIVKL ++ + P ++ E V D LY L D L+ LD
Sbjct: 79 NLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLD 130
Query: 243 ------YCHSQG--IMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYHPGKEYNVRVA 290
Y +Q I+HRD++ N+ + ++ D+GL+ + +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------QQS 179
Query: 291 SRYFKG---------PELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
G PE + ++ Y D +S + ++ + PF
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 112 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 219
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+A PE+L +DY +S+D W+LG + M+ + PF
Sbjct: 220 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 254
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 53/230 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D++E +R +G+G + +V + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 185 LCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYI 234
P + +L TP + E VN D + + + R+Y
Sbjct: 80 ARNHPFLTQL---------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------E 284
E++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y +A PE+L + Y ++D W++G + M+ P F +
Sbjct: 190 Y---IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAEN 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D++ ++ +G+G + +V +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L ++ R+Y E++
Sbjct: 62 TRHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--FCG 167
Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE+L D DY ++D W LG + M+ + P FY D
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +G G + V + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P I+++ + +I +++ + F +L + ++Y E+ AL
Sbjct: 65 HPFIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPDYI 170
Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
PE++ + Y+ S+D WS G + M+ PF+ N +
Sbjct: 171 APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
+ + RK+G G + E++ G + NE+ IK+ K ++ E KI + L GG I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F LS V +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 248 GIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFY 279
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
YE+ +G G SEV D+ +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 190 NIVKLLDI--VRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
IV + D P ++ E+V+ + + ++ I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ + +G+G + +V +E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLK 239
P + +L +T + E+VN D + + +Y E+
Sbjct: 399 GKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F G
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KENIWDGVTTKT--FCG 504
Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE++ Q Y S+D W+ G + M+ + P F G D
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGED 546
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 53/230 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D+ + +G+G + +V +E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 185 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELL 238
P + +L +T + E+VN D + + +Y E+
Sbjct: 77 PGKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY--- 187
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHD 334
+A PE++ Q Y S+D W+ G M AG + F G D
Sbjct: 188 IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEGED 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
P + + +T + E++N D + +Y E++ L
Sbjct: 77 HPFLTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 291
+ HS+GI++RD+K N+++D + +++ D+G+ E +Y +A
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---IA- 186
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
PE+L+ Q Y++S+D WS G + M+ + P F+G + ++L
Sbjct: 187 -----PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 22/190 (11%), Positives = 53/190 (27%), Gaps = 38/190 (20%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 189
Y ++ G + ++ + + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
+ ++LD+V + ++ E + + V + S + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
+ P V + + V +A +
Sbjct: 150 VALSIDHPSRVRVSIDGD--------------------VVLAYPATMPDA--------NP 181
Query: 309 SLDLWSLGCM 318
D+ +G
Sbjct: 182 QDDIRGIGAS 191
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+++E ++ +G+G + +V +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L S+ R+Y E++
Sbjct: 205 SRHPFLTALK-----YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGP 297
ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + + P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
E+L D DY ++D W LG + M+ + P FY D
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 353
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 43/233 (18%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKP---VKKKK----IKREIKILQ 183
+++E+++ +G G Y +VF + D K +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 184 NLCGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 236
++ P +V L + +T + LI +++N + F L ++++V+ Y+ E
Sbjct: 114 HIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----YNVRVASR 292
++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS------KEFVADETERAYD- 219
Query: 293 YFKG------PELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
F G P+++ +D ++D WSLG + ++ PF + Q
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 56/233 (24%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKPVKKKKIKR--------EIKIL 182
+E+++ +G+G + +VF + + +D + +K+LK K +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 183 QNLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRY 232
P IVKL T LI + + D F L ++ DV++
Sbjct: 81 VE-VNHPFIVKL---------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK-------- 283
Y+ EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
EY +A PE++ + + S D WS G + M+ P F G D
Sbjct: 190 VEY---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDR 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 30/173 (17%), Positives = 65/173 (37%), Gaps = 26/173 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
++V +G+G + ++ + + C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLY-----PTLSDY-----------DVR 231
I K + + + P N ++ + L V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 33/211 (15%)
Query: 126 LTVQWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREI 179
+ G + + K+ E+++G ++K+LK K + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYPTLSDYDVRYYIYELL 238
L+ PN++ +L + + P+LI + + + VL + + +
Sbjct: 59 PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAV 114
Query: 239 K-ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
K ALD + H+ I + +VMID E R+ + F PG+ Y
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA 173
Query: 289 -VASRYFKGPELLVDLQDYDYSL--DLWSLG 316
VA PE L + D+WS
Sbjct: 174 WVA------PEALQKKPEDTNRRSADMWSFA 198
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 42/258 (16%), Positives = 73/258 (28%), Gaps = 67/258 (25%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKR 177
+ + K+G G + EVF+ + D+ IKI+ ++I
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 178 EIKILQNLCG--------GPNIVKLLDIVRDQQSKTPSLI-------------------- 209
EI I + L + L + Q S P L+
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 210 ----------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
FE ++ S + +++L +L + HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
V++ + Y + S L V + DY S +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 319 FAGMIFRKEPFFYGHDNY 336
F + E F G +Y
Sbjct: 239 FCDV-SMDEDLFTGDGDY 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 60/245 (24%)
Query: 134 DDYEVVRKVGRGKYSEVF---EGVHCTDNEKCIIKILKP---VKKKK----IKREIKILQ 183
+ +E++R +G+G Y +VF + + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 184 NLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYY 233
P IV L T LI E+++ + F L + +Y
Sbjct: 77 E-VKHPFIVDL---------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK--------- 283
+ E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQL 339
EY +A PE+L+ ++ ++D WSLG M G P F G + +
Sbjct: 186 EY---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTI 230
Query: 340 VKIAK 344
KI K
Sbjct: 231 DKILK 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 40/241 (16%)
Query: 98 RRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
P + + D + + + W D + K+G G + V
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPW---CDLNIKEKIGAGSFGTVHRAEWH- 59
Query: 158 DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212
+KIL + RE+ I++ L PNIV + V S++ E+
Sbjct: 60 -GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPP--NLSIVTEY 115
Query: 213 VNNTDFKVLYPTLSDYDVRYYI--YELLK-ALD------YCHSQG--IMHRDVKPHNVMI 261
++ LY L R + L A D Y H++ I+HR++K N+++
Sbjct: 116 LSRGS---LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSL 315
D ++ +++ D+GL+ + + ++S+ G PE+L D + + D++S
Sbjct: 173 D-KKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSF 225
Query: 316 G 316
G
Sbjct: 226 G 226
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 39/213 (18%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLC 186
VQ + +G+G++ EV+ G E+ +KI +++ RE +I Q +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 187 GGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALD 242
NI+ + L+ + H + + F L + + L
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 243 YCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+ H + I HRD+K N+++ + + D GLA + + + +A +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT-IDIAPNHR 211
Query: 295 KG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++++ ++ D++++G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ- 183
L VQ ++V+++G+G+Y EV+ G EK +K+ ++ RE +I Q
Sbjct: 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQT 85
Query: 184 NLCGGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLK 239
L NI+ + LI + H N + + L T D + Y +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145
Query: 240 ALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
L + H++ I HRD+K N+++ + + D GLA + V +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN-EVDIPP 203
Query: 292 RYFKG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++ + + D++S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 41/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+ E+ +G+G++ +V+ G + I+++ + K KRE+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 189 PNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD--- 242
N+V + P L I LY + D + + + + A +
Sbjct: 89 ENVVLFMGAC----MSPPHLAIITSLCKGRT---LYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 243 ---YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
Y H++GI+H+D+K NV D+ K+ + D+GL + R G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 297 ---PELL--------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE++ D + D+++LG ++ + R+ PF
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 44/227 (19%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G D +K+L P + + K E+ +L+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD----- 242
NI+ + Q +++ + + LY L + ++ + +L+ A
Sbjct: 80 VNILLFMGYSTAPQ---LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 243 -YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
Y H++ I+HRD+K +N+ + E +++ D+GLA + G
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL---SGSILWM 189
Query: 297 -PELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
PE++ YS D+++ G + ++ + P+ +N DQ++
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 28/204 (13%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIVKLL 195
++ VG+G+Y EV+ G E +KI +K RE ++ + NI+ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 196 --DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ---- 247
D+ S LI H + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 248 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 297
I HRD+K N+++ + + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 298 ELL-----VDLQDYDYSLDLWSLG 316
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
++ D+ +++ +GRG+Y V++G D +K+ ++ E I
Sbjct: 4 AASEPSLDL---DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNI 58
Query: 182 -----LQNLCGGPNIVKLL--DIVRDQQSKTP-SLIFE-HVNNTDFKVLYPTLSDYDVRY 232
+++ NI + + D + L+ E + N + K L SD+
Sbjct: 59 YRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 233 YI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
+ + + + L Y H++ I HRD+ NV++ + D+GL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173
Query: 283 KEYNVRVASRYFKG---------PELL------VDLQDYDYSLDLWSLG 316
+ PE+L D + +D+++LG
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 29/175 (16%), Positives = 57/175 (32%), Gaps = 28/175 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVH--------CTDNEKCIIKILKPVKKKKIKREIKILQNLCG 187
+++ R ++E +K +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-----LYPTLSDY------------DV 230
+ K + P+ + V+ ++ L +L V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284
LL AL++ H +H +V N+ +D E Q ++ L +G A Y P +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 40/221 (18%), Positives = 86/221 (38%), Gaps = 38/221 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLC 186
+ + +G G + +V+ ++ +K + + +++E K+ L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYI-YELLKALDYC 244
PNI+ L + + L+ E +VL D+ ++ + ++Y
Sbjct: 65 H-PNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 245 HSQG---IMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEFYHPGKEYNVRVASRYF 294
H + I+HRD+K N++I + L++ D+GLA +H + +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-------A 174
Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
G PE++ + D+WS G + ++ + PF
Sbjct: 175 AGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 47/240 (19%), Positives = 87/240 (36%), Gaps = 32/240 (13%)
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKRE 178
E+L Q +++ RG++ V++ NE +KI K+ + + E
Sbjct: 14 LGTENLYFQS---MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYE 68
Query: 179 IKILQNLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI- 234
+ L + NI++ + + LI H + L + ++ +I
Sbjct: 69 VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 235 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
+ + L Y H I HRD+K NV++ + D+GLA + GK
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKS 186
Query: 285 YNVRVAS----RYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
RY PE+L +D +D++++G + + R D Y
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGP 189
+D + ++GRG + EVF G DN +K + K K +E +IL+ P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 190 NIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
NIV+L+ + +Q P I E V DF + L + + + ++Y
Sbjct: 173 NIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GPEL 299
S+ +HRD+ N ++ E+ L++ D+G++ G Y R K PE
Sbjct: 229 LESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEA 286
Query: 300 LVDLQDYDYSL--DLWSLG 316
L + YS D+WS G
Sbjct: 287 LNYGR---YSSESDVWSFG 302
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQ 183
E+ + +R +G G + +V + + + +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELL 238
NL NIVK I + LI E + + K Y ++ Y ++
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
K +DY S+ +HRD+ NV+++ + ++++ D+GL + KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 54/313 (17%), Positives = 114/313 (36%), Gaps = 47/313 (15%)
Query: 63 LASSASLSHARHQHQRLRQLA----TPPDTLAQKIGKSVRRSGAPSKARVYSDINVV--- 115
++ + H H H R R P G + S + N+
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 116 RPREYWDYESLTVQWGEQ-DDYEV---------VRKVGRGKYSEVFEGVHCTDNEKCI-- 163
+ D +L + + + +GRG + V+ G ++ K I
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 164 -IKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
+K L + + + E I+++ PN++ LL I + P ++ ++ + D
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 178
Query: 219 KVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
+ + + D+ + ++ K + + S+ +HRD+ N M+D E+ +++ D+
Sbjct: 179 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 236
Query: 274 GLAEFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDLWSLG-CMFAGMIF 324
GLA + + +V + E L Q + D+WS G ++ M
Sbjct: 237 GLARDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTR 292
Query: 325 RKEPFFYGHDNYD 337
P + + +D
Sbjct: 293 GAPP-YPDVNTFD 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPN 190
+R +G G + +V D + +K LK P + K+EI IL+ L +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
I+K D + + L+ E+V + + ++ + + ++ + + Y H+Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 304
+HRD+ NV++D R +++ D+GLA + Y VR PE L + +
Sbjct: 155 YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 305 DYDYSLDLWSLG 316
+ Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 46/223 (20%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+LL + + P I E + D+ + +S + Y ++ A++Y
Sbjct: 279 VQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
+ +HR++ N ++ E +++ D+GL+ G Y +++ + PE L
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+W+ G ++ + P + G D + K
Sbjct: 394 -NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
DYE+ R +G G++ +V +G++ + + IK K ++K +
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E ++ P+IVKL+ ++ ++ P I E + +V +L +
Sbjct: 66 EALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK---PVKKKKIKREIKILQNLCGGPNI 191
+ ++G+G + V + + +K L+ P +++ +REI+IL+ L I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI 86
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ L+ E++ + DF + L + Y ++ K ++Y S+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + +++ D+GLA+ K+ Y VR + PE L D
Sbjct: 147 RCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+ D+WS G + E F Y + + +++G +
Sbjct: 206 I-FSRQSDVWSFG------VVLYELFTYCDKSCSPSAEFLRMMGCER 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 41/221 (18%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
+ ++ ++ + + + + + +D E Y + D
Sbjct: 330 IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS-----TRD 384
Query: 136 YEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKI 181
YE+ R +G G++ +V +G++ + + IK K ++K +E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIY 235
++ P+IVKL+ ++ ++ P I E + + + +L + Y Y
Sbjct: 445 MRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAY 498
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 47/248 (18%), Positives = 105/248 (42%), Gaps = 27/248 (10%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IK 165
+ D++ + P + + + +GRG + V+ G ++ K I +K
Sbjct: 1 HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59
Query: 166 ILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L + + + E I+++ PN++ LL I + +P ++ ++ + D +
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN- 116
Query: 222 Y-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ + D+ + ++ K + Y S+ +HRD+ N M+D E+ +++ D+GLA
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 175
Query: 277 ------EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
E+Y + ++ ++ E L Q + D+WS G ++ M P
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWM-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP- 232
Query: 330 FYGHDNYD 337
+ + +D
Sbjct: 233 YPDVNTFD 240
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 44/262 (16%), Positives = 111/262 (42%), Gaps = 33/262 (12%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEK 161
+ D ++ + ++ + ++D + ++++G+G + V + +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 162 CI----IKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214
+K L+ ++ ++ REI+IL++L NIVK + + LI E++
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 215 N---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
D+ + + + Y ++ K ++Y ++ +HRD+ N++++ + ++++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKI 186
Query: 271 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFR 325
D+GL + Y V+ PE L + + + + D+WS G ++
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLY------ 239
Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
E F Y + + +++G
Sbjct: 240 -ELFTYIEKSKSPPAEFMRMIG 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
Y + R +G G + EV+EGV+ + I +K K K+K
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 62
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E I++NL P+IVKL+ I+ + P+ I E + + +L +
Sbjct: 63 EAVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y ++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 44/223 (19%), Positives = 92/223 (41%), Gaps = 22/223 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 241
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+L +V S+ P I E+++ L + ++ + Y
Sbjct: 242 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
+HRD++ N+++ E ++ D+GLA EY R +++ + PE +
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 355
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + P + G N + L ++ +
Sbjct: 356 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 3e-07
Identities = 59/362 (16%), Positives = 112/362 (30%), Gaps = 111/362 (30%)
Query: 60 LRGLASSASLSH---ARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVR 116
+ + S + H ++ +L TL K + V++ + + V+R
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRLF---WTLLSKQEEMVQK---------FVE-EVLR 88
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK 176
+Y+ L + + Y E + ++ DN+ K V + +
Sbjct: 89 I----NYKFLMSPIKTEQ---RQPSMMTRMYIEQRDRLY-NDNQV-FAK--YNVSRLQPY 137
Query: 177 REIKI-LQNLCGGPNIV--------K--L-LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 224
+++ L L N++ K + LD+ ++ DFK+ +
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS---------YKVQCKMDFKIFWLN 188
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
L + + + E+L+ L +++ DH I AE
Sbjct: 189 LKNCNSPETVLEMLQKL--------LYQIDPNWTSRSDHSSNIKLRIHSIQAEL------ 234
Query: 285 YNVRVASRYFKGPE----LLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
R K LLV ++Q+ + + ++L C
Sbjct: 235 ------RRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC--------------------- 266
Query: 339 LVKIAKVLGT-------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 391
K+L T D L+A HI LD H L + K++ Q L
Sbjct: 267 -----KILLTTRFKQVTDFLSA-ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL-- 318
Query: 392 PE 393
P
Sbjct: 319 PR 320
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 8e-07
Identities = 39/280 (13%), Positives = 76/280 (27%), Gaps = 83/280 (29%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 179
+ D+E+ Q+ +D V + + F+ D K I+ K EI
Sbjct: 6 HMDFETGEHQYQYKDILSVFED----AFVDNFDCKDVQDMPKSILS----------KEEI 51
Query: 180 KILQNLCGGPNIV----KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVR 231
++ + V +L + +Q + E V ++K L + +
Sbjct: 52 D---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 232 YYIYELLKALDYCHSQGIMHRDV---KPHNVMIDHEQRKLR-----------LIDWGLAE 277
+Y + ++ D +NV KLR ++ G+
Sbjct: 109 TRMYI------EQRDR--LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
GK V Y + C IF
Sbjct: 161 S---GK--TWVALD---------V-CLSYK-------VQCKMDFKIF------------- 185
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKP 377
+ + + + L K ++DP+ + S
Sbjct: 186 -WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 4e-06
Identities = 54/378 (14%), Positives = 110/378 (29%), Gaps = 98/378 (25%)
Query: 36 TTSVSKILFSP--LSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATPPDT--LAQ 91
+ I+ S +S + R+F LS Q+ + + L
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTL-----------LSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 92 KIGKSVRRSGAPSKA------------RVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
I R+ ++ +V++ NV R + Y ++ + +
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 140 RKVGRGKYSEVFEGVHCTDNE-KCII--KI--LKPVKKKKIKREIKILQNLCGGPNIVKL 194
+G GK + C + +C + KI L + +++LQ L
Sbjct: 157 GVLGSGKTWVALDV--CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL------YQ 208
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+D +S S I ++ ++ + LLK+ Y + ++ +V
Sbjct: 209 IDPNWTSRSDHSSNIKLRIH--------------SIQAELRRLLKSKPYENCLLVL-LNV 253
Query: 255 KPHNV--MIDHEQRKL---RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 309
+ + + L R + +F ++ + + D
Sbjct: 254 QNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISL--------DHHSMTLTPDEV 303
Query: 310 LDLWS--LGC------------------MFAGMIFRKEPF---FYGHDNYDQLVKIAK-- 344
L L C + A I R + H N D+L I +
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESS 362
Query: 345 --VLGTDELNAYLNKYHI 360
VL E ++ +
Sbjct: 363 LNVLEPAEYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 5e-05
Identities = 53/370 (14%), Positives = 105/370 (28%), Gaps = 105/370 (28%)
Query: 18 TTLFSS-FFAISSNTSSSRTTSVSKILFSPLSQSSRIF-----TPFGTLRGLASS----- 66
TT F +S+ T++ + + +P + + L +
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTP-DEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 67 -----ASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
S+ + + D L I S+ +++ ++V P +
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNC--DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
L++ W + +V+ V K K ++++ K
Sbjct: 388 PTILLSLIWFDVIKSDVMVVV-----------------NKL-------HKYSLVEKQPK- 422
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH---VNNTDFKVLYP--TLSDYDVRYYIYE 236
+ + + I + + K + H V++ + + L + Y Y
Sbjct: 423 -------ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQ-----RKLRL-IDWGLAEFYHPGKEYNVRVA 290
H I H H I+H + R + L + + H +N +
Sbjct: 476 --------H---IGH-----HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 291 SRYFKGPELLVDLQDY-DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVLGT 348
L L+ Y Y I +P Y++LV I L
Sbjct: 520 I-----LNTLQQLKFYKPY--------------ICDNDP------KYERLVNAILDFLPK 554
Query: 349 DELNAYLNKY 358
E N +KY
Sbjct: 555 IEENLICSKY 564
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 22/223 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 324
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+L +V S+ P I E+++ L + ++ + Y
Sbjct: 325 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVD 302
+HRD++ N+++ E ++ D+GLA EY R +++ K PE +
Sbjct: 381 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 438
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + P + G N + L ++ +
Sbjct: 439 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREIKILQN 184
E+ R +G+G + V+ G + + I IK L + + + RE +++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----VLYPTLSDYDVRYYIYELLKA 240
L PN++ L+ I+ + P ++ ++ + D + D+ + ++ +
Sbjct: 79 LN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y Q +HRD+ N M+D E +++ D+GLA + Y+V+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHR---HARLPV 192
Query: 297 ----PELLVDLQDYDYSLDLWSLG 316
E L + D+WS G
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFG 215
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 46/240 (19%), Positives = 97/240 (40%), Gaps = 40/240 (16%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIK 176
+ +D + R +G+G++ V E ++ + +K+LK ++
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFK---------VLYP 223
RE ++ P++ KL+ + ++K +I + + D
Sbjct: 74 REAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L + ++ ++ ++Y S+ +HRD+ N M+ E + + D+GL+ + G
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGD 191
Query: 284 EYNVRVASRY-FK--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYD 337
Y AS+ K E L D Y++ D+W+ G M+ M + P + G +N +
Sbjct: 192 YYRQGCASKLPVKWLALE---SLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
D +E+ K+G G+Y EV+EGV + +K LK ++ ++ +E ++
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ + PN+V+LL + + P I E + + Y +S + Y
Sbjct: 64 KEIK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMAT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-F 294
++ A++Y + +HRD+ N ++ E +++ D+GL+ G Y +++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 176
Query: 295 K--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
K PE L +S+ D+W+ G ++ + P + G D + K
Sbjct: 177 KWTAPES---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 30/185 (16%), Positives = 68/185 (36%), Gaps = 34/185 (18%)
Query: 111 DINVVRPREYWDYESLTVQWGEQDDYEVVR----KVGRGKYSEVFEGVHCTDNEKCIIKI 166
D + P + + + V W ++ + + +G+G +++ + + IIK
Sbjct: 311 DETKIIPN--YRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSY--LDFDVIIKE 366
Query: 167 LKP-----------VKKKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHV 213
++K + RE + L + G P + D ++ ++
Sbjct: 367 RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDNKRIMMSYI 421
Query: 214 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
N K + D Y++ + + H ++H D+ N + D + L +ID+
Sbjct: 422 NGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD---KDLYIIDF 473
Query: 274 GLAEF 278
GL +
Sbjct: 474 GLGKI 478
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 43/225 (19%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILKPVKKKKIK---REIKILQNLCGGPNI 191
++++G+G + V DN + +K L+ ++ ++ REI+IL++L NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNI 73
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + + LI E++ D+ + + + Y ++ K ++Y ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + ++++ D+GL + + V+ PE L +
Sbjct: 134 RYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 304 QDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ + + D+WS G ++ E F Y + + +++G
Sbjct: 193 K-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 36/213 (16%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 178
+D + + +G G++ V EG ++ + +K +K + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFEHVNNTDFK---------VLYPTLS 226
+++ PN+++LL + + S+ P +I + D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ ++ ++ ++Y ++ +HRD+ N M+ + + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYR 204
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
++ K E L D + Y D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 33/172 (19%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP----VKKKKIKR 177
D++EV R++G+G + V+EGV + IK + ++ +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------VLYPT 224
E +++ ++V+LL +V Q +I E + D K +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S + E+ + Y ++ +HRD+ N M+ E +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 36/217 (16%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW--DYESLTVQWG 131
H H ++ + L + + A Y + + + +
Sbjct: 4 HHHH-----SSGRENLYFQGKLPEPQFYAEPH--TYEEPGRAGRSFTREIEASRIHI--- 53
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQN 184
+ +G G EV G ++ + IK LK +++ E I+
Sbjct: 54 -------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 239
PNI++L +V + ++I E++ N + + + + +
Sbjct: 107 FD-HPNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y G +HRD+ NV++D ++ D+GL+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 32/236 (13%), Positives = 80/236 (33%), Gaps = 39/236 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKPV---KKKKIKREIKILQ 183
+D +G+G ++++F+GV + ++K+L + ++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYEL 237
L ++V + +++ E V Y ++ +L
Sbjct: 68 KLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAKQL 122
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI-------DWGLAEFYHPGKEYNVRV- 289
A+ + ++H +V N+++ E+ + D G++ P R+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 290 --ASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
PE + + ++ + + D WS G ++ +P D+ +L
Sbjct: 183 WVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 43/227 (18%), Positives = 99/227 (43%), Gaps = 23/227 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPE 298
+Y + ++HRD+ NV++ + +++ D+GLA+ ++ + K E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 26/151 (17%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
++ +++++G G++ V G +K++K + + + +E + + L P +
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH 245
VK + + P I E+++N Y L + Y++ + + +
Sbjct: 66 VKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S +HRD+ N ++D +++ D+G+
Sbjct: 122 SHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 43/223 (19%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+ +E + +GRG + +V E +K+LK + + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 219
E+KIL ++ N+V LL + +I E +
Sbjct: 78 MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLA 195
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 30/159 (18%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+E+ ++++G G++ V G IK++K + + + E K++
Sbjct: 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYEL 237
NL +V+L + Q+ P I E++ N + + + ++
Sbjct: 74 MNLS-HEKLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+A++Y S+ +HRD+ N +++ +Q +++ D+GL+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQNLC 186
+ + + VG G++ EV G ++K I IK LK +++ E I+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 187 GGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKAL 241
PNI++L +V + P +I E++ N + + + + + +
Sbjct: 105 -HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y G +HRD+ N++I+ ++ D+GL
Sbjct: 161 KYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 29/156 (18%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKA 240
NI++L ++ + P +I E++ N + S + + +
Sbjct: 104 S-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ N++++ ++ D+GL+
Sbjct: 160 MKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLS 194
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 6e-06
Identities = 31/161 (19%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+D++EV V ++G G++ EV+ G + K +K LK + E ++
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLM 62
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ L +V+L +V ++ P I E++ N + L+ +
Sbjct: 63 KQLQ-HQRLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAA 116
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++ + + + + +HRD++ N+++ + ++ D+GLA
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLA 156
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+E + +G G + +V E + +K+LKP +++ +
Sbjct: 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQ-------------------SKTPSLIFEHVNNT 216
E+K+L L NIV LL K S I +
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA 192
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
Y V+ +R K PE + + Y + D+WS G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 32/164 (19%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I + T LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 24/150 (16%), Positives = 65/150 (43%), Gaps = 13/150 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYCHS 246
V+L + +Q P + E + + + + + ++ + + Y
Sbjct: 66 VQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++HRD+ N ++ E + +++ D+G+
Sbjct: 123 ACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 35/231 (15%), Positives = 85/231 (36%), Gaps = 15/231 (6%)
Query: 56 PFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVV 115
G A+ +H R++ T + P + + +
Sbjct: 258 SASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFES 317
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILK----P 169
+ + + + + ++G G + V +GV+ ++ IK+LK
Sbjct: 318 PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377
Query: 170 VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTL 225
+++ RE +I+ L P IV+L+ + Q++ L+ E +
Sbjct: 378 ADTEEMMREAQIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+V ++++ + Y + +HR++ NV++ + ++ D+GL+
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 40/224 (17%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNLCGGPN 190
++ +G G + V +GV + E IK+++ + + + + +L +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAH 76
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHS 246
IV+LL + L+ +++ D + L + + ++ K + Y
Sbjct: 77 IVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDL 303
G++HR++ NV++ ++++ D+G+A+ P + + ++ K E +
Sbjct: 134 HGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE---SI 189
Query: 304 QDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y+ D+WS G ++ M F EP+ G + + K
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 32/167 (19%), Positives = 71/167 (42%), Gaps = 16/167 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++ +K+G G++ EV+ + K +K +KP + + E +++ L +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKL 245
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
VKL +V +K P I E + DF + + ++ + + +
Sbjct: 246 VKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
+ +HRD++ N+++ ++ D+GLA EY R ++
Sbjct: 302 QRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAK 346
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E + +G G + +V + +K+LK
Sbjct: 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E +++ D+G
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFG 202
Query: 275 LA 276
LA
Sbjct: 203 LA 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 28/152 (18%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 77
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 78 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+HRD+ NV++ E ++ D+GL
Sbjct: 134 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 39/251 (15%), Positives = 83/251 (33%), Gaps = 49/251 (19%)
Query: 72 ARHQHQRLRQLATPPDTLAQKIG----KSVRRSGAPSKARVYSDINVVRPREYWDYESLT 127
+ H H Q L ++I +V + S + + +
Sbjct: 3 SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62
Query: 128 VQWGEQ-----DDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILK 168
E +E + +G G + +V + +K+LK
Sbjct: 63 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 122
Query: 169 P----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 123 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRA 180
Query: 220 --------------VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-EN 239
Query: 266 RKLRLIDWGLA 276
+++ D+GLA
Sbjct: 240 NVMKIADFGLA 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 47/234 (20%), Positives = 89/234 (38%), Gaps = 35/234 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP------VKKKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL------ 238
L N+++L +V K ++ E L L + + + L
Sbjct: 78 LD-HRNLIRLYGVVLTPPMK---MVTELAPLGS---LLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 239 -KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK 295
+ + Y S+ +HRD+ N+++ + +++ D+GL Y ++ + F
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 296 --GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE L +S D W G ++ + +EP + G + L KI K
Sbjct: 190 WCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 34/187 (18%), Positives = 64/187 (34%), Gaps = 40/187 (21%)
Query: 117 PREYW--DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILKP--- 169
P Y D+ + Q +G G + +V + D + IK +K
Sbjct: 16 PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 170 -VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK--------- 219
+ E+++L L PNI+ LL + L E+ + +
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123
Query: 220 ---VLYPTLSDYDVRYYIYELLK-ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLR 269
+ + +LL A D Y + +HRD+ N+++ E +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAK 182
Query: 270 LIDWGLA 276
+ D+GL+
Sbjct: 183 IADFGLS 189
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 32/164 (19%), Positives = 66/164 (40%), Gaps = 29/164 (17%)
Query: 134 DDYEVVR--------KVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREI 179
+ R ++G G + V +GV+ ++ IK+LK +++ RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL- 238
+I+ L P IV+L+ + Q++ L+ E L+ L + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAE 114
Query: 239 ------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ NV++ + ++ D+GL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 30/168 (17%), Positives = 66/168 (39%), Gaps = 36/168 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------VKKKKI------------- 175
+ + +G GK S VF +C++K K VK+K+
Sbjct: 92 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 176 -KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI 234
+ E + LQ L G + K+ + +++ E ++ + + + +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
+L+ + + +GI+H D+ +NV++ E + +ID+ + E
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEE 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + +KILK P K ++ E ++Q L P IV
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81
Query: 193 KLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + + D ++ ++++ + Y
Sbjct: 82 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ Q ++ D+GL++ + Y
Sbjct: 139 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 35/213 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
++ + + +G G + +V E K +K+LK +K+ + E+KI+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFK-----------------VLYPTLS 226
L NIV LL P L I E+ D + T S
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
D+ ++ ++ + + + S+ +HRDV NV++ ++ D+GLA Y
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
V+ +R K PE + D Y D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E+ + +G G + +V K +K+LK
Sbjct: 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 119
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+G
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFG 236
Query: 275 LA 276
LA
Sbjct: 237 LA 238
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/161 (17%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 249
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 250 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ E ++ D+GL + ++
Sbjct: 306 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDT 345
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 40/236 (16%), Positives = 81/236 (34%), Gaps = 33/236 (13%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTV 128
+S+ H H + T + Q S +S +++ + + + +Y
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRT--STIMTDYNPNYCFAGK 58
Query: 129 QWGEQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPV----KK 172
D EV +R +G G + EV+EG + + +K L V +
Sbjct: 59 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLY 222
E I+ NIV+ + + ++ E + D K
Sbjct: 119 LDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 276
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+G+A
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 28/207 (13%), Positives = 70/207 (33%), Gaps = 38/207 (18%)
Query: 96 SVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEG-- 153
G+ + + + + + D + ++G G + +VF
Sbjct: 11 PTEGKGSGLQGHIIENPQYFSDACVHHIK--------RRDIVLKWELGEGAFGKVFLAEC 62
Query: 154 ---VHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
+ D +K LK + + RE ++L L +IV+ + + +
Sbjct: 63 HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCT--EGRPLL 119
Query: 208 LIFEHVNNTDFK------------------VLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
++FE++ + D V L + ++ + Y
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+HRD+ N ++ + +++ D+G++
Sbjct: 180 VHRDLATRNCLVG-QGLVVKIGDFGMS 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 33/183 (18%), Positives = 63/183 (34%), Gaps = 31/183 (16%)
Query: 122 DYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP 169
+Y D EV +R +G G + EV+EG + + +K L
Sbjct: 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 170 V----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------ 219
V + E I+ NIV+ + + ++ E + D K
Sbjct: 71 VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRET 127
Query: 220 ----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDW 273
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 274 GLA 276
G+A
Sbjct: 188 GMA 190
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 46/221 (20%), Positives = 80/221 (36%), Gaps = 42/221 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
++ E + +G G + +V + + +K+LK +++ + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLYPTLSDYDVRYYI 234
L NIV LL LIFE+ D + R
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 235 YELLKAL----------------DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
E L L ++ + +HRD+ NV++ + +++ D+GLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221
Query: 279 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
Y VR +R K PE L + Y D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.02 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.48 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.92 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.38 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=439.49 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=215.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+|+.||||++++ ...+.+.+|+++|++| +|||||++++++.+ ...+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 679999999999999999999999999999999963 2346789999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
+||||+.||+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC
Confidence 999999999998776 4699999999999999999999999999999999999999776 89999999999875432
Q ss_pred --cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHH
Q 015741 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (401)
Q Consensus 284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (401)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+.+|.+.. -++++.+++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 2456789999999999987 78999999999999999999999999 4555566666665542 256788888
Q ss_pred HhcCCCCChhhHHHhhh------hcCCCccccccccc
Q 015741 356 NKYHIELDPHLAALVGR------HSRKPWSKFITVEN 386 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~------~l~~~~~~~~~~~~ 386 (401)
.+ ||+.||+.|++++| +++|||++-+..++
T Consensus 266 ~~-lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 266 EK-LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp HH-HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HH-HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 88 79999999999998 48999998877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=444.49 Aligned_cols=243 Identities=19% Similarity=0.370 Sum_probs=214.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.+.|+++++||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+++|+++ +|||||++++++.+ ...+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 3579999999999999999999999999999999863 3346789999999999 99999999999987 4678999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cccc
Q 015741 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~ 286 (401)
||||.+|+|..++ .++++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+... ....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCccc
Confidence 9999999998776 4699999999999999999999999999999999999999777 8999999999987544 3456
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (401)
..+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++++.+++.+
T Consensus 229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 6799999999999876 78999999999999999999999999 45556666666655421 4678888888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
||+.||+.|+++.++++|||++..
T Consensus 307 -~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 307 -LLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -HcCCChhHCcCHHHHhcCHhhcCC
Confidence 899999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=429.41 Aligned_cols=241 Identities=23% Similarity=0.465 Sum_probs=193.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+|+.||||++++. ..+++.+|+++|+++ +|||||++++++.+ ...+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 6899999999999999999999999999999998642 245789999999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||++ |+|.+.+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC--------
T ss_pred EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCCc
Confidence 9999994 6665554 4699999999999999999999999999999999999999776 899999999988766666
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
....+||+.|||||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+.+.. -++++.+++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNGVYTLPKFLSPGAAGLIKR- 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH-
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 6678999999999999874445789999999999999999999994 444444444554432 25678888888
Q ss_pred CCCCChhhHHHhhhhcCCCcccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
||+.||+.|++++++++|||++.
T Consensus 246 ~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HccCChhHCcCHHHHHcCccccc
Confidence 89999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=443.56 Aligned_cols=243 Identities=19% Similarity=0.368 Sum_probs=206.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.-++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|++| +|||||++++++.+ ...+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEE
Confidence 347899999999999999999999999999999998643 246789999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
|+|||||.||+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecC
Confidence 99999999999987762 368999999999999999999999999999999999999776 899999999987653
Q ss_pred CC-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHH
Q 015741 282 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNA 353 (401)
Q Consensus 282 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~ 353 (401)
.. .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+.++.+... ++++.+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 32 2345689999999999987 78999999999999999999999999 45566666666665422 457888
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+ ||+.||..|++++++++|||++.
T Consensus 256 li~~-~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 256 LVSQ-LFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHH-HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHH-HccCChhHCcCHHHHhcCHHhhc
Confidence 8888 89999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=447.17 Aligned_cols=243 Identities=19% Similarity=0.370 Sum_probs=215.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.+.|+++++||+|+||.||+|+++.+|+.||||+++. ...+.+.+|+.+|+.+ +|||||+++++|.+ ...+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999863 3456789999999999 99999999999987 4678999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cccc
Q 015741 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~~ 286 (401)
||||.||+|.+++ ..+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... ....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCcccc
Confidence 9999999998776 4699999999999999999999999999999999999999777 8999999999887544 3456
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (401)
..+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+..... ++++.++|.+
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 6799999999999876 78999999999999999999999999 45566666666655421 4678888888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
||+.||+.|+++.++|+|||++..
T Consensus 384 -~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 -LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -HcCCChhHCcCHHHHhcCHHhcCC
Confidence 899999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=423.84 Aligned_cols=242 Identities=20% Similarity=0.348 Sum_probs=203.7
Q ss_pred CCe-EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCC
Q 015741 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (401)
Q Consensus 134 ~~y-~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~ 205 (401)
.+| ++.++||+|+||+||+|++..+++.||+|++... ..+++.+|+++|++| +|||||++++++.+. ....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcE
Confidence 455 7788999999999999999999999999998642 235689999999999 999999999998653 2356
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+|+|||||.+|+|..++ ..+++..++.++.||+.||+|||++| ||||||||+|||++.+++.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 89999999999998776 46899999999999999999999998 99999999999998544489999999998543
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHHHh--------CChhH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL--------GTDEL 351 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~-~i~~~~--------~~~~~ 351 (401)
.......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.. ..+...+. .+.... .++++
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred -CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 344556789999999999864 699999999999999999999999954 34444443 332221 24567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+++.+ |+..||..|+++.++++|||++-
T Consensus 260 ~~li~~-~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 260 KEIIEG-CIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHH-HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHH-HccCChhHCcCHHHHhcCccccC
Confidence 888888 89999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=436.50 Aligned_cols=247 Identities=28% Similarity=0.471 Sum_probs=215.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.++||+|+||+||+|+++ .+++.||+|++.+. ...++.+|+++|+.+.+|||||++++++.+ ..++|+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEE
Confidence 478999999999999999999875 45789999988643 456789999999998789999999999976 568899
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-----
Q 015741 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK----- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~----- 283 (401)
||||+++++|.++++.+++.+++.+++||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999999999999999999999999999999999999999999999999775699999999998654321
Q ss_pred ------------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 015741 284 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339 (401)
Q Consensus 284 ------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l 339 (401)
.....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 12345799999999999876679999999999999999999999999999988888
Q ss_pred HHHHHHhC------------------------------------------------------------ChhHHHHHHhcC
Q 015741 340 VKIAKVLG------------------------------------------------------------TDELNAYLNKYH 359 (401)
Q Consensus 340 ~~i~~~~~------------------------------------------------------------~~~~~~~l~~~~ 359 (401)
..|.+.+| +++..+++.+ |
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~-l 336 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK-L 336 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH-H
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH-H
Confidence 88776544 2345677888 8
Q ss_pred CCCChhhHHHhhhhcCCCccccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+.||++|++++|+|+|||++-+
T Consensus 337 L~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 337 LDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-58 Score=428.40 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=205.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++++.||+|+||+||+|++. .+++.||||++++. ...++.+|+++|+++ +|||||++++++.+ ..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--EG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--TT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CC
Confidence 367999999999999999999874 46789999998642 235688999999999 99999999999976 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+|+||||+.||+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccC
Confidence 789999999999998776 4699999999999999999999999999999999999999777 899999999986543
Q ss_pred C-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHH
Q 015741 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAY 354 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~ 354 (401)
. ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+.. -++++.++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 3 33456789999999999987 78999999999999999999999999 4556666666665532 25678888
Q ss_pred HHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
+.+ ||+.||+.|++ ++++++|||++-+..
T Consensus 257 i~~-~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 257 LRM-LFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHH-HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHH-HcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 888 79999999998 589999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=435.17 Aligned_cols=248 Identities=29% Similarity=0.564 Sum_probs=212.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----C
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----Q 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~ 202 (401)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+++|+.| +|||||++++++... .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccccc
Confidence 357899999999999999999999999999999999642 235688999999999 999999999998643 2
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...+|+|||||+| +|..++ ..+++.+++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 131 ~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 131 FKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp CCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred CCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 3578999999974 565554 3599999999999999999999999999999999999999776 8999999999866
Q ss_pred CCC-----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 280 HPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 280 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
... ......+||+.|||||++.+...|+.++||||+||++|||++|+.|| .+.+..+++..|.+..+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHHh
Confidence 322 23456799999999999887667899999999999999999999998 67788888888877654
Q ss_pred ------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+++..++|.+ ||+.||..|+++.++|+|||++.+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR-MLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHH-HSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHH-HCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 2345677888 89999999999999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-57 Score=426.31 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=204.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.| +|||||++++++.+ ...+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEec
Confidence 367999999999999999999999999999999997532 235799999999 99999999999976 5678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-----
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----- 284 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~----- 284 (401)
|+||+|..++ ..+++.+++.++.||+.||+|||++|||||||||+|||++.++..+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9999998876 46999999999999999999999999999999999999997775799999999988754322
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAY 354 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~ 354 (401)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.... -++.+.++
T Consensus 212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence 123579999999999987 789999999999999999999999994 334444444444321 14567788
Q ss_pred HHhcCCCCChhhHHHhhhh-------------cCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRH-------------SRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~-------------l~~~~~~~~ 382 (401)
+.+ ||..||..|+++.|+ ++|||.+.+
T Consensus 290 i~~-~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 290 IQE-GLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHH-HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHH-HccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 888 799999999999996 689998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=412.90 Aligned_cols=241 Identities=20% Similarity=0.357 Sum_probs=188.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC------
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~------ 203 (401)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|++| +|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999999999999999998632 235688999999999 99999999999875432
Q ss_pred ----CCcEEEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEec
Q 015741 204 ----KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (401)
Q Consensus 204 ----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DF 273 (401)
.++|+||||+.+|+|..++.. ..+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence 247899999999999877632 34456889999999999999999999999999999999776 8999999
Q ss_pred ccceecCCCCc-------------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 015741 274 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (401)
Q Consensus 274 g~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~ 340 (401)
|+|+.+..... .+..+||+.|||||++.+ ..|+.++|||||||++|||++ ||.. ..+...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHHH
Confidence 99987654321 234579999999999987 789999999999999999996 7742 223332
Q ss_pred HHHHHhC----------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 341 KIAKVLG----------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 341 ~i~~~~~----------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+..... .+...+++.+ |++.||..||++.++++|||++-+..
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~-~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQD-MLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHH-HcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2222211 2344566776 89999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=405.64 Aligned_cols=247 Identities=19% Similarity=0.336 Sum_probs=204.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..++|.+.++||+|+||+||+|++. .+++.||||+++... .+.|.+|+++|++| +|||||++++++.+ .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence 3478999999999999999999874 357899999997543 36789999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 204 KTPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
..+++|||||++|+|..++. .+++.++..++.||+.||+|||+++||||||||+|||++.++ .
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~ 166 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-L 166 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-C
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-c
Confidence 67899999999999987762 489999999999999999999999999999999999999776 8
Q ss_pred EEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 015741 268 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~ 343 (401)
+||+|||+|+........ ....||+.|||||++.+ +.|+.++|||||||++|||+| |+.|| .+.++.+.+..+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~i~ 244 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECIT 244 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHH
Confidence 999999999876443322 23468999999999987 689999999999999999998 89998 4555566666665
Q ss_pred HHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 344 KVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 344 ~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
+... ++++.+++.+ |++.||+.||++.++ ++|.+.+....+
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~-cl~~dP~~RPs~~~i--~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLG-CWQREPHMRKNIKGI--HTLLQNLAKASP 292 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHH--HHHHHHHHHHSC
T ss_pred cCCCCCCCccchHHHHHHHHH-HcCCChhHCcCHHHH--HHHHHHHHhcCC
Confidence 5421 3577788888 899999999999999 567777654433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=398.15 Aligned_cols=279 Identities=72% Similarity=1.228 Sum_probs=249.9
Q ss_pred CCcccccCCCcCCCCCcccccccccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHH
Q 015741 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ 183 (401)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~ 183 (401)
+.++...+.+...+.+.|++....+.++..++|++++.||+|+||.||+|++..+++.||+|+++....+.+.+|+.+++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 85 (330)
T 3nsz_A 6 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 85 (330)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHH
T ss_pred CceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHH
Confidence 34444566667778888988888888888999999999999999999999999999999999999888899999999999
Q ss_pred HhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC
Q 015741 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (401)
Q Consensus 184 ~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 263 (401)
++.+||||+++++++.+......++||||+.+++|..+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC
Confidence 99669999999999988767788999999999999999999999999999999999999999999999999999999997
Q ss_pred CCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 015741 264 EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 264 ~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~ 343 (401)
++..+||+|||+++............++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 77689999999999887666667778999999999988767799999999999999999999999988888888887766
Q ss_pred HHhC-------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 344 KVLG-------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 344 ~~~~-------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
+..+ ++.+.+++.+ |+..||..|+++.++++|||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK-LLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHT-TSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHH-HhcCCcccCCCHHHHhcCccHh
Confidence 6543 4456677777 8999999999999999999998
Q ss_pred ccc
Q 015741 381 FIT 383 (401)
Q Consensus 381 ~~~ 383 (401)
-+.
T Consensus 325 ~~~ 327 (330)
T 3nsz_A 325 TVV 327 (330)
T ss_dssp TCC
T ss_pred hhc
Confidence 754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=428.31 Aligned_cols=244 Identities=22% Similarity=0.416 Sum_probs=215.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++|++++.||+|+||.||+|+++.+|+.||+|+++... .+.+.+|+++|+.| +|||||+++++|.+ ...+|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999986533 45688999999999 99999999999976 56889999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|||.||+|..++ ..+++.+++.+++||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.+......
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999997765 258899999999999999999999999999999999999854 248999999999998877777
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------ChhHHHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (401)
...+||+.|||||++.+ ..|+.++|||||||++|||++|..|| .+.+..+.+..+..... ++++.++|
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 78899999999999987 78999999999999999999999999 55666666666655421 45678888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ ||+.||..|+++.++|+|||++-..
T Consensus 392 ~~-~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 392 RK-LLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HH-HccCChhHCcCHHHHhcCcCcCCCC
Confidence 88 8999999999999999999998644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=400.50 Aligned_cols=236 Identities=17% Similarity=0.297 Sum_probs=192.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|.+.++||+|+||+||+|++. .+++.||||+++... .+.|.+|+++|++| +|||||++++++.+ ..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--GR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CC
Confidence 467899999999999999999864 368899999997543 36799999999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC
Q 015741 205 TPSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~ 266 (401)
.+++|||||++|+|..++. .+++.++..++.||+.||+|||+++||||||||+|||++.++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~- 195 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL- 195 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-
Confidence 7899999999999987652 378999999999999999999999999999999999999766
Q ss_pred eEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 015741 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 267 ~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i 342 (401)
.+||+|||+++....... .....||+.|||||++.+ ..|+.++|||||||++|||+| |+.|| .+.++.+.+..+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~i 273 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDCI 273 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT-CSSCHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCC-CCCCHHHHHHHH
Confidence 899999999987644322 234578999999999987 789999999999999999999 89998 445556666666
Q ss_pred HHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 343 AKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 343 ~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+... ++++.+++.+ |++.||+.||++.++++
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~-cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRG-CWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHH-HCCSSTTTSCCHHHHHH
T ss_pred HcCCCCCCcccccHHHHHHHHH-HcCcChhHCcCHHHHHH
Confidence 55422 4577788877 89999999999999964
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=427.11 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=206.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHH---HHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREI---KILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~---~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
-++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+|. .+++.+ +|||||+++++|.+ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~--~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE--C
Confidence 47899999999999999999999999999999999642 223344554 444455 89999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+|+||||+.||+|..++ ..+++..++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecC
Confidence 6789999999999998776 4699999999999999999999999999999999999999777 89999999998875
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-CCHHHHH-HHHHHh------CChhHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLV-KIAKVL------GTDELN 352 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-~~~~~l~-~i~~~~------~~~~~~ 352 (401)
... ....+||+.|||||++.+...|+.++|||||||++|||++|..||.... .+...+. .+.... -++++.
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence 443 4557999999999999754679999999999999999999999995432 2232222 222211 256788
Q ss_pred HHHHhcCCCCChhhHHH-----hhhhcCCCccccccccc
Q 015741 353 AYLNKYHIELDPHLAAL-----VGRHSRKPWSKFITVEN 386 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~~~ 386 (401)
++|.+ ||+.||..|++ ++++++|||++-+..+.
T Consensus 423 dLI~~-lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 423 SLLEG-LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHH-HTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHH-HccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 88888 79999999998 69999999999877543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=394.96 Aligned_cols=232 Identities=16% Similarity=0.322 Sum_probs=188.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.+++++.++||+|+||+||+|++. ..||||+++.. ..+.|.+|+.+|+++ +|||||++++++.+ ..++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeEE
Confidence 477889999999999999999853 35899998642 236789999999999 99999999998854 3578
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
+|||||++|+|..++ ..+++.++..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC-----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCC
Confidence 999999999998765 3589999999999999999999999999999999999999766 8999999999876432
Q ss_pred --CcccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-HhC----------
Q 015741 283 --KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLG---------- 347 (401)
Q Consensus 283 --~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~-~~~---------- 347 (401)
......+||+.|||||++.+ ...|+.++|||||||+||||+||+.||. +.++.+.+..+.. ...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCCccccccc
Confidence 22345689999999999864 2468999999999999999999999994 4455555544433 211
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 -TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
++.+.+++.+ |++.||+.||++.+++
T Consensus 266 ~~~~l~~li~~-cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 266 CPKAMKRLVAD-CVKKVKEERPLFPQIL 292 (307)
T ss_dssp SCHHHHHHHHH-HTCSSSTTSCCHHHHH
T ss_pred chHHHHHHHHH-HcCCCHhHCcCHHHHH
Confidence 2456777777 8999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=393.77 Aligned_cols=237 Identities=18% Similarity=0.308 Sum_probs=197.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.+++++.++||+|+||+||+|... .+++.||||+++.. ..+.|.+|+.++++| +|||||++++++.+ .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--C
Confidence 467889999999999999999863 46789999999643 346799999999999 99999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
..+++|||||.+|+|..++ ..+++.++..++.||+.||+|||+++||||||||+|||++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 6789999999999998775 237889999999999999999999999999999999999976
Q ss_pred CCeEEEEecccceecCCCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHH
Q 015741 265 QRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 340 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~ 340 (401)
+ .+||+|||+++...... .....+||+.|||||++.+ +.|+.++|||||||+||||+| |..|| .+.++.+.+.
T Consensus 182 ~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~~ 258 (308)
T 4gt4_A 182 L-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVE 258 (308)
T ss_dssp G-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHHH
T ss_pred C-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHHH
Confidence 6 89999999998764332 2344678999999999987 689999999999999999998 78888 4555555555
Q ss_pred HHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 341 KIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 341 ~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+... ++.+.+++.+ |++.||..||++.+++++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~-C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIE-CWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 5544321 3467777777 899999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=397.99 Aligned_cols=241 Identities=18% Similarity=0.283 Sum_probs=200.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||+||+|.+... ++.||||+++... .+.+.+|+++|.++.+|||||++++++.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 358899999999999999999998654 3689999997532 356899999999996669999999998653
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 263 (401)
...+++|||||.+|+|..++. .+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 356799999999999987752 2788999999999999999999999999999999999997
Q ss_pred CCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 015741 264 EQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 339 (401)
Q Consensus 264 ~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l 339 (401)
++ .+||+|||+|+.+..... ....+||+.|||||++.+ +.|+.++|||||||+||||+| |+.||.....+....
T Consensus 221 ~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 221 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 76 899999999987754433 234578999999999987 789999999999999999998 899985444444444
Q ss_pred HHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 340 VKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 340 ~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
..+.+.. .++++.+++.+ |++.||+.||++.++++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~-c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHH-HcCcChhHCcCHHHHHHH
Confidence 4444432 24578888888 899999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=394.99 Aligned_cols=246 Identities=26% Similarity=0.483 Sum_probs=210.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---- 202 (401)
..++|++++.||+|+||.||+|.+..+++.||||++... ..+++.+|+.+++.+ +||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence 358899999999999999999999999999999998642 246688999999999 9999999999997542
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
...+|+||||+.++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 217 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----C
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCC
Confidence 245799999999887777777899999999999999999999999999999999999999776 8999999999887666
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCCh-------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD------------- 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~------------- 349 (401)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+++..+.+.++.+
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 56677899999999999987 68999999999999999999999998 6777888888887766532
Q ss_pred -----------------------------------hHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 350 -----------------------------------ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 350 -----------------------------------~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+++.+ ||..||.+|++++++++|||++..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK-MLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH-HSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHH-HcCCChhhCCCHHHHhcChhhhhc
Confidence 35677777 899999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=373.85 Aligned_cols=246 Identities=22% Similarity=0.446 Sum_probs=211.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+|+.||||++... ..+++.+|+++++.+ +||||+++++++.+ ...++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence 46899999999999999999999999999999998643 235688999999999 89999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCc
Confidence 999999999987765 5799999999999999999999999999999999999999776 899999999987766666
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
....+||+.|+|||++.+....+.++|||||||++|+|++|+.|| .+.+..+....+.... .++++.+++.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 247 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKR- 247 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH-
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 677889999999999987444568999999999999999999998 4444444444444331 25677888888
Q ss_pred CCCCChhhHHHhhhhcCCCccccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
|+..||..|++++++++|||++....
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 89999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=380.61 Aligned_cols=251 Identities=28% Similarity=0.576 Sum_probs=204.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+++.||||++.. ....++.+|+.+++.+.+||||+++++++...+...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 3789999999999999999999999999999999853 23356789999999996699999999999876666889
Q ss_pred EEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC---
Q 015741 208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~--- 282 (401)
+||||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+...
T Consensus 88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccc
Confidence 99999985 665554 3689999999999999999999999999999999999999776 8999999999865321
Q ss_pred -------------------CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 015741 283 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (401)
Q Consensus 283 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~ 343 (401)
......+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence 12244589999999999987668999999999999999999999888 5677777777776
Q ss_pred HHhC-----------------------------------------------------ChhHHHHHHhcCCCCChhhHHHh
Q 015741 344 KVLG-----------------------------------------------------TDELNAYLNKYHIELDPHLAALV 370 (401)
Q Consensus 344 ~~~~-----------------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~ 370 (401)
+.++ ++++.+++.+ ||+.||..|+++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~-~L~~dP~~R~t~ 323 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK-LLQFNPNKRISA 323 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH-HCCSSGGGSCCH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH-hhccCcccCCCH
Confidence 5544 3356677777 899999999999
Q ss_pred hhhcCCCcccccccccc
Q 015741 371 GRHSRKPWSKFITVENQ 387 (401)
Q Consensus 371 ~~~l~~~~~~~~~~~~~ 387 (401)
.++++|||++.+...+.
T Consensus 324 ~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 324 NDALKHPFVSIFHNPNE 340 (388)
T ss_dssp HHHTTSTTTTTTCCGGG
T ss_pred HHHhCCHHHHHhcCCcc
Confidence 99999999987655443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=370.39 Aligned_cols=237 Identities=17% Similarity=0.214 Sum_probs=184.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHH--HHHhcCCCCeeEEeeEEEcCCC--CCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI--LQNLCGGPNIVKLLDIVRDQQS--KTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~i--l~~l~~hpniv~~~~~~~~~~~--~~~~lv 209 (401)
.+|.+.++||+|+||+||+|++ +|+.||||+++....+.+..|.++ +.++ +|||||++++++.+.+. ..+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 4688999999999999999987 689999999987666665555544 4566 89999999999986543 257999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||+++|+|..++ ..+++..+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence 9999999998876 3688999999999999999999987 999999999999999776 8999999999877
Q ss_pred CCCCcc-----cccccCCCccccccccCCC-----CCCcccchHHHHHHHHHHHcCCCCCCCC-------------CCCH
Q 015741 280 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYG-------------HDNY 336 (401)
Q Consensus 280 ~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~ll~elltg~~Pf~~~-------------~~~~ 336 (401)
...... ...+||+.|||||++.+.. .++.++|||||||++|||+||..||... ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 544322 2357999999999986521 3678999999999999999997665311 1122
Q ss_pred HHHHHHHHHhC----------C----hhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 337 DQLVKIAKVLG----------T----DELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 337 ~~l~~i~~~~~----------~----~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+.......+ . ..+.+++.+ |+..||+.||++.++++
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~-cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-CWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHT-TCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHH-HcccCHhHCcCHHHHHH
Confidence 33332211100 0 134455666 89999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=362.47 Aligned_cols=244 Identities=30% Similarity=0.558 Sum_probs=212.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++++.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 57999999999999999999999999999999986422 36688999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
||||+.++.+..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence 99999986655443 4689999999999999999999999999999999999999776 8999999999876433 33
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~---------------- 348 (401)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..||+.+.+..+.+..+.+..+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 4556789999999999875568999999999999999999999998888888888887776442
Q ss_pred -------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 349 -------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 349 -------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+.+++.+ |++.||+.|++++++++|||++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQN-LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHH-HhccChhhCCCHHHHhcCcccccC
Confidence 345677877 899999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=374.83 Aligned_cols=245 Identities=24% Similarity=0.450 Sum_probs=212.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.+.|++.+.||+|+||.||+|+++.+|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN--R 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--S
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--C
Confidence 47899999999999999999999999999999998643 236789999999999 89999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC---eEEEEecccce
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~vkl~DFg~a~ 277 (401)
..+++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 67899999999999988764 5899999999999999999999999999999999999986553 69999999999
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... .
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCchhccCC
Confidence 8876666667789999999999876 679999999999999999999999994 445555555554332 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..|+++.++++|||++-..
T Consensus 246 s~~~~~li~~-~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 246 SELAKDFIRK-LLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CHHHHHHHHH-HSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CHHHHHHHHH-HCCCChhHCcCHHHHhcCcCcCCCc
Confidence 4567788888 8999999999999999999998543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=374.43 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=207.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|+++.+++.||||++++. ..+.+.+|..+++.+.+||||+++++++.+ ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 47899999999999999999999999999999998642 335678899999998789999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-C
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~ 282 (401)
|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC
Confidence 9999999999997765 4699999999999999999999999999999999999999776 899999999986432 2
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..+.... -++.+.+++.
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 33456689999999999876 67999999999999999999999999 4555555555655432 2467788888
Q ss_pred hcCCCCChhhHHHh------hhhcCCCcccccccc
Q 015741 357 KYHIELDPHLAALV------GRHSRKPWSKFITVE 385 (401)
Q Consensus 357 ~~~l~~dP~~R~~~------~~~l~~~~~~~~~~~ 385 (401)
+ |+..||..|+++ +++++|||++-+..+
T Consensus 257 ~-lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 257 S-FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp H-HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred H-HhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 8 799999999998 899999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.58 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=209.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|+++.+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCEE
Confidence 36899999999999999999999999999999998642 345688999999998 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence 9999999999997665 4689999999999999999999999999999999999999777 89999999998643 23
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -++++.+++.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 34456789999999999876 689999999999999999999999994 333334444443321 2567788888
Q ss_pred hcCCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 357 KYHIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 357 ~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
+ |++.||..|+ +++++++|||++-+..
T Consensus 238 ~-lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 238 G-LLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp H-HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred H-HhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 8 7999999999 8999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=360.06 Aligned_cols=244 Identities=23% Similarity=0.413 Sum_probs=209.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEEEEE
Confidence 4689999999999999999999999999999999853 3456789999999999 99999999999976 4578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
|||+.+++|..++. .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccC
Confidence 99999999987763 589999999999999999999999999999999999999776 89999999998765443 334
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (401)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+..... ++.+.+++.+
T Consensus 175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 5689999999999987 689999999999999999999999994 4444444444443321 3457788888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|++.||..||++.++++|||++...
T Consensus 253 -~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 253 -CLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -HccCChhHCcCHHHHhhChhhcccC
Confidence 8999999999999999999998743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=364.33 Aligned_cols=244 Identities=21% Similarity=0.396 Sum_probs=211.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEEE
Confidence 478999999999999999999999999999999986543 35688999999999 99999999999976 46789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|...+. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999999987763 48999999999999999999999999999999999999862 348999999999988766666
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYL 355 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l 355 (401)
....|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.+.. -++++.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 77789999999999876 678999999999999999999999994 444555555554432 145677778
Q ss_pred HhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+ |+..||..||++.++++|||++..
T Consensus 239 ~~-~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 239 DR-LLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HH-HcCCChhHCcCHHHHhcChhhccC
Confidence 87 899999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=361.13 Aligned_cols=245 Identities=32% Similarity=0.602 Sum_probs=204.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
-.++|++++.||+|+||.||+|.+ .+++.||+|+++... ...+.+|+++++++ +||||+++++++.+ ...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CCEE
Confidence 358899999999999999999998 468999999986432 35688999999999 99999999999965 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
++||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc
Confidence 9999999974444333 2489999999999999999999999999999999999999776 8999999999876533
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~-------------- 348 (401)
.......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+..+.+.+..+....+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 33455678999999999877567899999999999999999999998 455555666666655432
Q ss_pred ----------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 349 ----------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 349 ----------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+++.+++.+ |+..||..|+++.++++|||++-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN-MLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHH-HcCCChhHCCCHHHHhcCcccccCC
Confidence 345677877 8999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=359.20 Aligned_cols=245 Identities=25% Similarity=0.492 Sum_probs=203.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHH
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQ 183 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~ 183 (401)
.++|++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 378999999999999999999999999999999986432 245889999999
Q ss_pred HhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE
Q 015741 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (401)
Q Consensus 184 ~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 261 (401)
++ +||||+++++++.+.....+++||||+.+++|..+.. .+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 9999999999998766678899999999999877653 58999999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccceecCCCC-cccccccCCCccccccccCCCC--CCcccchHHHHHHHHHHHcCCCCCCCCCCCHHH
Q 015741 262 DHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338 (401)
Q Consensus 262 ~~~~~~vkl~DFg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~ 338 (401)
+.++ .+||+|||++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.. ......
T Consensus 171 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~ 248 (298)
T 2zv2_A 171 GEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCL 248 (298)
T ss_dssp CTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHH
T ss_pred CCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHH
Confidence 9776 89999999998765433 2345678999999999876332 47889999999999999999999943 333333
Q ss_pred HHHHHHHh--------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 339 LVKIAKVL--------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 339 l~~i~~~~--------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
...+.... -++.+.+++.+ |+..||..|+++.++++|||+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITR-MLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHH-HTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHH-HhhcChhhCCCHHHHhcCccccC
Confidence 33332221 13567788888 89999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=365.12 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=210.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ...+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 47899999999999999999999999999999999642 345678899999887799999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-C
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~ 282 (401)
|+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC
Confidence 9999999999998776 4689999999999999999999999999999999999999777 899999999986432 2
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+.... -++++.+++.
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 33456789999999999987 679999999999999999999999984 444445554544321 2467788888
Q ss_pred hcCCCCChhhHHHhh-hhcCCCccccccc
Q 015741 357 KYHIELDPHLAALVG-RHSRKPWSKFITV 384 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~-~~l~~~~~~~~~~ 384 (401)
+ |+..||..|+++. ++++|||++-+..
T Consensus 251 ~-lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 251 K-LFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp H-HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred H-HhcCCHhHcCCChHHHHcCccccCCCH
Confidence 8 7999999999998 9999999987754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.59 Aligned_cols=248 Identities=31% Similarity=0.517 Sum_probs=209.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----CCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~~~~~~lv 209 (401)
.+|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.+ +||||+++++++... +..++++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 4799999999999999999999999999999998643 23345799999999 999999999988542 22357799
Q ss_pred EeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 210 ~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||+.++.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.+....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 999997543322 24689999999999999999999999999999999999999776689999999999876555
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.++.+.++
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 5566789999999999977567999999999999999999999998 56667777777776543
Q ss_pred -------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 348 -------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++++.+++.+ ||..||..|+++.++++|||++.+...
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~-~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHH-hccCChhHCCCHHHHhCCHhhcccccc
Confidence 3456777888 899999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=370.03 Aligned_cols=247 Identities=23% Similarity=0.409 Sum_probs=207.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|+++.+++.||+|++++.. .+.+.+|..++.++.+||||+++++++.+ ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 478999999999999999999999999999999997432 24578999999988789999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec-CCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~-~~~ 282 (401)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.. ...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCC
Confidence 9999999999997665 4699999999999999999999999999999999999999777 8999999999863 334
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-------CCHHHHH-HHHHHh------CC
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLV-KIAKVL------GT 348 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-------~~~~~l~-~i~~~~------~~ 348 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+. .+.... -+
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 286 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence 45566789999999999987 789999999999999999999999995321 1222222 222211 14
Q ss_pred hhHHHHHHhcCCCCChhhHHHh------hhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALV------GRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~------~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ ||+.||..|+++ .++++|||++-+..
T Consensus 287 ~~~~~li~~-lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 287 VKAASVLKS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHHHHHHHH-HTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred HHHHHHHHH-HhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 577888888 799999999984 79999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=374.42 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=211.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++++.||+|+||+||+|+++.+++.||+|++++. ....+.+|..++..+ +||||+++++++.+ ...
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCE
Confidence 457899999999999999999999999999999999642 223488999999998 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+|+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhccc
Confidence 89999999999998776 3589999999999999999999999999999999999999776 899999999987654
Q ss_pred CCcc--cccccCCCcccccccc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------
Q 015741 282 GKEY--NVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------- 346 (401)
Q Consensus 282 ~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------- 346 (401)
.... ...+||+.|+|||++. +...++.++|||||||++|||++|+.||. +.+..+....+....
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhccccccCCccc
Confidence 4332 3468999999999986 23578999999999999999999999994 555556666654321
Q ss_pred --CChhHHHHHHhcCCCCChhh--HHHhhhhcCCCccccccccc
Q 015741 347 --GTDELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~~~~~ 386 (401)
-++++.++|.+ |+..+|+. |++++++++|||++-+..++
T Consensus 307 ~~~s~~~~dLi~~-lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 307 TDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp CCSCHHHHHHHHT-TSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ccCCHHHHHHHHH-HhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 25678888888 68888888 99999999999998876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=360.84 Aligned_cols=245 Identities=22% Similarity=0.439 Sum_probs=210.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.+.|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 36799999999999999999999999999999998642 246799999999999 89999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC---eEEEEecccce
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~vkl~DFg~a~ 277 (401)
...++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 67899999999999988764 4899999999999999999999999999999999999986542 69999999999
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.... .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCCcCccccccC
Confidence 8766655666789999999999876 679999999999999999999999984 444445555444321 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..||++.++++|||++...
T Consensus 245 ~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 245 SALAKDFIRR-LLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CHHHHHHHHH-HSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CHHHHHHHHH-HccCChhhCCCHHHHhcCCCccCCc
Confidence 4456777877 8999999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=358.95 Aligned_cols=245 Identities=28% Similarity=0.535 Sum_probs=205.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHhc--CCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~--~hpniv~~~~~~~~~~ 202 (401)
.++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++. +||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 578999999999999999999999999999999986322 356788888888773 4999999999997643
Q ss_pred CC---CcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 203 SK---TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 203 ~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
.. .++++|||+.+ +|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence 22 57899999985 6665542 289999999999999999999999999999999999999776 89999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhc
Confidence 9987766666667789999999999987 67999999999999999999999998 56666777777766543
Q ss_pred --------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 --------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 --------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+.+++.+ |++.||..|+++.++++|||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE-MLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSTTC---
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHH-HhcCCCccCCCHHHHhcCccccCC
Confidence 2455677877 899999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=360.14 Aligned_cols=243 Identities=21% Similarity=0.409 Sum_probs=209.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|++..+|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence 46899999999999999999999999999999998642 345678899999998 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence 9999999999998776 4589999999999999999999999999999999999999776 899999999987643
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.... -++++.+++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3345689999999999876 689999999999999999999999994 444455555554431 24578888888
Q ss_pred cCCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 358 YHIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 358 ~~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
|+..||..|+ +++++++|||++.+..
T Consensus 237 -lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 237 -LITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp -HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -HhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 7999999999 8999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=378.98 Aligned_cols=250 Identities=30% Similarity=0.584 Sum_probs=192.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~ 204 (401)
.++|++++.||+|+||.||+|++..+++.||||++... ..+++.+|+.+|+.+ +||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998642 236788999999999 9999999999986432 35
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+|+||||+. ++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTS
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccC
Confidence 6899999986 5665554 2489999999999999999999999999999999999999776 899999999987642
Q ss_pred CC----------------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcC--------
Q 015741 282 GK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-------- 325 (401)
Q Consensus 282 ~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg-------- 325 (401)
.. ..+..+||+.|+|||++.....|+.++|||||||++|||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 234457899999999876557899999999999999999994
Q ss_pred --CCCCCCCCC--------------------CHHHHHHHHHHhC------------------------------------
Q 015741 326 --KEPFFYGHD--------------------NYDQLVKIAKVLG------------------------------------ 347 (401)
Q Consensus 326 --~~Pf~~~~~--------------------~~~~l~~i~~~~~------------------------------------ 347 (401)
..|++.+.+ +.+++..+.+.++
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 234334433 2456666666554
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 -TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
++++.++|.+ ||..||.+|++++++|+|||++.+...+
T Consensus 369 ~s~~~~dLl~~-mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 369 SSADAIHLLKR-MLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp SCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCHHHHHHHHH-HhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 3455677777 8999999999999999999999875443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=359.88 Aligned_cols=245 Identities=29% Similarity=0.591 Sum_probs=194.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence 46899999999999999999999999999999998643 236788999999999 99999999999965 567899
Q ss_pred EEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 209 IFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 209 v~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
||||+.+ +|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAF 158 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEET
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceec
Confidence 9999995 665443 2488999999999999999999999999999999999999776 8999999999876
Q ss_pred CCC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------
Q 015741 280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------- 347 (401)
Q Consensus 280 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------- 347 (401)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 533 23445678999999999876567899999999999999999999998 45566666666665433
Q ss_pred -----------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -----------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -----------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |++.||..|+++.++++|||++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG-LLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHH-HCCCCcccCCCHHHHhCChhhhcccc
Confidence 2356777888 89999999999999999999987544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=373.18 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=210.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++++.||+|+||.||+|+++.+++.||+|++++. ..+.+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 143 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY 143 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCE
Confidence 457899999999999999999999999999999998642 234588999999998 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+|+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCC
Confidence 89999999999998776 3589999999999999999999999999999999999999777 89999999998775443
Q ss_pred c--ccccccCCCccccccccCCC---CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---h-------CC
Q 015741 284 E--YNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---L-------GT 348 (401)
Q Consensus 284 ~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---~-------~~ 348 (401)
. ....+||+.|+|||++.+.. .++.++|||||||++|||++|+.||. +.+..+....+.+. + -+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhccccccCCCccccc
Confidence 2 34568999999999997632 27889999999999999999999994 45555566665543 1 24
Q ss_pred hhHHHHHHhcCCCCChhh--HHHhhhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHL--AALVGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~--R~~~~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ |+..+|.. |++++++++|||++-+..
T Consensus 302 ~~~~~li~~-lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 302 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HHHHHHHHH-HSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred HHHHHHHHH-HccChhhhCCCCCHHHHhcCccccCCCH
Confidence 578888888 67888888 999999999999988654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=364.85 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=210.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|+++.+++.||+|+++.. ..+.+..|..++..+.+||||+++++++.+ ...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEE
Confidence 47899999999999999999999989999999998642 345678899999887789999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
|+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC
Confidence 9999999999998775 4699999999999999999999999999999999999999776 89999999998643 23
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.... -++++.+++.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 34456789999999999876 679999999999999999999999994 444455555554431 2467788888
Q ss_pred hcCCCCChhhHH-----HhhhhcCCCcccccccc
Q 015741 357 KYHIELDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 357 ~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
+ |+..||..|+ +++++++|||++.+..+
T Consensus 254 ~-lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 254 G-LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp H-HTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred H-HhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 8 7999999999 67999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=366.26 Aligned_cols=242 Identities=26% Similarity=0.469 Sum_probs=208.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 6799999999999999999999999999999998643 235688999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+++|...+. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999976653 489999999999999999999999999999999999997543 369999999998776555
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.... -++.+.+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5566789999999999876 679999999999999999999999984 444444444444431 1456778
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+ |+..||..|+++.++++|||++.
T Consensus 264 li~~-~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 264 LIDS-MLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHH-HSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHH-HcCCChhhCcCHHHHhcCcccCC
Confidence 8888 89999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=353.49 Aligned_cols=240 Identities=31% Similarity=0.623 Sum_probs=200.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++++.||+|+||.||+|.+ .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence 5799999999999999999998 678999999986432 36688999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
||||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 9999997 555443 3589999999999999999999999999999999999999776 8999999999766432 2
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 3345678999999999876567899999999999999999999998 45566667776666533
Q ss_pred -------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 -------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |+..||..||++.++++|||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSK-MLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHH-HcCCCcccCCCHHHHhcCcchhh
Confidence 2345577777 89999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.29 Aligned_cols=247 Identities=21% Similarity=0.430 Sum_probs=210.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.+ +|||||++++++.+ ...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 90 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EEDM 90 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 47899999999999999999999999999999998632 346788999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC
Confidence 99999999999987763 589999999999999999999999999999999999999776 89999999999887666
Q ss_pred cccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCC-CCHHHHHH-HHHHh------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVK-IAKVL------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-~~~~~l~~-i~~~~------~~~~~~~ 353 (401)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.... .....+.. +.... -++.+.+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~ 249 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence 6677899999999999864 2468999999999999999999999995432 23333332 22211 1457778
Q ss_pred HHHhcCCCCChhhHHH-hhhhcCCCccccccc
Q 015741 354 YLNKYHIELDPHLAAL-VGRHSRKPWSKFITV 384 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~-~~~~l~~~~~~~~~~ 384 (401)
++.+ |+..||..|++ ++++++|||++-+..
T Consensus 250 li~~-lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 250 LLKK-LLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHH-HSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHH-HhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 8888 89999999998 899999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=366.58 Aligned_cols=244 Identities=23% Similarity=0.438 Sum_probs=211.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ...+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence 46899999999999999999999999999999998754 345688999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|...+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++........
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999987763 48899999999999999999999999999999999999743 34799999999998866655
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAY 354 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~ 354 (401)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+.. -++.+.++
T Consensus 207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 666789999999999876 679999999999999999999999984 445555555554431 24577888
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |+..||..|+++.++++|||++-.
T Consensus 285 i~~-~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 285 IKN-LLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHT-TSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHH-HcCCChhHCcCHHHHhhCccccCC
Confidence 888 899999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=365.11 Aligned_cols=247 Identities=30% Similarity=0.549 Sum_probs=205.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC--
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-- 203 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~-- 203 (401)
...++|++++.||+|+||.||+|.+..+|+.||||++... ..+++.+|+++++.+ +||||+++++++.....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence 3468899999999999999999999999999999998532 235688999999999 89999999999975422
Q ss_pred --CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..+|+||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeeccccc
Confidence 3569999999 77887665 4689999999999999999999999999999999999999776 8999999999875
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
.. .....++|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 42 3445688999999999887567999999999999999999999998 56677777777766544
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |+..||..|+++.++++|||++.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK-MLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH-HccCChhHCCCHHHHhcChHHHhhcC
Confidence 3345667777 89999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=360.13 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEEE
Confidence 478999999999999999999999999999999986432 35688999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcc
Confidence 999999999988764 489999999999999999999999999999999999999766 89999999998654222
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHH
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (401)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||................. -++.+.++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 234568899999999998744457899999999999999999999965444333333322211 24566777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+ |+..||..|+++.++++|||++..
T Consensus 242 i~~-~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 242 LHK-ILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHH-HSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHH-HccCChhhCcCHHHHhhChhhccc
Confidence 888 899999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=371.14 Aligned_cols=250 Identities=28% Similarity=0.560 Sum_probs=204.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC---
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~--- 203 (401)
..++|++++.||+|+||.||+|++..+++.||||+++.. ..+++.+|+++|+++ +||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 358899999999999999999999999999999999642 236788999999999 89999999999875432
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+|+||||+++ +|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC-
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCccccc
Confidence 568999999885 7765553 489999999999999999999999999999999999999776 89999999998764
Q ss_pred CCC-----------------------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcC----------CC
Q 015741 281 PGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR----------KE 327 (401)
Q Consensus 281 ~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg----------~~ 327 (401)
... ..+..+||+.|+|||++.....++.++|||||||++|||++| +.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 332 135678999999999976657899999999999999999974 45
Q ss_pred CCCCCCC-----------------CHHHHHHHHHHhC-------------------------------------ChhHHH
Q 015741 328 PFFYGHD-----------------NYDQLVKIAKVLG-------------------------------------TDELNA 353 (401)
Q Consensus 328 Pf~~~~~-----------------~~~~l~~i~~~~~-------------------------------------~~~~~~ 353 (401)
|++.+.+ ..+++..+.+.+| ++.+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 5555543 2456666655544 344556
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.+ ||..||.+|++++++++|||++-+...
T Consensus 341 Ll~~-mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 341 LLES-MLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHH-HSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHH-HhcCCcccCCCHHHHhcChhhhhccCc
Confidence 7777 899999999999999999999887544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=366.11 Aligned_cols=242 Identities=21% Similarity=0.431 Sum_probs=202.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence 37899999999999999999999999999999998632 235789999999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+ +|++...+ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence 9999999 56665443 4699999999999999999999999999999999999999766 89999999998876666
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~ 357 (401)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.... ..+....+... .-++.+.+++.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 66677899999999999874445789999999999999999999994321 11111111000 124567788888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|+..||..||++.++++|||++.
T Consensus 242 -~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 242 -MIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -TSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -HcCCChhHCcCHHHHHhChhhcc
Confidence 89999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.78 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=206.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|+++.+++.||+|+++... .+.+.+|..+++++.+||||+++++++.+ ...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEE
Confidence 368999999999999999999999999999999996432 34578899999987789999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCC
Confidence 9999999999997665 4699999999999999999999999999999999999999776 89999999998643 33
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-------CCHHHHH-HHHHHh------CC
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLV-KIAKVL------GT 348 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-------~~~~~l~-~i~~~~------~~ 348 (401)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+. .+.... -+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 34556789999999999987 688999999999999999999999995321 1222222 222211 24
Q ss_pred hhHHHHHHhcCCCCChhhHHHh------hhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALV------GRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~------~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ |++.||..|+++ .++++|||++-+..
T Consensus 244 ~~~~~li~~-lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 244 VKAASVLKS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHHHH-HTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHH-HhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 577788888 799999999985 79999999987653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=367.71 Aligned_cols=246 Identities=28% Similarity=0.539 Sum_probs=208.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC-----------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----------- 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----------- 201 (401)
.++|++++.||+|+||.||+|.+..+|+.||||++... .....+|+++++.+ +||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC-----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCcccccccccc
Confidence 57899999999999999999999999999999998643 23345899999999 999999999998542
Q ss_pred -------------------------CCCCcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015741 202 -------------------------QSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGI 249 (401)
Q Consensus 202 -------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~i 249 (401)
...++++||||+.+ +|...+ ..+++..++.++.||+.||+|||++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 23458899999996 443322 458999999999999999999999999
Q ss_pred eeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCC
Q 015741 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 250 vHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf 329 (401)
+||||||+|||++.+++.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 99999999999985455899999999998776666667788999999999887567999999999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHhCC-----------------------------------hhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 330 FYGHDNYDQLVKIAKVLGT-----------------------------------DELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 330 ~~~~~~~~~l~~i~~~~~~-----------------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.+.+..+++..+.+..+. +.+.+++.+ |+..||..|+++.+++
T Consensus 243 -~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 243 -SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ-ILRYEPDLRINPYEAM 320 (383)
T ss_dssp -CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH-HCCSSGGGSCCHHHHH
T ss_pred -CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH-HccCChhhCCCHHHHh
Confidence 567777888887776543 236677777 8999999999999999
Q ss_pred CCCcccccc
Q 015741 375 RKPWSKFIT 383 (401)
Q Consensus 375 ~~~~~~~~~ 383 (401)
+|||++.+.
T Consensus 321 ~hp~f~~~~ 329 (383)
T 3eb0_A 321 AHPFFDHLR 329 (383)
T ss_dssp TSGGGHHHH
T ss_pred cCHHHHHHH
Confidence 999997653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.39 Aligned_cols=244 Identities=25% Similarity=0.435 Sum_probs=207.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence 367999999999999999999999999999999986432 35688999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~ 282 (401)
+||||+.+++|...+ ..+++.++..++.||+.||.|||++||+||||||+|||++. ++..+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999987665 46899999999999999999999999999999999999984 2347999999999876543
Q ss_pred C-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhH
Q 015741 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDEL 351 (401)
Q Consensus 283 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~ 351 (401)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.... -++.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 3 2345689999999999876 679999999999999999999999984 445555555555432 14577
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+++.+ |+..||..|+++.++++|||++..
T Consensus 245 ~~li~~-~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINK-MLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHH-HSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHH-HcCCChhHCCCHHHHhcCccccCC
Confidence 888888 899999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=366.79 Aligned_cols=245 Identities=26% Similarity=0.476 Sum_probs=197.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
.++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 47899999999999999999999999999999998642 235688999999999 99999999999975431
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
...++||||+.++.+..+...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC--------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc
Confidence 36799999999765555556799999999999999999999999999999999999999776 89999999998765544
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 4556789999999999987 67999999999999999999999998 45556666665544332
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+.+++.+ ||..||..|++++++++|||++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK-MLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH-HSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHH-HCcCChhhCCCHHHHhCCcchhhh
Confidence 1345677777 899999999999999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=364.83 Aligned_cols=245 Identities=21% Similarity=0.352 Sum_probs=193.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+ ...+++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEEEEEE
Confidence 57899999999999999999999999999999999743 346789999999999 99999999999976 46789999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC-CeEEEEecccceecCCCCccc
Q 015741 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~vkl~DFg~a~~~~~~~~~~ 286 (401)
||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++.........
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 999999997765 4699999999999999999999999999999999999998654 249999999998654444455
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH---HHHHHHHHHh--------CChhHHHHH
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVL--------GTDELNAYL 355 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~---~~l~~i~~~~--------~~~~~~~~l 355 (401)
...||+.|+|||++.+....+.++|||||||++|+|++|+.||....... ..+..+.... .++.+.+++
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 67899999999999874333455999999999999999999995433222 2222222211 145777888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+ |+..||..|+++.++++|||+..
T Consensus 256 ~~-~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 256 SR-IFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HH-HSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HH-HccCChhHCcCHHHHHhCcchhc
Confidence 88 89999999999999999999954
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=363.58 Aligned_cols=243 Identities=26% Similarity=0.424 Sum_probs=205.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 36799999999999999999999999999999998532 356789999999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEeccc
Q 015741 205 TPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGL 275 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~ 275 (401)
.+++||||+.+++|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 7899999999999865441 389999999999999999999999999999999999997544 2499999999
Q ss_pred ceecCCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------
Q 015741 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (401)
Q Consensus 276 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------- 346 (401)
+........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ..+.+..+.+..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHH
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCcccc
Confidence 987754432 345689999999999876 67899999999999999999999999542 233333333321
Q ss_pred --CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 347 --GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 347 --~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
-++.+.+++.+ |+..||..|+++.++++|||++..
T Consensus 257 ~~~s~~~~~li~~-~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRR-MLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHH-HCCCChhHCcCHHHHhcChhhcCC
Confidence 14567778888 899999999999999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=366.85 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=209.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++++.||+|+||+||+|+++.+++.||+|++++. ..+.+.+|..++..+ +||||+++++++.+ ...
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CCE
Confidence 458899999999999999999999999999999999642 224478999999998 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccC
Confidence 89999999999998775 3689999999999999999999999999999999999999776 899999999987754
Q ss_pred CCc--ccccccCCCccccccccC------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---h----
Q 015741 282 GKE--YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---L---- 346 (401)
Q Consensus 282 ~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~---~---- 346 (401)
... ....+||+.|+|||++.. ...++.++|||||||++|||++|+.||. +.+..+....+... .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccCcCCCc
Confidence 433 234589999999999862 2568999999999999999999999994 44555555555432 1
Q ss_pred ----CChhHHHHHHhcCCCCChhhH---HHhhhhcCCCccccccccc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLA---ALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R---~~~~~~l~~~~~~~~~~~~ 386 (401)
-++++.+++.+ |+. +|..| ++++++++|||++-+..+.
T Consensus 294 ~~~~~s~~~~dli~~-lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 294 VDEGVPEEARDFIQR-LLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp ---CCCHHHHHHHHT-TSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred cccCCCHHHHHHHHH-HcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 24577888888 677 99998 5899999999998876654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=361.27 Aligned_cols=240 Identities=24% Similarity=0.481 Sum_probs=203.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhc----CCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~----~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|++..+++.||||+++.. ....+..|+.+++.+. +||||+++++++.. ....
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCee
Confidence 57999999999999999999999999999999999743 2456788999999984 49999999999976 4578
Q ss_pred EEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC------------------
Q 015741 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------------------ 263 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~------------------ 263 (401)
++||||+ +++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 788766652 4889999999999999999999999999999999999974
Q ss_pred ------CCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHH
Q 015741 264 ------EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337 (401)
Q Consensus 264 ------~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~ 337 (401)
....+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~ 266 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEHME 266 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHH
T ss_pred ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcHHH
Confidence 234899999999987543 2345678999999999987 67999999999999999999999998 4555566
Q ss_pred HHHHHHHHhCC----------------------------------------------------hhHHHHHHhcCCCCChh
Q 015741 338 QLVKIAKVLGT----------------------------------------------------DELNAYLNKYHIELDPH 365 (401)
Q Consensus 338 ~l~~i~~~~~~----------------------------------------------------~~~~~~l~~~~l~~dP~ 365 (401)
.+..+....+. +.+.+++.+ |++.||.
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~ 345 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS-ILQIDPT 345 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH-HCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH-HhcCChh
Confidence 66655554332 344577777 8999999
Q ss_pred hHHHhhhhcCCCccc
Q 015741 366 LAALVGRHSRKPWSK 380 (401)
Q Consensus 366 ~R~~~~~~l~~~~~~ 380 (401)
.||++.++++|||++
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=360.12 Aligned_cols=243 Identities=22% Similarity=0.366 Sum_probs=209.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|++..+|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCEE
Confidence 47899999999999999999999999999999998642 345688999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC-
Confidence 9999999999997765 4689999999999999999999999999999999999999776 8999999999876432
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.... -++.+.+++.+
T Consensus 195 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 345689999999999887 679999999999999999999999994 444445555554431 25678888888
Q ss_pred cCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 358 YHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 358 ~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
|++.||..|++ ++++++|||++-+..
T Consensus 272 -lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 272 -LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -HhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 79999999998 999999999987553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=358.65 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=207.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----- 202 (401)
.++|++++.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 47899999999999999999999999999999998532 235688999999999 8999999999987643
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...+++||||+.++.+..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhccc
Confidence 34689999999975444333 3589999999999999999999999999999999999999776 899999999987
Q ss_pred cCCC-----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------
Q 015741 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (401)
Q Consensus 279 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------ 347 (401)
+... .......||+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+.+..+
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhh
Confidence 6422 22345678999999999877567899999999999999999999888 55666666666665543
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |+..||..|+++.++++|||++....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-LLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHH-HhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 3346677888 89999999999999999999976443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=345.71 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=214.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEEE
Confidence 478999999999999999999999999999999986432 35688999999999 99999999999975 46678
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~~~~~ 282 (401)
++|||+.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ ..+||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999986554 4589999999999999999999999999999999999997544 24999999999887666
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELN 352 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~ 352 (401)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+....+.... -++.+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC-CCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 55566789999999999876 678999999999999999999999994 344444444444332 145677
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCcccccccccccCCCCc-ccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE-VEF 396 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~~~~~~~-~dl 396 (401)
+++.+ |++.||..||++.++++|||++........+-..+ +|.
T Consensus 240 ~li~~-~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 283 (284)
T 3kk8_A 240 SLIDS-MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283 (284)
T ss_dssp HHHHH-HSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCCCC
T ss_pred HHHHH-HcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCccc
Confidence 88888 89999999999999999999987655444333333 554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=360.79 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=192.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence 47899999999999999999999999999999999754 346688999999999 89999999999976 457899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
|+.+++|...+. .+++.+++.++.||+.||.|||++||+||||||+|||++. ++..+||+|||+++.........
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999977663 4899999999999999999999999999999999999974 23489999999998775554455
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHH
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLN 356 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~ 356 (401)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..+.+.. -++.+.+++.
T Consensus 209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 6789999999999886 6789999999999999999999999965554443444444321 1346777888
Q ss_pred hcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+ |+..||+.|+++.++++|||+.-..
T Consensus 288 ~-~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 288 K-LIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp T-TSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred H-HccCChhhCcCHHHHhcCcccCCCc
Confidence 7 8999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=350.88 Aligned_cols=246 Identities=30% Similarity=0.544 Sum_probs=203.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEEE
Confidence 68999999999999999999999999999999985432 35578999999999 89999999999976 467889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
||||+.++++..+. ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccc
Confidence 99999999987664 4589999999999999999999999999999999999999766 8999999999876533 23
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....+++.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+.+..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 345678999999999977567899999999999999999999998 55566666666555432
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++++.+++.+ |+..||..||+++++++|||++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKG-CLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHH-HCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHH-HccCChhhcCCHHHHhcChHHHhccCH
Confidence 2346667777 899999999999999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=357.28 Aligned_cols=244 Identities=28% Similarity=0.553 Sum_probs=200.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++++.||+|+||.||+|.+..+++.||+|+++.... ..+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 579999999999999999999999999999999864332 2355799999999 89999999999976 4678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Cc
Q 015741 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~ 284 (401)
|||+.+ +|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccc
Confidence 999986 554443 3488999999999999999999999999999999999999776 8999999999765432 23
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 345578999999999877567899999999999999999999998 56666777777766544
Q ss_pred -------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ |++.||..|+++.++++|||+.-+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTK-LLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHH-HcCcCcccCCCHHHHhcChhhhhccc
Confidence 2345677887 89999999999999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=354.64 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.++|++.+.||+|+||.||+|++. .+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT-- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc--
Confidence 478999999999999999999985 68999999998743 234578899999999 89999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCccccc
Confidence 46789999999999997765 3589999999999999999999999999999999999999776 8999999999764
Q ss_pred CCC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHH
Q 015741 280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELN 352 (401)
Q Consensus 280 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~ 352 (401)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+.. -++.+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 322 23345679999999999876 678999999999999999999999994 444555555555432 145778
Q ss_pred HHHHhcCCCCChhhHH-----HhhhhcCCCcccccccc
Q 015741 353 AYLNKYHIELDPHLAA-----LVGRHSRKPWSKFITVE 385 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~~ 385 (401)
+++.+ |+..||..|+ ++.++++|||++.+..+
T Consensus 250 ~li~~-~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 250 DLLKK-LLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHH-HSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHH-HHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 88888 8999999999 88999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=357.41 Aligned_cols=246 Identities=29% Similarity=0.583 Sum_probs=201.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCEEE
Confidence 478999999999999999999999999999999986432 24577999999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC----CCeEEEEecccceecC
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYH 280 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~----~~~vkl~DFg~a~~~~ 280 (401)
+||||+.+ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999996 665554 358999999999999999999999999999999999999532 2369999999998764
Q ss_pred CC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 281 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+.+..+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 33 33455678999999999987566899999999999999999999998 55666677776665533
Q ss_pred ------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ |++.||..|+++.++++|||++-...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTA-MLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHH-HccCChhhCCCHHHHhCCcccCCCCC
Confidence 3556677888 89999999999999999999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=360.20 Aligned_cols=247 Identities=27% Similarity=0.518 Sum_probs=195.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---- 202 (401)
..++|++++.||+|+||.||+|.+..+|+.||||++... ..+++.+|+.+++.+ +||||+++++++....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence 358899999999999999999999999999999998642 235688999999999 8999999999986531
Q ss_pred CCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
....+++||++ +++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccccc
Confidence 25679999998 577766653 589999999999999999999999999999999999999766 89999999998653
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC------------
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------------ 348 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~------------ 348 (401)
. ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+.
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 3445688999999999887668999999999999999999999998 666777777777765442
Q ss_pred -------------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 349 -------------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 349 -------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
+.+.+++.+ ||..||..|+++.++++|||++.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~-mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHH-hCCCCcccCcCHHHHhcChhhhhccCC
Confidence 345677777 899999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=375.57 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=212.4
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
...++|++.+.||+|+||.||+|.+..+|+.||+|++... ....+.+|+.+|+.+ +||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 3467899999999999999999999999999999998542 335688999999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 205 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
.+++||||+.+|+|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceec
Confidence 7899999999999977652 389999999999999999999999999999999999999776 8999999999987
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHHh-------CChh
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVL-------GTDE 350 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~~-------~~~~ 350 (401)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ..+.+....... -+++
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 66655666789999999999987 6799999999999999999999999964332 333333333222 2467
Q ss_pred HHHHHHhcCCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 351 LNAYLNKYHIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
+.+++.+ |+..||..|+ ++.++++|||++.+..
T Consensus 416 ~~dLI~~-lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 416 ARSLCSQ-LLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHHHH-HTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHHHHH-hccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 8888888 7999999999 8999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=372.60 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=211.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|.+.+.||+|+||.||+|++..+|+.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEE
Confidence 37899999999999999999999999999999999643 235788999999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc
Confidence 99999999999988764 589999999999999999999999999999999999999766 89999999999876666
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+..+....+.... -++.+.+++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 56677899999999999874445789999999999999999999994 445555555554432 24677888888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|+..||..||++.++++|||++.
T Consensus 250 -~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 250 -MLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -HTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -HcCCCchhCcCHHHHHhCHHhhh
Confidence 89999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=353.04 Aligned_cols=250 Identities=21% Similarity=0.382 Sum_probs=207.3
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~-~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+ ....
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 3568887 8999999999999999999999999998642 246789999999999778999999999976 4678
Q ss_pred EEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~ 279 (401)
++||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998776 35899999999999999999999999999999999999986 1348999999999987
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------Ch
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TD 349 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~ 349 (401)
..........|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+... ++
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHhcccccCchhhcccCH
Confidence 65555566789999999999876 67899999999999999999999998 44455555555544321 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
.+.+++.+ |+..||..||+++++++|||++.+..++.
T Consensus 263 ~~~~li~~-~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 263 LATDFIQS-LLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHHHHH-HSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHHHHHHH-HcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 57777887 89999999999999999999988766543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=356.19 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=188.0
Q ss_pred CCeEEE---eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVV---RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~---~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++|++. +.||+|+||.||+|.+..+++.||||++.......+.+|+.+++.+.+||||+++++++.+ ....++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEE
Confidence 456664 7899999999999999999999999999887778899999999999669999999999976 46789999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEEecccceecCCCC-c
Q 015741 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~DFg~a~~~~~~~-~ 284 (401)
||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++...... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999997765 35899999999999999999999999999999999999975442 79999999998765432 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHh----------CC
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVL----------GT 348 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~------~~~~l~~i~~~~----------~~ 348 (401)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..+.+..+.+.. -+
T Consensus 166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 355678999999999876 6799999999999999999999999954321 122333332221 24
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+.+.+++.+ |+..||..|+++.++++|||++..
T Consensus 245 ~~~~~li~~-~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQG-LLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHH-HHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHH-HCCCChhHCCCHHHHhcChhhccC
Confidence 567788888 899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=362.77 Aligned_cols=249 Identities=29% Similarity=0.518 Sum_probs=207.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----CCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~~~~~l 208 (401)
..+|++.+.||+|+||.||+|++..+++ +|+|.+... .....+|+++++.+ +||||+++++++.... ..++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 3579999999999999999999876665 777766432 22345799999999 9999999999986532 234789
Q ss_pred EEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 209 IFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 209 v~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
||||+.++.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999998765433 2468999999999999999999999999999999999999944448999999999987666
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.++
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66666788999999999977567999999999999999999999998 56677778887777543
Q ss_pred --------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 --------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
++++.+++.+ |++.||..|+++.++++|||++-+...+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISR-LLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHH-HhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 3456777888 8999999999999999999998765443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=365.33 Aligned_cols=245 Identities=23% Similarity=0.417 Sum_probs=196.7
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEc--CCCCCcEEE
Q 015741 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~-~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~--~~~~~~~lv 209 (401)
.++|.+. +.||+|+||.||+|.+..+++.||||+++. ...+.+|+.++.++.+||||+++++++.. ....++++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 3678887 789999999999999999999999999964 35678999998777699999999998864 224578999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~~~~ 282 (401)
|||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ++.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999987763 38999999999999999999999999999999999999862 348999999999877655
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH---HHHHHHHHH----------hCCh
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKV----------LGTD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~---~~l~~i~~~----------~~~~ 349 (401)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+... .-++
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 55567789999999999876 689999999999999999999999996433211 122222221 1245
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+++.+ |+..||..|+++.++++|||+..
T Consensus 297 ~~~~li~~-~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 297 EVKMLIRN-LLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHT-TSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHHH-HCCCChhHCcCHHHHhcCccccC
Confidence 67788888 89999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=358.35 Aligned_cols=248 Identities=30% Similarity=0.561 Sum_probs=205.2
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 130 ~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
+.-.++|.+.+.||+|+||.||+|.+..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++......
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCc
Confidence 34458999999999999999999999999999999998642 135688999999999 899999999999764322
Q ss_pred ----CcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 205 ----TPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 205 ----~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..++||||+.+ +|.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC---
T ss_pred ccceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccc
Confidence 24899999995 555444 4699999999999999999999999999999999999999776 8999999999865
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 32 3345678999999999887568999999999999999999999998 45566666666655432
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |++.||..|+++.++++|||++.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-MLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHH-HCCCChhhcCCHHHHhcCcccccCCC
Confidence 4566777888 89999999999999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=362.58 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=203.2
Q ss_pred CCCCeEEEeeeccc--CCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..++|++++.||+| +||.||+|++..+++.||||+++... .+.+.+|+.+++.+ +|||||++++++.+ ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DN 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEE--CC
Confidence 35789999999999 99999999999999999999986432 35678899999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
.+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+...
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~ 178 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceee
Confidence 789999999999998775 4589999999999999999999999999999999999999776 8999999998654
Q ss_pred CCC--------CcccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH------
Q 015741 280 HPG--------KEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK------ 344 (401)
Q Consensus 280 ~~~--------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~------ 344 (401)
... .......||..|+|||++.+. ..++.++|||||||++|+|++|+.||... +..+.+..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGTVPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC-CSTTHHHHC--------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCCCCcc
Confidence 221 112334788899999998763 46899999999999999999999999543 32222221111
Q ss_pred ----------------------------------------------HhCChhHHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 345 ----------------------------------------------VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 345 ----------------------------------------------~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
..-++.+.+++.+ |++.||..|+++.++++|||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~-~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHH-HTCSCTTTSCCHHHHTTSGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH-HhhcCcccCCCHHHHhcCHH
Confidence 0123457778888 89999999999999999999
Q ss_pred cccccc
Q 015741 379 SKFITV 384 (401)
Q Consensus 379 ~~~~~~ 384 (401)
++.+..
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 987653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=359.35 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=205.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.++|++.+.||+|+||.||+|.++.+++.||+|+++... ....+|++++.++.+||||+++++++.+ ...+|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence 367999999999999999999999999999999997543 3456799999998789999999999976 5678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC---CeEEEEecccceecCCCC-cc
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~---~~vkl~DFg~a~~~~~~~-~~ 285 (401)
+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||+..+. ..+||+|||+++...... ..
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 9999987665 3589999999999999999999999999999999999985443 259999999998765432 34
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-CC-HHHHHHHHHHh----------CChhHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DN-YDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-~~-~~~l~~i~~~~----------~~~~~~~ 353 (401)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .. .+.+..+.... -++.+.+
T Consensus 178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 256 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256 (342)
T ss_dssp CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence 55688999999999876 568899999999999999999999996432 22 33333443321 2457788
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+ |+..||..|+++.++++|||+....
T Consensus 257 li~~-~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 257 LVSK-MLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHH-HTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHH-HCCCChhHCcCHHHHhcCCeecCcc
Confidence 8888 8999999999999999999996543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=346.52 Aligned_cols=242 Identities=23% Similarity=0.413 Sum_probs=198.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++... ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeEEE
Confidence 47899999999999999999999999999999998643 347789999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceec
Q 015741 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFY 279 (401)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~ 279 (401)
||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999987665 468999999999999999999999999999999999999532 247999999999877
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChh
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDE 350 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~ 350 (401)
..........+++.|+|||++. ..++.++|||||||++|+|++|+.||. +....+....+.... .++.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhccCCcccccccCcCCHH
Confidence 6555556678999999999975 468999999999999999999999994 333333222222111 2456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+++.+ |+..||..||++.++++|||++.
T Consensus 255 ~~~li~~-~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQ-MLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHH-HTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHH-HccCChhhCcCHHHHhcCHHhhc
Confidence 7788888 89999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=353.03 Aligned_cols=247 Identities=29% Similarity=0.534 Sum_probs=205.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..++|++++.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--CCEE
Confidence 4578999999999999999999999999999999985432 34578999999999 89999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
++||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC-------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCc
Confidence 9999999999987764 4689999999999999999999999999999999999999776 8999999999766433
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
.......+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 33445678999999999987557899999999999999999999998 45555666655554322
Q ss_pred ----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |+..||..||++.++++|||++....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKK-CLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHH-HTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHH-HhccCcccCCCHHHHhcCchhccCCh
Confidence 3456777877 89999999999999999999987544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=361.05 Aligned_cols=241 Identities=21% Similarity=0.408 Sum_probs=202.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
|...+.||+|+||.||+|.+..+|+.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ...+++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEEeC
Confidence 33467899999999999999999999999999764 346789999999999 99999999999976 4578999999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe-CCCCeEEEEecccceecCCCCcccc
Q 015741 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNV 287 (401)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~vkl~DFg~a~~~~~~~~~~~ 287 (401)
+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||+++..........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999986654 2489999999999999999999999999999999999994 2344899999999998876666666
Q ss_pred cccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHh
Q 015741 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNK 357 (401)
Q Consensus 288 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~ 357 (401)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.... -++.+.+++.+
T Consensus 248 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 789999999999876 67899999999999999999999998 4555566666665532 24577888888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+..||..|+++.++++|||++-.
T Consensus 326 -~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 326 -LLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -TSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -HcCCChhhCCCHHHHhcCcCcCCC
Confidence 899999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=354.33 Aligned_cols=246 Identities=21% Similarity=0.327 Sum_probs=207.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+++++++ +||||+++++++.+......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEE
Confidence 57899999999999999999999999999999998742 346688999999999 8999999999998776678899
Q ss_pred EEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE----eCCCCeEEEEeccccee
Q 015741 209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~vkl~DFg~a~~ 278 (401)
||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~ 165 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE 165 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCcee
Confidence 9999999999877642 8999999999999999999999999999999999998 5333 799999999998
Q ss_pred cCCCCcccccccCCCccccccccC-------CCCCCcccchHHHHHHHHHHHcCCCCCCCCC---CCHHHHHHHHHHhC-
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH---DNYDQLVKIAKVLG- 347 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~---~~~~~l~~i~~~~~- 347 (401)
...........||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ...+.+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 876666666789999999999852 2578999999999999999999999995432 33444444444321
Q ss_pred ------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+.+++.+ ||+.||+.|++++++++||=.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~-~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN-ILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHH-HSCCCTTTSCCHHHHHHHHHHHT
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHH-hccCChhhhccHHHhhhccHHHh
Confidence 1245566677 89999999999999999876544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.44 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=200.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----CCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----SKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~-----~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+++.||||++... ......+|++.+..+ +||||+++++++.... ..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence 37899999999999999999999999999999988543 335677888888888 9999999999986532 223
Q ss_pred cEEEEeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 206 PSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
+++||||+.++.+..+. ..+++..++.++.|++.||.||| ++||+||||||+|||++..++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 78999999987543222 35788999999999999999999 99999999999999999644599999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC---------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------- 348 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~--------- 348 (401)
............||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 8766666666788999999999877566899999999999999999999998 455666666666655432
Q ss_pred -----------------------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccccc
Q 015741 349 -----------------------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ 387 (401)
Q Consensus 349 -----------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~~ 387 (401)
+.+.+++.+ |++.||..|+++.++++|||++.+.....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA-LLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHH-HTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHH-HhccCccccCCHHHHhcCccccccCCccc
Confidence 356677777 89999999999999999999998765443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=360.72 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=200.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHH-HHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il-~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++++.||+|+||.||+|+++.+++.||+|++++.. ...+.+|..++ +.+ +||||+++++++.+ ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CCE
Confidence 468999999999999999999999999999999986432 23456666664 445 89999999999976 467
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-C
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~ 281 (401)
+|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccC
Confidence 89999999999997765 4589999999999999999999999999999999999999777 89999999998643 2
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHH
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (401)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.... -++.+.+++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 334556789999999999887 689999999999999999999999994 444455555554431 145778888
Q ss_pred HhcCCCCChhhHHHh----hhhcCCCcccccccc
Q 015741 356 NKYHIELDPHLAALV----GRHSRKPWSKFITVE 385 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~----~~~l~~~~~~~~~~~ 385 (401)
.+ |++.||..|+++ .++++|||++.+...
T Consensus 271 ~~-lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 271 EG-LLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp HH-HTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred HH-HcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 88 799999999986 699999999876643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.18 Aligned_cols=245 Identities=23% Similarity=0.442 Sum_probs=210.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 36799999999999999999999999999999998642 246799999999999 89999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC---eEEEEecccce
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~vkl~DFg~a~ 277 (401)
...++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 67899999999999987763 4789999999999999999999999999999999999986653 69999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
............|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.... .
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcccccChhhhccc
Confidence 8766555566789999999999876 678999999999999999999999994 444444444443321 2
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..||++.++++|||++-..
T Consensus 246 ~~~~~~li~~-~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 246 SELAKDFIRK-LLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHHHHHT-TSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred CHHHHHHHHH-HcCCChhhCcCHHHHhcCccccCCC
Confidence 4456777777 8999999999999999999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=341.74 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=209.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+..++..+|+|++.. ...+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence 3679999999999999999999999999999999864 3457899999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE---eCCCCeEEEEecccceecCCCC
Q 015741 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||+.+++|...+ ..+++.+++.++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCcc
Confidence 9999999987654 458999999999999999999999999999999999999 5444 89999999998887666
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||. .....+....+.+.. -++.+.+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 6667789999999999865 58999999999999999999999984 444445554544432 2456777
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+ |+..||..|+++.++++|||++....
T Consensus 241 li~~-~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 241 LIRR-LLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHH-HTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHH-HccCChhhCcCHHHHhcCHHHhcccc
Confidence 7877 89999999999999999999976433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=351.89 Aligned_cols=241 Identities=18% Similarity=0.340 Sum_probs=194.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC------
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~------ 203 (401)
++|++++.||+|+||.||+|++..+++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 579999999999999999999998999999999863 2346789999999999 99999999999865322
Q ss_pred -------------------------------------------------CCcEEEEeecCCCchhhhcCC------CCHH
Q 015741 204 -------------------------------------------------KTPSLIFEHVNNTDFKVLYPT------LSDY 228 (401)
Q Consensus 204 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~~~ 228 (401)
.+.++||||+.+++|..++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 237999999999999877632 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-------------cccccccCCCcc
Q 015741 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK 295 (401)
Q Consensus 229 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-------------~~~~~~~t~~y~ 295 (401)
.++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 6889999999999999999999999999999999766 89999999998775432 123457899999
Q ss_pred ccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHH
Q 015741 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAA 368 (401)
Q Consensus 296 aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~ 368 (401)
|||++.+ ..++.++|||||||++|+|++|..|+. ...+....+.... ..+++.+++.+ |+..||..||
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp 318 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLFTQKYPQEHMMVQD-MLSPSPTERP 318 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHH-HHCSSGGGSC
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcccccCChhHHHHHHH-HccCCCCcCC
Confidence 9999987 678999999999999999999876651 1111111111111 13456677777 8999999999
Q ss_pred HhhhhcCCCcccc
Q 015741 369 LVGRHSRKPWSKF 381 (401)
Q Consensus 369 ~~~~~l~~~~~~~ 381 (401)
++.++++|||++-
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.93 Aligned_cols=245 Identities=26% Similarity=0.475 Sum_probs=210.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----------------chHHHHHHHHHHHHhcCCCCeeEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNIVKLLD 196 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~il~~l~~hpniv~~~~ 196 (401)
.++|++++.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence 47899999999999999999999999999999998642 235688999999999 9999999999
Q ss_pred EEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEE
Q 015741 197 IVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLI 271 (401)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~ 271 (401)
++.+ ...+++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+
T Consensus 114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9976 56789999999999987665 46999999999999999999999999999999999999986652 69999
Q ss_pred ecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+.+..+.+..+.+..
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCc
Confidence 9999998876666677789999999999864 6899999999999999999999998 4555555555555432
Q ss_pred -----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 347 -----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 347 -----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
-++.+.+++.+ |+..||..||++.++++|||++....
T Consensus 269 ~~~~~~s~~~~~li~~-~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 269 NDWKNISDEAKELIKL-MLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHTTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cccCCCCHHHHHHHHH-HcCCChhHCCCHHHHhcCHhhhhchh
Confidence 14567788888 89999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=353.87 Aligned_cols=247 Identities=29% Similarity=0.559 Sum_probs=208.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~ 204 (401)
..++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+++++++ +||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 3578999999999999999999999999999999997432 25688999999999 9999999999996542 24
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
..++||||+.+ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCC
Confidence 67999999995 665554 4689999999999999999999999999999999999999766 8999999999876433
Q ss_pred Cc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------
Q 015741 283 KE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------- 347 (401)
Q Consensus 283 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------- 347 (401)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 22 234588999999999876567899999999999999999999998 55666666666655433
Q ss_pred --------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 --------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 --------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..|+++.++++|||++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCcchhhcc
Confidence 2456677777 8999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.75 Aligned_cols=247 Identities=25% Similarity=0.532 Sum_probs=210.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+++.||||++.. .....+.+|+++++++ +||||+++++++.+ ...++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence 3689999999999999999999999999999999853 3456789999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~~~~ 282 (401)
+||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.. ...+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999986654 568999999999999999999999999999999999999632 237999999999877666
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------ChhHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (401)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+.+..+.+..+..... ++.+.
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 65667789999999999875 5999999999999999999999998 45555666666555421 45678
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
+++.+ |+..||..||++.++++|||++......
T Consensus 255 ~li~~-~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 255 DLIRK-MLTFHPSLRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp HHHHH-HTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred HHHHH-HcCCChhhCcCHHHHhcCHhhccCcccC
Confidence 88888 8999999999999999999998866544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=355.00 Aligned_cols=243 Identities=24% Similarity=0.450 Sum_probs=207.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
++|++.+.||+|+||.||+|.+..+|+.||||+++... .+.+.+|+.+++++.+||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 67999999999999999999998899999999986532 35678999999998789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
....++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL 250 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence 56789999999999997775 3689999999999999999999999999999999999999776 8999999999888
Q ss_pred CCCCcccccccCCCccccccccC-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
..........||+.|+|||++.+ ...++.++|||||||++|+|++|..||. +....+.+..+.....
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW-HRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCCccc
Confidence 76666667789999999999853 2358899999999999999999999994 3344444444433321
Q ss_pred ---ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ---TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ---~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |+..||..||++.++++|||+++
T Consensus 330 ~~~~~~~~~li~~-~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISR-LLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHH-HcCCChhHCcCHHHHhcCcccCC
Confidence 3347777877 89999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=364.08 Aligned_cols=248 Identities=25% Similarity=0.504 Sum_probs=191.6
Q ss_pred CCeEE-EeeecccCCeeEEEEEEc--CCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEV-VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i-~~~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
+.|++ .++||+|+||.||+|+++ .+++.||||+++... ...+.+|+.+|+++ +||||+++++++.+.....+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 45776 458999999999999975 468899999997543 46788999999999 89999999999987667789999
Q ss_pred EeecCCCchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe---CCCCeEEEEeccc
Q 015741 210 FEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGL 275 (401)
Q Consensus 210 ~e~~~~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~vkl~DFg~ 275 (401)
|||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||+. .+...+||+|||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 9999864433221 1389999999999999999999999999999999999993 2334899999999
Q ss_pred ceecCCC----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--------CHHHHHHHH
Q 015741 276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKIA 343 (401)
Q Consensus 276 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--------~~~~l~~i~ 343 (401)
++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||..... ..+++..+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876432 2234568899999999998756799999999999999999999999954332 246677766
Q ss_pred HHhC--------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 344 KVLG--------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 344 ~~~~--------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
+.++ ++.+.++|.+ ||..||..|+++.++|+|||+
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~-~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK-LLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH-HSCSSGGGSCCHHHHHTSGGG
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH-HccCCcccCCCHHHHhcChhh
Confidence 6554 3345677777 899999999999999999999
Q ss_pred cccc
Q 015741 380 KFIT 383 (401)
Q Consensus 380 ~~~~ 383 (401)
+...
T Consensus 338 ~~~~ 341 (405)
T 3rgf_A 338 LEDP 341 (405)
T ss_dssp TSSS
T ss_pred ccCC
Confidence 7643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.33 Aligned_cols=242 Identities=26% Similarity=0.524 Sum_probs=204.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhc-----CCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-----~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++++.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.+. +|+||+++++++.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCe
Confidence 468999999999999999999999999999999997643 356788999999883 56799999999976 467
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC-eEEEEecccceec
Q 015741 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY 279 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~vkl~DFg~a~~~ 279 (401)
+++||||+.+ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 8999999985 554443 24899999999999999999999999999999999999997662 3999999999765
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~----------- 348 (401)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+++..+.+.++.
T Consensus 253 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 253 H--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp T--CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred C--CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 3 23345688999999999987 67999999999999999999999887 666777777777665442
Q ss_pred ------------------------------------------------------hhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 349 ------------------------------------------------------DELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 349 ------------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+.+++.+ ||+.||..|+++.++|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~-~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ-CLEWDPAVRMTPGQAL 407 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHH-HTCSSTTTSCCHHHHH
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHH-HCCCChhhCCCHHHHh
Confidence 335677887 8999999999999999
Q ss_pred CCCccccc
Q 015741 375 RKPWSKFI 382 (401)
Q Consensus 375 ~~~~~~~~ 382 (401)
+|||++..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=372.13 Aligned_cols=247 Identities=26% Similarity=0.494 Sum_probs=213.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|++..+++.||||++.. ...+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 3679999999999999999999999999999999853 2356799999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~ 281 (401)
++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||++..+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999987665 46899999999999999999999999999999999999952 334899999999988776
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhH
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDEL 351 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~ 351 (401)
........||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+.+..+.+..+.+.. -++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 666667789999999999875 6899999999999999999999998 4556666666665542 14567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
.+++.+ |+..||..||++.++++|||++....++
T Consensus 259 ~~li~~-~L~~dp~~R~s~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 259 KDLIRK-MLTYVPSMRISARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred HHHHHH-HCCCChhHCcCHHHHhhChhhccccccc
Confidence 788888 8999999999999999999998865533
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=369.30 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=199.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCEE
Confidence 47899999999999999999999999999999998642 234577899999998 89999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCC-
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~- 281 (401)
++||||+.+++|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCC
Confidence 9999999999997665 468999999999999999999998 9999999999999999776 899999999976432
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHH
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (401)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -++.+.+++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 233456789999999999977 689999999999999999999999994 333344444433321 246778888
Q ss_pred HhcCCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 356 NKYHIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 356 ~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
.+ |+..||..|+ +++++++|||++-+..
T Consensus 381 ~~-~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 381 SG-LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HH-HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HH-HcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 88 8999999999 9999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=347.02 Aligned_cols=241 Identities=19% Similarity=0.351 Sum_probs=206.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.|+..+.||+|+||.||+|++..+|+.||||+++.. ..+.+.+|+.+++++ +||||+++++++.. ....++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLV--GEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEEe
Confidence 478889999999999999999889999999998643 346788999999999 99999999999976 457899999
Q ss_pred ecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccccc
Q 015741 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (401)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~~~ 288 (401)
|+.+++|..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence 999999988765 589999999999999999999999999999999999999766 89999999998765432 23456
Q ss_pred ccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHhcC
Q 015741 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYH 359 (401)
Q Consensus 289 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~ 359 (401)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +....+.+..+.... -++.+.+++.+ |
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~ 278 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER-M 278 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH-H
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH-H
Confidence 89999999999876 678999999999999999999999994 344444444444332 13467788888 8
Q ss_pred CCCChhhHHHhhhhcCCCccccc
Q 015741 360 IELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+..||+.||++.++++|||+...
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ccCChhhCcCHHHHhcChhhccC
Confidence 99999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=364.40 Aligned_cols=245 Identities=23% Similarity=0.407 Sum_probs=196.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+|+++ +||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence 478999999999999999999999999999999986432 12478999999999 99999999999864
Q ss_pred CCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEecccc
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA 276 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a 276 (401)
...++||||+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 3468999999999997765 3589999999999999999999999999999999999997543 25999999999
Q ss_pred eecCCCCcccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------- 345 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------- 345 (401)
+...........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||............+...
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 87765555566789999999999853 3568889999999999999999999995443332222222221
Q ss_pred -hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 346 -LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 346 -~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.-++.+.+++.+ |+..||..|+++.++++|||++-.
T Consensus 370 ~~~~~~~~~li~~-~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 370 AEVSEKALDLVKK-LLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TTSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred cccCHHHHHHHHH-HccCChhHCcCHHHHhCCcccCCh
Confidence 124567788888 899999999999999999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=354.10 Aligned_cols=247 Identities=28% Similarity=0.490 Sum_probs=197.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLLDI 197 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~~hpniv~~~~~ 197 (401)
..++|++.+.||+|+||.||+|.+. +++.||||++.... .+.+.+|+++++++ +||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence 3588999999999999999999984 59999999985321 26789999999999 89999999999
Q ss_pred EEcC---CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 198 VRDQ---QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 198 ~~~~---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
+... ....+++||||+.+..+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence 8652 2346799999999644444432 489999999999999999999999999999999999999766 89999
Q ss_pred ecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---- 347 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---- 347 (401)
|||++.............+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+.+..+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence 9999986655555566788999999999877567999999999999999999999998 45566666666665443
Q ss_pred ----------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ----------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ----------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..||++.++++|||++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK-MLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHH-HhcCChhhCCCHHHHHcCchhhhcc
Confidence 2345677777 8999999999999999999998763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.42 Aligned_cols=244 Identities=29% Similarity=0.564 Sum_probs=203.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence 478999999999999999999998899999999986421 24678999999999 89999999999965 56
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++||||+.+ ++...+. .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 163 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceecc
Confidence 78999999997 5554442 478899999999999999999999999999999999999776 89999999998764
Q ss_pred CC-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 281 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.++.+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 33 33455688999999999876567899999999999999999998776 66677777777766543
Q ss_pred ----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..|+++.++++|||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHH-HHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHH-HhccChhhCCCHHHHhcChhhhcCC
Confidence 2456777887 8999999999999999999997644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=381.61 Aligned_cols=247 Identities=21% Similarity=0.325 Sum_probs=212.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|++..+++.||||+++.. ..+.+..|..++..+.+||+|+++++++.+ ...+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~ 417 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 417 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEE
Confidence 47899999999999999999999999999999998642 335678899999988789999999999965 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC-CC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~-~~ 282 (401)
|+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCC
Confidence 9999999999998776 4699999999999999999999999999999999999999777 89999999998643 33
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..|| .+.+..+.+..|.+.. -++++.++|.
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCC-CCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 44556789999999999876 78999999999999999999999999 4555555555555432 2567888888
Q ss_pred hcCCCCChhhHHHh-----hhhcCCCcccccccc
Q 015741 357 KYHIELDPHLAALV-----GRHSRKPWSKFITVE 385 (401)
Q Consensus 357 ~~~l~~dP~~R~~~-----~~~l~~~~~~~~~~~ 385 (401)
+ ||+.||..|+++ +++++|||++-+..+
T Consensus 575 ~-lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 575 G-LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp H-HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred H-HccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 8 799999999987 999999999877543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.05 Aligned_cols=243 Identities=25% Similarity=0.490 Sum_probs=206.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++++.||+|+||.||+|++..++..||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 5799999999999999999999999999999998642 346789999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+||+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999986654 4689999999999999999999999999999999999997532 359999999998887666
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+....+.+..+.+.. -++.+.+
T Consensus 194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 6667789999999999864 6999999999999999999999998 4555555555555432 1456778
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+ |++.||..|+++.++++|||++...
T Consensus 271 li~~-~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 271 LIKQ-MLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHH-HTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHH-HCCCChhhCccHHHHhcCcccccCc
Confidence 8888 8999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.27 Aligned_cols=243 Identities=25% Similarity=0.445 Sum_probs=203.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence 36899999999999999999999999999999998653 234578899999999 99999999999976
Q ss_pred CCCCcEEEEeecCCC-chhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 202 QSKTPSLIFEHVNNT-DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
....++||||+.++ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAA 178 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccce
Confidence 56788999999776 877665 3589999999999999999999999999999999999999766 89999999999
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHHh
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~ 357 (401)
............||+.|+|||++.+...++.++|||||||++|+|++|..||.......... .......++.+.+++.+
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~l~~li~~ 257 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA-IHPPYLVSKELMSLVSG 257 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTC-CCCSSCCCHHHHHHHHH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhc-cCCCcccCHHHHHHHHH
Confidence 88766666677899999999999874445889999999999999999999995321100000 00000125577888888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|+..||..||++.++++|||++.
T Consensus 258 -~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 258 -LLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -HTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -HccCChhhCcCHHHHhcCccccC
Confidence 89999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.14 Aligned_cols=237 Identities=23% Similarity=0.287 Sum_probs=193.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|+++++||+|+||+||+|++..+++.||||++... .......|+..+.++.+||||+++++++.+ ...+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 6799999999999999999999989999999998542 223456667666666699999999999976 567899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC----
T ss_pred EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCCC
Confidence 9999954 554443 3599999999999999999999999999999999999998776 899999999988765555
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------hCChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------LGTDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------~~~~~~~~~l~ 356 (401)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||+.. +....+.+. .-++.+.+++.
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 566779999999999875 6899999999999999999998777432 222222111 12457778888
Q ss_pred hcCCCCChhhHHHhhhhcCCCcccc
Q 015741 357 KYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+ |+..||+.||++.++++|||++.
T Consensus 287 ~-~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 M-MLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp H-HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred H-HcCCChhhCcCHHHHHhCccccC
Confidence 8 89999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.95 Aligned_cols=247 Identities=23% Similarity=0.413 Sum_probs=209.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999999999999999986432 35678999999999669999999999975
Q ss_pred CCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
....++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 56789999999999998775 3689999999999999999999999999999999999999776 89999999998
Q ss_pred ecCCCCcccccccCCCcccccccc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------ 346 (401)
............+++.|+|||++. ....++.++||||||+++|+|++|..||. +....+....+....
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc-CccHHHHHHHHhcCCcccCcc
Confidence 876666566678899999999985 23568899999999999999999999984 334444444443321
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
-++.+.+++.+ |+..||..||++.++++|||++....
T Consensus 252 ~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 252 EWDDYSDTVKDLVSR-FLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp TGGGSCHHHHHHHHH-HCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cccccCHHHHHHHHH-HccCCcccCCCHHHHHhChHhhhccc
Confidence 13457777887 89999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=340.72 Aligned_cols=246 Identities=24% Similarity=0.435 Sum_probs=205.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCEE
Confidence 47899999999999999999999999999999998542 245688999999999 89999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~-~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-S 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc-c
Confidence 9999999999987665 4689999999999999999999999999999999999999776 899999999865432 2
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+.... .++.+.+++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 3345678999999999876 678999999999999999999999983 444444444444432 24567788888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
|+..||..||++.++++|||++-.....
T Consensus 241 -~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 241 -LLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp -HCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred -HhccChhhCCCHHHHhhCccccCCccCc
Confidence 8999999999999999999998755433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=368.98 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=208.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
..++|++.+.||+|+||.||+|+++.+|+.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CCE
Confidence 457899999999999999999999999999999999642 235688999999999 99999999999976 467
Q ss_pred cEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 206 PSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
+|+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 899999999999976642 488999999999999999999999999999999999999776 899999999988
Q ss_pred cCCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHH-HHHHHHHHh------CC
Q 015741 279 YHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYD-QLVKIAKVL------GT 348 (401)
Q Consensus 279 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~-~l~~i~~~~------~~ 348 (401)
+..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ... ....+.... -+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 755443 334589999999999987 6899999999999999999999999965432 222 333333221 14
Q ss_pred hhHHHHHHhcCCCCChhhHHH-----hhhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAAL-----VGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ |+..||..|++ ++++++|||++.+..
T Consensus 418 ~~~~~li~~-lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 418 PASKDFCEA-LLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHHHHHH-HSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHHHHHHH-hccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 577888888 79999999995 589999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.35 Aligned_cols=247 Identities=22% Similarity=0.415 Sum_probs=204.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+ ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence 47899999999999999999999999999999998532 336789999999999 89999999999976 56
Q ss_pred CcEEEEeecCCCchhhhcC-------------------------------------------CCCHHHHHHHHHHHHHHH
Q 015741 205 TPSLIFEHVNNTDFKVLYP-------------------------------------------TLSDYDVRYYIYELLKAL 241 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------------------------------~~~~~~~~~i~~qi~~~L 241 (401)
..++||||+.+++|..++. .+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 7899999999999987763 125677888999999999
Q ss_pred HHHHhCCceeecCCCCCeeEeCCCC-eEEEEecccceecCCCC-----cccccccCCCccccccccCC-CCCCcccchHH
Q 015741 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWS 314 (401)
Q Consensus 242 ~~LH~~~ivHrDlkp~NIll~~~~~-~vkl~DFg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwS 314 (401)
+|||++||+||||||+|||++.++. .+||+|||++..+.... ......||+.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9999999999999999999985442 79999999998764321 23456789999999998642 57889999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 315 lG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
|||++|+|++|+.|| .+....+.+..+.+.. -++.+.+++.+ |+..||..||++.++++|||++.+..
T Consensus 262 lG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 262 AGVLLHLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN-LLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH-HSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHHCCCCC-CCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHH-HcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999998 4445555555554432 24567788888 89999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=339.97 Aligned_cols=246 Identities=24% Similarity=0.477 Sum_probs=204.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--CC
Confidence 5799999999999999999999989999999998643 256799999999999 89999999999976 45
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC---eEEEEeccccee
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~vkl~DFg~a~~ 278 (401)
..++||||+.+++|..++ ..+++.++..++.||+.||.|||++||+||||||+||+++.++. .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 789999999999998776 36899999999999999999999999999999999999986542 699999999988
Q ss_pred cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CC
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GT 348 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~ 348 (401)
...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +....+.+..+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHhcccCCcchhcccCC
Confidence 765555566678999999999876 678999999999999999999999984 444444444433221 13
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
+.+.+++.+ |+..||..||++.++++|||++.+...
T Consensus 240 ~~~~~li~~-~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 240 ELAKDFIRR-LLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHHHT-TSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHH-HccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 456777777 899999999999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=343.01 Aligned_cols=248 Identities=27% Similarity=0.505 Sum_probs=201.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~-------- 201 (401)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++++++ +||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 478999999999999999999999999999999986543 35688999999999 999999999988532
Q ss_pred ----CCCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 202 ----QSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 202 ----~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
.....++||||+. ++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2356789999998 57776654 5889999999999999999999999999999999999986666899999999
Q ss_pred ceecCCC----CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 276 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
+...... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +....+.+..+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHHSCCCCH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCch
Confidence 9866432 223445678899999998765678999999999999999999999984 445555555544332
Q ss_pred -------------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 347 -------------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 347 -------------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
-++.+.+++.+ |+..||..||++.++++|||++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ-ILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT-TSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH-HcCCCccccCCHHHHhCCcccccccC
Confidence 24567777777 89999999999999999999987554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=354.38 Aligned_cols=244 Identities=25% Similarity=0.455 Sum_probs=202.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhc-------CCCCeeEEeeEEEcC--
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-------GGPNIVKLLDIVRDQ-- 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-------~hpniv~~~~~~~~~-- 201 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+++.+. +|+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999999999999999997543 467889999999984 278899999998732
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCC-----------
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ----------- 265 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~----------- 265 (401)
....+++||||+.++.+..+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 345789999999776665554 3489999999999999999999998 999999999999998653
Q ss_pred -------------------------------------CeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCc
Q 015741 266 -------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308 (401)
Q Consensus 266 -------------------------------------~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 308 (401)
..+||+|||++..... ......||+.|+|||++.+ ..++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ 272 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNT 272 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT-SCCCT
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC-CCCCc
Confidence 2699999999987643 3445678999999999987 67999
Q ss_pred ccchHHHHHHHHHHHcCCCCCCCCCC-----CHHHHHHHHHHhCC-----------------------------------
Q 015741 309 SLDLWSLGCMFAGMIFRKEPFFYGHD-----NYDQLVKIAKVLGT----------------------------------- 348 (401)
Q Consensus 309 ~~DiwSlG~ll~elltg~~Pf~~~~~-----~~~~l~~i~~~~~~----------------------------------- 348 (401)
++|||||||++|+|++|+.||..... ..+.+..+.+..+.
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 99999999999999999999954322 34455555555443
Q ss_pred -------------hhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 349 -------------DELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 349 -------------~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
+.+.+++.+ |++.||..||++.++++|||++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLP-MLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGG-GGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhhcccchhhHHHHHHHHHH-HhccChhhcCCHHHHhhCcccc
Confidence 234566777 8999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=336.32 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=205.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEEE
Confidence 6799999999999999999999989999999998643 236789999999999 99999999999976 4678899
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC---
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--- 283 (401)
|||+.+++|..++. .+++.+++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchh
Confidence 99999999988764 488999999999999999999999999999999999999766 89999999997654322
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------hCChhHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------LGTDELNAYL 355 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------~~~~~~~~~l 355 (401)
......|++.|+|||++.+...++.++||||||+++|+|++|..||.........+..+... ..++.+.+++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 23445788999999998774445789999999999999999999996554443333333221 1245677778
Q ss_pred HhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+ |+..||..||++.++++|||++..
T Consensus 243 ~~-~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 243 HK-ILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HH-HSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HH-HCCCCchhCCCHHHHhcCccccCh
Confidence 77 899999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.69 Aligned_cols=245 Identities=30% Similarity=0.554 Sum_probs=203.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~---- 203 (401)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986421 35688999999999 89999999999976432
Q ss_pred CCcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
...+++|||+.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA- 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC----
T ss_pred eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC-
Confidence 245899999985 665554 4689999999999999999999999999999999999999766 899999999976532
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------------- 347 (401)
......+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 2345678999999999877567899999999999999999999998 45555566666555432
Q ss_pred ----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |+..||..|+++.++++|||++.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-MLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH-HcCCCcccCCCHHHHhcCcchhhccC
Confidence 3456777887 89999999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=345.62 Aligned_cols=246 Identities=23% Similarity=0.410 Sum_probs=202.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence 367999999999999999999999999999999986432 23578999999999 999999999998653
Q ss_pred CCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEEecccc
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLA 276 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~DFg~a 276 (401)
..++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 378999999999987765 35899999999999999999999999999999999999986542 4999999999
Q ss_pred eecCCCCcccccccCCCcccccccc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH---------
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------- 345 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------- 345 (401)
.............|++.|+|||++. +...++.++|||||||++|+|++|..||............+...
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8875544445567999999999974 23578899999999999999999999996544332222222221
Q ss_pred -hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 346 -LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 346 -~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..++.+.+++.+ |+..||..||++.++++|||++...
T Consensus 245 ~~~~~~~~~li~~-~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 245 AEVSEKALDLVKK-LLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TTSCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhcCHHHHHHHHH-HcccCHhhCCCHHHHhhCcCcCCHH
Confidence 124567788888 8999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.34 Aligned_cols=246 Identities=20% Similarity=0.366 Sum_probs=208.3
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
...++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 114 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 114 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CC
Confidence 3467899999999999999999999999999999998643 346688999999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceeccc
Confidence 789999999999987765 4689999999999999999999999999999999999999766 899999999987653
Q ss_pred C-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHH
Q 015741 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAY 354 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~ 354 (401)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. .....+....+.+.. -.+.+.++
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASL 271 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 3 33445678999999999886 678999999999999999999999984 333344444443321 13567777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+.+ |+..||..||++.++++|+|+....
T Consensus 272 i~~-~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 272 IQK-MLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHH-HTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHH-HccCChhHCcCHHHHhcCccccCCC
Confidence 877 8999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=344.11 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=205.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---CC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~~ 204 (401)
..++|++.+.||+|+||.||+|.+..+|+.||||+++... ...+.+|+.+++++ +||||+++++++.... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccc
Confidence 3588999999999999999999999999999999996433 34578999999999 9999999999876431 35
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
..+++|||+.+ +|...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred eEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence 78999999984 666554 4689999999999999999999999999999999999999766 8999999999876432
Q ss_pred Cc-----------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----
Q 015741 283 KE-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---- 347 (401)
Q Consensus 283 ~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---- 347 (401)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCch
Confidence 11 123468999999999876567899999999999999999999998 44454555544443322
Q ss_pred ----------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 ----------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 ----------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
++.+.+++.+ |+..||..||++.++++|||++.+...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR-MLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH-hcCcCcccCCCHHHHhcCccccccCCcc
Confidence 3355677777 8999999999999999999998876544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=340.12 Aligned_cols=246 Identities=18% Similarity=0.341 Sum_probs=188.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHH-HHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKRE-IKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E-~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+++.||+|+++... ......| ...++.+ +||||+++++++.+ ....+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCCEE
Confidence 478999999999999999999999999999999986432 1223333 3345555 99999999999976 45789
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+||||+++ ++...+ ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYL 160 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence 99999986 553332 3689999999999999999999998 999999999999999766 8999999999877
Q ss_pred CCCCcccccccCCCccccccc---cCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CC
Q 015741 280 HPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GT 348 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~ 348 (401)
..........|++.|+|||++ .....++.++|||||||++|+|++|+.||.........+....... -+
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 655555556899999999997 2336789999999999999999999999965555555555444432 14
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ |+..||..||++.++++|||++....
T Consensus 241 ~~~~~li~~-~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 241 AEFVDFTSQ-CLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHH-HhhcChhhCcCHHHHHhCcccccCcc
Confidence 567788888 89999999999999999999987443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.59 Aligned_cols=247 Identities=20% Similarity=0.369 Sum_probs=207.7
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
...++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--CC
Confidence 3457899999999999999999999999999999998543 245688999999999 99999999999976 46
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|..+. ..+++.+++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceeccc
Confidence 789999999999987765 4689999999999999999999999999999999999999766 899999999987653
Q ss_pred C-CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHH
Q 015741 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAY 354 (401)
Q Consensus 282 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~ 354 (401)
. .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||. .....+....+.+.. -.+.+.++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASL 245 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhhccCCCccccCHHHHHH
Confidence 3 23445678999999999876 678999999999999999999999984 333333333333221 13567777
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.+ |+..||..||++.++++|||+.....
T Consensus 246 i~~-~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 246 IQK-MLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHH-HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHH-HcccChhhCcCHHHHhhChheecCCc
Confidence 777 89999999999999999999976443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=336.44 Aligned_cols=244 Identities=19% Similarity=0.316 Sum_probs=202.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~ 205 (401)
...|.+.+.||+|+||.||+|.+..++..||+|++... ..+.+.+|+.+++.+ +||||+++++++.+. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence 35689999999999999999999999999999998642 235688999999999 999999999998653 2456
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+++||||+.+++|..++ ..+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 89999999999998776 46899999999999999999999999 99999999999998444489999999997543
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------ChhHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELN 352 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------~~~~~ 352 (401)
........|++.|+|||++.+ .++.++|||||||++|+|++|+.||............+..... .+.+.
T Consensus 184 -~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 184 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred -ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 333445678999999998864 5899999999999999999999999544433333333322211 35677
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.+ |+..||..||++.++++|||++-
T Consensus 261 ~li~~-~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 261 EIIEG-CIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHH-HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHH-HccCChhhCCCHHHHhhCccccc
Confidence 88888 89999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.81 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=196.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCeE
Confidence 37899999999999999999999889999999998643 235788999999999 89999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc
Confidence 9999999999997765 3689999999999999999999999999999999999999766 89999999998776554
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||. .....+....+.... ..+.+.+++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence 45566789999999998874344689999999999999999999984 333333333333321 14567788888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|+..||..||++.++++|||++.
T Consensus 245 -~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 245 -MLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp -HTCSSGGGSCCHHHHHHSHHHHT
T ss_pred -HccCChhhCCCHHHHHhChhhcc
Confidence 89999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=335.26 Aligned_cols=242 Identities=22% Similarity=0.414 Sum_probs=205.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.+ +||||+++++++.+ ....
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCEE
Confidence 47899999999999999999999999999999998532 246789999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|...+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCccc-
Confidence 9999999999987665 3689999999999999999999999999999999999999766 8999999999765432
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
......|++.|+|||++.+ ..++.++||||||+++|+|++|..||. .....+....+.... -++.+.+++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCC-CCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 2345678999999999886 678999999999999999999999984 333344433333221 24577788888
Q ss_pred cCCCCChhhHHHhhhhcCCCccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
|+..||..|+++.++++|||++..
T Consensus 246 -~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 246 -LLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -HSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -HhhcCHhhCCCHHHHhhCHHHHhh
Confidence 899999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.23 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=197.0
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~-~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+.|++. +.||+|+||.||+|.+..+++.||||+++.. ....+.+|++++.++.+||||+++++++.+ ...+++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEE
Confidence 4779985 7899999999999999899999999998643 356789999999997689999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999997766 46899999999999999999999999999999999999986552 39999999987653221
Q ss_pred --------cccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC--------------HH
Q 015741 284 --------EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------------YD 337 (401)
Q Consensus 284 --------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~--------------~~ 337 (401)
......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1234468999999999864 135788999999999999999999999543221 11
Q ss_pred HHHHHHHHh----------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 338 QLVKIAKVL----------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 338 ~l~~i~~~~----------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
....+.+.. -++.+.+++.+ |+..||..|+++.++++|||++-...+
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISK-LLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHH-HhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 122222211 24467788888 899999999999999999999875443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=337.20 Aligned_cols=244 Identities=21% Similarity=0.407 Sum_probs=181.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCeE
Confidence 46799999999999999999999899999999998643 236788999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++||||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCC
Confidence 9999999999998765 3489999999999999999999999999999999999999766 8999999999876432
Q ss_pred -CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHHHHH
Q 015741 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYL 355 (401)
Q Consensus 283 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~~~l 355 (401)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.+..+... .-++++.+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-KNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-C-----CCSSCCCCCTTSCHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhH-HHHHHHHhhcccCCccccCHHHHHHH
Confidence 22334678999999999876 6789999999999999999999999854322 2222211100 1245677888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ |+..||..||++.++++|||+....
T Consensus 244 ~~-~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 244 HQ-LLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HH-HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HH-HcccCHhhCCCHHHHhcCccccCCC
Confidence 88 8999999999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.66 Aligned_cols=252 Identities=22% Similarity=0.387 Sum_probs=203.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC----CCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----~~~ 205 (401)
..++|++.+.||+|+||.||+|++..+++.||||++.. ...+.+.+|+.+++++.+||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 46899999999999999999999999999999999864 345789999999999878999999999997643 457
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecC
Confidence 89999999999998775 3588999999999999999999999999999999999999766 89999999997664
Q ss_pred CCC-cccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------C
Q 015741 281 PGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------G 347 (401)
Q Consensus 281 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~ 347 (401)
... ......|++.|+|||++.. ...++.++|||||||++|+|++|..||. +....+.+..+.+.. .
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcCccccCCcccc
Confidence 322 2344578999999999862 2568899999999999999999999984 344444444443321 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
++.+.+++.+ |+..||..||++.++++|||++....+.
T Consensus 260 ~~~l~~li~~-~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 260 SKKFQSFIES-CLVKNHSQRPATEQLMKHPFIRDQPNER 297 (326)
T ss_dssp CHHHHHHHHH-HCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred CHHHHHHHHH-HhccChhhCCCHHHHhhChHHhhCcccc
Confidence 4577888888 8999999999999999999998765544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=344.34 Aligned_cols=247 Identities=22% Similarity=0.357 Sum_probs=199.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC--
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK-- 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~-- 204 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++++ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 478999999999999999999999999999999996432 24688999999999 999999999998754322
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|..++ ..+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence 458999999999998775 4689999999999999999999999999999999999999776 899999999986643
Q ss_pred CC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +....+....+.... -
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCCCcccccCCC
Confidence 32 1234568999999999987 689999999999999999999999994 444444333333221 2
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ |+..||..|++..+++.|+|.+....
T Consensus 247 ~~~l~~li~~-~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 247 SADLDAVVLK-ALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHH-HHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 4567778888 89999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=347.80 Aligned_cols=247 Identities=19% Similarity=0.351 Sum_probs=201.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.++|++++.||+|+||.||+|++. .+++.||||+++.. ..+.+.+|+++++++.+||||+++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 368999999999999999999984 47899999998642 245678899999999789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF 209 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeec
Confidence 45789999999999997765 4689999999999999999999999999999999999999776 8999999999876
Q ss_pred CCCC--cccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHH-HHHHHh------C
Q 015741 280 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLV-KIAKVL------G 347 (401)
Q Consensus 280 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~-~i~~~~------~ 347 (401)
.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+. .+.... -
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 4322 23345799999999998752 3578999999999999999999999954322 222222 222111 1
Q ss_pred ChhHHHHHHhcCCCCChhhHH-----HhhhhcCCCcccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAA-----LVGRHSRKPWSKFIT 383 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~ 383 (401)
++.+.+++.+ |+..||..|+ +++++++|||++.+.
T Consensus 290 ~~~~~~li~~-~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 290 SALAKDLIQR-LLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp CHHHHHHHHH-HTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHH-HhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 3456777777 8999999999 999999999998765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.82 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=201.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+++++++ +||||+++++++.+ ....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCeE
Confidence 356999999999999999999999999999999986421 25688999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.++.+..+ ...+++.+++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB-
T ss_pred EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC-
Confidence 999999985433322 24689999999999999999999999999999999999999766 8999999999865432
Q ss_pred cccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~ 353 (401)
....||+.|+|||++.+ ...++.++|||||||++|||++|+.||. +.+..+.+..+.+.. -++.+.+
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 34578999999999852 3578999999999999999999999984 344444444444321 1456778
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++.+ |+..||..||++.++++|||+...
T Consensus 285 li~~-~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 285 FVDS-CLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHH-HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHH-HcccChhhCcCHHHHhhChhhhcc
Confidence 8887 899999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.01 Aligned_cols=243 Identities=24% Similarity=0.421 Sum_probs=196.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~-hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+. +++.||||++... ..+.+.+|+.+++++.+ ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 356999999999999999999985 4899999998643 23668999999999953 6999999999876 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||| +.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++.+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCC
Confidence 99999 5677877665 3588899999999999999999999999999999999996 44 79999999998765432
Q ss_pred c---ccccccCCCccccccccCC----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----
Q 015741 284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---- 346 (401)
Q Consensus 284 ~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---- 346 (401)
. ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.........+..+....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 2 2456799999999998641 3688999999999999999999999965444444444443221
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
..+.+.+++.+ |+..||..||++.++++|||++..
T Consensus 289 ~~~~~~~~~~~li~~-~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCccchHHHHHHHHH-HcccChhhCCCHHHHhhCcCcccc
Confidence 13467788887 899999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=347.74 Aligned_cols=242 Identities=24% Similarity=0.423 Sum_probs=202.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCCC-----eeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hpn-----iv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.+..|++ |+++++++.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCc
Confidence 578999999999999999999999999999999997543 3567889999998855664 9999999876 467
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCCeeEeC-CCCeEEEEecccce
Q 015741 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAE 277 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~-~~~~vkl~DFg~a~ 277 (401)
+++||||+.+ +|..++ ..+++..++.++.|++.||.||| +.||+||||||+|||++. +...+||+|||+++
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 8999999976 665543 34889999999999999999999 579999999999999963 23479999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCC---------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------- 348 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~--------- 348 (401)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+..+.
T Consensus 210 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 210 QLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp ETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred eccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 7643 3345688999999999987 67999999999999999999999998 556666777776665432
Q ss_pred -------------------------------------------------------------hhHHHHHHhcCCCCChhhH
Q 015741 349 -------------------------------------------------------------DELNAYLNKYHIELDPHLA 367 (401)
Q Consensus 349 -------------------------------------------------------------~~~~~~l~~~~l~~dP~~R 367 (401)
+.+.+++.+ ||+.||+.|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~dP~~R 364 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR-MLDYDPKTR 364 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH-HTCSCTTTS
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH-hcCCChhhC
Confidence 145677777 899999999
Q ss_pred HHhhhhcCCCccccc
Q 015741 368 ALVGRHSRKPWSKFI 382 (401)
Q Consensus 368 ~~~~~~l~~~~~~~~ 382 (401)
+++.++|+|||++..
T Consensus 365 pta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 365 IQPYYALQHSFFKKT 379 (382)
T ss_dssp CCHHHHTTSGGGCC-
T ss_pred CCHHHHhcCcccccC
Confidence 999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=340.37 Aligned_cols=248 Identities=29% Similarity=0.552 Sum_probs=206.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-CCCeEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCeeEEeeEEEc---C
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---Q 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~hpniv~~~~~~~~---~ 201 (401)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++.+. +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 578999999999999999999995 678999999986422 245778888888764 79999999999862 1
Q ss_pred CCCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
.....++||||+.+ +|..++. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccc
Confidence 34578999999995 7665542 389999999999999999999999999999999999999776 8999999999
Q ss_pred eecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------- 347 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--------- 347 (401)
.............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.+..+
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 87654444556688999999999876 67899999999999999999999998 45566666766665433
Q ss_pred ------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.+.+++.+ |+..||..|+++.++++|||++.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHH-HcCCCcccCCCHHHHhcCccccccchh
Confidence 2345677777 899999999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.44 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=194.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCC-CCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h-pniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+ .+++.||||++... ..+.+.+|+.+++++.+| |||+++++++.+ ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 57899999999999999999987 57899999998642 235688999999999432 999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||| +.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+++......
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC----
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCccc
Confidence 99999 5667877665 4689999999999999999999999999999999999998 44 79999999998765433
Q ss_pred c---ccccccCCCccccccccC----------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---
Q 015741 284 E---YNVRVASRYFKGPELLVD----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (401)
Q Consensus 284 ~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--- 347 (401)
. .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.........+..+.....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 235679999999999853 256889999999999999999999999654444444443332211
Q ss_pred -----ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 -----TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 -----~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+.+.+++.+ |+..||..||++.++++|||++..
T Consensus 242 ~~~~~~~~l~~li~~-~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHH-HcCCChhHCCCHHHHHhCcccccc
Confidence 2467788888 899999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=332.68 Aligned_cols=239 Identities=18% Similarity=0.206 Sum_probs=198.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+..+..+.+||||+++++++.+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 36799999999999999999999989999999998742 345688899999998789999999999976 46789
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC----------------
Q 015741 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---------------- 264 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---------------- 264 (401)
+||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999998776 348999999999999999999999999999999999999743
Q ss_pred --CCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 015741 265 --QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 265 --~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i 342 (401)
...+||+|||.+....... ...|++.|+|||++.+...++.++|||||||++|+|++|..|+... +....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence 2369999999998765332 3468999999999987556778999999999999999998766322 222233
Q ss_pred HHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 343 AKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 343 ~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.. -++.+.+++.+ |+..||..||++.++++|||++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKV-MIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHH-HTCSSGGGSCCHHHHHTCTTC--
T ss_pred HcCCCCCCCcccCHHHHHHHHH-HhCCCcccCCCHHHHhhChHhhh
Confidence 2221 14577888888 89999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=338.33 Aligned_cols=243 Identities=23% Similarity=0.410 Sum_probs=204.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|.+.+.||+|+||.||+|.+..+|+.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence 36799999999999999999999999999999998753 335688999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE---eCCCCeEEEEecccceecCCCC
Q 015741 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
|||+.+++|...+ ..+++..++.++.|++.||.|||++||+||||||+||++ +.+ ..+||+|||++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence 9999999987664 468999999999999999999999999999999999999 434 4899999999976532 2
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+.+.. -++.+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY-EETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 3345678999999999876 678999999999999999999999984 444444444554432 1356778
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+ |+..||..||++.++++|||++-..
T Consensus 241 li~~-~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICH-LLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHH-HHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHH-HcCCChhHCcCHHHHhcCccccCCC
Confidence 8888 8999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=339.32 Aligned_cols=241 Identities=22% Similarity=0.480 Sum_probs=200.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEE-cCCCeEEEEEEecccc--hHHHHHHHHHHHHhcCCC------CeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVH-CTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGP------NIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~hp------niv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++... .+.+.+|+.+++.+ +|+ +++++++++.+ .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--C
Confidence 47899999999999999999998 5688999999997543 36788999999988 444 59999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--------------
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------- 264 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-------------- 264 (401)
..+++||||+ +++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 6789999999 666655542 47899999999999999999999999999999999999863
Q ss_pred ----CCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 015741 265 ----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (401)
Q Consensus 265 ----~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~ 340 (401)
...+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|| ...+..+.+.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHHH
Confidence 23699999999987543 3345678999999999886 67899999999999999999999998 4555555555
Q ss_pred HHHHHhCC--------------------------------------------------hhHHHHHHhcCCCCChhhHHHh
Q 015741 341 KIAKVLGT--------------------------------------------------DELNAYLNKYHIELDPHLAALV 370 (401)
Q Consensus 341 ~i~~~~~~--------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~ 370 (401)
.+.+..+. +.+.+++.+ |+..||..||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK-MLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH-HTCSSTTTSCCH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH-HhCcCcccccCH
Confidence 55544431 235577777 899999999999
Q ss_pred hhhcCCCccccc
Q 015741 371 GRHSRKPWSKFI 382 (401)
Q Consensus 371 ~~~l~~~~~~~~ 382 (401)
.++++|||++.+
T Consensus 324 ~ell~hp~f~~~ 335 (339)
T 1z57_A 324 REALKHPFFDLL 335 (339)
T ss_dssp HHHTTSGGGGGG
T ss_pred HHHhcCHHHHHH
Confidence 999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=336.14 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=203.0
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
...++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYH--DGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--C-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeee--CCeEE
Confidence 4468899999999999999999999999999999998643 346788999999999 99999999999976 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~- 282 (401)
+||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccccc
Confidence 999999999987664 4689999999999999999999999999999999999999766 8999999987543211
Q ss_pred CcccccccCCCcccccccc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------Ch
Q 015741 283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~ 349 (401)
.......|+..|+|||++. ....++.++||||||+++|+|++|..||. ..+..+.+..+.+... ++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHhccCCcccCCccccCH
Confidence 1223457889999999984 23678899999999999999999999984 4444444444443321 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+.+++.+ |+..||..||++.++++|||++.+..
T Consensus 251 ~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 251 EFRDFLKI-ALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHHHH-HSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHHHHHH-HcccChhhCCCHHHHhcChHHhhhcc
Confidence 57777888 89999999999999999999988654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=334.80 Aligned_cols=245 Identities=25% Similarity=0.532 Sum_probs=207.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|++++.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEEE
Confidence 689999999999999999999988999999999853 2356789999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+++|...+ ..+++.+++.++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++.......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999986654 4689999999999999999999999999999999999997543 369999999998776555
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||. +.+..+.+..+.... -++.+.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 5555678899999999875 58999999999999999999999984 444444444444321 1346777
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.+ |+..||..||++.++++|||++....+
T Consensus 256 li~~-~l~~dp~~Rps~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 256 LIRK-MLTFHPSLRITATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHH-HTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred HHHH-HcccChhhCcCHHHHhcCHHHhccccC
Confidence 8888 899999999999999999999876554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=341.83 Aligned_cols=247 Identities=26% Similarity=0.473 Sum_probs=203.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEeccc--chHHHHHHHHHHHHhcCCCC------eeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~~hpn------iv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ..+.+.+|+.+++.+ +|++ ++.+++++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeee--C
Confidence 478999999999999999999997776 79999999753 346688899999998 5544 8999998876 4
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC----------------
Q 015741 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---------------- 263 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---------------- 263 (401)
...++||||+.++.+..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 5789999999766655443 25899999999999999999999999999999999999932
Q ss_pred --CCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 264 --EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 264 --~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
....+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~ 250 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREHLVM 250 (355)
T ss_dssp EESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHH
T ss_pred ccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHH
Confidence 234899999999987533 3345678999999999986 67999999999999999999999998 45555555665
Q ss_pred HHHHhCC--------------------------------------------------hhHHHHHHhcCCCCChhhHHHhh
Q 015741 342 IAKVLGT--------------------------------------------------DELNAYLNKYHIELDPHLAALVG 371 (401)
Q Consensus 342 i~~~~~~--------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~~ 371 (401)
+.+..+. +.+.+++.+ |+..||..||++.
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR-MLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH-HTCSSTTTSCCHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH-HhcCChhhCcCHH
Confidence 5555432 145577777 8999999999999
Q ss_pred hhcCCCcccccccccc
Q 015741 372 RHSRKPWSKFITVENQ 387 (401)
Q Consensus 372 ~~l~~~~~~~~~~~~~ 387 (401)
++++|||++.+..+++
T Consensus 330 e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 330 EALLHPFFAGLTPEER 345 (355)
T ss_dssp HHTTSGGGGGCCHHHH
T ss_pred HHhcChhhcCCChhhc
Confidence 9999999998765443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.32 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=207.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+.|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999998643 347789999999999 99999999999976 457899
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cc
Q 015741 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~ 285 (401)
||||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCB
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccccc
Confidence 999999999988764 588999999999999999999999999999999999999766 89999999998765432 23
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
....|++.|+|||++.+ ..++.++||||||+++|+|++|..||. .....+....+.+.. .++.+.+++.+
T Consensus 177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 253 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS-ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA- 253 (303)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH-
T ss_pred CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC-CcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH-
Confidence 45578899999999876 678999999999999999999999984 333444333333321 14567788888
Q ss_pred CCCCChhhHHHhhhhcCCCcccccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|+..||..||++.++++|||+....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 8999999999999999999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=334.01 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=204.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999998642 245688999999999 999999999998766567889
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
+||||+.+++|..++. .+++..++.++.|++.||+|||++| |+||||||+||+++.++ .+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCch
Confidence 9999999999987763 3899999999999999999999999 99999999999999766 899999999
Q ss_pred ceecCCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 276 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
+........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCCTTS
T ss_pred heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc-ccCHHHHHHHHhhcccccCCccc
Confidence 976643322 234578999999999887 678999999999999999999999984 3333343444433321
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |+..||..||++.++++|+|..-
T Consensus 241 ~~~l~~li~~-~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 241 SDELNEIITR-MLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCCHHHHHTSTTCCG
T ss_pred CHHHHHHHHH-HcCCCcccCCCHHHHHhChhhhh
Confidence 4577888888 89999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.92 Aligned_cols=244 Identities=21% Similarity=0.395 Sum_probs=202.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....++|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e 104 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIVME 104 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEEee
Confidence 57899999999999999999999989999999998753 357789999999999 99999999999976 457899999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
|+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ...
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhccccC
Confidence 99999998765 3689999999999999999999999999999999999999776 89999999998765432 234
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (401)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||. .....+....+.... -++.+.+++.+
T Consensus 184 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 184 TVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYA-DIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred ccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 4578899999999876 678999999999999999999999984 333333333333221 14567788888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|+..||..||++.++++|||++...
T Consensus 262 -~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 262 -CLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -HTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -HccCChhhCcCHHHHHhCHHHhcCC
Confidence 8999999999999999999998644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=335.96 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=196.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CCeE
Confidence 47899999999999999999999999999999998432 235688999999999 99999999999975 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccc
Confidence 9999999999998775 3589999999999999999999999999999999999999776 89999999997654332
Q ss_pred --cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----------CChh
Q 015741 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-----------GTDE 350 (401)
Q Consensus 284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-----------~~~~ 350 (401)
......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||. +....+......... -++.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC-SSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 2234578999999999987 678999999999999999999999994 333333322221110 1356
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
+.+++.+ |+..||..|++..+.+.+.|.+....
T Consensus 244 l~~li~~-~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 244 LSNVILR-ATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHH-HSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHH-HhcCCHhHccccHHHHHHHHHHHHhh
Confidence 7777877 79999999996666666777766543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=340.85 Aligned_cols=244 Identities=20% Similarity=0.371 Sum_probs=206.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--------------------HHHHHHHHHHHHhcCCCCee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNIV 192 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~il~~l~~hpniv 192 (401)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... +.+.+|+.+++++ +||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 47899999999999999999998 899999999863211 7899999999999 899999
Q ss_pred EEeeEEEcCCCCCcEEEEeecCCCchhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCee
Q 015741 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVL------Y-----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVM 260 (401)
Q Consensus 193 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIl 260 (401)
++++++.+ ....++||||+.+++|..+ + ..+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999976 4678999999999999876 3 358999999999999999999999 99999999999999
Q ss_pred EeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCc-ccchHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 015741 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339 (401)
Q Consensus 261 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l 339 (401)
++.++ .+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.......+.+
T Consensus 185 ~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99776 8999999999876433 3455678999999999987435665 9999999999999999999996554445555
Q ss_pred HHHHHH-------------------------hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 340 VKIAKV-------------------------LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 340 ~~i~~~-------------------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
..+... ..++.+.+++.+ |+..||..||++.++++|||++-...
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-FLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH-HccCChhhCCCHHHHhcCccccCCCH
Confidence 544322 124567788888 89999999999999999999987554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.29 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=203.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCEEEE
Confidence 57899999999999999999999999999999998643 235688999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+++|..++ ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...... .
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 186 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-c
Confidence 99999999998776 3689999999999999999999996 999999999999999776 8999999998755322 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH----------------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI---------------------- 342 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i---------------------- 342 (401)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .+.+..+
T Consensus 187 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPD--AKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp ----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCC--HHHHHHHHC--------------------
T ss_pred ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 344578999999999887 679999999999999999999999995432 2111111
Q ss_pred ---------------------HHHh--------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 343 ---------------------AKVL--------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 343 ---------------------~~~~--------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
.... -++.+.+++.+ |+..||..||++.++++|||++....++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHH-HHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHH-HhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 1000 13467788888 8999999999999999999998865443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=358.25 Aligned_cols=244 Identities=16% Similarity=0.177 Sum_probs=191.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhc--CCCCeeEEe-------eE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLL-------DI 197 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~--~hpniv~~~-------~~ 197 (401)
.++|++.+.||+|+||.||+|++..+|+.||||+++.. ..+.+.+|+.+++.+. +|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999889999999998632 2367889995555443 799999998 66
Q ss_pred EEcCCC----------C-----CcEEEEeecCCCchhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHhCCceee
Q 015741 198 VRDQQS----------K-----TPSLIFEHVNNTDFKVLYP---TLSD-------YDVRYYIYELLKALDYCHSQGIMHR 252 (401)
Q Consensus 198 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~i~~qi~~~L~~LH~~~ivHr 252 (401)
+.+.+. . ..+++|||+ +|+|..++. .+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 654321 1 378999999 578877664 3444 6777899999999999999999999
Q ss_pred cCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCC----------CCCCcccchHHHHHHHHHH
Q 015741 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGM 322 (401)
Q Consensus 253 Dlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~ll~el 322 (401)
||||+|||++.++ .+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999776 89999999998643 33445567 999999999862 1789999999999999999
Q ss_pred HcCCCCCCCCCCCHHHHHHHHHH--hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 323 IFRKEPFFYGHDNYDQLVKIAKV--LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 323 ltg~~Pf~~~~~~~~~l~~i~~~--~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++|+.||.. ....+....+... .-++.+.+++.+ |+..||..||++.++++|||++.+.
T Consensus 307 ltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPITK-DAALGGSEWIFRSCKNIPQPVRALLEG-FLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC-------CCSGGGGSSCCCCCHHHHHHHHH-HTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCcc-cccccchhhhhhhccCCCHHHHHHHHH-HcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999843 2222222222211 125677888888 8999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=333.07 Aligned_cols=234 Identities=19% Similarity=0.320 Sum_probs=186.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+ +++.||||++.... .+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNLS 110 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCCE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCceE
Confidence 57899999999999999999986 68899999986432 35688999999999 89999999999965 45688
Q ss_pred EEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+||||+.+++|..++.. +++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccc
Confidence 99999999999877642 888999999999999999999999 99999999999999766 8999999999765
Q ss_pred CCCC-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 280 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.... -++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 4332 2345678999999999887 678999999999999999999999984 333333333332211 1457
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..||..||++.++++
T Consensus 268 l~~li~~-~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 268 VAAIIEG-CWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HccCChhhCcCHHHHHH
Confidence 7888888 89999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.02 Aligned_cols=239 Identities=22% Similarity=0.340 Sum_probs=200.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+++++++ +||||+++++++.+......++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEE
Confidence 57899999999999999999999999999999999742 346788999999999 8999999999998776668899
Q ss_pred EEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE----eCCCCeEEEEeccccee
Q 015741 209 IFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 209 v~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~vkl~DFg~a~~ 278 (401)
||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~ 165 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARE 165 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceE
Confidence 9999999999888753 8999999999999999999999999999999999998 4333 799999999998
Q ss_pred cCCCCcccccccCCCccccccccCC-------CCCCcccchHHHHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHhC-
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKEPFFYG---HDNYDQLVKIAKVLG- 347 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~ll~elltg~~Pf~~~---~~~~~~l~~i~~~~~- 347 (401)
...........||+.|+|||++.+. ..++.++|||||||++|||++|+.||... ....+.+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 7666556667899999999997531 45778999999999999999999999542 234444444443211
Q ss_pred ------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 ------------------------------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 ------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.+.+.+++.+ |++.||+.|+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~-~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN-ILEADQEKCWGFDQFF 301 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHH-HSCCCTTTSCCHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHH-hhccChhhhccHHHHH
Confidence 1245566667 8999999999988874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.62 Aligned_cols=238 Identities=18% Similarity=0.297 Sum_probs=195.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|++.+.||+|+||.||+|.+. .++..||||+++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 478999999999999999999875 345689999997532 35688999999999789999999999965
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
...+++||||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 159 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 467899999999999987752 368889999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||. +....+.
T Consensus 238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~~ 314 (370)
T 2psq_A 238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEEL 314 (370)
T ss_dssp TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGH
T ss_pred CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHHH
Confidence 776 899999999987654322 233456778999999887 679999999999999999999 888884 4444444
Q ss_pred HHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
...+..... .+.+.+++.+ |+..||..||++.+++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 333333221 3467777887 899999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=342.75 Aligned_cols=241 Identities=18% Similarity=0.298 Sum_probs=197.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|. +..+++.||||+++... .+.+.+|+++++++.+||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 36889999999999999999998 44567899999997532 356899999999998899999999998764
Q ss_pred CCCcEEEEeecCCCchhhhcCC----------------------------------------------------------
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPT---------------------------------------------------------- 224 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------------- 224 (401)
...+++||||+.+++|..++..
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3457899999999999776521
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc---cccccc
Q 015741 225 -----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVA 290 (401)
Q Consensus 225 -----------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~ 290 (401)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... .....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCC
Confidence 78889999999999999999999999999999999999766 899999999986643322 234567
Q ss_pred CCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcCCCC
Q 015741 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIEL 362 (401)
Q Consensus 291 t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~ 362 (401)
|..|+|||++.+ ..++.++|||||||++|+|++ |..||............+.... .++.+.+++.+ |+..
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~ 335 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHG 335 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH-HTCS
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-HccC
Confidence 888999999876 679999999999999999998 9999854444443333333321 24577888887 8999
Q ss_pred ChhhHHHhhhhcCC
Q 015741 363 DPHLAALVGRHSRK 376 (401)
Q Consensus 363 dP~~R~~~~~~l~~ 376 (401)
||..||++.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.92 Aligned_cols=237 Identities=19% Similarity=0.310 Sum_probs=196.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeEEE
Confidence 57899999999999999999999999999999988643 346688999999999 89999999999976 4678899
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|||+.+++|..++ ..+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccc
Confidence 9999999998775 3588999999999999999999999999999999999999766 8999999999876433221
Q ss_pred ---------------cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHH----HHHHHHHH-
Q 015741 286 ---------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD----QLVKIAKV- 345 (401)
Q Consensus 286 ---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~----~l~~i~~~- 345 (401)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 14578999999999887 7899999999999999999999998854222111 11111111
Q ss_pred ---hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 346 ---LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 346 ---~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.-++.+.+++.+ |+..||+.||++.++++
T Consensus 244 ~~~~~~~~l~~li~~-~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 244 CPPNCPPSFFPITVR-CCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CCTTCCTTHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 124577888888 89999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.46 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=201.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhc----------CCCCeeEEeeEEEc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC----------GGPNIVKLLDIVRD 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~----------~hpniv~~~~~~~~ 200 (401)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++. .||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 47899999999999999999999999999999999754 2466889999999883 27999999999875
Q ss_pred CC--CCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCC-----CCe
Q 015741 201 QQ--SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----QRK 267 (401)
Q Consensus 201 ~~--~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~-----~~~ 267 (401)
.. ...++++|||+ +++|..++ ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+ ...
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 32 33789999999 77776654 2489999999999999999999998 99999999999999532 237
Q ss_pred EEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-----CCHHHHHHH
Q 015741 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKI 342 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-----~~~~~l~~i 342 (401)
+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .+.+.+..+
T Consensus 177 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 99999999987643 3345678999999999987 678999999999999999999999995332 133444444
Q ss_pred HHHhCC------------------------------------------------hhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 343 AKVLGT------------------------------------------------DELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 343 ~~~~~~------------------------------------------------~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.+.++. +.+.+++.+ |++.||..||++.+++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP-MLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG-GGCSSTTTCBCHHHHH
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH-HhccCccccCCHHHHh
Confidence 443332 244566766 8999999999999999
Q ss_pred CCCcccccccccc
Q 015741 375 RKPWSKFITVENQ 387 (401)
Q Consensus 375 ~~~~~~~~~~~~~ 387 (401)
+|||++.......
T Consensus 333 ~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 333 NHPWLKDTLGMEE 345 (373)
T ss_dssp TCGGGTTCTTCTT
T ss_pred hChhhhcccCccc
Confidence 9999987554433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.11 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=201.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+.....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 36799999999999999999999999999999998643 246789999999999 8999999999987665678
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.++....+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCc
Confidence 89999999988333221 3589999999999999999999999999999999999999766 899999999987643
Q ss_pred C---CcccccccCCCccccccccCCC-CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhH
Q 015741 282 G---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDEL 351 (401)
Q Consensus 282 ~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~ 351 (401)
. .......|+..|+|||++.+.. .++.++||||||+++|+|++|..||. +.+..+....+.+.. ..+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHhcCCCCCCCccCHHH
Confidence 2 2234457899999999987522 34779999999999999999999984 344444444443321 14567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+++.+ |+..||..||++.++++|||++...
T Consensus 241 ~~li~~-~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKG-MLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHH-HTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHH-HccCChhhCCCHHHHhcCcccccCC
Confidence 888888 8999999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.53 Aligned_cols=245 Identities=20% Similarity=0.351 Sum_probs=181.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++ +||||+++++++.+. ...++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcEE
Confidence 57899999999999999999998889999999998642 245678999999998 899999999999763 56889
Q ss_pred EEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 209 IFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 209 v~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 169 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSA 169 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchh
Confidence 999999999877653 388999999999999999999999999999999999999766 89999999987
Q ss_pred ecCCCC------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 278 FYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 278 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
...... ......|++.|+|||++.+...++.++|||||||++|+|++|+.||.... ..+.+....+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHTSSCCCTT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc-hhhHHHHHhccCCCccc
Confidence 654322 12345789999999998654568999999999999999999999995433 222222221110
Q ss_pred -----------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 347 -----------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 347 -----------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.++.+.+++.+ |+..||..||++.++++|||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSTTC----
T ss_pred cccccchhhhhhhHHHHHHHHH-HccCChhhCcCHHHHhhChhhhcCC
Confidence 12456777777 8999999999999999999998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=333.71 Aligned_cols=243 Identities=25% Similarity=0.404 Sum_probs=193.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---------
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--------- 202 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~--------- 202 (401)
++|++++.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhccc
Confidence 6799999999999999999999999999999998643 336688999999999 9999999999886532
Q ss_pred --CCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 203 --SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 203 --~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
....++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 163 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLA 163 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcch
Confidence 356789999999999987763 467888999999999999999999999999999999999766 8999999999
Q ss_pred eecCCC---------------CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 277 EFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 277 ~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
...... .......|++.|+|||++.+...++.++|||||||++|+|++ ||..+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 765421 122345788999999998865578999999999999999998 66433322233333
Q ss_pred HHHHhC----------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 342 IAKVLG----------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 342 i~~~~~----------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+..... .+.+.+++.+ |+..||..||++.++++|||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 241 LRSVSIEFPPDFDDNKMKVEKKIIRL-LIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHSTTCCCCTTCCTTTSHHHHHHHHH-HTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccccccccCccccccchHHHHHHHHH-HHhcCcccCcCHHHHhCCCCcCCC
Confidence 222111 1236777777 899999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.25 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=196.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++.+||||+++++++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEE
Confidence 47899999999999999999999999999999998643 345689999999999899999999999976 467899999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe-----EEEEecccceecCCC
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-----LRLIDWGLAEFYHPG 282 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~-----vkl~DFg~a~~~~~~ 282 (401)
|+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ . +||+|||+++.+...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence 99 88887664 4689999999999999999999999999999999999998665 4 999999999876433
Q ss_pred Cc--------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHH-------
Q 015741 283 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV------- 345 (401)
Q Consensus 283 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~------- 345 (401)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +..+.+..+...
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 22 245689999999999887 678999999999999999999999995432 222233333221
Q ss_pred ---hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 346 ---LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 346 ---~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
...+.+.+++.+ |+..||..||+++++.+
T Consensus 243 ~~~~~~p~~~~li~~-~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENFPEMATYLRY-VRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTCHHHHHHHHH-HHHCCTTCCCCHHHHHH
T ss_pred HHhccChHHHHHHHH-HHhCCCCCCCCHHHHHH
Confidence 114477777777 89999999999877765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.82 Aligned_cols=243 Identities=16% Similarity=0.251 Sum_probs=197.8
Q ss_pred CCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++++.||+|+||.||+|. +..+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--C
Confidence 4789999999999999999999 4457789999998643 234688999999999 99999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC--CeEEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI 271 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~vkl~ 271 (401)
...++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 56789999999999987752 388999999999999999999999999999999999998433 269999
Q ss_pred ecccceecCCC---CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-
Q 015741 272 DWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL- 346 (401)
Q Consensus 272 DFg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~- 346 (401)
|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf-~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCC
Confidence 99999754221 22334567889999999876 679999999999999999998 88887 4445444444444332
Q ss_pred ------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 347 ------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.++.+.+++.+ |++.||..||++.+++++.|.-.
T Consensus 305 ~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQ-CWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHH-HcCCCHhHCcCHHHHHHHHHHHh
Confidence 13467777877 89999999999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.33 Aligned_cols=236 Identities=17% Similarity=0.300 Sum_probs=193.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCc
Confidence 578999999999999999999997554 45999999753 235688999999999 89999999999965 457
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.+++|..++ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLED 203 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC-
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCccccccc
Confidence 88999999999998776 3689999999999999999999999999999999999999766 899999999987654
Q ss_pred CCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 282 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
... .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+..... ++
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPY-WNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 322 122345667999999876 678999999999999999999 99888 44444555445444322 45
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..||..||++.++++
T Consensus 282 ~l~~li~~-~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLD-CWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH-HccCChhhCcCHHHHHH
Confidence 67778887 89999999999998874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=350.05 Aligned_cols=246 Identities=15% Similarity=0.141 Sum_probs=184.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhc-CCCCeeEEe-------eEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL-------DIV 198 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~-~hpniv~~~-------~~~ 198 (401)
..+|++.+.||+|+||.||+|.+..+++.||||+++... .+.+.+|+.+++.|. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999999999999999997632 356788888777774 499988755 555
Q ss_pred EcCCC---------------CCcEEEEeecCCCchhhhcC----CCCHHHH------HHHHHHHHHHHHHHHhCCceeec
Q 015741 199 RDQQS---------------KTPSLIFEHVNNTDFKVLYP----TLSDYDV------RYYIYELLKALDYCHSQGIMHRD 253 (401)
Q Consensus 199 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~----~~~~~~~------~~i~~qi~~~L~~LH~~~ivHrD 253 (401)
..... ..+++||||+. ++|..++. .+.+... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 43322 33799999999 88877764 2444444 56679999999999999999999
Q ss_pred CCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 015741 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (401)
Q Consensus 254 lkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf~~~ 332 (401)
|||+|||++.++ .+||+|||+++.... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...
T Consensus 220 ikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999776 899999999987632 2224566799999999864 246899999999999999999999999544
Q ss_pred CCCHHH-HHH---HH--------H--HhCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 333 HDNYDQ-LVK---IA--------K--VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 333 ~~~~~~-l~~---i~--------~--~~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
...... ... .. . ..-++.+.+++.+ |+..||+.|+++.++++|||++.+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR-FLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH-HTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCHHHHHHH
Confidence 211000 000 00 0 0114577788888 8999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=325.42 Aligned_cols=236 Identities=17% Similarity=0.338 Sum_probs=197.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ..+.+.+|+++++++ +||||+++++++.+ ....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEEE
Confidence 478999999999999999999985 6788999999753 457799999999999 89999999999965 45689999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--c
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--~ 284 (401)
||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccccccccc
Confidence 9999999987763 388999999999999999999999999999999999998766 89999999998654322 1
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+....+....+.... .++.+.+++.
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 223455677999999876 679999999999999999999 88887 4445555544444332 1456777888
Q ss_pred hcCCCCChhhHHHhhhhcCC
Q 015741 357 KYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~ 376 (401)
+ |+..||..||++.+++++
T Consensus 242 ~-~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 H-CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp H-HTCSSGGGSCCHHHHHHH
T ss_pred H-HccCCcccCcCHHHHHHH
Confidence 7 899999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.72 Aligned_cols=246 Identities=18% Similarity=0.321 Sum_probs=183.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..++|++.+.||+|+||.||+|.+..++. .||||+++.. ..+.+.+|+++++++ +||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccc
Confidence 46789999999999999999999876665 8999998643 346789999999999 99999999999876432
Q ss_pred C----CcEEEEeecCCCchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEE
Q 015741 204 K----TPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (401)
Q Consensus 204 ~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl 270 (401)
. ..+++|||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl 178 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCV 178 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEE
Confidence 2 2489999999999987652 488999999999999999999999999999999999999766 8999
Q ss_pred EecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh
Q 015741 271 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 271 ~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
+|||+++........ ....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY-AGIENAEIYNYLIGGN 256 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTC
T ss_pred eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc-cccChHHHHHHHhcCC
Confidence 999999876443322 23455678999999876 679999999999999999999 78787 4444444444443332
Q ss_pred C-------ChhHHHHHHhcCCCCChhhHHH-------hhhhcCCCccccc
Q 015741 347 G-------TDELNAYLNKYHIELDPHLAAL-------VGRHSRKPWSKFI 382 (401)
Q Consensus 347 ~-------~~~~~~~l~~~~l~~dP~~R~~-------~~~~l~~~~~~~~ 382 (401)
. ++.+.+++.+ |+..||..||+ +++++.|+|..-.
T Consensus 257 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQ-CWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCCTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCccCHHHHHHHHH-HccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1 3567788888 89999999999 8999999998663
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=328.24 Aligned_cols=237 Identities=15% Similarity=0.238 Sum_probs=196.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-------eEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
.++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe--
Confidence 578999999999999999999988776 57999998643 346789999999999 89999999999975
Q ss_pred CCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC-------eEEEE
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-------KLRLI 271 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-------~vkl~ 271 (401)
....++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 456789999999999987763 3889999999999999999999999999999999999987662 19999
Q ss_pred ecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-----
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----- 346 (401)
|||++..... .....++..|+|||++.+...++.++|||||||++|+|++|..|++...+............
T Consensus 164 Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (289)
T 4fvq_A 164 DPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP 240 (289)
T ss_dssp CCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCC
Confidence 9999865432 23456788999999998656789999999999999999998777766555444433332221
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++.+.+++.+ |++.||..||++.+++++
T Consensus 241 ~~~~l~~li~~-~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 241 KAAELANLINN-CMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SSCTTHHHHHH-HSCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 14567888888 899999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=331.05 Aligned_cols=239 Identities=22% Similarity=0.331 Sum_probs=193.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEeeEEEcC--CCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--QSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~hpniv~~~~~~~~~--~~~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+ +++.||||++.......+.+|.+++... .+||||+++++++.+. ....+++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 47899999999999999999987 7999999999887778888888888873 2899999999987543 23467899
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||+.+++|..+++ .+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++..
T Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMH 163 (301)
T ss_dssp ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeeec
Confidence 99999999988875 5889999999999999999999 99999999999999999766 8999999999876
Q ss_pred CCCCcc-----cccccCCCccccccccCCC-----CCCcccchHHHHHHHHHHHcC----------CCCCCCCCC---CH
Q 015741 280 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFR----------KEPFFYGHD---NY 336 (401)
Q Consensus 280 ~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~ll~elltg----------~~Pf~~~~~---~~ 336 (401)
...... ....||+.|+|||++.+.. .++.++|||||||++|||++| ..||..... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 543322 2347899999999987632 344789999999999999999 888865332 33
Q ss_pred HHHHHHHHHhC--------------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 337 DQLVKIAKVLG--------------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 337 ~~l~~i~~~~~--------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+........ .+.+.+++.+ |+..||..||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-CWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH-HCCSSGGGSCCHHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHH-HhhcChhhCCCHHHHHH
Confidence 33333221111 1346677777 89999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=321.87 Aligned_cols=236 Identities=15% Similarity=0.283 Sum_probs=196.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+ .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEEE
Confidence 57899999999999999999987 46788999999753 457799999999999 89999999999965 56789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc-
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~- 285 (401)
||+++++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhc
Confidence 9999999877653 489999999999999999999999999999999999999776 8999999999876544322
Q ss_pred -cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 286 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| ......+....+.... .++.+.+++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPY-DLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCc-cccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence 22345567999999876 678999999999999999999 88888 4444444444443332 1456777787
Q ss_pred hcCCCCChhhHHHhhhhcCC
Q 015741 357 KYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~ 376 (401)
+ |+..||..||++.+++++
T Consensus 240 ~-~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 240 S-CWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp H-TTCSSGGGSCCHHHHHHH
T ss_pred H-HcCCChhhCcCHHHHHHH
Confidence 7 899999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.33 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=197.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
+|.....||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEE
Confidence 3444468999999999999999999999999986532 46788999999999 99999999999976 457889999
Q ss_pred ecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 212 HVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 212 ~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
|+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.+++.+||+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999987753 356888899999999999999999999999999999999744589999999998764332 2
Q ss_pred ccccccCCCccccccccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYL 355 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l 355 (401)
.....|+..|+|||++.+. ..++.++||||||+++|+|++|+.||................. .++.+.+++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 3445788999999998652 2478999999999999999999999954333333222222111 145677788
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ |+..||+.||++.++++|||++...
T Consensus 260 ~~-~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LK-CFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HH-TTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HH-HccCChhhCCCHHHHhcChhhhhcc
Confidence 77 8999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=330.39 Aligned_cols=246 Identities=19% Similarity=0.316 Sum_probs=184.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHH-HHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKI-KREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~-~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||.||+|.+..+++.||||++..... .++ .++..+++.+ +||||+++++++.+ ...++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCcEE
Confidence 4789999999999999999999998999999999965321 223 3344455665 99999999999976 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+||||+ ++.+..+. ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCC
Confidence 999999 44444332 4689999999999999999999995 999999999999999776 8999999999876555
Q ss_pred CcccccccCCCcccccccc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CCh
Q 015741 283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~ 349 (401)
.......+++.|+|||++. ....++.++|||||||++|+|++|+.||.......+.+..+.... -++
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 5555668899999999985 235688999999999999999999999966555555555554432 145
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.+.+++.+ |+..||..||++.++++|||++....
T Consensus 259 ~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 259 DFQSFVKD-CLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp HHHHHHHH-HTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHH-HccCChhHCcCHHHHhhCHHHHhccc
Confidence 67788888 89999999999999999999987544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=327.56 Aligned_cols=239 Identities=18% Similarity=0.328 Sum_probs=190.8
Q ss_pred CCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccch---HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~----~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++++.||+|+||.||+|+ +..+++.||||++..... +.+.+|+++++++ +||||+++++++.......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCc
Confidence 5789999999999999999998 556899999999975443 5688999999999 8999999999987655567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+++||||+.+++|..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccC
Confidence 899999999999987763 389999999999999999999999999999999999999776 899999999987644
Q ss_pred CCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-----------CHHHHHHHHHHh
Q 015741 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-----------NYDQLVKIAKVL 346 (401)
Q Consensus 282 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-----------~~~~l~~i~~~~ 346 (401)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... .......+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 322 223356677999999886 6789999999999999999999998742110 011111111111
Q ss_pred -----------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 -----------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 -----------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.++.+.+++.+ |+..||..||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTE-CWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 13567777777 89999999999998863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=321.05 Aligned_cols=236 Identities=19% Similarity=0.303 Sum_probs=193.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC
Confidence 3578999999999999999999999999999999985322 16789999999999 899999999998542
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCC----eEEEE
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQR----KLRLI 271 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~----~vkl~ 271 (401)
.++||||+.+++|...+ ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. .+||+
T Consensus 96 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 ----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp ----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred ----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 36999999999986654 35899999999999999999999999 999999999999986552 39999
Q ss_pred ecccceecCCCCcccccccCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~--- 347 (401)
|||+++... .......|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.................+
T Consensus 172 Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 999997543 33455678999999999843 246789999999999999999999999655444433333222211
Q ss_pred ------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 ------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 ------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+.+++.+ |+..||..||++.++++
T Consensus 250 ~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIEL-CWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 3567788888 89999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.79 Aligned_cols=243 Identities=23% Similarity=0.438 Sum_probs=200.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~-~hpniv~~~~~~~~~~ 202 (401)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++++. .||||+++++++.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 578999999999999999999999999999999986432 245778999999994 36999999999976
Q ss_pred CCCcEEEEeecCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
....+++||++.+ ++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 4578899999986 7887665 46899999999999999999999999999999999999985445899999999987
Q ss_pred cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH---HHhCChhHHHHH
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA---KVLGTDELNAYL 355 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~---~~~~~~~~~~~l 355 (401)
... .......|++.|+|||++.+...++.++|||||||++|+|++|+.||... +...... ....++.+.+++
T Consensus 200 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~li 274 (320)
T 3a99_A 200 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQRVSSECQHLI 274 (320)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHCCCCCSSCCCHHHHHHH
T ss_pred ccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhhhcccccccccCCHHHHHHH
Confidence 653 33445678999999999876444578899999999999999999999421 1111000 001245778888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ |+..||..||++.++++|||++...
T Consensus 275 ~~-~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 275 RW-CLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HH-HTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HH-HccCChhhCcCHHHHhcCHhhcCcc
Confidence 88 8999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=324.44 Aligned_cols=236 Identities=17% Similarity=0.282 Sum_probs=194.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++++.||+|+||.||+|.+ .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEEE
Confidence 57899999999999999999987 47888999999753 457799999999999 89999999999965 56789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
||+.+++|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHS
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccccccccccc
Confidence 999999998775 3589999999999999999999999999999999999999766 899999999976543221
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (401)
.....+++.|+|||++.+ ..++.++||||||+++|+|++ |+.|| ...+..+....+.+... ++.+.+++.
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCc-cccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence 223345677999999886 578999999999999999998 88888 44444455555544321 456777777
Q ss_pred hcCCCCChhhHHHhhhhcCC
Q 015741 357 KYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~ 376 (401)
+ |+..||..||++.+++++
T Consensus 256 ~-~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 256 S-CWHEKADERPTFKILLSN 274 (283)
T ss_dssp H-TTCSSGGGSCCHHHHHHH
T ss_pred H-HccCChhHCcCHHHHHHH
Confidence 7 899999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.02 Aligned_cols=239 Identities=20% Similarity=0.314 Sum_probs=197.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++... .+.+.+|+.+++++.+||||+++++++.+ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--G 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--C
Confidence 57899999999999999999985 3567899999997532 46788999999999889999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
...++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 57789999999999987652 378999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.........
T Consensus 180 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 180 HGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp TTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 766 8999999999876544322 23456778999999876 679999999999999999999 88888544444333
Q ss_pred HHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
...+.... .++.+.+++.+ |+..||..||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKT-CWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHH-HcCCCchhCcCHHHHHHH
Confidence 33333322 14567788887 899999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=323.93 Aligned_cols=240 Identities=21% Similarity=0.311 Sum_probs=201.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC------------
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------------ 201 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~------------ 201 (401)
++|++++.||+|+||.||+|.+..+++.||+|+++... +.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccccc
Confidence 67999999999999999999998899999999997543 5678999999999 999999999988541
Q ss_pred --CCCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 202 --QSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 202 --~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
....+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 167 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFG 167 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcch
Confidence 134578999999999998776 3588999999999999999999999999999999999999766 89999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH----hCChh
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----LGTDE 350 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----~~~~~ 350 (401)
++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||... .+....+... .-++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 243 (284)
T 2a19_B 168 LVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGIISDIFDKK 243 (284)
T ss_dssp TCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTCCCTTSCHH
T ss_pred hheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhcccccccCCHH
Confidence 9988766555566689999999999886 67899999999999999999999887321 1111111111 12456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+++.+ |+..||..||++.+++++.|.-.
T Consensus 244 ~~~li~~-~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 244 EKTLLQK-LLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHH-HccCChhhCcCHHHHHHHHHHHh
Confidence 7777877 89999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.96 Aligned_cols=234 Identities=16% Similarity=0.301 Sum_probs=196.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+ .++..||||+++.. ..+.+.+|+.+|+++ +||||+++++++. ...+++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEEE
Confidence 357899999999999999999998 46788999999753 467899999999999 9999999999985 3467999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY 339 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCce
Confidence 99999999987764 588889999999999999999999999999999999999766 899999999986643211
Q ss_pred --ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+.+..+.+... ++.+.++
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 122345667999999876 679999999999999999999 88888 45555555555554322 3567777
Q ss_pred HHhcCCCCChhhHHHhhhhc
Q 015741 355 LNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+ |+..||..||++++++
T Consensus 418 i~~-cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 418 MMR-CWKNRPEERPTFEYIQ 436 (454)
T ss_dssp HHH-HTCSSGGGSCCHHHHH
T ss_pred HHH-HccCChhHCcCHHHHH
Confidence 877 8999999999998886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=333.36 Aligned_cols=238 Identities=18% Similarity=0.248 Sum_probs=190.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCC--CCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQ--SKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~--~~~~~l 208 (401)
.++|++.+.||+|+||.||+|++ .++.||||+++.... ....+|+.+++++ +||||+++++++.+.. ...+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEE
Confidence 57899999999999999999987 489999999975443 3456688889898 8999999999997643 234689
Q ss_pred EEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC----------CceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 209 IFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 209 v~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~----------~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
||||+.+++|..++ ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcc
Confidence 99999999998776 3589999999999999999999999 999999999999999766 8999999999
Q ss_pred eecCCCCc---ccccccCCCccccccccCC----CCCCcccchHHHHHHHHHHHcCCCCCCCCCC--------------C
Q 015741 277 EFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------------N 335 (401)
Q Consensus 277 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--------------~ 335 (401)
+....... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....+ .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 87654332 2345789999999998762 3456788999999999999999999854321 2
Q ss_pred HHHHHHHHHHhC--------------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 336 YDQLVKIAKVLG--------------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 336 ~~~l~~i~~~~~--------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+........ .+.+.+++.+ |+..||+.||++.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE-CWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 222222111111 0126677777 89999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=336.60 Aligned_cols=238 Identities=19% Similarity=0.313 Sum_probs=196.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|.+.+.||+|+||.||+|.+.. .+..||+|+++... ...+.+|+++++++.+||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence 5789999999999999999999753 33689999997532 25688999999999889999999999965
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
....++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 147 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 147 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred -CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 466899999999999987752 388999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus 226 ~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~-~~~~~~~~ 302 (382)
T 3tt0_A 226 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEEL 302 (382)
T ss_dssp TTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHH
T ss_pred CCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence 776 89999999998765432 2233456778999999987 689999999999999999999 88888 34443443
Q ss_pred HHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 339 LVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 339 l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
...+.... -++.+.+++.+ |+..||..||++.+++++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 33333321 14577788888 899999999999999865
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=332.44 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=198.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++.. ..+.+.+|+.+++++.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 3588999999999999999999973 45678999998643 346789999999999789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPT--------------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 256 (401)
....++||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4678999999999999877631 68889999999999999999999999999999
Q ss_pred CCeeEeCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q 015741 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG 332 (401)
Q Consensus 257 ~NIll~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~ 332 (401)
+|||++.++ .+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 201 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999766 899999999987644332 233456778999999876 679999999999999999998 99898544
Q ss_pred CCCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 333 HDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 333 ~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
.........+.... .++.+.+++.+ |+..||..||++.+++++-..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-CWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HcCCCchhCcCHHHHHHHHHH
Confidence 44433333332221 14577777877 899999999999999876443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.02 Aligned_cols=238 Identities=18% Similarity=0.276 Sum_probs=197.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+.+|+|++++++++.+ ....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEE
Confidence 47899999999999999999999999999999998643 346789999999999889999999999865 567899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC----CeEEEEecccceecCCCC
Q 015741 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~vkl~DFg~a~~~~~~~ 283 (401)
|+ +++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 888877753 589999999999999999999999999999999999997554 139999999998765432
Q ss_pred c--------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHHh-------
Q 015741 284 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKVL------- 346 (401)
Q Consensus 284 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~~------- 346 (401)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 2 244578999999999876 678999999999999999999999995432 2233333332221
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-++.+.+++.+ |+..||..||+++++++
T Consensus 245 ~~~~~~~~l~~li~~-~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 245 LCAGFPEEFYKYMHY-ARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HTTTSCHHHHHHHHH-HHHCCTTCCCCHHHHHH
T ss_pred HHhhCcHHHHHHHHH-HhcCCcccCCCHHHHHH
Confidence 14567777777 79999999999988864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=336.54 Aligned_cols=239 Identities=17% Similarity=0.235 Sum_probs=186.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccchHHHHHHHHHHHHhc--------------CCCCee
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVKKKKIKREIKILQNLC--------------GGPNIV 192 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~il~~l~--------------~hpniv 192 (401)
..++|++.+.||+|+||.||+|.+..+ ++.||||++.... ..+.+|+++++++. +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 357899999999999999999998664 5889999986543 23444554444432 599999
Q ss_pred EEeeEEEcCC--CCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe--CC
Q 015741 193 KLLDIVRDQQ--SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HE 264 (401)
Q Consensus 193 ~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~--~~ 264 (401)
++++++.+.. ..+.++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 9999987542 25689999999 88988775 4689999999999999999999999999999999999998 55
Q ss_pred CCeEEEEecccceecCCCCc--------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH
Q 015741 265 QRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~ 336 (401)
+ .+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.
T Consensus 191 ~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 191 D-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp T-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred C-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 5 899999999987643221 133459999999999887 679999999999999999999999996444443
Q ss_pred HHHHHHHHH------------h----CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 337 DQLVKIAKV------------L----GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 337 ~~l~~i~~~------------~----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
......... + .++.+.+++.. |+..||..||++.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMET-VKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHH-HhcCCCCCCCCHHHHHH
Confidence 332211111 1 14566777777 79999999999888764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=335.21 Aligned_cols=245 Identities=24% Similarity=0.432 Sum_probs=176.3
Q ss_pred CCCeEEEe-eecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCCcEEE
Q 015741 133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~-~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~~~lv 209 (401)
.++|.+.+ .||+|+||.||+|.+..+++.||||++... ....+|+..+.++.+||||+++++++... ....+++|
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 57899965 699999999999999999999999999653 33445555444444999999999998652 23457899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~~~~ 282 (401)
|||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++.....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 99999999977762 48999999999999999999999999999999999999753 23699999999987643
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHH---HHHHHHHH----------hCCh
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD---QLVKIAKV----------LGTD 349 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~---~l~~i~~~----------~~~~ 349 (401)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....+... .-++
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 23345678999999999866 6788999999999999999999999954322111 01111111 1145
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+.+++.+ |+..||..||++.++++|||++..
T Consensus 263 ~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 263 DAKQLIRL-LLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHH-HSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHH-HCCCChhHCcCHHHHhcCcccccc
Confidence 67788888 899999999999999999999763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=333.19 Aligned_cols=237 Identities=20% Similarity=0.330 Sum_probs=194.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++++.||+|+||.||+|++. .+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence 3578999999999999999999987 345899999997532 35688999999999 99999999999965
Q ss_pred CCCcEEEEeecCCCchhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLY---------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 255 (401)
....++||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 56789999999999998765 357889999999999999999999999999999
Q ss_pred CCCeeEeCCCCeEEEEecccceecCCCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 015741 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 331 (401)
Q Consensus 256 p~NIll~~~~~~vkl~DFg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~ 331 (401)
|+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 202 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~- 278 (343)
T 1luf_A 202 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY- 278 (343)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred cceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence 9999999766 89999999997654322 1234467788999999876 679999999999999999999 888884
Q ss_pred CCCCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 332 GHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 332 ~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+....+....+.+.. -++.+.+++.+ |+..||..||++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRL-CWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHH-HcccCcccCCCHHHHHH
Confidence 444444444433321 13467777777 89999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=339.76 Aligned_cols=236 Identities=21% Similarity=0.346 Sum_probs=194.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++.+.||+|+||.||+|.+..+++.||||+++... .+.+.+|+++++++ +||||+++++++.+ ...+++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcEE
Confidence 578999999999999999999998899999999987532 24678999999999 99999999999965 467899
Q ss_pred EEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCce
Confidence 999999999877653 489999999999999999999999999999999999999766 899999999986543211
Q ss_pred c---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHH
Q 015741 285 Y---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNA 353 (401)
Q Consensus 285 ~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~ 353 (401)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+....+.+.. .++.+.+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTREFVEKGGRLPCPELCPDAVFR 346 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11234567999999876 678999999999999999998 88887 4444444433333321 1346777
Q ss_pred HHHhcCCCCChhhHHHhhhhcC
Q 015741 354 YLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+ |+..||..||++.++++
T Consensus 347 li~~-cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 347 LMEQ-CWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHH-HcCCCchhCcCHHHHHH
Confidence 7777 89999999999998863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=328.68 Aligned_cols=237 Identities=16% Similarity=0.327 Sum_probs=194.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .+.+.+|+++++++ +||||+++++++.+ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ--D 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--C
Confidence 578999999999999999999873 455899999986532 35688999999999 99999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 256 (401)
...++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 67899999999999987753 278889999999999999999999999999999
Q ss_pred CCeeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q 015741 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG 332 (401)
Q Consensus 257 ~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~ 332 (401)
+|||++.++ .+||+|||++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +
T Consensus 179 ~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~ 255 (314)
T 2ivs_A 179 RNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-G 255 (314)
T ss_dssp GGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-T
T ss_pred heEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC-C
Confidence 999999766 8999999999876543322 23456678999999876 678999999999999999999 888884 3
Q ss_pred CCCHHHHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 333 HDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 333 ~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
....+....+.... -++.+.+++.+ |+..||..||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ-CWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 33333333333221 14577788887 899999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=345.32 Aligned_cols=247 Identities=16% Similarity=0.219 Sum_probs=193.3
Q ss_pred CCCCeEEEeeecccCCeeEEEE-----EEcCCCeEEEEEEecccchHHHHHHHHHHHHhcC--CCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~--hpniv~~~~~~~~~~~~ 204 (401)
..++|.+.+.||+|+||.||+| .+..+++.||+|+++......+.+|+++++.+.. |+||+++++++.. ..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--SS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec--CC
Confidence 3578999999999999999999 4667899999999998888899999999999832 8999999999976 45
Q ss_pred CcEEEEeecCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC-----------CC
Q 015741 205 TPSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------EQ 265 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-----------~~ 265 (401)
..++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 678999999999998776 24899999999999999999999999999999999999986 44
Q ss_pred CeEEEEecccceecC---CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 015741 266 RKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i 342 (401)
.+||+|||+++.+. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...
T Consensus 221 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (365)
T 3e7e_A 221 -GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298 (365)
T ss_dssp -TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSC
T ss_pred -CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechh
Confidence 89999999997653 2333456689999999999987 679999999999999999999999985432211100000
Q ss_pred HHH-hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 343 AKV-LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 343 ~~~-~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+. ...+.+.+++.+ |+..+|..|+...+.+.+.+.+.+.
T Consensus 299 ~~~~~~~~~~~~~~~~-~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 299 FRRLPHLDMWNEFFHV-MLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp CTTCSSHHHHHHHHHH-HHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccccCcHHHHHHHHHH-HcCCCCCCcchHHHHHHHHHHHHHH
Confidence 000 112334555555 6888888886555555555555443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.88 Aligned_cols=237 Identities=18% Similarity=0.331 Sum_probs=197.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+..++..||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ...+++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence 357899999999999999999999888999999999753 457899999999999 99999999999965 4678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCce
Confidence 99999999987762 478899999999999999999999999999999999998766 899999999987643321
Q ss_pred --ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.+... ++.+.++
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 122345567999999876 678999999999999999999 88887 44444444444433321 3567777
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..||..||++.++++
T Consensus 452 i~~-cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRA-CWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HcCcChhHCcCHHHHHH
Confidence 877 89999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.68 Aligned_cols=241 Identities=18% Similarity=0.296 Sum_probs=198.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+. .+++.||||+++... .+.+.+|+.+++++.+||||+++++++.+.
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 3578999999999999999999853 467899999997532 356889999999997899999999998654
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYPT-------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 263 (401)
...++++|||+.+++|..++.. +++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3568999999999999877632 678899999999999999999999999999999999986
Q ss_pred CCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 015741 264 EQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 339 (401)
Q Consensus 264 ~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l 339 (401)
++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus 184 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 66 899999999987644332 233467788999999876 678999999999999999998 998985544444444
Q ss_pred HHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 340 VKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 340 ~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
..+.... .++.+.+++.+ |+..||..||++.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 4443322 24577888888 899999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.03 Aligned_cols=239 Identities=18% Similarity=0.298 Sum_probs=194.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3588999999999999999999975 356789999997532 35688999999999789999999999965
Q ss_pred CCCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE
Q 015741 201 QQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (401)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 261 (401)
....++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 467899999999999987753 27888999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHH
Q 015741 262 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (401)
Q Consensus 262 ~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~ 337 (401)
+.++ .+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+
T Consensus 191 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~ 267 (334)
T 2pvf_A 191 TENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE 267 (334)
T ss_dssp CTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc-CcCCHHH
Confidence 9766 899999999987654332 223456678999999876 678999999999999999999 88888 3444344
Q ss_pred HHHHHHHHh-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 338 QLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 338 ~l~~i~~~~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
....+.... .++.+.+++.+ |+..||..||++.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 333433332 13567777877 899999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=329.45 Aligned_cols=236 Identities=18% Similarity=0.309 Sum_probs=188.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeE----EEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~----vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|++..+++. ||+|.++. ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC---
Confidence 57899999999999999999998777765 57777643 2346789999999999 999999999999763
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 168 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEcc
Confidence 367999999999987765 3589999999999999999999999999999999999999766 89999999998765
Q ss_pred CCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 281 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 281 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+....+.... ...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred CCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc-CCCHHHHHHHHHcCCCCCCCccCCH
Confidence 43322 23355778999999987 689999999999999999999 998884 333333333332222 134
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+++.+ |+..||..||++.+++++
T Consensus 247 ~~~~li~~-~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVK-CWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHH-HTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCCCHHHHHHH
Confidence 67777777 899999999999998865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=331.34 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=175.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||.||+|.+..+++.||||+++... ...+..|+..+.+..+||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEE
Confidence 578999999999999999999999999999999986532 23456666644443499999999999976 457889
Q ss_pred EEeecCCCchhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 209 IFEHVNNTDFKVL--------YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 209 v~e~~~~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
||||+.+ +|..+ ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQL 176 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC-
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceec
Confidence 9999997 44332 24588999999999999999999999 999999999999999766 8999999999877
Q ss_pred CCCCcccccccCCCcccccccc---CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-----------
Q 015741 280 HPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----------- 345 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~----------- 345 (401)
..........|++.|+|||++. ....++.++|||||||++|+|++|+.||.......+.+..+.+.
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 5554445557899999999983 23568999999999999999999999995433322332222111
Q ss_pred hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 346 ~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
..++.+.+++.+ |+..||..||++.++++|||+....
T Consensus 257 ~~~~~l~~li~~-~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 257 EFSPSFINFVNL-CLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCHHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHH-HhhCChhhCcCHHHHHhChHHHHhH
Confidence 013467777877 8999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=322.20 Aligned_cols=235 Identities=21% Similarity=0.374 Sum_probs=183.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---Cc
Confidence 57899999999999999999998643 467999998643 235688999999999 99999999999843 46
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 168 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCc
Confidence 789999999999987753 588999999999999999999999999999999999999766 899999999987654
Q ss_pred CCc--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhH
Q 015741 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDEL 351 (401)
Q Consensus 282 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~ 351 (401)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+.+..+.... -++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 332 223355678999999876 678999999999999999997 888884 444445544444322 14567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+++.+ |+..||..||++.++++
T Consensus 247 ~~li~~-~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 247 YSLMTK-CWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHH-HccCChhhCcCHHHHHH
Confidence 788887 89999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.04 Aligned_cols=234 Identities=17% Similarity=0.321 Sum_probs=195.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++++.||+|+||.||+|.+ .+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ...++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEEE
Confidence 57899999999999999999997 46788999998753 457899999999999 99999999999853 3578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
||+.+++|..++. .+++.++..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc
Confidence 9999999988875 588999999999999999999999999999999999999666 899999999987654322
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (401)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+....+.+..+.+.. .++.+.+++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCC-cccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence 123355678999999876 678999999999999999999 88887 4444444444443332 135777778
Q ss_pred HhcCCCCChhhHHHhhhhcC
Q 015741 356 NKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+ |+..||+.||++.++++
T Consensus 244 ~~-~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 244 RL-CWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HH-HTCSSGGGSCCHHHHHH
T ss_pred HH-HhccChhhCCCHHHHHH
Confidence 77 89999999999988864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=322.24 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=193.5
Q ss_pred CCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.+.|++++.||+|+||.||+|+ +..+++.||+|+++.. ..+.+.+|+++++.+ +||||+++++++.+....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence 4679999999999999999998 4678999999998743 346789999999999 899999999999876667
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
.+++||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE 177 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccccccccc
Confidence 789999999999998776 3589999999999999999999999999999999999999776 89999999998775
Q ss_pred CCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC-------------CCCHHHHHHHH
Q 015741 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG-------------HDNYDQLVKIA 343 (401)
Q Consensus 281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~-------------~~~~~~l~~i~ 343 (401)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|..|+... ......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 4432 234467778999999876 67889999999999999999999875211 11111111111
Q ss_pred HH-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 344 KV-L-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 344 ~~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.. . -++.+.+++.+ |+..||..||++.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRK-CWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHH-HcCCCCCCCCCHHHHHH
Confidence 11 0 13567788888 89999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=316.84 Aligned_cols=235 Identities=18% Similarity=0.345 Sum_probs=185.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..+.+.+|+++++.+ +||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C--
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCc
Confidence 57899999999999999999997 4899999998632 235688999999999 89999999999965 456
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeecCCCCCeeEeCC-------CCeEEEEec
Q 015741 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------QRKLRLIDW 273 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~-------~~~vkl~DF 273 (401)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||++| |+||||||+|||++.+ ...+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 89999999999998876 46899999999999999999999999 9999999999999852 347999999
Q ss_pred ccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------
Q 015741 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------- 346 (401)
Q Consensus 274 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------- 346 (401)
|++....... .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||. +.+.......+....
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHTSCCCCCCCT
T ss_pred Cccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHhhhcCCCCCCCCc
Confidence 9998664332 234578999999999876 678999999999999999999999994 333333333322211
Q ss_pred -CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 -GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 -~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++.+.+++.+ |+..||..||++.+++++
T Consensus 238 ~~~~~~~~li~~-~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMED-CWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHH-HhcCCcccCcCHHHHHHH
Confidence 13567788888 899999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.35 Aligned_cols=239 Identities=15% Similarity=0.176 Sum_probs=188.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCeeEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLL 195 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~~hpniv~~~ 195 (401)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... ...+.+|+.+++.+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 5789999999999999999999976 78899999986432 12356777888887 999999999
Q ss_pred eEEEcC--CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC-CeEE
Q 015741 196 DIVRDQ--QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLR 269 (401)
Q Consensus 196 ~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~vk 269 (401)
+++.+. .....++||||+ +++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 998762 246789999999 899988875 589999999999999999999999999999999999998543 3799
Q ss_pred EEecccceecCCCC--------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 270 LIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 270 l~DFg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
|+|||+++.+.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.....+...+..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999998764321 1144578999999999887 67899999999999999999999999544444443332
Q ss_pred HHHH----------------hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 342 IAKV----------------LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 342 i~~~----------------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.... ..++.+.+++.+ |+..||..||++.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVC-AHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHH-HhhcCcccCCCHHHHHH
Confidence 2221 123467777777 89999999999988864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.12 Aligned_cols=241 Identities=18% Similarity=0.311 Sum_probs=197.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..++|++++.||+|+||.||+|+ +..+++.||+|++.... .+.+.+|+++++++ +||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence 35789999999999999999998 46789999999997543 35589999999999 999999999999876677
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECC
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecc
Confidence 8899999999999987753 489999999999999999999999999999999999999766 89999999998775
Q ss_pred CCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC-------------HHHHHHHH
Q 015741 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-------------YDQLVKIA 343 (401)
Q Consensus 281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~-------------~~~l~~i~ 343 (401)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4332 233457778999999876 67899999999999999999999998432111 01111111
Q ss_pred HH--------hCChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 344 KV--------LGTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 344 ~~--------~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.. ..++.+.+++.+ |+..||..||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKL-CWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 11 113567788888 899999999999999543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.11 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=187.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
..+|.+.+.||+|+||+||.. ...+++.||||++.+.....+.+|+++++.+.+|||||++++++.+ ....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEEC
Confidence 467999999999999997643 3468999999999776666678999999998789999999999876 5678999999
Q ss_pred cCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC----CCeEEEEecccceecCCCC-
Q 015741 213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 213 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~----~~~vkl~DFg~a~~~~~~~- 283 (401)
+.+ +|..++. ...+.++..++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++......
T Consensus 100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 975 6665542 24555678999999999999999999999999999999532 2368899999998765332
Q ss_pred ---cccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 284 ---EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 284 ---~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
......||+.|+|||++.+ ...++.++|||||||++|||++ |..||.. .. ......+.....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-SL-QRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS-TT-THHHHHHTTCCCCTTSCTTCHH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch-hh-HHHHHHHhccCCccccCccccc
Confidence 2344679999999999874 2567789999999999999999 8888732 22 222222211111
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
.+.+.+++.+ |+..||..||++.++++|||+.-+
T Consensus 257 ~~~~~~li~~-~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 257 DVIARELIEK-MIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHH-HSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cHHHHHHHHH-HHhCCHhhCCCHHHHHhCccccCh
Confidence 1235567777 899999999999999999999643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.03 Aligned_cols=236 Identities=17% Similarity=0.291 Sum_probs=191.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeE----EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++++.||+|+||.||+|.+..+++. ||+|++... ....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---C
Confidence 57899999999999999999999877765 777776432 235678899999999 99999999999853 4
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++||||+.+++|..++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLP 166 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccC
Confidence 578999999999987765 2588899999999999999999999999999999999998766 89999999998765
Q ss_pred CCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+.... .++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 4332 244567778999999976 679999999999999999999 999984 333333333333321 134
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+++.+ |+..||..||++.+++++
T Consensus 245 ~~~~li~~-~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVK-CWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHH-HTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 67777887 899999999999998865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=338.93 Aligned_cols=240 Identities=20% Similarity=0.287 Sum_probs=187.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.....+.+.+|+.+++++.+||||+++++++.+ ...+++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEec
Confidence 4567778999999999998754 468999999999877677889999999987689999999999865 5678999999
Q ss_pred cCCCchhhhcCCC----------CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC------------CCeEEE
Q 015741 213 VNNTDFKVLYPTL----------SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------QRKLRL 270 (401)
Q Consensus 213 ~~~~~l~~~~~~~----------~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~------------~~~vkl 270 (401)
+. ++|..++... .+..++.++.||+.||+|||++||+||||||+|||++.+ ...+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5887776321 223456799999999999999999999999999999743 247999
Q ss_pred EecccceecCCCCc-----ccccccCCCccccccccC------CCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 015741 271 IDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (401)
Q Consensus 271 ~DFg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~ 338 (401)
+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||++ |..||..... .+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-RE- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-HH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-hH-
Confidence 99999987754322 234579999999999864 2468899999999999999999 8888843322 22
Q ss_pred HHHHHHHhC-------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 339 LVKIAKVLG-------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 339 l~~i~~~~~-------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
..+.+... ++++.+++.+ |++.||..||++.++++|||+.
T Consensus 248 -~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQ-MIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp -HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGS
T ss_pred -HHHhcCCCCcccccccccccchHHHHHHHHH-HhhCChhhCCCHHHHHhCCccC
Confidence 22222111 1456777777 8999999999999999999995
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=321.60 Aligned_cols=237 Identities=19% Similarity=0.334 Sum_probs=197.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence 357899999999999999999999999999999998754 346789999999999 89999999999965 5678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCcc
Confidence 99999999987763 388999999999999999999999999999999999998766 899999999986643332
Q ss_pred --ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+.+... ++.+.++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 233456778999999876 678999999999999999999 88787 44443333333333321 3567788
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..||..||++.++++
T Consensus 245 i~~-~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 245 MRA-CWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HhCCChhhCcCHHHHHH
Confidence 888 89999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=331.96 Aligned_cols=243 Identities=23% Similarity=0.418 Sum_probs=193.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc---CCCCeeEEeeEEEc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLDIVRD 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~---~hpniv~~~~~~~~ 200 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.++.++. +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 478999999999999999999998999999999986432 234567999999885 79999999999865
Q ss_pred CCCCCcEEEEee-cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 201 QQSKTPSLIFEH-VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 201 ~~~~~~~lv~e~-~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
....++|||+ +.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.+++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4567899999 7888987765 358999999999999999999999999999999999999944448999999999
Q ss_pred eecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH---HhCChhHHH
Q 015741 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK---VLGTDELNA 353 (401)
Q Consensus 277 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~---~~~~~~~~~ 353 (401)
...... ......|+..|+|||++.+....+.++|||||||++|+|++|+.||... ........ ..-.+.+.+
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEILEAELHFPAHVSPDCCA 262 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHTCCCCCTTSCHHHHH
T ss_pred hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHHhhhccCCcccCCHHHHH
Confidence 877533 3455678999999999876444456899999999999999999998421 11111000 012456778
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
++.+ |+..||+.|+++.++++|||++...
T Consensus 263 li~~-~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 263 LIRR-CLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHH-HTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHH-HccCChhhCcCHHHHhcChhhcCch
Confidence 8888 8999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=323.87 Aligned_cols=243 Identities=24% Similarity=0.425 Sum_probs=193.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~-hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++++.||+|+||.||+|.+ .+++.||+|++... ..+.+.+|+.+++++.+ ||||+++++++.+ ....
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 57899999999999999999998 46889999998642 23668899999999943 6999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++|| +.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC-----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccccCcc
Confidence 99999 5677876665 4588999999999999999999999999999999999997 44 89999999998764332
Q ss_pred c---ccccccCCCccccccccCC----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----
Q 015741 284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---- 346 (401)
Q Consensus 284 ~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---- 346 (401)
. .....|++.|+|||++.+. ..++.++|||||||++|+|++|+.||.........+..+....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 2 2345789999999998641 3688899999999999999999999965444444443333211
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
..+.+.+++.+ |+..||..||++.++++|||++..
T Consensus 261 ~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 FPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CcccchHHHHHHHHH-HccCCcccCcCHHHHhcCccccCC
Confidence 13467788887 899999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=326.00 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=195.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe-----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+..+++ .||+|+++.. ..+.+.+|+.+++++.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 35889999999999999999999876654 8999999754 245688999999999789999999999965
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 265 (401)
....++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 457899999999999977652 368899999999999999999999999999999999999766
Q ss_pred CeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 015741 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 266 ~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~ 341 (401)
.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...... ..+..
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~ 278 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYK 278 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHH
Confidence 899999999986643322 123456778999999876 678999999999999999998 88888544333 33333
Q ss_pred HHHH-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 342 IAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 342 i~~~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+... . .++.+.+++.+ |+..||..||++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQA-CWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHH-HhccChhhCcCHHHHHH
Confidence 3332 1 24567777777 89999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.04 Aligned_cols=237 Identities=27% Similarity=0.481 Sum_probs=185.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~ 107 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNEL 107 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCcE
Confidence 46899999999999999999999999999999998642 235688999999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeee
Confidence 89999999999977652 488999999999999999999999999999999999999766 8999999999766
Q ss_pred CCCC-cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CCh
Q 015741 280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTD 349 (401)
Q Consensus 280 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~ 349 (401)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.....+...+....... .++
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred cCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 4332 2234578899999999876 6789999999999999999999999975554544443322221 134
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..||..||++.++++
T Consensus 266 ~l~~li~~-~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 266 ELRQLVNM-CINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 67777877 89999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=329.30 Aligned_cols=238 Identities=18% Similarity=0.278 Sum_probs=194.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEE--EEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~v--avK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|++..++..+ |+|.++.. ..+.+.+|+++++++.+||||+++++++.+ ....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCce
Confidence 378999999999999999999998888865 89988642 345688999999998789999999999976 4678
Q ss_pred EEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 207 SLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
++||||+++++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~ 180 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 180 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-C
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-e
Confidence 99999999999977752 478999999999999999999999999999999999998766 8
Q ss_pred EEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh
Q 015741 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~ 346 (401)
+||+|||+++............++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGGTC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHhhcCC
Confidence 99999999975433333344566788999999876 678999999999999999998 999983 444444433333321
Q ss_pred C-------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 347 G-------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 347 ~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
. ++.+.+++.+ |+..||..||++.+++++
T Consensus 259 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCCTTBCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 1 4567788888 899999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=341.15 Aligned_cols=235 Identities=17% Similarity=0.308 Sum_probs=191.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ..+++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence 3578999999999999999999985 4577999999753 457899999999999 99999999999854 467899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY 335 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCce
Confidence 99999999988764 488999999999999999999999999999999999998666 899999999987643321
Q ss_pred --ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+.+... ++.+.++
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 123345678999999876 679999999999999999999 88887 45555555555544321 3467777
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..||+.||+++++++
T Consensus 414 i~~-cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQ-CWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HccCChhhCcCHHHHHH
Confidence 877 89999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=323.07 Aligned_cols=240 Identities=18% Similarity=0.305 Sum_probs=186.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
..++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 45789999999999999999998765 4568999998643 235688999999999 89999999999876443
Q ss_pred C---CcEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 204 K---TPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 204 ~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
. ..++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~ 189 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVA 189 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEe
Confidence 2 468999999999998765 3589999999999999999999999999999999999999766 89999
Q ss_pred ecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC
Q 015741 272 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG 347 (401)
Q Consensus 272 DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~ 347 (401)
|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+....+....+.....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcCCC
Confidence 9999986643321 233456778999999876 679999999999999999999 77777 44444444444433321
Q ss_pred -------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 -------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 -------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
++.+.+++.+ |+..||..||++.+++++
T Consensus 268 ~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYS-CWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCBTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 3567788887 899999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=318.85 Aligned_cols=232 Identities=20% Similarity=0.304 Sum_probs=186.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+ .++.||+|++... ..+.+.+|+++++++ +||||+++++++.+ ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEEEE
Confidence 47899999999999999999987 4789999999654 346789999999999 99999999998743 4789999
Q ss_pred ecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 212 HVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 212 ~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
|+.+++|..++. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++..+||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~- 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-
Confidence 999999987763 36788899999999999999999 89999999999999997775689999999976532
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH-HHHHh-------CChhHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVL-------GTDELNAY 354 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~-i~~~~-------~~~~~~~~ 354 (401)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+.. +.... -++.+.++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred -ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 2334578999999999876 68899999999999999999999999654444333222 21111 13567788
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..||..||++.++++
T Consensus 237 i~~-~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 237 MTR-CWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HhcCChhhCcCHHHHHH
Confidence 887 89999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.33 Aligned_cols=235 Identities=17% Similarity=0.324 Sum_probs=195.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||.||+|.+. +++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....+++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEEE
Confidence 478999999999999999999984 7789999999753 457899999999999 89999999999965 45789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--c
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~--~ 284 (401)
||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccccc
Confidence 9999999987652 488999999999999999999999999999999999998766 89999999997654321 1
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+....+....+.... .++.+.+++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCC-CCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 123456678999999876 678999999999999999999 78887 4444444444444332 1456777787
Q ss_pred hcCCCCChhhHHHhhhhcC
Q 015741 357 KYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~ 375 (401)
+ |+..||..||++.++++
T Consensus 240 ~-~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 240 H-CWRERPEDRPAFSRLLR 257 (267)
T ss_dssp H-HTCSSGGGSCCHHHHHH
T ss_pred H-HccCChhhCcCHHHHHH
Confidence 7 89999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.61 Aligned_cols=234 Identities=16% Similarity=0.304 Sum_probs=193.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..++|++.+.||+|+||.||+|.+ .++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+. ...+++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEEE
Confidence 357899999999999999999987 4789999999754 456799999999999 999999999998753 34689999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc--c
Confidence 9999999987763 268899999999999999999999999999999999999766 8999999999865322 2
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHh
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (401)
....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+.+..+.+... ++.+.+++.+
T Consensus 344 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ---CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 23366788999999987 689999999999999999998 998884 4444444444444321 3577788877
Q ss_pred cCCCCChhhHHHhhhhcC
Q 015741 358 YHIELDPHLAALVGRHSR 375 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~ 375 (401)
|+..||..||++.++++
T Consensus 422 -cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 -CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -HTCSSGGGSCCHHHHHH
T ss_pred -HcCCChhHCcCHHHHHH
Confidence 89999999999998863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=317.21 Aligned_cols=236 Identities=23% Similarity=0.367 Sum_probs=191.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CC
Confidence 57899999999999999999987543 456999998753 346788999999999 99999999999854 34
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.+++|..++ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIED 165 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC--
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccc
Confidence 68999999999998776 3489999999999999999999999999999999999999766 899999999986643
Q ss_pred CCc--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhH
Q 015741 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDEL 351 (401)
Q Consensus 282 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~ 351 (401)
... .....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.. ....+....+.... .++.+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCccc-CChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 322 233456778999999876 678999999999999999998 9999853 33333333333321 13567
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+++.+ |+..||..||++.+++++
T Consensus 244 ~~li~~-~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTR-CWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HccCCchhCcCHHHHHHH
Confidence 777877 899999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.10 Aligned_cols=238 Identities=19% Similarity=0.283 Sum_probs=190.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++.+ +|++++..+..+.. .....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEEE
Confidence 57899999999999999999999999999999998643 346789999999999 66665555555433 2567799999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe--CCCCeEEEEecccceecCCCCc-
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~--~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
|+ +++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++..+||+|||++........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99 88887665 3589999999999999999999999999999999999994 2334899999999987654322
Q ss_pred -------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHH----------
Q 015741 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV---------- 345 (401)
Q Consensus 285 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~---------- 345 (401)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+.+..+...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred cccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 245578999999999887 679999999999999999999999995422 222222222221
Q ss_pred -hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 346 -LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 346 -~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.-++.+.+++.+ |+..||..||++.++++
T Consensus 244 ~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 244 KGYPSEFATYLNF-CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHH-HHTSCTTCCCCHHHHHH
T ss_pred hhCCHHHHHHHHH-HHhcCcCcCCCHHHHHH
Confidence 114567777777 89999999999888864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.77 Aligned_cols=241 Identities=20% Similarity=0.333 Sum_probs=187.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--CCeE
Confidence 378999999999999999999999999999999986432 26688999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++|||+.+++|..++ ..+++.+++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCccccccc
Confidence 9999999999998776 3589999999999999999999999999999999999999776 89999999997664332
Q ss_pred --cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhH
Q 015741 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDEL 351 (401)
Q Consensus 284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~ 351 (401)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||... +...+....... -++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhccCCCCccccCCCCCHHH
Confidence 2234578899999999876 67899999999999999999999999432 222332222211 13457
Q ss_pred HHHHHhcCCCCChhhHH-HhhhhcCCCccccc
Q 015741 352 NAYLNKYHIELDPHLAA-LVGRHSRKPWSKFI 382 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~-~~~~~l~~~~~~~~ 382 (401)
.+++.+ |+..||..|+ ++++++ +.+.+.+
T Consensus 266 ~~li~~-~l~~dP~~Rp~s~~~l~-~~l~~~l 295 (309)
T 2h34_A 266 DAVIAR-GMAKNPEDRYVTCGDLS-AAAHAAL 295 (309)
T ss_dssp HHHHHH-HTCSSGGGSCSSHHHHH-HHHHHTC
T ss_pred HHHHHH-hccCCHHHHHHhHHHHH-HHHHHHH
Confidence 777877 8999999999 777765 3444443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.41 Aligned_cols=241 Identities=17% Similarity=0.293 Sum_probs=198.4
Q ss_pred CCCeEEEe-eecccCCeeEEEEEEc--CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~-~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---CC
Confidence 46788877 9999999999999863 46889999999753 245688999999999 99999999999943 45
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGA 162 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeecc
Confidence 799999999999988762 489999999999999999999999999999999999999766 899999999987754
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
.... ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+....+....+.... -++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence 3322 22345778999999876 678999999999999999998 99998 4445555554444331 145
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+++.+ |+..||..||++.+++++.+.-.
T Consensus 241 ~l~~li~~-~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 241 ELYALMSD-CWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHHH-TTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCcCHHHHHHHHHHHH
Confidence 77777877 89999999999999998765543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.31 Aligned_cols=233 Identities=16% Similarity=0.263 Sum_probs=192.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|++ +++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeE
Confidence 47899999999999999999997 48999999987432 35688999999999 999999999999876567889
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+||||+.+++|..++. .+++..++.++.||+.||.|||++| |+||||||+||+++.++ .++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeeec
Confidence 9999999999987763 3789999999999999999999999 99999999999999766 78999998875432
Q ss_pred CCCcccccccCCCccccccccCCC--CCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChh
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (401)
.....+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||. +....+....+.... -++.
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 23457889999999987622 23337999999999999999999994 344444434433321 1457
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..||..||++.++++
T Consensus 240 ~~~li~~-~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKI-CMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHH
Confidence 7788888 89999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=329.75 Aligned_cols=244 Identities=17% Similarity=0.298 Sum_probs=190.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHH--hcCCCCeeEEeeEEEc---CCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQN--LCGGPNIVKLLDIVRD---QQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~~hpniv~~~~~~~~---~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|++ +++.||||+++......+..|.+++.. + +||||+++++.+.. .....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEE
Confidence 47899999999999999999976 789999999987777777777666543 5 99999999986543 2233568
Q ss_pred EEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 208 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
+||||+.+++|..++ ...++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccce
Confidence 999999999998876 3568888999999999999999999 999999999999999766 8999999999
Q ss_pred eecCCCC---------cccccccCCCccccccccCC------CCCCcccchHHHHHHHHHHHcCCCCCCCCCCC------
Q 015741 277 EFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN------ 335 (401)
Q Consensus 277 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~------ 335 (401)
+.+.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||+.+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 8764321 12245789999999998752 34567899999999999999998888665431
Q ss_pred ----------HHHHHHHHHHhC---------------ChhHHHHHHhcCCCCChhhHHHhhhhc------CCCcccc
Q 015741 336 ----------YDQLVKIAKVLG---------------TDELNAYLNKYHIELDPHLAALVGRHS------RKPWSKF 381 (401)
Q Consensus 336 ----------~~~l~~i~~~~~---------------~~~~~~~l~~~~l~~dP~~R~~~~~~l------~~~~~~~ 381 (401)
.+.+........ .+.+.+++.+ |+..||..||++.+++ .++|.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED-CWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHH-HSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHH-HhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 111111111100 0147778888 8999999999999994 4566654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.67 Aligned_cols=237 Identities=19% Similarity=0.305 Sum_probs=192.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+|++.+.||+|+||.||+|.+..+ +..+|+|.++... .+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCce
Confidence 5699999999999999999987543 3468999986432 35688999999999 899999999987543 4567
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++|||+.+++|..++. .+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECccccccccccc
Confidence 89999999999987763 478899999999999999999999999999999999999766 8999999999866432
Q ss_pred Cc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------Chh
Q 015741 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (401)
Q Consensus 283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (401)
.. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|++.+....+....+..... ++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 233456778999999876 67899999999999999999977776666666555555444322 456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..||..||++.++++
T Consensus 261 l~~li~~-~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLK-CWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHH
Confidence 7788888 89999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=333.37 Aligned_cols=236 Identities=18% Similarity=0.313 Sum_probs=183.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCc
Confidence 468999999999999999999876 46778999998643 235689999999999 99999999999965 467
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.++||||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLED 199 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCcccccccc
Confidence 899999999999987763 588999999999999999999999999999999999999766 899999999987653
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +....+....+..... .+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCCCCCccccH
Confidence 3211 12234667999999876 679999999999999999998 999984 3344444444433321 34
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..||..||++.++++
T Consensus 278 ~l~~li~~-cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLD-CWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH-HhCcChhhCcCHHHHHH
Confidence 67777777 89999999999988765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.87 Aligned_cols=239 Identities=18% Similarity=0.273 Sum_probs=192.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
..++|++.+.||+|+||.||+|.+ .+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence 467899999999999999999996 57899999998643 346789999999999 89999999999865 467889
Q ss_pred EEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 209 IFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 209 v~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
||||+.+++|..++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTE 191 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 999999999988763 378899999999999999999999999999999999999766 899999999986542
Q ss_pred CC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHHHh--C-------
Q 015741 282 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVKIAKVL--G------- 347 (401)
Q Consensus 282 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--~~l~~i~~~~--~------- 347 (401)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......... +
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 22 2234568899999999876 678999999999999999999999985432210 0111000000 0
Q ss_pred -----------ChhHHHHHHhcCCCCChhhHHHhhhhcCCC
Q 015741 348 -----------TDELNAYLNKYHIELDPHLAALVGRHSRKP 377 (401)
Q Consensus 348 -----------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~ 377 (401)
...+.+++.+ |+..||+.||++.+++++-
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVK-CLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHH-HTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHH-HcCCCcccCcCHHHHHHHH
Confidence 1235566666 8999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=315.59 Aligned_cols=233 Identities=15% Similarity=0.326 Sum_probs=181.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+ +..+|+|+++.. ..+.+.+|+.+++++ +||||++++++.. ....+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---~~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST---APQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc---CCccE
Confidence 57899999999999999999975 335999998642 235689999999999 9999999999763 34578
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC--
Q 015741 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-- 281 (401)
+||||+.+++|...+. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC---------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceecccccccc
Confidence 9999999999977763 488999999999999999999999999999999999999776 899999999976542
Q ss_pred -CCcccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------
Q 015741 282 -GKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------- 347 (401)
Q Consensus 282 -~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------- 347 (401)
........|++.|+|||++.. ...++.++||||||+++|+|++|+.||.. ..+.+.+..+.....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS-CCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc-cchHHHHHHHhcccccCcchhhcccc
Confidence 222344578999999999862 35688899999999999999999999954 344444444433311
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 -TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+.+++.+ |+..||..||++.++++
T Consensus 254 ~~~~l~~li~~-~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 254 CPKRMKRLMAE-CLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 2457777887 79999999999998863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=325.50 Aligned_cols=242 Identities=20% Similarity=0.331 Sum_probs=177.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEc------CCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD------QQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~------~~~ 203 (401)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++.+||||+++++++.. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 468999999999999999999999999999999885433 35688999999999669999999999853 223
Q ss_pred CCcEEEEeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 204 KTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
..++++|||+. |+|..++ ..+++.+++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence 45789999997 5554443 24899999999999999999999999 99999999999999766 899999999
Q ss_pred ceecCCCCcc-------------cccccCCCcccccccc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 015741 276 AEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (401)
Q Consensus 276 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~ 340 (401)
+......... ....+++.|+|||++. ....++.++|||||||++|+|++|+.||... ...+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~ 263 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-AKLRIVN 263 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch-hHHHhhc
Confidence 9876433221 1446889999999983 2356889999999999999999999999432 2221111
Q ss_pred HHHHH----hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 341 KIAKV----LGTDELNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 341 ~i~~~----~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
..... ...+.+.+++.+ |+..||..||++.+++++-+
T Consensus 264 ~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 GKYSIPPHDTQYTVFHSLIRA-MLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --CCCCTTCCSSGGGHHHHHH-HSCSSGGGSCCHHHHHHHHH
T ss_pred CcccCCcccccchHHHHHHHH-HccCChhhCcCHHHHHHHHH
Confidence 11000 113457788888 89999999999999997743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.77 Aligned_cols=238 Identities=18% Similarity=0.302 Sum_probs=194.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence 3578999999999999999999876 357899999986432 34588999999999 99999999999965
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEE
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vk 269 (401)
....++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~k 178 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVK 178 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEE
Confidence 457889999999999987652 458889999999999999999999999999999999999766 899
Q ss_pred EEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Q 015741 270 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (401)
Q Consensus 270 l~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~ 345 (401)
|+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEG 256 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHHHTT
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHHHcC
Confidence 999999976543321 123356788999999876 678999999999999999999 77777 444444444443332
Q ss_pred h-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 346 L-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 346 ~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
. .++.+.+++.+ |+..||..||++.+++++
T Consensus 257 ~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHHH
Confidence 1 13467777777 899999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=316.30 Aligned_cols=237 Identities=20% Similarity=0.322 Sum_probs=195.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
-.|.+.+.||+|+||.||+|.+..+++ .+|+|+++... .+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPP-EGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecC-CCCc
Confidence 357788999999999999999765544 79999987532 35688999999999 999999999999754 3445
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+++|||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCC
Confidence 89999999999987763 478899999999999999999999999999999999999766 8999999999765332
Q ss_pred C-----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------Chh
Q 015741 283 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (401)
Q Consensus 283 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (401)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||+...+..+....+..... ++.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHH
Confidence 1 2234467788999999876 67899999999999999999988888777666665555544332 446
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..||..||++.++++
T Consensus 257 l~~li~~-~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQ-CWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HccCChhhCcCHHHHHH
Confidence 7777887 89999999999998864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=329.11 Aligned_cols=236 Identities=18% Similarity=0.235 Sum_probs=193.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC--------CCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeE-----------
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK----------- 193 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~----------- 193 (401)
.++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|+++++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCcc
Confidence 4789999999999999999999977 4889999999754 5788999999999 8999887
Q ss_pred ----EeeEEEcCCCCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 194 ----LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 194 ----~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
+++++... ....++||||+ +++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 56666542 46789999999 89998775 358999999999999999999999999999999999999965
Q ss_pred C-CeEEEEecccceecCCCCc--------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC
Q 015741 265 Q-RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335 (401)
Q Consensus 265 ~-~~vkl~DFg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~ 335 (401)
+ ..+||+|||+++.+..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 4 2799999999976643221 133478999999999887 67999999999999999999999999655445
Q ss_pred HHHHHHHHHHh----------------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 336 YDQLVKIAKVL----------------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 336 ~~~l~~i~~~~----------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+....... -++.+.+++.+ |+..||..||++.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKV-VMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHH-HHhCChhhCCCHHHHHH
Confidence 55444433321 14677788887 89999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.40 Aligned_cols=235 Identities=18% Similarity=0.313 Sum_probs=186.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEE----EEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC----IIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++++.||+|+||.||+|.+..+++.+ |+|.+.. ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC---
Confidence 578999999999999999999998787654 6666642 3457799999999999 999999999999763
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 168 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC-----
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEcc
Confidence 378999999999987765 3588999999999999999999999999999999999999766 89999999998764
Q ss_pred CCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+.+.. .++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCCCCCCCccCCH
Confidence 3322 223355678999999986 689999999999999999999 888883 444333333333322 144
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+++.+ |+..||..||++.++++
T Consensus 247 ~l~~li~~-~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 247 DVYMIMRK-CWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 67777877 89999999999999885
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.69 Aligned_cols=244 Identities=19% Similarity=0.242 Sum_probs=194.7
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
...++|++.+.||+|+||.||+|.+ .+++.||||+++... ...+.+|+++++.+ +||||+++++++.+ ....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCC
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCce
Confidence 3468899999999999999999985 578999999987533 23689999999999 89999999999965 4567
Q ss_pred EEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCCeeEeCCCCeEEEEecccc
Q 015741 207 SLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~vkl~DFg~a 276 (401)
++||||+.+++|..++. .+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~ 181 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence 89999999999987763 288899999999999999999999 999999999999999766 8999999999
Q ss_pred eecCCCCc--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHhC---
Q 015741 277 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY----GHDNYDQLVKIAKVLG--- 347 (401)
Q Consensus 277 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~----~~~~~~~l~~i~~~~~--- 347 (401)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. ..........+.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 87653322 334568999999999876 5789999999999999999999999941 1111111111100000
Q ss_pred -----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 -----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+.+++.+ |+..||..||++.+++++-+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALL-CTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHH-HTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHH-HhCcCCccCCCHHHHHHHhcCcc
Confidence 1345666677 89999999999999998755433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=324.39 Aligned_cols=243 Identities=16% Similarity=0.247 Sum_probs=193.2
Q ss_pred CCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|. +..+++.||||++... ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--S 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC--C
Confidence 4789999999999999999998 5567889999998642 235688999999999 99999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLI 271 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~ 271 (401)
...++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 56789999999999987762 37888999999999999999999999999999999999843 2369999
Q ss_pred ecccceecCCCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-
Q 015741 272 DWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL- 346 (401)
Q Consensus 272 DFg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~- 346 (401)
|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.+..+....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCcCHHHHHHHHhcCCC
Confidence 999997553322 1234567888999999876 678999999999999999998 88887 4444444444433321
Q ss_pred ------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 347 ------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
-++.+.+++.+ |+..||..||++.+++++.|.-.
T Consensus 264 ~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQ-CWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHH-HhcCChhhCcCHHHHHHHHHHHh
Confidence 14567777877 89999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=313.73 Aligned_cols=237 Identities=19% Similarity=0.288 Sum_probs=187.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++.+ +|++++..+..+... ....+++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEEE
Confidence 57899999999999999999999999999999987543 345689999999999 666665555555332 467799999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE---eCCCCeEEEEecccceecCCCCc
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|+ +++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCccc
Confidence 99 88887664 368999999999999999999999999999999999999 5444 899999999987654322
Q ss_pred --------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHH---h-----
Q 015741 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV---L----- 346 (401)
Q Consensus 285 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~---~----- 346 (401)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+.+..+... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 234578999999999887 6799999999999999999999999954321 11222222111 1
Q ss_pred ---CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 ---GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ---~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-++.+.+++.+ |+..||+.||++.++++
T Consensus 243 ~~~~~~~l~~li~~-~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 243 CKGYPSEFATYLNF-CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTTSCHHHHHHHHH-HHTSCTTCCCCHHHHHH
T ss_pred hccCCHHHHHHHHH-HHhcCCCCCCCHHHHHH
Confidence 14577777877 89999999999988874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=321.78 Aligned_cols=239 Identities=21% Similarity=0.322 Sum_probs=189.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEeeEEEcCCC--CCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~hpniv~~~~~~~~~~~--~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+ +++.||||++.........+|.+++..+ .+||||+++++++.+... ..+++|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 36899999999999999999987 4899999999877777777777776654 389999999999876433 578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||+.+++|..++. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..+
T Consensus 114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKF 192 (337)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceee
Confidence 99999999988763 589999999999999999999999 999999999999999766 8999999999776
Q ss_pred CCCCcc-----cccccCCCccccccccCCCCCCcc------cchHHHHHHHHHHHcC----------CCCCCCC---CCC
Q 015741 280 HPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDLWSLGCMFAGMIFR----------KEPFFYG---HDN 335 (401)
Q Consensus 280 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DiwSlG~ll~elltg----------~~Pf~~~---~~~ 335 (401)
...... ....||+.|+|||++.+ ..+... +|||||||++|||++| ..||... ...
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 433221 24578999999999876 344443 8999999999999999 7777432 223
Q ss_pred HHHHHHHHHHhC--------------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 336 YDQLVKIAKVLG--------------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 336 ~~~l~~i~~~~~--------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+........ .+.+.+++.+ |+..||..||++.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE-CWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH-HSCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHH-hhhhChhhCCCHHHHHHH
Confidence 333333222111 1235667777 899999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=324.76 Aligned_cols=242 Identities=21% Similarity=0.338 Sum_probs=191.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCCc
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTP 206 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~~ 206 (401)
..++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCcee
Confidence 457899999999999999999999999999999998543 346688999999999 999999999998632 23477
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
++||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~ 184 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence 8999999999987655 3489999999999999999999999999999999999998766 8999999998765
Q ss_pred CCCCc----------ccccccCCCccccccccCCC--CCCcccchHHHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHH
Q 015741 280 HPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFY---GHDNYDQLVKIAK 344 (401)
Q Consensus 280 ~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~ll~elltg~~Pf~~---~~~~~~~l~~i~~ 344 (401)
..... .....|++.|+|||++.+.. .++.++|||||||++|+|++|+.||.. .............
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 32111 12345789999999986522 368899999999999999999999832 1111111111000
Q ss_pred H-----hCChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 345 V-----LGTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 345 ~-----~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
. ..++.+.+++.+ |+..||..||++.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNS-MMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHH-HhhcChhhCCCHHHHHHH
Confidence 0 114567788888 899999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=314.96 Aligned_cols=235 Identities=17% Similarity=0.287 Sum_probs=191.0
Q ss_pred CCCeEEEe-eecccCCeeEEEEEE--cCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVR-KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~-~Lg~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+++++.+ +||||+++++++. ..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE---AE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE---SS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEC---CC
Confidence 57899988 999999999999954 4567899999986432 46789999999999 9999999999984 35
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
..++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeecc
Confidence 678999999999998775 3589999999999999999999999999999999999999776 899999999987754
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~ 349 (401)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. +.+..+....+.... -++
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 4322 22345678999999876 578899999999999999999 998984 334433333333221 145
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..||..||++.++++
T Consensus 248 ~l~~li~~-~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNL-CWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 67787877 89999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=320.37 Aligned_cols=237 Identities=16% Similarity=0.279 Sum_probs=188.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--YK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--CC
Confidence 578999999999999999999886543 46999998743 234688999999999 99999999999965 56
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 198 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhc
Confidence 789999999999998775 3589999999999999999999999999999999999999766 89999999998764
Q ss_pred CCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 015741 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (401)
Q Consensus 281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~ 348 (401)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+.+..+.+... +
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHCCCcCCCcccCC
Confidence 3321 122345678999999876 678999999999999999999 999984 3444444444443321 3
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+.+++.+ |+..||..||++.+++++
T Consensus 277 ~~l~~li~~-~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQ-CWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHH-HTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 467777777 899999999999988754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.80 Aligned_cols=233 Identities=16% Similarity=0.310 Sum_probs=185.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+. ....++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEEe
Confidence 47899999999999999999987 5899999999754 456789999999999 899999999987643 346799999
Q ss_pred ecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
|+.+++|..++.. +++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++...... ..
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccccccc--cc
Confidence 9999999877642 78889999999999999999999999999999999999766 8999999999765432 23
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhc
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (401)
...++..|+|||++.+ ..++.++||||||+++|+|++ |..||. .....+....+.+.. .++.+.+++.+
T Consensus 173 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 249 (278)
T 1byg_A 173 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN- 249 (278)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH-
T ss_pred CCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH-
Confidence 3467788999999876 678999999999999999998 888884 333333333333221 14567777877
Q ss_pred CCCCChhhHHHhhhhcC
Q 015741 359 HIELDPHLAALVGRHSR 375 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~ 375 (401)
|+..||..||++.++++
T Consensus 250 ~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhcCChhhCCCHHHHHH
Confidence 89999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=319.03 Aligned_cols=240 Identities=18% Similarity=0.250 Sum_probs=194.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHh-cCCCCeeEEeeEEEcCCC--CCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~hpniv~~~~~~~~~~~--~~~~lv 209 (401)
.++|++.+.||+|+||.||+|.+ +++.||||+++......+.+|.++++.+ .+||||+++++++.+... ...++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 36799999999999999999987 5899999999887778889999999883 289999999999976432 378999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||+.+++|..++. .+++.+++.++.|++.||.||| ++||+||||||+|||++.++ .+||+|||++...
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 197 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEE
T ss_pred EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceec
Confidence 99999999988763 5899999999999999999999 89999999999999999776 8999999999876
Q ss_pred CCCCc-----ccccccCCCccccccccCCC-----CCCcccchHHHHHHHHHHHcC----------CCCCCCCCC---CH
Q 015741 280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFR----------KEPFFYGHD---NY 336 (401)
Q Consensus 280 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~ll~elltg----------~~Pf~~~~~---~~ 336 (401)
..... .....|++.|+|||++.+.. .++.++|||||||++|+|++| ..||..... ..
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 54432 24457899999999987632 223689999999999999999 788854322 23
Q ss_pred HHHHHHHHHh--C--C----------hhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 337 DQLVKIAKVL--G--T----------DELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 337 ~~l~~i~~~~--~--~----------~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+....... . . +.+.+++.+ |+..||..||++.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-CWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHH-HCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHH-HhccChhhCCCHHHHHHH
Confidence 3333222110 0 0 145566666 899999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=317.95 Aligned_cols=238 Identities=20% Similarity=0.329 Sum_probs=192.2
Q ss_pred CCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
+.|++++.||+|+||.||++.. ..+++.||||+++... .+.+.+|+++++++ +||||+++++++.+.....
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence 3359999999999999988754 3578999999997532 45689999999999 8999999999998866678
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccc
Confidence 899999999999988874 489999999999999999999999999999999999999766 89999999998875443
Q ss_pred c----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCC----------HHHHHHHHHHh---
Q 015741 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN----------YDQLVKIAKVL--- 346 (401)
Q Consensus 284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~----------~~~l~~i~~~~--- 346 (401)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ......+.+..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred cccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 2 233457778999999876 67889999999999999999999998432111 01111111111
Q ss_pred --------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 --------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 --------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.++.+.+++.+ |+..||..||++.++++
T Consensus 268 ~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKN-CWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cCCCCCccccHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 13567788887 89999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.65 Aligned_cols=238 Identities=18% Similarity=0.304 Sum_probs=183.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..|++.+.||+|+||.||+|.+..++ ..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+. ....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCCe
Confidence 46889999999999999999875433 46899998642 346789999999999 999999999987543 3567
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
++||||+.+++|..++. .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence 89999999999988763 478889999999999999999999999999999999999766 8999999999865432
Q ss_pred Cc-----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChh
Q 015741 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDE 350 (401)
Q Consensus 283 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~ 350 (401)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+.+.. .++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 21 123456678999999876 6899999999999999999995555545555544444443321 1456
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+++.+ |+..||..||++.+++++
T Consensus 325 l~~li~~-cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLK-CWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 7777877 899999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=340.68 Aligned_cols=235 Identities=17% Similarity=0.308 Sum_probs=195.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
..++|++.+.||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+++|+++ +||||+++++++.+ ..+++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEe
Confidence 3578999999999999999999985 4578999999753 457899999999999 99999999999854 467899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
|||+.+++|.+++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY 418 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCce
Confidence 99999999988774 388999999999999999999999999999999999998666 899999999976542211
Q ss_pred --ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+.+... .+.+.++
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 122345667999999876 679999999999999999999 88887 45555555555544322 3467788
Q ss_pred HHhcCCCCChhhHHHhhhhcC
Q 015741 355 LNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+ |+..||+.||+++++++
T Consensus 497 i~~-cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 497 MCQ-CWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HcCCChhHCcCHHHHHH
Confidence 877 89999999999998864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.84 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=198.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEc----CCCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD----QQSKT 205 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~----~~~~~ 205 (401)
++|++.+.||+|+||.||+|.+..+|+.||||+++.. ..+.+.+|+++++++ +||||+++++++.+ .....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCe
Confidence 6799999999999999999999899999999998643 245688999999999 99999999998754 12456
Q ss_pred cEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC--eEEEEecccce
Q 015741 206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 277 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~vkl~DFg~a~ 277 (401)
.++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+||+++.++. .+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 789999999999987763 4888999999999999999999999999999999999986542 48999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH-----HHHH-------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-----IAKV------- 345 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~-----i~~~------- 345 (401)
............|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+.. ....
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------CCSCCCC
T ss_pred ccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchhhhhhhhh
Confidence 8766665666789999999999876 689999999999999999999999995432111 0000 0000
Q ss_pred ---------h---------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 346 ---------L---------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 346 ---------~---------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
. -++.+.+++.+ |+..||..||++.++++|||++.+.
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~-mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQC-MLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHH-HSCSSCC---CCTTCCCCTTHHHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHH-HccCCHhhCcCHHHHhcCHHHHHHH
Confidence 0 01356777777 8999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=333.72 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=191.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+++++.|.++++++.+..++.+ ....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence 47899999999999999999999999999999998643 345689999999999555677676666544 567789999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe--CCCCeEEEEecccceecCCCCc-
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~--~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
|+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||+++.+.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99 88887665 3689999999999999999999999999999999999994 2334899999999987754332
Q ss_pred -------ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHH----------
Q 015741 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV---------- 345 (401)
Q Consensus 285 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~---------- 345 (401)
.....||..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..+.+..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred cccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 125678999999999887 6799999999999999999999999954332 22222222221
Q ss_pred -hCChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 346 -LGTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 346 -~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
...+++.+++.+ |+..||+.||++.++++
T Consensus 242 ~~~p~~l~~li~~-cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 242 RGYPTEFASYFHY-CRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp TTSCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred cCCcHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 114567777777 79999999998877653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.69 Aligned_cols=239 Identities=18% Similarity=0.334 Sum_probs=191.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~----~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++++.||+|+||.||+|+. ..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence 47899999999999999999984 5689999999987543 35688999999999 9999999999987665567
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+++||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccc
Confidence 89999999999998775 2488999999999999999999999999999999999999766 899999999987754
Q ss_pred CCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC----------CC-HHHHHHHHHHh
Q 015741 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----------DN-YDQLVKIAKVL 346 (401)
Q Consensus 282 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~----------~~-~~~l~~i~~~~ 346 (401)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... .. ......+.+..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 4321 23456677999999876 578899999999999999999998874211 00 11111111111
Q ss_pred -----------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 -----------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 -----------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-++.+.+++.+ |+..||..||++.++++
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTE-CWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 13567777777 89999999999998863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=339.36 Aligned_cols=235 Identities=17% Similarity=0.294 Sum_probs=191.7
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEc--CCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~-~Lg~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..+++.+.+ .||+|+||.||+|.+. .++..||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence 346677766 8999999999999875 35678999999753 457799999999999 99999999999965 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
.+++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 5899999999999987763 488999999999999999999999999999999999999766 89999999998664
Q ss_pred CCCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh-------CC
Q 015741 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GT 348 (401)
Q Consensus 281 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------~~ 348 (401)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+.+..+.+.. .+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 33221 12234578999999876 689999999999999999998 99998 4556666666555432 14
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
+.+.+++.+ |+..||..||++.+++
T Consensus 566 ~~l~~li~~-cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 566 PELYALMSD-CWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHHHHHH-TTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHH-HcCCChhHCcCHHHHH
Confidence 577777777 8999999999988874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.03 Aligned_cols=235 Identities=18% Similarity=0.291 Sum_probs=184.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-CC--eEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-~~--~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC--
Confidence 5789999999999999999998643 33 36899998642 246788999999999 999999999999753
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
..++||||+.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL 171 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccc
Confidence 378999999999987765 3489999999999999999999999999999999999998766 8999999999877
Q ss_pred CCCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHh--------
Q 015741 280 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------- 346 (401)
Q Consensus 280 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~-------- 346 (401)
..... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+.+..+.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHHccCCCCCCCcC
Confidence 54332 123456778999999876 678899999999999999999 998884 444444444443321
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-++.+.+++.+ |+..||..||++.++++
T Consensus 250 ~~~~l~~li~~-~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQ-CWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHH-HccCCcccCcCHHHHHH
Confidence 13567788887 89999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=314.22 Aligned_cols=225 Identities=24% Similarity=0.418 Sum_probs=182.4
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEc--CCCCCcEEE
Q 015741 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~-~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~--~~~~~~~lv 209 (401)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++.++.+||||+++++++.+ .....+++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3678887 789999999999999999999999999964 45678999998666699999999999865 234568999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~~~~ 282 (401)
|||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.+ ...+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999999977652 48999999999999999999999999999999999999863 3489999999987542
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH--------------HHHhCC
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI--------------AKVLGT 348 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i--------------~~~~~~ 348 (401)
+ ..++.++|||||||++|+|++|..||..... .+....+ ....-+
T Consensus 172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCCchhcccCC
Confidence 1 3567799999999999999999999943221 1110000 001125
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
+.+.+++.+ |+..||..||++.++++|||++...
T Consensus 231 ~~~~~li~~-~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 231 EEVKMLIRN-LLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHHHH-HcccChhhCCCHHHHhcChhhcccc
Confidence 567788888 8999999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.43 Aligned_cols=233 Identities=17% Similarity=0.278 Sum_probs=187.8
Q ss_pred CeEE-EeeecccCCeeEEEEEE--cCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEV-VRKVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i-~~~Lg~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.+.+ .+.||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+++|+++ +|||||++++++.+ ...
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SSE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CCE
Confidence 3444 35899999999999965 3567899999997532 46799999999999 89999999999964 347
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence 8999999999998776 3589999999999999999999999999999999999999776 89999999998765433
Q ss_pred c----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 284 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
. .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+... ++++
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~l 601 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCPREM 601 (635)
T ss_dssp -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2 223345678999999976 689999999999999999998 99998 44455454444444321 3467
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+++.+ |+..||+.||++.++++
T Consensus 602 ~~li~~-cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 602 YDLMNL-CWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHH-HcCCCHhHCcCHHHHHH
Confidence 777877 89999999999998863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.54 Aligned_cols=230 Identities=18% Similarity=0.270 Sum_probs=184.7
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
|...+.||+|+||.||+|.+ +++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 107 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCL 107 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEE
Confidence 44458899999999999985 6889999998642 246789999999999 99999999999965 457899
Q ss_pred EEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC
Q 015741 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~ 282 (401)
+|||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKF 186 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSC
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccc
Confidence 999999999977653 488999999999999999999999999999999999999766 8999999999876433
Q ss_pred Cc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-----------HhC-
Q 015741 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-----------VLG- 347 (401)
Q Consensus 283 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~-----------~~~- 347 (401)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...... +.+..+.+ ...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCS
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhhccc
Confidence 22 233578999999999865 5889999999999999999999998543221 11111111 110
Q ss_pred ---------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 ---------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 ---------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+.+++.+ |+..||..||++.++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQ-CLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 1235566666 89999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.18 Aligned_cols=234 Identities=18% Similarity=0.182 Sum_probs=182.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhc--------CCCCeeE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNIVK 193 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~--------~hpniv~ 193 (401)
.++|++.+.||+|+||+||+|++ +|+.||||+++... .+.+.+|+.+++.+. +||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36788999999999999999997 78999999986432 277899999999985 4888888
Q ss_pred EeeEEEcC----------------------------CCCCcEEEEeecCCCch-hhhc-CCCCHHHHHHHHHHHHHHHHH
Q 015741 194 LLDIVRDQ----------------------------QSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDY 243 (401)
Q Consensus 194 ~~~~~~~~----------------------------~~~~~~lv~e~~~~~~l-~~~~-~~~~~~~~~~i~~qi~~~L~~ 243 (401)
+.+++... ....+++||||+.+|++ ..+. ..+++..++.++.||+.||+|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 88765311 15678999999999864 4443 357999999999999999999
Q ss_pred HH-hCCceeecCCCCCeeEeCCC-------------------CeEEEEecccceecCCCCcccccccCCCccccccccCC
Q 015741 244 CH-SQGIMHRDVKPHNVMIDHEQ-------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303 (401)
Q Consensus 244 LH-~~~ivHrDlkp~NIll~~~~-------------------~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 303 (401)
|| ++||+||||||+|||++.++ ..+||+|||+|+..... ..+||+.|+|||++.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC
Confidence 99 99999999999999998664 27999999999876532 35899999999999863
Q ss_pred CCCCcccchHHHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHh-------------CChhHHHHHHhcCCCCChhhHHH
Q 015741 304 QDYDYSLDLWSLGCM-FAGMIFRKEPFFYGHDNYDQLVKIAKVL-------------GTDELNAYLNKYHIELDPHLAAL 369 (401)
Q Consensus 304 ~~~~~~~DiwSlG~l-l~elltg~~Pf~~~~~~~~~l~~i~~~~-------------~~~~~~~~l~~~~l~~dP~~R~~ 369 (401)
. +.++||||||++ .++++.|..||............+.+.. -++++.+++.+ ||+.| +
T Consensus 253 -~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~d-----s 324 (336)
T 2vuw_A 253 -G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT-MLNFS-----S 324 (336)
T ss_dssp -S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH-GGGSS-----S
T ss_pred -C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHH-HhccC-----C
Confidence 3 889999998777 7778889988821000000111221110 13467778888 78877 8
Q ss_pred hhhhc-CCCccc
Q 015741 370 VGRHS-RKPWSK 380 (401)
Q Consensus 370 ~~~~l-~~~~~~ 380 (401)
+.++| +|||++
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 99999 999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=330.03 Aligned_cols=244 Identities=14% Similarity=0.160 Sum_probs=181.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCC-CCe---------e---
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNI---------V--- 192 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h-pni---------v--- 192 (401)
....|.+.+.||+|+||.||+|.+..+|+.||||+++.. ..+.+.+|+.+++.+ .| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccch
Confidence 345689999999999999999999999999999998722 246789999999988 54 321 1
Q ss_pred ---------EEeeEEEcCC---CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015741 193 ---------KLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIM 250 (401)
Q Consensus 193 ---------~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iv 250 (401)
.+..++.... ....+++|+++ +++|..++. .+++..+..++.||+.||+|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111111 23345566554 567766552 256677888889999999999999999
Q ss_pred eecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCcccccccc---------CCCCCCcccchHHHHHHHHH
Q 015741 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDLWSLGCMFAG 321 (401)
Q Consensus 251 HrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwSlG~ll~e 321 (401)
||||||+|||++.++ .+||+|||+++.... .....+| +.|+|||++. ....++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTC-CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCC-eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999777 799999999986532 2445577 9999999983 33568889999999999999
Q ss_pred HHcCCCCCCCCCCCHHHHHHHHHH--hCChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 322 MIFRKEPFFYGHDNYDQLVKIAKV--LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 322 lltg~~Pf~~~~~~~~~l~~i~~~--~~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
|++|+.||... ...+....+... .-++.+.+++.+ |+..||..|+++.++++|||++.+.
T Consensus 310 lltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 310 IWCADLPNTDD-AALGGSEWIFRSCKNIPQPVRALLEG-FLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHSSCCCCTT-GGGSCSGGGGSSCCCCCHHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHCCCCCCCc-chhhhHHHHHhhcccCCHHHHHHHHH-HccCChhhCcCHHHHHhCHHHHHHH
Confidence 99999999532 221111111110 124677888888 8999999999999999999998753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=332.97 Aligned_cols=236 Identities=22% Similarity=0.396 Sum_probs=192.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..++|++.+.||+|+||.||+|.+..+ +..||+|+++... .+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence 357899999999999999999998643 4679999986432 36688999999999 99999999999843 4
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++||||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecC
Confidence 5789999999999987763 488999999999999999999999999999999999999776 89999999998764
Q ss_pred CCCcc--cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Chh
Q 015741 281 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (401)
Q Consensus 281 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (401)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+..... ++.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 43322 23456678999999876 689999999999999999997 88887 45555555555554321 357
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+++.+ |+..||..||++.++++
T Consensus 621 l~~li~~-~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTK-CWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhHCcCHHHHHH
Confidence 7788887 89999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.82 Aligned_cols=233 Identities=18% Similarity=0.299 Sum_probs=187.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||.||+|.+.. .+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 105 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS--PPHLA 105 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC--SSCEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCceE
Confidence 5789999999999999999998743 4899998642 235678899999999 99999999999976 45689
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC--
Q 015741 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281 (401)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-- 281 (401)
++|||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcccccccc
Confidence 9999999999988874 488999999999999999999999999999999999998 44 799999999865431
Q ss_pred ----CCcccccccCCCccccccccC--------CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---
Q 015741 282 ----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--- 346 (401)
Q Consensus 282 ----~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--- 346 (401)
........|+..|+|||++.+ ...++.++|||||||++|+|++|..||. .....+....+....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS-SCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhccCCCCC
Confidence 122334568889999999864 2357889999999999999999999984 333333333333221
Q ss_pred -----CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 347 -----GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 347 -----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
-++.+.+++.+ |+..||..||++.++++
T Consensus 263 ~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 LSQIGMGKEISDILLF-CWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCSSCCTTHHHHHHH-HHCSSTTTSCCHHHHHH
T ss_pred CCcCCCCHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 13467788888 89999999999998874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.34 Aligned_cols=239 Identities=20% Similarity=0.275 Sum_probs=192.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC---
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--- 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~--- 204 (401)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ...+.+|+++++++ +||||+++++++.+....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 78999999986432 34678999999999 899999999999764321
Q ss_pred CcEEEEeecCCCchhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 205 TPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
..|+||||+.+++|..... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence 2689999999999977654 68999999999999999999999999999999999999864 7999999999876533
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhCChhHHHHHHhcCCCCC
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (401)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...........+.+.+++.+ |+..|
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~-~l~~d 308 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-LPEDDPVLKTYDSYGRLLRR-AIDPD 308 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS-CCTTCHHHHHCHHHHHHHHH-HTCSS
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccccc-ccccccccccCHHHHHHHhh-hccCC
Confidence 45679999999999875 45889999999999999999988874211000 00000001124567778888 89999
Q ss_pred hhhHHHhhhhcCCCcccc
Q 015741 364 PHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 364 P~~R~~~~~~l~~~~~~~ 381 (401)
|..|++..+.+.|+|...
T Consensus 309 P~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 309 PRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp GGGSCSSHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999999888888888765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=294.59 Aligned_cols=209 Identities=13% Similarity=0.129 Sum_probs=171.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
.++|++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+.++.++ +||||+++++++.+ ....
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 106 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAGG 106 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCcE
Confidence 368999999999999999999999899999999997532 26789999999999 99999999999976 4678
Q ss_pred EEEEeecCCCchhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc
Q 015741 207 SLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
|+||||+.+++|..+++. ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~----------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA----------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC-----------
T ss_pred EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc-----------
Confidence 999999999999887753 56677889999999999999999999999999999999776 78888543
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHH-------H----HHHH--HhCChhHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-------V----KIAK--VLGTDELN 352 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l-------~----~i~~--~~~~~~~~ 352 (401)
|++ .++.++|||||||++|+|++|+.||..... .+.+ . .... ..-++.+.
T Consensus 175 --------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 --------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGV-RSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp --------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB-CCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred --------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc-chhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 222 367899999999999999999999954322 1100 0 0001 11245678
Q ss_pred HHHHhcCCCCChhhHHHhhhhcC
Q 015741 353 AYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+++.+ |+..||..| ++.++++
T Consensus 238 ~li~~-~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAAR-SVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHH-HHCTTSSCC-CHHHHHH
T ss_pred HHHHH-HcccCCccC-CHHHHHH
Confidence 88888 799999999 9998875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-34 Score=290.08 Aligned_cols=184 Identities=20% Similarity=0.151 Sum_probs=129.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
..++.|++|.+..++..-.|+.|++|++... +.+++.+|+++|+++..|+||+++++++++ ...+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 4567788888887777778999999998532 235689999999999889999999999976 5678
Q ss_pred EEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-Ccc
Q 015741 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~~~ 285 (401)
||||||++|++|.+.+..........|+.||+.||+|+|++|||||||||+|||++.++ .+||+|||+|+..... ...
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CCS
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCccc
Confidence 99999999999998875422223346899999999999999999999999999999777 8999999999876543 334
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCC
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~P 328 (401)
...+||+.|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus 397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 56789999999999875 567789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=250.97 Aligned_cols=180 Identities=17% Similarity=0.213 Sum_probs=139.9
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
...+.||+|+||.||+|. ..++.+++|...... .+++.+|+++++++ +||||+++..++.+ ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVD--LDN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEE--TTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEe--CCc
Confidence 345789999999999994 467888998864321 24579999999999 99999944444433 345
Q ss_pred cEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
.++||||+++++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 6899999999999988866 6789999999999999999999999999999985 799999999998754322
Q ss_pred -------ccccccCCCccccccccC-CCCCCcccchHHHHHHHHHHHcCCCCC
Q 015741 285 -------YNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 285 -------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~ll~elltg~~Pf 329 (401)
.....||++|+|||++.+ ...|+..+|+|+..+-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135689999999999864 135777899999999888888877776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=208.99 Aligned_cols=143 Identities=18% Similarity=0.237 Sum_probs=117.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------------------chHHHHHHHHHHHHhcCCCCe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNI 191 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~il~~l~~hpni 191 (401)
...|.+.+.||+|+||.||+|.+ .+|+.||+|+++.. ....+.+|+.+++++ + |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence 45577779999999999999999 88999999998632 234688999999999 4 4
Q ss_pred eEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEE
Q 015741 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (401)
Q Consensus 192 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~ 271 (401)
+++.+++.. ...++||||+++++|.. +. ..+...++.|++.||.|||++||+||||||+|||++ ++ .+||+
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~ 234 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWII 234 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEEC
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEE
Confidence 566665543 35689999999999987 32 234567999999999999999999999999999999 65 89999
Q ss_pred ecccceecCCCCcccccccCCCcccccccc
Q 015741 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (401)
Q Consensus 272 DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 301 (401)
|||+++.. ..++|||.+.
T Consensus 235 DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET------------TSTTHHHHHH
T ss_pred ECCCCeEC------------CCCCHHHHHH
Confidence 99999743 2367888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=186.12 Aligned_cols=135 Identities=18% Similarity=0.199 Sum_probs=108.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeE--EEEEEecccc---------------------------hHHHHHHHHHHHHh
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPVK---------------------------KKKIKREIKILQNL 185 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~il~~l 185 (401)
-|++.+.||+|+||.||+|.+..+|+. ||||+++... ...+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 9999975321 12578999999999
Q ss_pred cCCCC--eeEEeeEEEcCCCCCcEEEEeecCC-C----chhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCC
Q 015741 186 CGGPN--IVKLLDIVRDQQSKTPSLIFEHVNN-T----DFKVLYPTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPH 257 (401)
Q Consensus 186 ~~hpn--iv~~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~ 257 (401)
.|++ ++.+++. ...++||||+.+ | .|.......++.++..++.|++.+|.||| ++||+||||||+
T Consensus 128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 6664 3444442 245899999953 3 56555444445678899999999999999 999999999999
Q ss_pred CeeEeCCCCeEEEEecccceec
Q 015741 258 NVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 258 NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999985 6999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=166.98 Aligned_cols=135 Identities=15% Similarity=0.224 Sum_probs=101.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------hH--------HHHHHHHHHHHhcCCC
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KK--------KIKREIKILQNLCGGP 189 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~--------~~~~E~~il~~l~~hp 189 (401)
-|++.+.||+|++|.||+|.+ .+|+.||||+++... .. ...+|...|.++ .+.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hhc
Confidence 489999999999999999997 579999999975310 00 123567777777 333
Q ss_pred Ce--eEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC-
Q 015741 190 NI--VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR- 266 (401)
Q Consensus 190 ni--v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~- 266 (401)
++ ...++. ...++||||++|..+..+.. ..++..++.||+.+|.+||++|||||||||.|||++.++.
T Consensus 174 gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 174 GFPVPEPIAQ------SRHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp TCSCCCEEEE------ETTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCCeeeec------cCceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 33 223322 12379999999998876542 2345678899999999999999999999999999986541
Q ss_pred --------eEEEEecccceecC
Q 015741 267 --------KLRLIDWGLAEFYH 280 (401)
Q Consensus 267 --------~vkl~DFg~a~~~~ 280 (401)
.+.|+||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-13 Score=126.08 Aligned_cols=138 Identities=18% Similarity=0.240 Sum_probs=111.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+.|++...++.|+.+.||++.. .++.+++|+... .....+.+|+.+++.+..+..+++++++..+ ....|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 4688889999999999999874 468999999864 3456799999999999667788899998865 45678999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015741 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (401)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 246 (401)
||++|.++...... ......++.++..+|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999998776422 22345778899999999998
Q ss_pred ---------------CCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 247 ---------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 247 ---------------~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
..++|+|++|.||+++. +..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhccc
Confidence 44899999999999985 43567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=118.78 Aligned_cols=136 Identities=17% Similarity=0.159 Sum_probs=101.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCC-eeEEeeEEEcCCCCCcEEEEee
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpn-iv~~~~~~~~~~~~~~~lv~e~ 212 (401)
..|.+....+.|..+.||++.. .+|+.+++|+........+.+|+.+++.+..+.- +++++++..+ ....++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEe
Confidence 3455544445666799999864 5678899999876555678999999999955522 6678887765 3457899999
Q ss_pred cCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 015741 213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-------------------------------------------- 248 (401)
Q Consensus 213 ~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------------- 248 (401)
++|..+. ..... ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 97 VPGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp CSSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cCCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 9999885 22222 2356778888888888743
Q ss_pred --------------ceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 249 --------------IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 249 --------------ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
++|+|++|.||+++.++ .+.|+|||.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998543 567999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.7e-11 Score=117.32 Aligned_cols=140 Identities=19% Similarity=0.333 Sum_probs=107.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEec--cc----chHHHHHHHHHHHHhcC-CCCeeEEeeEEEcCCC-CCcEEE
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PV----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS-KTPSLI 209 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~--~~----~~~~~~~E~~il~~l~~-hpniv~~~~~~~~~~~-~~~~lv 209 (401)
.++.|+.|.++.||++.. .+..+++|+.. .. ....+.+|..+++.|.. +..+++++.++.+... ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 357889999999999875 35688899875 32 23578899999999943 3468888888765321 457899
Q ss_pred EeecCCCchh-hhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 015741 210 FEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------ 246 (401)
Q Consensus 210 ~e~~~~~~l~-~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------ 246 (401)
|||++|..+. .....+++.+...++.+++..|..||+
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9999998874 344567888888999999999999997
Q ss_pred ----------------CCceeecCCCCCeeEeCCCC-eEEEEecccceec
Q 015741 247 ----------------QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY 279 (401)
Q Consensus 247 ----------------~~ivHrDlkp~NIll~~~~~-~vkl~DFg~a~~~ 279 (401)
..++|+|+++.|||++.++. .+.|+||+.+..-
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999986653 4689999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.3e-11 Score=113.70 Aligned_cols=185 Identities=17% Similarity=0.242 Sum_probs=122.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCC--eeEEeeEEEcCC-CCCcEEEEeecCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQ-SKTPSLIFEHVNN 215 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpn--iv~~~~~~~~~~-~~~~~lv~e~~~~ 215 (401)
+.++.|....||++. ..+++|+.... ....+.+|..+|+.+..+.. +++++....+.. ....|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999852 46889986543 34678999999999844432 445544432221 1245789999999
Q ss_pred Cchhh-hcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 015741 216 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------------ 246 (401)
Q Consensus 216 ~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------------ 246 (401)
..+.. ....++..+...++.|++..|..||+
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 98864 34567788888888899988888886
Q ss_pred ----------CCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCcccccccCCCccccccc----cCCCC------
Q 015741 247 ----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQD------ 305 (401)
Q Consensus 247 ----------~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~------ 305 (401)
..++|+|++|.||+++.+ +..+.|+||+.+....+............-..|+.. ..++.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 137999999999999964 446789999998765432211111100000122211 10000
Q ss_pred ---CCcccchHHHHHHHHHHHcCCCCC
Q 015741 306 ---YDYSLDLWSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 306 ---~~~~~DiwSlG~ll~elltg~~Pf 329 (401)
...-.+.|++|.++|.+.+|..+|
T Consensus 261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 261 LEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=5.6e-08 Score=90.71 Aligned_cols=135 Identities=18% Similarity=0.254 Sum_probs=96.5
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCC-C-CeeEEeeEEEcCCCCCcEEEEeecCCC
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-p-niv~~~~~~~~~~~~~~~lv~e~~~~~ 216 (401)
+.++.|....||+. +..+++|+-... ....+.+|..+|+.|..+ + .+++.+.+... .....+++||+++|.
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCCe
Confidence 55788988999987 567888885432 346789999999999543 2 35666666643 245668999999998
Q ss_pred chhh-hcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 015741 217 DFKV-LYPTLSDYDVRYYIYELLKALDYCHSQ------------------------------------------------ 247 (401)
Q Consensus 217 ~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------------------ 247 (401)
.+.. ....++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 8765 234455556666666666666666642
Q ss_pred ------------CceeecCCCCCeeEeC---CCCeEEEEecccceecC
Q 015741 248 ------------GIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 248 ------------~ivHrDlkp~NIll~~---~~~~vkl~DFg~a~~~~ 280 (401)
.++|+|++|.||+++. ++..+.|+||+.+..-.
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999986 34345899999987644
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.2e-07 Score=86.56 Aligned_cols=134 Identities=14% Similarity=0.112 Sum_probs=95.7
Q ss_pred eecccCCe-eEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchh
Q 015741 141 KVGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (401)
Q Consensus 141 ~Lg~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (401)
.+..|..| .||+.....++..+++|+-.......+.+|..+|+.|..+--+.+++.++.+. ...++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence 34445544 69988776778889999987766778999999999996555577888888764 4678999999998776
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------------
Q 015741 220 VLYPTLSDYDVRYYIYELLKALDYCHSQ---------------------------------------------------- 247 (401)
Q Consensus 220 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------------------------------------------------- 247 (401)
...... ......+..++...|.-||..
T Consensus 109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 543221 122234445555555555521
Q ss_pred ------CceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 248 ------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 248 ------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
.++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred cccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 268999999999998543 567999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3.1e-07 Score=87.35 Aligned_cols=83 Identities=12% Similarity=0.104 Sum_probs=59.0
Q ss_pred EEEeee-cccCCeeEEEEEEc--C----CCeEEEEEEecccc------hHHHHHHHHHHHHhcCC--CCeeEEeeEEEcC
Q 015741 137 EVVRKV-GRGKYSEVFEGVHC--T----DNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRDQ 201 (401)
Q Consensus 137 ~i~~~L-g~G~fg~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h--pniv~~~~~~~~~ 201 (401)
...+.| +.|....+|+.... . +++.+++|+..... ...+.+|+.+++.|..+ -.+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88989999988652 1 26789999875432 25688999999998554 3577888876543
Q ss_pred C-CCCcEEEEeecCCCchh
Q 015741 202 Q-SKTPSLIFEHVNNTDFK 219 (401)
Q Consensus 202 ~-~~~~~lv~e~~~~~~l~ 219 (401)
. ....++||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 2 13468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.4e-06 Score=84.05 Aligned_cols=74 Identities=16% Similarity=0.225 Sum_probs=50.5
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc----------chHHHHHHHHHHHHhcCC-C-CeeEEeeEEEcCCCCCc
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~il~~l~~h-p-niv~~~~~~~~~~~~~~ 206 (401)
.+.||.|..+.||++....+++.++||...+. ..+++..|.++++.+..+ + .+++++.+. ....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCcc
Confidence 57899999999999976556788999986432 234578899999988443 3 345666542 2345
Q ss_pred EEEEeecCCC
Q 015741 207 SLIFEHVNNT 216 (401)
Q Consensus 207 ~lv~e~~~~~ 216 (401)
++|||++.+.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.4e-05 Score=74.96 Aligned_cols=134 Identities=15% Similarity=0.197 Sum_probs=78.9
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCC-CCeeEEeeE------EEcCCCCCcEEEEe
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI------VRDQQSKTPSLIFE 211 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-pniv~~~~~------~~~~~~~~~~lv~e 211 (401)
++.|+.|..+.||++.. ++..+++|+... ....+..|..+++.|..+ -.+++++.. ..+ ....+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTEEEEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCEEEEEEE
Confidence 35567778899999875 344589999875 345566677777776322 134444431 111 345689999
Q ss_pred ecCCCchh---------------hhc---CCC--C-----------HHH-------------------------------
Q 015741 212 HVNNTDFK---------------VLY---PTL--S-----------DYD------------------------------- 229 (401)
Q Consensus 212 ~~~~~~l~---------------~~~---~~~--~-----------~~~------------------------------- 229 (401)
|++|..+. .+. ..+ + +..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986431 110 111 1 000
Q ss_pred HHHHHHHHHHHHHHHH-------------hCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 230 VRYYIYELLKALDYCH-------------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 230 ~~~i~~qi~~~L~~LH-------------~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
+..+..++..++++|+ ...++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 0111122334566665 25799999999999997555 789999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.02 E-value=4.3e-05 Score=71.15 Aligned_cols=77 Identities=17% Similarity=0.180 Sum_probs=61.0
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCCCCcEEEEeecCC
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~~~~~lv~e~~~~ 215 (401)
-.+.|+.|....+|+... ++..+++|+........+..|...|+.|..+ ..+++++.+..+ ....++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEeccC
Confidence 357789999999999874 5778899998766667899999999998543 568888887754 3467899999998
Q ss_pred Cch
Q 015741 216 TDF 218 (401)
Q Consensus 216 ~~l 218 (401)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.3e-05 Score=69.52 Aligned_cols=70 Identities=10% Similarity=0.026 Sum_probs=46.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeec-CC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV-NN 215 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~-~~ 215 (401)
++.|+.|....+|++ +.+++|+...... ....+|..+++.+..+.-.++++.+. . ..-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~--~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--P--ATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--T--TTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--C--CCCEEEEeecCCC
Confidence 577889999999998 5688898754321 12467888888875443335666543 2 1235899999 66
Q ss_pred Cch
Q 015741 216 TDF 218 (401)
Q Consensus 216 ~~l 218 (401)
..+
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.81 E-value=8.1e-05 Score=72.55 Aligned_cols=74 Identities=14% Similarity=0.145 Sum_probs=53.5
Q ss_pred EeeecccCCeeEEEEEEcC-------CCeEEEEEEecccch-HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++.|+.|....||++.... +++.+++|+...... ..+.+|..+++.|..+.-.+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CEEE
Confidence 4678889899999998642 257899999854223 6677899999998655445777776532 2899
Q ss_pred eecCCCch
Q 015741 211 EHVNNTDF 218 (401)
Q Consensus 211 e~~~~~~l 218 (401)
||++|..+
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=4.5e-05 Score=71.06 Aligned_cols=139 Identities=17% Similarity=0.200 Sum_probs=80.1
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCC-CeeEEeeEEEc----CCCCCcEEEE
Q 015741 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIF 210 (401)
Q Consensus 137 ~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hp-niv~~~~~~~~----~~~~~~~lv~ 210 (401)
.-++.|+.|....+|+... .++ .+++|+... .....+..|+.+++.|..+. .+++++..... ......+++|
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3457788899899999875 333 688999876 34567788999998885431 13444421000 0023457899
Q ss_pred eecCCCchhh---------------hc---CCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 015741 211 EHVNNTDFKV---------------LY---PTL--------SDYDVRY---------------YIYELLKALDYCHS--- 246 (401)
Q Consensus 211 e~~~~~~l~~---------------~~---~~~--------~~~~~~~---------------i~~qi~~~L~~LH~--- 246 (401)
+|++|..+.. +. ..+ ....... +...+...++.+..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998864311 00 111 0000000 00113344555542
Q ss_pred ----CCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 247 ----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 247 ----~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
.+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 3699999999999998543 457999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.79 E-value=5e-05 Score=71.25 Aligned_cols=136 Identities=14% Similarity=0.136 Sum_probs=73.6
Q ss_pred eeecccCCee-EEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEEeeEEEcCCCCCcEEEEeecCCCc
Q 015741 140 RKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 140 ~~Lg~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hp-niv~~~~~~~~~~~~~~~lv~e~~~~~~ 217 (401)
+.|+.|.... +|+... .++..+++|...+.....+..|+.+++.|..+. .+++++.+. .... +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence 4565554444 666643 236678888765433256678888888885442 356677653 2222 68999987755
Q ss_pred hhhhcC--------------------------CCC---HHHHH-------H-HH------------HHHHHHHHHH----
Q 015741 218 FKVLYP--------------------------TLS---DYDVR-------Y-YI------------YELLKALDYC---- 244 (401)
Q Consensus 218 l~~~~~--------------------------~~~---~~~~~-------~-i~------------~qi~~~L~~L---- 244 (401)
+...+. .++ ..... . +. ..+...++.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 422110 011 11100 0 00 0111122222
Q ss_pred --HhCCceeecCCCCCeeEeCC---CCeEEEEecccceecC
Q 015741 245 --HSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYH 280 (401)
Q Consensus 245 --H~~~ivHrDlkp~NIll~~~---~~~vkl~DFg~a~~~~ 280 (401)
+...++|||+.+.||+++.+ ...+.|+||+.+..-.
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 23479999999999999864 1378999999987654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00029 Score=64.58 Aligned_cols=76 Identities=14% Similarity=0.118 Sum_probs=55.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCCCCcEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~~~~~lv 209 (401)
+..-++.+|.|..+.||+... .+|+.|++|+-... ....+..|...|+.|... --+++++.+. .-+++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEE
Confidence 455678999999999999986 67899999986432 235688999999998443 2355666542 13689
Q ss_pred EeecCCCc
Q 015741 210 FEHVNNTD 217 (401)
Q Consensus 210 ~e~~~~~~ 217 (401)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00012 Score=71.18 Aligned_cols=79 Identities=13% Similarity=0.132 Sum_probs=46.5
Q ss_pred HhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccccccc--CCCccccccccCCC--CCCcccchHHHHHHHH
Q 015741 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDLWSLGCMFA 320 (401)
Q Consensus 245 H~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwSlG~ll~ 320 (401)
+...++|+|++|.|||++.++ ++++||+.+..-.+......... ...|.+|+...... .-....++..+...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 346799999999999998554 89999999876533222111111 12345555432100 1112344557777777
Q ss_pred HHHcC
Q 015741 321 GMIFR 325 (401)
Q Consensus 321 elltg 325 (401)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00016 Score=69.24 Aligned_cols=133 Identities=12% Similarity=0.174 Sum_probs=82.3
Q ss_pred eeecccCCeeEEEEEEcC-------CCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 140 RKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
+.|..|-...+|++.... +++.+++|+.-+. ....+.+|..+++.|..+.-.+++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEE
Confidence 567778888999987632 3578999986432 345677999999998666555777776632 2899
Q ss_pred eecCCCchhhh--c----------------C---C----CC--HHHHHHHHHHHHH-------------------HHHHH
Q 015741 211 EHVNNTDFKVL--Y----------------P---T----LS--DYDVRYYIYELLK-------------------ALDYC 244 (401)
Q Consensus 211 e~~~~~~l~~~--~----------------~---~----~~--~~~~~~i~~qi~~-------------------~L~~L 244 (401)
||++|..+... . . . .. ..++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998654211 0 0 0 11 2334444433321 23333
Q ss_pred H----h----CCceeecCCCCCeeEeCC---CCeEEEEeccccee
Q 015741 245 H----S----QGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEF 278 (401)
Q Consensus 245 H----~----~~ivHrDlkp~NIll~~~---~~~vkl~DFg~a~~ 278 (401)
. . ..++|+|+.+.||+++.+ ...+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 258999999999999865 23789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00028 Score=65.84 Aligned_cols=133 Identities=14% Similarity=0.183 Sum_probs=79.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEEeeEEEcC-----CCCCcEEEEe
Q 015741 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ-----QSKTPSLIFE 211 (401)
Q Consensus 140 ~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hp-niv~~~~~~~~~-----~~~~~~lv~e 211 (401)
..|+ |....||++.. .+|+.+++|+..+. ....+..|..+++.|..+. .+++++.. +. .....+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3456 77889998754 45668999998643 4567888999998884331 24555443 11 0234578999
Q ss_pred ecCCCchhh-----h----------c---CC--------CCHHH----HHH------------------HHHHHHHHHHH
Q 015741 212 HVNNTDFKV-----L----------Y---PT--------LSDYD----VRY------------------YIYELLKALDY 243 (401)
Q Consensus 212 ~~~~~~l~~-----~----------~---~~--------~~~~~----~~~------------------i~~qi~~~L~~ 243 (401)
+++|..+.. . . .. ..... ... .+.+++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998854321 0 0 00 11110 001 11112222222
Q ss_pred H----HhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 244 C----HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 244 L----H~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
+ ....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcC
Confidence 2 224589999999999998 4 6899999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00053 Score=67.23 Aligned_cols=74 Identities=16% Similarity=0.175 Sum_probs=50.3
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchH--HHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCC
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~ 216 (401)
++.|+.|-...+|++.....+..+++|+..+.... ...+|..+++.|..+.-.+++++.+. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N----GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEEeeCCc
Confidence 46788899999999987443588999987542211 12689999999955544567887762 1 2599999875
Q ss_pred ch
Q 015741 217 DF 218 (401)
Q Consensus 217 ~l 218 (401)
.+
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00054 Score=65.12 Aligned_cols=74 Identities=14% Similarity=0.133 Sum_probs=46.7
Q ss_pred EeeecccCCeeEEEEEEcC--------CCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 139 VRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++.|+.|....+|++.... .++.+++|+...... .....|..+++.|..+.-++++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence 4678888889999987632 136889998754322 12468899999885543355777654 1 258
Q ss_pred EEeecCCCch
Q 015741 209 IFEHVNNTDF 218 (401)
Q Consensus 209 v~e~~~~~~l 218 (401)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0052 Score=57.67 Aligned_cols=71 Identities=10% Similarity=0.144 Sum_probs=44.1
Q ss_pred cccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCC--CCeeEEeeEEEc----CCCCCcEEEEeecCCC
Q 015741 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QQSKTPSLIFEHVNNT 216 (401)
Q Consensus 143 g~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h--pniv~~~~~~~~----~~~~~~~lv~e~~~~~ 216 (401)
|.|....||+... .+| .+++|+..... ...|+.+++.|..+ |++++.+..... ......+++|+|++|.
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 3444678999874 345 89999876543 25677777777432 325555532100 1134568999999987
Q ss_pred ch
Q 015741 217 DF 218 (401)
Q Consensus 217 ~l 218 (401)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0061 Score=58.98 Aligned_cols=74 Identities=12% Similarity=0.157 Sum_probs=51.1
Q ss_pred EeeecccCCeeEEEEEEcCC-------CeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 139 VRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
++.|..|-...+|++..... ++.+++|+..+... -...+|..+++.|..+.-.+++++.+ . -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCEE
Confidence 46677788889999886421 57899998644221 22468999999886555566777644 1 2689
Q ss_pred EeecCCCch
Q 015741 210 FEHVNNTDF 218 (401)
Q Consensus 210 ~e~~~~~~l 218 (401)
|||++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.027 Score=53.99 Aligned_cols=30 Identities=30% Similarity=0.596 Sum_probs=24.6
Q ss_pred ceeecCCCCCeeEeC-----CCCeEEEEeccccee
Q 015741 249 IMHRDVKPHNVMIDH-----EQRKLRLIDWGLAEF 278 (401)
Q Consensus 249 ivHrDlkp~NIll~~-----~~~~vkl~DFg~a~~ 278 (401)
++|+|+.+.|||+.. +...+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 344799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.48 E-value=0.19 Score=43.57 Aligned_cols=92 Identities=10% Similarity=-0.020 Sum_probs=56.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCcccccccc
Q 015741 223 PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (401)
Q Consensus 223 ~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 301 (401)
.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|.+.+ +.+. .....+.+||...
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------~~~~~~~~pe~~~ 110 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------AGEPPPVAGKLGY 110 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CCSS
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------ccccCCCChhhcc
Confidence 589999999999999999877622 2212233456888888777 554442 1110 1122456888753
Q ss_pred CCCCCCcccchHHHHHHHHHHHcCCCCC
Q 015741 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 302 ~~~~~~~~~DiwSlG~ll~elltg~~Pf 329 (401)
...+.+.=|||||++||..+--..|-
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 24556788999999999998765553
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.92 E-value=0.13 Score=50.25 Aligned_cols=59 Identities=12% Similarity=0.147 Sum_probs=18.0
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEE------EEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCII------KILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vav------K~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
+.+.|| ||+||+|.......+||+ |..+. .....+.+|..+++.+ +|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEEe
Confidence 345666 999999998665568888 66543 1224577888888888 89999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.38 E-value=1.1 Score=38.54 Aligned_cols=121 Identities=9% Similarity=0.188 Sum_probs=76.0
Q ss_pred HHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCC-chhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 015741 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (401)
Q Consensus 177 ~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 255 (401)
.|+.+|+. .||+.+.. .+-.+. ..+.+.++.-..+ ++.. ++..+..+.+.++.+|+....+++.+ +|--|.
T Consensus 35 ~el~LL~~--~~~~Fl~~-~I~e~e--D~v~~~y~~~~~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~ 106 (215)
T 4ann_A 35 HLMYLLEQ--HSPYFIDA-ELTELR--DSFQIHYDINDNHTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRTR--YTFVLA 106 (215)
T ss_dssp GGGGGGGS--CCTTBCCE-EEEECS--SEEEEEECCCTTSEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGSS--EECCCS
T ss_pred HHHHHHhc--cCCcccce-EEEEcc--cEEEEEEEcCcccCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcCc--eEEEEe
Confidence 45555554 68888866 444332 3434444444322 3443 56788888999999988877555443 788899
Q ss_pred CCCeeEeCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccch-HHHHHHHHHHHcCCCCC
Q 015741 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL-WSLGCMFAGMIFRKEPF 329 (401)
Q Consensus 256 p~NIll~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wSlG~ll~elltg~~Pf 329 (401)
|+||+++.++ .+++.--|+-..+ +|..+ + ..|. -..=|++..+++++..|
T Consensus 107 P~NL~f~~~~-~p~i~~RGik~~l----------------~P~~~------~-ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 107 PDELFFTRDG-LPIAKTRGLQNVV----------------DPLPV------S-EAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGGEEECTTS-CEEESCCEETTTB----------------SCCCC------C-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred cceEEEcCCC-CEEEEEccCccCC----------------CCCCC------C-HHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999776 7888877764322 22211 1 1122 23557788888888777
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 401 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-95 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 285 bits (731), Expect = 4e-95
Identities = 222/291 (76%), Positives = 258/291 (88%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 4 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE 393
AKVLGT++L Y++KY+IELDP ++GRHSRK W +F+ ENQHL PE
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-47
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 13/268 (4%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
++ Y + +G G + V++ C E IK + K+ RE++I++ L NI
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 192 VKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKAL 241
V+L K L+ ++V T ++V TL V+ Y+Y+L ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 362 LDPHLAALVGRHSRKPWSKFITVENQHL 389
+ + K + E L
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-44
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 14/223 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
IV S+ EH++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y D+WS+G M + P +L+ +V G
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-44
Identities = 55/234 (23%), Positives = 112/234 (47%), Gaps = 17/234 (7%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REI 179
YE +T +D +E++ ++G G + +V++ + + K++ +++++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIY 235
IL + PNIVKLLD + + ++ E + L++ ++
Sbjct: 61 DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
+ L AL+Y H I+HRD+K N++ + ++L D+G++ + + + + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 295 KGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE+++ + YDY D+WSLG M + P + + L+KIAK
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (392), Expect = 2e-44
Identities = 53/223 (23%), Positives = 104/223 (46%), Gaps = 13/223 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 190
D Y+++ ++G G + V V + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
++ L D D+ LI E ++ + +S+ +V Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+H D+KP N+M + ++ +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ D+W++G + ++ P F G D+ + L + +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWE 246
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-44
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+E+ R +G+GK+ V+ +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
PNI++L D LI E+ + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+D +DLWSLG + + K P F + + +I++V
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 1e-43
Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + + F L TLS+ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 298 ELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E++ + Y +D+WS G + ++ P F+ L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS 229
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 4e-43
Identities = 48/223 (21%), Positives = 95/223 (42%), Gaps = 13/223 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 190
D Y++ ++G G + V K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
+V L D D +I+E ++ + + +S+ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M ++ +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y D+WS+G + ++ P F G ++ + L +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWN 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 71/261 (27%), Positives = 133/261 (50%), Gaps = 16/261 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCH 245
NI+ + DI+R +Q K L+ + +K+L LS+ + Y++Y++L+ L Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 361
+ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+ +++
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 362 LDPHLAALVGRHSRKPWSKFI 382
+L + + ++ PW++
Sbjct: 245 ARNYLLS-LPHKNKVPWNRLF 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-42
Identities = 52/246 (21%), Positives = 105/246 (42%), Gaps = 17/246 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ Y + +GRG++ V V + + + K +K + +K+EI IL NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+ L + + +IFE ++ D F+ + L++ ++ Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 248 GIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
+ D+WSLG + ++ P F N + I T + + E+
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYT-----FDEEAFKEISIEA 234
Query: 367 AALVGR 372
V R
Sbjct: 235 MDFVDR 240
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-42
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 15/249 (6%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 193 KLLDIVRDQQS--KTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCH 245
+++D+ + + K ++ E ++ + F + ++ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
S I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
+ YD S D+WSLG + ++ P FY + + + + + N E+
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRMGQYE-FPNPEWSEVS 245
Query: 364 PHLAALVGR 372
+ L+
Sbjct: 246 EEVKMLIRN 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-42
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 15/221 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
N+VK R + L E+ + + F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 303
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + +D+WS G + M+ + + + Q K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK 220
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 70/274 (25%), Positives = 136/274 (49%), Gaps = 16/274 (5%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKK 174
++ E W + Y ++ VG G Y V V K IK L + K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL-YPTLSDYD 229
RE+++L+++ N++ LLD+ ++ L+ + K++ + L +
Sbjct: 64 AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+++ +Y++LK L Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
+R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGTP 238
Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 383
++ + + + + +K ++ +T
Sbjct: 239 PAE-FVQRLQSDEAKNYMKGLPELEKKDFASILT 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 72/265 (27%), Positives = 128/265 (48%), Gaps = 13/265 (4%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G G Y VF+ + +E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
NIV+L D++ + +L+FE + F L V+ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
Y S+D+WS GC+FA + P F G+D DQL +I ++LGT + + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 365 HLAALVGRHSRKPWSKFITVENQHL 389
S + + L
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDL 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-41
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY------PTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D V+ L + V + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE + Y+ D+WSLGC+ + P F + KI +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE 228
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (362), Expect = 8e-41
Identities = 74/258 (28%), Positives = 133/258 (51%), Gaps = 18/258 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ Y + K+G G Y V++ + E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
NIVKL D++ ++ L+FEH++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 304
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N + P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232
Query: 365 HLAALVGRHSRKPWSKFI 382
+ PW F+
Sbjct: 233 KYDPNFTVYEPLPWESFL 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 74/257 (28%), Positives = 135/257 (52%), Gaps = 14/257 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
++++ V K+G G Y V++ + E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 246
PNIVKLLD++ + F H + F + ++ Y+++LL+ L +CHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+ +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + + P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---PD 235
Query: 366 LAALVGRHSRKPWSKFI 382
+ +R+ +SK +
Sbjct: 236 YKPSFPKWARQDFSKVV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 49/218 (22%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
NIV LD ++ E++ + + + + E L+AL++ HS
Sbjct: 78 NIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G + + + V + Y+ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+D+WSLG M MI + P + + L IA
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT 230
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (363), Expect = 2e-40
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCG 187
+ +R++G G + V+ ++E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PN ++ + T L+ E+ + +V L + ++ + L+ L Y
Sbjct: 75 -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187
Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ YD +D+WSLG + RK P F + L IA+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ 228
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 77/263 (29%), Positives = 126/263 (47%), Gaps = 22/263 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G+G + EVF+ H +K +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 189 PNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK 239
N+V L++I R + S + L+F+ + +L + +++ + LL
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 294
L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
+ PELL+ +DY +DLW GC+ A M R P G+ QL I+++ G+ +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 355 LNKYHIELDPHLAALVGRHSRKP 377
N + EL L + G+ +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVK 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-40
Identities = 73/257 (28%), Positives = 128/257 (49%), Gaps = 17/257 (6%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 188
E + +G G+++ V++ N+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH 245
PNI+ LLD + SL+F+ + ++ L+ ++ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
I+HRD+KP+N+++D E L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364
Y +D+W++GC+ A ++ R PF G + DQL +I + LGT + + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 365 HLAALVGRHSRKPWSKF 381
+ G +S
Sbjct: 236 TFKSFPGIPLHHIFSAA 252
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-40
Identities = 70/275 (25%), Positives = 135/275 (49%), Gaps = 17/275 (6%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PV 170
RP ++ E W + Y+ + VG G Y V + +K L +
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 171 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLY--PTL 225
K+ RE+++L+++ N++ LLD+ +S + H+ D + L
Sbjct: 60 HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+D V++ IY++L+ L Y HS I+HRD+KP N+ ++ + +++D+GLA H E
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRL 234
Query: 346 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380
+GT L K E + + + + ++
Sbjct: 235 VGTPGAE-LLKKISSESARNYIQSLTQMPKMNFAN 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-39
Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 23/265 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVKKKK-----IKREIKILQNLCG 187
YE V ++G G Y +VF+ +K ++ ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 188 G--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELL 238
PN+V+L D+ ++ + L+FEHV+ L P + ++ +++LL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
+L+ Y +DLWS+GC+FA M RK P F G + DQL KI V+G +
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 359 HIELDPHLAALVGRHSRKPWSKFIT 383
+ S +P KF+T
Sbjct: 244 ALPRQ-----AFHSKSAQPIEKFVT 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-39
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + + + + R+Y E++ AL+Y
Sbjct: 68 -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 301
H +GI+HRD+KP N++++ + +++ D+G A+ P + N V + + PELL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + S DLW+LGC+ ++ P F + Y KI K
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIK 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 7e-39
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 188
+D Y+ +G G +SEV + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCH 245
PNIV L DI LI + V+ + F + ++ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ Y ++D WS+G + ++ P FY ++ +I K
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILK 223
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-38
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQ 183
+ Y+V +G G + V+ G+ +DN IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKA 240
+ G +++LLD S L F + L + R + +++L+A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R + PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + S +WSLG + M+ PF
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 65/292 (22%), Positives = 130/292 (44%), Gaps = 18/292 (6%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKK 173
+++ E + Y+ ++ +G G V + IK L K
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYD 229
+ RE+ +++ + NI+ LL++ Q++ + L+ E ++ +V+ L
Sbjct: 62 RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+ Y +Y++L + + HS GI+HRD+KP N+++ + +++D+GLA V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
+RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 237
Query: 350 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEVEFLVICS 401
++ +L P + V + F + L + E + +
Sbjct: 238 -----CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 47/221 (21%), Positives = 95/221 (42%), Gaps = 16/221 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 190
+ ++GRG + V++G+ + L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 191 IVKLLDIVRD--QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
IV+ D + K L+ E + + K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 246 SQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ YD S+D+++ G M + P+ + ++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (330), Expect = 4e-36
Identities = 54/254 (21%), Positives = 97/254 (38%), Gaps = 22/254 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D YE+ +G G SEV + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 187 GGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P IV + D + P ++ E+V+ + + ++ I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
D D++SLGC+ ++ + P F G + + +
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPI-----PPSAR 237
Query: 359 HIELDPHLAALVGR 372
H L L A+V +
Sbjct: 238 HEGLSADLDAVVLK 251
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 54/254 (21%), Positives = 113/254 (44%), Gaps = 25/254 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQN 184
D Y+ ++G G+++ V + + + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L +
Sbjct: 70 IQ-HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 242 DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
++ + + D+WS+G + ++ P F G + L ++ V + ++Y
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYE-----FEDEY 239
Query: 359 HIELDPHLAALVGR 372
+ R
Sbjct: 240 FSNTSALAKDFIRR 253
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-36
Identities = 48/219 (21%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
P + + + +++ + E++N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
Q Y++S+D WS G + M+ + P F+G D + I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI 215
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-36
Identities = 43/253 (16%), Positives = 104/253 (41%), Gaps = 26/253 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKALDYC 244
NI+ + Q +++ + + + L+ + + + +DY
Sbjct: 64 VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLV 301
H++ I+HRD+K +N+ + + +++ D+GLA + S + PE++
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 302 DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
Y + D+++ G + ++ + P + +N DQ++ + +G L+ L+K
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFM---VGRGYLSPDLSKVR 235
Query: 360 IELDPHLAALVGR 372
+ L+
Sbjct: 236 SNCPKAMKRLMAE 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 9e-36
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 16/227 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ V R +GRG + EV+ + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 188 G--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
G P IV + S I + +N D + S+ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ H++ +++RD+KP N+++D E +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
YD S D +SLGCM ++ P F H D+ L
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTLTMA 225
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-35
Identities = 35/217 (16%), Positives = 91/217 (41%), Gaps = 14/217 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 63
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
+LL ++ +++ ++ E++ L L + + ++ +A++Y
Sbjct: 64 QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
+HRD+ NV++ + ++ D+GL + + + + PE L + + +
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFS 178
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WS G + + + D + ++ K
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-34
Identities = 49/249 (19%), Positives = 94/249 (37%), Gaps = 42/249 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILK----PVKKKKIKREIKILQN 184
++ E + +G G + +V ++ + +K+LK +++ + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--------------------- 222
L NIV LL S LIFE+ D L
Sbjct: 97 LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 223 ----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
L+ D+ + Y++ K +++ + +HRD+ NV++ H + +++ D+GLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD 213
Query: 279 YHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
Y VR + PE L + Y D+WS G + + + G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 336 YDQLVKIAK 344
K+ +
Sbjct: 273 DANFYKLIQ 281
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (315), Expect = 7e-34
Identities = 39/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK + +++ E + + L G I +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMH 251
++ L+ + + + +L S V ++L + H + +++
Sbjct: 67 YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 252 RDVKPHNVMID----HEQRKLRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 299
RD+KP N +I + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+ ++ DL +LG +F + + G K ++ +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 9e-34
Identities = 39/227 (17%), Positives = 81/227 (35%), Gaps = 21/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVK------KKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
L N+++L +V K ++ E + Y ++ +
Sbjct: 68 LDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGP 297
+ Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + ++ D W G M + + G + L KI K
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-33
Identities = 35/219 (15%), Positives = 88/219 (40%), Gaps = 14/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++V ++G G++ EV+ G + + K +K LK + E +++ L +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRL 70
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V + +I E++ N L+ + ++ + + +
Sbjct: 71 VRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDLQD 305
+ +HRD++ N+++ + ++ D+GLA + A K ++
Sbjct: 128 RNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + ++ + G N + + + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-32
Identities = 35/219 (15%), Positives = 87/219 (39%), Gaps = 14/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + +Q L+FE + + + + + ++ + + Y
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDLQD 305
++HRD+ N ++ Q +++ D+G+ F + + + PE+
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y D+WS G + + + + N + + I+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 2e-32
Identities = 46/218 (21%), Positives = 94/218 (43%), Gaps = 13/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D++++R +G G + V + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P I+++ +D Q + + E + ++Y E+ AL+Y HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP N+++D + +++ D+G A++ + + PE++ + Y
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPY 178
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ S+D WS G + M+ P FY + KI
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-32
Identities = 37/220 (16%), Positives = 87/220 (39%), Gaps = 16/220 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKL 74
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V ++ ++ E+++ L + ++ + Y
Sbjct: 75 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQ 304
+HRD++ N+++ E ++ D+GLA + + PE +
Sbjct: 132 MNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 189
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + + + G N + L ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-32
Identities = 48/253 (18%), Positives = 110/253 (43%), Gaps = 21/253 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-------KKKIKREIKILQ 183
+++E+++ +G G Y +VF + + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 242
++ P +V L + + L + + + ++++V+ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 299
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
+D ++D WSLG + ++ P F + +I++ + E Y
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-----PYP 256
Query: 360 IELDPHLAALVGR 372
E+ L+ R
Sbjct: 257 QEMSALAKDLIQR 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (303), Expect = 4e-32
Identities = 43/225 (19%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + ++ E + + F S V +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 250 MHRDVKPHNVMIDHEQRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 299
+HRDVKP N ++ ++ + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + DL SLG + + G + K +
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 5e-32
Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 13/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
D ++ ++ +G G + V H +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCHS 246
P +VKL +D + + + + S+ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ ++D W+LG + M P F+ KI
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVS 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 42/218 (19%), Positives = 85/218 (38%), Gaps = 10/218 (4%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D++ ++ +G+G + +V +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 188 GPNIVKLLDIVRDQQSK-TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P + L + ++ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++D W LG + M+ + P FY D+ I
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM 219
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-32
Identities = 38/221 (17%), Positives = 91/221 (41%), Gaps = 14/221 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D ++++G G++ V G IK++K + + + E K++ NL +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + Q + +I E++ N + ++ +A++Y S+
Sbjct: 62 VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQD 305
+HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 120 QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SK 177
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
+ D+W+ G + + + + N + IA+ L
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-31
Identities = 38/236 (16%), Positives = 84/236 (35%), Gaps = 29/236 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
+D + +G G + +V + D + I + + E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------FKVLYPTLSDY 228
PNI+ LL + L E+ + + TLS
Sbjct: 70 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++ ++ + +DY + +HRD+ N+++ E ++ D+GL+ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ E L Y + D+WS G + ++ + G + K+ +
Sbjct: 187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (297), Expect = 3e-31
Identities = 37/227 (16%), Positives = 82/227 (36%), Gaps = 20/227 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
++ + +G G++ EV G ++ I +K +K + E I+
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALD 242
PN++ L +V S +I E + N + + + + +
Sbjct: 86 H-PNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
Y +HRD+ N++++ ++ D+GL+ F ++ K P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 303 -----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + D+WS G + ++ E ++ N D + I +
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 4e-31
Identities = 43/223 (19%), Positives = 91/223 (40%), Gaps = 17/223 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
+ E+ R +G G++ +V +G++ + + +K K +K +E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
P+IVKL+ ++ + +I E + + +L + Y Y+L AL
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPELLV 301
Y S+ +HRD+ NV++ ++L D+GL+ + Y + +
Sbjct: 123 YLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + + D+W G ++ F G N D + +I
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 1e-30
Identities = 39/218 (17%), Positives = 86/218 (39%), Gaps = 11/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNL 75
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+LL + + F L +S + Y ++ A++Y +
Sbjct: 76 VQLLGVCTREPPFYIITEF-MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E +++ D+GL+ + + +
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+W+ G + + + G D Q+ ++ +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE 230
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-30
Identities = 45/243 (18%), Positives = 86/243 (35%), Gaps = 35/243 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + +G G + +V E + +K+LKP ++ + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---------------------FKVLYP 223
L NIV LL +I E+ D +
Sbjct: 83 LGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L D+ + Y++ K + + S+ +HRD+ N+++ H + ++ D+GLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDS 199
Query: 284 EYNVRVASRYFKG--PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
Y V+ +R + Y + D+WS G + + G + K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 342 IAK 344
+ K
Sbjct: 260 MIK 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-30
Identities = 38/227 (16%), Positives = 91/227 (40%), Gaps = 21/227 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKK----IKREIKILQN 184
+ +++ ++ +G G + V++G+ + E IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
+ P++ +LL I T LI + + + + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 297
++Y + ++HRD+ NV++ Q +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E ++ + Y + D+WS G ++ + G + + K
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 41/228 (17%), Positives = 92/228 (40%), Gaps = 21/228 (9%)
Query: 132 EQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCI--IKILKPVKKKK----IKREIKILQN 184
++D+ + ++G G + V +GV+ ++ IK+LK +K + RE +I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKA 240
L P IV+L+ + + + L+ E K L + +V ++++
Sbjct: 66 L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
+ Y + +HRD+ NV++ + ++ D+GL++ Y +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE + + + D+WS G + + + + + I +
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 2e-29
Identities = 44/250 (17%), Positives = 86/250 (34%), Gaps = 42/250 (16%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQ 183
+++ E VR +G G + VF+ +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------------ 219
PNIVKLL + + L+FE++ D
Sbjct: 72 EFDN-PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
P LS + ++ + Y + +HRD+ N ++ E +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 277 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 335 NYDQLVKIAK 344
+ + + +
Sbjct: 248 HEEVIYYVRD 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-28
Identities = 39/219 (17%), Positives = 86/219 (39%), Gaps = 20/219 (9%)
Query: 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + + +KILK P K ++ E ++Q L P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + D ++ ++++ + Y
Sbjct: 72 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 305
+HRD+ NV++ Q ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + + G + + K
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-28
Identities = 43/221 (19%), Positives = 94/221 (42%), Gaps = 20/221 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKK----KKIKREIKILQNLCGGPNIV 192
+GRG + V+ G ++ K I +K L + + E I+++ PN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG 248
LL I + P ++ ++ + D + + D+ + ++ K + + S+
Sbjct: 92 SLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-----FKGPELLVDL 303
+HRD+ N M+D + +++ D+GLA + + +V + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Q + D+WS G + ++ R P + + +D V + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 39/227 (17%), Positives = 86/227 (37%), Gaps = 21/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKAL 241
NI++L ++ + +I E++ N S + + + +
Sbjct: 67 SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGP 297
Y + +HRD+ N++++ ++ D+GL+ E + + P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E + + S D+WS G + ++ E ++ N++ + I
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 2e-26
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 28/287 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNL-------- 185
Y +VRK+G G +S V+ +N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 186 --CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF------KVLYPTLSDYDVRYYIYEL 237
G +I+KLLD + ++ + K + + V+ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 238 LKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 293
L LDY GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-----FYGHDNYDQLVKIAKVLGT 348
++ PE+L+ + D+WS C+ +I F + D + +I ++LG
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEVE 395
N + + L+ S+ + V + + E
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-25
Identities = 42/236 (17%), Positives = 87/236 (36%), Gaps = 30/236 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + R++G+G + V+EGV + IK + + + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------YPTLSDYDVR 231
++V+LL +V Q + +I E + D K S +
Sbjct: 80 F-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288
E+ + Y ++ +HRD+ N M+ + +++ D+G+ + Y
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG 195
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + PE L D + D+WS G + + E + G N L + +
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-25
Identities = 43/244 (17%), Positives = 91/244 (37%), Gaps = 37/244 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKKKK----IKREIKIL 182
D + + +G G + +V ++ K +K+LK +K + E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------------YP 223
+ + NI+ LL +I E+ + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
LS D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA H
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHID 189
Query: 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
Y + PE L D + Y + D+WS G + + + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 341 KIAK 344
+ +
Sbjct: 249 LLKE 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 6e-25
Identities = 41/224 (18%), Positives = 84/224 (37%), Gaps = 26/224 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 192
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYCHSQ- 247
+ L+ ++ + F L T++ + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 248 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 295
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 296 GPELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE+L + + D++++G +F + R D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 8e-24
Identities = 41/243 (16%), Positives = 93/243 (38%), Gaps = 36/243 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKP----VKKKKIKREIKILQN 184
D ++ + +GRG + +V E +K+LK + + + E+KIL +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------------VLYPTL 225
+ N+V LL +I E + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA + +Y
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDY 190
Query: 286 ----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
+ R+ ++ + + Y D+WS G + + + G ++ +
Sbjct: 191 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 342 IAK 344
K
Sbjct: 249 RLK 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 34/203 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------------VKKKKIKREIKILQ 183
+ + +G GK S VF +C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 184 NLCGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
+ KL + + + +++ E ++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 296
+ +GI+H D+ +NV++ E +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 297 PELLVDLQDYDYSLDLWSLGCMF 319
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 401 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.99 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 85.19 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-58 Score=438.11 Aligned_cols=280 Identities=72% Similarity=1.233 Sum_probs=254.2
Q ss_pred CCCCcccccCCCcCCCCCcccccccccccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHH
Q 015741 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181 (401)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~i 181 (401)
.|++.+++.+++...+.++|++....+.++..++|+++++||+|+||+||+|+++.+|+.||||+++....+++.+|+++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i 82 (328)
T d3bqca1 3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI 82 (328)
T ss_dssp CCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH
T ss_pred CCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH
Confidence 46777888898988899999999999988899999999999999999999999999999999999998888999999999
Q ss_pred HHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeE
Q 015741 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (401)
Q Consensus 182 l~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 261 (401)
|+.+.+||||+++++++.......+++||||+.+++|....+.+++.+++.+++||+.||+|||++||+||||||+|||+
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 99996799999999999877777899999999999999998999999999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 262 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
+.++..+||+|||+|+...........++|+.|+|||.+.+...++.++|||||||++|+|++|+.||..+.++.++...
T Consensus 163 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~ 242 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242 (328)
T ss_dssp ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred cCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence 97776899999999998877767777889999999999987667899999999999999999999999888887777776
Q ss_pred HHHHhC-------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCc
Q 015741 342 IAKVLG-------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPW 378 (401)
Q Consensus 342 i~~~~~-------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~ 378 (401)
+.+.++ ++++.++|.+ ||+.||+.|++++|+|+|||
T Consensus 243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK-LLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH-HccCChhHCcCHHHHhcCcc
Confidence 665543 2346677777 89999999999999999999
Q ss_pred cccc
Q 015741 379 SKFI 382 (401)
Q Consensus 379 ~~~~ 382 (401)
++-+
T Consensus 322 F~~v 325 (328)
T d3bqca1 322 FYTV 325 (328)
T ss_dssp GTTS
T ss_pred cCCC
Confidence 9764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=419.79 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=206.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+++ +|||||++++++.+ ...+|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence 368999999999999999999999999999999986432 35689999999999 99999999999987 467899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
||||+.+|+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcc
Confidence 999999999987764 489999999999999999999999999999999999999766 89999999998764332
Q ss_pred -cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHH
Q 015741 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (401)
Q Consensus 284 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (401)
.....+||+.|+|||++.+...++.++|||||||++|||++|+.||....+.......+.... -++++.++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 234568999999999998744457889999999999999999999965444333333322211 14567788
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+ |++.||+.|++++++++|||++.
T Consensus 240 i~~-~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 240 LHK-ILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHH-HSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHH-HcCCChhHCcCHHHHhcCHhhCc
Confidence 888 89999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-57 Score=414.47 Aligned_cols=240 Identities=24% Similarity=0.452 Sum_probs=209.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+++.||+|++.+ ...+.+.+|+++++++ +|||||++++++.+ ...+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEEE
Confidence 689999999999999999999999999999999853 2346789999999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+++|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~-~~ 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-SR 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCC-CC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCC-Cc
Confidence 999999999997765 4699999999999999999999999999999999999999776 899999999987643 33
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+.+.. -++++.+++.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLISR- 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH-
T ss_pred ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH-
Confidence 456789999999999987 67999999999999999999999998 4555555555554432 25678888888
Q ss_pred CCCCChhhHHHhhhhcCCCcccc
Q 015741 359 HIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 359 ~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|++.||..|++++++++|||+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 89999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-57 Score=419.41 Aligned_cols=242 Identities=22% Similarity=0.414 Sum_probs=212.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++|++++.||+|+||+||+|++..+|+.||||+++. ...+.+.+|+++++++ +|||||++++++.+ ...+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999864 3456799999999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-ccc
Q 015741 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (401)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~~ 286 (401)
|||+.+|+|..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence 9999999998775 4699999999999999999999999999999999999999776 89999999998875443 345
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC---------ChhHHHHHHh
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (401)
..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+..... ++.+.+++.+
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCC-CCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 6689999999999987 68999999999999999999999999 45555666665554421 4567888888
Q ss_pred cCCCCChhhHHHhhhhcCCCcccc
Q 015741 358 YHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
|++.||..|++++++++|||++.
T Consensus 253 -~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 -CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -HccCChhHCcCHHHHhcCHhhCC
Confidence 89999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=412.13 Aligned_cols=242 Identities=27% Similarity=0.436 Sum_probs=196.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .+.+.+|+++++++ +|||||++++++.+.....+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 368999999999999999999999999999999986432 35588999999999 999999999999876667889
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCCeeEeCCCCeEEEEeccc
Q 015741 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (401)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NIll~~~~~~vkl~DFg~ 275 (401)
+||||+++|+|..++ ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccc
Confidence 999999999998765 35899999999999999999999976 99999999999999776 899999999
Q ss_pred ceecCCCCc-ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------C
Q 015741 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------G 347 (401)
Q Consensus 276 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~ 347 (401)
|+.+..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+....+.... -
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCccc
Confidence 987754432 345789999999999876 68999999999999999999999998 4445555555554432 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWS 379 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~ 379 (401)
++++.+++.+ |++.||..||++.++++|||.
T Consensus 239 s~~l~~li~~-~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITR-MLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHH-HcCCChhHCcCHHHHHhCCcC
Confidence 4578888888 899999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=414.39 Aligned_cols=244 Identities=23% Similarity=0.401 Sum_probs=209.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
..+.|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ ...+++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~l 86 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWI 86 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCeEEE
Confidence 356799999999999999999999999999999998643 346789999999999 99999999999976 467899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcc
Confidence 99999999997664 3589999999999999999999999999999999999999777 8999999999765322 2
Q ss_pred cccccccCCCccccccccC----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh---------CChh
Q 015741 284 EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDE 350 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~---------~~~~ 350 (401)
......||+.|+|||++.. ...|+.++|||||||++|||++|+.|| .+.+..+.+..+.+.. -+++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT-TTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 2345689999999999842 356899999999999999999999998 4555666666665542 1457
Q ss_pred HHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 351 LNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 351 ~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+++.+ |++.||..|+++.++++|||++.
T Consensus 245 ~~~li~~-~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKK-CLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHH-HSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHH-HccCChhHCcCHHHHhcCcccCC
Confidence 7888888 89999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=410.48 Aligned_cols=245 Identities=26% Similarity=0.433 Sum_probs=208.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+++|+++ +|||||++++++.+ ...+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCEEE
Confidence 679999999999999999999999999999999863 2346689999999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
+||||+.+|+|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCc
Confidence 999999999997664 4699999999999999999999999999999999999999776 89999999998875332
Q ss_pred --cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHH
Q 015741 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (401)
Q Consensus 284 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (401)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+.. -++++.+++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 2345689999999999987 689999999999999999999999994 455555555555432 256788888
Q ss_pred HhcCCCCChhhHHHhhh------hcCCCcccccccc
Q 015741 356 NKYHIELDPHLAALVGR------HSRKPWSKFITVE 385 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~------~l~~~~~~~~~~~ 385 (401)
.+ ||+.||..|++++| +++|||++-+...
T Consensus 242 ~~-~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 242 EK-LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HT-TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HH-HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 88 89999999999998 4789999877543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-57 Score=425.03 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=206.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.++|++++.||+|+||+||+|++..+|+.||+|+++.. ..+++.+|+.+|+++ +|||||++++++.+ ...+++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 57899999999999999999999999999999998642 246789999999999 99999999999976 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||||+.+|+|..++ ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-T
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-c
Confidence 99999999998776 3699999999999999999999975 999999999999999776 8999999999876432 2
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------------------ 346 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------------------ 346 (401)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........+...+....
T Consensus 160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 345689999999999987 6899999999999999999999999966544433222111110
Q ss_pred -------------------------------CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 347 -------------------------------GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 347 -------------------------------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
.++++.+++.+ ||+.||..|++++|+|+|||++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH-HcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 13467778888 89999999999999999999987544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=405.96 Aligned_cols=242 Identities=19% Similarity=0.340 Sum_probs=202.8
Q ss_pred CCe-EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCC
Q 015741 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (401)
Q Consensus 134 ~~y-~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~ 205 (401)
++| ++.++||+|+||+||+|++..+++.||+|++... ..+.+.+|+++|+++ +|||||++++++.+. ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCE
Confidence 344 6778999999999999999999999999998643 235688999999999 899999999998753 3456
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
+++||||+++|+|..++ ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 89999999999998775 46899999999999999999999998 99999999999997544589999999998643
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELN 352 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~ 352 (401)
.......+||+.|+|||++.+ .++.++|||||||++|||++|+.||....+..+....+.... .++++.
T Consensus 167 -~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred -CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 333456789999999999865 599999999999999999999999954433333333333221 245788
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
+++.+ |++.||+.||+++++++|||+|
T Consensus 244 ~li~~-~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEG-CIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHH-HSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHH-HccCCHhHCcCHHHHhCCcccC
Confidence 88888 8999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-55 Score=417.38 Aligned_cols=244 Identities=22% Similarity=0.415 Sum_probs=214.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++|++++.||+|+||.||+|+++.+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++.+ ...+|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999986533 35688999999999 99999999999976 56789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+|+|...+ ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ ++.+||+|||+++.+......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999997665 248999999999999999999999999999999999999643 348999999999988777777
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYL 355 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l 355 (401)
....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+.... -++++.+++
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 77899999999999987 68899999999999999999999998 4556666666665542 145778888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKFIT 383 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~~~ 383 (401)
.+ ||..||..|+++.++++|||++...
T Consensus 261 ~~-~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 261 RK-LLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HH-HCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HH-HccCChhHCcCHHHHhcCcccCCCC
Confidence 88 8999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-55 Score=418.37 Aligned_cols=242 Identities=24% Similarity=0.445 Sum_probs=213.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
++|++++.||+|+||.||+|++..+|+.||||+++... ...+.+|+.+|+++ +|||||++++++.+ ...+|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 67999999999999999999999999999999987533 45688999999999 99999999999976 56789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC-CCCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+|+|...+. ++++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.+......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 9999999976542 4899999999999999999999999999999999999973 3348999999999998777777
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------ChhHHHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (401)
....||+.|+|||++.+ ..|+.++|||||||++|+|++|..|| .+.+..+.+..+.+... ++++.+++
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 77899999999999887 78999999999999999999999998 56666666666665421 45778888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+ ||+.||..|+++.++|+|||++-
T Consensus 264 ~~-~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 264 KN-LLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HT-TSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HH-HccCChhHCcCHHHHhcCHhhCC
Confidence 88 89999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=414.34 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=193.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
.+.|++.+.||+|+||+||+|+++.+++.||||++... ....+.+|+.+|+++ +|||||++++++.+ ...+|+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 46799999999999999999999999999999998643 235678999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCCC
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~~ 283 (401)
||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||+.. +++.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999997765 35999999999999999999999999999999999999953 33489999999998876666
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (401)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +....+....+.+.. -++++.+
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 6667789999999999987 689999999999999999999999994 444555555555432 1456788
Q ss_pred HHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 354 YLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 354 ~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+ |++.||..|+++.|+++|||++-
T Consensus 243 li~~-~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 243 FIRH-LMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHH-HSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHH-HccCCHhHCcCHHHHhcCHhhCC
Confidence 8888 89999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=407.25 Aligned_cols=246 Identities=22% Similarity=0.433 Sum_probs=212.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+++ +|||||++++++.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 36799999999999999999999999999999998532 246789999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCC---eEEEEecccce
Q 015741 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~vkl~DFg~a~ 277 (401)
..+|+||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 6789999999999998765 46999999999999999999999999999999999999986552 59999999999
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.... -
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCC-CCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8876666677889999999999986 68999999999999999999999998 4555555555554432 1
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ |+..||..|++++++++|||++....
T Consensus 244 s~~~~~li~~-~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 244 SALAKDFIRR-LLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp CHHHHHHHHT-TSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred CHHHHHHHHH-HccCChhHCcCHHHHhcCcccCCCCh
Confidence 4467778888 89999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=411.82 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=210.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
-++|++++.||+|+||.||+|+++.+|+.||||++++. ..+.+.+|+.+|+++ +||||+++++++.+ ...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--cccc
Confidence 36899999999999999999999999999999998632 346788999999999 89999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC-C
Q 015741 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~-~ 282 (401)
|+||||+.+|+|..++ ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence 9999999999997665 4689999999999999999999999999999999999999777 899999999987643 3
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHH
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (401)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+.... -++++.++|.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 34456789999999999987 789999999999999999999999984 444444444444321 2568888888
Q ss_pred hcCCCCChhhHHH-----hhhhcCCCcccccc
Q 015741 357 KYHIELDPHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 357 ~~~l~~dP~~R~~-----~~~~l~~~~~~~~~ 383 (401)
+ ||+.||..|++ ++++++|||++.+.
T Consensus 238 ~-~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 238 G-LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp H-HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred h-hccCCchhhcccccccHHHHHcCcccccCC
Confidence 8 79999999994 89999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-55 Score=408.07 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=205.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+.|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+++|+++ +|||||++++++.+ ...+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEE--CCEEE
Confidence 45999999999999999999999999999999986432 24688999999999 99999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+|++..+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence 999999999886543 4699999999999999999999999999999999999999766 899999999986543
Q ss_pred ccccccCCCccccccccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh--------CChhHHHH
Q 015741 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (401)
.....||+.|+|||++.+ .+.|+.++|||||||++|||++|..||. +....+.+..+.... -++.+.++
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 344689999999999864 2468999999999999999999999984 445555555555432 14578888
Q ss_pred HHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 355 LNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+.+ |++.||..||++.++++|||+..
T Consensus 247 i~~-~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 247 VDS-CLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHH-HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHH-HCcCChhHCcCHHHHHhCHHhcC
Confidence 888 89999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-54 Score=406.60 Aligned_cols=242 Identities=21% Similarity=0.417 Sum_probs=210.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+++++ +|||||++++++.+ ...+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCeee
Confidence 679999999999999999999999999999999863 2346789999999999 99999999999976 56889
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.++++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--V 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--C
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--c
Confidence 999999999987665 4588999999999999999999999999999999999999776 899999999988643 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+.++.+.. -++++.+++.+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 234 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR- 234 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH-
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCC-CCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 345789999999999876 67999999999999999999999999 4555555555655432 14678888888
Q ss_pred CCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 359 HIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 359 ~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
|+..||..|+ +++++++|||++-+..
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 7999999996 9999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-54 Score=396.56 Aligned_cols=245 Identities=22% Similarity=0.404 Sum_probs=212.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCeeEEeeEEEc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~hpniv~~~~~~~~ 200 (401)
.++|++.+.||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+++++..|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999999999999999986431 24588999999999559999999999976
Q ss_pred CCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
...+|+||||+++|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence 56889999999999998776 4699999999999999999999999999999999999999766 89999999999
Q ss_pred ecCCCCcccccccCCCccccccccC-----CCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------ 346 (401)
.+.........+||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||. +.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhCCCCCCCc
Confidence 8876666677889999999999853 2457889999999999999999999994 455555555555432
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
-++++.+++.+ |++.||..|++++++++|||++.+
T Consensus 238 ~~~~~s~~~~~li~~-~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSR-FLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHH-HCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHH-HccCChhHCcCHHHHHcCHHHHHh
Confidence 14578888888 899999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=404.83 Aligned_cols=243 Identities=21% Similarity=0.396 Sum_probs=212.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++++.||+|+||+||+|+++.+++.||||+++.... ..+.+|+++|+.+ +|||||++++++.+ ...+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 4789999999999999999999999999999999975443 4578999999999 99999999999986 46789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC-CCeEEEEecccceecCCCCcc
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~vkl~DFg~a~~~~~~~~~ 285 (401)
||+.+++|...+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999987763 48999999999999999999999999999999999999753 347999999999988766666
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------CChhHHHHH
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYL 355 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l 355 (401)
....+++.|+|||.+.+ ..|+.++|||||||++|+|++|..|| .+.+..+.+..+.+.. -++++.+++
T Consensus 161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 77889999999999876 68999999999999999999999998 4555566666665532 145677888
Q ss_pred HhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 356 NKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 356 ~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+ |+..||..|++++++++|||++.
T Consensus 239 ~~-~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 239 DR-LLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HH-HccCChhHCcCHHHHhcCHhhcc
Confidence 88 89999999999999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=402.63 Aligned_cols=241 Identities=28% Similarity=0.521 Sum_probs=207.2
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEE
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv 209 (401)
.++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++ +|||||++++++.+ ...+|+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence 4688999999999999999999999999986322 24588999999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-cc
Q 015741 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (401)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~~ 285 (401)
|||+.++++..+.. .+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccc
Confidence 99999998876653 489999999999999999999999999999999999999766 89999999998765432 33
Q ss_pred cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------------
Q 015741 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------ 347 (401)
Q Consensus 286 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------------ 347 (401)
...+||+.|+|||++.+...|+.++|||||||++|||++|..|| .+.++.+++..+.+..+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 45689999999999877677899999999999999999998777 67778888888877643
Q ss_pred ----------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 ----------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 ----------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ ||+.||+.|++++|+|+|||++-.+.
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~-~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHH-HHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hccCCCCChHHhcccCCHHHHHHHHH-HccCChhhCcCHHHHhCCHhhCCCCC
Confidence 3456777888 89999999999999999999986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-54 Score=408.68 Aligned_cols=242 Identities=21% Similarity=0.369 Sum_probs=210.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||.||+|+++.+|+.||||+++. ...+.+.+|+++|+.+ +|||||++++++.+ ...++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--ccccc
Confidence 689999999999999999999999999999999853 2345688999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+.+|++...+ ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.+.. .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--C
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc--c
Confidence 999999999987665 4699999999999999999999999999999999999999776 899999999998753 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHhc
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (401)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.... -++++.+++.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 271 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN- 271 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH-
T ss_pred cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCC-CCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH-
Confidence 345789999999999987 78999999999999999999999999 4555555555655542 25678888888
Q ss_pred CCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 359 HIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 359 ~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
||..||.+|+ +++++++|||++-+..
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 8999999994 8999999999976653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=397.87 Aligned_cols=245 Identities=30% Similarity=0.599 Sum_probs=210.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
|+|++++.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ ...+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence 6899999999999999999999999999999998532 246789999999999 99999999999977 567899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
||||+.++.+.... ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence 99999987654432 3589999999999999999999999999999999999999776 8999999999877543 3
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------------- 347 (401)
......||+.|+|||++.....++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 4456689999999999877666789999999999999999999998 46666777777665432
Q ss_pred -------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.+++.+ |++.||..|++++|+++|||++-++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~-mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQ-MLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHH-HccCChhHCcCHHHHhCCHhhccCCC
Confidence 2456778888 89999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=408.12 Aligned_cols=244 Identities=23% Similarity=0.409 Sum_probs=204.2
Q ss_pred CCCeEEEe-eecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC--CCCCcEEE
Q 015741 133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (401)
Q Consensus 133 ~~~y~i~~-~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~--~~~~~~lv 209 (401)
.++|+++. .||+|+||.||+|++..+++.||||+++. ...+.+|+.++.++.+|||||+++++|.+. ...++|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 36899875 59999999999999999999999999964 466889999987766899999999998752 34578999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC--CCeEEEEecccceecCCC
Q 015741 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (401)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~--~~~vkl~DFg~a~~~~~~ 282 (401)
||||+||+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999999987752 48999999999999999999999999999999999999752 347999999999988777
Q ss_pred CcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH--------------hCC
Q 015741 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------------LGT 348 (401)
Q Consensus 283 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~--------------~~~ 348 (401)
......+||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||.. .+..+....+... .-+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 245 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEE-TTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence 66777899999999999876 6899999999999999999999999943 3222222221111 125
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
+++.+++.+ ||+.||..|+++.++++|||++.
T Consensus 246 ~~~~~li~~-~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 246 EEVKMLIRN-LLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHHHHH-HSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHH-HccCChhHCcCHHHHHcCHHhhC
Confidence 577888888 89999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=398.09 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=208.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
++|++++.||+|+||+||+|+++.+|+.||||++++ ...+.+..|..++.+..+|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 679999999999999999999999999999999963 2335577788777653499999999999976 46789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCC-C
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~-~ 283 (401)
+||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence 999999999998776 4699999999999999999999999999999999999999766 8999999999866533 3
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh------CChhHHHHHHh
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (401)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+.... -++++.+++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 3455689999999999987 78999999999999999999999999 4555555555554331 25678888888
Q ss_pred cCCCCChhhHHHhh-hhcCCCccccccc
Q 015741 358 YHIELDPHLAALVG-RHSRKPWSKFITV 384 (401)
Q Consensus 358 ~~l~~dP~~R~~~~-~~l~~~~~~~~~~ 384 (401)
|++.||..|+++. ++++|||++-+..
T Consensus 237 -~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 237 -LFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp -HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred -hcccCCCCCcCHHHHHHhCchhccCCH
Confidence 8999999999995 8999999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=404.21 Aligned_cols=248 Identities=31% Similarity=0.527 Sum_probs=213.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----CCCCcEEEE
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLIF 210 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~~~~~~lv~ 210 (401)
+|+.+++||+|+||+||+|++..+|+.||||+++... ....+|+++|+++ +||||+++++++... +..++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999996533 3446899999999 999999999998643 345678999
Q ss_pred eecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
||++++.+..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.+.....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999987544332 35899999999999999999999999999999999999997766899999999998876666
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
....+|++.|+|||.+.+...|+.++|||||||++|||++|+.|| ...+..+++..+.+.++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 677889999999999887678999999999999999999999988 56667777777766543
Q ss_pred ------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccccc
Q 015741 348 ------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVEN 386 (401)
Q Consensus 348 ------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~~ 386 (401)
++++.+++.+ ||+.||+.|+++.|+|+|||++-+...+
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred cccccccCchhhhcccCCCHHHHHHHHH-HccCChhHCcCHHHHhcCHhhccccCCC
Confidence 3456677777 8999999999999999999998765444
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.9e-53 Score=404.78 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHH---HHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E---~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
-++|++++.||+|+||.||+|++..+|+.||||++.+. ....+.+| +.+++.+ +|||||++++++.+ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence 37899999999999999999999999999999998632 22334555 4445555 79999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+|+||||+.+|+|..++ ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecC
Confidence 6789999999999998775 3589999999999999999999999999999999999999776 89999999998775
Q ss_pred CCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHH-------hCChhHH
Q 015741 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKV-------LGTDELN 352 (401)
Q Consensus 281 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~-~~~~l~~i~~~-------~~~~~~~ 352 (401)
.. .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||..... +...+...... .-++++.
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 43 345568999999999997656799999999999999999999999954332 22222211100 1156788
Q ss_pred HHHHhcCCCCChhhHHH-----hhhhcCCCcccccc
Q 015741 353 AYLNKYHIELDPHLAAL-----VGRHSRKPWSKFIT 383 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~-----~~~~l~~~~~~~~~ 383 (401)
++|.+ ||+.||..|++ ++++++|||++-+.
T Consensus 238 ~li~~-~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 238 SLLEG-LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHH-HTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHH-HcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 88888 89999999999 69999999998664
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=395.15 Aligned_cols=248 Identities=29% Similarity=0.549 Sum_probs=210.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-CeEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCeeEEeeEEEcC---
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQ--- 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l~--~hpniv~~~~~~~~~--- 201 (401)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ....+.+|+.+|+.|. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999655 678999998532 2345778888888763 799999999998642
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccce
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~ 277 (401)
....++++|||+.++.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence 235789999999998765432 3589999999999999999999999999999999999999766 89999999998
Q ss_pred ecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC----------
Q 015741 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (401)
Q Consensus 278 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~---------- 347 (401)
............||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+++..+.+..+
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence 7665566677899999999999887 78999999999999999999999998 56677788887776543
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ ||+.||+.|+++.|+|+|||++-+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHH-HCcCChhHCcCHHHHhcChhhcCchh
Confidence 2355677887 89999999999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=394.39 Aligned_cols=239 Identities=24% Similarity=0.441 Sum_probs=201.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCeeEEeeEEEcCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~-~hpniv~~~~~~~~~~ 202 (401)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ..++.+|+.+|+++. .|||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 468999999999999999999999999999999986421 234679999999983 38999999999976
Q ss_pred CCCcEEEEeecCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
....++||||+.+ +++..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 4678999999976 4554443 46999999999999999999999999999999999999997656899999999987
Q ss_pred cCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH------hCChhHH
Q 015741 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELN 352 (401)
Q Consensus 279 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~------~~~~~~~ 352 (401)
.. ........||+.|+|||++.+...++.++|||||||++|||++|+.||.. .+. +.+. .-++++.
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~---i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEE---IIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HHHCCCCCSSCCCHHHH
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----chH---HhhcccCCCCCCCHHHH
Confidence 64 33445678999999999998755567889999999999999999999942 111 2221 1257888
Q ss_pred HHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
+++.+ |++.||+.||+++++++|||++-+
T Consensus 233 ~li~~-~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 233 HLIRW-CLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHH-HTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHH-HccCCHhHCcCHHHHhcCHhhCCC
Confidence 88888 899999999999999999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.3e-52 Score=384.87 Aligned_cols=240 Identities=30% Similarity=0.603 Sum_probs=204.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|+++++||+|+||+||+|++ .+|+.||||+++... .+++.+|+.+|+++ +|||||++++++.+ ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence 6899999999999999999998 478999999986432 46799999999999 99999999999976 467889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
+|||+.++.+..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||.+....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence 99999998876664 3589999999999999999999999999999999999999776 89999999998765432 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....+++.|+|||.+.+...++.++|||||||++|||++|+.|| .+.++.+++.++.+..+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 345578999999999987677899999999999999999999998 55667777777766543
Q ss_pred ------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccc
Q 015741 348 ------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 380 (401)
Q Consensus 348 ------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~ 380 (401)
++.+.+++.+ ||+.||+.|+++.|+++|||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSK-MLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccCcchhhhcccCCHHHHHHHHH-HccCChhHCcCHHHHhcCcccC
Confidence 2355677888 8999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-52 Score=386.38 Aligned_cols=237 Identities=18% Similarity=0.316 Sum_probs=201.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||+||+|++..+++.||||+++. ...+++.+|+++|+++ +|||||++++++.+ ...+++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEEe
Confidence 4789999999999999999999999999999999864 3457899999999999 99999999999965 46788999
Q ss_pred eecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
||+.+|++..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCce
Confidence 999999987765 3578999999999999999999999999999999999999776 899999999987654332
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (401)
.....|+..|+|||++.+ ..|+.++|||||||++|||++|+.||+.+.+..+....+.+.. -++.+.+++.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 233457889999999887 6899999999999999999999889876655544444443332 2457888888
Q ss_pred hcCCCCChhhHHHhhhhcC
Q 015741 357 KYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~ 375 (401)
+ |++.||+.||++.++++
T Consensus 251 ~-cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 251 A-CWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp H-HTCSSGGGSCCHHHHHH
T ss_pred H-HcCCCHhHCcCHHHHHH
Confidence 8 89999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=393.27 Aligned_cols=247 Identities=30% Similarity=0.543 Sum_probs=203.4
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---
Q 015741 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--- 202 (401)
Q Consensus 131 ~~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~--- 202 (401)
...++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++|+.+ +|||||+++++|.+..
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCcccc
Confidence 34689999999999999999999999999999999986422 35688999999999 9999999999997643
Q ss_pred -CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 203 -SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...+++||||+ +.++..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQA 171 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred ccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceecc
Confidence 23579999999 45555444 4799999999999999999999999999999999999999776 8999999999876
Q ss_pred CCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------------
Q 015741 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (401)
Q Consensus 280 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------ 347 (401)
. ...+...||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+
T Consensus 172 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred C--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 4 34456789999999999987667899999999999999999999998 45566666655554433
Q ss_pred -------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++.+.+++.+ ||+.||..|+++.++|+|||++-+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK-MLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHH-HCcCChhHCcCHHHHhcChhhCcCCC
Confidence 3456677877 89999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=381.89 Aligned_cols=239 Identities=16% Similarity=0.306 Sum_probs=203.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||+||+|++ .+++.||||+++. ...+.+.+|+++++++ +|||||++++++.+ ..+++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEEE
Confidence 47899999999999999999997 4678999999974 3457799999999999 99999999998854 3568999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc-
Q 015741 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (401)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~- 284 (401)
||+.+|+|...+. .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCccc
Confidence 9999999987653 489999999999999999999999999999999999999766 899999999998754432
Q ss_pred -ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHH
Q 015741 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (401)
Q Consensus 285 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (401)
.....|++.|+|||++.+ +.++.++|||||||++|||+||+.||+......+.+..+.+... ++++.+++.
T Consensus 166 ~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 234578889999999876 67999999999999999999988888777776666666655422 457788888
Q ss_pred hcCCCCChhhHHHhhhhcC--CCcc
Q 015741 357 KYHIELDPHLAALVGRHSR--KPWS 379 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~--~~~~ 379 (401)
+ |++.||+.||+++++++ ++|+
T Consensus 245 ~-cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 245 L-CWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp H-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HcCCCHhHCcCHHHHHHHhhhhh
Confidence 7 89999999999999976 4554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=377.17 Aligned_cols=237 Identities=16% Similarity=0.319 Sum_probs=192.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++++.||+|+||+||+|++. +++.||||+++. ...+++.+|+++++++ +|||||++++++.+ ....++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEEE
Confidence 468999999999999999999984 678899999864 3457899999999999 99999999999975 45788999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
||+.+|+|..++ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence 999999998764 2478889999999999999999999999999999999999776 899999999987654332
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHHh
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (401)
.....||..|+|||++.+ ..|+.++|||||||++|||+|++.||+......+.+..+..... ++++.+++.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 234578899999999887 68999999999999999999987777676666666666655422 4577788888
Q ss_pred cCCCCChhhHHHhhhhcCC
Q 015741 358 YHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 358 ~~l~~dP~~R~~~~~~l~~ 376 (401)
|++.||+.||++++++++
T Consensus 238 -cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 -CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -HTCSSGGGSCCHHHHHHH
T ss_pred -HccCCHhHCcCHHHHHHH
Confidence 899999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=384.46 Aligned_cols=245 Identities=30% Similarity=0.469 Sum_probs=205.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC-----
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~----- 202 (401)
.++|+++++||+|+||+||+|++..+|+.||||++... ...++.+|+++|+++ +||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 47899999999999999999999999999999998532 236688999999999 9999999999986532
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
...++++|||+.++.+.... ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~ 166 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 166 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeee
Confidence 34679999999988876554 3689999999999999999999999999999999999999777 899999999987
Q ss_pred cCCCC-----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC------
Q 015741 279 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (401)
Q Consensus 279 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------ 347 (401)
+.... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.++.+.+..+.+..+
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence 64322 2234579999999999987668999999999999999999999888 55666666666666543
Q ss_pred --------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
.+.+.++|.+ ||+.||+.|++++|+|+|||++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~-mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-LLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHH-HCcCChhHCcCHHHHHcChhhcc
Confidence 3344567777 89999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=378.69 Aligned_cols=243 Identities=30% Similarity=0.547 Sum_probs=212.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~l 208 (401)
++|+++++||+|+||+||+|++..+++.||||+++.. ...++.+|+.+|+.+ +||||+++++++.+ ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence 5899999999999999999999999999999998642 246789999999998 99999999999976 457789
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-c
Q 015741 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (401)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-~ 284 (401)
++|++.++++..+. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.++...... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence 99999999876654 4689999999999999999999999999999999999999776 89999999998875443 3
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....++++|+|||++.+...++.++|||||||++|||++|+.||+.+.+..+++..+....+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567788999999887566899999999999999999999999888888888877766544
Q ss_pred ------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccc
Q 015741 348 ------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 381 (401)
Q Consensus 348 ------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |++.||..|++++|+|+|||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~-mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQN-LLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHH-HccCChhHCcCHHHHhcChhhcC
Confidence 2356678887 89999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=391.41 Aligned_cols=244 Identities=26% Similarity=0.491 Sum_probs=200.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcC----CCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSK 204 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~----~~~ 204 (401)
++|+++++||+|+||+||+|++..+|+.||||+++.. ...++.+|+.+++++ +|||||++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6899999999999999999999999999999999642 235688999999999 999999999999754 236
Q ss_pred CcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 205 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
.+|+||||+.++.+......+++..++.+++||+.||+|||++||+||||||+|||++.++ .+|++|||+++.......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence 7899999999999988888999999999999999999999999999999999999999776 799999999987766666
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~----------------- 347 (401)
.....+|+.|+|||++.+ ..+++++||||+||++|+|++|+.|| .+.++..++..+....+
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 677789999999999987 68999999999999999999999888 55666666666554332
Q ss_pred -------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccc
Q 015741 348 -------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 382 (401)
Q Consensus 348 -------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~ 382 (401)
++++.+++.+ ||..||+.|++++++|+|||++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~-mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK-MLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH-HSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHH-HCcCChhHCcCHHHHhcCcccCCC
Confidence 1245667777 899999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=384.79 Aligned_cols=249 Identities=29% Similarity=0.545 Sum_probs=203.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC--CCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--KTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~--~~~ 206 (401)
.++|+++++||+|+||+||+|++..+|+.||||++++.. .+++.+|+.+|+++ +||||+++++++..... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence 467999999999999999999999999999999997533 34688999999999 99999999999875432 123
Q ss_pred EEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC-
Q 015741 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~- 283 (401)
++++||+.+++|..++ ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+++......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence 4556777889988776 4799999999999999999999999999999999999999766 89999999998764332
Q ss_pred ---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------------
Q 015741 284 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------- 347 (401)
Q Consensus 284 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~------------- 347 (401)
.....+||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..++...+.....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2345678999999999876577899999999999999999999998 44555555554443322
Q ss_pred ------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCcccccccc
Q 015741 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 385 (401)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~~ 385 (401)
++.+.+++.+ ||+.||..|++++++|+|||++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~-~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH-HccCChhHCcCHHHHhcCHhhccCCCC
Confidence 2356778888 899999999999999999999865443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-50 Score=375.63 Aligned_cols=243 Identities=22% Similarity=0.359 Sum_probs=195.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC--C
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--K 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~--~ 204 (401)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ...+.+|+++++.+ +|||||++++++.+... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 478999999999999999999999999999999996422 34688999999998 99999999999876433 3
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
.+|+||||+.+++|.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+.....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence 578999999999987665 4699999999999999999999999999999999999999776 799999999876543
Q ss_pred CC----cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh----------C
Q 015741 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (401)
Q Consensus 282 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~----------~ 347 (401)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||+||+.|| .+.+..+.+.++.+.. -
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-CCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 22 2345689999999999876 68999999999999999999999998 4555555555544431 1
Q ss_pred ChhHHHHHHhcCCCCChhhHH-HhhhhcCCCcccc
Q 015741 348 TDELNAYLNKYHIELDPHLAA-LVGRHSRKPWSKF 381 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~-~~~~~l~~~~~~~ 381 (401)
++.+.+++.+ |++.||..|+ +++++ .|+|.+.
T Consensus 242 s~~l~~li~~-~L~~dp~~R~~sa~~l-~~~l~r~ 274 (277)
T d1o6ya_ 242 SADLDAVVLK-ALAKNPENRYQTAAEM-RADLVRV 274 (277)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCSSHHHH-HHHHHHH
T ss_pred CHHHHHHHHH-HccCCHhHCHhHHHHH-HHHHHHH
Confidence 4567888888 8999999998 55555 4667654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=383.17 Aligned_cols=238 Identities=21% Similarity=0.351 Sum_probs=197.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe-----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||+||+|++..+++ .||+|++... ....+.+|+.++.++.+|||||++++++.+ .
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--S 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--C
Confidence 4789999999999999999999876543 7999998532 335688999999998789999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 257 (401)
..+++||||+++|+|..++. .+++.+++.++.||+.||+|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 67899999999999987752 3788899999999999999999999999999999
Q ss_pred CeeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 015741 258 NVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 333 (401)
Q Consensus 258 NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~ 333 (401)
|||++.++ .+||+|||+|+........ ....||+.|+|||++.+ +.|+.++|||||||++|||+| |..||. +.
T Consensus 194 Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~-~~ 270 (325)
T d1rjba_ 194 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP-GI 270 (325)
T ss_dssp GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TC
T ss_pred ccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCC-CC
Confidence 99999776 8999999999876544332 34567899999999886 689999999999999999998 788884 44
Q ss_pred CCHHHHHHHHHH-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 334 DNYDQLVKIAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 334 ~~~~~l~~i~~~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+..+.+.++.+. . .++++.+++.+ |++.||+.||+++++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~-cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-CWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 444444444432 1 14567888888 899999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=376.94 Aligned_cols=234 Identities=15% Similarity=0.318 Sum_probs=190.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
.++|++.+.||+|+||+||+|+. +..||||+++. ...+.+.+|+.+|+++ +|||||++++++.+ ..++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEEE
Confidence 57899999999999999999975 34699999863 2346789999999999 99999999998753 4578
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC
Q 015741 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~ 283 (401)
+||||+++|+|..++ ..+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC-----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccC
Confidence 999999999998765 3489999999999999999999999999999999999999776 89999999998764322
Q ss_pred ---cccccccCCCccccccccCC--CCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH-hC----------
Q 015741 284 ---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG---------- 347 (401)
Q Consensus 284 ---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~-~~---------- 347 (401)
......||+.|+|||++.+. ..|+.++|||||||++|||+||+.||. +.++.+.+..+... ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCcchhcccc
Confidence 23456789999999998642 358999999999999999999999994 44555555443332 21
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 -TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
++.+.+++.+ |+..||..||++.+++++
T Consensus 238 ~~~~l~~li~~-cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAE-CLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHH-HcCCCHhHCcCHHHHHHH
Confidence 3467788888 899999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=374.40 Aligned_cols=245 Identities=18% Similarity=0.287 Sum_probs=200.9
Q ss_pred CCCCeEEEee-ecccCCeeEEEEEEcC--CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 132 EQDDYEVVRK-VGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 132 ~~~~y~i~~~-Lg~G~fg~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
..++|.+.+. ||+|+||+||+|.+.. ++..||||+++.. ..+++.+|+++|+++ +|||||++++++.+ .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence 3577888884 9999999999998753 4568999999643 235689999999999 99999999999864 3
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
.+++||||+++|+|..++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhccc
Confidence 578999999999998764 2489999999999999999999999999999999999999776 89999999998875
Q ss_pred CCCcc----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 015741 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (401)
Q Consensus 281 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~ 348 (401)
..... ....||+.|+|||++.+ +.++.++|||||||++|||+| |+.|| .+....+.+..+.+... +
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~ 238 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP 238 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 44322 23467889999999876 689999999999999999998 89888 44555666555554322 3
Q ss_pred hhHHHHHHhcCCCCChhhHHHhhhh---cCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAALVGRH---SRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~~~~~~---l~~~~~~~~~~ 384 (401)
+++.+++.+ |+..||+.||++.++ |+++|....+.
T Consensus 239 ~~l~~li~~-cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 239 PELYALMSD-CWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHHHHHHH-TTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHH-HcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 567788887 899999999887666 67787765443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=368.44 Aligned_cols=236 Identities=17% Similarity=0.288 Sum_probs=200.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|+++++||+|+||+||+|++ .+++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEEE
Confidence 36788999999999999999998 5788999999874 3457899999999999 99999999999975 46789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--
Q 015741 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
||+.+|++..+. ..+++..+..++.||++||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCcee
Confidence 999999987663 3588999999999999999999999999999999999999766 899999999987654332
Q ss_pred ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHH
Q 015741 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (401)
Q Consensus 285 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (401)
.....+|..|+|||.+.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+... ++.+.+++.
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 234568889999999987 679999999999999999998 78787 45555555555555422 457888888
Q ss_pred hcCCCCChhhHHHhhhhcCC
Q 015741 357 KYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~~ 376 (401)
+ |++.||+.||+++++++|
T Consensus 236 ~-cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 S-CWHEKADERPTFKILLSN 254 (258)
T ss_dssp H-TTCSSGGGSCCHHHHHHH
T ss_pred H-HccCCHhHCcCHHHHHHH
Confidence 8 899999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=371.61 Aligned_cols=241 Identities=16% Similarity=0.288 Sum_probs=199.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
.++|++.+.||+|+||+||+|++. +++.||||+++.. ..+.+.+|+.+++++ +|||||++++++.+ ..+++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence 478999999999999999999985 4567999999643 357799999999999 99999999999854 3468999
Q ss_pred eecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCC--
Q 015741 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (401)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~-- 283 (401)
||+.+|++...+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCce
Confidence 999999987665 3589999999999999999999999999999999999999766 89999999998764433
Q ss_pred cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHHHH
Q 015741 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (401)
Q Consensus 284 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (401)
......||+.|+|||++.+ +.++.++|||||||++|||++|+.||+.+....+.+..+.+... ++.+.+++.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 2234578899999999986 68999999999999999999998888777777767666655432 457788888
Q ss_pred hcCCCCChhhHHHhhhhcC--CCcccc
Q 015741 357 KYHIELDPHLAALVGRHSR--KPWSKF 381 (401)
Q Consensus 357 ~~~l~~dP~~R~~~~~~l~--~~~~~~ 381 (401)
+ |++.||+.||++++++. ++|+..
T Consensus 249 ~-cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 Q-CWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp H-HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred H-HcccCHhHCcCHHHHHHHHhhhhcC
Confidence 8 89999999999999876 677754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=382.71 Aligned_cols=247 Identities=26% Similarity=0.527 Sum_probs=205.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC---C
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---S 203 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~---~ 203 (401)
..++|+++++||+|+||+||+|++..+|+.||||+++.. ..+++.+|+++|+++ +|||||++++++.... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence 357899999999999999999999999999999998643 235688999999999 9999999999986432 2
Q ss_pred CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 204 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
...+++|||+.+++|..++ +++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD- 172 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCT-
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccC-
Confidence 3446677888999998876 4699999999999999999999999999999999999999776 89999999997643
Q ss_pred CCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC--------------
Q 015741 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------- 347 (401)
Q Consensus 282 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------------- 347 (401)
.......|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+.......+.+..+
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 33455678899999999887667899999999999999999999998 56666666666655433
Q ss_pred -----------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCCCccccccc
Q 015741 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 384 (401)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~~~~~~~~~ 384 (401)
++++.++|.+ ||+.||..|+++.++|+|||++-+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHH-HCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 3456677887 89999999999999999999986543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-50 Score=376.88 Aligned_cols=237 Identities=17% Similarity=0.307 Sum_probs=185.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||+||+|+++.+++ .||||.+... ..+.+.+|+++|+++ +|||||++++++.+ ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CCE
Confidence 4679999999999999999999876654 5889987542 235689999999999 99999999999965 467
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+++||||+.+|+|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccC
Confidence 899999999999977542 489999999999999999999999999999999999999776 899999999987754
Q ss_pred CCcc------cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 282 GKEY------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 282 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
.... ....+|+.|+|||++.+ +.++.++|||||||++|||+| |+.|| .+....+.+..+.+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCccc
Confidence 3221 12356888999999887 689999999999999999998 78887 44555555555544322
Q ss_pred ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 ~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
++.+.+++.+ |+..||..||++.+++++
T Consensus 259 ~~~l~~li~~-cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLD-CWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHH-HTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHH-HcCCCHhHCcCHHHHHHH
Confidence 3567777777 899999999999888753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=370.18 Aligned_cols=239 Identities=18% Similarity=0.299 Sum_probs=192.8
Q ss_pred eEEE-eeecccCCeeEEEEEEcC--CCeEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcE
Q 015741 136 YEVV-RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (401)
Q Consensus 136 y~i~-~~Lg~G~fg~V~~~~~~~--~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~ 207 (401)
+.+. ++||+|+||+||+|.+.. +++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ ...+
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~ 83 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWM 83 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEE
Confidence 4443 579999999999998643 4578999998642 235789999999999 99999999999864 3468
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc
Q 015741 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (401)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~ 284 (401)
+||||+++|+|..++ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCS
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhcccccc
Confidence 999999999998765 3589999999999999999999999999999999999999776 899999999987754432
Q ss_pred c----cccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhHH
Q 015741 285 Y----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (401)
Q Consensus 285 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (401)
. ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+... ++++.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCPREMY 240 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 2 23468889999999876 678999999999999999998 88888 44444444444444321 45677
Q ss_pred HHHHhcCCCCChhhHHHhhhh---cCCCccccc
Q 015741 353 AYLNKYHIELDPHLAALVGRH---SRKPWSKFI 382 (401)
Q Consensus 353 ~~l~~~~l~~dP~~R~~~~~~---l~~~~~~~~ 382 (401)
+++.+ |+..||..||++.++ |+++|.+.+
T Consensus 241 ~li~~-cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 241 DLMNL-CWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHH-HTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHH-HcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 88877 899999999999887 566665543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=367.31 Aligned_cols=237 Identities=16% Similarity=0.266 Sum_probs=190.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC----eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.+.|++.+.||+|+||+||+|.+..++ ..||||+++.. ....+.+|+++++++ +|||||++++++.+ ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--CC
Confidence 467999999999999999999986554 47999998643 234688999999999 99999999999965 46
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
.++++|||+.++++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.+.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 161 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhccc
Confidence 788999999999886654 4589999999999999999999999999999999999999776 89999999998765
Q ss_pred CCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 281 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
.... .....||..|+|||++.+ +.++.++|||||||++|||++|+.||+.+....+.+..+.+... ++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 4322 223467889999999887 78999999999999999999988888776666655555544322 24
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
.+.+++.+ |+..||+.||++.++++
T Consensus 241 ~l~~li~~-cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQ-CWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHH-HCcCCHhHCcCHHHHHH
Confidence 57777777 89999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=370.09 Aligned_cols=240 Identities=18% Similarity=0.300 Sum_probs=190.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||.||+|++.. +++.||||+++.. ..+.+.+|..++.++.+|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 4789999999999999999999754 3478999998643 2356788888998887899999999988654 4
Q ss_pred CCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 264 (401)
..+++||||+++|+|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 56799999999999987752 37889999999999999999999999999999999999976
Q ss_pred CCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 015741 265 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (401)
Q Consensus 265 ~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~ 341 (401)
+ .+||+|||+|+....... .....||+.|+|||++.+ +.++.++|||||||++|||++|..|++.+....+.+..
T Consensus 171 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 171 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp G-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred C-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 6 899999999987643322 234578999999999987 78999999999999999999986654455544444444
Q ss_pred HHHH-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 342 IAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 342 i~~~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+. . -++++.+++.+ |++.||..||++.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 3332 1 24578888888 899999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=373.55 Aligned_cols=247 Identities=19% Similarity=0.334 Sum_probs=203.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
++|++++.||+|+||+||+|++. .+|+.||||+++.. ..+.+.+|+++++++.+||||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence 77999999999999999999874 46899999998532 245688999999999666899999999977 4
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..++++|||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhc
Confidence 5789999999999997665 4688999999999999999999999999999999999999776 89999999998764
Q ss_pred CCC--cccccccCCCccccccccCCC-CCCcccchHHHHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHH-------hCC
Q 015741 281 PGK--EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV-------LGT 348 (401)
Q Consensus 281 ~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~ll~elltg~~Pf~~~~--~~~~~l~~i~~~-------~~~ 348 (401)
... ......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.... .....+...... ..+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 234568999999999987533 57889999999999999999999995432 233333332211 125
Q ss_pred hhHHHHHHhcCCCCChhhHH-----HhhhhcCCCccccccc
Q 015741 349 DELNAYLNKYHIELDPHLAA-----LVGRHSRKPWSKFITV 384 (401)
Q Consensus 349 ~~~~~~l~~~~l~~dP~~R~-----~~~~~l~~~~~~~~~~ 384 (401)
+.+.+++.+ |++.||..|+ +++|+++|||++.+..
T Consensus 261 ~~~~~li~~-~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 261 ALAKDLIQR-LLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp HHHHHHHHH-HTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHH-HcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 578888888 8999999998 5899999999987663
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=369.22 Aligned_cols=236 Identities=18% Similarity=0.308 Sum_probs=191.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecc----cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~ 204 (401)
.++|++++.||+|+||+||+|++..+|+ +||+|.++. ...+.+.+|+++++++ +|||||++++++.+ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~---~ 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---S 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---C
Confidence 4679999999999999999999987775 688888753 2346799999999999 99999999999975 3
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecC
Q 015741 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (401)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~ 280 (401)
..+++|||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecc
Confidence 467889999999876543 3589999999999999999999999999999999999999776 89999999998765
Q ss_pred CCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 015741 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (401)
Q Consensus 281 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~ 349 (401)
.... .....||+.|+|||++.+ +.|+.++|||||||++|||+| |..|| .+.+..+....+.+... ++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~-~~~~~~~~~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICTI 240 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCGGGHHHHHHHTCCCCCCTTBCH
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 4332 233468899999999887 689999999999999999999 55555 55555444444444322 35
Q ss_pred hHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 350 ELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 350 ~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+.+++.+ |+..||..||++.+++.|
T Consensus 241 ~~~~li~~-cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 241 DVYMIMVK-CWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH-hCCCChhhCcCHHHHHHH
Confidence 67788887 899999999999999877
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=362.59 Aligned_cols=236 Identities=21% Similarity=0.373 Sum_probs=186.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~ 205 (401)
.++|++.+.||+|+||.||+|++..+ +..||||.++.. ..+.+.+|+.+++++ +|||||++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---Ce
Confidence 47899999999999999999998654 356889988643 235689999999999 99999999999853 46
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCC
Q 015741 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (401)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~ 281 (401)
+++||||+.+|++..+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 160 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccC
Confidence 79999999999987653 3589999999999999999999999999999999999999776 899999999987653
Q ss_pred CCc--ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------ChhH
Q 015741 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (401)
Q Consensus 282 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (401)
... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+..... ++.+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 322 344567889999999986 689999999999999999998 66666 55566666555554322 3578
Q ss_pred HHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 352 NAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 352 ~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.+++.+ |+..||..||++.+++++
T Consensus 239 ~~li~~-cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTK-CWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HcCCCHhHCcCHHHHHHH
Confidence 888888 899999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=369.70 Aligned_cols=239 Identities=18% Similarity=0.263 Sum_probs=199.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeE--EEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
-++|++.+.||+|+||+||+|+++.++.. ||||.++.. ..+.+.+|+++|.++.+|||||++++++.+ ...+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCee
Confidence 37899999999999999999999888874 667776532 345689999999998679999999999976 4678
Q ss_pred EEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCe
Q 015741 207 SLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (401)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 267 (401)
++||||+++|+|.+++ ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~ 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-C
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-c
Confidence 9999999999998775 3478999999999999999999999999999999999999776 8
Q ss_pred EEEEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC
Q 015741 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347 (401)
Q Consensus 268 vkl~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~ 347 (401)
+||+|||+++............||..|+|||.+.+ +.++.++|||||||++|||++|..|++.+.+..+.+..+.+...
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999986654444455678999999999987 68999999999999999999988776666666665555544321
Q ss_pred -------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 348 -------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 348 -------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
++++.+++.+ |+..||+.||++.+++++
T Consensus 245 ~~~~~~~~~~~~~li~~-cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 4578888888 899999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=361.02 Aligned_cols=253 Identities=20% Similarity=0.337 Sum_probs=208.0
Q ss_pred cCCCcCCCCCcccccccccccCCCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHH
Q 015741 110 SDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIK 180 (401)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~ 180 (401)
.+...+++...|++ ..++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+|+.
T Consensus 7 ~~~~~~~~~~~~~~--------~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~ 78 (311)
T d1t46a_ 7 IDPTQLPYDHKWEF--------PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78 (311)
T ss_dssp CCTTTSCCCGGGBC--------CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH
T ss_pred eCcccCCCcccccC--------CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHH
Confidence 34444444555543 3479999999999999999999863 45679999999753 2356889999
Q ss_pred HHHHhcCCCCeeEEeeEEEcCCCCCcEEEEeecCCCchhhhcC---------------------CCCHHHHHHHHHHHHH
Q 015741 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLK 239 (401)
Q Consensus 181 il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~ 239 (401)
+++++.+|||||++++++.+ ...++++|||+.+|+|..++. .+++.++..++.||+.
T Consensus 79 ~~~~l~~HpnIv~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 156 (311)
T d1t46a_ 79 VLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (311)
T ss_dssp HHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCEEEEEEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 99999779999999999965 456899999999999877652 4788999999999999
Q ss_pred HHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCcc---cccccCCCccccccccCCCCCCcccchHHHH
Q 015741 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316 (401)
Q Consensus 240 ~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 316 (401)
||+|||++||+||||||+|||++.++ .+||+|||+++........ ....||+.|+|||++.+ +.++.++||||||
T Consensus 157 gl~~LH~~~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G 234 (311)
T d1t46a_ 157 GMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234 (311)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHH
T ss_pred HHHHHHhCCeeecccccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchH
Confidence 99999999999999999999999766 8999999999877543322 34578999999999986 6899999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHH-h-------CChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 317 ~ll~elltg~~Pf~~~~~~~~~l~~i~~~-~-------~~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
|++|||+|++.||+.+....+.+.++.+. . -++.+.+++.+ |+..||..||++.++++
T Consensus 235 ~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~-cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT-CWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 99999999777777776666666655443 1 24677788888 89999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=364.64 Aligned_cols=237 Identities=19% Similarity=0.284 Sum_probs=198.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCC
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~ 202 (401)
..++|++++.||+|+||+||+|+++. +++.||||+++... .+++.+|+++|+++ +||||+++++++.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-- 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence 46789999999999999999999753 46899999986432 45689999999999 99999999999965
Q ss_pred CCCcEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 015741 203 SKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (401)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 255 (401)
....+++|||+.+|+|..++. .+++..+..++.|++.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 467889999999999887652 27888999999999999999999999999999
Q ss_pred CCCeeEeCCCCeEEEEecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 015741 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (401)
Q Consensus 256 p~NIll~~~~~~vkl~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~ 332 (401)
|+|||++.++ .+||+|||+|+....... .....+++.|+|||.+.+ ..|+.++|||||||++|||++|..|++.+
T Consensus 168 p~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999999776 899999999986643322 234578889999999987 68999999999999999999998766567
Q ss_pred CCCHHHHHHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 333 HDNYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 333 ~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
.++.+.+..+.+... ++++.+++.+ |++.||..||++.+++
T Consensus 246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~-cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRL-CWSKLPADRPSFCSIH 293 (301)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHH-HcCCChhHCcCHHHHH
Confidence 676666666554422 3567787777 8999999999999984
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=355.60 Aligned_cols=234 Identities=18% Similarity=0.289 Sum_probs=185.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc------chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~---~~~vavK~~~~~------~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||+||+|++..+ ...||||++++. ..+.+.+|+.+|+++ +|||||++++++.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT--- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee---
Confidence 46799999999999999999986533 247899998642 235789999999999 99999999999965
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
...++||||+.++++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL 161 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhc
Confidence 3568999999999987554 3599999999999999999999999999999999999999776 8999999999987
Q ss_pred CCCCc----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 015741 280 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (401)
Q Consensus 280 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~ellt-g~~Pf~~~~~~~~~l~~i~~~~~------- 347 (401)
..... .....++..|+|||++.+ ..++.++|||||||++|||+| |..|| .+.+..+.+..+.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhCCCCCCCccc
Confidence 54432 223457778999999987 789999999999999999998 78887 55566665555544311
Q ss_pred -ChhHHHHHHhcCCCCChhhHHHhhhhc
Q 015741 348 -TDELNAYLNKYHIELDPHLAALVGRHS 374 (401)
Q Consensus 348 -~~~~~~~l~~~~l~~dP~~R~~~~~~l 374 (401)
++.+.+++.+ |+..||+.||++.+++
T Consensus 240 ~~~~l~~li~~-cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 240 CPQDIYNVMVQ-CWAHKPEDRPTFVALR 266 (273)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHH
T ss_pred ccHHHHHHHHH-HcCCChhHCcCHHHHH
Confidence 3577777888 8999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=356.96 Aligned_cols=238 Identities=19% Similarity=0.295 Sum_probs=191.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-------eEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~ 201 (401)
.++|++.+.||+|+||.||+|++..++ ..||||+++... ...+.+|...+.++.+|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 478999999999999999999876554 479999986432 35678899999998789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEe
Q 015741 202 QSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 262 (401)
...+++||||+.+|+|..++ ..+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus 91 -~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 91 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 46789999999999998776 2479999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccceecCCCC---cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 015741 263 HEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339 (401)
Q Consensus 263 ~~~~~vkl~DFg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l 339 (401)
.++ .+||+|||+++...... ......+++.|+|||.+.+ +.|+.++|||||||++|||++++.|++.+.+..+..
T Consensus 170 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 170 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp TTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 776 89999999998765432 2334578889999999987 789999999999999999998544444554444444
Q ss_pred HHHHHHhC-------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 340 VKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 340 ~~i~~~~~-------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
..+..... ++.+.+++.+ |++.||..||++.++++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~-cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHH-HccCCHhHCcCHHHHHH
Confidence 44433321 4578888888 89999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=352.76 Aligned_cols=234 Identities=15% Similarity=0.283 Sum_probs=187.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++.+.||+|+||.||+|.+ .|++||||+++... .+.+.+|+++++++ +||||+++++++.+. ...+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEec-CCcEEEEEe
Confidence 46899999999999999999997 57899999997543 46799999999999 999999999998653 245799999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCccc
Q 015741 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (401)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~~~ 286 (401)
|+.+|+|..++. .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCCC--Cc
Confidence 999999987753 389999999999999999999999999999999999999776 8999999999865432 33
Q ss_pred ccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHh-------CChhHHHHHHhcC
Q 015741 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYH 359 (401)
Q Consensus 287 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~ 359 (401)
...++..|+|||++.+ +.++.++|||||||++|||+|+..|++...+..+....+.+.. .++.+.+++.+ |
T Consensus 159 ~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~-c 236 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN-C 236 (262)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH-H
T ss_pred cccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH-H
Confidence 4567889999999987 6899999999999999999985444445555555544543321 14678888888 8
Q ss_pred CCCChhhHHHhhhhcC
Q 015741 360 IELDPHLAALVGRHSR 375 (401)
Q Consensus 360 l~~dP~~R~~~~~~l~ 375 (401)
+..||.+||++.++++
T Consensus 237 l~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 237 WHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cccCHhHCcCHHHHHH
Confidence 9999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=353.51 Aligned_cols=237 Identities=18% Similarity=0.280 Sum_probs=198.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCC
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~ 203 (401)
.++|++.+.||+|+||+||+|.+.. +++.||||+++... ...+.+|+++++++ +|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--C
Confidence 4789999999999999999998753 35789999997432 24588999999999 89999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEE
Q 015741 204 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (401)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl 270 (401)
...++||||+.+|+|..++. .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl 174 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI 174 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEE
Confidence 57799999999999877642 367888999999999999999999999999999999999766 8999
Q ss_pred EecccceecCCCCc---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC
Q 015741 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347 (401)
Q Consensus 271 ~DFg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~ 347 (401)
+|||+++....... .....+++.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+..+.+...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999986643322 233468899999999887 68899999999999999999997666677777666666655322
Q ss_pred -------ChhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 348 -------TDELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 348 -------~~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
++.+.+++.+ |++.||..||++.++++
T Consensus 254 ~~~p~~~~~~l~~li~~-cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 3578888888 89999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=352.24 Aligned_cols=234 Identities=19% Similarity=0.322 Sum_probs=189.3
Q ss_pred EEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 138 VVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 138 i~~~Lg~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..++||+|+||+||+|++..++ ..||||.++.. ..+++.+|+++|+++ +|||||++++++.+. ....++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999986543 36899998642 236699999999999 899999999998653 35678999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecccceecCCCCc--
Q 015741 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (401)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~~~~~~-- 284 (401)
||+.+++|..+.. .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcccccccc
Confidence 9999999987653 366788899999999999999999999999999999999665 899999999987654322
Q ss_pred ---ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHhC-------ChhHHHH
Q 015741 285 ---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (401)
Q Consensus 285 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (401)
.....||..|+|||.+.+ ..++.++||||||+++|||++|+.||+...+..+....+.+... ++++.++
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 223467889999999876 68999999999999999999999999776655555554443321 3578888
Q ss_pred HHhcCCCCChhhHHHhhhhcCC
Q 015741 355 LNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 355 l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
+.+ |+..||+.||++.++++|
T Consensus 267 i~~-cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLK-CWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHH-HcCCCHhHCcCHHHHHHH
Confidence 888 899999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=349.25 Aligned_cols=244 Identities=20% Similarity=0.268 Sum_probs=189.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEee
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e~ 212 (401)
++|++++.||+|+||.||+|++..+|+.||||++... ...++.+|+++++.+.+|++|+.+..++.+ ....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEEE
Confidence 6799999999999999999999999999999998643 345689999999999444455555555544 4677899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeC--CCCeEEEEecccceecCCCCc---
Q 015741 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE--- 284 (401)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~vkl~DFg~a~~~~~~~~--- 284 (401)
++++.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++. .+..+||+|||+|+.+.....
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 9776554432 46999999999999999999999999999999999999853 233799999999988754322
Q ss_pred -----ccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHHH-----------h
Q 015741 285 -----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVKIAKV-----------L 346 (401)
Q Consensus 285 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~~~--~~l~~i~~~-----------~ 346 (401)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred eeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence 234579999999999887 679999999999999999999999995432211 111111111 0
Q ss_pred CChhHHHHHHhcCCCCChhhHHHhh---hhcCCCcccc
Q 015741 347 GTDELNAYLNKYHIELDPHLAALVG---RHSRKPWSKF 381 (401)
Q Consensus 347 ~~~~~~~~l~~~~l~~dP~~R~~~~---~~l~~~~~~~ 381 (401)
-++++.+++.+ |+..||..||+.. ++|+++|.+.
T Consensus 244 ~p~~~~~li~~-cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 244 YPSEFATYLNF-CRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp SCHHHHHHHHH-HHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHH-HccCChhHCcCHHHHHHHHHHHHHHc
Confidence 13567777777 7999999998754 6677776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=342.86 Aligned_cols=237 Identities=17% Similarity=0.215 Sum_probs=185.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHH--HHhcCCCCeeEEeeEEEcCCC--CCcEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKIL--QNLCGGPNIVKLLDIVRDQQS--KTPSLI 209 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il--~~l~~hpniv~~~~~~~~~~~--~~~~lv 209 (401)
++|.+.+.||+|+||.||+|++ +|+.||||+++......+.+|.+++ ..+ +|||||++++++.+.+. ..+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 5688999999999999999986 6899999999877666666666555 455 89999999999976433 357899
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHh--------CCceeecCCCCCeeEeCCCCeEEEEecccceec
Q 015741 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (401)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~--------~~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~~ 279 (401)
|||+.+|+|..++. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccc
Confidence 99999999988774 68899999999999999999996 5999999999999999776 8999999999877
Q ss_pred CCCCc-----ccccccCCCccccccccCCC-----CCCcccchHHHHHHHHHHHcCCCCCCCCC-------------CCH
Q 015741 280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------------DNY 336 (401)
Q Consensus 280 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~ll~elltg~~Pf~~~~-------------~~~ 336 (401)
..... .....||+.|+|||++.+.. .++.++|||||||+||||+||..||.... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 54332 23467999999999986522 25678999999999999999987763211 122
Q ss_pred HHHHHHHHHhC----------C----hhHHHHHHhcCCCCChhhHHHhhhhcC
Q 015741 337 DQLVKIAKVLG----------T----DELNAYLNKYHIELDPHLAALVGRHSR 375 (401)
Q Consensus 337 ~~l~~i~~~~~----------~----~~~~~~l~~~~l~~dP~~R~~~~~~l~ 375 (401)
+.+.......+ . ..+.+++.+ |+..||+.||++.++++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~-cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-CWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHT-TCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHH-HcccCHhHCcCHHHHHH
Confidence 22222211111 0 125566666 89999999999999865
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-44 Score=337.56 Aligned_cols=235 Identities=18% Similarity=0.288 Sum_probs=186.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEEe
Q 015741 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (401)
Q Consensus 133 ~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~e 211 (401)
.++|++++.||+|+||+||+|++..+|+.||||+++. .....+.+|+++++.|.+|+|++.+++++.+ ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 3689999999999999999999999999999999854 3346688999999999777999999999876 567789999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCC----CCeEEEEecccceecCCCC
Q 015741 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK 283 (401)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~----~~~vkl~DFg~a~~~~~~~ 283 (401)
|+. ++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ ...+||+|||+|+......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 995 5655443 358999999999999999999999999999999999999742 3479999999998764321
Q ss_pred --------cccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHHh-------
Q 015741 284 --------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVL------- 346 (401)
Q Consensus 284 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~~--~~~~l~~i~~~~------- 346 (401)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+...++....
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 2234579999999999987 7899999999999999999999999953322 222222222110
Q ss_pred ----CChhHHHHHHhcCCCCChhhHHHhhh
Q 015741 347 ----GTDELNAYLNKYHIELDPHLAALVGR 372 (401)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dP~~R~~~~~ 372 (401)
-++++.+++.. |+..+|..||..+.
T Consensus 240 l~~~~p~~l~~ii~~-~~~~~~~~rP~y~~ 268 (293)
T d1csna_ 240 LCAGFPEEFYKYMHY-ARNLAFDATPDYDY 268 (293)
T ss_dssp HTTTSCHHHHHHHHH-HHHCCTTCCCCHHH
T ss_pred hcCCCCHHHHHHHHH-HhcCCcccCcCHHH
Confidence 13456666655 67788888875443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-44 Score=342.63 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=195.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHhc----------CCCCeeEEeeEEEcC
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRDQ 201 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~----------~hpniv~~~~~~~~~ 201 (401)
++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++++.+. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46999999999999999999999999999999997543 366788999998872 358899999998766
Q ss_pred CCCCcEEEEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCCeeEeCCCC-----eEE
Q 015741 202 QSKTPSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR-----KLR 269 (401)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~-----~vk 269 (401)
.....+++|+++..+..... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 56667777777766542211 2358899999999999999999998 89999999999999975542 489
Q ss_pred EEecccceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHHHHHHHcCCCCCCCCC-----CCHHHHHHHHH
Q 015741 270 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKIAK 344 (401)
Q Consensus 270 l~DFg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ll~elltg~~Pf~~~~-----~~~~~l~~i~~ 344 (401)
++|||.+.... ......+||+.|+|||++.+ ..++.++||||+||++++|++|+.||.... ...+.+..+.+
T Consensus 173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred Eeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 99999998654 23345689999999999886 678999999999999999999999985322 12233333333
Q ss_pred HhC------------------------------------------------ChhHHHHHHhcCCCCChhhHHHhhhhcCC
Q 015741 345 VLG------------------------------------------------TDELNAYLNKYHIELDPHLAALVGRHSRK 376 (401)
Q Consensus 345 ~~~------------------------------------------------~~~~~~~l~~~~l~~dP~~R~~~~~~l~~ 376 (401)
.++ ++.+.+++.+ |++.||..||+++|+|+|
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~-mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP-MLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG-GGCSSTTTCBCHHHHHTC
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH-HCCCChhHCcCHHHHhcC
Confidence 322 1345666777 899999999999999999
Q ss_pred Ccccccc
Q 015741 377 PWSKFIT 383 (401)
Q Consensus 377 ~~~~~~~ 383 (401)
||++-..
T Consensus 329 p~f~~~~ 335 (362)
T d1q8ya_ 329 PWLKDTL 335 (362)
T ss_dssp GGGTTCT
T ss_pred cccCCCC
Confidence 9998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.8e-27 Score=201.84 Aligned_cols=166 Identities=17% Similarity=0.206 Sum_probs=121.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------------------hHHHHHHHHHHHHhcCCCCeeEE
Q 015741 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKL 194 (401)
Q Consensus 136 y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~il~~l~~hpniv~~ 194 (401)
+.+.++||+|+||+||+|++ .+|+.||||+++... .....+|...+.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 35789999999999999998 578999999875310 12345688889998 88999998
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCCeeEeCCCCeEEEEecc
Q 015741 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (401)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~vkl~DFg 274 (401)
+++. ..+++|||+++..+.. +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||
T Consensus 80 ~~~~------~~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 80 YAWE------GNAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EEEE------TTEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred EEec------CCEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 8764 1269999999877654 4455677899999999999999999999999999999954 58999999
Q ss_pred cceecCCCCcccccccCCCccccccccCCCCCCcccchHHHHHH
Q 015741 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318 (401)
Q Consensus 275 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~l 318 (401)
.|................. ...+.+. +.|+.++|+||+.--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~-~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR-NIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH-HHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH-HHHHHHc--CCCCCcccHHHHHHH
Confidence 9987643322110000000 0011121 468889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=3.1e-07 Score=81.05 Aligned_cols=138 Identities=18% Similarity=0.241 Sum_probs=92.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCcEEEE
Q 015741 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (401)
Q Consensus 134 ~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~~lv~ 210 (401)
..|++++..+-++.+.||+.. .+++.+++|+.... ....+.+|...++.+..+--+.+++.+..+ ....++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEE
Confidence 456676766556667899875 46777888887543 234578999999988555456788887765 35678999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015741 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (401)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 246 (401)
++++|..+........ ....++.++...|..||+
T Consensus 90 ~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred Eecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 9999988754432111 112223333333333331
Q ss_pred ---------C------CceeecCCCCCeeEeCCCCeEEEEeccccee
Q 015741 247 ---------Q------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (401)
Q Consensus 247 ---------~------~ivHrDlkp~NIll~~~~~~vkl~DFg~a~~ 278 (401)
. .++|+|+.|.|||++.++ .+.|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhccc
Confidence 1 278999999999998543 456999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=2.9e-06 Score=74.20 Aligned_cols=76 Identities=17% Similarity=0.139 Sum_probs=55.4
Q ss_pred eecccC-CeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCC-CeeEEeeEEEcCCCCCcEEEEeecCCCch
Q 015741 141 KVGRGK-YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (401)
Q Consensus 141 ~Lg~G~-fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hp-niv~~~~~~~~~~~~~~~lv~e~~~~~~l 218 (401)
.+..|. .+.||+... .++..+++|.........+..|...++.|..+. .+++++.+..+ ....++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccc
Confidence 344444 367898875 567778999987777777899999999885432 36777777655 3567899999998765
Q ss_pred h
Q 015741 219 K 219 (401)
Q Consensus 219 ~ 219 (401)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=8e-06 Score=76.44 Aligned_cols=75 Identities=15% Similarity=0.198 Sum_probs=50.7
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCeeEEeeEEEcCCCCCc
Q 015741 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 139 ~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~h--pniv~~~~~~~~~~~~~~ 206 (401)
.+.||.|....||++.+..+++.++||.-.+ ....+...|...|+.+..+ ..+++++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCC
Confidence 4678999999999998777788999997432 1234567799888877444 3466676653 2344
Q ss_pred EEEEeecCCCc
Q 015741 207 SLIFEHVNNTD 217 (401)
Q Consensus 207 ~lv~e~~~~~~ 217 (401)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 79999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.46 E-value=0.00028 Score=65.56 Aligned_cols=77 Identities=13% Similarity=0.142 Sum_probs=54.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecc-cchHHHHHHHHHHHHhcCCCCeeEEeeEEEcCCCCCc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~il~~l~~hpniv~~~~~~~~~~~~~~ 206 (401)
++++ +.|+.|-.-.+|++.... ..+.|++++.-. .......+|..+++.+..+.-.+++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------ 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------ 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence 3444 678888899999998643 246788888642 2334567899999998666556788888732
Q ss_pred EEEEeecCCCch
Q 015741 207 SLIFEHVNNTDF 218 (401)
Q Consensus 207 ~lv~e~~~~~~l 218 (401)
.+|+||++|..+
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 489999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=8.1e-05 Score=67.45 Aligned_cols=67 Identities=13% Similarity=0.262 Sum_probs=44.6
Q ss_pred eeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CeeEEee-----EEEcCCCCCcEEEEeecCCCc
Q 015741 148 SEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLD-----IVRDQQSKTPSLIFEHVNNTD 217 (401)
Q Consensus 148 g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~hp-niv~~~~-----~~~~~~~~~~~lv~e~~~~~~ 217 (401)
-.||++.. .+|+.|++|+..+. ..+++..|...+..|..+. -++..+. .+. .....+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCCcC
Confidence 58999976 67889999998764 4577899999999884331 1111111 111 1345678888888754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.99 E-value=0.00086 Score=59.91 Aligned_cols=50 Identities=14% Similarity=0.210 Sum_probs=33.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHhc
Q 015741 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLC 186 (401)
Q Consensus 135 ~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~ 186 (401)
+..-.+.|..|---+.|+... . +..+++|+.... ..+.+..|++++..|.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t-~-~g~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT-T-KDPLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE-S-SCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEE-C-CCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 445556778888889999875 3 345899998653 4567788888888884
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=85.19 E-value=3.3 Score=35.55 Aligned_cols=141 Identities=16% Similarity=0.224 Sum_probs=79.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHhcCCCCeeEEee---------------
Q 015741 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD--------------- 196 (401)
Q Consensus 132 ~~~~y~i~~~Lg~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~hpniv~~~~--------------- 196 (401)
..++++.++.=-.|+-|..|. . .++-.++||--.....+.+-.|+...-.+ .-|...-+.-
T Consensus 67 ~l~~~K~i~~s~~Gs~Gv~FV-~--~e~gaiVlK~s~tta~E~y~~eLAr~LGv-pvPqmRvI~~~~~E~~~~~~~~l~~ 142 (342)
T d1cjaa_ 67 NLQQFKGIERSEKGTEGLFFV-E--TESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAI 142 (342)
T ss_dssp CGGGEEEEEECCSTTSCEEEE-E--ESSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHH
T ss_pred hHHhhhceEEeecCCceEEEE-E--cCCceEEEecCCchHHHHHHHHHHHHhCC-CCCceEEecCCCHHHHHHHHHHhcC
Confidence 345677777666777776664 2 34667788876544445555555544444 4565544320
Q ss_pred -----EEEcCCCCCcEEEEeecCCCchhhhcCC-CCHHHHHHHHHHH--HHHHH-HHHhC---CceeecC-CCCCeeEeC
Q 015741 197 -----IVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYEL--LKALD-YCHSQ---GIMHRDV-KPHNVMIDH 263 (401)
Q Consensus 197 -----~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi--~~~L~-~LH~~---~ivHrDl-kp~NIll~~ 263 (401)
.....-..-..++|||.+|..+.+.... .++......+.++ +-+++ +++.. .+++|+- .++||+++.
T Consensus 143 ~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~ 222 (342)
T d1cjaa_ 143 DKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSE 222 (342)
T ss_dssp CSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEES
T ss_pred CChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEec
Confidence 0001112345789999999887665432 1111122233332 22333 34432 3566632 889999998
Q ss_pred CCCeEEEEecccc
Q 015741 264 EQRKLRLIDWGLA 276 (401)
Q Consensus 264 ~~~~vkl~DFg~a 276 (401)
++..+..+|=|..
T Consensus 223 n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 223 RGATVVPIDSKII 235 (342)
T ss_dssp BTTCEEECSCCCC
T ss_pred CCcEEEEecCCcc
Confidence 8878888885554
|